Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,anterograde trans-synaptic signaling (GO:0098916),0.6310614344452474,2.678016335747113,0.0,0.0,0.0,81/224,11.89%,GRIA2;GABRB3;DLG2;GRM5;KCND2;GABRA5;GRIN1;NRXN1;CACNA1A;GABRB1;RIT2;GRIA4;DLGAP1;SYT1;MTNR1B;MBP;CACNA1B;PRKAR2B;SYN2;PTCHD1;PLP1;GRM7;ASIC2;NLGN1;KCNQ3;CHRM3;GABRA2;GRM1;GLRA1;GRIN2A;GABRG3;DOC2A;GABRA3;MPZ;SNAP25;GRIA1;GRIK1;HTR2C;GABRA4;GRIN2B;HCRTR1;SNCA;APBA2;SLC18A3;CAMK4;GABRB2;SLC1A1;GLRA3;GRIK2;SLC12A6;KCNN1;SLC1A2;NRXN2;GABARAP;KCNMB4;CACNA1E;AMPH;SLC6A2;SLC6A5;CACNB2;GRIA3;HOMER1;SYT10;GABRD;RPS6KA1;PCDHB6;GABRG2;SST;GPR176;GLRA2;HCRTR2;RPS6KA2;GAD1;CPLX1;CACNB4;HAP1;KCNQ2;CALM1;NRGN;PNOC;NPTX1
prerank,chemical synaptic transmission (GO:0007268),0.6018133424985478,2.6305858371882,0.0,0.0,0.0,98/284,11.92%,GRIA2;GABRB3;DLG2;GRM5;KCND2;GABRA5;GRIN1;NRXN1;CACNA1A;GABRB1;RIT2;GRIA4;DLGAP1;PTPRN2;CDH8;SYT1;MTNR1B;MBP;CACNA1B;PRKAR2B;RIMS1;SYN2;PTCHD1;PLP1;GRM7;ASIC2;NLGN1;KCNQ3;SHISA6;CHRM3;GABRA2;ERC2;GRM1;GLRA1;GRID1;GRID2;GRIN2A;GABRG3;DOC2A;GABRA3;MPZ;SNAP25;GRIA1;GRIK1;HTR2C;GABRA4;LIN7A;GRIN2B;HCRTR1;SNCA;APBA2;SLC17A6;SLC18A3;CAMK4;GABRB2;SLC1A1;GRIN2D;GLRA3;GRIK2;GRIK5;DLGAP2;UNC13A;SLC12A6;KCNN1;HSPA8;PPFIA3;SLC1A2;NRXN2;GABARAP;KCNMB4;CACNA1E;AMPH;SNPH;SLC6A2;SLC6A5;CACNB2;GRIA3;HOMER1;SYT10;GABRD;RPS6KA1;PCDHB6;GABRG2;SST;GPR176;GLRA2;HCRTR2;RPS6KA2;GAD1;CPLX1;CACNB4;HAP1;KCNQ2;CALM1;NRGN;PNOC;NPTX1;DVL1
prerank,cytoplasmic translation (GO:0002181),0.6618104958812646,2.5000795245449168,0.0,0.0,0.0,56/91,19.67%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPL22L1;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;EIF3I;EIF2B3;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;RPS25;RPS29;RWDD1;RPS9;RPL31;RPL19;RPL3;RPS10;EIF4A1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6698770702008612,2.498096679850416,0.0,0.0,0.0,45/87,15.81%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;RPS25;RPS29
prerank,cotranslational protein targeting to membrane (GO:0006613),0.66117789569722,2.485429014968264,0.0,0.0,0.0,47/91,15.81%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;ARL6IP1;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;SRPRA;RPS25;RPS29
prerank,protein targeting to ER (GO:0045047),0.6164048587646247,2.336125826407152,0.0,0.0,0.0,48/99,15.81%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;SGTB;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;SRPRA;SEC61G;RPS25;RPS29
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.6617754501895075,2.3106218750565626,0.0,0.0,0.0,24/57,11.89%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;DLGAP1;LRRC7;NLGN1;SHISA6;MAPK8IP2;NETO1;GRIN2A;GRIA1;GRIN2B;DLGAP2;CACNG2;SHISA8;SHISA7;GRIA3;CACNG3;RELN;OPRM1;CACNG8;NPTX1
prerank,cellular response to copper ion (GO:0071280),0.8693088325510369,2.290995217885862,0.0,0.0,0.0,10/16,5.23%,MT2A;SNCA;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A
prerank,glutamate receptor signaling pathway (GO:0007215),0.7201438643151878,2.2792346411137347,0.0,0.0,0.0,17/37,10.21%,GRIA2;GRM5;GRIN1;GRIA4;GRM7;GRM1;GRID2;GRIN2A;GRM8;GRIK1;GRIN2B;GRIK2;PLCB1;GRIA3;HOMER1;GRIN3A;HOMER2
prerank,response to copper ion (GO:0046688),0.8241462274368672,2.253941884189729,0.0,7.896746005650883e-05,0.001,11/20,7.23%,MT2A;SNCA;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;ATP5F1D
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6976173708635619,2.203439701622724,0.0,0.00028715440020548667,0.004,15/34,8.57%,MPP2;GABRA5;GRIN1;MAPK8IP2;GABRA2;GLRA1;GRID2;GRIN2A;GABRG3;GABRA3;GABRA4;GRIN2B;GRIN2D;AKT1;GABRG2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5724520508380408,2.2006631247740485,0.0,0.00026322486685502943,0.004,50/110,14.45%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;HELZ2;RPL10A;RPS24;PPP2R1A;RPL27A;RPS17;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;PABPC1;RPL14;SMG8;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;MAGOHB;MAGOH;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28
prerank,extracellular structure organization (GO:0043062),-0.5084326959105818,-2.1638304710047542,0.0,0.0023838217422035095,0.002,72/204,12.79%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;TGFBR1;ITGA9;DAG1;ADAMTS12;THSD4;ADAMTSL3;COL8A1;COL5A1;COL4A6;COL1A1;COL22A1;DCN;NID1;ADAMTS6;COL4A3;ADAMTSL5;ITGAV;LOXL1;LAMA1;COL6A3;ECM2;LAMC3;BGN;COL4A4;ELN;VTN;COL23A1;SPARC;COL6A1;ITGA10;COL8A2;FBLN5;HSPG2;ITGB1;VIT;MFAP5;THBS1;ADAMTS5;COL6A2;NID2;CDH1;ITGA11;ITGB5;ST7;COL15A1;RECK;ADAMTSL4;ADAMTS9;COL13A1;TNC;ITGB8;COL18A1;LAMA3;LAMA4;COL5A3;COL27A1;MMP14;SH3PXD2A;ADAM19;ADAMTS15;MMP2;LUM;FN1
prerank,collagen fibril organization (GO:0030199),-0.5685178480706781,-2.1623601802657304,0.0,0.0011919108711017548,0.002,31/88,11.18%,COL1A2;COL3A1;COL4A5;COL5A2;ADAMTS2;TGFBR1;COL8A1;COL5A1;COL4A6;COL1A1;COL12A1;COL22A1;COL4A3;LOXL1;COL6A3;COL4A4;COL23A1;COL25A1;COL6A1;COL8A2;COL26A1;PLOD2;COL6A2;COL15A1;CYP1B1;COL13A1;COL18A1;LAMA3;COL5A3;COL27A1;P4HA2
prerank,regulation of NMDA receptor activity (GO:2000310),0.7016501804925328,2.1539498692316155,0.0,0.0008504188006085565,0.013,15/32,9.59%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;LRRC7;NLGN1;MAPK8IP2;GRIN2A;GRIA1;GRIN2B;GRIA3;CCL2;RELN;OPRM1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5568886343161229,2.151872629073531,0.0,0.0007896746005650881,0.013,32/107,7.67%,CAMK2A;NRG3;GRM5;CACNA1A;DLGAP1;LRP8;LRRC4C;SYT1;CACNA1B;RIMS1;GRM7;DGKI;TMEM108;NLGN1;MAPK8IP2;GRM1;RIMS2;GRID1;GRID2;GRM8;MCTP1;CDH2;GRIK1;RIMS3;GRIK2;GRIK5;DLGAP2;UNC13A;KCNMB4;KCTD13;HOMER1;CLSTN3
prerank,neurotransmitter secretion (GO:0007269),0.6465639093780318,2.1501800927857118,0.0,0.0007896746005650883,0.014,19/44,11.92%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;PCLO;RIMS2;SNAP25;LIN7A;SNCA;UNC13A;HSPA8;PPFIA3;NRXN2;SNPH;SYT10;GAD1;CPLX1;DVL1
prerank,peptide biosynthetic process (GO:0043043),0.5256409028369089,2.1339868284836547,0.0,0.0009377385881710423,0.017,70/153,19.34%,RPS6;RPS19;RPS20;RPL38;RPL29;PCSK1;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;CARNS1;MRPL13;RPL13;MRPS18A;RPL12;MRPS7;RPS15;EIF4EBP2;RPL14;MRPS14;GGT7;RPL5;FARSB;RPS4X;RPL21;GGT1;RPS7;RPL23A;EEF1A2;RPL8;MRPL36;MRPL23;RPS14;RPS3;RPS2;RPS5;EEF1A1;RPL18A;RPS28;RPS25;RPS29;HBS1L;TNIP1;MRPS5;RPS9;RPL31;MRPL18;RPL19;RPL3;RPS10
prerank,external encapsulating structure organization (GO:0045229),-0.4968150719898386,-2.1239985887825688,0.0,0.00238382174220351,0.005,71/205,12.79%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;ITGA9;DAG1;ADAMTS12;THSD4;ADAMTSL3;COL8A1;COL5A1;COL4A6;COL1A1;COL22A1;DCN;NID1;ADAMTS6;COL4A3;ADAMTSL5;ITGAV;LOXL1;LAMA1;COL6A3;ECM2;LAMC3;BGN;COL4A4;ELN;VTN;COL23A1;SPARC;COL6A1;ITGA10;COL8A2;FBLN5;HSPG2;ITGB1;VIT;MFAP5;THBS1;ADAMTS5;COL6A2;NID2;CDH1;ITGA11;ITGB5;ST7;COL15A1;RECK;ADAMTSL4;ADAMTS9;COL13A1;TNC;ITGB8;COL18A1;LAMA3;LAMA4;COL5A3;COL27A1;MMP14;SH3PXD2A;ADAM19;ADAMTS15;MMP2;LUM;FN1
prerank,synapse assembly (GO:0007416),0.5924551828883612,2.1212706932133583,0.0,0.0011612861773016004,0.022,23/67,9.15%,SPOCK2;DNM3;DSCAM;KIRREL3;GABRB3;ADGRL3;NRXN1;LRRTM3;NLGN1;GPM6A;GABRA2;GRID2;DNER;SHANK3;CDH2;FGF13;GABRB2;NRXN2;NRCAM;LGI2;PCDHB6;GABRG2;SHANK2
prerank,signal release from synapse (GO:0099643),0.6349909217871654,2.1059929874669248,0.0,0.0014038659565601568,0.028,18/43,11.92%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;PCLO;SNAP25;LIN7A;SNCA;UNC13A;HSPA8;PPFIA3;NRXN2;SNPH;SYT10;GAD1;CPLX1;DVL1
prerank,response to zinc ion (GO:0010043),0.7257147284059783,2.101970116589358,0.0,0.0015793492011301764,0.033,14/25,11.74%,MT2A;GLRA1;KHK;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;SLC30A3;GLRA2;SLC30A5
prerank,regulation of actomyosin structure organization (GO:0110020),-0.8551093806395178,-2.098773933685294,0.0,0.002681799459978948,0.008,8/13,7.78%,AKAP13;ROCK2;ASAP3;ROCK1;ALMS1;SLC9A1;FHOD1;CDC42
prerank,cellular response to zinc ion (GO:0071294),0.8184976498210969,2.0910225129959703,0.0,0.0018162515812997029,0.041,11/15,9.42%,MT2A;GLRA1;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;GLRA2
prerank,positive regulation of synaptic transmission (GO:0050806),0.5778105894263662,2.0882373898532154,0.0,0.0018801776203930672,0.044,26/72,10.81%,MPP2;SLC24A2;NRXN1;SYT1;RIMS1;ADCY8;NLGN1;RIMS2;GRIN2A;SHANK3;RIMS3;GRIN2B;GRIN2D;GRIK2;CACNG2;NPTN;KCTD13;SHISA7;CLSTN3;CACNG3;ADRA1A;CCL2;RELN;SHANK2;CACNG8;HAP1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5124142696258505,2.084340813934177,0.0,0.0019382922013870347,0.048,54/159,12.48%,CLDN5;DSCAM;BSG;KIRREL3;ADGRL3;HMCN1;CDH12;CDH8;PTPRD;LRRC4C;CADM1;IGSF11;MAG;LRFN5;IL1RAPL1;NLGN1;TENM2;PLXNB3;CDH7;CDH19;CDH20;GRID2;TENM1;PCDHGB4;PTPRT;CDH18;MPZ;CDH2;ROBO4;CNTN6;TENM4;CDH10;TGFB2;DSCAML1;CLDN14;UNC5D;NPTN;TENM3;VSTM2L;PECAM1;PCDHB6;LRRC4B;ROBO2;NTNG1;DCHS1;ROBO3;CADM3;PTPRM;CELSR2;CNTN4;CRB1;NECTIN1;CNTN2;ITGAM
prerank,chloride transmembrane transport (GO:1902476),0.6227510133227429,2.07199630132328,0.0,0.002266022766838949,0.057,20/48,10.99%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;ANO5;GABRD;GABRG2;ANO4;SLC12A3;GLRA2;CLCN1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.664777772371719,2.0600651552262126,0.0,0.002763861101977809,0.073,11/35,9.35%,CDH12;CDH8;NLGN1;CDH7;CDH19;CDH20;PCDHGB4;CDH18;CDH10;PCDHB6;DCHS1
prerank,regulation of cation channel activity (GO:2001257),0.5405212761071365,2.027355985988571,0.0,0.004580112683277512,0.122,32/89,11.22%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;LRRC7;FGF12;NLGN1;SHISA6;MAPK8IP2;FGF14;NETO1;GRIN2A;ANK3;GRIA1;FGF13;GRIN2B;CACNG2;SHISA8;SHISA7;CACNB2;GRIA3;HOMER1;EPO;KCNAB1;CACNG3;RELN;OPRM1;CACNG8;CACNB4;CALM1;JPH3
prerank,bone development (GO:0060348),-0.6233045448324781,-2.0268747923958514,0.0,0.01239587305945825,0.046,13/39,12.29%,AKAP13;RANBP3L;SULF1;LRP6;SH3PXD2B;CYP26B1;SULF2;SKI;FGFR2;SLC10A7;GJA1;MBTPS2;GNAS
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6010206180654747,2.011940399560912,0.0,0.005406233803868681,0.151,19/46,10.73%,GRM5;NRXN1;SYT1;GRM7;DGKI;NLGN1;MAPK8IP2;GRM1;GRM8;SHANK3;CDH2;GRIK1;CACNG2;UNC13A;HOMER1;CACNG3;CCL2;RELN;CACNG8
prerank,regulation of glucose import (GO:0046324),-0.6670891384206162,-2.007415278786011,0.0,0.0158921449480234,0.068,11/30,4.55%,PRKAG2;IGF1;PID1;RHOQ;SORBS1;APPL2;GRB10;ENPP1;OSBPL8;IRS1;CREBL2
prerank,extracellular matrix organization (GO:0030198),-0.45505594161608315,-2.0067476934856274,0.0,0.013792111508463163,0.069,82/276,12.79%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;TGFBR1;ITGA9;DAG1;ADAMTS12;THSD4;ADAMTSL3;COL8A1;COL5A1;COL4A6;COL1A1;GSN;COL12A1;COL22A1;DCN;NID1;ADAMTS6;COL4A3;FLRT2;ADAMTSL5;ITGAV;LOXL1;SH3PXD2B;LAMA1;COL6A3;ECM2;LAMC3;BGN;COL4A4;ELN;VTN;COL23A1;SPARC;COL25A1;COL6A1;ITGA10;COL8A2;FBLN5;COL26A1;PLOD2;HSPG2;ITGB1;VIT;MFAP5;THBS1;ADAMTS5;COL6A2;NID2;CDH1;ITGA11;ITGB5;ST7;COL15A1;RECK;ADAMTSL4;CYP1B1;ADAMTS9;COL13A1;TNC;ITGB8;COL18A1;LAMA3;LAMA4;COL5A3;COL27A1;MMP14;SH3PXD2A;P4HA2;ADAM19;ADAMTS15;MMP2;LUM;SCUBE1;FN1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.7460094750631698,2.0062911526564324,0.0,0.00584944148566732,0.169,9/18,4.96%,GRIA2;CDH8;GRID1;GRID2;GRIK1;SLC17A6;GRIK2;GRIK5;UNC13A
prerank,cellular zinc ion homeostasis (GO:0006882),0.6850272361584326,1.9977152914269167,0.0,0.006402004797438393,0.191,13/26,11.74%,SLC39A10;MT2A;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;SLC30A1;SLC39A8;SLC30A5
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.6619021678516539,-1.9969539912656706,0.0,0.01609079675987369,0.092,13/27,10.72%,EGFR;DDX5;BMP4;TNRC6B;PUM2;WTIP;DDX6;EIF4ENIF1;STAT3;DHX9;PUM1;MAP2K1;LIMD1
prerank,dendrite self-avoidance (GO:0070593),0.740478720604,1.9874831085738203,0.0,0.007515523784688426,0.223,10/16,12.10%,DSCAM;BSG;ROBO4;CNTN6;DSCAML1;NPTN;VSTM2L;ROBO3;CNTN4;CNTN2
prerank,eye morphogenesis (GO:0048592),-0.7220463975762647,-1.9873454350269577,0.0,0.017481359442825736,0.112,12/19,15.76%,FBN1;COL5A2;EFEMP1;COL5A1;SHROOM2;RARG;MFAP5;SKI;STAT3;NIPBL;VEGFA;FBN2
prerank,actin filament bundle assembly (GO:0051017),-0.6362759535468466,-1.9782421144897353,0.0,0.01918976502473825,0.135,7/33,3.48%,CALD1;DPYSL3;PAWR;MYO1B;LIMA1;BAIAP2L1;SHROOM2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.6853856614145755,-1.9587138492046996,0.0,0.026655461299184696,0.198,9/24,11.64%,SULF1;CCBE1;IL6ST;ARNT;SULF2;EIF2AK3;CYP1B1;HIF1A;RORA
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6927912951265949,-1.958316803217564,0.0,0.02493080238721171,0.201,8/21,10.62%,BMP6;TGFBR1;BMPR1A;RBPMS;DAB2;BMP4;CCN3;SMAD4
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.844133265393886,1.9576156172010564,0.0,0.012503181175613897,0.363,7/10,8.57%,GABRA5;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRG2
prerank,synaptic vesicle exocytosis (GO:0016079),0.5907194538507315,1.951982281953505,0.0,0.013016894222218066,0.387,14/40,11.21%,SYT1;RIMS1;PCLO;SYT7;RIMS2;SNAP25;RIMS3;SNCA;UNC13A;STX3;SNPH;SYT10;CPLX1;SYT2
prerank,inorganic anion transmembrane transport (GO:0098661),0.5493669858432713,1.9455807282383086,0.0,0.014485593454115837,0.423,22/63,9.42%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;SLC37A4;ANO5;GABRD;SLC37A1;SLC25A14;GABRG2;ANO4;SLC12A3;GLRA2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7828374530042527,-1.9437914962452312,0.0,0.029431029971051022,0.247,6/13,2.70%,BMP6;TGFBR1;BMPR1A;RBPMS;DAB2;BMP4
prerank,positive regulation of synapse assembly (GO:0051965),0.6629223214086506,1.9432740863043632,0.0,0.014597015343778903,0.437,10/27,8.03%,NRXN1;PTPRD;IL1RAPL1;EPHB1;NLGN1;GRID2;SEMA4A;SEMA4D;CLSTN3;LRRC4B
prerank,embryonic limb morphogenesis (GO:0030326),-0.6177440540482833,-1.942072943453408,0.0,0.028265314943270187,0.254,17/34,17.05%,CACNA1C;GLI3;LRP6;AFF3;OSR1;CYP26B1;WDPCP;RARG;SKI;CREBBP;ECE1;MAP3K20;NIPBL;HDAC1;PTCH1;SALL1;TBX2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.6653513244571028,-1.9412862583765975,0.00196078431372549,0.026619342787939194,0.254,9/26,11.64%,SULF1;CCBE1;IL6ST;ARNT;SULF2;EIF2AK3;CYP1B1;HIF1A;RORA
prerank,cell junction assembly (GO:0034329),0.5105978501627418,1.940218277233592,0.0,0.015143171752012867,0.456,28/100,9.35%,SPOCK2;CLDN5;DNM3;DSCAM;KIRREL3;ADGRL3;NRXN1;CDH12;CDH8;ACTB;CTNND2;NLGN1;GPM6A;CDH7;CDH19;CDH20;ITGA6;DNER;CDH18;SHANK3;CDH2;CDH10;NRXN2;NRCAM;PCDHB6;VMP1;SHANK2;DCHS1
prerank,eye development (GO:0001654),-0.5684474723599164,-1.9392830037961275,0.0,0.026073050305350887,0.262,15/54,6.59%,PBX1;CACNA1C;FBN1;SMOC1;COL5A2;EFEMP1;COL5A1;FOXC1;SH3PXD2B;LAMA1;SHROOM2;RBP4;PBX3;SKI;RAB3GAP1
prerank,actin filament bundle organization (GO:0061572),-0.6219795222880935,-1.9353381727093462,0.0,0.02636226397260352,0.28,7/33,3.48%,CALD1;DPYSL3;PAWR;MYO1B;LIMA1;BAIAP2L1;SHROOM2
prerank,neuromuscular process controlling balance (GO:0050885),0.7818670508270575,1.9202252556206236,0.002070393374741201,0.020170545511576824,0.556,2/12,0.54%,PCDH15;NRXN1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.6348818968403086,1.919999618739862,0.0021645021645021645,0.019654123391842193,0.558,9/27,7.62%,SYT1;RIMS1;SYT6;SYT7;RIMS2;SYT12;SYT11;RIMS3;SYT10
prerank,neuron cell-cell adhesion (GO:0007158),0.7527310673658872,1.9199689588670295,0.0,0.01912293086773835,0.558,9/14,12.13%,NCAM2;NRXN3;NRXN1;NLGN1;ASTN1;NRXN2;ASTN2;CNTN4;RET
prerank,regulation of regulated secretory pathway (GO:1903305),0.6081389321267874,1.9164968595970306,0.0,0.01951327499817415,0.574,10/34,3.46%,SYT1;RIMS1;SYT6;SYT7;RIMS2;DOC2A;SYT12;SYT11;PREPL;RIMS3
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6205594298621858,1.903935052471285,0.0,0.023184036349923744,0.647,11/33,4.69%,NRG3;CACNA1A;LRP8;LRRC4C;CACNA1B;NLGN1;GRID1;GRID2;GRIK1;GRIK2;GRIK5
prerank,regulation of muscle contraction (GO:0006937),-0.6471111032027785,-1.8990124468465184,0.0,0.04655074124358521,0.453,5/26,2.75%,ATP1A2;PLCE1;TPM1;PPP1R12B;ANXA6
prerank,chloride transport (GO:0006821),0.5284211247542931,1.8988009732205655,0.0,0.024558880077574244,0.679,21/74,9.42%,GABRB3;GABRA5;SLC4A1;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;CLIC5;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;ANO5;GABRD;GABRG2;ANO4;SLC12A3;GLRA2
prerank,endodermal cell differentiation (GO:0035987),-0.6210979908794123,-1.8978985620088247,0.0,0.04504168449742421,0.461,17/31,19.87%,COL8A1;COL12A1;ITGAV;VTN;COL6A1;ITGB5;CTR9;SETD2;LAMA3;MMP14;RTF1;MMP2;FN1;ITGA5;ITGA4;INHBA;CDC73
prerank,zinc ion homeostasis (GO:0055069),0.6347547933053994,1.8930539544060625,0.0,0.02590517896975716,0.702,13/28,11.74%,SLC39A10;MT2A;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;SLC30A1;SLC39A8;SLC30A5
prerank,muscle organ development (GO:0007517),-0.5453512055316416,-1.890062874488717,0.0,0.04797441256184563,0.502,19/54,15.24%,LAMA2;IGF1;LARGE1;FHL1;COL6A3;MEF2A;SPEG;ITGA11;MRAS;VAMP5;SMTN;CHD2;EVC;MEF2C;SRI;FKTN;SOX6;MKX;EMD
prerank,mRNA destabilization (GO:0061157),-0.5906766983261496,-1.8851722871135657,0.0,0.049606195302044465,0.525,12/38,9.95%,ROCK2;CELF1;FTO;DIS3L2;ROCK1;YTHDF3;MOV10;RC3H1;PUM1;TUT4;DHX36;UPF1
prerank,odontogenesis (GO:0042476),-0.6087371628042716,-1.8814091045511931,0.0,0.050710389788692835,0.548,11/35,6.61%,COL1A2;LRP6;ANKRD11;GLI2;FOXC1;BMP4;BCOR;EDA;OSR1;WNT6;FGFR2
prerank,translation (GO:0006412),0.4471385455071494,1.8788521720343496,0.0,0.030910120079262027,0.768,86/208,20.34%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;VARS1;GARS1;RPL10A;RPS24;EEF1B2;RPL27A;RARS1;RPS17;RPL22L1;RPS6KB2;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;TUFM;MRPL13;RPL13;MRPS18A;EEF1D;RPL12;MRPS7;RPS15;EIF4EBP2;RPL14;MRPS14;RPL5;FARSB;RPS4X;RPL21;RPS7;RPL23A;EEF1A2;RPL8;AIMP2;MRPL36;MRPL23;RPS14;GATB;RPS3;RPS2;IARS1;RPS5;EEF1A1;RPL18A;GATC;RPS28;RPS25;RPS29;RWDD1;HBS1L;TNIP1;MRPS5;NDUFA7;EEF2;RPS9;RPL31;MRPS28;MRPL18;RPL19;RPL3;RPS10;EEF1E1;MRPL37;MRPL2;ASMT
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.6371692347186195,1.8779217522677414,0.0,0.030448383435742236,0.771,9/25,7.97%,MPP2;GRIN1;MAPK8IP2;GLRA1;GRID2;GRIN2A;GRIN2B;GRIN2D;AKT1
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5443256299012337,-1.8771705378227852,0.0019047619047619048,0.05197767842239392,0.575,32/50,28.55%,ZIC1;GLI3;FBXL17;SMO;BTRC;DCDC2;TTC23;GPC3;IFT81;CREBBP;FGFR2;GAS1;TULP3;EVC;GLIS2;HERC4;RORA;SUFU;ARMC9;GLI1;PTCH1;WDR11;VCP;MEGF8;PDCL;DLG5;KIF7;MGRN1;GAS8;PTCH2;IFT122;KCTD6
prerank,regulation of stress fiber assembly (GO:0051492),-0.512556478260173,-1.8755027824703234,0.0,0.05150048222218833,0.588,24/74,7.95%,PHLDB2;ROCK2;LPAR1;ARHGAP6;TGFBR1;CGNL1;ASAP3;TPM1;ARHGAP28;CCN2;ROCK1;ABL1;ARHGEF10L;PPM1E;ARAP1;ALMS1;SLC9A1;WASF2;PAK2;NRP1;FHOD1;CDC42;RAPGEF3;S100A10
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6765496795881758,-1.8700093956027375,0.0018018018018018018,0.0537313420692671,0.611,8/20,6.42%,IGF1;LRP1;BMPR1A;IGFBP5;PDGFRB;VTN;IGFBP3;NRP1
prerank,skeletal system development (GO:0001501),-0.4614834912043563,-1.8657065166566478,0.0,0.05487374279649233,0.637,40/148,13.93%,BMP6;AKAP13;COL1A2;SULF1;FBN1;IGF1;TGFBR1;SOX5;CREB3L2;COL1A1;PKD1;ANKRD11;GLI2;BMP5;WWOX;BMP7;SH3PXD2B;NPR3;PCSK5;CDH11;RBP4;EXT1;SULF2;ZBTB16;FGFR2;EIF2AK3;SLC10A7;IGF2;GJA1;TNFRSF11B;COL13A1;ITGB8;PRELP;MMP14;EVC;GNAS;SUFU;SOX6;CHD7;TRPS1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5281494907457096,1.8594062560678122,0.0,0.039160681328023236,0.848,25/59,12.10%,DSCAM;BSG;KIRREL3;HMCN1;CADM1;IGSF11;PLXNB3;PTPRT;CDH2;ROBO4;CNTN6;DSCAML1;NPTN;TENM3;VSTM2L;PECAM1;PCDHB6;ROBO2;ROBO3;CADM3;PTPRM;CELSR2;CNTN4;NECTIN1;CNTN2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.7331012241698494,-1.855619438517491,0.0,0.06087574412034518,0.691,8/15,11.62%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;PARP1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.5206557003161444,-1.855196927131491,0.0,0.05908472461032984,0.691,26/65,16.39%,FBN1;SMAD3;TGFBR1;LDLRAD4;LTBP1;SMAD6;SMURF2;TGFBR2;HTRA3;TGFB1I1;SMAD2;BCL9L;SNX6;SKI;SKIL;PDPK1;PMEPA1;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;FBN2;VASN
prerank,dermatan sulfate metabolic process (GO:0030205),-0.743453628656687,-1.8531415256081882,0.0,0.05910233905670081,0.703,4/13,2.90%,UST;DSE;DCN;BGN
prerank,regulation of establishment of cell polarity (GO:2000114),-0.7090031083512138,-1.8495464782332487,0.0037735849056603774,0.05995311681641827,0.715,7/16,6.50%,ROCK2;GSN;ROCK1;RIPOR2;BCAS3;RAP1B;ARFGEF1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.4967371227853432,-1.8481230518406624,0.0,0.05924950491509045,0.722,36/82,18.77%,BMP6;RANBP3L;IGF1;SMOC1;CRIM1;BMPR1A;WNT4;SMAD6;DDX5;BMP7;IL6ST;TMEM64;BMP4;YAP1;SKI;FGFR2;REST;NBR1;LIMD1;MEF2C;SUFU;IL6R;TRPM4;ATRAID;CCN1;ACVR1;PTCH1;RUNX2;FBN2;SUCO;TWIST2;CCN4;PRKACA;PRKD1;NPNT;BMP2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5928100716431906,-1.8437195923545473,0.0,0.06108543214396493,0.737,15/35,10.58%,RBFOX2;ZMIZ1;DDX5;NR3C2;YAP1;DDX17;PPARGC1B;NR3C1;UBR5;TRIP4;AR;MED1;PMEPA1;TADA3;CALCOCO1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.6958468901021466,-1.8434309985533974,0.0,0.05948718802135122,0.738,12/17,16.75%,PBX1;RBPJ;KAT2B;EP300;CREBBP;NOTCH3;MAML2;WWC1;MAML1;STAT1;PLXND1;HEYL
prerank,cell-matrix adhesion (GO:0007160),-0.4824420867903078,-1.8408381866312227,0.002109704641350211,0.06026161139482107,0.749,32/95,16.01%,ITGBL1;COL3A1;SORBS1;ADAMTS12;VCL;PKD1;ITGAV;ECM2;VTN;ITGA10;FBLN5;BCR;ITGB1;NID2;ITGA11;MKLN1;ITGB5;PTPRK;ACTN2;ADAMTS9;COL13A1;ITGB8;ADAM9;ZYX;FN1;CTTN;EMILIN1;MSLN;TMEM8B;WHAMM;DDR1;ITGA4
prerank,transcription by RNA polymerase II (GO:0006366),-0.4114234602339796,-1.8367222947971902,0.0,0.06225180206782879,0.769,132/305,28.25%,NOTCH2;MLLT3;MAF;SOX5;TEAD1;PRRX1;NFKB1;RBPJ;THRB;DDX5;GLIS3;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NCOR1;CCNT2;NR3C2;PABPN1;TBL1X;CCNH;TBL1XR1;NR6A1;NFIX;RREB1;CCNT1;INTS4;YAP1;PCF11;WDR33;TAF3;RARG;CDK7;NR3C1;MED17;CREBBP;SCAF8;MED26;CPSF3;AR;CTR9;PHAX;TAF4;PPARGC1A;TBP;SSU72;ZBTB1;CDK13;MED1;CCNK;TEAD3;RPRD2;SETD2;SLBP;MNAT1;NR1H3;NOTCH3;MAML2;AFF4;RTF1;PARP1;RORA;ERCC3;TFCP2;TEAD2;IRF9;NABP2;COPS2;MAML1;NELFB;HDAC1;TAF5L;SNAPC3;TAF8;RXRA;TAF13;MNT;GTF2B;ICE1;PIR;PMF1;NR4A1;RNGTT;MED27;NR4A2;CSTF3;NFIC;INTS6;POLR2H;SNRPF;TRIP11;CDC73;NFX1;MED16;TAF12;NFYA;TAF9B;TAF2;DRAP1;INTS14;RPAP1;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;GTF2H1;EAF2;NR2F1;TBPL1;SNAPC1;CTDP1;POLR2E;CPSF1;PPARA;NCBP2;NR2C1;TAF7;LSM11;ZBTB7B;HDAC3;TAF1C;SNAPC5;GTF2H4;GTF2E2;THRA;POLR2D;NELFA;CDK9;ESR1;NELFE
prerank,regulation of AMPA receptor activity (GO:2000311),0.6190163023196005,1.8333277299670496,0.0040650406504065045,0.05383825943408201,0.92,10/25,10.73%,NLGN1;SHISA6;MAPK8IP2;SHANK3;CACNG2;SHISA8;SHISA7;CACNG3;RELN;CACNG8
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.7490207848408348,-1.8316733734820208,0.0,0.06515779428689593,0.798,4/12,2.90%,UST;DSE;DCN;BGN
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6709540214034395,1.8311797596003148,0.002044989775051125,0.05416137749527942,0.926,7/20,8.00%,MRAP2;BICD1;STMN1;YWHAB;SNCA;GRK2;RNF157
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.6572937821780777,-1.8290390238943675,0.0,0.06574838075455897,0.808,11/20,19.27%,CELF1;TNRC6B;WTIP;TNRC6A;MOV10;LIMD1;CNOT8;HELZ;TNRC6C;CNOT1;AJUBA
prerank,embryonic eye morphogenesis (GO:0048048),-0.7780642719762341,-1.8264966764808326,0.0036900369003690036,0.06599422296837086,0.814,7/11,17.05%,FBN1;EFEMP1;LRP6;RARG;MFAP5;FBN2;TBX2
prerank,negative regulation of axonogenesis (GO:0050771),0.6036161677090223,1.82528607373195,0.001984126984126984,0.05660454743199536,0.939,13/27,14.97%,DCC;MAG;MCF2;MAP2;FGF13;THY1;EFNB3;OMG;LINGO1;RTN4R;DIP2B;RTN4;GDI1
prerank,response to ethanol (GO:0045471),0.7369467445316795,1.8225823577122917,0.00408997955010225,0.05784366449139271,0.943,6/14,10.09%,GRIN1;GLRA1;GRIN2A;GRIN2B;GLRA2;GRIN3A
prerank,positive regulation of cell junction assembly (GO:1901890),0.5284090303697242,1.818942725101821,0.0,0.05924171085055641,0.947,15/56,8.03%,CLDN5;CNTNAP2;TEK;NRXN1;PTPRD;IL1RAPL1;EPHB1;NLGN1;GRID2;PPM1F;KDR;THY1;PTPRJ;CLSTN3;LRRC4B
prerank,pteridine-containing compound metabolic process (GO:0042558),0.7372709766098785,1.8179311233207291,0.002136752136752137,0.05857806186991824,0.948,6/13,17.04%,NOS3;PRKG2;AKT1;CALM1;GCH1;HSP90AA1
prerank,actin cytoskeleton reorganization (GO:0031532),-0.5044518885035592,-1.816638579900062,0.0017825311942959,0.07478476670733318,0.854,25/63,19.13%,AUTS2;PARVA;PHACTR1;SIPA1L1;GSN;MCU;PTK7;KIT;FLNA;NRK;CXADR;DTNBP1;NRP1;MKLN1;ANXA1;FER;RHOA;RALA;RICTOR;CTTN;FARP2;WHAMM;EFS;PTPN1;GAB1
prerank,potassium ion transport (GO:0006813),0.46406564718316023,1.815041720617996,0.0,0.05944236846214458,0.952,31/120,8.42%,KCND2;HCN1;SLC24A4;SLC24A2;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;KCNMB2;KCNMB3;KCNJ11;KCNN1;KCNK13;KCNK10;KCNMB4;HCN2;KCNJ10;KCND3;KCNC3;KCNH1;KCNQ5;KCNK9;KCNN3;KCNAB1;LRRC55;KCNC1;KCNK1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.7526871344184359,-1.8114611267545337,0.0018281535648994515,0.0782489486878302,0.873,7/12,19.21%,ROCK2;ROCK1;FLOT2;APOE;RANBP9;PICALM;ABCA7
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.6068656046296442,1.8080352612852688,0.0,0.06315878199519619,0.96,8/29,6.73%,CAMK2A;SHISA6;NETO1;MCTP1;GRIK2;SHISA8;PPFIA3;SHISA7
prerank,alanine transport (GO:0032328),0.7699548670238081,1.8045392196516032,0.002061855670103093,0.06454472395562193,0.963,3/10,9.57%,SLC6A6;SLC6A17;SLC36A1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.7926992728681336,-1.8045301800246036,0.001876172607879925,0.08381168393625266,0.891,5/10,9.89%,PID1;APPL2;GRB10;ENPP1;SELENOS
prerank,presynapse assembly (GO:0099054),0.6799561315458347,1.8043434894215131,0.0,0.06340794570463375,0.963,5/16,1.68%,PTPRD;LRRTM3;PCLO;IL1RAPL1;NLGN1
prerank,synaptic vesicle cycle (GO:0099504),0.5908107552104075,1.8028136611743057,0.004395604395604396,0.06357598420549473,0.967,10/30,12.16%,RIMS1;PCLO;NLGN1;SYT7;SNAP25;SNCA;SLC17A6;SYT10;CPLX1;PLD2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.541833793837091,-1.8019088792246507,0.0,0.08425674705478833,0.894,20/46,15.53%,ZIC1;TCF7L2;SMAD3;XPO4;GSK3B;FLNA;KHDRBS1;UBR5;CDH1;DHX9;RAPGEF3;JUP;BAG3;PRKCD;MAVS;TPR;YWHAE;EMD;EFCAB7;ANP32B
prerank,regulation of ion transport (GO:0043269),0.4894654770129006,1.8018716765784542,0.0,0.06297654939506578,0.968,22/76,12.77%,NKAIN2;SYT1;KCNJ3;SYT6;SPTBN4;NKAIN1;SYT7;NKAIN3;KCNJ6;SYT12;SYT11;ANK3;SNCA;KCNJ11;CA2;KCNJ10;SYT10;ATP1A1;SYT2;P2RX7;KCNA2;KCNJ8
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7629623220464585,1.8008531884047978,0.004219409282700422,0.06267522619221859,0.971,6/11,17.04%,NOS3;PRKG2;AKT1;CALM1;GCH1;HSP90AA1
prerank,Rho protein signal transduction (GO:0007266),-0.5233728445923993,-1.79911381078077,0.0,0.08515233014010677,0.901,17/53,17.65%,COL1A2;ROCK2;ARHGAP29;ARHGAP6;ROCK1;PDPN;RHOJ;CTNNAL1;CDC42;CDC42EP5;RHOA;AGTR1;ARHGDIB;ADRA2A;ARHGEF11;CDC42EP4;ARHGEF1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.6627941699214323,1.7980994116316764,0.004158004158004158,0.06350072994888915,0.973,6/18,3.04%,GRIN1;NRXN1;RIMS1;NLGN1;RIMS2;SHANK3
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.7237411023784972,-1.7959989751937628,0.0,0.08711784912416462,0.907,4/13,1.77%,FSTL1;FBN1;LTBP1;NBL1
prerank,digestive tract development (GO:0048565),-0.587588281352198,-1.795153107023931,0.0019880715705765406,0.08632083397601374,0.911,18/32,21.36%,GLI3;PKD1;GLI2;CLMP;RARB;SMO;PCSK5;KIT;FGFR2;CHD8;NIPBL;GLI1;CCDC39;SALL1;MEGF8;PKDCC;ZIC3;GATA6
prerank,axon development (GO:0061564),0.4904260439200387,1.7930412446513266,0.0,0.06607836445745492,0.976,22/78,11.46%,DCC;CTNNA2;ACTB;PLP1;GRM7;SPTBN4;ADGRB1;ANK3;MAP1B;APBB1;PAX2;DSCAML1;NRCAM;ZDHHC17;SHTN1;PLPPR4;NTNG1;NTNG2;TAOK2;CNTN4;BRSK2;SLITRK5
prerank,positive regulation of DNA replication (GO:0045740),-0.6780845116079428,-1.7911619488925878,0.001968503937007874,0.08957469307388623,0.925,10/16,26.06%,EGFR;GLI2;DHX9;BRPF3;GLI1;CTC1;PCNA;STN1;ATAD5;EGF
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.4757957137318708,-1.7910034668111048,0.0,0.08787172698654426,0.925,20/86,7.30%,BMP6;SULF1;TGFBR1;BMPR1A;FOXD1;RBPJ;RBPMS;ZNF423;BMP5;BMP7;DAB2;EP300;BMP4;NUMA1;TGFB1I1;SMAD2;THBS1;CREBBP;TWSG1;ZEB2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.6083632407866569,-1.7905100923691404,0.003968253968253968,0.08668668439617137,0.926,10/26,13.64%,ROCK2;ASAP3;ROCK1;PRKN;ALMS1;SLC9A1;FHOD1;CDC42;SYNPO2;SYNPO
prerank,glucose transmembrane transport (GO:1904659),0.6487827061351186,1.7884832923090481,0.006521739130434782,0.06882014143924745,0.982,4/18,2.66%,SLC2A1;RAB4B;SLC2A3;SLC2A5
prerank,circulatory system development (GO:0072359),-0.44864801910326435,-1.787138730690609,0.0,0.08856627513635693,0.933,35/118,12.79%,AKAP13;CACNA1C;FBN1;COL3A1;NXN;TGFBR1;PLCE1;PKD1;NTRK3;GLI2;PDLIM5;FOXC1;ADAP2;KAT2B;SH3PXD2B;BCOR;OSR1;TGFBR2;PCSK5;MICAL2;RBP4;HSPG2;MEF2A;PDLIM7;CXADR;FOXC2;ECE1;NCOA6;KDM6A;ID2;PDLIM2;MEF2C;PKD2;FBXW7;FN1
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.6165180459686528,-1.785421011561841,0.001893939393939394,0.08920260959325532,0.937,9/24,9.06%,ROCK2;ERRFI1;FOXC1;ROCK1;NUMA1;HOXA7;RUNX1;SRSF6;MED1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7241583210644581,1.7811375013267392,0.0021929824561403508,0.07302548232438792,0.989,6/12,4.96%,SYT1;RIMS1;SYT7;RIMS2;RIMS3;UNC13A
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.4585854067299817,-1.7808338612643593,0.0,0.09280545233617782,0.951,41/108,22.43%,WLS;TRABD2B;SULF1;NXN;LRP1;MDFIC;WWOX;GRB10;PTK7;RNF43;PRKN;LRRK2;BTRC;VGLL4;DCDC2;GPC3;SULF2;RSPO3;AXIN1;SKI;FGFR2;RUNX1;DACT1;RSPO2;TLE1;TCF7L1;FZD7;EMD;CSNK2A1;SALL1;FOXL1;SFRP4;DACT3;BMP2;MDFI;CDC73;TERT;FRZB;PPP2CA;SPIN1;SENP2
prerank,Golgi organization (GO:0007030),-0.4565871954014405,-1.7791231446287177,0.0,0.09324410430080651,0.953,49/112,24.11%,VTI1A;GBF1;LRRK2;FBXW8;CSNK1A1;RAB30;ATL3;UBXN2B;HUWE1;ATP8B1;BCAS3;GOLGB1;SEC23IP;VTI1B;STX16;ARFGEF1;ARHGAP21;OBSL1;SEC22B;CDC42;USP6NL;VCPIP1;ATP8B2;ATL2;TBC1D20;COG3;COG7;STX5;SURF4;PRMT5;GOSR2;TJAP1;TMED3;PRKD1;VAMP4;SEC16B;CSNK1D;TMED5;TMED4;TRIP11;SEC16A;STX17;CUL7;COG4;PLEKHM2;PI4K2B;PLK5;LMAN1;BAG5
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5230781949382207,1.7743997304392904,0.0,0.07763010791039053,0.992,17/54,7.96%,DPP10;KCNJ3;KCNIP4;KCNJ6;KCNN2;AKAP6;BIN1;KCNIP1;KCNMB2;KCNMB3;KCNN1;DPP6;KCNMB4;KCNJ10;KCNN3;GNG2;KCNAB1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5386427537438302,-1.7740967443935833,0.0,0.09728691374313568,0.958,17/43,17.44%,IGF1;FOXP1;BMPR1A;IGFBP5;PDGFRB;BMP4;THBS1;GJA1;JUN;ID2;MMP2;IL6R;STAT1;ERN1;ADAMTS1;IL18;CCN4
prerank,regulation of transmembrane transport (GO:0034762),0.5743879326630146,1.7735773648136512,0.0,0.07702460984876931,0.992,9/31,7.24%,ACTB;SLC2A1;KCNJ3;KCNJ6;SNCA;KCNJ11;OCLN;KCNJ10;TRIB3
prerank,cellular response to purine-containing compound (GO:0071415),0.760818107895112,1.772751479299677,0.010706638115631691,0.07646271093284143,0.992,5/10,6.95%,RYR2;RYR3;SLC8A1;TRPM2;P2RY1
prerank,cell differentiation in hindbrain (GO:0021533),0.728282771378656,1.7726570378581215,0.008676789587852495,0.0753714034139355,0.992,7/11,19.82%,PROX1;GRID2;CEND1;LHX1;KNDC1;FAIM2;CBLN1
prerank,excitatory postsynaptic potential (GO:0060079),0.6515655882495517,1.771581449359221,0.002178649237472767,0.07518659378713657,0.992,8/19,7.97%,MPP2;GRIN1;MAPK8IP2;GRID2;GRIN2A;GRIN2B;GRIN2D;AKT1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.4801315851758778,-1.7713107185425543,0.0,0.09879616776021213,0.963,16/74,7.19%,PHLDB2;SMAD3;TGFBR1;DAG1;EPHA3;COL1A1;LDLRAD4;BMP5;FOXC1;DAB2;PDPN;TGFBR2;TGFB1I1;SMAD2;BCL9L;MTOR
prerank,axonogenesis (GO:0007409),0.4136070355456756,1.7707349330669895,0.0,0.07480693566845693,0.993,71/237,12.13%,DSCAM;BSG;NRXN3;NRXN1;DCC;CTNNA2;ACTB;EPHA6;SEMA3C;EPHB1;SPTBN4;SEMA6A;DAB1;UNC5C;SPTB;ADGRB1;CXCL12;EPHA5;SEMA4A;SEMA4F;ANK3;SHANK3;MAP1B;ROBO4;APBB1;CNTN6;PAX2;SEMA6D;SEMA4D;DOK6;SEMA7A;EFNB3;TNR;RPS6KA5;NOTCH1;DSCAML1;NCAM1;UNC5D;SLIT3;SLIT1;NPTN;ENAH;PRKCQ;NRCAM;RAP1GAP;VSTM2L;ZDHHC17;UNC5B;EFNA2;HSP90AB1;SHTN1;ROBO2;B4GALT6;EPHA10;PLPPR4;NTNG1;NTNG2;SPTBN5;RELN;TAOK2;TUBB3;ROBO3;FEZ1;CNTN4;BRSK2;DOK5;SPTBN1;SLITRK5;DOK2;CNTN2;RET
prerank,regulation of dopamine secretion (GO:0014059),0.592813124443341,1.768966723710593,0.011363636363636364,0.0751700542567326,0.994,9/25,11.72%,SYT1;SYT6;SYT7;SYT12;SYT11;SNCA;SYT10;SYT2;KCNA2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5785799185062679,1.7677757302898156,0.004310344827586207,0.07509919896968273,0.994,8/32,16.08%,PGLYRP1;RPS19;S100A9;RPL30;CXCL14;HMGN2;DEFA6;RNASE3
prerank,cellular transition metal ion homeostasis (GO:0046916),0.4645321126880199,1.7662821669619817,0.0,0.07542520541968828,0.994,26/91,11.74%,SLC39A10;TFRC;ALAS2;TMPRSS6;MT2A;SLC40A1;ABCG2;FTH1;SLC22A17;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;SLC30A1;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1;SLC39A8;ATOX1;SLC30A5
prerank,central nervous system neuron differentiation (GO:0021953),0.5680545991934052,1.76550534874878,0.0021551724137931034,0.07504133140862888,0.994,15/33,17.37%,SPOCK1;MDGA2;PROX1;GRID2;CEND1;MAP2;TOX;NTRK2;LHX1;SIN3A;KNDC1;CHD5;SOX4;CTNNB1;FAIM2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6880839167873319,-1.7654842719845503,0.003683241252302026,0.10534324989864782,0.974,7/16,8.22%,IGF1;IGFBP2;IGFBP5;BMP5;IGFBP3;IGFBP6;IGFBP4
prerank,neurotransmitter transport (GO:0006836),0.4881403428281712,1.764526569697421,0.0,0.07482166840354211,0.994,29/73,15.59%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;GABRA2;SNAP25;LIN7A;SLC17A6;SLC18A3;SLC1A1;UNC13A;HSPA8;PPFIA3;SLC1A2;NRXN2;SNPH;SLC6A2;GAD1;CPLX1;PPFIA2;DVL1;PPFIA4;CHAT;TSPOAP1;PDZD11;GLS2;GLS;SYN1
prerank,mesenchymal cell differentiation (GO:0048762),-0.515179282815116,-1.7631021439206536,0.003795066413662239,0.10637804524583161,0.979,16/51,6.61%,ROCK2;RANBP3L;TGFBR3;TGFBR1;LRP6;WNT4;RBPJ;FBXL17;LIMS1;DDX5;FOXC1;BMP7;ROCK1;GSK3B;DDX17;FGFR2
prerank,sensory perception of smell (GO:0007608),0.723240825910704,1.7622494470469323,0.008639308855291577,0.07579794419396675,0.995,3/11,7.62%,SLC24A4;ADCY3;SYT10
prerank,gene silencing by miRNA (GO:0035195),-0.5785198680440181,-1.7620427390719318,0.0019880715705765406,0.10564094247028186,0.98,16/32,23.36%,DICER1;TNRC6B;PUM2;ZC3H7A;WTIP;TNRC6A;MOV10;PUM1;LIMD1;CNOT8;TNRC6C;CNOT1;AJUBA;RBM4;XPO5;AGO1
prerank,negative regulation of cell differentiation (GO:0045596),-0.42506178202555356,-1.7619926792507346,0.0,0.10394284803504614,0.98,58/181,21.04%,RANBP3L;EGFR;COL5A2;SMAD3;TGFBR1;CRIM1;EFEMP1;ADAMTS12;COL5A1;LDLRAD4;ABCA1;SMAD6;BMP5;ITGAV;BMP7;TMEM64;BMP4;JAG1;ENPP1;OSR1;YAP1;SKI;ZBTB16;ADGRV1;REST;WNT9A;CTR9;NBR1;RUNX1T1;IGF2;MED1;NR1H3;LIMD1;ID2;RORA;IL17RD;HES1;SUFU;RB1;EIF2AK4;TRPM4;NELFB;TRIB2;ANKRD26;PTCH1;ANP32B;VASN;TRIO;PDCD4;TWIST2;WNT5A;HNRNPU;PTPN11;ITGB3;CDC73;SPRED2;CDK6;PPP2CA
prerank,regulation of dendrite extension (GO:1903859),0.6610322023407527,1.7606891607489217,0.0,0.07602218722196877,0.995,7/18,11.21%,SYT1;RIMS1;RIMS2;CPNE9;UNC13A;RNF157;SYT2
prerank,negative regulation of translation (GO:0017148),-0.4656748138336779,-1.7605485014665172,0.0,0.10383765894005118,0.983,26/87,19.58%,SAMD4A;ROCK2;IGFBP5;CELF1;FTO;ROCK1;YTHDF3;SYNCRIP;DDX6;EIF4ENIF1;EIF2AK3;LARP1;PUM1;DHX36;LSM14A;CNOT8;TPR;EIF2AK4;YBX1;EIF2AK2;DDX3X;DAPK1;CPEB1;CNOT1;CNOT10;RBM4
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5947821901644071,1.7604908230656526,0.004032258064516129,0.0752191379524932,0.995,7/26,3.04%,GRIN1;NRXN1;RIMS1;TMEM108;NLGN1;RIMS2;SHANK3
prerank,synapse organization (GO:0050808),0.446953815573947,1.7603943754196354,0.0,0.07427097427420067,0.995,40/125,12.45%,SPOCK2;DNM3;DSCAM;KIRREL3;GRM5;ADGRL3;NRXN1;PTPRD;LRRC4C;LRFN5;CTNND2;NLGN1;GPM6A;DNER;ANK3;SHANK3;CDH2;SNCA;UNC13A;PPFIA3;NRXN2;ELFN1;NRCAM;WNT7B;ARHGAP39;RAB39B;CACNB2;PCDHB6;LRRC4B;NTNG1;SHANK2;APBB2;CACNB4;F2R;PPFIA2;DVL1;CNTN2;PPFIA4;SNCB;DCTN1
prerank,positive regulation of actin nucleation (GO:0051127),-0.7534096380134787,-1.7597521830959417,0.007326007326007326,0.10300096444437665,0.983,7/11,15.29%,GSN;FCHSD2;WASF2;BRK1;NCKAP1;WASF1;WHAMM
prerank,positive regulation of B cell proliferation (GO:0030890),0.5829607491553674,1.7586229485640315,0.0,0.07456784442478905,0.996,9/29,14.85%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;CD40;NFATC2;CD38
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5537300533205606,1.7564630361435731,0.002109704641350211,0.07543417242064708,0.996,14/37,11.91%,HMCN1;PTPRD;CADM1;IL1RAPL1;NLGN1;TENM2;GRID2;TENM1;TENM4;TENM3;DCHS1;CADM3;CRB1;NECTIN1
prerank,embryonic skeletal system development (GO:0048706),-0.5632191794633146,-1.7553756338366926,0.0038095238095238095,0.10697888556200176,0.989,13/35,9.49%,SULF1;COL1A1;PDGFRA;OSR1;HOXB3;PCSK5;RBP4;SULF2;DYNC2I1;HOXC4;HOXA3;WNT9A;HOXB4
prerank,chondrocyte differentiation (GO:0002062),-0.5763308045189656,-1.7541189186174253,0.0,0.1065991254880521,0.989,15/32,15.59%,SULF1;SOX5;CREB3L2;BMP4;OSR1;WNT5B;NFIB;SULF2;SLC39A14;EIF2AK3;RUNX1;CCN3;MEF2C;SOX6;RUNX2
prerank,cell projection organization (GO:0030030),-0.583778363669085,-1.7539463588979884,0.004016064257028112,0.10519086417977391,0.989,9/30,13.84%,PARVA;RHOQ;GSN;RHOJ;PACSIN2;ITGB1;CDC42;NCKAP1;P2RY12
prerank,inhibitory synapse assembly (GO:1904862),0.739498942022693,1.752896520375874,0.004228329809725159,0.0772581644021211,0.996,6/11,8.57%,GABRB3;GABRA2;FGF13;GABRB2;LGI2;GABRG2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6803949453155114,1.748046114096719,0.014462809917355372,0.08062577671769551,0.998,9/15,17.07%,GRM5;GRM7;GRM1;GRM8;HOMER1;HOMER2;GRM3;HOMER3;GRIK3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.42848008181657427,-1.7470915898185688,0.0,0.11261695371175486,0.995,64/138,28.18%,NOTCH2;TEAD1;RBPJ;THRB;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NCOR1;NR3C2;TBL1X;CCNH;TBL1XR1;NR6A1;YAP1;TAF3;RARG;CDK7;NR3C1;MED17;CREBBP;MED26;AR;TAF4;PPARGC1A;TBP;MED1;TEAD3;MNAT1;NR1H3;NOTCH3;MAML2;RORA;ERCC3;TEAD2;MAML1;HDAC1;TAF8;RXRA;TAF13;GTF2B;NR4A1;MED27;NR4A2;POLR2H;TAF12;TAF9B;TAF2;GTF2F1;POLR2K;GTF2H1;NR2F1;POLR2E;PPARA;NR2C1;TAF7;HDAC3;GTF2H4;GTF2E2;THRA;POLR2D;CDK9;ESR1
prerank,neuropeptide signaling pathway (GO:0007218),0.5000971961278017,1.7467003129682444,0.0,0.08062480181078123,0.998,16/58,15.06%,GLRA1;NXPH2;HCRTR1;GPR149;GLRA3;SORCS3;SORCS1;ADCYAP1;GLRA2;HCRTR2;OPRM1;GRP;PNOC;SORL1;OPRK1;OPRL1
prerank,heart development (GO:0007507),-0.4303519336086351,-1.7439610379944057,0.0,0.1153953094129745,0.996,53/150,19.53%,AKAP13;TGFBR3;CACNA1C;FBN1;COL3A1;TGFBR1;PLCE1;PKD1;NTRK3;GLI2;PDLIM5;FLRT2;BMP5;FOXC1;ADAP2;KAT2B;BMP7;SH3PXD2B;BMP4;BCOR;OSR1;TGFBR2;PCSK5;MICAL2;RBP4;GPC3;MEF2A;PDLIM7;CXADR;FOXC2;ECE1;NCOA6;KDM6A;ID2;NIPBL;PDLIM2;MEF2C;PKD2;SCUBE1;FN1;CHD7;VEGFA;ACVR1;SALL1;FOXL1;CITED2;TBX2;WDR11;EEF1AKMT4-ECE2;ZDHHC16;BMP2;PTPN11;MEGF8
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.46005566007516385,-1.7418168737304918,0.0,0.11678920611234922,0.996,35/95,16.75%,TGFBR3;SMAD3;TGFBR1;LDLRAD4;SMAD6;SMURF2;NREP;DAB2;EP300;DKK3;TGFBR2;HTRA3;TGFB1I1;SMAD2;BCL9L;THBS1;SNX6;SKI;CREBBP;SKIL;ZEB2;PDPK1;PMEPA1;SMAD4;GIPC1;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;LATS1;VASN;CITED2
prerank,BMP signaling pathway (GO:0030509),-0.4899079963395983,-1.7417882170056431,0.0,0.1150638733475545,0.996,25/62,21.85%,BMP6;TGFBR3;SMAD3;BMPR1A;SMAD6;DDX5;BMP5;BMP7;BMP4;RGMB;SMAD2;RGMA;SMAD4;SLC33A1;SMURF1;ACVR1;ZFYVE16;RUNX2;TGFB3;PDCD4;BMP2;MEGF8;SMAD9;SMAD1;TMEM100
prerank,camera-type eye development (GO:0043010),-0.5936412968500615,-1.741680911982571,0.003663003663003663,0.11349445427035092,0.996,11/25,15.76%,CACNA1C;FBN1;EFEMP1;LAMA1;SHROOM2;SKI;RAB3GAP1;CYP1B1;NES;VEGFA;FBN2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6506956183292968,1.7415502245383272,0.008695652173913044,0.08418701656268293,0.998,8/18,10.73%,NRXN1;NLGN1;SHANK3;CACNG2;CACNG3;CCL2;RELN;CACNG8
prerank,positive regulation of developmental growth (GO:0048639),0.5213978205268547,1.7398695996307216,0.002105263157894737,0.0845903237786048,0.999,15/49,13.88%,SYT1;RIMS1;RIMS2;CPNE9;SEMA4D;SEMA7A;UNC13A;PLCB1;RNF157;SHTN1;CDKL5;NTN1;SYT2;DLL1;INSR
prerank,regulation of catecholamine secretion (GO:0050433),0.5741599882540034,1.739337952983111,0.0044943820224719105,0.08413794851258975,0.999,10/29,11.72%,SYT1;SYT6;SYT7;SYT12;SYT11;SNCA;GRK2;SYT10;SYT2;KCNA2
prerank,cellular response to BMP stimulus (GO:0071773),-0.48209084211062453,-1.738918522295799,0.0,0.11589173962640106,0.997,26/66,21.85%,BMP6;TGFBR3;SMAD3;BMPR1A;ADAMTS12;SMAD6;DDX5;BMP5;BMP7;BMP4;RGMB;SMAD2;RGMA;SMAD4;SLC33A1;SMURF1;ACVR1;ZFYVE16;RUNX2;TGFB3;PDCD4;BMP2;MEGF8;SMAD9;SMAD1;TMEM100
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.5312712282330485,-1.738294157730882,0.005671077504725898,0.11495128986868494,0.997,13/40,7.19%,TCF7L2;SMAD3;TGFBR1;COL1A1;FOXC1;DAB2;PDPN;JAG1;TGFBR2;TGFB1I1;SMAD2;BCL9L;MTOR
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.49843873966021957,-1.7375302995800974,0.0,0.11437308119459515,0.997,17/56,15.84%,BMP6;TGFBR1;BMPR1A;LDLRAD4;RBPMS;SMAD6;BMP5;BMP7;DAB2;BMP4;TWSG1;PMEPA1;SMAD4;BMPER;EMILIN1;ACVR1;TGFB3
prerank,positive regulation of dendrite extension (GO:1903861),0.665043926063563,1.7367871017196506,0.0,0.0852662762821927,0.999,7/17,11.21%,SYT1;RIMS1;RIMS2;CPNE9;UNC13A;RNF157;SYT2
prerank,DNA conformation change (GO:0071103),-0.6571744234495369,-1.7361356656119569,0.0038314176245210726,0.1147214213435439,0.997,6/17,17.21%,ABL1;TOP1;HMGB1;HAT1;ERCC3;TOP2B
prerank,skeletal system morphogenesis (GO:0048705),-0.5253980658047781,-1.7329209145879119,0.003861003861003861,0.11798284869289426,0.997,18/42,19.53%,TGFBR1;PDGFRA;LRP6;ANKRD11;WWOX;HOXB3;CYP26B1;SKI;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4;HOXB9;FBN2;SIX1;SFRP4;MEGF8
prerank,cellular defense response (GO:0006968),-0.5374442993920012,-1.7285556294552915,0.0038910505836575876,0.12286346114546198,0.998,12/40,19.73%,ZNF148;DCDC2;CCR9;LBP;ITGB1;LSP1;VEZF1;BECN1;TCIRG1;CX3CR1;LGALS3BP;NCF2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.7326566607551677,-1.723960326140264,0.009433962264150943,0.1276298160775759,0.999,5/11,10.88%,PDK1;MAP3K5;CYP1B1;PRKCD;PRODH
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.6177147286873634,-1.723622223517341,0.007407407407407408,0.1265307487901179,0.999,6/21,8.55%,ROCK2;ERRFI1;ROCK1;BMP4;RUNX1;MAFG
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.4414770911870956,-1.7206413356645507,0.0,0.129005002594312,0.999,38/112,15.95%,COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;SOX5;APPL2;BMPR1A;ZMIZ1;WNT4;LIMS1;SMAD6;WWOX;TGFBR2;CLEC3B;NR3C1;ITGB1;SMAD2;SKI;TWSG1;ITGB5;PTPRK;RHOA;JUN;ADAM9;SMAD4;ARHGEF18;MEF2C;PDE3A;ZYX;APPL1;SOX6;PARD3;SMURF1;ACVR1;PRKCZ;TGFB3;LRRC32
prerank,negative regulation of secretion by cell (GO:1903531),0.5299327250202627,1.7202904712707185,0.00202020202020202,0.09943472383162023,0.999,9/38,6.03%,GRM7;IL1RAPL1;SYT11;RHBDF2;SNCA;TRH;IL12A;NOTCH1;SLC30A1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.42836008729662095,-1.7132609190355372,0.0,0.13853671740267318,1.0,41/128,15.95%,BMP6;COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;APPL2;BMPR1A;ZMIZ1;SMAD6;SMURF2;DDX5;BMP5;BMP7;BMP4;TGFBR2;RGMB;TGFB1I1;ITGB1;SMAD2;SKI;TWSG1;ITGB5;RGMA;PTPRK;RHOA;JUN;ADAM9;SMAD4;ARHGEF18;ZYX;APPL1;SLC33A1;PARD3;SMURF1;ACVR1;PRKCZ;ZFYVE16;RUNX2;TGFB3;LRRC32
prerank,regulation of microtubule depolymerization (GO:0031114),0.5804929082933683,1.7119615988593415,0.014553014553014554,0.1063519229289786,0.999,14/25,19.69%,NAV3;MAP1B;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;TRPV4;CLASP1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5305264112339232,1.7115875427149103,0.010482180293501049,0.10559205710056128,0.999,12/41,7.78%,KCNJ3;KCNJ6;KCNN2;ANK3;AKAP6;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;KCNN3;GNG2
prerank,rRNA metabolic process (GO:0016072),0.41964228716012447,1.7115140510532258,0.0,0.10450322972422033,0.999,51/160,16.10%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;RPL21;DKC1;RPS7;RPL23A;RPL8;POP5;RPS14;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;DIS3L;RRP1B;RRP1;NOP56;RPS25;MDN1;UTP15
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.4194662027106067,-1.7086698722200024,0.0,0.14432682775897956,1.0,58/152,23.11%,RNF220;WLS;SULF1;LRRK1;EGFR;NFKB1;COL1A1;SMURF2;LGR4;PTK7;TNKS2;LRRK2;TBL1X;WNT5B;TBL1XR1;RNF146;GPC3;SULF2;UBR5;RSPO3;AXIN1;LYPD6;SKI;ADGRA2;FGFR2;ZEB2;XIAP;DACT1;JUP;WNK1;CSNK1E;RSPO2;USP47;PSMF1;TRPM4;PPM1A;PSMB2;UBE2B;ZBED3;DDX3X;CSNK2A1;SALL1;PRDM15;USP34;SFRP4;VCP;CSNK1D;BMP2;CDC73;TERT;DKK2;PSMC1;GID8;SPIN1;PLEKHA4;PSMB6;CCAR2;PSMA3
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5852033936885437,1.708027705602848,0.011013215859030838,0.10676400599639993,1.0,8/24,4.44%,DSCAM;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.616267761396372,-1.7064638246706947,0.005747126436781609,0.14605377836763128,1.0,11/22,15.21%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;SMAD4;PARP1;LMCD1;P2RX4
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.6517077447134803,-1.7036248712371589,0.0055762081784386614,0.14870927485622634,1.0,7/16,10.32%,RBFOX2;DDX5;DDX17;PPARGC1B;TRIP4;AR;TADA3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6027293297028772,1.698816948645187,0.015625,0.11597803336870774,1.0,7/20,4.44%,SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,positive regulation of proteolysis (GO:0045862),-0.482545809614918,-1.6978844146239005,0.0019083969465648854,0.15641649858446321,1.0,22/55,24.46%,CCBE1;CYFIP2;BTRC;CTSC;CTSH;SNX9;WDR48;ASPH;NRDC;ADAM9;RCN3;OGT;APOE;ADRA2A;ATP5IF1;FBXW11;TANK;FGFR4;TBC1D10A;PERP;HDAC2;NKD2
prerank,inorganic cation transmembrane transport (GO:0098662),0.39116939925490996,1.6936290485277874,0.0,0.12039104290789052,1.0,68/268,12.77%,KCND2;SLC6A6;HCN1;SLC24A4;SLC24A2;TRPC5;CACNA1A;SCN1A;KCNH7;SLC6A17;ASIC2;SLC40A1;KCNQ3;KCNC2;KCNN2;UCP2;KCNH5;SLC39A2;ASIC4;KCNH8;RYR3;GAS6;SLC8A1;KCNJ11;KCNN1;SCN4B;ASIC1;KCNK13;KCNK10;SLC30A1;HCN2;KCNJ10;TRPM2;KCND3;KCNC3;SLC6A2;SLC6A5;KCNH1;KCNQ5;ATP1A3;KCNK9;SLC6A8;KCNN3;SLC30A3;SLC25A14;KCNAB1;LRRC55;SCN3A;KCNC1;KCNK1;SLC25A27;ATP6V1F;ATP6V1A;SLC12A3;SLC36A1;SLC39A8;KCNQ2;ATP1A4;ATP1A1;ATP5F1B;P2RX7;KCNA2;SLC30A5;SCN2A;TRPC1;TMCO1;MCOLN2;KCNJ8
prerank,stress fiber assembly (GO:0043149),-0.6520838421455902,-1.6931499508446406,0.015238095238095238,0.16073769461715093,1.0,9/15,16.32%,PHACTR1;SORBS1;ITGB1;ITGB5;TNFAIP1;RHOA;ZYX;CUL3;ARRB1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.6520838421455902,-1.6931499508446406,0.015238095238095238,0.16073769461715093,1.0,9/15,16.32%,PHACTR1;SORBS1;ITGB1;ITGB5;TNFAIP1;RHOA;ZYX;CUL3;ARRB1
prerank,ganglioside biosynthetic process (GO:0001574),0.6481507378842275,1.6928688178235891,0.008639308855291577,0.11991166353957176,1.0,6/15,11.96%,ST6GALNAC3;ST8SIA4;B4GALNT1;B4GALT6;ST8SIA6;ST8SIA3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.35162137083023326,-1.6904375879069677,0.0,0.16337592422595937,1.0,213/807,17.31%,BMP6;FOXP2;PRDM6;FOXP1;FHL2;NR2F2;AEBP1;TCF7L2;GLI3;SMAD3;RBFOX2;FOXD1;NFKB1;PRDM5;ZNF148;KANK2;HDAC8;WNT4;RBPJ;PHF21A;THRB;MIDEAS;LIMS1;SMURF2;GLI2;ZNF423;DDX5;GLIS3;ATXN1;FOXP4;NR1D2;ZHX2;MDFIC;ZFHX3;ZEB1;RARB;MDM4;WWOX;FOXC1;PER3;BMP7;ZMYM5;ZIC2;DAB2;FOXO3;EP300;BMP4;DICER1;HDAC4;BCOR;KAT6B;DKK3;NCOR1;PRKN;CUX1;OSR1;WWC2;MXI1;BTRC;TBL1X;BRD7;FOXN3;WWP2;FRK;KCNIP3;TBL1XR1;NR6A1;NFIX;RREB1;NIBAN2;VGLL4;YAP1;FLNA;RCOR1;KHDRBS1;EZH1;TAF3;RARG;MEF2A;HMGB1;RCOR3;DLG1;ZKSCAN3;NR3C1;LCOR;SMAD2;SMARCC2;ATP8B1;CBX5;SBNO2;SNX6;LBH;SKI;CREBBP;ZBTB16;DCAF1;STAT3;HOXA7;NSD1;TFDP2;JDP2;FGFR2;L3MBTL3;DNMT3A;NAB1;SHC1;FOXC2;CHD8;RUNX1;SKIL;WWP1;ZEB2;SCMH1;REST;BCL7A;GTF2IRD1;AR;CTR9;FOXK1;MBD2;RUNX1T1;IGF2;SP100;CBFA2T2;SP2;PTPRK;IMPACT;ZBTB1;DACT1;MED1;UBE2I;MIER1;BTAF1;CHD3;PRMT2;NR1H3;JUN;MPHOSPH8;HCFC1;PCGF2;SMAD4;LIMD1;PARP9;ATF7IP;GLIS2;ID2;NIPBL;USP47;BCLAF1;TLE1;RTF1;WWC1;FNIP1;PARP1;MEF2C;ARID5B;PCGF6;PBXIP1;HES1;ZNF692;TPR;SUFU;TCF3;PIAS4;RB1;EHMT1;BHLHE41;PATZ1;CGGBP1;KDM1B;IRF1;PPM1A;TSHZ3;SOX13;TCERG1;KAT8;TRPS1;STAT1;HINFP;VEGFA;ZNF318;USP2;MCPH1;HDAC1;CBX7;CNOT2;CBFA2T3;PRDM2;SCML4;PHC2;PTCH1;RXRA;RUNX2;JARID2;MNT;FOXK2;KDM2A;SALL1;LOXL3;ATOH8;L3MBTL2;NOP53;SFPQ;DAP;HEYL;CITED2;EPC1;PDCD4;TBX2;CNOT1;ZFP37;ZMYND15;TWIST2
prerank,glucose import (GO:0046323),0.6794280847883544,1.6903454966861882,0.013452914798206279,0.12190391626382974,1.0,3/13,1.71%,SLC2A1;RAB4B;SLC2A3
prerank,cell projection assembly (GO:0030031),-0.5991227751203612,-1.6895219300379825,0.009380863039399626,0.16343038362827783,1.0,6/22,11.54%,PARVA;RHOQ;GSN;RHOJ;CDC42;NCKAP1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.6479502350781327,-1.6889816282163859,0.007434944237918215,0.16236018084398732,1.0,4/15,2.90%,UST;DSE;DCN;BGN
prerank,histone modification (GO:0016570),-0.43131334126506204,-1.6885822031681537,0.001949317738791423,0.16116531199136114,1.0,37/109,19.99%,EYA2;EYA1;PRDM5;MIDEAS;UBE2N;EYA4;EP300;HDAC4;KAT6B;HLCS;TBL1X;TBL1XR1;RCOR1;HUWE1;BAZ2A;RCOR3;CREBBP;NSD3;UFL1;NSD1;TRRAP;ENY2;MIER1;PRMT2;PRKCD;EHMT1;KAT8;UBE2B;HDAC1;BAZ1B;ATXN7;TAF6L;MSL3;PRMT8;PARK7;CDK2;NTMT1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.33677739339508445,-1.6884728196381464,0.0,0.15952856512993374,1.0,426/1668,18.36%,ZBTB20;NFIA;BMP6;PBX1;FOXP2;PRDM6;IGF1;AUTS2;FOXP1;FHL2;NR2F2;EGFR;HLF;PKNOX2;ZIC4;AEBP1;NFAT5;ZIC1;PID1;TCF4;TCF7L2;GLI3;SMAD3;RHOQ;ZBTB7C;MAF;SOX5;TEAD1;BMPR1A;FOXD1;PRRX1;CREB3L2;NFKB1;TRAK1;PRDM5;HOXB6;CDK8;ZNF148;KANK2;HIVEP2;ZKSCAN2;PKD1;ZMIZ1;LRP6;HDAC8;INO80;RBPJ;PHF21A;THRB;CCNL2;DCN;MIDEAS;SMAD6;SMURF2;GLI2;DDX5;GLIS3;HOXC6;ATXN1;FOXP4;NR1D2;ZHX2;ZNF462;ZFHX3;ZEB1;RARB;BMP5;MDM4;BRWD1;WWOX;FOXC1;PER3;FGF1;KLF9;KAT2B;PIAS1;ZMYM5;ZIC2;DAB2;FOXO3;PPP1R12A;EP300;BMP4;ARID1B;DICER1;HDAC4;CREB5;GTF2H2;ABL1;BCOR;KAT6B;NCOR1;PRKN;PPM1D;ARNT;TNRC6B;JAG1;CUX1;OSR1;WWC2;CCNT2;CCNL1;NR3C2;TFEB;MXI1;HOXB3;MEOX2;KDM7A;TBL1X;BRD7;ELF1;RBBP8;WWP2;FRK;NFIB;KCNIP3;CCNH;TBL1XR1;NR6A1;SSBP3;NFIX;KIT;RREB1;KMT2C;CCNT1;BCLAF3;YAP1;SLC9A1;TBK1;RCOR1;TNRC6A;MED15;DDX17;EZH1;GMEB1;BAZ1A;TAF3;RARG;ANXA4;MEF2A;KMT2D;CDK7;HMGB1;RCOR3;DLG1;PPARGC1B;ZKSCAN3;NR3C1;SS18;LCOR;KLF3;ZNF182;MOV10;SMAD2;SMARCC2;BCL9L;BCAS3;CBX5;SBNO2;PRRX2;HOXA5;FUS;PLSCR1;GABPB2;PBX3;MED17;TBX15;SKI;CREBBP;ZBTB16;DCAF1;ZIC5;STAT3;TEF;HOXA7;NSD1;TFDP2;PHF8;JDP2;MED26;HOXC8;MED12;FGFR2;DNMT3A;FHOD1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HOXC4;SKIL;CAMK2D;HIVEP3;DHX9;AKAP8L;ZEB2;HOXA3;REST;KDM5B;MYSM1;VEZF1;HDGFL2;CEBPG;HOXB5;CRTC3;ZBTB37;GTF2IRD1;ZBTB8A;AR;ZFX;RGMA;DHX36;ZNF496;PRPF6;SAFB2;CTR9;FOXK1;MBD2;PPARGC1A;CDC5L;MAFG;IGF2;SETD3;SP140;SP100;SP2;SSU72;NCOA6;IMPACT;NFYC;PIAS3;ZBTB1;CDK13;NCOA1;DACT1;CHD2;MED1;UBE2I;JUP;PHF2;HNRNPK;ATF2;CCNK;TEAD3;CHD4;HOXB4;MIER1;UBP1;CHD3;ZNF467;MNAT1;WASL;ZNF569;RFX2;GABPA;NR1H3;SSBP2;JUN;TADA3;HIF1A;HCFC1;CALCOCO1;PCGF2;SMAD4;MED21;SENP1;PARP9;THAP3;MAML2;CRTC1;GLIS2;ID2;NIPBL;MAVS;BCLAF1;ZBTB24;CREBRF;VGLL3;DCAF6;ZXDC;RTF1;WWC1;NFATC4;ZBED4;FNIP1;TBX18;PARP1;RAD21;RORA;MEF2C;ARID5B;NRF1;PCGF6;FBXL19;TFCP2;HES1;TEAD2;EPC2;ZNF692;IRF9;PKD2;TPR;SUFU;TCF3;TCF7L1;PIAS4;RB1;BHLHE41;OGT;ZBTB34;PATZ1;CGGBP1;KDM1B;IRF1;MAML1;PPM1A;TSHZ3;HTATSF1;YBX1;SOX13;MLLT10;TCERG1;KAT8;GLI1;ATF6;CCN1;SOX6;SIX5;TRPS1;APOE;KDM3B;ZFP3;STAT1;CC2D1B;PRKDC;HINFP;VEGFA;CRLF3;USP2;MCPH1;ACVR1;ZNF367;HDAC1;MED8;CBX7;ZSCAN18;ZBED3;NCK1;ZKSCAN1;KDM3A;MKX;CIAO1;DDX3X;CNOT2;PRDM2;ZNF18;CARF;HOXB9;MED13L;ZNF697;NCK2;PTCH1;EFCAB7;RXRA;HOXC5;KLF15;RUNX2;BBX;MNT;FOXK2;TGFB3;KDM2A;SALL1;ABHD14B;PRDM15;ATOH8;TNIP2;IKZF2;BRD3;KLF6;TNRC6C;ARRB1;NOP53;SFPQ;ZNF112;PTOV1;FOXL1;HEYL;CITED2;CAMTA2;IL18;EPC1;MYBL1;SERPINE1;SIX1;STAT5A;TBX2;NR4A1;CNOT1;SMARCD2;ZFP37;NFYB;TWIST2;TLR4;CRTC2;WNT5A;PHIP;BAZ2B;MED27;NR4A2;PRKD1;CC2D1A;STAT5B;BAZ1B;LPIN2;BCL2L12;NFIC;ZFHX4;HNRNPU;TAF6L;POU6F2;SOD2;TFCP2L1;TRAF6;LPIN3
prerank,response to cadmium ion (GO:0046686),0.5771831145654046,1.6872484002583457,0.006369426751592357,0.12407866065931654,1.0,10/26,7.97%,MT2A;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;AKT1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.6320295288649711,-1.686617399672337,0.01098901098901099,0.16039147288792613,1.0,9/17,17.10%,NSA2;LAS1L;MPHOSPH6;URB1;PRKDC;MAK16;MTREX;EXOSC10;WDR12
prerank,positive regulation of nervous system development (GO:0051962),0.5147534451147189,1.685969205650826,0.008316008316008316,0.12423391137848466,1.0,10/42,9.59%,NRXN1;PTPRD;IL1RAPL1;EPHB1;MME;NLGN1;GRID2;CLSTN3;LRRC4B;OPRM1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3644396683153096,-1.6849916968717211,0.0,0.16136639485685295,1.0,183/476,24.97%,IGF1;MLLT3;NR2F2;EGFR;ZIC1;TCF4;GLI3;SMAD3;TGFBR1;TEAD1;CREB3L2;NFKB1;COL1A1;ZMIZ1;LRP6;WNT4;GLI2;ZNF423;NR1D2;MDFIC;ZFHX3;FOXC1;TRIM44;BMP7;ZIC2;IL31RA;FOXO3;EP300;BMP4;ARID1B;HDAC4;CREB5;KAT6B;TFEB;BTRC;TBL1X;BRD7;ELF1;NFIB;TBL1XR1;RREB1;NIBAN2;YAP1;RGMB;CREBL2;TGFB1I1;ZKSCAN3;SMAD2;SMARCC2;AXIN1;MED17;LBH;CREBBP;ZBTB16;FZD2;CDH1;STAT3;NSD3;TRIP4;NSD1;PHF8;MED12;SHC1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HIVEP3;REST;MAP3K5;HNRNPD;AR;ZNF496;FOXK1;PPARGC1A;SETD3;SP100;NCOA6;MAP2K1;NCOA1;MED1;PRMT2;NR1H3;JUN;TADA3;HIF1A;HCFC1;CALCOCO1;SMAD4;PARP9;ATF7IP;GLIS2;ID2;ZXDC;RORA;MEF2C;HES1;TEAD2;TCF3;FZD7;IRF1;PPM1A;DTX3L;KAT8;GLI1;BICRA;MMS19;ING5;APOE;STAT1;NAA15;HINFP;CRLF3;ZNF318;PITHD1;BRCA2;ACVR1;HDAC1;KDM3A;ILF2;RXRA;RUNX2;MAP2K7;FOXK2;TGFB3;SALL1;ATOH8;KLF6;ARHGEF11;AFAP1L2;CITED2;EPC1;MYBL1;SIX1;RNF20;PICALM;WNT5A;PHIP;FBXW11;NEK4;FZD1;INPP5K;BMP2;RNF14;INHBA;KARS1;SPP1;PML;ING1;MED16;NOS1;CDKN1C;NFYA;ZIC3;XRCC6;GATA6;KMT2A;NIF3L1;DVL3;FGF2;MAP3K12;SPIN1;MYRF;WAC;CAND2;MAFB;MED13;CD80;SMARCD3;MED14;HDAC2;GTF2H1;TFAP4;RNF6;CXXC1;DYRK1B;KMT2E;FOXE1;SNAI1;NAA16;ELF2;SOX11
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.36000514110164433,-1.684963084022398,0.0,0.15965127896290135,1.0,162/572,19.45%,BMP6;FOXP2;PRDM6;FOXP1;FHL2;NR2F2;AEBP1;TCF7L2;GLI3;SMAD3;NFKB1;PRDM5;ZNF148;KANK2;HDAC8;RBPJ;PHF21A;THRB;SMURF2;GLI2;DDX5;GLIS3;ATXN1;FOXP4;NR1D2;ZHX2;ZFHX3;ZEB1;RARB;MDM4;WWOX;FOXC1;PER3;ZMYM5;DAB2;FOXO3;EP300;BMP4;DICER1;HDAC4;BCOR;NCOR1;PRKN;CUX1;OSR1;WWC2;MXI1;TBL1X;WWP2;FRK;NFIB;KCNIP3;TBL1XR1;NR6A1;NFIX;RREB1;YAP1;EZH1;TAF3;RARG;MEF2A;HMGB1;DLG1;ZKSCAN3;NR3C1;LCOR;SMAD2;CBX5;SKI;CREBBP;ZBTB16;DCAF1;STAT3;HOXA7;NSD1;JDP2;FGFR2;DNMT3A;FOXC2;CHD8;RUNX1;SKIL;ZEB2;REST;GTF2IRD1;AR;CTR9;MBD2;IGF2;SP100;SP2;IMPACT;ZBTB1;DACT1;MED1;UBE2I;MIER1;BAG3;CHD3;NR1H3;JUN;HCFC1;PCGF2;SMAD4;PARP9;GLIS2;ID2;NIPBL;RTF1;WWC1;NFATC4;FNIP1;PARP1;MEF2C;ARID5B;HES1;ZNF692;TPR;SUFU;TCF3;RB1;BHLHE41;CGGBP1;KDM1B;PPM1A;SOX13;TCERG1;TRPS1;STAT1;VEGFA;USP2;MCPH1;HDAC1;CBX7;CNOT2;PRDM2;PTCH1;RXRA;MNT;SALL1;NOP53;SFPQ;CITED2;EPC1;TBX2;CNOT1;ZFP37;NR4A2;CC2D1A;NFIC;HNRNPU;TRAF6;HSBP1;ZNF436;NFATC3;BMP2;MDFI;UBE2D3;KMT5A;BPTF;ELK4;IFI27
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.6808876381198499,-1.6841872473345858,0.007380073800738007,0.15956226177652524,1.0,3/13,3.12%,RHOQ;OPA1;LRRK2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.7072227357571101,-1.684063917956064,0.005758157389635317,0.1580930291584753,1.0,3/11,6.91%,HMGB1;TWSG1;RUNX1
prerank,potassium ion transmembrane transport (GO:0071805),0.419777226676894,1.6820707798936432,0.0,0.12756908237994774,1.0,34/135,10.90%,KCND2;HCN1;SLC24A4;SLC24A2;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;SLC12A6;KCNJ11;KCNN1;KCNK13;KCNK10;HCN2;KCNJ10;KCND3;KCNC3;KCNH1;KCNQ5;ATP1A3;KCNK9;KCNN3;KCNAB1;LRRC55;KCNC1;KCNK1;SLC12A3;KCNQ2;ATP1A4;ATP1A1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.46196286378360835,1.6820371462388606,0.0,0.1263157044740645,1.0,25/75,11.92%,DCC;CTNNA2;ACTB;SPTBN4;MAPK8IP2;ADGRB1;ANK3;MAP1B;MAP2;APBB1;PAX2;MFSD2A;DSCAML1;NRCAM;ZDHHC17;SHTN1;PLPPR4;NTNG1;NTNG2;TAOK2;CELSR2;CNTN4;BRSK2;SLITRK5;DVL1
prerank,carbohydrate transport (GO:0008643),0.725661182034945,1.681851791541023,0.010638297872340425,0.12522324802294263,1.0,3/11,2.66%,AQP9;AQP11;SLC2A5
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.6726082911836385,-1.6814457522870274,0.005791505791505791,0.16044374968051833,1.0,6/15,3.93%,LRP6;ANKRD11;GLI2;FOXC1;EDA;WNT6
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.4024839069832561,-1.6809354702071926,0.0,0.15957948360698807,1.0,86/166,31.98%,NOTCH2;TEAD1;RBPJ;THRB;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NCOR1;NR3C2;TBL1X;CCNH;TBL1XR1;NR6A1;YAP1;TAF3;RARG;CDK7;NR3C1;MED17;CREBBP;MED26;AR;TAF4;PPARGC1A;CAVIN1;TAF1D;TBP;NCOA6;MED1;TEAD3;MNAT1;NR1H3;BRF1;NOTCH3;MAML2;RORA;ERCC3;TEAD2;MAML1;HDAC1;TAF8;RXRA;TAF13;GTF2B;NR4A1;MED27;NR4A2;POLR2H;TAF12;TAF9B;TAF2;GTF2F1;POLR2K;GTF2H1;NR2F1;TBPL1;GTF3C1;POLR2E;POLR3H;PPARA;NR2C1;TAF7;HDAC3;TAF1C;GTF2H4;GTF2E2;POLR1G;THRA;POLR2D;CDK9;ESR1;BRF2;TAF1A;RRN3;POLRMT;NR1H4;POLR1C;SNW1;GTF2A1;HDAC10;NR5A2;NR2C2AP;MAML3;E2F3
prerank,melanocyte differentiation (GO:0030318),-0.7177915272155397,-1.6806687061643546,0.011811023622047244,0.15840126844714147,1.0,5/11,14.79%,LRMDA;ENPP1;KIT;MEF2C;USP13
prerank,positive regulation of DNA binding (GO:0043388),-0.5491240949742572,-1.6801911673738485,0.007476635514018692,0.15762413152529328,1.0,18/31,26.06%,IGF1;FOXC1;PRKN;NIBAN2;HMGB1;SKI;CEBPG;NGF;HES1;RB1;TXN;TRAF6;PARK7;H1-0;NME1;TWIST1;EDF1;EGF
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7077000590850419,-1.6792578721883638,0.00945179584120983,0.15771749910538374,1.0,5/11,9.45%,MLLT3;DAB2;WNT5B;RSPO3;CSNK1E
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.43533049787937933,-1.6792061777471747,0.0,0.15616416233175193,1.0,40/95,19.51%,GPC6;UST;DSE;ST3GAL4;ANGPT1;DCN;B4GALT1;CEMIP;SDC2;BGN;FMOD;HS3ST3A1;GPC4;GPC3;EXT1;HSPG2;OGN;GLCE;HS2ST1;SLC10A7;NDST1;ABCC5;PRELP;CHST15;ST3GAL3;LUM;NDST2;HEXA;PXYLP1;CHST11;SDC4;CHPF2;HS6ST1;CHSY1;XYLT2;B4GALT5;GCNT2;OMD;CHST12;B4GALT7
prerank,negative regulation of axon extension (GO:0030517),0.5365533758734624,1.6769637517125526,0.012605042016806723,0.129403976794601,1.0,9/30,4.44%,SEMA3C;MAG;SEMA6A;SEMA4A;SEMA4F;MAP2;SEMA6D;SEMA4D;SEMA7A
prerank,androgen receptor signaling pathway (GO:0030521),-0.7203348090549878,-1.6745339387992604,0.007339449541284404,0.1624303092063817,1.0,7/11,18.83%,ZMIZ1;DDX5;DDX17;AR;PMEPA1;KDM3A;RNF14
prerank,metal ion transport (GO:0030001),0.4443594625644838,1.673429823833046,0.0020242914979757085,0.13273569993854953,1.0,32/86,19.30%,CAMK2A;TRPC5;CACNA1A;CACNA1B;RAMP2;SLC39A2;RYR2;RYR3;CACNA2D1;SLC8A1;SLC30A1;CACNA1E;TRPM2;TPT1;CACNG3;NIPA1;GRIN3A;SLC39A8;CACNG8;SLC30A5;TRPC1;NIPAL3;PSEN1;ATP2B2;SLC3A2;NIPAL4;CALCRL;FYN;MMGT1;MAGT1;ATP2C1;TRPV4
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.6997693098312872,1.6733272457608168,0.0064794816414686825,0.13156598198042263,1.0,6/12,8.33%,PROM1;PODXL;MYO1E;MAGI2;CD24;BASP1
prerank,nuclear migration (GO:0007097),-0.6752693174464298,-1.6729840570536558,0.014571948998178506,0.16303471052560473,1.0,8/13,18.27%,SYNE2;PCM1;SYNE3;CLMN;DOCK7;DYNC1H1;FBXW11;TMEM201
prerank,retrograde axonal transport (GO:0008090),0.6256587974840772,1.672285039678996,0.012448132780082987,0.13158432203396708,1.0,6/16,11.45%,DLG2;TMEM108;KIF1A;DST;HAP1;ACTR10
prerank,ethanol metabolic process (GO:0006067),-0.6889123437961568,-1.6719746339228327,0.012867647058823529,0.16297934668540887,1.0,3/12,10.52%,ALDH1A1;ALDH2;SULT1A1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.7189320822616925,-1.6696860530941973,0.013084112149532711,0.1655266222242562,1.0,9/11,25.79%,PUM2;WTIP;STAT3;DHX9;PUM1;LIMD1;AJUBA;XPO5;FXR1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5450645914976818,1.6688437610100706,0.008695652173913044,0.1345408100712769,1.0,9/32,6.13%,CAMK2A;RIMS1;RIMS2;SYT11;PREPL;MCTP1;RIMS3;SLC30A1;KCNMB4
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.4174583977956641,-1.6679552434040144,0.0,0.16670860050476544,1.0,43/132,18.04%,ZBTB20;IGF1;RNF152;DCN;FOXO3;ROCK1;ARNT;LRRK2;TFEB;PRKAA2;GSK3B;VGLL4;IRS1;TPCN1;HMGB1;MOV10;SNX9;RC3H1;UFL1;PFKFB4;TRIM8;ZSWIM8;ZC3HAV1;ABHD5;ABCD2;DACT1;NRDC;UPF1;PRKCD;HIF1A;ADAM9;CNOT8;TRIM5;DTX3L;ATF6;APOE;DAPK1;ADRA2A;PRXL2C;CNOT1;PRKD1;PRKAA1;PTPN1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4957555478810293,-1.6669886862121042,0.001984126984126984,0.16678881085898423,1.0,8/45,2.70%,BMP6;TGFBR1;BMPR1A;RBPMS;BMP5;BMP7;DAB2;BMP4
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.45340660073377814,-1.6659329782828118,0.001984126984126984,0.16704575161721416,1.0,16/74,7.97%,EYA2;IGF1;EYA1;TCF7L2;TGFBR1;BMP5;EYA4;ITGAV;CFLAR;BMP4;BIRC6;GSK3B;THBS1;SH3RF1;BCL2;AR
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5956577269528909,1.6655661687242236,0.02159827213822894,0.13735073552495433,1.0,11/20,17.04%,TMEM35A;CLU;PFDN6;BBS10;HSP90AB1;CCT2;HOPX;HSPD1;NDUFAF1;PTGES3;HSP90AA1
prerank,cellular response to drug (GO:0035690),0.57294187458102,1.6652954298590232,0.012738853503184714,0.13636041404474883,1.0,5/25,3.84%,TFRC;PDE4B;ACER2;GAS6;PPM1F
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5144735207263984,1.6628824425666935,0.004032258064516129,0.13789046950428138,1.0,11/41,6.45%,SLC24A2;GRIN1;GRIN2A;RYR2;HTR2C;RYR3;GRIN2B;CACNA2D1;GRIN2D;SLC8A1;TRPM2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5371099992918256,-1.6628525209773275,0.00784313725490196,0.17133718772087725,1.0,11/29,17.75%,PKD1;PIAS1;IL31RA;GHR;STAT3;CTR9;FER;PKD2;STAT1;STAT5A;STAT5B
prerank,histone lysine demethylation (GO:0070076),-0.5702087265823917,-1.6625041732517387,0.0076481835564053535,0.17032296998422874,1.0,10/25,15.84%,KDM7A;KDM4B;PHF8;KDM5B;KDM6A;PHF2;KDM1B;KDM3B;KDM3A;KDM2A
prerank,positive regulation of secretion (GO:0051047),0.7068955804216849,1.6623076519562496,0.02914798206278027,0.13726445626304073,1.0,5/11,16.58%,TRH;XBP1;ACSL3;NPR1;GPLD1
prerank,retinoid metabolic process (GO:0001523),-0.45266143209517523,-1.6596195658809287,0.0,0.1737047561330203,1.0,15/71,9.27%,GPC6;ALDH1A1;ALDH1A2;LRP1;RBP1;SDC2;CYP26B1;GPC4;RBP4;GPC3;HSPG2;ABCA4;DHRS3;AKR1B1;CYP1B1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.5043281608680815,-1.658149222698282,0.0,0.17437333906145402,1.0,20/43,18.77%,BMP6;IGF1;BMPR1A;WNT4;BMP7;IL6ST;BMP4;YAP1;MEF2C;IL6R;ATRAID;CCN1;ACVR1;RUNX2;FBN2;SUCO;CCN4;PRKD1;NPNT;BMP2
prerank,cellular response to cadmium ion (GO:0071276),0.5840895734285674,1.6580987328350865,0.008620689655172414,0.14118512491571045,1.0,10/24,7.97%,MT2A;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;AKT1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.5057678838082479,-1.6560152534404027,0.0019230769230769232,0.17698812229726144,1.0,18/45,21.07%,EGFR;EFEMP1;PLCE1;SLC30A10;GAREM1;SHC1;BRAF;PDPK1;PLCG1;KIF16B;REPS2;NCK2;HBEGF;GAB1;PTPN11;PIK3R1;AAMP;DGKD
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.380600780616928,-1.6539479500162555,0.0,0.17918745025023547,1.0,65/248,15.24%,RNF220;BICC1;WLS;MLLT3;LRRK1;EGFR;TCF7L2;GLI3;RBMS3;IGFBP2;NFKB1;COL1A1;LRP6;SMURF2;LGR4;PTK7;TNKS2;DAB2;TMEM64;STK3;DKK3;PRKN;LRRK2;CSNK1A1;BTRC;TBL1X;TBL1XR1;GSK3B;RNF146;GPC3;IGFBP6;UBR5;AXIN1;LYPD6;ADGRA2;FGFR2;CHD8;ZEB2;IGFBP4;XIAP;DACT1;JUP;WNK1;CSNK1E;LIMD1;USP47;TLE4;TLE1;LZTS2;PSMF1;CUL3;FZD7;TRPM4;PPM1A;SOX13;GLI1;UBAC2;APOE;PSMB2;UBE2B;HDAC1;ZBED3;DDX3X;LATS1;EMD
prerank,negative regulation of cell development (GO:0010721),-0.5808001970053012,-1.6538039134741327,0.011857707509881422,0.1778665591156408,1.0,6/25,7.45%,FBN1;IGF1;APPL2;PCM1;GSK3B;REST
prerank,response to sterol (GO:0036314),-0.704571204778007,-1.6527384271417092,0.002004008016032064,0.17796783971902808,1.0,4/11,11.64%,TGFBR1;TGFBR2;SMAD2;RORA
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.477622515616759,-1.6525923540247243,0.001941747572815534,0.17672133682826796,1.0,19/55,16.31%,GPC6;DCN;CEMIP;SDC2;BGN;FMOD;GPC4;SLC9A1;GNS;GPC3;HSPG2;OGN;PRELP;CEMIP2;LUM;GUSB;HEXA;SDC4;GALNS
prerank,negative regulation of metabolic process (GO:0009892),-0.4804266011078201,-1.6512947299272147,0.001838235294117647,0.17721779071526603,1.0,21/54,20.37%,ALDH1A1;RBPJ;ZNF423;LGR4;NPR3;DOCK7;ADAMTS5;FOXC2;LAMA4;NRDC;NR1H3;RB1;ACOT11;CCDC3;LNPEP;PLCL1;TLR4;ABHD6;MAP2K6;FIS1;TLE3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6515659064011585,1.65128071605159,0.017699115044247787,0.1485736866663188,1.0,5/13,13.71%,TMSB4X;HEY1;PER2;SIN3A;PSEN1
prerank,embryonic organ morphogenesis (GO:0048562),-0.5051123190052109,-1.6509107622367503,0.007766990291262136,0.17652402019808702,1.0,21/42,20.44%,FBN1;EFEMP1;PDGFRA;HOXB3;RBP4;RARG;MFAP5;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4;ID2;NIPBL;HES1;ACVR1;HOXB9;FBN2;SIX1;MEGF8;RBPMS2
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4477038468014266,-1.6491617209306677,0.0,0.17837597229790886,1.0,26/73,17.71%,ITGBL1;COL3A1;PTN;FBLN1;PLPP3;ITGAV;DAB2;ABL1;ITGA10;ITGB1;FYB1;ITGA11;NRP1;ITGB5;CDC42;ITGB8;LAMA3;ADAM9;TEC;ZYX;CUL3;FN1;ITGA5;DOCK1;ADAMTS1;PRKD1
prerank,rRNA processing (GO:0006364),0.403737277866354,1.6489717734098839,0.0,0.150450796871626,1.0,55/172,16.10%,TSR3;EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;TFB1M;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;ERI1;RPL21;DKC1;RPS7;RPL23A;NHP2;NOP2;RPL8;POP5;RPS14;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;RRP1B;RRP1;NOP56;RPS25;MDN1;UTP15
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6399770922072087,-1.6489400470677504,0.007619047619047619,0.17735633761994113,1.0,8/16,11.62%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;PARP1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.5166562172895719,-1.646463403894403,0.005893909626719057,0.180431664677445,1.0,9/38,12.06%,BMP6;SASH1;ANKRD17;PUM2;PLSCR1;DHX9;PUM1;DDX60;RIOK3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.3290953121748982,-1.6454367021484289,0.0,0.1807894317191637,1.0,424/1646,18.70%,ZBTB20;NFIA;PBX1;FOXP2;IGF1;BNC2;MLLT3;FOXP1;DENND4A;NR2F2;EGFR;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;TGFBR1;ZBTB7C;MAF;SOX5;RBFOX2;EFEMP1;TEAD1;FOXD1;PRRX1;CREB3L2;NFKB1;TRAK1;PRDM5;COL1A1;HOXB6;ZNF148;HIVEP2;ZKSCAN2;ZMIZ1;LRP6;WNT4;RBPJ;CCNL2;MIDEAS;LIMS1;SMAD6;SMURF2;GLI2;ZNF423;DDX5;GLIS3;HOXC6;ATXN1;FOXP4;NR1D2;ZHX2;MDFIC;ZFHX3;ZEB1;MDM4;BRWD1;FOXC1;TRIM44;KLF9;BMP7;PIAS1;ZIC2;IL31RA;FOXO3;EP300;BMP4;ARID1B;HDAC4;CREB5;GTF2H2;ERC1;ABL1;BCOR;KAT6B;DKK3;NCOR1;ARNT;CUX1;OSR1;WWC2;CCNT2;CCNL1;NR3C2;TFEB;MXI1;HOXB3;MEOX2;KDM7A;BTRC;TBL1X;BRD7;FOXN3;ELF1;RBBP8;WWP2;NFIB;SETD5;CCNH;TBL1XR1;NR6A1;NFIX;KIT;GON4L;RREB1;CCNT1;NIBAN2;VGLL4;YAP1;WTIP;RCOR1;RGMB;CREBL2;DDX17;KHDRBS1;GMEB1;BAZ1A;ANXA4;TGFB1I1;CDK16;MEF2A;KMT2D;BAZ2A;HMGB1;RCOR3;PPARGC1B;ZKSCAN3;NR3C1;LCOR;KLF3;ZNF182;SRSF10;SMAD2;SMARCC2;ATP8B1;CBX5;SBNO2;PRRX2;AXIN1;HOXA5;FUS;SNX6;PBX3;MED17;LBH;TBX15;CREBBP;ZBTB16;FZD2;CDH1;ZIC5;STAT3;TEF;NSD3;HOXA7;TRIP4;NSD1;TFDP2;PHF8;JDP2;MED26;TRRAP;HOXC8;MED12;L3MBTL3;NAB1;SHC1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HOXC4;CAMK2D;HIVEP3;DHX9;WWP1;ZEB2;SCMH1;HOXA3;REST;KDM5B;POFUT1;VEZF1;HDGFL2;CEBPG;HOXB5;MAP3K5;ZBTB37;HNRNPD;BCL7A;GTF2IRD1;ZBTB8A;AR;ZFX;DHX36;ZNF496;SAFB2;CTR9;FOXK1;MBD2;PPARGC1A;RUNX1T1;CDC5L;MAFG;IGF2;SETD3;SP140;SP100;CBFA2T2;SP2;PTPRK;NCOA6;MAP2K1;NFYC;PIAS3;ZBTB1;NCOA1;CHD2;MED1;UBE2I;PHF2;HNRNPK;ATF2;CCNK;TEAD3;CHD4;HOXB4;UBP1;BTAF1;CHD3;ZNF467;ZFAT;MNAT1;PRMT2;ZNF569;RFX2;GABPA;NR1H3;SSBP2;JUN;TADA3;TULP3;HIF1A;MPHOSPH8;HCFC1;CALCOCO1;SMAD4;MED21;LIMD1;PARP9;ATF7IP;GLIS2;ID2;NIPBL;USP47;CDK11B;BCLAF1;ZBTB24;CREBRF;TLE1;GPBP1L1;VGLL3;ZXDC;WWC1;NFATC4;TBX18;RAD21;RORA;MEF2C;ARID5B;NRF1;PCGF6;FBXL19;SPTY2D1;PBXIP1;TFCP2;HES1;TEAD2;EPC2;ZNF692;IRF9;SUFU;TCF3;TCF7L1;PIAS4;RB1;EHMT1;BHLHE41;OGT;ZBTB34;CCAR1;FZD7;CRABP2;PATZ1;IRF1;PPM1A;TSHZ3;HTATSF1;YBX1;SOX13;DTX3L;KAT8;GLI1;BICRA;ATF6;MMS19;SOX6;CHD7;SIX5;TRPS1;ING5;APOE;KDM3B;PHF1;ZFP3;STAT1;CC2D1B;NAA15;HINFP;VEGFA;CRLF3;ZNF318;PITHD1;BRCA2;ACVR1;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;KDM3A;MKX;USP13;CIAO1;ILF2;CNOT2;CBFA2T3;PRDM2;ZNF18;TAF5L;SCML4;CARF;HOXB9;PHC2;MED13L;ZNF697;RXRA;HOXC5;KLF15;RUNX2;BBX;JARID2;MNT;MAP2K7;FOXK2;TGFB3;KDM2A;SALL1;VSX1;LOXL3;PRDM15;ATOH8;L3MBTL2;PRMT5;IKZF2;BRD3;KLF6;ARRB1;SFPQ;ZNF112;DAP;FOXL1;ARHGEF11;GLRX2;AFAP1L2;HEYL;CITED2;CAMTA2;EPC1;PDCD4;MYBL1;SIX1;STAT5A;TBX2;NR4A1;ATXN1L;RNF20;SMARCD2;ZFP37;NFYB;ZMYND15;TWIST2;PICALM;WNT5A;PHIP;BAZ2B;MED27;NR4A2;CC2D1A;STAT5B;BAZ1B;NFIC;ZFHX4;FBXW11;TAF6L;MSL3;POU6F2;SOD2;TFCP2L1;TRAF6;NEK4;RHOH;ZKSCAN7;FZD1;RRP8;HMG20A;ZNF436;NFATC3;INPP5K
prerank,long-term synaptic potentiation (GO:0060291),0.589523310596721,1.6442505085043413,0.025,0.1553402749968752,1.0,7/21,9.15%,MPP2;SLC24A2;GRIN2A;GRIN2B;GRIN2D;NPTN;SHANK2
prerank,protein autoubiquitination (GO:0051865),-0.46753747142567303,-1.6440880119970314,0.0037593984962406013,0.18151930436974045,1.0,25/61,20.04%,RNF220;PRKN;WWP2;RNF115;RNF146;UHRF2;RNF213;SH3RF1;RNF8;RNFT1;DDB2;TRAF2;CUL3;DTX3L;SH3RF2;UBE2B;SH3RF3;ERCC8;RNF181;BFAR;TRAF6;UBE2D3;LRSAM1;RNF11;NFX1
prerank,RNA destabilization (GO:0050779),-0.6169313990104834,-1.6435536697197295,0.013513513513513514,0.18089169905858002,1.0,6/18,7.62%,ROCK2;CELF1;FTO;ROCK1;YTHDF3;PUM1
prerank,adherens junction organization (GO:0034332),0.4859706176530375,1.6417773404913751,0.0021413276231263384,0.1572989874700847,1.0,19/48,14.24%,CDH12;CDH8;ACTB;CADM1;CADM2;RAMP2;CDH7;CDH19;CDH20;CDH18;CDH2;CDH10;DCHS1;CADM3;TJP1;NECTIN1;SMAD7;CTNND1;JAM3
prerank,regulation of ossification (GO:0030278),-0.5123000599742644,-1.6417508546731732,0.007575757575757576,0.18250539258310067,1.0,19/36,24.97%,PTN;LRP6;RBPJ;SMAD6;BMP4;ENPP1;ZBTB16;NBR1;MEF2C;BMP2K;ACVR1;ECM1;WNT5A;CHSY1;BMP2;PTPN11;LRP4;TWIST1;SOX11
prerank,regulation of dendrite development (GO:0050773),0.5104511777505105,1.6393996433247189,0.008316008316008316,0.15914021292440644,1.0,14/37,9.89%,ADGRB3;DCC;CSMD3;LRP8;HECW1;TNIK;MFSD2A;SEMA4D;ALK;HECW2;ZDHHC15;CDKL5;LZTS1;DAB2IP
prerank,endoderm formation (GO:0001706),-0.5229799776785592,-1.6390885495176564,0.005628517823639775,0.1860043131624905,1.0,14/35,16.01%,COL8A1;COL12A1;ITGAV;VTN;COL6A1;ITGB5;SETD2;LAMA3;MMP14;MMP2;FN1;DUSP1;ITGA5;ITGA4
prerank,cytosolic transport (GO:0016482),-0.4263715607308652,-1.6390349281562484,0.001968503937007874,0.1846147932712017,1.0,51/108,26.35%,DENND2A;VTI1A;VPS13A;ERC1;GBF1;EEA1;TMEM87A;SNX6;VTI1B;STX16;CORO7;MON2;CCDC91;KIF16B;GOSR1;VPS54;WDR91;VPS13C;STX5;BECN1;TMEM87B;DENND5A;PIK3C3;HEATR5A;DOP1B;ANKRD27;EHD3;GOSR2;LAMP1;ANKFY1;TBC1D17;HEATR5B;SNF8;CLN5;TBC1D10A;WDR81;STX8;VPS26B;BET1L;RGP1;TBC1D23;SPAG9;AP2A1;PTPN23;MYO1D;RAB9A;RAB7A;BAIAP3;RAB5A;PHETA1;TBC1D10B
prerank,embryonic digit morphogenesis (GO:0042733),-0.6197406229961578,-1.6384241154368968,0.0074487895716946,0.18425265942570643,1.0,9/18,17.05%,GLI3;OSR1;WDPCP;CREBBP;ECE1;MAP3K20;HDAC1;SALL1;TBX2
prerank,mRNA metabolic process (GO:0016071),-0.4336308377688091,-1.6361793219526533,0.005859375,0.186621827709405,1.0,50/90,33.43%,SON;DDX5;CELF1;DIS3L2;HNRNPR;PCF11;U2AF2;AKAP8L;CPSF3;PCBP2;PPARGC1A;PRPF3;SLBP;SF3A1;USP39;SCAF11;SF3A3;TCERG1;SRSF1;ERN1;SFPQ;PRKACA;CSTF3;SNRPF;CNOT10;RNASE4;SRSF7;SRSF11;GEMIN2;SRSF2;NUDT21;HSF1;DHX15;NONO;KIN;PRMT9;NCBP2;PCBP3;PRPF8;LSM11;LSM6;PRPF18;ZFP36L2;SF3A2;TBRG4;SF3B4;NUDT16;NUDT16L1;HNRNPA2B1;HSPA1A
prerank,negative regulation of cell junction assembly (GO:1901889),-0.5532731606533571,-1.6360350050024728,0.005825242718446602,0.1854429944531084,1.0,6/25,5.45%,PHLDB2;ROCK2;ARHGAP6;ROCK1;THBS1;BCAS3
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6462468496358937,-1.635517792941252,0.018656716417910446,0.18510102871522216,1.0,11/15,28.53%,WNT5B;GPC3;RSPO3;RNF213;DACT1;CSNK1E;SFRP4;CSNK1D;SPEF1;ZNRF3;DAAM2
prerank,axon guidance (GO:0007411),0.386232924540313,1.6347685770370994,0.0,0.16432098427410924,1.0,60/201,12.13%,DSCAM;BSG;NRXN3;NRXN1;DCC;EPHA6;SEMA3C;TMEFF1;EPHB1;SPTBN4;PLXNB3;SEMA6A;DAB1;UNC5C;SPTB;CXCL12;EPHA5;SEMA4A;SEMA4F;SHANK3;ROBO4;CNTN6;SEMA6D;SEMA4D;DOK6;SEMA7A;EFNB3;TNR;RPS6KA5;NOTCH1;DSCAML1;NCAM1;UNC5D;SLIT3;SLIT1;NPTN;ENAH;PRKCQ;LHX1;RAP1GAP;VSTM2L;UNC5B;EFNA2;PLXNA4;ROBO2;EPHA10;SPTBN5;RELN;TUBB3;ROBO3;FEZ1;NTN1;PTPRM;CHN1;CNTN4;DOK5;SPTBN1;DOK2;CNTN2;RET
prerank,nervous system development (GO:0007399),0.3624006827117313,1.634767324391411,0.0,0.16290442406484967,1.0,104/429,14.75%,SPOCK2;PAX8;DNM3;DSCAM;KIRREL3;ST8SIA4;NELL1;ADGRL3;NAV3;SPOCK1;RBFOX3;NRXN1;TRPC5;LSAMP;MYT1L;LY6H;ERBB4;SLC2A1;MAL;MBP;LRCH4;PROX1;ASIC2;EPHB1;FGF12;NLGN1;CHRM3;GPM6A;SEMA6A;SH3GL2;PCDH1;TENM1;NRG1;ADGRB1;GPM6B;SH3GL3;DOC2A;DNER;MPZ;SEMA4F;AHI1;SHANK3;MOBP;CDH2;GRIK1;FGF13;CNTN6;ADAM22;APBA2;ADAM23;MOG;EFNB3;RBFOX1;NAB2;GJB1;DSCAML1;NRXN2;NPAS2;CYP26C1;NRCAM;NFASC;LHX1;ARHGAP26;FGF5;SRRM4;NINJ1;MTF1;PCDHB6;IL1RAPL2;ROBO2;RELN;SHANK2;ACVR1C;DCHS1;FEZ1;DPF3;HAP1;CNTN4;SMPD1;KCNQ2;PCDHA4;APC;NRGN;MBD5;SCN2A;NPTX1;DVL1;DPYSL2;DCTN1;SH3GL1;KALRN;DPYSL5;VCAN;HAPLN3;PTPRZ1;SERF1A;NHEJ1;STMN3;DCX;LGI1;PPT1;CHRM2;HPCAL4;HAPLN4
prerank,cardiac conduction system development (GO:0003161),-0.5641420658968499,-1.6337675441401156,0.01107011070110701,0.18673270313927492,1.0,11/24,21.37%,NOTCH2;BMPR1A;GJB6;BMP4;GJA1;SMAD4;TBX18;MAML1;CACNA1G;GATA6;SMAD1
prerank,regulation of interleukin-4 production (GO:0032673),0.5951018492979309,1.6335437261943233,0.013043478260869565,0.16321966551679937,1.0,3/21,6.50%,LEF1;SLC7A5;PRKCQ
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.5334346869960008,-1.6332629104829903,0.015267175572519083,0.18630552706266454,1.0,9/32,10.53%,ZBTB20;IGF1;PID1;ARNT;PRKAA2;NUPR1;PFKFB4;PPARGC1A;HIF1A
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.43046747219436676,-1.6332157818406112,0.0019455252918287938,0.18500413588093584,1.0,30/87,15.95%,COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;APPL2;BMPR1A;ZMIZ1;SMAD6;FMOD;TGFBR2;ITGB1;SMAD2;SKI;TWSG1;ITGB5;PTPRK;RHOA;JUN;ADAM9;SMAD4;ARHGEF18;ZYX;APPL1;PARD3;SMURF1;ACVR1;PRKCZ;TGFB3;LRRC32
prerank,regulation of autophagy (GO:0010506),-0.37995130620993095,-1.6297280882923868,0.0019305019305019305,0.18994644800654184,1.0,71/216,22.60%,PRKAG2;ITPR1;RNF152;LEPR;DCN;EIF4G3;FOXO3;EP300;ROCK1;ATP6V1B2;ABL1;PRKN;LRRK2;TFEB;PRKAA2;NUPR1;GSK3B;RPTOR;TPCN1;HMGB1;ZKSCAN3;ATP6V0D1;DNM1L;SNX6;UBQLN1;STAT3;UFL1;BCL2;TRIM8;MTOR;TPCN2;PIP4K2C;FOXK1;VDAC1;PTPN22;EIF4E;USP33;RB1CC1;ABL2;PRKAB2;TRIM5;FBXW7;MTMR3;KLHL22;KAT8;ATF6;GFAP;CTSA;ERN1;USP13;FOXK2;DAPK1;DAP;RUBCN;DAPK2;PRKACA;RMC1;PRKD1;PRKAA1;GPR137B;EIF4G1;PLEKHF1;ORMDL3;PRKAG3;BMF;PRKAB1;BNIP3;DCAF12;VPS26B;TICAM1;ATP6V1G2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5906662877528437,-1.6291253917530792,0.011428571428571429,0.1896189971114527,1.0,9/20,20.12%,IGF1;FOXC1;EP300;NIBAN2;RB1;GTF2B;TRAF6;PARK7;H1-0
prerank,regulation of biosynthetic process (GO:0009889),0.6819233590158803,1.6290536158199294,0.029411764705882353,0.1682140742356276,1.0,3/11,10.32%,THRSP;SNCA;MID1IP1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.6835273826815512,-1.6288119113192312,0.019762845849802372,0.18609244406223224,1.0,9/12,24.34%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;CUL3;RB1;CDC27;ANAPC11;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.6835273826815512,-1.6288119113192312,0.019762845849802372,0.18609244406223224,1.0,9/12,24.34%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;CUL3;RB1;CDC27;ANAPC11;CDC16
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.6835273826815512,-1.6288119113192312,0.019762845849802372,0.18609244406223224,1.0,9/12,24.34%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;CUL3;RB1;CDC27;ANAPC11;CDC16
prerank,protein K63-linked ubiquitination (GO:0070534),-0.5036163238010108,-1.626173792326441,0.015037593984962405,0.18913922794568988,1.0,19/41,22.77%,RNF152;UBE2N;UBE2E2;PRKN;WWP2;RNF115;TRAF3IP2;RNF8;TRAF2;TRIM5;UBE2B;TRAF3;HECTD1;BFAR;UBE2S;TRAF6;ARIH2;TRAF5;UBE2V2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.39529445348438014,1.6260093710390493,0.0,0.17098114082487448,1.0,54/168,14.45%,EXOSC5;RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;HELZ2;RPL10A;RPS24;PPP2R1A;RPL27A;RPS17;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;CNOT6L;RPL12;RPS15;PABPC1;RPL14;SMG8;RPL5;RPS4X;ERI1;RPL21;RPS7;RPL23A;RPL8;MAGOHB;MAGOH;RPS14;RPS3;RPS2;RPS5;RPL18A;ATM;RPS28
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5605096832625136,-1.6255078534134035,0.017716535433070866,0.1890319921955847,1.0,8/25,5.30%,SULF1;BMPR1A;FOXD1;RBPJ;ZNF423;BMP4;NUMA1;SMAD2
prerank,regulation of BMP signaling pathway (GO:0030510),-0.445565585106222,-1.6250060772253396,0.002036659877800407,0.18859891100553047,1.0,20/73,10.80%,FSTL1;SULF1;CRIM1;BMPR1A;FOXD1;RBPJ;SMAD6;SMURF2;ZNF423;NBL1;BMP4;NUMA1;HTRA3;SMAD2;SKI;TWSG1;SKIL;XIAP;SMAD4;BMPER
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.48240673972068376,-1.6239549827466135,0.003590664272890485,0.18907207132917628,1.0,19/46,20.37%,ALDH1A1;RBPJ;ZNF423;LGR4;NPR3;DOCK7;ADAMTS5;FOXC2;LAMA4;NRDC;NR1H3;RB1;ACOT11;LNPEP;PLCL1;TLR4;ABHD6;MAP2K6;TLE3
prerank,pharyngeal system development (GO:0060037),-0.6308425935130375,-1.6236621878280015,0.023636363636363636,0.18828880899876888,1.0,5/15,2.70%,TGFBR1;BMPR1A;BMP5;BMP7;BMP4
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.48110385531204997,-1.6232519595410928,0.007905138339920948,0.18768897186114736,1.0,17/46,17.44%,IGF1;FOXP1;TCF7L2;IGFBP5;PDGFRB;BMP4;ELN;IGFBP3;THBS1;OGN;ID2;APOD;IL6R;STAT1;PRKDC;IL18;CCN4
prerank,sensory perception of chemical stimulus (GO:0007606),0.6193809022442662,1.6226615992524454,0.017204301075268817,0.1743798936697856,1.0,5/15,13.89%,SLC24A4;ADCY3;SYT10;GNAL;CD36
prerank,mesonephric tubule development (GO:0072164),-0.6228812897707617,-1.6212442185068214,0.020370370370370372,0.19011794771381962,1.0,10/15,18.09%,PKD1;FOXC1;BMP7;BMP4;OSR1;FGFR2;PKD2;SALL1;SIX1;NPNT
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6896496576444423,-1.6210347678483046,0.02071563088512241,0.18914895783035193,1.0,6/11,18.77%,EFNB2;FRS2;MEF2C;FZD7;SOX6;BMP2
prerank,regulation of acrosome reaction (GO:0060046),0.6880712508729547,1.6209213315588256,0.043010752688172046,0.17538607616186927,1.0,2/10,5.65%,GLRA1;PLCB1
prerank,neural crest cell development (GO:0014032),0.4953306498869931,1.6201286127076417,0.013071895424836602,0.17519772470078065,1.0,11/44,6.01%,ERBB4;SEMA3C;SEMA6A;NRG1;SEMA4A;SEMA4F;CDH2;SEMA6D;SEMA4D;SEMA7A;CYP26C1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.5683255030102834,-1.6165785960872732,0.006024096385542169,0.19615792626638814,1.0,7/22,9.06%,NOTCH2;KLF9;STXBP4;FGFR2;SRSF6;PTPRK;MED1
prerank,regulation of monocyte differentiation (GO:0045655),-0.65249552885529,-1.6160157487142877,0.01289134438305709,0.19586535354984205,1.0,4/14,6.18%,FOXP1;IL34;ACIN1;HOXA7
prerank,protein export from nucleus (GO:0006611),-0.5541343341727931,-1.61402331225101,0.011673151750972763,0.19842932182102016,1.0,14/27,23.70%,RANBP3L;PKD1;XPO4;STYX;DUSP16;NUP42;NUP214;TPR;SMURF1;RANBP3;DESI1;CHP1;XPO5;XPO1
prerank,regulation of neurotransmitter transport (GO:0051588),0.6138900677962813,1.6118628008270939,0.02391304347826087,0.18625406371539652,1.0,5/16,10.56%,CAMK2A;RIMS1;MCTP1;KCNMB4;CPLX1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6822026833649981,-1.611673314209546,0.02626641651031895,0.20155923240783646,1.0,2/10,2.69%,ROCK2;ROCK1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5863190311334896,-1.6110806678620218,0.011741682974559686,0.2012682653195312,1.0,10/19,13.56%,TGFBR3;TGFBR1;BMPR1A;RBPJ;VGLL4;RBP4;FGFR2;RUNX1;MEF2C;GLI1
prerank,cellular response to misfolded protein (GO:0071218),-0.5857413720770285,-1.6108431409711805,0.014056224899598393,0.20045136355764218,1.0,14/20,31.82%,UGGT2;KLHL15;DNAJB14;POMT2;CUL3;AUP1;DERL1;VCP;TOR1A;BAG6;DNAJC18;RNF126;UFD1;UBE2W
prerank,diterpenoid metabolic process (GO:0016101),-0.4646892414217595,-1.6107505861844436,0.006036217303822937,0.19926582654146607,1.0,12/55,7.97%,GPC6;ALDH1A1;LRP1;RBP1;SDC2;GPC4;RBP4;GPC3;HSPG2;ABCA4;DHRS3;AKR1B1
prerank,GTP metabolic process (GO:0046039),-0.6321052453465643,-1.6099426595344026,0.01486988847583643,0.19938746436643487,1.0,3/15,3.12%,RHOQ;OPA1;LRRK2
prerank,neutral amino acid transport (GO:0015804),0.5442968672633657,1.609899555489166,0.01639344262295082,0.1879871333393616,1.0,7/28,9.57%,SLC7A5;SLC6A6;SLC6A17;SLC1A1;SLC7A8;SLC43A2;SLC36A1
prerank,regulation of protein export from nucleus (GO:0046825),-0.5679099085915345,-1.609131005323077,0.015037593984962405,0.19947698091490138,1.0,13/23,19.45%,TCF7L2;XPO4;PTPN14;GSK3B;RAPGEF3;SP100;BAG3;TPR;YWHAE;EMD;ANP32B;PARK7;IFI27
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5139879576395576,-1.6082411807971122,0.009363295880149813,0.19982347795075983,1.0,15/34,22.02%,DOCK5;LIMS1;ABL1;RREB1;FLNA;NRP1;CDC42;S100A10;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CRKL
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.5945536132133953,-1.608235179607524,0.017857142857142856,0.1985663161337999,1.0,10/19,30.79%,IRS1;ABHD5;ABCD2;PRKCD;AKT2;DAGLB;TWIST1;PNPLA2;PPARA;ANGPTL3
prerank,positive regulation of telomerase activity (GO:0051973),0.502911581488902,1.6073072185868815,0.014799154334038054,0.1905769094019761,1.0,15/33,18.94%,PRKCQ;KLF4;HSP90AB1;CCT2;DKC1;CCT4;PARM1;PTGES3;XRCC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;TCP1
prerank,calcium ion import across plasma membrane (GO:0098703),0.6439816847375244,1.6051751394962839,0.022727272727272728,0.1925176538107808,1.0,4/14,6.45%,SLC24A2;CACNA2D1;SLC8A1;TRPM2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.5729301046152404,-1.6051686128613532,0.016697588126159554,0.20303714430057251,1.0,7/23,10.53%,ZBTB20;IGF1;NFKB1;ARNT;PRKAA2;PFKFB4;HIF1A
prerank,calcium ion import into cytosol (GO:1902656),0.6303123414661015,1.6050064589668978,0.029166666666666667,0.19121939363132406,1.0,4/15,6.45%,SLC24A2;CACNA2D1;SLC8A1;TRPM2
prerank,calcium ion transport into cytosol (GO:0060402),0.572133205141892,1.6041429569641537,0.00881057268722467,0.19113826933365283,1.0,10/21,11.22%,GRIN1;GRIN2A;RYR2;GRIN2B;CACNA2D1;GRIN2D;SLC8A1;TRPM2;ADRA1A;JPH3
prerank,organelle disassembly (GO:1903008),-0.5177910728782733,-1.6040187785022268,0.01727447216890595,0.20371246675717866,1.0,16/33,22.89%,GBF1;UFL1;DENR;UBA5;TEX264;RB1CC1;ULK2;STX5;ATG2A;GFM2;MRRF;ATG2B;VCP;KIF9;ZFAND1;PLK5
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5061494271133,-1.603079578302159,0.007722007722007722,0.20425354617203365,1.0,17/37,25.95%,APPL2;STAT3;ABCD2;IL17RA;HIF1A;APOD;APPL1;IL17D;PDCD4;TLR4;CHID1;ADCY7;TICAM1;NLRC3;SIRPA;MAPK14;PPARA
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5363973050706807,1.6026476746823546,0.015533980582524271,0.1916399460875244,1.0,11/27,13.71%,CTNNA2;IL1RAPL1;MBOAT1;HOMER1;AKT1;NTNG1;NTNG2;BRSK2;CCDC88A;EFHC2;PSEN1
prerank,neuron development (GO:0048666),0.4009738044642087,1.6025623828158828,0.0019120458891013384,0.19028120663616455,1.0,37/141,10.81%,CNTNAP2;GPRIN1;MYT1L;FRY;PLP1;TMEM108;NLGN1;TENM2;GPM6A;SH3GL2;PBX2;TENM1;GPM6B;EPHA5;MAP2;STMN1;NTRK2;TENM4;STX3;TGFB2;ALK;PPP1R9A;TENM3;GPRIN3;SRRM4;ADCYAP1;STMN4;RASGRF1;BICDL1;B4GALT6;CAMSAP1;RAB35;STMN2;ATP8A2;PTPRM;MICALL2;CNTN4
prerank,embryonic digestive tract development (GO:0048566),-0.5949245881119781,-1.6025120862890325,0.013435700575815739,0.2041478453114839,1.0,11/18,20.84%,GLI3;PDGFRA;GLI2;RARB;PCSK5;FGFR2;ID2;NIPBL;SALL1;RBPMS2;PKDCC
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6508176618037822,-1.6023632878178131,0.032432432432432434,0.20315864866147273,1.0,7/13,18.77%,NFKB1;BMP5;DKK3;REST;ERLIN1;APOE;BMP2
prerank,Golgi to endosome transport (GO:0006895),-0.6188890801776974,-1.6020271090099443,0.017142857142857144,0.20246495760458955,1.0,8/16,14.39%,VPS13A;GBF1;CORO7;MON2;KIF16B;WIPI1;VPS13C;DOP1B
prerank,intracellular cholesterol transport (GO:0032367),-0.6306845036837003,-1.6011774479699805,0.029038112522686024,0.20282711175027315,1.0,5/15,11.63%,LRP6;ABCA1;LDLR;RELCH;NPC2
prerank,keratan sulfate catabolic process (GO:0042340),-0.6788419187797926,-1.600004332799371,0.018484288354898338,0.2037952184004886,1.0,8/11,18.91%,FMOD;GNS;OGN;PRELP;LUM;HEXA;GALNS;OMD
prerank,limb development (GO:0060173),-0.5321448939893121,-1.5997876844270804,0.024344569288389514,0.20298170762954434,1.0,15/28,25.77%,SMOC1;GLI3;KAT2B;PCSK5;MAP3K20;RSPO2;CHD7;PTCH1;SALL1;IQCE;MEGF8;LRP4;KREMEN1;ZNRF3;COMP
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.6743795815903737,-1.5997205658775742,0.018691588785046728,0.20191537733069015,1.0,5/12,9.11%,ELF1;RC3H1;RUNX1;LYN;PTPN22
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7085204218696715,-1.598298636020498,0.014625228519195612,0.20361222987400981,1.0,6/10,19.37%,GRB10;ARNT;VTN;HIF1A;ITGA5;ITGB3
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5339031926202985,1.5980681091971167,0.023157894736842106,0.19558009477354416,1.0,11/24,18.89%,LIG3;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5167359281808287,1.5954025565374035,0.014644351464435146,0.19825020142520045,1.0,17/32,19.69%,NAV3;MAP2;STMN1;FGF13;SNCA;TUBB4A;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;FKBP4;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,anterior/posterior pattern specification (GO:0009952),-0.4637353172184813,-1.5952381087973553,0.007736943907156673,0.2082759078644043,1.0,19/53,16.75%,WLS;TGFBR1;HOXB6;HOXC6;HOXB3;PCSK5;SMAD2;HOXA5;SKI;HOXA7;HOXC4;HOXA3;HOXB5;HOXB4;HES1;BHLHE41;HOXB9;HOXC5;HEYL
prerank,response to histamine (GO:0034776),0.7008705711503866,1.595049511216205,0.017278617710583154,0.1973711509171779,1.0,4/10,8.57%,GABRB3;GABRB1;GABRB2;GABRG2
prerank,neuronal action potential (GO:0019228),0.5635406567203044,1.594788880862461,0.021929824561403508,0.19623413824042443,1.0,10/22,15.66%,SCN1A;ANK3;KCNMB2;KCNMB3;KCNMB4;SCN3A;KCNA2;SCN2A;CACNA1I;SCN8A
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.479412760118963,-1.592525491325487,0.009708737864077669,0.21187435525660842,1.0,15/44,11.39%,ROCK2;CELF1;FTO;ROCK1;TNRC6B;YTHDF3;TNRC6A;MOV10;EIF4ENIF1;RC3H1;ZC3HAV1;PUM1;DHX36;UPF1;CNOT8
prerank,energy reserve metabolic process (GO:0006112),-0.5799698333645892,-1.5923736869394778,0.02766798418972332,0.21098208361374435,1.0,7/19,9.04%,PRKAG2;PID1;LEPR;PHKB;GSK3B;GFPT1;PHKA1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6061307700723892,-1.5922888978655432,0.025048169556840076,0.20996233408569928,1.0,10/16,16.37%,DDX5;DDX17;HNRNPM;DHX9;SRSF6;CDK13;SLU7;RSRC1;SRSF1;SFPQ
prerank,Golgi localization (GO:0051645),-0.6798998343117574,-1.5900351570467133,0.02099236641221374,0.21294789224103594,1.0,6/11,18.62%,UVRAG;ARHGAP21;CDC42;ARCN1;TBCCD1;COPG1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.5488760781365692,-1.5899297795464944,0.026717557251908396,0.21198305115526292,1.0,11/24,22.07%,TGFBR1;SOX5;EFEMP1;ADAMTS12;ZBTB16;WNT9A;SOX6;TRPS1;PTPN11;PKDCC;PTHLH
prerank,positive regulation of wound healing (GO:0090303),-0.5185739720674664,-1.589042494929609,0.011695906432748537,0.2124242516695951,1.0,11/36,7.19%,ST3GAL4;MYLK;PLPP3;VTN;RREB1;ITGB1;THBS1;ARFGEF1;FOXC2;ANXA1;MTOR
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.6023781869045916,-1.5890221422239483,0.026690391459074734,0.21125105049340762,1.0,7/17,9.06%,ATP1A2;BMP7;BMP4;NR3C1;TFPI;AR;MED1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.3237911999617409,-1.589015143003281,0.0,0.21007763909592894,1.0,290/1082,18.83%,NFIA;BMP6;PBX1;IGF1;AUTS2;MLLT3;NR2F2;EGFR;HLF;NFAT5;ZIC1;PID1;TCF4;TCF7L2;GLI3;SMAD3;RHOQ;TGFBR1;TEAD1;BMPR1A;CREB3L2;NFKB1;COL1A1;CDK8;PKD1;ZMIZ1;LRP6;HDAC8;WNT4;INO80;RBPJ;THRB;DCN;GLI2;ZNF423;GLIS3;NR1D2;ZNF462;MDFIC;ZFHX3;RARB;BMP5;WWOX;FOXC1;FGF1;TRIM44;KAT2B;BMP7;ZIC2;DAB2;IL31RA;FOXO3;PPP1R12A;EP300;BMP4;ARID1B;HDAC4;CREB5;ABL1;KAT6B;PRKN;ARNT;JAG1;OSR1;CCNT2;TFEB;HOXB3;MEOX2;BTRC;TBL1X;BRD7;ELF1;NFIB;TBL1XR1;SSBP3;NFIX;RREB1;RPTOR;KMT2C;CCNT1;BCLAF3;NIBAN2;YAP1;SLC9A1;TBK1;RGMB;CREBL2;DDX17;RARG;TGFB1I1;MEF2A;KMT2D;CDK7;HMGB1;PPARGC1B;ZKSCAN3;NR3C1;SS18;SMAD2;SMARCC2;BCL9L;BCAS3;SBNO2;AXIN1;HOXA5;PLSCR1;GABPB2;MED17;LBH;SKI;CREBBP;ZBTB16;FZD2;CDH1;STAT3;SCAF8;NSD3;HOXA7;TRIP4;NSD1;TFDP2;PHF8;MED12;FGFR2;EIF2AK3;FHOD1;SHC1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HOXC4;HIVEP3;DHX9;MTOR;AKAP8L;ZEB2;REST;MYSM1;VEZF1;CEBPG;CRTC3;MAP3K5;HNRNPD;AR;RGMA;DHX36;ZNF496;PRPF6;FOXK1;PPARGC1A;CDC5L;IGF2;SETD3;SP100;NCOA6;MAP2K1;NCOA1;MED1;JUP;ATF2;CCNK;HOXB4;UBP1;WASL;PRMT2;GABPA;NR1H3;SSBP2;JUN;TADA3;HIF1A;HCFC1;CALCOCO1;SMAD4;MED21;SENP1;PARP9;THAP3;ATF7IP;MAML2;CRTC1;GLIS2;ID2;MAVS;BCLAF1;CREBRF;DCAF6;ZXDC;ZBED4;PARP1;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;WDR43;PKD2;TCF3;OGT;FZD7;KDM1B;IRF1;MAML1;PPM1A;YBX1;DTX3L;MLLT10;TCERG1;KAT8;GLI1;BICRA;ATF6;MMS19;CCN1;ING5;APOE;STAT1;PRKDC;NAA15;HINFP;VEGFA;CRLF3;ZNF318;PITHD1;BRCA2;ACVR1;HDAC1;ZBED3;NCK1;KDM3A;ILF2;DDX3X;PRDM2;NCK2;EFCAB7;RXRA;KLF15;RUNX2;MAP2K7;FOXK2;TGFB3;SALL1;ABHD14B;PRDM15;ATOH8;TNIP2;KLF6;ARRB1;SFPQ;PTOV1;ICE1;ARHGEF11;AFAP1L2;HEYL;CITED2;CAMTA2;IL18;EPC1;MYBL1;SERPINE1;SIX1;NR4A1;RNF20;SMARCD2;NFYB;PICALM;TLR4;CRTC2;WNT5A;PHIP;NR4A2;PRKD1;STAT5B;LPIN2;BCL2L12;NFIC;HNRNPU;FBXW11;TAF6L;TRAF6;LPIN3;NEK4;FZD1;NFATC3;INPP5K;BMP2;RNF14
prerank,brain morphogenesis (GO:0048854),0.6516863685804403,1.588946337649824,0.042826552462526764,0.20397002460521946,1.0,4/12,10.52%,CTNNA2;SHANK3;PAX2;SPEF2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6981000128416869,-1.5869481682862792,0.015122873345935728,0.21284598321099213,1.0,6/10,18.04%,GHR;STAT3;LYN;STAT5A;STAT5B;PTPN1
prerank,modification-dependent protein catabolic process (GO:0019941),-0.3735734618048797,-1.5866506192629226,0.0,0.2122329740537908,1.0,99/193,33.25%,FBXL7;SMURF2;RNF43;SPSB1;PRKN;BIRC6;ARIH1;BTRC;TRIP12;KLHL15;RNF146;RNF217;RBBP6;RNF213;RC3H1;UBQLN1;OS9;RNF19A;UBE4B;UBE2H;ASB2;FBXL4;ANAPC5;RNF8;FBXO10;ANAPC7;UBE2K;UBE2I;ANAPC4;ANAPC16;NUB1;NTAN1;USP33;UBE2R2;PSMF1;WDR91;UBR3;CUL3;TRIM25;DTX3L;TRPC4AP;CDC26;UBE2B;SMURF1;UBR4;FBXO45;TOPORS;CDC27;UBE2E1;ARRB1;FEM1A;RNF20;BFAR;FBXO22;UBE2S;MYLIP;SYVN1;AREL1;RNF14;SPSB4;RNF11;ANAPC11;TTC3;ARIH2;WDR81;FBXW4;RNF144A;SIAH2;RNF6;CNOT4;BAG6;CDC16;FBXL14;UBQLN4;ANAPC1;ZNRF3;FBXO11;SPSB2;UBE3C;LONP1;PSMD13;FZR1;CDC34;MIB1;KCTD6;RBX1;UBA52;RNF126;UBE2L3;UBA1;ADRM1;HERPUD1;UFD1;MAD2L1;RC3H2;BUB1B;RNF130;DDB1;ANKIB1
prerank,limb morphogenesis (GO:0035108),-0.5750330777134474,-1.5858628988758006,0.025,0.21250256248869406,1.0,10/20,21.90%,GLI3;LRP6;PCSK5;CYP26B1;SKI;NIPBL;PTCH1;IQCE;MEGF8;FBXW4
prerank,positive regulation of glycolytic process (GO:0045821),-0.5858181898817665,-1.584972034925575,0.014925373134328358,0.21193217396054648,1.0,6/20,10.53%,ZBTB20;IGF1;ARNT;PRKAA2;PFKFB4;HIF1A
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5858181898817665,-1.584972034925575,0.014925373134328358,0.21193217396054648,1.0,6/20,10.53%,ZBTB20;IGF1;ARNT;PRKAA2;PFKFB4;HIF1A
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.6194495121640347,-1.584087192950548,0.02462121212121212,0.21260062385630213,1.0,9/15,15.53%,TCF7L2;XPO4;GSK3B;RAPGEF3;BAG3;TPR;YWHAE;EMD;ANP32B
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.3551943396331571,-1.5839359811240756,0.0,0.21176068384525668,1.0,126/327,26.11%,NFIA;BNC2;DENND4A;TGFBR1;EFEMP1;ZMIZ1;ZNF423;ATXN1;NR1D2;ZFHX3;FOXC1;EP300;ERC1;ABL1;KAT6B;WWC2;TFEB;FOXN3;GON4L;RREB1;WTIP;CREBL2;KMT2D;BAZ2A;PPARGC1B;NR3C1;SRSF10;SBNO2;PRRX2;FUS;CREBBP;STAT3;NSD3;TRIP4;NSD1;TRRAP;NAB1;REST;POFUT1;HNRNPD;GTF2IRD1;CTR9;PPARGC1A;IGF2;NFYC;ATF2;CHD3;ZFAT;SSBP2;TULP3;HIF1A;HCFC1;LIMD1;CDK11B;GPBP1L1;WWC1;RORA;MEF2C;SPTY2D1;TEAD2;SUFU;TCF3;TCF7L1;COPS2;RB1;CCAR1;FZD7;CRABP2;PATZ1;YBX1;SOX13;SOX6;CHD7;PHF1;HINFP;BRCA2;USP13;PRDM2;TAF5L;FOXK2;VSX1;PRMT5;SFPQ;GLRX2;MYBL1;SIX1;ATXN1L;RNF20;ZFP37;NFYB;TAF6L;MSL3;POU6F2;RHOH;HMG20A;BMP2;RNF14;AJUBA;NFX1;PML;NFYA;PPP2CA;NIF3L1;EZH2;ZNF205;SPIN1;DRAP1;IRF2;NFXL1;MAFB;CCAR2;TRAPPC2;RNF6;NONO;ZNF35;CXXC1;NFKB2;MZF1;SOX11;RPS6KA4;DVL2;ACTR5;LDB1;EDF1;OGG1;ZNF219
prerank,regulation of bone mineralization (GO:0030500),-0.46361750622321335,-1.5827739969603412,0.008264462809917356,0.21284580421314403,1.0,22/55,16.44%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;BCOR;ENPP1;OSR1;ADGRV1;NBR1;KL;ATP2B1;MEF2C;TRPM4;ATRAID;CCN1;BMP2K;ACVR1;FBN2;TGFB3;ECM1
prerank,supramolecular fiber organization (GO:0097435),-0.3552355168788526,-1.5815415288596573,0.0,0.21391931901559946,1.0,99/333,20.00%,COL1A2;COL3A1;COL4A5;COL5A2;ADAMTS2;TGFBR1;CGNL1;COL8A1;COL5A1;COL4A6;TNXB;COL1A1;GSN;COL12A1;TPM1;COL22A1;COL4A3;PCM1;MPRIP;MYO1B;LOXL1;VIM;COL6A3;COL4A4;PRKN;FIGN;COL23A1;COL25A1;COL6A1;SHROOM2;TSPAN5;FAT1;COL8A2;FBLN5;SNCAIP;COL26A1;PLOD2;HSPG2;DLG1;RND3;SLK;COL6A2;SHROOM3;VPS4B;TMOD3;CORO7;TUBGCP6;INPPL1;CDC42;COL15A1;TUBGCP2;ARHGAP17;FIGNL2;CYP1B1;COL13A1;COL18A1;LAMA3;NCSTN;COL5A3;COL27A1;RHOA;GGA3;TPM3;CLIP4;P4HA2;RHOBTB2;LUM;MYO1F;EFEMP2;LOX;KATNA1;GFAP;EMILIN1;ZBED3;WHAMM;CARMIL1;LOXL3;DYNC1H1;MYH11;COL9A2;IAPP;TSPAN15;DPT;RHOBTB1;RHOH;MAP7D3;COL14A1;RHOC;MFAP4;TRIOBP;B4GALT7;TUBGCP4;ADAMTS14;NCKAP5L;AVIL;LMOD1;COL20A1;MARCKS;TPM2
prerank,ribosome biogenesis (GO:0042254),0.3810584029443169,1.5812940171917769,0.0,0.21440246048430797,1.0,53/187,16.10%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPF2;RPL37;RPS27;RPL7;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;RPL21;DKC1;RPS7;RPL23A;RPL8;POP5;MRPL36;RPS14;URB2;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;RRP1B;RRP1;NOP56;RPS25;MDN1;UTP15
prerank,skin development (GO:0043588),-0.4469634088352428,-1.5800059463866691,0.01876172607879925,0.21576122747518572,1.0,16/65,11.74%,COL1A2;COL3A1;COL5A2;ERRFI1;COL5A1;COL1A1;PKD1;JAG1;BCR;ANXA1;CLIC4;MED1;TXNIP;COL5A3;ADAM9;UGCG
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4879457274524574,-1.5797548078173969,0.007858546168958742,0.21512414621705322,1.0,15/39,14.40%,ZMIZ1;RBPJ;KAT2B;IL6ST;EP300;ROBO1;JAG1;TSPAN5;YAP1;CREBBP;STAT3;CCN3;MAML2;MAML1;BMP2K
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3962958166383512,-1.5797086874264636,0.002044989775051125,0.21406719244987518,1.0,34/129,14.85%,RNF220;WLS;LRRK1;EGFR;NFKB1;COL1A1;SMURF2;LGR4;PTK7;TNKS2;LRRK2;TBL1X;TBL1XR1;RNF146;GPC3;UBR5;AXIN1;LYPD6;ADGRA2;FGFR2;ZEB2;XIAP;DACT1;JUP;WNK1;CSNK1E;USP47;PSMF1;TRPM4;PPM1A;PSMB2;UBE2B;ZBED3;DDX3X
prerank,regulation of DNA repair (GO:0006282),-0.48684586488495474,-1.5787314744101106,0.00796812749003984,0.21486845609306607,1.0,11/44,7.71%,EYA2;EYA1;EGFR;UBE2N;EYA4;TRIP12;UBR5;DHX9;BRCC3;CEBPG;RNF8
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.519341354267463,-1.5781119987719523,0.025490196078431372,0.21494746829113678,1.0,10/31,9.49%,TGFBR1;PDGFRA;OSR1;TGFBR2;HOXB3;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4
prerank,regulation of B cell proliferation (GO:0030888),0.4788839353906787,1.5773092687449155,0.018480492813141684,0.21949495466801866,1.0,11/44,14.85%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;TNFRSF21;CD40;ATM;NFATC2;CD38
prerank,negative regulation of immune system process (GO:0002683),-0.6133542577646612,-1.5771430982318593,0.0375234521575985,0.2154764881016131,1.0,4/16,15.22%,COL3A1;HOXA7;LYN;IL17D
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.4449858175473142,-1.5759737802147764,0.005703422053231939,0.21660215340563077,1.0,22/63,20.28%,IGF1;TCF7L2;TGFBR1;WWOX;ITGAV;CFLAR;BMP4;BIRC6;DEPTOR;THBS1;PAK2;SH3RF1;AR;SP100;TRAF2;STX4;LTBR;ACVR1;PHIP;BCL2L12;PARK7;PML
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.5402122152048264,-1.5752842965399498,0.017578125,0.21697667744805177,1.0,7/24,5.83%,PHLDB2;ARHGAP6;CGNL1;ARHGAP28;ARAP1;WASF2;PAK2
prerank,cellular response to metal ion (GO:0071248),0.4033932796610339,1.57523870651927,0.0020491803278688526,0.22140644670336515,1.0,28/123,7.97%,DLG2;SYT1;MT2A;ADCY8;SYT6;NLGN1;SYT7;GLRA1;SYT12;SYT11;ANK3;RYR3;CPNE9;SNCA;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;TRPM2;CPNE8;CPNE1;KCNH1;SYT10;AKT1
prerank,negative regulation of cartilage development (GO:0061037),-0.6428026493897301,-1.5750644339373916,0.015355086372360844,0.21621628072460664,1.0,4/13,7.65%,TGFBR1;EFEMP1;ADAMTS12;WNT9A
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.5660008627601213,1.574779437475728,0.029978586723768737,0.22049532803692232,1.0,12/21,19.69%,NAV3;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,cellular glucan metabolic process (GO:0006073),-0.6589926957968257,-1.5745662851682896,0.029182879377431907,0.2159718297200418,1.0,5/11,14.95%,PRKAG2;PHKB;GSK3B;PHKA1;PYGM
prerank,regulation of protein import into nucleus (GO:0042306),-0.49672746816410757,-1.574182966743406,0.016697588126159554,0.2155793541206871,1.0,14/36,12.63%,ZIC1;SMAD3;MDFIC;BMP4;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;SUFU;APOD
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.36102471508051687,1.5731675733451504,0.0,0.22150936599136842,1.0,82/306,14.46%,PAX8;ALAS2;CHEK1;RPS6;RPS19;RPS20;RPL38;RPL29;PTMA;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;HOXD3;RPL10A;TBRG1;RPS24;EEF1B2;FUT9;RPL27A;RPS17;RPS6KB2;RPS8;RPA3;RPS16;RPS27A;RPLP1;XAB2;RPL41;RPLP0;RPL30;RPL7A;TUFM;ING4;MRPL13;RPL13;MRPS18A;EEF1D;RPL12;MRPS7;RPS15;PIF1;POLR2J;EIF4EBP2;SET;POLR2B;RPL14;MRPS14;RPL5;FARSB;RPS4X;RPL21;THAP1;RPS7;POLR2I;RPL23A;MCM3;EEF1A2;RPL8;BCL3;MED20;MRPL36;BRIP1;MRPL23;RPS14;POLD1;RNASEH2A;RPS3;RPS2;RPS5;EEF1A1;RPL18A;ATM;RPS28;POLR3A
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5582888726532489,-1.573159529096483,0.024761904761904763,0.21534253708195403,1.0,4/21,6.72%,EYA2;EYA1;EYA4;BCL2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5582888726532489,-1.573159529096483,0.024761904761904763,0.21534253708195403,1.0,4/21,6.72%,EYA2;EYA1;EYA4;BCL2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.3400812979353597,-1.5727121227512633,0.0,0.2151072977572943,1.0,131/497,17.31%,SAMD4A;FOXP2;FOXP1;NR2F2;TCF7L2;GLI3;RBFOX2;FOXD1;PRDM5;ZNF148;WNT4;RBPJ;MIDEAS;LIMS1;IGFBP5;SMURF2;ZNF423;ATXN1;NR1D2;ZHX2;MDFIC;ZEB1;BMP7;ZIC2;BMP4;HDAC4;BCOR;KAT6B;DKK3;NCOR1;ENPP1;BTRC;BRD7;FOXN3;WWP2;GSK3B;NIBAN2;VGLL4;SYNCRIP;RCOR1;KHDRBS1;DDX6;RCOR3;ZKSCAN3;NR3C1;SMAD2;SMARCC2;EIF4ENIF1;ATP8B1;CBX5;EIF2AK1;SBNO2;SNX6;LBH;ZBTB16;HOXA7;TFDP2;L3MBTL3;EIF2AK3;NAB1;SHC1;CHD8;WWP1;SCMH1;REST;LARP1;BCL7A;PDS5A;DHX36;FOXK1;MBD2;RUNX1T1;CBFA2T2;PTPRK;UBE2I;BTAF1;SELENOS;PRMT2;JUN;LSM14A;MPHOSPH8;SMAD4;LIMD1;ATF7IP;GLIS2;ID2;NIPBL;USP47;BCLAF1;TLE1;CNOT8;ARID5B;PCGF6;PBXIP1;HES1;PIAS4;RB1;EHMT1;BHLHE41;PATZ1;IRF1;TSHZ3;YBX1;SOX13;KAT8;EIF2AK2;HINFP;ZNF318;HDAC1;DDX3X;CBFA2T3;SCML4;PHC2;RUNX2;JARID2;FOXK2;SALL1;DAPK1;LOXL3;ATOH8;L3MBTL2;SFPQ;DAP;HEYL;CITED2;EPC1;PDCD4;TBX2;CNOT1;ZMYND15;TWIST2
prerank,positive regulation of glucose import (GO:0046326),-0.5707409696631196,-1.5725175998586174,0.025878003696857672,0.2143492386857101,1.0,6/21,4.55%,IGF1;RHOQ;SORBS1;OSBPL8;IRS1;CREBL2
prerank,ribosomal small subunit biogenesis (GO:0042274),0.4856427654828917,1.571886496213921,0.017964071856287425,0.222217792916465,1.0,14/39,15.79%,TSR3;RPS6;RPS19;RPS27;RPS24;RPS17;RPS16;MRPS7;RPS15;RPS7;RPS14;RPS5;RPS28;RPS25
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.5201740059873567,-1.5708771262584345,0.015180265654648957,0.21629365847116477,1.0,8/29,8.00%,SMAD3;DICER1;PUM2;ZC3H7A;SMAD2;PUS10;PUM1;TUT4
prerank,RNA biosynthetic process (GO:0032774),-0.5068735323124471,-1.5700870195561338,0.019157088122605363,0.21666485702483515,1.0,16/31,28.50%,TAF4;TBP;NCOA6;BRF1;TTF1;TAF13;PRMT5;GTF2B;HELB;PRIM2;POLA2;TERT;TAF12;TBPL1;TAF7;BRF2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.5957093857599352,-1.5698826964689918,0.023679417122040074,0.2159568072455243,1.0,7/17,6.42%,IGF1;DOCK5;IGFBP5;PDGFRB;VTN;DOCK7;NRP1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5954236638412271,-1.569179845441064,0.023166023166023165,0.21611195605107592,1.0,9/16,25.95%,APPL2;ABCD2;APOD;PDCD4;CHID1;ADCY7;NLRC3;SIRPA;PPARA
prerank,cellular response to glucose starvation (GO:0042149),-0.47767089709649124,-1.5686658850306512,0.013592233009708738,0.21601801082248034,1.0,20/41,23.65%,PRKAG2;FOXO3;PRKAA2;EIF2AK3;SESN1;IMPACT;BRSK1;SIK1;MTMR3;BECN1;PIK3C3;PIK3R4;PRKAA1;RRP8;PRKAG3;TBL2;ATG14;SIK2;SZT2;NUAK1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.6353524005804465,-1.5682873946228733,0.028268551236749116,0.21566137323997372,1.0,3/13,5.68%,ERRFI1;CBLB;SNX6
prerank,regulation of synapse maturation (GO:0090128),0.6672850326200013,1.5678413037654342,0.029473684210526315,0.22737067407538167,1.0,4/10,9.89%,ARHGEF15;NRXN1;RELN;DAB2IP
prerank,defense response to Gram-positive bacterium (GO:0050830),0.47140130528758295,1.5673007901479907,0.014705882352941176,0.22664765476218823,1.0,11/40,16.08%,TIRAP;PGLYRP1;MBL2;IL12A;TLR2;PPP1R11;GBP4;DROSHA;DEFA6;STAB2;RNASE3
prerank,regulation of protein sumoylation (GO:0033233),-0.6091986310496614,-1.5671225478422781,0.021153846153846155,0.21678520546981345,1.0,12/17,29.73%,ZMIZ1;PIAS1;HDAC4;SAE1;PIAS3;PIAS4;PARK7;GNL3L;GNL3;MUL1;EGR1;UBA2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.5226867657882732,-1.5648035003552685,0.015594541910331383,0.21989052842011514,1.0,8/27,5.83%,PHLDB2;ARHGAP6;CGNL1;ARHGAP28;PRKN;ARAP1;WASF2;PAK2
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5342823990799555,1.5641467068383392,0.01702127659574468,0.23032724234954355,1.0,6/25,7.34%,TMTC2;GRIN1;ANK3;SNCA;SLC8A1;CIB2
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.5825950938490712,-1.5632415048179285,0.021739130434782608,0.22175191069180322,1.0,8/18,22.26%,SETD7;KMT2D;SETD3;SETD2;EHMT1;ASH1L;KMT2A;PRDM9
prerank,Ras protein signal transduction (GO:0007265),-0.3906713273676092,-1.5628449096011696,0.001968503937007874,0.2214367998547817,1.0,47/137,22.49%,COL1A2;ROCK2;PLD1;IGF1;ARHGAP29;ARHGAP6;PLCE1;KSR1;ROCK1;PDPN;RREB1;SHOC2;RAP1B;CTNNAL1;MRAS;SHC1;RAPGEF3;BRK1;CDC42EP5;RHOA;JUN;NCKAP1;RALA;AGTR1;SETDB1;RB1;ARHGDIB;USP50;WASF1;RAPGEF2;FARP2;GNB1;ADRA2A;ARHGEF11;CDC42EP4;ARHGEF1;PRKD1;RASSF1;RHOH;PARK7;CDK2;RTKN;RAPGEF1;FGF2;CRKL;RIT1;CDC42EP1
prerank,atrial septum development (GO:0003283),-0.6380270727983341,-1.562730638069148,0.017341040462427744,0.220621023493229,1.0,3/13,2.12%,NOTCH2;ANK2;MDM4
prerank,cell-cell junction assembly (GO:0007043),0.44512916475037617,1.561948484125061,0.004338394793926247,0.23268170558029927,1.0,16/63,7.08%,CLDN5;CDH12;CDH8;ACTB;CTNND2;RAMP2;CDH7;CDH19;CDH20;CDH18;CDH2;CDH10;GJB1;WDR1;EPB41L3;CNTNAP1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.4480792159703609,1.5612910280688792,0.017167381974248927,0.23071390983040416,1.0,27/56,21.30%,NDUFC1;NDUFAF5;NDUFA1;NDUFA2;TIMM21;NDUFC2;DMAC2;NDUFA13;NDUFA3;TMEM126A;DMAC1;NDUFB2;ECSIT;NDUFAF1;NDUFB9;BCS1L;NDUFAF6;NDUFAB1;NDUFA7;NDUFA12;OXA1L;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.4480792159703609,1.5612910280688792,0.017167381974248927,0.23071390983040416,1.0,27/56,21.30%,NDUFC1;NDUFAF5;NDUFA1;NDUFA2;TIMM21;NDUFC2;DMAC2;NDUFA13;NDUFA3;TMEM126A;DMAC1;NDUFB2;ECSIT;NDUFAF1;NDUFB9;BCS1L;NDUFAF6;NDUFAB1;NDUFA7;NDUFA12;OXA1L;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5819074778814588,-1.5611586675476705,0.03180914512922465,0.22248074647738128,1.0,12/18,32.24%,ANKRD17;PUM2;PUM1;DDX60;NOP53;SEC14L1;GPATCH3;DHX58;BIRC3;C1QBP;UFD1;ZCCHC3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.37117979096973275,-1.5595790773303089,0.002066115702479339,0.22451165794362263,1.0,76/186,29.69%,BICC1;TRABD2B;MLLT3;NXN;TCF7L2;LRP1;GLI3;RBMS3;IGFBP2;LRP6;WWOX;GRB10;RNF43;DAB2;TMEM64;STK3;DKK3;PRKN;CSNK1A1;GSK3B;VGLL4;IGFBP6;AXIN1;RNF213;CHD8;IGFBP4;DACT1;LIMD1;TLE4;TLE1;LZTS2;PSMF1;CUL3;SOX13;GLI1;UBAC2;APOE;PSMB2;HDAC1;LATS1;EMD;WNT5A;SFRP4;DACT3;INVS;BMP2;MDFI;FRZB;TLE3;DKK2;PSMC1;DVL3;PSMB6;PSMA3;SIAH2;PSMA4;NKD2;LRP4;KREMEN1;DVL2;ZNRF3;LMBR1L;TPBG;PSME1;CXXC4;MCC;PSMD13;SDHAF2;PSMB10;PSMA5;PSMB9;RUVBL2;MAD2L2;TSKU;RBX1;HIC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.5858656364355155,-1.5581916782742398,0.02862595419847328,0.22483174049220336,1.0,4/16,5.45%,PHLDB2;ARHGAP6;THBS1;BCAS3
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.5858656364355155,-1.5581916782742398,0.02862595419847328,0.22483174049220336,1.0,4/16,5.45%,PHLDB2;ARHGAP6;THBS1;BCAS3
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6375429516436235,1.5577826176920928,0.03571428571428571,0.23506158464793891,1.0,4/12,8.37%,EPHB1;SPTBN4;HSP90AB1;B4GALT6
prerank,sodium ion transmembrane transport (GO:0035725),0.4153565375953792,1.5565989105779252,0.010570824524312896,0.2354078282409402,1.0,22/84,11.75%,SLC6A6;HCN1;SLC24A4;SLC24A2;SCN1A;SLC6A17;ASIC2;ASIC4;SLC8A1;SCN4B;ASIC1;HCN2;SLC6A2;SLC6A5;ATP1A3;SLC6A8;SCN3A;KCNK1;SLC12A3;ATP1A4;ATP1A1;SCN2A
prerank,metal ion homeostasis (GO:0055065),0.4729111820704846,1.555761947499514,0.01037344398340249,0.23523879901100267,1.0,9/40,9.07%,TMTC2;GRIN1;ANK3;SNCA;SLC8A1;SLC12A6;CIB2;SLC7A8;SLC12A3
prerank,sodium ion transport (GO:0006814),0.4158179684241995,1.5553843988349423,0.004166666666666667,0.23444968223797,1.0,19/85,9.07%,SLC6A6;HCN1;SLC24A4;SLC24A2;SCN1A;SLC6A17;ASIC2;ASIC4;FGF13;SLC8A1;SCN4B;ASIC1;HCN2;SLC6A2;SLC6A5;SLC6A8;SCN3A;KCNK1;SLC12A3
prerank,cell proliferation in forebrain (GO:0021846),-0.6826836764920863,-1.554144664926603,0.017142857142857144,0.2316243676300676,1.0,4/10,14.50%,PCM1;DOCK7;NUMBL;NUMB
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.439253411291455,-1.55411801222413,0.01125703564727955,0.23063203230049298,1.0,15/61,8.31%,EYA2;EYA1;EGFR;UBE2N;EYA4;PDGFRB;HMGB1;USP7;NBN;DHX9;BRCC3;CEBPG;RNF8;DHX36;WRN
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.6291172137247631,-1.5537938571780894,0.03731343283582089,0.23025009141342492,1.0,5/13,7.80%,LRRK2;NUPR1;SEC22B;CHMP4B;CHMP4A
prerank,regulation of synapse assembly (GO:0051963),0.4685202241804719,1.553690163449094,0.01282051282051282,0.23597762965044367,1.0,15/46,9.21%,NRXN1;PTPRD;LRFN5;IL1RAPL1;EPHB1;NLGN1;GRID2;SNCA;SLIT1;TLR2;CLSTN3;LRRC4B;IL1RAPL2;ROBO2;LHFPL4
prerank,positive regulation of cell differentiation (GO:0045597),-0.3570861918207119,-1.5534488004772598,0.0019083969465648854,0.22991475309985432,1.0,75/237,18.37%,BMP6;RANBP3L;IGF1;TCF4;SMAD3;TGFBR1;SOX5;PTN;BMPR1A;NFKB1;COL1A1;WNT4;BOC;NBL1;ZEB1;MEDAG;FOXC1;CCN2;BMP7;IL6ST;CDON;DAB2;TMEM64;CTNNA1;BMP4;PDPN;ABL1;TGFBR2;RIPOR2;YAP1;CREBL2;IGFBP3;TGFB1I1;MEF2A;SMAD2;BCL9L;HOXA5;ZBTB16;MTOR;REST;CDC42;AR;DHX36;GJA1;IMPACT;HOXB4;NGF;RHOA;SMAD4;ID2;MEF2C;AGTR1;TCF3;IL6R;TRPM4;ATRAID;CCN1;SOX6;WDFY2;ACVR1;BLOC1S5;RAPGEF2;GLIPR2;RUNX2;FBN2;TGFB3;CMKLR1;SUCO;HEYL;IL18;CCN4;PRKD1;NPNT;SYAP1;GCNT2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.32106120545373834,-1.5530641630021587,0.0,0.2295448530769569,1.0,218/834,18.36%,NFIA;BMP6;PBX1;IGF1;AUTS2;NR2F2;EGFR;HLF;NFAT5;PID1;TCF4;TCF7L2;GLI3;SMAD3;RHOQ;TEAD1;BMPR1A;NFKB1;CDK8;PKD1;ZMIZ1;LRP6;HDAC8;INO80;RBPJ;THRB;DCN;GLI2;GLIS3;NR1D2;ZNF462;ZFHX3;RARB;BMP5;WWOX;FOXC1;FGF1;KAT2B;DAB2;FOXO3;PPP1R12A;EP300;BMP4;HDAC4;ABL1;KAT6B;PRKN;ARNT;JAG1;OSR1;CCNT2;TFEB;HOXB3;MEOX2;TBL1X;ELF1;NFIB;TBL1XR1;MICAL2;SSBP3;NFIX;RREB1;KMT2C;CCNT1;BCLAF3;YAP1;SLC9A1;TBK1;DDX17;RARG;MEF2A;KMT2D;CDK7;HMGB1;PPARGC1B;NR3C1;SS18;SMAD2;BCL9L;BCAS3;SBNO2;HOXA5;PLSCR1;GABPB2;MED17;SKI;CREBBP;STAT3;HOXA7;TFDP2;MED12;FGFR2;FHOD1;ELF4;FOXC2;CHD8;RUNX1;HOXC4;DHX9;AKAP8L;ZEB2;REST;MYSM1;VEZF1;CEBPG;CRTC3;AR;RGMA;DHX36;PRPF6;PPARGC1A;CDC5L;IGF2;SETD3;GCN1;NCOA6;CDK13;NCOA1;MED1;JUP;ATF2;CCNK;HOXB4;UBP1;WASL;GABPA;NR1H3;SSBP2;JUN;HIF1A;HCFC1;CALCOCO1;SMAD4;MED21;NOTCH3;SENP1;THAP3;MAML2;CRTC1;GLIS2;MAVS;BCLAF1;CREBRF;DCAF6;WWC1;ZBED4;PARP1;RORA;MEF2C;NRF1;TFCP2;HES1;PKD2;TCF3;OGT;KDM1B;IRF1;MAML1;YBX1;MLLT10;TCERG1;KAT8;GLI1;ATF6;CCN1;STAT1;PRKDC;HINFP;VEGFA;CRLF3;ACVR1;HDAC1;ZBED3;NCK1;DDX3X;PRDM2;NCK2;PLXND1;EFCAB7;RXRA;KLF15;RUNX2;FOXK2;TGFB3;SALL1;ABHD14B;PRDM15;ATOH8;TNIP2;KLF6;ARRB1;SFPQ;PTOV1;HEYL;CITED2;CAMTA2;IL18;EPC1;MYBL1;SERPINE1;SIX1;NR4A1;SMARCD2;NFYB;TLR4;CRTC2;WNT5A;PHIP;NR4A2;PRKD1;STAT5B;LPIN2;BCL2L12;NFIC;HNRNPU;TAF6L;TRAF6;LPIN3
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.5427137219983058,-1.5524569581604601,0.026465028355387523,0.22968069037212827,1.0,11/24,26.26%,AUTS2;PLCE1;WASF2;CDC42;BRK1;NCKAP1;ARPC2;AVIL;PIK3R1;ACTR2;TWF2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6569425769909647,-1.5502807850513658,0.02962962962962963,0.2327897709813869,1.0,7/12,19.58%,BMP4;PTPN14;KHDRBS1;NUP214;TPR;IFI27;RBM4
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.6410565258591323,-1.5501580598575617,0.033707865168539325,0.2319723424246482,1.0,10/13,30.59%,SAE1;SENP6;UBA5;UBA7;DESI1;DESI2;NAE1;UBA2;ATG10;UBA1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.5446441352547968,-1.550120240256097,0.024714828897338403,0.2310144773755317,1.0,17/23,35.97%,OS9;SELENOS;SURF4;FAF2;AUP1;DERL1;SYVN1;VCP;SEC16A;LMAN1;PREB;SEL1L;DERL2;HERPUD1;UFD1;SEC13;TMEM129
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5826253546910872,1.5474697270315225,0.02414486921529175,0.24555267187244859,1.0,3/16,9.43%,KLRC1;IL12A;CYRIB
prerank,positive regulation of cytokinesis (GO:0032467),-0.4966268283716387,-1.5474141567139303,0.01694915254237288,0.2352475011364402,1.0,9/32,14.98%,SVIL;CDC14A;CSPP1;CDC42;RHOA;GIPC1;CUL3;CDC14B;CDC25B
prerank,positive regulation of cell division (GO:0051781),-0.4804584678491563,-1.5469805183273928,0.013157894736842105,0.23510441932482115,1.0,11/38,14.98%,SVIL;FGF1;CDC14A;CSPP1;FGFR2;CDC42;RHOA;GIPC1;CUL3;CDC14B;CDC25B
prerank,central nervous system myelination (GO:0022010),0.6682884634585459,1.5466773683775084,0.030107526881720432,0.24532215740412305,1.0,5/11,8.37%,PLP1;TENM4;CLU;CNTNAP1;B4GALT6
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.6398509361405808,-1.546286059392668,0.03275529865125241,0.23556634984801014,1.0,7/13,19.78%,IRAK2;PIK3AP1;PIK3C3;PIK3R4;TNIP2;TRAF6;IRAK1
prerank,cartilage development (GO:0051216),-0.46753005522680596,-1.5458048809215021,0.01160541586073501,0.23554231701442155,1.0,15/49,11.68%,SULF1;SOX5;CREB3L2;PKD1;BMP4;OSR1;WNT5B;NFIB;SULF2;SLC39A14;ZBTB16;RUNX1;ITGB8;CCN3;MEF2C
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.44961812829327497,-1.5440270750428533,0.013944223107569721,0.23816030336555713,1.0,13/51,11.09%,FSTL1;FBN1;CRIM1;BMPR1A;SMAD6;SMURF2;NBL1;HTRA3;SKI;SKIL;SMAD4;BMPER;GREM2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.5508859582125988,1.543790765349702,0.02412280701754386,0.24893600214716993,1.0,9/20,21.18%,LY6H;CHRM3;GRK2;PLCB1;CHRM2;GNAQ;LY6G6D;CDK5R1;RGS10
prerank,protein localization to synapse (GO:0035418),0.6250333625349718,1.5430901333326943,0.039735099337748346,0.24859057666122383,1.0,5/12,8.72%,NRXN1;PCLO;NLGN1;NRXN2;ZDHHC15
prerank,cellular response to leucine (GO:0071233),-0.6938121300123767,-1.542571690457978,0.030965391621129327,0.23892441693424277,1.0,6/10,13.12%,UBR2;RPTOR;MTOR;SESN1;UBR1;KLHL22
prerank,response to leucine (GO:0043201),-0.6938121300123767,-1.542571690457978,0.030965391621129327,0.23892441693424277,1.0,6/10,13.12%,UBR2;RPTOR;MTOR;SESN1;UBR1;KLHL22
prerank,positive regulation of cell communication (GO:0010647),0.510780270605394,1.5413572597365992,0.017057569296375266,0.25006027032926065,1.0,10/28,8.17%,SYT1;RIMS1;RIMS2;ANK3;RIMS3;GRIK2;KCTD13;HOMER1;CLSTN3;NMB
prerank,P-body assembly (GO:0033962),-0.6321551050064778,-1.54119048296429,0.03294573643410853,0.24051131415249,1.0,7/12,16.14%,DDX6;EIF4ENIF1;RC3H1;LSM14A;LIMD1;EDC3;DYNC1H1
prerank,Notch signaling pathway (GO:0007219),-0.4410627834633131,-1.5408756951412441,0.011695906432748537,0.24018779239104127,1.0,22/59,16.75%,PBX1;NOTCH2;GMDS;RBPJ;ZNF423;KAT2B;EP300;JAG1;DTX4;CREBBP;POFUT1;NCSTN;NOTCH3;MAML2;WWC1;HES1;MAML1;YBX1;DTX3L;STAT1;PLXND1;HEYL
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.6154686627137782,-1.5408111446963888,0.04638218923933209,0.23925590549450607,1.0,6/13,16.92%,IL6ST;JAK1;STAT3;TYK2;STAT1;OAS2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.42019447597085674,-1.5405808616487755,0.003992015968063872,0.23859842809147913,1.0,37/80,26.35%,DENND2A;VTI1A;ERC1;GBF1;TMEM87A;SGSM2;SNX6;VTI1B;STX16;GOSR1;VPS54;STX5;SURF4;TMEM87B;DENND5A;HEATR5A;EHD3;SNX8;GOSR2;ANKFY1;TBC1D17;HEATR5B;CLN5;TBC1D10A;VPS26B;BET1L;RGP1;LMAN1;TBC1D23;SPAG9;RAB9A;SNX12;RAB7B;RAB7A;BAIAP3;PHETA1;TBC1D10B
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.3384861308827254,-1.539987295309702,0.0,0.23876278441448429,1.0,114/417,17.55%,FOXP2;FOXP1;NR2F2;TCF7L2;GLI3;RBFOX2;FOXD1;PRDM5;ZNF148;WNT4;RBPJ;MIDEAS;LIMS1;SMURF2;ZNF423;ATXN1;NR1D2;ZHX2;MDFIC;ZEB1;BMP7;ZIC2;BMP4;HDAC4;BCOR;KAT6B;DKK3;NCOR1;BTRC;BRD7;FOXN3;WWP2;NIBAN2;VGLL4;RCOR1;KHDRBS1;EIF4A2;RCOR3;ZKSCAN3;NR3C1;SMAD2;SMARCC2;ATP8B1;CBX5;SBNO2;SNX6;LBH;ZBTB16;HOXA7;TFDP2;L3MBTL3;NAB1;SHC1;CHD8;WWP1;SCMH1;REST;BCL7A;FOXK1;MBD2;RUNX1T1;CBFA2T2;PTPRK;UBE2I;BTAF1;PRMT2;JUN;MPHOSPH8;SMAD4;LIMD1;ATF7IP;GLIS2;ID2;NIPBL;USP47;BCLAF1;TLE1;ARID5B;PCGF6;PBXIP1;HES1;COPS2;PIAS4;RB1;EHMT1;BHLHE41;PATZ1;IRF1;TSHZ3;SOX13;KAT8;HINFP;ZNF318;HDAC1;CBFA2T3;SCML4;PHC2;RUNX2;JARID2;FOXK2;SALL1;LOXL3;ATOH8;L3MBTL2;SFPQ;DAP;HEYL;CITED2;EPC1;PDCD4;TBX2;ZMYND15;TWIST2;WNT5A
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6169133882688982,-1.5371579708023786,0.02524271844660194,0.24347397756509945,1.0,7/14,20.79%,GHR;STAT3;LYN;STAT5A;STAT5B;PTPN1;PIK3R1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5578960236728514,1.5370786294792365,0.03571428571428571,0.25587956028563813,1.0,5/19,7.54%,GRM5;RYR2;KDR;TRPM2;PTPRJ
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5423195443310336,-1.5370042220873017,0.0248565965583174,0.2427773455575387,1.0,17/23,28.55%,GLI3;ENPP1;BTRC;GPC3;TULP3;GLIS2;HERC4;SUFU;PTCH1;GPR161;VCP;MEGF8;KIF7;MGRN1;PTCH2;IFT122;KCTD6
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.48002255713493025,1.536654554447358,0.02575107296137339,0.2550599294756017,1.0,10/39,7.09%,FGF12;HECW1;FGF14;NETO1;ANK3;FGF13;WNK2;SCN4B;HECW2;GLRX
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6055261343943774,-1.5362458437898248,0.03238095238095238,0.24347623313003894,1.0,5/14,4.83%,LRP1;BMPR1A;TPM1;IGFBP5;IGFBP3
prerank,regulation of myoblast differentiation (GO:0045661),-0.5010332832718232,-1.5355494052916665,0.038314176245210725,0.24378024990104322,1.0,7/32,6.24%,RANBP3L;BOC;BMP4;FLOT2;RIPOR2;IGFBP3;TRIP4
prerank,positive regulation of cellular senescence (GO:2000774),0.6552349664868494,1.535403034922465,0.0455531453362256,0.2557213129942432,1.0,5/10,19.56%,SIRT1;HMGA2;YPEL3;B2M;EEF1E1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6642235988723513,1.535234218723152,0.03469387755102041,0.25449593788522196,1.0,4/10,9.09%,KDR;TLR2;CCL2;NAMPT
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.6228306155656363,1.5322581445734726,0.056768558951965066,0.25818947264278413,1.0,5/13,6.73%,SHISA6;GRIK2;SHISA8;PPFIA3;SHISA7
prerank,negative regulation of autophagy (GO:0010507),-0.4407297192384045,-1.5301880368695202,0.007797270955165692,0.2535042368360164,1.0,27/54,28.60%,LEPR;EIF4G3;SMG1;LRRK2;NUPR1;ZKSCAN3;STAT3;BCL2;MTOR;FOXK1;PTPN22;EIF4E;SNRNP70;KLHL22;CTSA;FOXK2;DAP;RUBCN;EIF4G1;NRBP2;BMF;WDR6;DAPL1;RRAGA;HGF;MET;MT3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5745757040877539,1.5297797427237658,0.034552845528455285,0.26122242001515067,1.0,4/18,15.88%,NAV3;CD34;HOMER2;HOMER3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5553604151316296,-1.5295462648057774,0.03731343283582089,0.2536620807974259,1.0,8/21,16.82%,IGF1;BMPR1A;IGFBP5;GJA1;JUN;MMP2;ERN1;ADAMTS1
prerank,regulation of hemopoiesis (GO:1903706),-0.6730315678747876,-1.5293150458140405,0.032196969696969696,0.25310835465637144,1.0,5/10,15.22%,PTN;CREBBP;RUNX1;MYSM1;IL17D
prerank,spliceosomal complex assembly (GO:0000245),-0.46446502649360166,-1.5289562897908704,0.01730769230769231,0.2527190208365709,1.0,15/46,14.46%,CELF2;CELF1;LUC7L2;SRSF10;SF3B1;SRSF6;PRPF6;SF3A1;YTHDC1;USP39;SCAF11;SF3A3;DDX23;RBM5;SRSF1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5783403764491849,-1.5286847719642034,0.028735632183908046,0.2522459796157977,1.0,8/18,15.95%,SMAD3;LTBP1;ITGAV;ITGB8;HIF1A;SMAD4;FN1;LRRC32
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.5720825973079273,-1.5281182410917253,0.03007518796992481,0.25236309649468563,1.0,10/18,30.89%,KLF9;NR3C1;ANXA1;REST;PCK2;FAM107A;HNRNPU;ZFP36L2;UBE2L3;BCL2L11
prerank,ceramide biosynthetic process (GO:0046513),0.4743187268493367,1.528018240048136,0.01680672268907563,0.2627738535160888,1.0,10/40,11.96%,ST6GALNAC3;ST8SIA4;SGMS1;FA2H;DEGS2;B4GALNT1;B4GALT6;SMPD1;ST8SIA6;ST8SIA3
prerank,epidermis development (GO:0008544),-0.435376605256209,-1.5263941591953791,0.013358778625954198,0.25484394725536674,1.0,12/56,14.63%,SVEP1;CCN2;FLOT2;FGFR2;LAMA3;ATP2A2;EMP1;UGCG;CRABP2;YBX1;GLI1;HDAC1
prerank,ganglioside metabolic process (GO:0001573),0.5534785104091061,1.5249039973856042,0.03648068669527897,0.26722109892455576,1.0,6/20,11.96%,ST6GALNAC3;ST8SIA4;B4GALNT1;NEU2;ST8SIA6;ST8SIA3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3654152177280746,-1.5243937478021274,0.002008032128514056,0.2579819565847482,1.0,53/182,17.89%,SLC24A3;ROCK2;NOTCH2;IGF1;FOXP1;BMPR1A;RBMS3;NFKB1;ZNF148;WNT4;CELF1;BMP4;DICER1;ROBO1;SMO;PRKN;TNRC6B;PRKAA2;WWP2;FLOT2;DLG4;YAP1;TNRC6A;MOV10;RUNX1;ANXA7;REST;PARP10;MAP2K1;PTPN22;LDLR;ITGB8;PARP14;HIF1A;PARP9;ID2;MEF2C;SETDB1;RB1;FBXW7;APOBEC1;APOE;HINFP;VEGFA;EMILIN1;HDAC1;CCDC3;ATOH8;TNRC6C;CITED2;PICALM;PRKAA1;MYADM
prerank,sphingolipid metabolic process (GO:0006665),0.394162084371928,1.5232786603932922,0.0081799591002045,0.26872721798748095,1.0,35/108,18.02%,ST6GALNAC3;GAL3ST1;SGMS1;ACER2;FA2H;DEGS2;CERT1;ENPP2;ORMDL1;B4GALNT1;ORMDL2;NEU2;SPNS2;PPP2R1A;ELOVL7;SGPP2;ELOVL4;TECR;ARSA;SERINC1;GLA;SMPD1;HACD3;CPTP;HACD1;PPM1L;PPT1;SAMD8;PRKD3;GALC;KDSR;GLB1;SGPP1;HEXB;SPTLC2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5829980103247764,-1.5228241617195608,0.04604051565377532,0.26027819424684573,1.0,5/16,11.68%,RANBP3L;BOC;RIPOR2;IGFBP3;MEF2C
prerank,positive regulation of autophagy (GO:0010508),-0.4072310580623456,-1.5221782312471608,0.0074211502782931356,0.26052712143661455,1.0,32/81,25.25%,RNF152;DCN;FOXO3;ROCK1;PRKN;LRRK2;TFEB;PRKAA2;GSK3B;TBK1;TPCN1;HMGB1;UFL1;TRIM8;LARP1;SESN1;PAFAH1B2;TRIM5;EIF2AK4;ATF6;DAPK1;PRKD1;PRKAA1;PARK7;PLEKHF1;ORMDL3;BNIP3;WAC;TICAM1;IRGM;TRIM68;PHB2
prerank,inositol lipid-mediated signaling (GO:0048017),-0.44337579214027917,-1.5220921364882818,0.011299435028248588,0.2596858143749839,1.0,18/50,17.28%,IGF1;GAB2;PLCE1;PDGFRA;PI4KA;ADAP2;PDGFRB;PLCD3;IRS1;PLCB3;NGF;PLCD1;RHOA;PITPNM2;OGT;PIK3C3;PLCL1;PIK3CD
prerank,ureteric bud development (GO:0001657),-0.570184034023875,-1.5220637844652258,0.04918032786885246,0.25874789540374316,1.0,11/17,18.77%,FOXC1;BMP7;BMP4;OSR1;GPC3;FGFR2;PKD2;SALL1;SIX1;NPNT;BMP2
prerank,neuron projection morphogenesis (GO:0048812),0.37889977729035074,1.5211072779076955,0.0020408163265306124,0.27104753161072703,1.0,40/137,12.47%,NYAP2;CNTNAP2;DCC;CTNNA2;ACTB;EPHB1;SPTBN4;CTNND2;NLGN1;MAPK8IP2;GPM6A;ADGRB1;ANK3;SHANK3;MAP1B;MAP2;APBB1;PAX2;TNIK;DSCAML1;PAK1;NRCAM;CPNE1;EPB41L3;CNTNAP1;ZDHHC17;UBB;SHTN1;PLPPR4;NTNG1;NTNG2;TAOK2;DAB2IP;CELSR2;CNTN4;BRSK2;SLITRK5;DVL1;SRGAP2;DOCK10
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4677666319193713,1.5190797648398444,0.024793388429752067,0.27335432378489705,1.0,12/44,7.78%,KCNJ3;KCNJ6;KCNN2;AKAP6;WNK2;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;KCNN3;GNG2
prerank,cellular response to calcium ion (GO:0071277),0.4249194085412408,1.5188583725966929,0.0102880658436214,0.27216205197937354,1.0,14/67,7.62%,SYT1;ADCY8;SYT6;NLGN1;SYT7;SYT12;SYT11;RYR3;CPNE9;TRPM2;CPNE8;CPNE1;KCNH1;SYT10
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.6038561091063076,-1.5184615456972652,0.03531598513011153,0.2652585958236259,1.0,4/14,7.65%,TGFBR1;EFEMP1;ADAMTS12;WNT9A
prerank,receptor signaling pathway via STAT (GO:0097696),-0.5093294095751674,-1.518346371676878,0.03740157480314961,0.2645483425625067,1.0,10/25,17.75%,PKD1;PIAS1;IL31RA;GHR;STAT3;CTR9;PKD2;STAT1;STAT5A;STAT5B
prerank,response to amyloid-beta (GO:1904645),0.4610524196976031,1.5166653373788124,0.02032520325203252,0.274992566785019,1.0,8/44,3.72%,IGF1R;GRM5;GRIN1;CACNA1A;CACNA1B;MMP12;GRIN2A;CACNA2D1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5237239662881857,1.5164140213715298,0.04852320675105485,0.2739431987141614,1.0,3/23,4.90%,CADM1;KLRC1;IL12A
prerank,regulation of metal ion transport (GO:0010959),-0.5828883554074236,-1.5159836478604654,0.03773584905660377,0.26830516620614286,1.0,7/16,8.15%,STIM1;ANK2;DLG1;SLC30A10;BCL2;IL16;CAMK2G
prerank,protein K48-linked ubiquitination (GO:0070936),-0.44249351560092587,-1.5152836135836083,0.01694915254237288,0.26872970333766655,1.0,23/54,21.13%,RNF152;UBE2E2;PRKN;RNF115;RNF146;UBR5;UBE2H;RNF8;UBE2K;RNF216;UBE2R2;CUL3;DTX3L;UBE2B;FBXO38;TOPORS;UBE2E1;BFAR;SYVN1;UBE2D3;IFI27;TTC3;ARIH2
prerank,smooth muscle contraction (GO:0006939),-0.601556379242147,-1.5152269954073787,0.03804347826086957,0.2678117881998711,1.0,8/14,16.25%,ROCK2;MYLK;ROCK1;EDNRA;TPCN2;SMTN;BDKRB2;MYH11
prerank,receptor clustering (GO:0043113),0.5192758419741337,1.5150874552753502,0.035794183445190156,0.2750500909607783,1.0,7/27,5.91%,DLG2;NRXN1;LRRC7;NLGN1;MAGI2;THY1;NRXN2
prerank,response to cholesterol (GO:0070723),-0.5606441345250663,-1.5147384822738488,0.055445544554455446,0.2677215187397788,1.0,6/17,5.30%,TGFBR1;LRP6;SMO;TGFBR2;GRAMD1C;SMAD2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5198208750222724,-1.514045503756418,0.031192660550458717,0.2681799459978948,1.0,7/26,7.41%,IGF1;RHOQ;SORBS1;OSBPL8;IRS1;CREBL2;BRAF
prerank,negative regulation of ossification (GO:0030279),-0.5266457763943497,-1.5132318851539757,0.04,0.2688532391617233,1.0,8/23,17.76%,RBPJ;SMAD6;BCOR;ENPP1;MEF2C;TRPM4;ECM1;CHSY1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6623375507018965,-1.5132125231942861,0.055970149253731345,0.2678853672654932,1.0,5/10,12.63%,PIAS1;HDAC4;SAE1;PIAS3;PIAS4
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.5039974328272941,-1.5113925797518084,0.026022304832713755,0.2704192936951163,1.0,11/28,15.49%,ZIC1;SMAD3;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;EFCAB7
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5445390384531457,-1.5108367426060807,0.03731343283582089,0.27063573217005166,1.0,12/21,28.16%,SAMD4A;PAN3;TUT4;CNOT8;CNOT2;PAN2;CNOT1;CNOT10;CNOT4;TNKS1BP1;PNLDC1;PARN
prerank,regulation of neuron projection development (GO:0010975),0.3710854744868338,1.5101694294455523,0.0019569471624266144,0.28311888497138493,1.0,56/163,16.55%,SPOCK1;DCC;CSMD3;CTNNA2;RIT2;LRRC4C;LRRC7;MINAR1;MAG;IL1RAPL1;PLXNB3;S100A9;ITGA6;MBOAT1;MAGI2;SHANK3;CDH2;TOX;KIF1A;MFSD2A;NTRK2;SCARF1;FUT9;PAK1;NPTN;PLPPR5;TENM3;ITM2C;NDNF;AKT1;SCARB2;STMN2;ZDHHC15;CDKL5;NTNG1;NTNG2;RTN4R;RELN;DAB2IP;CHN1;PPFIA2;BRSK2;CCDC88A;RET;EFHC2;PSEN1;CIB1;PRAG1;KNDC1;PAK3;RTN4RL1;FKBP4;CRMP1;RAP1A;STX1B;RAB29
prerank,modified amino acid transport (GO:0072337),-0.5785220935309626,-1.5099919401642492,0.03467153284671533,0.2713792857045364,1.0,6/15,18.64%,SLC6A13;SLC16A12;PDPN;SLC5A6;CTNS;MGST1
prerank,peroxisome organization (GO:0007031),-0.5220920798339739,-1.5098819051307295,0.03007518796992481,0.27055037548311966,1.0,18/25,38.00%,ABCD3;DNM1L;ABCD2;LONP2;PEX6;ABCD4;SEC16B;PEX7;FIS1;ACOT8;PEX11B;PEX10;PEX11A;PEX16;PEX19;PLAAT3;PEX12;PEX11G
prerank,detection of calcium ion (GO:0005513),0.6137031516279512,1.5090204430776277,0.05405405405405406,0.28377455990881517,1.0,8/13,14.31%,SYT1;RYR2;KCNMB2;KCNMB3;KCNMB4;CALM1;CALM2;CALM3
prerank,epithelial cell migration (GO:0010631),-0.48065804483733504,-1.5086860393378352,0.028,0.2719335757561407,1.0,15/37,15.47%,FSTL1;KANK2;ROCK1;ABL1;KIT;DPP4;ADGRA2;NRP1;ZEB2;CYP1B1;RHOA;GIPC1;FAP;STAT1;PLXND1
prerank,regulation of sodium ion transport (GO:0002028),0.4911849814849214,1.5086073645580005,0.02301255230125523,0.28305998867912807,1.0,9/34,5.57%,NKAIN2;SPTBN4;FGF12;NKAIN1;NKAIN3;CNKSR3;ANK3;WNK2;SCN4B
prerank,artery morphogenesis (GO:0048844),-0.49078795636811123,-1.508492716917727,0.03428571428571429,0.2713834833949453,1.0,12/30,17.05%,LRP1;TGFBR1;BMPR1A;PDGFRB;BMP4;JAG1;NRP1;ADAMTS9;HES1;PKD2;VEGFA;TBX2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.5252042629374911,-1.508465847554431,0.03288201160541586,0.2704313331988648,1.0,4/23,7.01%,ATP1A2;ANK2;DIAPH1;CAMK2D
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.4436168670603124,-1.5081448335590957,0.02404809619238477,0.27026908866864513,1.0,13/53,11.13%,EYA2;EYA1;EGFR;DDX5;UBE2N;EYA4;PLA2R1;DHX9;BRCC3;CEBPG;RNF8;PRKCD;BCLAF1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.6583082373867106,-1.5080827194493542,0.04038461538461539,0.2693806209195194,1.0,5/10,19.36%,SETD7;SETD3;SETD2;EHMT1;KMT5A
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.42876169681057785,1.5058775998385072,0.02186878727634195,0.2868582722302747,1.0,13/63,14.85%,TFRC;TIRAP;SLC7A1;MIF;IL7;VAV3;FGF10;IL12A;TNFSF13B;AIF1;CD40;NFATC2;CD38
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.5808732478096921,-1.5051056723667515,0.04299065420560748,0.27441019073438644,1.0,6/16,13.72%,SOX5;PTN;FOXC1;DHX36;HOXB4;SOX6
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.48484653618888596,-1.5047339289458739,0.04242424242424243,0.274252601384968,1.0,17/33,28.75%,APPL2;PKD1;INO80;STXBP4;MN1;ID2;FBXW7;APPL1;GLI1;TRIM39;CDC73;EZH2;PLK5;PHB2;TCIM;PSME1;E2F1
prerank,protein stabilization (GO:0050821),-0.3665389107997162,-1.503966507740738,0.0,0.27497600507384956,1.0,70/168,25.25%,IGF1;PARVA;ANK2;PLPP3;MDM4;PER3;TRIM44;STK3;EP300;PRKN;TBL1X;FLOT2;CCNH;FLNA;CREBL2;COA8;CDK7;USP7;CCT6A;STXBP4;EPHA4;PPARGC1A;LAMP2;BAG3;USP33;PRKCD;HCFC1;RPL11;COG3;ATF7IP;COG7;CCT8;TELO2;PEX6;FBXW7;RASSF2;RAB21;NAA15;USP2;UBE2B;ZBED3;USP13;TRIM39;PDCL3;CCT5;TNIP2;NOP53;ZSWIM7;LAMP1;SYVN1;MORC3;PARK7;ATP1B3;SEC16A;PIK3R1;SUGT1;WDR81;DVL3;TAF9B;RABL3;WFS1;CHP1;HIP1R;USP9X;BAG5;BAG6;NAA16;IRGM;STX12;PHB2
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.5834159667291763,-1.5034456377026106,0.041176470588235294,0.2751198038597083,1.0,8/16,19.21%,LRP1;ROCK1;APOE;HDAC1;IFNGR1;HMGCR;CYP51A1;ABCA7
prerank,regulation of telomere maintenance (GO:0032204),-0.5130457802963848,-1.5030132514949148,0.04816955684007707,0.27504311509322804,1.0,16/26,27.53%,SMG6;HDAC8;SMG1;USP7;NBN;YLPM1;HNRNPD;DHX36;UPF1;MRE11;TERF2;PML;ERCC1;PPP1R10;GNL3;ATRX
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5780996212744398,-1.5028162371319127,0.05194805194805195,0.27441818454988426,1.0,7/16,10.24%,PDGFRA;PDGFRB;ABL1;PLAT;NRP1;FER;PDGFC
prerank,defense response to bacterium (GO:0042742),0.3875860631061971,1.4997238164311288,0.004008016032064128,0.29760917276777027,1.0,21/105,14.41%,TIRAP;PGLYRP1;MBL2;RPS19;S100A9;S100A8;ADGRB1;ISG15;IL12A;TLR2;RPL30;EPX;NOD1;SLPI;PPP1R11;GBP4;DROSHA;DEFA6;LCN2;LPO;STAB2
prerank,Wnt signaling pathway (GO:0016055),-0.39401242305787115,-1.498798071835852,0.007751937984496124,0.2816583646298878,1.0,18/92,6.01%,WLS;NXN;TCF7L2;LRP6;WNT4;PLPP3;LRRK2;CSNK1A1;BTRC;WNT5B;GPC4;WNT6;GSK3B;RYK;RARG;BCL9L;AXIN1;FZD2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.5123209221869791,-1.4987456939598363,0.02394106813996317,0.2807248079162408,1.0,18/26,41.85%,ERRFI1;CBLB;SNX6;SHC1;FBXW7;NCK2;ADRA2A;HBEGF;EGF;APP;GPRC5A;ZGPAT;CBL;ADAM17;TSG101;SOCS4;BTC;CHMP6
prerank,membrane depolarization (GO:0051899),0.47941573718752245,1.4987199464442156,0.035634743875278395,0.2979779432368274,1.0,11/32,15.66%,CACNA1A;SCN1A;CACNA1B;CACNG2;CACNA1E;SCN3A;CACNB4;P2RX7;SCN2A;CACNA1I;SCN8A
prerank,autophagy of nucleus (GO:0044804),-0.5766522219043994,-1.4986590493446899,0.04779411764705882,0.28000573784355925,1.0,12/16,34.10%,RB1CC1;WIPI1;ULK2;ATG2A;ATG9A;WDR45B;ATG2B;ATG5;WIPI2;ATG3;WDR45;ATG12
prerank,negative regulation of gene expression (GO:0010629),-0.3418847694071854,-1.4984992738973624,0.0,0.27936784697593153,1.0,79/302,17.89%,SLC24A3;SAMD4A;ROCK2;NOTCH2;IGF1;FOXP1;BMPR1A;RBMS3;NFKB1;ZNF148;WNT4;IGFBP5;CELF1;LGR4;DIS3L2;KAT2B;BMP4;DICER1;ROBO1;SMO;NCOR1;PRKN;PPM1D;TNRC6B;PRKAA2;WWP2;FLOT2;YAP1;SYNCRIP;TNRC6A;DDX6;MOV10;EIF4ENIF1;TWSG1;DNMT3A;EIF2AK3;RUNX1;ANXA7;PTBP3;REST;LARP1;PARP10;DHX36;MAP2K1;PTPN22;ITGB8;LSM14A;PARP14;HIF1A;MPHOSPH8;PARP9;ID2;CNOT8;ATP2B1;MEF2C;SETDB1;RB1;FBXW7;YBX1;EIF2AK2;APOE;PHF1;HINFP;VEGFA;EMILIN1;HDAC1;ERN1;DDX3X;CCDC3;JARID2;DAPK1;ATOH8;TNRC6C;CITED2;EPC1;CNOT1;PICALM;PRKAA1;MYADM
prerank,muscle contraction (GO:0006936),-0.3781752053066892,-1.4978917608781412,0.005859375,0.2797326368792804,1.0,21/126,8.81%,CALD1;ROCK2;SORBS1;VCL;TPM1;MYLK;VIM;ROCK1;PABPN1;TLN1;SNTA1;MYOF;TMOD3;EDNRA;SNTB1;ITGB5;TPCN2;SSPN;ASPH;SMTN;ACTN2
prerank,regulation of focal adhesion assembly (GO:0051893),-0.4319118318060397,-1.4974130137996997,0.022181146025878003,0.2796709740439392,1.0,15/54,7.95%,PHLDB2;ROCK2;ARHGAP6;EPHA3;VCL;LIMS1;ROCK1;ABL1;SLC9A1;SLK;THBS1;BCAS3;MAP4K4;NRP1;S100A10
prerank,cation transport (GO:0006812),0.3602202427309753,1.496682546413891,0.0,0.3006101505983557,1.0,33/167,11.75%,SLC6A6;GRIN1;SCN1A;SLC6A17;KCNJ3;SLC7A1;KCNJ6;KCNN2;FGF13;SLC1A1;KCNMB2;KCNMB3;SLC8A1;KCNN1;SCN4B;ASIC1;KCNMB4;KCNJ10;TRPM2;KCND3;KCNH1;KCNK9;SLC7A8;KCNAB1;SCN3A;KCNC1;KCNK1;SLC66A1;SLC12A3;SLC36A1;ATP1A4;KCNA2;SCN2A
prerank,urogenital system development (GO:0001655),0.6316198061703467,1.4966656737312143,0.07236842105263158,0.29895764253059964,1.0,4/11,6.58%,PAX8;AMH;PAX2;LHX1
prerank,ceramide transport (GO:0035627),0.6206190409063955,1.496657553376006,0.05439330543933055,0.29733648274978947,1.0,7/12,20.86%,PLTP;CERT1;ABCB4;PLEKHA3;CPTP;SGPP1;PSAP
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.44074732541076955,-1.4961153564600345,0.024844720496894408,0.28165062991304834,1.0,22/51,19.91%,ROCK2;LPAR1;TGFBR1;TPM1;CCN2;ABL1;ARHGEF10L;PPM1E;NRP1;FHOD1;CDC42;RAPGEF3;S100A10;SYNPO2;RHOA;SYNPO;CARMIL1;TGFB3;SORBS3;MYOC;RHOC;NF2
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.390252587395749,-1.494202713992001,0.01764705882352941,0.28479585034433785,1.0,29/87,20.54%,ROCK2;NOTCH2;LRP1;RHOQ;EPHA3;PDGFRA;PDGFRB;ROCK1;ABL1;RND3;MTOR;RAPGEF3;ARHGAP17;IQGAP2;SEMA3E;RHOA;PRKCD;ABL2;RHOBTB2;RICTOR;ARHGDIB;ARHGAP18;FAM107A;RHOBTB1;RHOH;RHOC;CDK10;TAOK1;BAIAP2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6381954489370876,1.4941833211778368,0.05732484076433121,0.3005449463293545,1.0,5/10,14.31%,PDE4B;CACNA2D1;CACNB2;CALM1;CALM3
prerank,protein localization to cell surface (GO:0034394),-0.5240127206249182,-1.493551388089685,0.05152671755725191,0.28524046815289833,1.0,10/26,14.60%,ANK2;VCL;ANGPT1;FBLN5;FLNA;PIGK;PTPRK;GGA3;USP4;SMURF1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.4799460767697522,-1.4934294274349071,0.03189493433395872,0.2844983646255137,1.0,11/34,17.35%,ROCK2;CTNNA1;GSK3B;RIPOR2;UBXN2B;ACTN2;LEPROTL1;LEPROT;ILRUN;LATS1;PICALM
prerank,signal peptide processing (GO:0006465),-0.6264029213956045,-1.4920293350870615,0.047151277013752456,0.2866978692202024,1.0,8/11,27.46%,PCSK5;HM13;SEC11C;SEC11A;SPPL3;CLN5;PARL;SPCS3
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5264569180373369,-1.4918832701167617,0.0570902394106814,0.28599284846463624,1.0,12/24,22.78%,IGF1;SORBS1;ENPP1;GSK3B;IRS1;IGF2;SELENOS;PPP1R3B;INPP5K;AKT2;PPP1R3C;PPP1R3F
prerank,regulation of glycolytic process (GO:0006110),-0.41402898034193525,-1.4916499703734831,0.011152416356877323,0.2855056607221575,1.0,16/68,12.87%,ZBTB20;PRKAG2;IGF1;EP300;HDAC4;NCOR1;ARNT;PRKAA2;NUPR1;RANBP2;PFKFB4;NUP42;NUP214;HIF1A;TPR;OGT
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3309909790607934,-1.4914375227541974,0.0,0.28495241781076164,1.0,156/366,30.95%,NFIA;BNC2;DENND4A;TGFBR1;EFEMP1;ANKRD17;ZNF423;ATXN1;NR1D2;ZFHX3;FOXC1;FOXO3;EP300;ERC1;ABL1;KAT6B;WWC2;TFEB;FOXN3;GON4L;RREB1;WTIP;CREBL2;KMT2D;BAZ2A;PPARGC1B;NR3C1;SRSF10;RBBP6;SBNO2;PRRX2;FUS;CREBBP;STAT3;NSD3;TRIP4;NSD1;TRRAP;NAB1;REST;POFUT1;HNRNPD;GTF2IRD1;CTR9;PPARGC1A;IGF2;NFYC;GEMIN5;ATF2;EIF4E;CHD3;ZFAT;SSBP2;TULP3;HIF1A;HCFC1;LIMD1;CDK11B;GPBP1L1;WWC1;RORA;MEF2C;SPTY2D1;TEAD2;SUFU;TCF3;TCF7L1;RB1;CCAR1;FZD7;CRABP2;PATZ1;YBX1;SOX13;SOX6;CHD7;PHF1;HINFP;ESCO1;BRCA2;USP13;PRDM2;TAF5L;FOXK2;VSX1;PRMT5;SFPQ;GLRX2;MYBL1;SIX1;ATXN1L;RNF20;ZFP37;NFYB;TAF6L;MSL3;POU6F2;RHOH;HMG20A;BMP2;RNF14;AJUBA;NFX1;EIF2B4;PML;NFYA;PPP2CA;EZH2;ZNF205;SPIN1;DRAP1;RABL3;IRF2;NFXL1;MAFB;CCAR2;TRAPPC2;RNF6;NONO;ZNF35;CXXC1;NFKB2;MZF1;SOX11;RPS6KA4;DVL2;ACTR5;LDB1;EDF1;OGG1;ZNF219;NFIL3;JMJD1C;SOX12;OBI1;ATRX;SAP30L;APP;ESR1;MYBL2;ZBTB4;E2F1;SP3;ZFPL1;UTP4;FOXO4;HIC1;ZBTB38;CALR;MLX;MLXIPL;DDX25;UBE2L3;HDAC10;SKOR2;NR5A2
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.4225784838791428,-1.4907231429636283,0.01606425702811245,0.2855297748895296,1.0,25/62,24.48%,KAT2B;EP300;TNRC6B;KMT2C;TNRC6A;KMT2D;MOV10;THBS1;HOXA5;CREBBP;ZBTB16;RUNX1;LYN;CTR9;MEF2C;HSPA9;HDAC1;TNRC6C;CDC73;CDK6;KMT2A;MAFB;AGO1;CNOT4;KMT2E
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.3968475143208344,-1.490618960250986,0.007797270955165692,0.2847693993466988,1.0,15/85,7.39%,BMP6;TGFBR3;IGF1;EGFR;TCF7L2;ANGPT1;LIMS1;BMP5;FGF1;BMP4;OSR1;NUPR1;YAP1;FGFR2;SRSF6
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.536052449360877,-1.4894509038826498,0.04247104247104247,0.2861757799636142,1.0,11/21,24.88%,MED17;MED12;DHX36;MED1;JUN;BCLAF1;MED16;MED13;MED14;PAXIP1;TWIST1
prerank,chordate embryonic development (GO:0043009),-0.432770743485664,-1.4883810278293692,0.015841584158415842,0.28744782950540126,1.0,19/55,15.84%,SULF1;ALDH1A2;TGFBR1;COL1A1;PKD1;BMP5;BMP7;PCSK5;RBP4;SULF2;FGFR2;IGF2;DACT1;PKD2;CHD7;HINFP;VEGFA;PTCH1;TGFB3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.4867556660233268,-1.4870658921428248,0.031835205992509365,0.2892771697331875,1.0,10/30,10.62%,FSTL1;TGFBR3;SMAD3;SMURF2;NREP;DKK3;SMAD2;TWSG1;XIAP;SMAD4
prerank,positive regulation of binding (GO:0051099),-0.3963526482357961,-1.486870001916375,0.01338432122370937,0.2887024113657576,1.0,32/84,20.71%,IGF1;TCF7L2;LRP1;PKD1;FOXC1;STK3;BMP4;PRKN;LRRK2;VTN;GSK3B;MARK3;HMGB1;SKI;DHX9;CEBPG;DACT1;NGF;USP33;RPL11;PARP9;HES1;DTX3L;TXN;APOE;RAPGEF2;DERL1;BMP2;SPPL3;TERT;CLN5;NME1
prerank,organelle organization (GO:0006996),-0.32655405439104407,-1.4859522936521137,0.0,0.2897260271293496,1.0,141/388,25.25%,ARHGAP10;MICAL3;PLCE1;TPM1;OPA1;BRWD1;DIAPH1;GBF1;PRKN;LRRK2;FBXW8;SYNE3;CSNK1A1;RAB30;NUMA1;ATL3;MICAL2;ABCD3;WDPCP;YTHDF3;ODF2;PACSIN2;WTIP;HPS3;UBXN2B;HUWE1;DNM1L;ATP8B1;BCAS3;CXADR;GOLGB1;SEC23IP;VPS4B;VPS13D;ARFGEF1;AFG1L;RAB3GAP1;EIF2AK3;ARHGAP21;OBSL1;CDC42;CHMP4B;CHMP4A;ABCD2;PPARGC1A;MARK4;USP6NL;SEC31A;PALLD;MTX3;CHMP5;ATP8B2;ATL2;RANBP10;TBC1D20;WASL;CHMP3;GABPA;LONP2;FAM161A;HCFC1;COG3;LIMD1;RHOT1;COG7;STX4;ZMYM4;PARP1;NRF1;YME1L1;PEX6;ABCD4;PKD2;VPS13C;FGD1;SURF4;SIRT5;ZMYM3;CAPZB;APOE;TTC17;FGD4;NECTIN2;DOP1B;RANBP9;STOML2;ZFYVE16;MARK1;FAF2;AUP1;TJAP1;TMED3;MIA3;PHIP;PRKD1;ATXN7;MICAL1;SEC16B;CSNK1D;SMPD4;PARK7;TMED5;TMED4;SIPA1L3;AJUBA;TMCC1;PLEKHF1;TRIP11;PEX7;CNN2;TERT;SEC16A;KIF9;SPRYD3;STX17;PYROXD2;DES;KIFAP3;MAST2;WDR81;CUL7;PPID;COG4;PLEKHM2;SIRT4;SSBP1;TOR1A;PI4K2B;VAPA;ARMC2;LMAN1;SPTSSB;RHOT2;BAG5;KIF3A;SAR1B;SIRT3;RAB7A;CENPT;CLUH;PHB2
prerank,regulation of feeding behavior (GO:0060259),-0.6286524637699922,-1.4841628832061031,0.052823315118397086,0.2925426042032147,1.0,4/11,12.77%,LEPR;AGRP;STAT3;EIF2AK4
prerank,positive regulation of ossification (GO:0045778),-0.4618699504194605,-1.4833800987356993,0.04054054054054054,0.293225913638156,1.0,22/39,20.84%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;OSR1;ZBTB16;ADGRV1;KL;ATP2B1;MEF2C;ATRAID;CCN1;ACVR1;FBN2;TGFB3;WNT5A;BMP2;PTPN11;TMEM119;PKDCC
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5435028000643212,-1.4831872412193665,0.03917910447761194,0.29268515990077826,1.0,6/19,15.90%,ENPP1;TPST1;SLC35B3;SLC26A2;SULT1A1;ABHD14B
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5104639360322755,-1.4830841214464014,0.040515653775322284,0.2919316220365496,1.0,8/24,6.61%,PARVA;BMPR1A;SMAD6;BMP4;ROBO1;TGFBR2;NRP1;FGFR2
prerank,positive regulation of signal transduction (GO:0009967),-0.3453322474743996,-1.4826893412894044,0.0019880715705765406,0.29179860089104276,1.0,66/238,15.98%,BMP6;WLS;SULF1;IGF1;SASH1;TGFBR1;SORBS1;ZMIZ1;RBPJ;NTRK3;LIMS1;GRB10;ITGAV;FGF1;CCBE1;TRIM44;KAT2B;AXL;IL6ST;EP300;ROBO1;PTGIS;SMO;ARNT;JAG1;LRRK2;VTN;TSPAN5;NLGN2;DLG4;YAP1;DCDC2;FLNA;TTC23;IRS1;SULF2;SLC39A14;RSPO3;SKI;CREBBP;STAT3;NRP1;FGFR2;F3;IGF2;DACT1;MN1;RSPO2;CCN3;HIF1A;EVC;MAML2;PKD2;ARMC9;MAML1;GLI1;ING5;TPD52L1;BMP2K;ERN1;PRKCZ;TRIM39;ITGA5;CSNK2A1;SALL1;LOXL3
prerank,RNA metabolic process (GO:0016070),-0.3743426288151639,-1.4818179721764357,0.010330578512396695,0.29279974431901307,1.0,39/127,19.58%,RBMS1;CELF2;RBFOX2;TENT2;RBPMS;ATXN1;HNRNPH1;FTO;RBM39;DICER1;PABPN1;HNRNPR;SYNCRIP;DDX17;WTAP;RBMS2;RBM6;HNRNPM;DHX9;HNRNPUL1;HNRNPD;DHX36;PCBP2;HNRNPK;DUSP11;XRN2;ALKBH1;APOBEC1;RBM5;PAPOLG;DDX3X;MTREX;RNGTT;HNRNPU;POLR2H;HNRNPA3;RNASE4;SIDT2;RBM4
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.5763155903879263,-1.4815237449071854,0.043782837127845885,0.2925206356499042,1.0,9/15,30.89%,NR3C1;ANXA1;REST;FAM107A;HNRNPU;ZFP36L2;GPER1;UBE2L3;BCL2L11
prerank,regulation of actin filament-based process (GO:0032970),-0.4036896865461135,-1.4811319812567314,0.015779092702169626,0.29244911490752695,1.0,31/70,27.49%,ROCK2;LRP1;RHOQ;EPHA3;PDGFRB;ROCK1;ABL1;RND3;MTOR;ARHGAP17;IQGAP2;RHOA;PRKCD;RHOBTB2;RICTOR;ARHGAP18;FAM107A;RHOBTB1;RHOH;RHOC;CDK10;TAOK1;CNN2;BAIAP2;F11R;ARHGAP35;HIP1R;ARHGAP44;TWF2;TESK1;EFNA5
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.46159830190763723,1.4807425476248763,0.032679738562091505,0.32735248564736696,1.0,19/38,21.30%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;NDUFB2;NDUFAF1;NDUFB9;NDUFAB1;NDUFA7;NDUFA12;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,regulation of gene expression (GO:0010468),-0.3071576922162246,-1.4804551013606744,0.0,0.2930165822665021,1.0,233/903,19.00%,NFIA;BMP6;SLC24A3;ROCK2;NOTCH2;PRDM6;IGF1;BNC2;FOXP1;DENND4A;PID1;AHNAK;AFDN;SMAD3;TGFBR1;EFEMP1;ANK2;BMPR1A;RBMS3;FOXD1;SON;NFKB1;PRDM5;ZNF148;ANGPT1;GSN;WNT4;RBPJ;NTRK3;CLK1;LIMS1;ZNF423;CELF1;ATXN1;NR1D2;ZNF462;ZFHX3;HNRNPH1;FOXC1;FGF1;TRIM44;BMP7;AFF3;EP300;ROCK1;BMP4;DICER1;ROBO1;HDAC4;ERC1;ABL1;SMO;KAT6B;PRKN;TNRC6B;OSR1;WWC2;TFEB;PRKAA2;MBNL2;PABPN1;FOXN3;WWP2;FLOT2;WNT6;GSK3B;GON4L;RREB1;PUM2;YAP1;ZC3H7A;WTIP;TNRC6A;CREBL2;KMT2D;BAZ2A;PPARGC1B;NR3C1;CTSH;SRSF10;MOV10;UBR5;AFF1;SBNO2;PRRX2;HOXA5;FUS;PLSCR1;CREBBP;RC3H1;CDH1;STAT3;NSD3;TRIP4;NSD1;DTNBP1;MED26;TRRAP;ZUP1;EIF2AK3;NAB1;RUNX1;LYN;ANXA7;MTOR;PTBP3;F3;BRAF;REST;LARP1;PARP10;POFUT1;PUM1;HNRNPD;GTF2IRD1;AR;FUBP1;DHX36;CTR9;PCBP2;PPARGC1A;IGF2;GJA1;MAP2K1;NFYC;KDM6A;MED1;PTPN22;HNRNPK;ATF2;CLK2;ITGB8;NGF;CHD3;ZFAT;GABPA;SSBP2;TADA3;TULP3;PARP14;HIF1A;HCFC1;CALCOCO1;RPL11;LIMD1;PARP9;ID2;AFF4;CLK3;CDK11B;YTHDC1;TLE1;GPBP1L1;ADAM19;NFKBIZ;WWC1;RORA;MEF2C;TRIM5;SPTY2D1;TRIM11;TEAD2;SUFU;SETDB1;TCF3;TCF7L1;RB1;SNRNP70;FBXW7;YBX3;FN1;CCAR1;FZD7;CRABP2;PATZ1;ADNP2;CGGBP1;YBX1;SOX13;ATRAID;SOX6;CHD7;APOE;PHF1;HINFP;VEGFA;EMILIN1;BRCA2;HDAC1;USP13;DDX3X;PRDM2;TAF5L;TRIM39;PDCL3;CCDC3;FOXK2;EPHX2;VSX1;ATOH8;IFNGR1;PRMT5;TNRC6C;SFPQ;TRAF3;GLRX2;CITED2;MYBL1;SIX1;ATXN1L;RNF20;ZFP37;NFYB;PIK3CD;PICALM;TLR4;CCN4;WNT5A;PRKAA1;MYADM;SFRP4;TAF6L;MSL3;POU6F2;GCNT2;SEC16B;RHOH;HMG20A;MYOM1;BMP2;RNF14;PARK7;MUSK
prerank,heme catabolic process (GO:0042167),0.5814424877809882,1.4795065154991904,0.058212058212058215,0.3264002577373546,1.0,2/14,9.69%,ABCG2;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.5814424877809882,1.4795065154991904,0.058212058212058215,0.3264002577373546,1.0,2/14,9.69%,ABCG2;SLCO2B1
prerank,"transcription, DNA-templated (GO:0006351)",-0.3452021376229886,-1.4792624472106732,0.00199203187250996,0.2945832790486764,1.0,87/207,28.75%,MLLT3;MAF;SOX5;NFKB1;THRB;DDX5;GLIS3;FOXO3;GTF2H2;CCNT2;CCNH;NFIX;RREB1;CCNT1;CREBL2;TAF3;MEF2A;CDK7;BAZ2A;CTR9;TAF4;TBP;NCOA6;CCNK;MNAT1;BRF1;AFF4;RTF1;PARP1;ERCC3;IRF9;COPS2;NELFB;TTF1;MMS19;TAF5L;SNAPC3;TOPORS;TAF13;MNT;PRMT5;GTF2B;PIR;PMF1;EPC1;RNGTT;NR4A2;NFIC;POLR2H;GTF3C4;TRIP11;CDC73;NFX1;MED16;TAF12;NFYA;TAF9B;TAF2;DRAP1;RPAP1;GTF2F1;POLR2K;HSF1;GTF2H1;EAF2;TBPL1;GTF3C1;CTDP1;POLR2E;POLR3H;NCBP2;TAF7;GTF3C6;ZBTB7B;TAF1C;GTF2H4;GTF2E2;THRA;NFKBIB;POLR2D;NELFA;CDK9;NELFE;BRF2;MRPL12;TAF1A;E2F1
prerank,negative regulation of ion transport (GO:0043271),0.5181447804132121,1.4785611401784597,0.04042553191489362,0.3267384798897268,1.0,5/24,4.15%,CD33;GPM6B;SYT11;SNCA;WNK2
prerank,mitochondrion distribution (GO:0048311),-0.6148378654819037,-1.4783840562701493,0.04093567251461988,0.29555160242168,1.0,5/12,13.35%,TRAK1;LRRK2;MEF2A;DNM1L;ARMC1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4044950533406318,1.4782018899022538,0.0166358595194085,0.3257428841625121,1.0,20/75,14.15%,SLC39A10;SLC24A2;KCNJ3;KCNJ6;CACNA2D1;SLC8A1;SLC12A6;KCNJ11;HCN2;KCNJ10;TRPM2;ATP1A3;KCNK9;SLC12A3;SLC39A8;ATP1A4;ATP1A1;KCNJ8;ATP1B1;ATP2B4
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.41310755669910393,-1.477866986585849,0.023809523809523808,0.295716536380101,1.0,24/67,22.02%,DOCK5;PLEKHA2;LIMS1;ECM2;ABL1;GSK3B;RREB1;FLNA;VIT;NRP1;CDC42;S100A10;RSU1;JUP;FN1;CARMIL1;DOCK1;MYADM;NPNT;MYOC;TRIOBP;P4HB;CDK6;CRKL
prerank,organic anion transport (GO:0015711),0.4067830556273713,1.477760110410601,0.01680672268907563,0.32493849694209925,1.0,15/76,10.65%,SLCO1C1;SLC4A1;CA4;SLCO4C1;AQP9;ABCG2;SLC35A1;SLC52A2;SLC25A42;CA2;SLCO5A1;SLC52A3;SLCO2B1;ABCC4;SLC39A8
prerank,positive regulation of organelle organization (GO:0010638),-0.4750785158431414,-1.4770435455348354,0.04419889502762431,0.296537492139524,1.0,15/32,27.39%,UVRAG;ATL3;GSK3B;ANXA2;RAB3GAP1;STX18;ANXA1;PPARGC1A;SURF4;SORBS3;AKT2;LMAN1;IRGM;HTRA2;ADRB2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.6271207301629318,-1.4768673687880973,0.056776556776556776,0.2959746982284754,1.0,3/11,3.07%,BMPR1A;BMP4;JAG1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6470334946266119,1.476394831909534,0.05942622950819672,0.32608965013599406,1.0,7/10,17.03%,GALNT13;MGAT5B;GALNT3;GALNT2;POGLUT1;GALNT16;GALNT4
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.5602353257709058,1.4760798843789684,0.06407322654462243,0.32506747123156443,1.0,7/16,11.96%,ST6GALNAC3;ST8SIA4;B4GALNT1;ST8SIA1;B4GALT6;ST8SIA6;ST8SIA3
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4762857164863667,1.4759548573079124,0.033707865168539325,0.3236921666358214,1.0,6/31,2.79%,SYT1;SYT6;SYT7;DOC2A;SYT12;SYT11
prerank,neuron projection development (GO:0031175),0.3585262457447505,1.4754330627426957,0.0,0.3230344920707456,1.0,38/168,10.81%,NYAP2;CNTNAP2;GPRIN1;FRY;PLP1;GRM7;TMEM108;EPHB1;CTNND2;NLGN1;GPM6A;SH3GL2;GPM6B;SHANK3;MAP2;STMN1;TNIK;STX3;OMG;PAK1;PPP1R9A;GPRIN3;EPB41L3;CNTNAP1;ADCYAP1;STMN4;RASGRF1;BICDL1;UBB;SHTN1;CAMSAP1;RAB35;STMN2;TAOK2;DAB2IP;PTPRM;MICALL2;CNTN4
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5789183764072408,-1.4750249035614982,0.0425531914893617,0.29889632424297574,1.0,4/16,10.16%,PRKAG2;APPL2;PPARGC1A;LONP2
prerank,histone ubiquitination (GO:0016574),-0.5226339897429286,-1.474696813941707,0.051601423487544484,0.29860583588528916,1.0,11/21,22.39%,UBE2N;UBR2;HUWE1;RNF8;CTR9;DTX3L;UBE2B;UBE2E1;RNF20;CDC73;WAC
prerank,sensory perception of taste (GO:0050909),0.6184076966696085,1.4743931488179942,0.08668076109936575,0.3234433515506258,1.0,3/10,13.89%,ASIC2;ASIC1;CD36
prerank,positive regulation of potassium ion transport (GO:0043268),0.4625455155023056,1.4733851579645314,0.05060728744939271,0.32390498281116664,1.0,11/38,7.78%,KCNJ3;KCNJ6;KCNN2;AKAP6;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;KCNN3;GNG2
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.4436804713591675,-1.472920851422852,0.04242424242424243,0.30169300957301853,1.0,20/44,19.91%,ROCK2;LPAR1;TGFBR1;TPM1;CCN2;ABL1;ARHGEF10L;PPM1E;NRP1;FHOD1;CDC42;RAPGEF3;S100A10;RHOA;CARMIL1;TGFB3;SORBS3;MYOC;RHOC;NF2
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.45525762563564565,-1.4727709051401825,0.02702702702702703,0.30105713419005176,1.0,17/40,15.84%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;OSR1;WNT6;ADGRV1;KL;ATP2B1;MEF2C;ATRAID;CCN1;ACVR1;FBN2;TGFB3
prerank,lipid modification (GO:0030258),0.45999472433494115,1.4714385576526967,0.042283298097251586,0.3265203233003234,1.0,10/37,8.86%,DGKI;PLPPR1;MBOAT1;PLPPR5;DGKH;CYP2E1;DGKB;SGPP2;PLPPR4;PLPP4
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4077920509654364,-1.470883848031572,0.019762845849802372,0.30421463503805923,1.0,28/67,20.91%,ROCK2;SULF1;ITGAV;AXL;ROCK1;CYFIP2;WASF2;SHB;PAK2;NRP1;CDC42;VAV2;BRK1;RHOA;ABI1;NCKAP1;VEGFA;NCK1;VEGFD;NCK2;CYBA;DOCK1;PRKD1;ITGB3;NCF2;BAIAP2;PIK3R1;AAMP
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5485685640055873,1.4702647164368943,0.05708245243128964,0.3275779748650258,1.0,6/19,11.67%,SLCO1C1;PAX8;KLF4;PDGFB;KLF2;MAPK8
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4330119589683158,-1.4701747331495127,0.033582089552238806,0.3049087355368611,1.0,22/47,27.71%,DOCK5;LIMS1;FBLN1;PDPN;ABL1;RREB1;FLNA;NRP1;CDC42;S100A10;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CRKL;KANK1;AP1AR;TESK1;EFNA5;FERMT2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3801056280630853,1.4700176943711942,0.011673151750972763,0.32644025607217814,1.0,19/107,6.24%,SLC39A10;SLC24A4;SLC24A2;MT2A;CXCL12;RYR2;HTR2C;SLC8A1;ATP2B3;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;SLC30A1;NPTN
prerank,protein K11-linked ubiquitination (GO:0070979),-0.4953019761830625,-1.4695827740366159,0.04580152671755725,0.305356391011853,1.0,18/27,31.82%,UBE2E2;PRKN;UBE2H;ANAPC5;ANAPC7;ANAPC4;CDC26;UBE2B;CDC27;UBE2S;UBE2D3;ANAPC11;ANAPC13;CDC16;ANAPC1;FZR1;UBE2L3;UBE2W
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.5295389485477245,-1.469520553196612,0.04655493482309125,0.30456107595133713,1.0,13/21,33.67%,OPA1;PRKN;LRRK2;EIF2AK3;SELENOS;NCK1;SYVN1;PARK7;TMBIM6;BCL2L11;HERPUD1;HSPA1A;CREB3L1
prerank,ncRNA processing (GO:0034470),0.3499397013639066,1.469222141245156,0.0038684719535783366,0.32651449431143037,1.0,62/200,18.35%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL15;RPL10;LIN28B;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;INTS2;RPL21;DKC1;RPS7;RPP30;RPL23A;RPL8;POP5;DROSHA;RPS14;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;INTS11;RRP1B;RRP1;NOP56;INTS10;RPS25;MDN1;UTP15;EXOSC4;RPS9;ADAR;AGO4;RPL31;NVL
prerank,clathrin coat assembly (GO:0048268),0.5658321032132771,1.4692143273107114,0.05689277899343545,0.32488562260032616,1.0,6/15,14.07%,NSG2;HIP1;FCHO1;CALY;SGIP1;CLTB
prerank,canonical Wnt signaling pathway (GO:0060070),-0.40676993456490423,-1.468331734962886,0.015717092337917484,0.3061138050260029,1.0,25/68,22.10%,TCF7L2;LRP6;WNT4;PLPP3;LRRK2;CSNK1A1;WNT5B;WNT6;GSK3B;RYK;RARG;BCL9L;AXIN1;FZD2;WNT9A;CSNK1E;TCF7L1;FZD7;WNT5A;NR4A2;SFRP4;FZD1;FRZB;DVL3;WNT16
prerank,positive regulation of protein import (GO:1904591),-0.48819646735273137,-1.4677881567637163,0.0367504835589942,0.3064207272896208,1.0,11/30,15.49%,ZIC1;SMAD3;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;EFCAB7
prerank,activin receptor signaling pathway (GO:0032924),-0.5697572364909882,-1.4677851365197438,0.0637065637065637,0.30548234177867195,1.0,5/15,19.36%,SMAD3;TGFBR1;SMAD2;ACVR1;INHBA
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4831647301384564,1.4677696819437935,0.03278688524590164,0.32647911848462724,1.0,11/28,19.66%,FGF10;THY1;IL12A;PRKCQ;CCL2;CYRIB;HSPD1;SH3KBP1;NCKAP1L;NOD2;CD47
prerank,cellular response to interleukin-6 (GO:0071354),-0.5039593910562761,-1.4676933666612486,0.054924242424242424,0.30473676926910187,1.0,13/26,14.18%,PID1;NFKB1;IL6ST;PTGIS;JAK1;YAP1;SBNO2;STAT3;CTR9;FER;SMAD4;IL6R;STAT1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.585958060941614,-1.4671894410966346,0.06451612903225806,0.3048878758931759,1.0,6/14,25.07%,DHX9;DHX36;YBX3;CPEB1;PKM;UNK
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.42223210023274477,-1.4669626250779202,0.026923076923076925,0.30437467061575546,1.0,26/58,26.93%,UBE2N;UVRAG;HMGB1;NBN;NSMCE2;BRCC3;RNF8;SMC5;HERC2;XRCC4;PAXX;POLM;PIAS4;PRKDC;ERCC8;KDM2A;MRE11;DCLRE1A;XRCC6;UBE2V2;SMARCAL1;ERCC1;PAXIP1;ZBTB7A;IFFO1;ABRAXAS1
prerank,regulation of secretion by cell (GO:1903530),0.4268999816808577,1.466766239114446,0.028629856850715747,0.32705493270269603,1.0,11/54,6.13%,CAMK2A;SYT1;RIMS1;RIMS2;SCG5;MCTP1;RAB3C;LGI3;RHBDF2;STXBP5L;KCNMB4
prerank,myelination (GO:0042552),0.4427285944060918,1.465734231127904,0.035343035343035345,0.32765632003149936,1.0,17/46,16.78%,GAL3ST1;MAL;MBP;PLP1;MPZ;CMTM8;NFASC;EPB41L3;CNTNAP1;B4GALT6;TPPP;TNFRSF21;SCN2A;MAL2;SCN8A;PLLP;HES5
prerank,positive regulation of bone mineralization (GO:0030501),-0.4706805319853813,-1.4655354569242642,0.031189083820662766,0.3066735797100317,1.0,19/35,20.84%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;KL;ATP2B1;MEF2C;ATRAID;CCN1;ACVR1;FBN2;TGFB3;BMP2;TMEM119;PKDCC
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5447513068426401,1.465405448371826,0.05656108597285068,0.32682803406737443,1.0,8/18,21.18%,CHRM3;GRK2;PLCB1;OPRM1;CHRM2;GNAQ;CDK5R1;RGS10
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4942725073688911,-1.4647375938513532,0.04752851711026616,0.30746590796211193,1.0,13/28,18.70%,PID1;APPL2;GRB10;ENPP1;TNS2;IRS1;PIP4K2C;PTPN2;PRKCD;NCK1;PRKCZ;PTPN1;INPP5K
prerank,peptidyl-lysine modification (GO:0018205),-0.38068934077490324,-1.4646143459731225,0.008146639511201629,0.30680508192384076,1.0,30/99,15.98%,EYA1;LOXL1;KAT2B;PIAS1;EP300;HDAC4;PLOD2;SAE1;RANBP2;SENP3;SENP7;NSMCE2;P3H3;NNAT;SENP6;NUP42;PIAS3;UBE2I;NUP214;SENP1;SENP5;TPR;PIAS4;TRPM4;SIRT5;LOX;ESCO1;METTL21A;TOPORS;LOXL3
prerank,negative regulation of vascular permeability (GO:0043116),0.5941073459764954,1.4642650156832462,0.09339407744874716,0.3275678629853867,1.0,5/12,7.54%,CLDN5;SH3GL2;RAMP2;PDE2A;PTPRJ
prerank,oligodendrocyte development (GO:0014003),0.5597515861292554,1.4625815865532605,0.058823529411764705,0.32936749778886487,1.0,6/15,9.18%,PLP1;CNTNAP1;NSUN5;EIF2B3;B4GALT6;TPPP
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.5512295315208642,-1.4611612596416432,0.0546448087431694,0.3137570332955834,1.0,10/17,28.25%,CCNT1;CTR9;ZC3H3;CPEB1;RNF20;NUDT21;HSF1;NCBP2;CDK9;NELFE
prerank,negative regulation of cholesterol transport (GO:0032375),-0.6478470758320857,-1.4609736122928234,0.06072106261859583,0.31320689221885334,1.0,1/10,1.19%,NFKB1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5786560704942735,1.4606220328548596,0.04791666666666667,0.3320121690754507,1.0,6/15,13.24%,KCNJ3;KCNN2;KCND3;ATP1A1;KCNJ8;ATP1B1
prerank,positive regulation of cation channel activity (GO:2001259),0.44192857002987834,1.4603987001677137,0.05263157894736842,0.330850768517915,1.0,13/40,15.65%,TMSB4X;ANK3;SHANK3;AKAP6;ATPSCKMT;LRRC55;CCL2;RELN;HAP1;CALM1;CALM2;CALM3;NLGN3
prerank,action potential (GO:0001508),0.44097957714946545,1.4603388501627883,0.03036876355748373,0.32940061078571786,1.0,13/44,16.40%,KCND2;SCN1A;ANK3;AKAP6;KCNMB2;KCNMB3;KCNMB4;SCN3A;KCNA2;SCN2A;CACNA1I;SCN8A;GNAQ
prerank,negative regulation of phosphorylation (GO:0042326),-0.3913683628626156,-1.4592944204659661,0.021653543307086614,0.3160460843740022,1.0,34/85,22.57%,PTPN13;PID1;LRP6;NTRK3;FBLN1;PLPP3;BMP7;ROCK1;BMP4;HDAC4;NCOR1;PRKN;LRRK2;NUPR1;IBTK;IGFBP3;LYN;IMPACT;ANKLE2;FKBP8;PRKDC;ZBED3;CBFA2T3;MYADM;HNRNPU;INPP5K;PARK7;INHBA;CDKN1C;CDK5RAP3;ATG14;CRKL;PRKRIP1;CHP1
prerank,intraciliary retrograde transport (GO:0035721),-0.6175436140357049,-1.4590303404551563,0.055865921787709494,0.31571363702506655,1.0,9/12,32.84%,IFT43;DYNC2I1;DYNC2LI1;DYNC2I2;IFT140;TTC21B;IFT122;WDR35;DYNC2H1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5127164265023284,-1.4586305933101469,0.04693140794223827,0.3156464622109352,1.0,6/23,5.30%,TGFBR3;SMAD3;SMURF2;NREP;DKK3;SMAD2
prerank,neural crest cell migration (GO:0001755),0.4539821402206461,1.4582525354344782,0.04883227176220807,0.33227542451145925,1.0,8/36,4.44%,ERBB4;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.6232762196028431,-1.4575827864527953,0.066543438077634,0.31703055494415155,1.0,5/11,18.53%,LRP6;RYK;WNT5A;NR4A2;FZD1
prerank,hexose transmembrane transport (GO:0008645),0.5133173677597801,1.4566092837940452,0.04956896551724138,0.3342767791296834,1.0,3/21,2.66%,SLC2A1;SLC2A3;SLC2A5
prerank,aminoglycan catabolic process (GO:0006026),-0.4794783181057765,-1.455784094403181,0.05029013539651837,0.32021728916264297,1.0,6/28,4.72%,GPC6;SDC2;GPC4;GNS;GPC3;HSPG2
prerank,kidney development (GO:0001822),-0.40731163799562753,-1.4556479893092427,0.028846153846153848,0.3195661152691811,1.0,16/65,5.92%,SULF1;TGFBR1;KANK2;PKD1;WNT4;GLI2;FOXC1;BMP7;BMP4;OSR1;PCSK5;ARL3;SULF2;CTSH;PYGO1;ZBTB16
prerank,transport along microtubule (GO:0010970),-0.6000599772698805,-1.4551262756085899,0.06066176470588235,0.31979777342752574,1.0,9/13,30.17%,ARHGAP21;CDC42;SPG11;BAG3;COPG2;COPG1;CLIP3;APP;APBA1
prerank,epidermal cell differentiation (GO:0009913),-0.44916872415037506,-1.4547829599741702,0.05056179775280899,0.31957233826363524,1.0,15/41,23.38%,JAG1;BCR;ANXA1;CLIC4;MED1;TXNIP;ADAM9;UGCG;ERCC3;GLI1;HDAC1;WNT5A;GATA6;WNT16;HDAC2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.44369308249586326,-1.454224553380769,0.0392156862745098,0.3199808818035488,1.0,12/43,11.49%,SMAD3;TEAD1;DDX5;FOXO3;BMP4;NFIB;NR3C1;STAT3;REST;JUN;HIF1A;NFATC4
prerank,sterol metabolic process (GO:0016125),-0.41059474114763633,-1.4528246279314283,0.026217228464419477,0.32219581322364366,1.0,21/60,26.35%,PRKAG2;ABCA1;CYP7B1;CYP26B1;CYP27A1;SOAT1;INSIG2;OSBPL5;CYP1B1;APOE;RXRA;HMGCR;SQLE;CYP51A1;FDX1;SC5D;ARV1;LBR;GBA2;SCAP;CLN8
prerank,glycerolipid metabolic process (GO:0046486),0.6154167743780955,1.452100704417056,0.08478260869565217,0.34232955314544367,1.0,6/11,18.08%,GAL3ST1;PGP;DGKB;PIP5K1A;PNPLA3;DGKG
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.5522437463856901,-1.4502126455097222,0.06346153846153846,0.327254245731801,1.0,12/17,31.47%,HM13;OS9;SELENOS;FAF2;AUP1;DERL1;SYVN1;VCP;SEL1L;DERL2;HERPUD1;UFD1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.5207557512422418,-1.4500584078583139,0.05273833671399594,0.32668405954020047,1.0,6/20,11.54%,ROCK2;RHOQ;ROCK1;DLG1;FHOD1;NCKAP1
prerank,phospholipid transport (GO:0015914),0.42322365089366853,1.450041001654768,0.031598513011152414,0.34547146310665205,1.0,18/52,14.95%,PLTP;TMEM30A;ATP8A1;ATP11A;ATP10A;MFSD2A;ATP10B;PITPNM1;PRELID3A;SCARB2;ATP11C;ATP8A2;ABCB4;PRELID2;CPTP;SCARB1;ATP11B;SCP2
prerank,hemopoiesis (GO:0030097),0.39007640214014255,1.4499586361273844,0.016701461377870562,0.3440386083720144,1.0,18/87,9.01%,FLT1;KIRREL3;MECOM;KITLG;TEK;TIRAP;CSF1R;ARMC6;FST;TOX;KDR;FLT3;TAL1;TGFB2;RTKN2;MELK;CD34;TPO
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.3217667710291164,-1.4494493679000742,0.0,0.3270879815432746,1.0,141/341,29.56%,FBXL7;FBXL17;SMURF2;RNF43;SPSB1;PRKN;BIRC6;ARIH1;RAD23B;BTRC;TBL1X;WWP2;TRIP12;RNF115;TBL1XR1;KLHL15;RNF146;RNF217;UBXN2B;TGFB1I1;HUWE1;RBBP6;RNF213;VPS4B;RC3H1;UBQLN1;OS9;RNF19A;UBE4B;WWP1;UBE2H;ASB2;ZSWIM8;FBXL4;ANAPC5;RNF8;FBXO10;ANAPC7;PCBP2;UBE2K;MAEA;UBE2I;ANAPC4;ANAPC16;NUB1;TNFAIP1;NTAN1;RNF216;USP33;VPS37C;SPOPL;UBE2R2;GID4;KCTD5;PSMF1;WDR91;FBXL19;UBR3;CUL3;FBXW7;TRIM25;KLHL22;DTX3L;NHLRC3;TRPC4AP;PSMB2;CDC26;UBE2B;SMURF1;UBR4;FBXO45;TOPORS;ERCC8;CDC27;UBE2E1;ARRB1;FEM1A;RNF20;BFAR;FBXO22;UBE2S;MYLIP;SYVN1;PPP2R5C;FBXW11;FBXW5;AREL1;VCP;RNF14;SPSB4;UBE2D3;IFI27;COP1;RNF11;PML;ANAPC11;TTC3;PSMC1;ARIH2;WDR81;APPBP2;SHARPIN;KCTD17;GID8;FBXW4;PSMB6;RNF144A;RMND5A;PSMA3;SIAH2;ARMC8;USP9X;RNF6;PSMA4;CNOT4;PTPN23;BAG6;CDC16;FBXL14;UBQLN4;ANAPC1;ZNRF3;FBXO11;PCNP;SPSB2;PSME1;UBE3C;PSMD13;FZR1;CDC34;TNFAIP3;MIB1;KCTD6;PSMB10;PSMA5;SPSB3;PSMB9;KBTBD7;VPS28;RBX1;NFE2L2
prerank,RNA processing (GO:0006396),-0.34974584873059383,-1.4493126282326918,0.006237006237006237,0.326466454492235,1.0,65/176,24.25%,RBMS1;CELF2;SON;TENT2;RBPMS;CELF1;ATXN1;HNRNPH1;RBM39;DICER1;PABPN1;HNRNPR;SYNCRIP;DDX17;RBMS2;RBM6;FUS;U2AF2;AKAP8L;SF3B1;HNRNPUL1;HNRNPD;TUT4;PRPF6;RNPC3;PPARGC1A;TSEN2;SLU7;HNRNPK;PRPF3;SF3A1;USP39;SCAF11;DUSP11;XRN2;SF3A3;RSRC1;ZCRB1;DDX23;TCERG1;APOBEC1;RBM5;SRSF1;SFPQ;RNGTT;PRKACA;CSTF3;HNRNPU;ZMAT5;SNRPF;RBM4;SRSF7;SRSF11;GEMIN2;SRRM1;PPP2CA;SRSF2;USB1;LUC7L3;CCAR2;NUDT21;SMU1;DHX15;NONO;PABPC4
prerank,protein monoubiquitination (GO:0006513),-0.45770555408950614,-1.4492972801461277,0.035580524344569285,0.3255668477947162,1.0,21/36,31.82%,PRKN;HUWE1;CTR9;UBE2R2;CUL3;TRIM25;KLHL22;DTX3L;UBE2B;TOPORS;UBE2E1;RNF20;UBE2D3;CDC73;WAC;MGRN1;OBI1;RBX1;RNF126;KBTBD8;UBE2W
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.6186433124549149,-1.448674339424368,0.0744466800804829,0.3259944733088076,1.0,7/11,24.29%,UGGT2;POMT2;AUP1;DERL1;VCP;TOR1A;BAG6
prerank,regulation of cellular component movement (GO:0051270),-0.42773759669697065,-1.4483836181496115,0.03231939163498099,0.32567854607201846,1.0,15/49,10.56%,ROCK2;TGFBR3;EGFR;TGFBR1;DIAPH1;ROCK1;PDPN;ABL1;ARAP1;CD9;LYN;ZSWIM8;SP100;RHOA;ABL2
prerank,epithelial to mesenchymal transition (GO:0001837),-0.4299655843813408,-1.4476297399284417,0.035381750465549346,0.32653249678740504,1.0,11/47,4.59%,ROCK2;TGFBR3;TGFBR1;WNT4;RBPJ;LIMS1;DDX5;BMP7;ROCK1;GSK3B;DDX17
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.4558296673051469,-1.447143580875291,0.049429657794676805,0.32676015807019215,1.0,14/37,18.24%,IGF1;BMPR1A;TPM1;IGFBP5;GJA1;JUN;MEF2C;MMP2;EFEMP2;ERN1;TGFB3;ADAMTS1;PDCD4;SOD2
prerank,reticulophagy (GO:0061709),-0.5918059347556878,-1.447018270246523,0.07272727272727272,0.3260892065592079,1.0,7/12,17.33%,UFL1;UBA5;TEX264;RB1CC1;ULK2;ATG2A;ATG2B
prerank,muscle cell migration (GO:0014812),-0.6414909059678471,-1.4469402323905811,0.06177606177606178,0.32532076093176165,1.0,7/10,20.91%,ROCK1;PLAT;CCN3;DDR1;SIX1;ITGB3;AAMP
prerank,mRNA splice site selection (GO:0006376),-0.4826762685155183,-1.4468042814189637,0.04933586337760911,0.32467786808006277,1.0,12/30,14.46%,CELF2;CELF1;LUC7L2;PRPF39;SFSWAP;SRSF10;SRSF6;SLU7;SF3A1;YTHDC1;SF3A3;SRSF1
prerank,regulation of peptide hormone secretion (GO:0090276),0.4112835195380524,1.4466973455822454,0.027600849256900213,0.349585993615583,1.0,11/67,6.27%,PAX8;CACNA1A;SLC2A1;MTNR1B;SYT7;KCNC2;SNAP25;HADH;HTR2C;KCNJ11;CACNA1E
prerank,response to interleukin-4 (GO:0070670),0.620233454118877,1.446623124509547,0.07422680412371134,0.3481693678417069,1.0,3/10,13.68%,LEF1;TCF7;XBP1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3496049463143414,-1.4463825379296926,0.011538461538461539,0.3247772461504646,1.0,70/173,24.83%,ANK2;SEC24D;VTI1A;GBF1;PROS1;CD55;ATL3;CTSC;GOLGB1;TFG;SEC23A;VTI1B;VAMP7;SEC22B;KDELR1;COPB1;COPZ2;SEC31A;BCAP29;ARCN1;DCTN5;ARFGAP1;ARFGAP3;ATL2;TBC1D20;COG3;COG7;GOSR1;CAPZA1;CNIH4;DYNC1LI1;TRAPPC6B;KDELR3;CUL3;STX5;COPB2;CAPZB;WHAMM;COPG2;DYNC1H1;GOSR2;TMED3;MIA3;VAMP4;SEC16B;NAPA;COPG1;TMED5;TMED4;TRIP11;NRBP2;SEC16A;MPPE1;STX17;COPE;COG4;ERGIC1;VAPA;BET1L;F5;ACTR1A;NSF;TRAPPC2;LMAN1;USO1;PREB;HYOU1;SAR1B;MCFD2;TEX261
prerank,COPII-coated vesicle budding (GO:0090114),-0.4063617112252429,-1.446134719747433,0.023121387283236993,0.3245077788501867,1.0,31/68,27.38%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;SEC23B;STX5;GOSR2;MIA3;SEC16B;NAPA;CSNK1D;SEC16A;VAPA;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SCAP;SEC24A;TMED2
prerank,cellular response to interleukin-4 (GO:0071353),0.6233753441278265,1.4461252247097032,0.07024793388429752,0.34756284537556653,1.0,3/10,13.68%,LEF1;TCF7;XBP1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6058963606901027,-1.4457445918303995,0.07706093189964158,0.3244301262677054,1.0,3/11,3.24%,TGFBR3;TGFBR1;TGFBR2
prerank,protein modification by small protein conjugation (GO:0032446),-0.322265900575612,-1.4454577665493658,0.0,0.32419975693967734,1.0,118/361,22.83%,RNF220;PDZRN3;FBXL7;EYA1;RNF152;FBXL17;SMURF2;UBE2N;RNF43;UBR2;TRIM44;PIAS1;SPSB1;PRKN;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;SAE1;HUWE1;USP7;RANBP2;UHRF2;RNF213;DTX4;OS9;UFL1;NSMCE2;WWP1;UBE2H;ASB2;ZSWIM8;RNF8;NUP42;UBA5;FBXO10;ANAPC7;CTR9;UBE2K;HLTF;PIAS3;VCPIP1;UBE2I;ANAPC16;NUB1;TNFAIP1;LZTR1;SELENOS;HERC2;RNF103-CHMP3;UBR1;UBE2R2;NUP214;HIF1A;RFWD3;RTF1;TRIM5;UBR3;TRIM11;TPR;CUL3;PIAS4;FBXW7;TRPM4;DTX3L;TRPC4AP;PRKDC;UBE2B;SMURF1;TRIM39;FBXO45;CUL2;TOPORS;CDC27;UBE2E1;MSL2;ARRB1;RNF181;RNF20;DERL1;ASB5;KLHL18;UBE2S;MYLIP;UBA7;SYVN1;FBXW11;FBXW5;EIPR1;AREL1;SDE2;VCP;RNF14;DCUN1D3;SPSB4;UBE2D3;CDC73;DTX2;NFX1;NUP98;PCNA;ANAPC11;CUL1;TRIM63;HIF3A;ARIH2;CUL7;CDK5RAP3;NAE1;DET1;NUP43;ARRDC4;WAC;CAND2;UBE2V2;RNF144A
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.36831785333004674,-1.4448146643926985,0.0148975791433892,0.32460812751668433,1.0,29/104,14.60%,SMAD3;TGFBR1;CRIM1;BMPR1A;LDLRAD4;SMAD6;SMURF2;NBL1;TGFBR2;HTRA3;TGFB1I1;SMAD2;BCL9L;SNX6;SKI;SKIL;PDPK1;PMEPA1;CCN3;SMAD4;BMPER;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;ACVR1
prerank,positive regulation of DNA repair (GO:0045739),-0.43407112125022124,-1.4447587627365857,0.035849056603773584,0.3238421836783468,1.0,11/46,7.71%,EYA2;EYA1;EGFR;UBE2N;EYA4;SPIDR;HMGB1;DHX9;BRCC3;CEBPG;RNF8
prerank,response to purine-containing compound (GO:0014074),0.5402133909447558,1.443827940009412,0.06903765690376569,0.35100490137099344,1.0,6/17,13.32%,RYR2;KCNJ11;TRPM2;P2RY1;P2RX7;VGF
prerank,negative regulation of signal transduction (GO:0009968),-0.3317771130218317,-1.4432987557411214,0.00404040404040404,0.3261378502397791,1.0,70/249,18.77%,TRABD2B;SULF1;EGFR;NXN;PID1;LRP1;GLI3;ADAMTS12;KANK2;DCN;IGFBP5;LGR4;BMP5;WWOX;GRB10;RNF43;DKK3;ENPP1;LRRK2;TNS2;BTRC;CYP26B1;WWP2;NIBAN2;VGLL4;IRAK3;IRS1;GPC3;IGFBP3;SULF2;THBS1;ASAH2;BCL2;LYN;PIP4K2C;DACT1;PTPN12;LEPROT;PTPN2;PRKCD;MMP14;TULP3;NOTCH3;GLIS2;TLE1;HERC4;SUFU;APOD;RB1;FBXW7;APPL1;EMILIN1;ACVR1;OTUD4;NCK1;PRKCZ;CSNK2A1;PTCH1;ARRB1;TSPAN15;CNOT1;NR4A2;LRRC14;PTPN1;CX3CR1;SFRP4;VCP;DACT3;INPP5K;BMP2
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5533526790014459,1.443172610835588,0.0668103448275862,0.35091255621624934,1.0,6/17,16.58%,HCAR2;MFSD2A;ALK;AKT1;SORL1;GPLD1
prerank,keratinocyte differentiation (GO:0030216),-0.48170448483482164,-1.4431459556993482,0.06641366223908918,0.32563861067081395,1.0,8/29,11.74%,JAG1;BCR;ANXA1;CLIC4;MED1;TXNIP;ADAM9;UGCG
prerank,T cell differentiation (GO:0030217),-0.4488460948937607,-1.4425883375126662,0.04428044280442804,0.32591374447332777,1.0,15/40,25.99%,GLI3;LEPR;KIT;ANXA1;PTPN22;PTPN2;SOX13;CHD7;PIK3CD;RHOH;RABL3;GPR89B;GPR89A;LMBR1L;FCER1G
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4989301536183395,-1.442466583292805,0.05555555555555555,0.32532290372206163,1.0,9/26,17.09%,FOXP1;KANK2;DAB2;NCOR1;STRN3;HDAC1;CNOT2;HEYL;CNOT1
prerank,postsynaptic membrane organization (GO:0001941),0.5313609407438104,1.441447362001777,0.06382978723404255,0.35324416549935556,1.0,6/17,9.21%,NRXN1;NLGN1;SHANK3;NRXN2;SHISA7;LHFPL4
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.49959880764556985,-1.4412648614285242,0.06179775280898876,0.3271909633997573,1.0,4/22,7.19%,ZBTB20;SORBS1;CREBL2;MTOR
prerank,regulation of dendrite morphogenesis (GO:0048814),0.46401692038757353,1.4411673084783296,0.05052631578947368,0.35238511164216546,1.0,9/32,9.61%,ADGRB3;PTPRD;IL1RAPL1;HECW1;TNIK;SEMA4D;HECW2;CDKL5;LZTS1
prerank,cardiac muscle tissue development (GO:0048738),-0.42863717737997925,-1.4411330931396995,0.027522935779816515,0.3265835786818808,1.0,14/50,13.07%,AKAP13;NOTCH2;BMPR1A;GJB6;BMP5;BMP7;BMP4;RBP4;GJA1;ADAMTS9;SMAD4;TBX18;SIK1;MAML1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.49052888993558286,-1.440976132467392,0.06097560975609756,0.3260249719521002,1.0,14/25,24.29%,NGLY1;FBXL17;UGGT2;KLHL15;POMT2;YME1L1;CUL3;CLPP;AUP1;DERL1;VCP;ZYG11B;TOR1A;BAG6
prerank,cell-cell junction organization (GO:0045216),0.3927747287757758,1.4407537230335683,0.014522821576763486,0.35173393056934654,1.0,21/79,12.08%,CLDN5;CDH12;CDH8;CADM1;CSF1R;CADM2;CTNND2;CDH7;CDH19;CDH20;CDH18;CDH2;CDH10;OCLN;TGFB2;DCHS1;CADM3;F2R;TJP1;NECTIN1;MARVELD2
prerank,myoblast differentiation (GO:0045445),-0.5777991714320603,-1.4404905216233612,0.06928838951310862,0.32621434542289823,1.0,8/14,14.36%,IGF1;TCF7L2;DDX5;JAG1;DDX17;REST;RB1;HINFP
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.4052934682916605,-1.440065232748176,0.017928286852589643,0.3262444170518925,1.0,22/66,20.88%,SULF1;TGFBR3;NR2F2;KLF9;ROBO1;SPARC;NFIB;NUPR1;THBS1;FGFR2;PTPRK;MED1;FBXW7;APOE;STAT1;BRCA2;DUSP10;ATOH8;ATP5IF1;CDC73;CDKN1C;CDK6
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5407216699606361,-1.439990889057131,0.051470588235294115,0.325491530613493,1.0,3/17,3.68%,BMP6;SASH1;CD55
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.4123954456725514,-1.4393896664748331,0.0248565965583174,0.3241997569396773,1.0,27/61,27.38%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;SEC16B;NAPA;CSNK1D;SEC16A;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SEC24A;TMED2
prerank,vesicle coating (GO:0006901),-0.4123954456725514,-1.4393896664748331,0.0248565965583174,0.3241997569396773,1.0,27/61,27.38%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;SEC16B;NAPA;CSNK1D;SEC16A;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SEC24A;TMED2
prerank,COPII vesicle coating (GO:0048208),-0.4123954456725514,-1.4393896664748331,0.0248565965583174,0.3241997569396773,1.0,27/61,27.38%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;SEC16B;NAPA;CSNK1D;SEC16A;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SEC24A;TMED2
prerank,transition metal ion transport (GO:0000041),0.4596987505575242,1.4389280330783223,0.05263157894736842,0.3543042278796649,1.0,10/35,11.89%,TFRC;TRPC5;FTH1;SLC39A2;SLC30A1;MELTF;SLC39A8;ATOX1;SLC30A5;TRPC1
prerank,regulation of cellular localization (GO:0060341),-0.4306802771225021,-1.4378052978402278,0.054924242424242424,0.32690545835562757,1.0,16/46,11.62%,ADCY5;GSN;PARD6G;PRKN;LRRK2;NUMA1;CDK16;STXBP4;LYN;CAMK2D;CSNK1E;BRSK1;FER;GOSR1;WWC1;PARP1
prerank,positive regulation of dendritic spine development (GO:0060999),0.5229791184966034,1.437290584046713,0.047520661157024795,0.35634508993212927,1.0,5/20,13.71%,LRP8;NLGN1;SHANK3;RELN;PSEN1
prerank,V(D)J recombination (GO:0033151),-0.5996956940816929,-1.436430769591499,0.08241758241758242,0.3290150768589284,1.0,5/11,14.31%,HMGB1;DCAF1;XRCC4;TCF3;PRKDC
prerank,lamellipodium organization (GO:0097581),-0.4771383823255165,-1.435462710668563,0.06779661016949153,0.3303114701297948,1.0,11/29,16.70%,VCL;KIT;ITGB1;ABLIM3;ARFIP2;P2RY12;CTTN;WASF1;WHAMM;CARMIL1;ARHGEF6
prerank,establishment of epithelial cell polarity (GO:0090162),-0.53951210294951,-1.4343473788638557,0.06407766990291262,0.33175274121305154,1.0,7/19,21.48%,MYO9A;CYTH3;CDC42;RHOA;PARD3;SIPA1L3;MSN
prerank,negative chemotaxis (GO:0050919),0.4579761333960201,1.4322757638574404,0.04878048780487805,0.3658837400395036,1.0,10/33,6.18%,SEMA3C;SEMA6A;UNC5C;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;SLIT3;SLIT1
prerank,ribosomal small subunit assembly (GO:0000028),0.5628245740699855,1.4320683030441295,0.081799591002045,0.364734904509003,1.0,8/16,16.70%,RPS19;RPS27;MRPS7;RPS15;RPS14;RPS5;RPS28;XRCC5
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.4001752523114188,-1.4320438592751874,0.026717557251908396,0.3358445369581397,1.0,26/66,20.88%,EGFR;APPL2;KANK2;PKD1;INO80;ANKRD17;FHL1;UBE2E2;BRD7;RPTOR;DLG1;ANXA1;DACT1;PRMT2;ID2;PKD2;RB1;APPL1;CCND3;DDX3X;ADAMTS1;FAM107A;DCUN1D3;EIF4G1;CDC73;CDK6
prerank,histone H2A ubiquitination (GO:0033522),-0.5431951488374299,-1.431479180220001,0.06871609403254973,0.3362383712261615,1.0,6/17,14.56%,UBR2;BCOR;RNF8;DDB2;DTX3L;UBE2B
prerank,polarized epithelial cell differentiation (GO:0030859),-0.5826363934159106,-1.430848893309539,0.0842911877394636,0.33677441662980084,1.0,6/13,21.64%,MYO9A;RAB10;CDC42;RHOA;MSN;SCRIB
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.40920539176704346,-1.4293481962040036,0.03696498054474708,0.339384889140013,1.0,33/68,28.65%,GTF2H2;PABPN1;CCNH;PCF11;WDR33;CDK7;SCAF8;CPSF3;CAVIN1;TAF1D;TBP;SSU72;SLBP;MNAT1;ERCC3;TTF1;PRMT5;CSTF3;POLR2H;SNRPF;CSTF1;POLR2K;CPSF4;NUDT21;GTF2H1;POLR2E;CPSF1;NCBP2;LSM11;TAF1C;GTF2H4;POLR1G;TAF1A
prerank,dendritic spine organization (GO:0097061),0.483494924039762,1.4293083339544956,0.054989816700611,0.36939650042982547,1.0,4/26,3.04%,IGF1R;EPHB1;CTNND2;SHANK3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.5537452062686645,-1.4289640778204618,0.06679035250463822,0.33935449804161766,1.0,7/15,22.55%,STAT3;IL17RA;HIF1A;APPL1;IL17D;TLR4;TICAM1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.3855396041806717,-1.4287347528343688,0.027777777777777776,0.3389663811782617,1.0,36/76,31.10%,ANGPT1;PIAS1;HDAC4;LRRK2;SAE1;HUWE1;AXIN1;UBQLN1;WDR48;XIAP;PIAS3;CUL3;PIAS4;FBXW7;FANCI;SPRTN;DERL1;FAM107A;TRAF6;TANK;DCUN1D3;TBC1D7;CDK5RAP3;SPHK1;SENP2;WFS1;PAXIP1;FBXO4;HDAC3;GNL3;MUL1;DCUN1D5;BIRC3;UBA2;UBE2L3;CAV1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5462132353456767,-1.428483853509318,0.07885304659498207,0.3387230667466698,1.0,5/17,3.07%,NOTCH2;BMPR1A;RBPJ;BMP4;JAG1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3952057592914689,-1.427602474525582,0.017475728155339806,0.33990511758668823,1.0,24/76,20.09%,UACA;EGFR;SASH1;NFAT5;LIMS1;TRIM44;BMP7;EP300;NR3C2;DLG1;PTPN22;CCN3;RHOA;RASSF2;PPM1A;EIF2AK2;DDX3X;C1QTNF3;PDCD4;TLR4;TRAF6;IFI35;IRAK1;TRIP6
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5334658371858918,1.4270959665106637,0.09716599190283401,0.37275424140859176,1.0,2/16,6.05%,CLDN5;CLDN14
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5411283348042698,-1.4267629445599233,0.06415094339622641,0.34101311106700644,1.0,5/18,8.85%,EGFR;DDX5;BMP4;NCOR1;MAP2K1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.47445711429701154,-1.4255101824863543,0.05,0.34303934039840966,1.0,4/26,6.72%,EYA2;EYA1;EYA4;BCL2
prerank,regulation of response to stress (GO:0080134),0.6074931639359079,1.425386454188643,0.10337552742616034,0.375008848141162,1.0,5/10,19.33%,ADCY8;MLC1;OPRM1;STOX1;SLC38A2
prerank,mRNA processing (GO:0006397),-0.3273674760417367,-1.4249159023005897,0.0,0.34350072601991527,1.0,115/287,28.06%,SRRM2;SON;DDX5;CELF1;HNRNPH1;GTF2H2;PABPN1;CCNH;HNRNPR;SYNCRIP;PCF11;WDR33;CASC3;CDK7;IK;SRSF10;RBM6;DDX46;FUS;HNRNPM;U2AF2;DHX9;AKAP8L;SF3B1;CPSF3;SRSF6;HNRNPUL1;HNRNPD;RBM10;PRPF6;PCBP2;RNPC3;DDX42;PPARGC1A;CDC5L;PRCC;SLU7;GEMIN5;HNRNPK;RPRD2;PRPF3;MNAT1;SF3A1;SF3B6;YTHDC1;USP39;SCAF11;ERCC3;SF3A3;RSRC1;ZCRB1;SNRNP70;CCAR1;DNAJC8;DDX23;YBX1;CWC22;TCERG1;RBM5;SRSF1;ERN1;CWF19L1;EFTUD2;GEMIN7;SNU13;MTREX;SFPQ;PPIH;UBL5;PRPF40B;RNGTT;PPWD1;PRKACA;WBP11;CSTF3;HNRNPU;ZMAT5;POLR2H;SNRPF;HNRNPA3;RBM4;SRSF7;SRSF11;GEMIN2;SRRM1;UPF3B;SRSF2;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;DDX41;GTF2H1;SMU1;DHX15;NONO;PRPF38A;POLR2E;KIN;CPSF1;PRMT9;NCBP2;PRPF8;CRNKL1;LSM6;RBM22;RBM19;CACTIN;GTF2H4;SUGP1;PRPF18;POLR2D;HNRNPL;ISY1
prerank,zinc ion transmembrane transport (GO:0071577),0.5056413394762289,1.4243967425175128,0.06326530612244897,0.37560234429148703,1.0,7/22,11.74%,SLC39A10;SLC39A2;SLC30A1;TRPM2;SLC30A3;SLC39A8;SLC30A5
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.47700190729836023,-1.4237334295325554,0.076,0.3453906453318103,1.0,11/27,19.53%,DICER1;PCF11;ZC3H12C;NYNRIN;CPSF3;XRN1;KHNYN;ZC3H12B;ERN1;CSTF3;RNASE4
prerank,glycine transport (GO:0015816),0.6181788235202335,1.4233373355131045,0.0891304347826087,0.3764207152502348,1.0,4/10,9.57%,SLC6A17;SLC6A5;SLC7A8;SLC36A1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3441163253027027,-1.4231911908410992,0.008333333333333333,0.34576417516145674,1.0,65/161,29.47%,BICC1;MLLT3;TCF7L2;GLI3;RBMS3;IGFBP2;LRP6;DAB2;TMEM64;STK3;DKK3;PRKN;CSNK1A1;GSK3B;IGFBP6;AXIN1;CHD8;IGFBP4;DACT1;LIMD1;TLE4;TLE1;LZTS2;TBX18;PSMF1;CUL3;SOX13;GLI1;UBAC2;APOE;PSMB2;HDAC1;LATS1;EMD;WNT5A;SFRP4;DACT3;INVS;BMP2;FRZB;TLE3;DKK2;PSMC1;DVL3;PSMB6;PSMA3;SIAH2;PSMA4;NKD2;LRP4;KREMEN1;DVL2;ZNRF3;LMBR1L;TPBG;PSME1;MCC;PSMD13;SDHAF2;PSMB10;PSMA5;PSMB9;RUVBL2;MAD2L2;RBX1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6213076164207405,-1.4223105664514921,0.07532956685499058,0.34693751445258775,1.0,7/10,31.10%,ERRFI1;ENPP1;IMPACT;MVP;CHP1;TESK1;CAV1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5994868127519664,-1.4222568501617703,0.06375227686703097,0.34617409333113747,1.0,4/11,10.06%,LRRK2;USP7;MAP2K1;CHMP3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5680740160053224,-1.421994435149932,0.06679764243614932,0.3459331750117261,1.0,11/15,31.47%,OS9;SELENOS;FAF2;AUP1;DERL1;SYVN1;VCP;SEL1L;DERL2;HERPUD1;UFD1
prerank,regulation of water loss via skin (GO:0033561),0.5548847944740993,1.4212403129532478,0.10480349344978165,0.37812819418696647,1.0,3/15,3.29%,HRNR;FA2H;STMN1
prerank,establishment of skin barrier (GO:0061436),0.5548847944740993,1.4212403129532478,0.10480349344978165,0.37812819418696647,1.0,3/15,3.29%,HRNR;FA2H;STMN1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5046442240029173,-1.4210950827260305,0.05410821643286573,0.34710320162270114,1.0,9/22,19.72%,TIMP3;ROCK1;SNX9;PTPN3;NRDC;ADAM9;APOE;ADRA2A;TIMP2
prerank,muscle cell differentiation (GO:0042692),0.4593900992100047,1.4209687174942687,0.058,0.37714248873940964,1.0,8/32,12.16%,MRTFA;SGCZ;SYNE1;TMEM204;MRTFB;NINJ1;NRAP;MEGF10
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4673980979875352,-1.4206334743169546,0.046875,0.34735903778956584,1.0,6/32,7.19%,ZBTB20;PRKAG2;SORBS1;PRKAA2;CREBL2;MTOR
prerank,actin filament capping (GO:0051693),-0.5282676612352634,-1.4202836910430299,0.07450980392156863,0.3464647721036335,1.0,10/18,26.26%,ADD3;GSN;SVIL;CAPZA1;CAPZB;TRIOBP;AVIL;VILL;TWF1;TWF2
prerank,barbed-end actin filament capping (GO:0051016),-0.5282676612352634,-1.4202836910430299,0.07450980392156863,0.3464647721036335,1.0,10/18,26.26%,ADD3;GSN;SVIL;CAPZA1;CAPZB;TRIOBP;AVIL;VILL;TWF1;TWF2
prerank,neutrophil migration (GO:1990266),0.4132751292758682,1.41969272838956,0.03815261044176707,0.3787333379154646,1.0,7/58,9.00%,BSG;PDE4B;S100A9;S100A8;TGFB2;PECAM1;CCL2
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.439501680179697,-1.4189232952667625,0.046153846153846156,0.34872077757430336,1.0,10/40,10.56%,EGFR;LPAR1;ARHGAP6;PDGFRA;NTRK3;PDGFRB;KIT;EDNRA;PLCG1;ABL2
prerank,connective tissue development (GO:0061448),-0.4481355284332495,-1.4183996734999451,0.05605786618444846,0.3491223444023388,1.0,11/35,13.72%,SULF1;SOX5;CREB3L2;PKD1;SH3PXD2B;SULF2;ZBTB16;PGRMC2;ITGB8;ARID5B;SOX6
prerank,anterior/posterior axis specification (GO:0009948),-0.5515183530118161,-1.4183174211714207,0.09811320754716982,0.34839256784586514,1.0,2/15,5.85%,WLS;SKI
prerank,negative regulation of proteolysis (GO:0045861),-0.4540500014806269,-1.4178258750720938,0.05917159763313609,0.34863244362410734,1.0,8/34,8.09%,TIMP3;DNAJC1;ROCK1;LRRK2;PLAT;GAS1;PTPN3;EPHA4
prerank,histone H3-K36 demethylation (GO:0070544),-0.6232627543922091,-1.4176520595715145,0.08834586466165413,0.34816546731558645,1.0,4/10,15.84%,KDM7A;KDM4B;PHF8;KDM2A
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.48463775288533595,-1.416807703798053,0.05103969754253308,0.3491352421859773,1.0,11/26,19.26%,EGFR;FOXC1;GAREM1;PDPK1;MED1;PLCG1;PTPN12;STAT5B;SYAP1;INPP5K;PTPN11
prerank,spindle assembly (GO:0051225),-0.3907358910659234,-1.4167234335997638,0.03441295546558704,0.3484510127823912,1.0,34/67,30.47%,INO80;NCOR1;NUMA1;FLNA;PIBF1;CEP63;SPICE1;TUBGCP6;TUBGCP2;STAG1;RHOA;LSM14A;RAB11A;ABRAXAS2;MAPRE1;TOGARAM1;MAP9;RCC1;STAG2;CSNK1D;NEK6;TUBGCP4;SMC1A;HAUS7;HAUS8;BCCIP;NEK7;HDAC3;ABRAXAS1;HAUS3;KIF11;MZT1;HAUS5;HAUS4
prerank,regulation of interferon-alpha production (GO:0032647),-0.4860029246545366,-1.4163960809521423,0.072,0.3483852471587248,1.0,9/23,17.43%,TBK1;PTPRS;DHX9;DHX36;SETD2;MAVS;STAT1;DDX3X;TLR4
prerank,positive regulation of protein binding (GO:0032092),-0.41116695679318854,-1.415004928529909,0.021442495126705652,0.3508768359684991,1.0,23/56,21.04%,TCF7L2;LRP1;PKD1;STK3;BMP4;ABL1;PRKN;LRRK2;VTN;GSK3B;MARK3;DACT1;PPP2CB;USP33;RPL11;DTX3L;APOE;RAPGEF2;DERL1;BMP2;SPPL3;TERT;PPP2CA
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.40177774157929363,-1.4138083216517752,0.031683168316831684,0.35262404911391226,1.0,11/62,6.93%,AKAP13;NOTCH2;IGF1;COL3A1;AUTS2;LPAR1;ROBO1;SHOC2;MAP4K4;SHC1;LYN
prerank,mitotic cytokinetic process (GO:1902410),-0.51770504177848,-1.4128404226419855,0.08576998050682261,0.3540764051719264,1.0,7/20,10.27%,VPS4B;KLHDC8B;CHMP4B;CHMP4A;CHMP5;CHMP3;RHOA
prerank,epithelial cell morphogenesis (GO:0003382),-0.5375895942591804,-1.412581369009122,0.07550644567219153,0.35386056096430735,1.0,8/17,28.14%,COL22A1;COL15A1;COL18A1;RILPL2;SIPA1L3;RILPL1;DACT2;MET
prerank,positive regulation of biosynthetic process (GO:0009891),-0.4338422829727705,-1.4125686094542256,0.04554455445544554,0.3530265574222261,1.0,9/40,7.19%,ZBTB20;SORBS1;WNT4;VIM;SLC5A3;BMP4;CREBL2;RUNX1;MTOR
prerank,stem cell differentiation (GO:0048863),-0.4309375348379934,-1.412245819954721,0.05138339920948617,0.3530260198563475,1.0,12/39,13.09%,MLLT3;LRP6;FBXL17;OSR1;KIT;UFL1;FGFR2;PUM1;HOXB4;SETD2;MEF2C;NELFB
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.47406103259692745,-1.411549767651464,0.0636182902584493,0.353835521414353,1.0,14/26,29.50%,KMT5B;SETD5;KMT2D;CTR9;SETD3;SETD2;OGT;KMT5C;EEF2KMT;KMT2A;PRDM9;TET2;ANTKMT;TET3
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.36691164522747444,-1.4113163736107075,0.02636916835699797,0.35350402566889577,1.0,43/100,24.46%,FHIT;ARAF;PIAS1;DAB2;PRKN;LRRK2;ARIH1;RAD23B;CSNK1A1;GSK3B;RNF217;USP7;UFL1;RNF19A;NUB1;CSNK1E;RPL11;GIPC1;OGT;TRIB2;SH3RF2;CBFA2T3;TRIM39;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;PARK7;COP1;ZYG11B;DESI1;ARIH2;DET1;WAC;RNF144A;CCAR2;XPO1;EIF3H;BAG5;BAG6;NKD2
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.4380037830546841,-1.411292037589943,0.0625,0.35268757836371567,1.0,16/35,25.76%,FOXO3;ARNT;HOXA5;STAT3;LYN;MED1;HIF1A;HSPA9;STAT1;PRKDC;STAT5B;INHBA;CDK6;MAFB;LDB1;MAPK14
prerank,aorta morphogenesis (GO:0035909),-0.527756440322936,-1.4108396834248265,0.08030592734225621,0.35287454763143616,1.0,6/17,3.07%,LRP1;BMPR1A;RBPJ;MYLK;PDGFRB;JAG1
prerank,epithelial structure maintenance (GO:0010669),-0.6129814689693271,-1.4102779882121548,0.07889546351084813,0.3532926968078678,1.0,3/11,12.98%,RBP4;CXADR;STRAP
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.47908548442262316,-1.4092351045103275,0.07875457875457875,0.3550036501240025,1.0,13/26,31.73%,IRAK3;TRAFD1;MAPKBP1;PCBP2;ILRUN;CARD16;NLRC3;DHX58;CACTIN;MUL1;TNFAIP3;C1QBP;TYRO3
prerank,regulation of cation transmembrane transport (GO:1904062),0.4680076266485729,1.4086616758415282,0.06576402321083172,0.40327841771496753,1.0,8/29,7.96%,DPP10;KCNIP4;FGF12;KCNN2;KCNIP1;DPP6;HOMER1;KCNAB1
prerank,negative regulation of type I interferon production (GO:0032480),-0.42750190047258263,-1.4085169806684035,0.051440329218107,0.35577969210104565,1.0,24/40,37.84%,TAX1BP1;TBK1;PTPRS;PCBP2;RNF216;MAVS;TRIM25;ILRUN;IKBKE;UBA7;NLRX1;NLRC3;SIRPA;GPATCH3;DHX58;CACTIN;TNFAIP3;IFIH1;UFD1;PYCARD;OTUD5;PIN1;TRAF3IP1;NLRC5
prerank,positive regulation of cell cycle process (GO:0090068),-0.3660305425194586,-1.4084707174518538,0.02071563088512241,0.3550528960995094,1.0,23/91,17.60%,IGF1;INO80;SVIL;PDGFRB;CDC14A;NUMA1;CSPP1;UBXN2B;PLSCR1;CDC42;IGF2;MAP3K20;RHOA;GIPC1;RAD21;DYNC1LI1;TPR;CUL3;CDC14B;CDC25B;DYNC1H1;CEP295;PHIP
prerank,phosphate ion homeostasis (GO:0055062),-0.6242194697959456,-1.4080662332818807,0.08834586466165413,0.35513835769384716,1.0,3/10,20.62%,ENPP1;SFRP4;FGFR4
prerank,negative regulation of chemotaxis (GO:0050922),0.45045183591084614,1.4079390294799734,0.07221006564551423,0.40340995420901765,1.0,10/31,10.48%,SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;NOTCH1;ROBO2;AIF1
prerank,regulation of RNA metabolic process (GO:0051252),-0.4055851008271436,-1.4072031122574697,0.034,0.35633888332625,1.0,14/59,12.68%,AHNAK;SON;CLK1;CELF1;HNRNPH1;MBNL2;FUS;RC3H1;PTBP3;PCBP2;MED1;CLK2;CLK3;SNRNP70
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5334019491564929,-1.4062126565778656,0.08901515151515152,0.3578105137314092,1.0,5/17,10.83%,PRKAG2;NCOR1;PRKAA2;PANK2;PRKAB2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4375319125188706,-1.406208728866876,0.06627680311890838,0.3569758970168774,1.0,15/36,19.97%,ERRFI1;EPHA7;ENPP1;NBN;IMPACT;PDGFC;PPP2R5E;RASSF2;MOB1B;VEGFA;PPP2R5D;DDX3X;MRE11;PPP2R5C;MVP
prerank,regulation of lamellipodium assembly (GO:0010591),-0.4520265570284487,-1.4058879308371173,0.05353728489483748,0.356836750367723,1.0,15/34,26.26%,AUTS2;PLCE1;WASF2;CDC42;BRK1;FER;NCKAP1;ARPC2;CAPZB;AVIL;PIK3R1;SLIT2;ACTR2;TWF1;TWF2
prerank,response to cytokine (GO:0034097),-0.35130158391012745,-1.405757874414082,0.014705882352941176,0.35629160658207115,1.0,29/141,10.53%,PTPN13;COL3A1;DPYSL3;TIMP3;ALDH1A2;NFAT5;PID1;SMAD3;AFF3;IL6ST;HDAC4;PTPN14;TBK1;IRAK3;PTPN9;PLSCR1;STAT3;ASAH2;BCL2;ANXA1;IRAK2;SP100;NUB1;SETD2;PTPN12;CXCL16;PTPN2;RHOA;ADAM9
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.4102865696130334,1.4049604230572614,0.041501976284584984,0.4090614389737355,1.0,18/57,17.11%,RPS6;RPS19;RPL38;RPL35A;RPF2;RPL7;RPS24;RPS17;RPS16;RPS15;RPL14;RPL5;RPS7;MRPL36;URB2;RPS28;RPS25;NAF1
prerank,regulation of histone modification (GO:0031056),-0.5761201928560648,-1.4048425002719382,0.08623853211009175,0.3575536759406257,1.0,5/13,8.57%,UBE2N;SETD5;MTHFR;AKAP8L;IGF2
prerank,regulation of RNA splicing (GO:0043484),-0.38792015800082685,-1.404292488354669,0.030364372469635626,0.35803941850962245,1.0,19/69,14.72%,AHNAK;SON;CLK1;CELF1;HNRNPH1;RBM39;MBNL2;KHDRBS1;SRSF10;FUS;U2AF2;PTBP3;HNRNPK;CLK2;CLK3;YTHDC1;SNRNP70;CWC22;ERN1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5689260068677033,-1.4042437133789645,0.06525911708253358,0.3573059168360737,1.0,4/14,16.18%,IRAK3;PIBF1;THBS1;CMKLR1
prerank,response to calcium ion (GO:0051592),0.36905048390895767,1.4041997899089065,0.025896414342629483,0.40926379256513656,1.0,34/102,19.44%,SYT1;ADCY8;SYT6;NLGN1;SYT7;SYT12;SYT11;RYR2;RYR3;CPNE9;KCNMB2;KCNMB3;KCNMB4;TRPM2;CPNE8;CPNE1;KCNH1;HOMER1;SYT10;SMPD1;CALM1;SYT2;TRPC1;CALM2;CALM3;PPP3CA;HPCA;GPLD1;KCNMA1;CPNE7;SYT4;SYT5;PDCD6;ALG2
prerank,lipid translocation (GO:0034204),0.49065261453494424,1.4039871280970786,0.07086614173228346,0.4080734360560325,1.0,8/21,11.06%,TMEM30A;ATP8A1;ATP11A;ATP10A;ATP10B;ATP11C;ATP8A2;ABCB4
prerank,regulation of endothelial cell migration (GO:0010594),-0.37763680862016186,-1.4039460116169227,0.027184466019417475,0.3572787565465246,1.0,27/85,17.71%,ROCK2;FOXP1;NR2F2;SASH1;PTN;ANGPT1;DCN;FGF1;BMP4;ABL1;SPARC;RHOJ;THBS1;BCAS3;NRP1;FOXC2;SP100;GLUL;ADAMTS9;BMPER;ANXA3;APOE;VEGFA;ATOH8;PIK3CD;WNT5A;PRKD1
prerank,regulation of gastrulation (GO:0010470),-0.5576706307069252,-1.4037721434217416,0.10486891385767791,0.35684979915062515,1.0,3/14,3.11%,PHLDB2;DAG1;OSR1
prerank,cellular response to leucine starvation (GO:1990253),-0.6373636593794738,-1.4036731446852735,0.07407407407407407,0.35626520137221757,1.0,6/10,21.42%,MTOR;GCN1;SESN1;IMPACT;EIF2AK4;LARS1
prerank,protein polyubiquitination (GO:0000209),-0.3174033390887513,-1.4029296477187254,0.002044989775051125,0.35721734350096135,1.0,120/297,29.47%,FBXL7;SASH1;RNF152;FBXL17;PELI2;SMURF2;UBE2N;TNKS2;UBE2E2;UBR2;SPSB1;PRKN;FBXW8;ARIH1;BTRC;WWP2;TRIP12;RNF115;RNF146;RNF217;HUWE1;UBR5;RBBP6;RNF213;RC3H1;BCL2;RNF19A;UBE4B;WWP1;UBE2H;TRAF3IP2;FBXL4;ANAPC5;RNF8;FBXL12;FBXO10;ANAPC7;UBE2K;DDB2;ANAPC4;RNF216;TRAF2;UBE2R2;TRIM5;PSMF1;FBXL19;FBXL18;NPEPPS;CUL3;FBXW7;FBXO30;DTX3L;NHLRC3;PSMB2;CDC26;UBE2B;SMURF1;FBXO38;TOPORS;ERCC8;LNPEP;CDC27;UBE2E1;TRAF3;HECTD1;RNF20;BFAR;FBXO22;UBE2S;MYLIP;SYVN1;FBXW11;FBXW5;HERC6;AREL1;TRAF6;RNF14;UBE2D3;TPP2;LRSAM1;IFI27;ANAPC11;CUL1;TTC3;PSMC1;ARIH2;SHARPIN;FBXW4;TRAF5;PSMB6;UBE2V2;RNF144A;RMND5A;PSMA3;ANKRD39;SIAH2;ANAPC13;RNF6;PSMA4;CDC16;FBXL14;TRIM68;FBXO4;ANAPC1;FBXW9;FBXO11;PSME1;UBE3C;PSMD13;SHPRH;FZR1;CDC34;MUL1;TNFAIP3;PSMB10;PSMA5;FBXL3;PSMB9;KBTBD7;RBX1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.49279773344908606,1.4027255340465619,0.08035714285714286,0.40958776375893285,1.0,9/24,18.35%,PRKAR2B;PDE2A;PDE11A;PEX5L;APLNR;RNF157;PDE4D;GNAI1;PRKAR1A
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5709378280990511,-1.4015228235365351,0.10357815442561205,0.3596019872242955,1.0,5/12,13.59%,RESF1;MPHOSPH8;ATF7IP;SETDB1;APOBEC1
prerank,defense response to fungus (GO:0050832),0.5152943850646721,1.4008517584795925,0.08704453441295547,0.4124001876644066,1.0,3/17,11.59%,S100A9;S100A8;BCL10
prerank,positive regulation of sodium ion transport (GO:0010765),0.5742183693142461,1.400647761723128,0.08222222222222222,0.4111985748578886,1.0,3/12,5.57%,CNKSR3;ANK3;SCN4B
prerank,phosphorylation (GO:0016310),-0.309432394693288,-1.4006384281627426,0.002079002079002079,0.36093477954764286,1.0,130/385,22.26%,PRKAG2;ROCK2;GRK5;TGFBR1;BMPR1A;EPHA7;CDK8;TLK1;PI4KA;PDK1;STK3;FAM20A;ROCK1;ABL1;BIRC6;LRRK2;JAK1;PRKAA2;TGFBR2;CSNK1A1;FRK;GK5;TOP1;GSK3B;CCNT1;STK17B;RYK;TBK1;IRAK3;NRK;IGFBP3;MARK3;CDK16;BCR;CDK7;DGKA;PAK2;STAT3;MAP4K4;NADK;TAOK3;EIF2AK3;LYN;CAMK2D;MTOR;MERTK;BRAF;GRK4;MAP3K5;PDPK1;DCLK1;MARK4;MAP2K1;CDK13;GRK3;WNK4;CLK2;MAP3K20;WNK1;CSNK1E;HIPK1;PANK2;BRSK1;FER;PRKCD;DMPK;LIMD1;FAM20C;CLK3;CDK11B;MKNK2;TEC;SIK1;COPS2;EIF2AK4;MAML1;GMFB;PGK1;TBCK;TRIB2;COPS8;MAPK6;TYK2;EIF2AK2;PRKDC;BMP2K;ACVR1;ERN1;LATS1;CDC25B;PRKCZ;CSNK2A1;PIK3R4;GRK6;MARK1;DAPK1;SIK3;IKBKE;DAPK2;PIK3CD;PRKACA;PXK;PRKD1;MORC3;PRKAA1;NEK4;CSNK1D;MAP3K1;BMP2;CDK10;CDK2;NEK6;FASTK;IRAK1;TAOK1;SHPK;GNPTG;NRBP2;BCKDK;PRKAG3;CDK6;DGKD;MAST2;PPP4R1;PRKAB1;MKNK1;MAP3K12;PRKCA;SIK2;SPHK1
prerank,aminoglycan metabolic process (GO:0006022),0.6093145913039871,1.4001012720463888,0.12394957983193278,0.4108192742972729,1.0,3/10,5.44%,B3GAT1;CHST9;B3GAT2
prerank,wound healing (GO:0042060),-0.39164848956139114,-1.4000785647273495,0.04291044776119403,0.36142573646792653,1.0,12/62,5.64%,IGF1;COL3A1;SMAD3;TGFBR1;PDGFRA;TPM1;DCBLD2;CFLAR;FGF1;ANXA6;MYOF;FUT10
prerank,cell part morphogenesis (GO:0032990),-0.5725041562462583,-1.4000311137267092,0.12316176470588236,0.3606979267563735,1.0,7/13,28.80%,PID1;PACSIN2;DNM1L;WASF1;FIS1;MYH14;SUPV3L1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.4176071562685558,-1.3982399114841964,0.04940711462450593,0.36407013019772183,1.0,16/50,20.09%,EGFR;SASH1;NFAT5;LIMS1;TRIM44;EP300;NR3C2;RHOA;EIF2AK2;DDX3X;PDCD4;TLR4;TRAF6;IFI35;IRAK1;TRIP6
prerank,peptide catabolic process (GO:0043171),-0.4783929956278315,-1.3980665178331546,0.07524752475247524,0.3636498297669881,1.0,8/23,18.02%,CPQ;XPNPEP1;CTSH;ECE1;ANPEP;NPEPPS;LNPEP;CHAC2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.45692534427923676,1.3974891973864867,0.08884297520661157,0.41566011331547764,1.0,10/30,21.01%,MIF;CXCL12;SIRT1;CLU;TPT1;RPS3;THOC1;MDM2;THOC5;RTEL1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.4627975285840819,-1.396951941099204,0.07386363636363637,0.3652242974006056,1.0,8/29,14.17%,ZBTB20;SORBS1;CREBL2;MTOR;LDLR;NR1H3;APOE;SLC27A1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.600474010968599,-1.3968525712086013,0.08365019011406843,0.3646136621350571,1.0,5/11,10.17%,VCL;KIT;ITGB5;JUP;CCN3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.479823378412008,-1.3966188752921123,0.08239700374531835,0.36435174764509154,1.0,16/24,35.69%,SEC24D;SEC23A;SEC31A;MFSD6;TAP2;SAR1B;TAPBPL;TAP1;FCER1G;SEC24A;ERAP1;CALR;SEC24C;IDE;SEC13;TAPBP
prerank,regulation of organelle assembly (GO:1902115),-0.3849994172004105,-1.3960391045589053,0.0444015444015444,0.36492697387689405,1.0,36/72,32.00%,GSN;ALMS1;TBC1D16;DCDC2;SPICE1;STX18;TBC1D19;TBC1D24;SENP6;ATXN2L;USP6NL;TBC1D2B;TBC1D20;IFT88;MTMR3;TBC1D22B;DYNC2LI1;CEP295;CEP76;NPRL3;ATG5;TBC1D17;RABGAP1;KIF9;TBC1D10A;MSN;RAB5A;IFT140;TBC1D10B;ATG3;TBC1D9B;RABEP2;STIL;RDX;CEP295NL;NPRL2
prerank,stress granule assembly (GO:0034063),-0.5020062154559545,-1.3956725506436705,0.05675146771037182,0.3648915402682167,1.0,9/20,16.14%,PRRC2C;YTHDF3;DDX6;ATXN2L;UBAP2L;CSDE1;LSM14A;DDX3X;DYNC1H1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.3943110196558118,-1.3956134018875461,0.041501976284584984,0.36422541254356733,1.0,29/62,28.25%,MLLT3;GTF2H2;CCNT2;CCNH;CCNT1;CDK7;CTR9;CDK13;CCNK;SETD2;MNAT1;AFF4;RTF1;ERCC3;NELFB;POLR2H;CDC73;GTF2F1;POLR2K;GTF2H1;EAF2;CTDP1;POLR2E;NCBP2;GTF2H4;POLR2D;NELFA;CDK9;NELFE
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4876994481434467,-1.3953608078821842,0.09041591320072333,0.3631987599486188,1.0,8/23,10.70%,DAB2;EP300;TGFB1I1;THBS1;CREBBP;ZEB2;SMAD4;GIPC1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4876994481434467,-1.3953608078821842,0.09041591320072333,0.3631987599486188,1.0,8/23,10.70%,DAB2;EP300;TGFB1I1;THBS1;CREBBP;ZEB2;SMAD4;GIPC1
prerank,monocyte chemotaxis (GO:0002548),0.4510687089631296,1.394211940499592,0.0709812108559499,0.42186351059167987,1.0,8/32,20.51%,FLT1;RPS19;CCL2;PDGFB;CCL25;PTPRO;CCL13;CCL19
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4579423308245126,-1.393934542432932,0.07495069033530571,0.36568998771002026,1.0,5/30,8.57%,IGF1;IGFBP2;HMGB1;RC3H1;IGF2
prerank,cellular response to organonitrogen compound (GO:0071417),0.3607850341549276,1.3929363709291553,0.02574257425742574,0.42340040839566667,1.0,17/99,9.42%,GABRB3;HCN1;GABRB1;ACTB;IPO5;AQP9;GLRA1;AKAP6;PDE2A;RYR3;GABRB2;HCN2;TRPM2;P2RY1;CIB2;GABRG2;GLRA2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.6063379260328888,-1.3911064703107696,0.09523809523809523,0.3717325239555343,1.0,4/10,18.53%,LRP6;RYK;WNT5A;FZD1
prerank,regulation of vasculogenesis (GO:2001212),0.5488933939883777,1.3909278639193818,0.09016393442622951,0.4265745462736762,1.0,4/14,9.06%,HEY1;KDR;CD34;RIN2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.592320311169853,1.3907654262326694,0.09782608695652174,0.42533848172937067,1.0,5/10,17.04%,NAB2;CLU;HSP90AB1;SORL1;HSP90AA1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.4996794182942724,-1.3894028120667543,0.07948243992606285,0.37473783971035707,1.0,5/21,6.01%,LRP6;CSNK1A1;GSK3B;AXIN1;FZD2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5666118150759977,-1.3886808538960744,0.0825147347740668,0.3756055484648837,1.0,6/13,21.57%,HMGB1;PDPK1;IGF2;PLCG1;ITGA4;FGF2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.4449197518354838,-1.3885912612129803,0.068,0.37498414562945853,1.0,12/35,10.56%,NOTCH2;PDGFRA;NTRK3;ABL1;BAIAP2L1;BCAS3;NRP1;CDC42;RAPGEF3;IQGAP2;SEMA3E;ABL2
prerank,regulation of transferase activity (GO:0051338),-0.520525348377421,-1.3884260431795226,0.08754863813229571,0.3745316215341888,1.0,11/17,30.55%,SMG6;NABP2;PARP4;FEM1A;PPP1R3F;SPTSSB;BAG5;LDB2;LDB1;JMJD8;PINX1
prerank,filopodium assembly (GO:0046847),0.5385738915910012,1.3883122404406754,0.08723404255319149,0.429843036190325,1.0,5/16,12.14%,DNM3;FGD5;SPATA13;FGD3;SRGAP2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5603039720786018,-1.3879017961845668,0.09140767824497258,0.37498094857822895,1.0,4/13,15.90%,ENPP1;TPST1;SULT1A1;ABHD14B
prerank,regulation of cellular catabolic process (GO:0031329),-0.3940962937556282,-1.386275822264471,0.04085603112840467,0.37816129007761884,1.0,20/62,17.69%,ITPR1;EP300;ROCK1;ABL1;PRKN;LRRK2;NUPR1;RPTOR;TPCN2;PIP4K2C;USP33;LONP2;ABL2;WDR91;MTMR3;KAT8;USP13;DAPK1;DAPK2;RMC1
prerank,aorta development (GO:0035904),-0.5542864392649105,-1.3852824197149856,0.08241758241758242,0.3797270860270265,1.0,9/14,17.05%,LRP1;PDGFRB;ROBO1;JAG1;ADAMTS9;PKD2;EFEMP2;HECTD1;TBX2
prerank,hippo signaling (GO:0035329),-0.47164798960930254,-1.3852373300146865,0.08102766798418973,0.3790041324536916,1.0,10/26,14.89%,TEAD1;STK3;YAP1;AMOTL2;TEAD3;WWC1;TEAD2;MOB1B;YWHAE;LATS1
prerank,response to axon injury (GO:0048678),-0.5115211704456607,-1.3850836723763809,0.08382066276803118,0.378560803518176,1.0,5/18,15.21%,DPYSL3;NREP;APOD;P2RY12;P2RX4
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4188764257300186,1.3847550264393806,0.052845528455284556,0.43733758728495714,1.0,8/41,10.22%,GRM5;LRP8;CSF1R;DOCK3;GAS6;NTRK2;RELN;PDGFB
prerank,regulation of telomerase activity (GO:0051972),0.410000101508839,1.3843608787185573,0.05450733752620545,0.436545332870956,1.0,19/45,18.94%,PRKCQ;KLF4;TERF1;HSP90AB1;PIF1;MEN1;CCT2;DKC1;CCT4;ATM;PARM1;PTGES3;XRCC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;TCP1
prerank,histone deacetylation (GO:0016575),-0.4148607506165915,-1.3838432268744523,0.055449330783938815,0.3807764869347694,1.0,11/43,9.54%,PRDM5;HDAC8;MIDEAS;HDAC4;TBL1X;TBL1XR1;RCOR1;BAZ2A;RCOR3;REST;MIER1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.594159801900708,-1.3836636737557746,0.1005586592178771,0.3804117278040339,1.0,4/11,17.55%,TGFBR2;FGFR2;STAT1;WNT5A
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.4484155346930605,-1.3835022211745074,0.06457925636007827,0.3799578657119353,1.0,4/30,2.75%,AKAP13;COL3A1;LPAR1;ROBO1
prerank,response to amino acid starvation (GO:1990928),-0.37538114632153813,-1.3834293115754999,0.04158790170132325,0.3793689416849468,1.0,21/72,17.78%,RNF152;ATP6V1B2;TFEB;RPTOR;ATP6V0D1;EIF2AK3;MTOR;LARP1;MAP3K5;GCN1;SESN1;IMPACT;ATF2;WDR59;CASTOR2;EIF2AK4;EIF2AK2;DAP;TCIRG1;PRKD1;NPRL3
prerank,negative regulation of histone acetylation (GO:0035067),0.5904499608161622,1.3826327363479582,0.10491071428571429,0.4391436859071068,1.0,4/11,12.75%,SIRT1;SNCA;SET;SIN3A
prerank,positive regulation of gene expression (GO:0010628),-0.30206940899175544,-1.3820769786947362,0.0,0.381703006736186,1.0,80/442,11.32%,BMP6;SLC24A3;SAMD4A;ROCK2;PLD1;IGF1;EGFR;PID1;AFDN;SMAD3;TGFBR1;ANK2;RBMS3;FOXD1;ANGPT1;GSN;RBPJ;NTRK3;LIMS1;DDX5;CELF1;FGF1;VIM;KAT2B;BMP7;EP300;ROCK1;BMP4;ROBO1;SMO;PRKN;TNRC6B;OSR1;ZCCHC4;WNT6;GSK3B;PLA2R1;YTHDF3;YAP1;TNRC6A;CTSH;MOV10;UBR5;THBS1;HOXA5;PLSCR1;STAT3;DTNBP1;MED26;U2AF2;EIF2AK3;MTOR;SF3B1;F3;BRAF;HNRNPD;AR;FUBP1;DHX36;PPARGC1A;TAF1D;GJA1;TBP;MAP2K1;MED1;PTPN22;PHF2;ATF2;PLXNB2;ITGB8;NGF;GABPA;TADA3;HIF1A;HCFC1;CALCOCO1;RPL11;ID2;TLE1;ADAM19
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5130272838007797,-1.3816353091997962,0.096,0.3819932754196652,1.0,8/20,18.05%,GSN;PLA2R1;THBS1;PLCG1;PIAS4;ITGA4;PDCD4;SFRP4
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5124111366404764,-1.381564252319441,0.08687258687258688,0.3813575345105505,1.0,4/18,8.57%,IGF1;IGFBP2;HMGB1;IGF2
prerank,response to amino acid (GO:0043200),0.44992260154681185,1.381542514034426,0.06652806652806653,0.4400766032888302,1.0,6/31,9.42%,GRIN1;IPO5;GLRA1;GLRA3;MEAK7;GLRA2
prerank,neutrophil chemotaxis (GO:0030593),0.4072693747940513,1.3813762348513536,0.04665314401622718,0.43876683613287754,1.0,13/53,20.51%,BSG;PDE4B;S100A9;S100A8;TGFB2;CCL2;EDN1;CCL25;PPIA;NCKAP1L;CKLF;CCL13;CCL19
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5926990230913514,-1.3813702050217955,0.08687615526802218,0.38093984090249117,1.0,8/11,32.98%,WIPI1;UGCG;APOE;PIK3C3;WDR45B;WIPI2;ATG10;WDR45
prerank,regulation of chromatin organization (GO:1902275),-0.5525488281274201,-1.380806152638604,0.0928030303030303,0.3814984422066763,1.0,4/14,8.57%,MLLT3;TLK1;SETD5;IGF2
prerank,regulation of cartilage development (GO:0061035),-0.514032168774006,-1.3803638429532838,0.09302325581395349,0.3817100945382551,1.0,8/18,22.07%,SOX5;BMP4;ZBTB16;SOX6;TRPS1;BMP2;TAPT1;PTHLH
prerank,regulation of neuron migration (GO:2001222),0.46745430675410315,1.3801843754499554,0.08314606741573034,0.44016771911811964,1.0,11/26,14.03%,CAMK2A;CTNNA2;SEMA6A;SHTN1;NEXMIF;NTNG1;NTNG2;ARHGEF2;DAB2IP;SRGAP2;ADGRG1
prerank,neuron migration (GO:0001764),0.4156972746702519,1.3798736023582925,0.05893909626719057,0.43920714190179494,1.0,13/48,9.85%,ADGRL3;SPOCK1;GPM6A;DNER;MAP1B;FGF13;NTRK2;ASTN1;NRCAM;NDNF;CDKL5;RELN;ASTN2
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.49815684164292284,-1.379810816999774,0.0944558521560575,0.38223155418096916,1.0,4/22,7.81%,CACNA1C;STIM1;ADGRV1;CACNA1D
prerank,microtubule polymerization or depolymerization (GO:0031109),0.48047613661412464,1.3793744592588002,0.08172043010752689,0.4386534862905525,1.0,9/24,19.30%,STMN1;FGF13;STMN4;STMN2;TPPP;STMN3;TPPP3;KIF18A;TRPV4
prerank,regulation of defense response to virus by host (GO:0050691),-0.4560480289100481,-1.3791854838179147,0.068762278978389,0.382928687260126,1.0,11/30,17.54%,TRIM44;DHX9;TRAF3IP2;PTPN22;RNF216;PARP9;MAVS;EIF2AK4;DTX3L;STAT1;ZDHHC1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.44743423272139615,1.3785190775725482,0.06981519507186858,0.43919069034761654,1.0,8/32,11.89%,GRIN1;AKAP6;SNCA;THY1;APLNR;F2R;P2RX7;TRPC1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5915118563564766,-1.3782028970876916,0.10095238095238095,0.3845129829980029,1.0,7/11,29.15%,PARP10;PARP14;PARP9;PARP4;PARP6;PARP12;PARP3
prerank,base conversion or substitution editing (GO:0016553),0.570699923446124,1.3778485780870349,0.1069182389937107,0.43923286730504696,1.0,1/11,0.14%,ADARB2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.47656367498644675,-1.37754295459193,0.06679764243614932,0.38523774040246783,1.0,12/26,20.64%,ANK2;FHL1;WWP2;DLG1;ITGB1;CACNA1D;VAMP2;ACTN2;YWHAE;AKAP9;ATP1B3;CAB39
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.47814706090230275,-1.3774918661460511,0.08108108108108109,0.38453266908451444,1.0,13/25,28.85%,RNF8;CDK13;WDR43;NELFB;TCERG1;HNRNPU;CDC73;EAF2;RECQL5;LDB1;NELFA;NELFE;ZMYND11
prerank,regulation of neuroinflammatory response (GO:0150077),-0.5036044399310416,-1.3768979115125308,0.10128913443830571,0.3851132061725372,1.0,3/19,6.13%,IGF1;NUPR1;DAGLA
prerank,lipid droplet formation (GO:0140042),-0.602631882234961,-1.3759096704841498,0.10477941176470588,0.38675999019313834,1.0,7/10,31.17%,ZFYVE1;AUP1;SQLE;CDS2;BSCL2;PLA2G4C;FITM2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5983803528687668,-1.3758074202914778,0.11299435028248588,0.3862393451020348,1.0,4/11,8.85%,EGFR;DDX5;BMP4;MAP2K1
prerank,positive regulation of chemokine production (GO:0032722),0.41195381445122997,1.3751203080460261,0.05295315682281059,0.44471436293823596,1.0,8/44,10.48%,TIRAP;MBP;IL17F;CSF1R;IL7;TLR2;ADCYAP1;AIF1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.35918527199615236,-1.3745982689376903,0.022132796780684104,0.388332574651144,1.0,51/107,31.66%,ITPR1;CREB3L2;PRKN;GSK3B;THBS1;UBQLN1;OS9;UFL1;EIF2AK3;BCL2;MAP3K5;UBA5;AIFM1;SELENOS;ERLEC1;TRAF2;JUN;TMEM259;ATP2A2;RCN3;MBTPS2;ERP44;ATF6;ERN1;NCK1;MBTPS1;DERL1;SYVN1;VCP;TMTC3;SEC16A;P4HB;ATP2A3;PIK3R1;CDK5RAP3;WFS1;EIF2B5;BAG6;HYOU1;QRICH1;ATF6B;SEL1L;PPP1R15B;USP19;CCDC47;BAK1;UFM1;ATG10;BCL2L11;HERPUD1;CEBPB
prerank,mitochondrial genome maintenance (GO:0000002),-0.5947702302895378,-1.3744766913045856,0.125,0.38782330956020744,1.0,4/11,19.24%,OPA1;MEF2A;PARP1;MGME1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5066387478863492,-1.374325115873025,0.09056603773584905,0.3873510848089724,1.0,7/18,20.00%,LBP;THBS1;NECTIN2;TNIP2;TLR4;WNT5A;KARS1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.377294667971702,1.3739721178375195,0.034764826175869123,0.4460451263919852,1.0,15/75,8.00%,CAMK2A;MRAP2;RGS12;GIT1;METAP2;GNG4;YWHAB;RGS20;PLCB1;RGS5;KCTD8;RGS11;GUCA1B;ADCYAP1;RNF157
prerank,sensory perception of pain (GO:0019233),0.49655118609714016,1.3737706364200097,0.10782241014799154,0.4448429922595494,1.0,8/21,15.06%,MME;CCL2;OPRM1;RETREG1;P2RX7;KCNA2;OPRK1;OPRL1
prerank,DNA methylation (GO:0006306),-0.4830008658762589,-1.3736690322396718,0.08477842003853564,0.3881399275948562,1.0,6/23,12.83%,PPM1D;BAZ2A;DNMT3A;ATF7IP;N6AMT1;EHMT1
prerank,positive regulation of macroautophagy (GO:0016239),-0.40800617593290434,-1.3734875938697295,0.06439393939393939,0.38778820191295593,1.0,12/48,11.15%,DCN;PRKAA2;UVRAG;TBK1;VPS13D;RAB3GAP1;LARP1;PIP4K2C;VDAC1;SESN1;BAG3;PAFAH1B2
prerank,positive regulation of signaling (GO:0023056),0.42821012198205377,1.3732528497520053,0.06903765690376569,0.44423249744564774,1.0,10/37,8.17%,SYT1;RIMS1;RIMS2;RIMS3;SNCA;GRIK2;KCTD13;HOMER1;CLSTN3;NMB
prerank,negative regulation of neuron projection development (GO:0010977),0.39212255319986894,1.3731374333476214,0.048582995951417005,0.4428010586918668,1.0,22/56,16.55%,SPOCK1;DCC;MINAR1;MAG;NLGN1;MCF2;THY1;EFNB3;OMG;LINGO1;ITM2C;STMN2;RTN4R;CIB1;PRAG1;RTN4;GDI1;RTN4RL1;FKBP4;CRMP1;STX1B;RAB29
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.4729335794307443,1.3730532463968592,0.09710743801652892,0.4413953227702005,1.0,5/24,8.10%,MIF;CXCL12;SIRT1;CLU;TPT1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.5271955160639157,-1.3728115880405796,0.10153256704980843,0.38866949734186934,1.0,5/15,10.96%,TGFBR1;PDGFRA;TGFBR2;FGFR2;NIPBL
prerank,positive regulation of locomotion (GO:0040017),0.4656162984064628,1.3724020351444792,0.07006369426751592,0.44130044755113135,1.0,7/27,10.48%,SPOCK2;CSF1R;PPM1F;STX3;NTN1;PDGFB;AIF1
prerank,cellular response to lipid (GO:0071396),-0.32652957400625954,-1.3721620733194628,0.011695906432748537,0.38928748730953056,1.0,38/191,13.00%,ATP1A2;ROCK2;EGFR;PID1;NFKB1;EPHA3;ADCY5;PTK7;VIM;AXL;PABPN1;WNT5B;WNT6;IRS1;LBP;HMGB1;NR3C1;LCOR;SBNO2;TFPI;ADCY1;LYN;WNT9A;ADCY6;AR;CTR9;MED1;CHMP5;SELENOS;UPF1;NR1H3;RHOA;ADAM9;ABL2;RORA;MEF2C;FZD7;ADNP2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.4882027833205877,-1.3715914645789054,0.0830188679245283,0.3897992738889484,1.0,6/23,8.29%,PRKAG2;CEMIP;BMP7;RPTOR;AXIN1;UBE2K
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.3726079302931555,-1.3715485424538898,0.04474708171206226,0.38910225902208795,1.0,24/77,18.94%,IGF1;TCF7L2;TGFBR1;OPA1;ITGAV;CFLAR;BMP4;PRKN;BIRC6;THBS1;SH3RF1;ASAH2;BCL2;AR;ACAA2;RB1;ACVR1;DDX3X;CSNK2A1;PHIP;NR4A2;CX3CR1;TMEM14A;PARK7
prerank,ribosome assembly (GO:0042255),0.4040049298368309,1.3706598800035827,0.060362173038229376,0.444252593264722,1.0,15/47,17.49%,RPS19;RPF2;RPS27;RPL10;RPLP0;MRPS7;RPS15;RPL5;RPL23A;NOP2;RPS14;RPS5;RPS28;MDN1;PPAN
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.5162181924490752,-1.3702308494789732,0.11262135922330097,0.39146285084082166,1.0,12/16,41.54%,PDS5A;NIPBL;RAD21;PDS5B;RB1;SMC1A;BOD1;POGZ;MAU2;REC8;SGO1;DSCC1
prerank,cellular protein modification process (GO:0006464),-0.28310169984525313,-1.3700186811519053,0.0,0.3911110826521653,1.0,287/983,21.50%,UST;PTPN13;FSTL1;PRKAG2;CP;ROCK2;FBN1;COL3A1;FBXL7;GRK5;TGFBR1;LARGE1;BMPR1A;ST3GAL4;CDK8;NGLY1;TLK1;LTBP1;IGFBP5;PDK1;SDC2;ARAF;B3GALT1;TNKS2;UBE2E2;LOXL1;PPP1R12A;STK3;FAM20A;ROCK1;BMP4;SPSB1;ABL1;PPM1D;BIRC6;LRRK2;JAK1;PTPN14;PRKAA2;PPM1E;TGFBR2;FBXW8;HLCS;CSNK1A1;KLHL13;BTRC;WWP2;FRK;GSK3B;CCNT1;STK17B;RYK;TBK1;PLOD2;IRAK3;NRK;GPC3;ASB3;PLAT;IGFBP3;MARK3;PTPN9;CDK16;BCR;CDK7;PTPRS;PIGK;THBS1;STT3A;FUT10;PAK2;ZBTB16;PTPN21;UFL1;MAP4K4;DUSP16;TAOK3;EIF2AK3;WDTC1;ITIH2;LYN;PTPN3;CAMK2D;ANXA1;MTOR;OBSL1;ASB2;MERTK;ZC3HAV1;BRAF;FBXL4;GRK4;PARP10;OGA;MAP3K5;PDPK1;FBXL12;DCLK1;FBXO10;IGFBP4;ASB13;SETD3;PTPRK;MARK4;MAP2K1;KTN1;DDB2;DAPP1;CDK13;GRK3;WNK4;PTPN22;UBE2I;PPP4R2;PPP2CB;PMM2;CLK2;PPM1H;TNC;MAP3K20;WNK1;NUB1;CSNK1E;HIPK1;PTPN12;BRSK1;FER;EGLN3;MAN2A1;ST3GAL3;DCAF10;PRKCD;PARP14;HIF1A;ABL2;GGCX;WIPI1;DMPK;COG3;FAM20C;PARP9;DNAJC3;COG7;CLK3;CDK11B;YES1;DCAF6;DUSP11;SERPIND1;LGALS1;PARP1;PPP2R5E;UGCG;PSMF1;PPM1M;FBXL19;FBXL18;RAB11A;LRRC41;MKNK2;TEC;SIK1;CUL3;COPS2;FBXW7;FBXO30;EIF2AK4;WSB2;FN1;MTMR3;MAML1;DCAF8;PPM1A;KLHL22;MXRA8;GMFB;SIRT5;TBCK;PARP4;CCN1;TRIB2;COPS8;MAPK6;LOX;TYK2;IGFBP7;EIF2AK2;APOE;PIK3C3;PSMB2;PRKDC;BMP2K;PPP2R5D;DUSP1;ACVR1;CDC14B;ERN1;MSLN;LATS1;CDC25B;PRKCZ;MBTPS1;PPP1CB;CUL2;CSNK2A1;PIK3R4;ERCC8;GRK6;MARK1;KLHL11;DAPK1;UBE2E1;DUSP10;DCAF4;MANBA;SIK3;FEM1A;UBL5;WDR45B;IKBKE;ASB5;DAPK2;PIK3CD;PIGS;FBXO22;UBE2S;PRKACA;MIA3;MAN2A2;PXK;UBA7;PRKD1;MORC3;PRKAA1;RPN1;PPP2R5C;PTPN1;RABGGTB;FBXW11;ATG5;FBXW5;B4GALT5;GCNT2;NEK4;RCN1;CSNK1D;MAP3K1;BMP2;DCUN1D3;PARK7;CHM;SPSB4;CDK10;ABCA7;UBE2D3;TRIOBP;GPAA1;CDK2;NEK6;B4GALT7;FASTK;IRAK1;TAOK1;COP1;NRBP2;SPP1;PPP2R1B;P4HB;PIGH;WIPI2;CUL1;BCKDK;PRKAG3;CDK6;PSMC1;HIF3A;PPP2CA;CHML;MAST2;PPP4R1;PTPRA;PARP6;CUL7;AKT2;NAE1;PRKAB1;MKNK1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5979505673826664,1.3698475340206306,0.11868131868131868,0.4447724325802178,1.0,5/10,17.11%,TSR3;RPUSD1;DKC1;NHP2;NAF1
prerank,melanosome organization (GO:0032438),-0.4635336743318549,-1.3688898302365617,0.0835030549898167,0.3930099707816194,1.0,6/26,19.03%,KIF13A;SHROOM2;DTNBP1;AP3B1;BLOC1S5;HPS1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.37997558996925085,1.3688580481929484,0.03643724696356275,0.4456171933701831,1.0,31/69,21.30%,NDUFC1;SDHC;NDUFA4;COX4I1;NDUFA1;COX6A1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;COX6B1;NDUFB2;COX7C;NDUFAF1;UQCRH;NDUFB9;UQCC3;COA6;NDUFAB1;NDUFA7;COX10;NDUFA12;COX8A;NDUFB4;NDUFB8;NDUFA10;NDUFS3;UQCRC2;NDUFA6;COX5B;NDUFB7
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.5669709495370492,-1.3686795144712454,0.09851301115241635,0.3927321895877186,1.0,8/12,35.42%,TNKS2;PARP10;PARP1;PARP6;PARP12;PARP3;PARP2;TIPARP
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6182981590015514,-1.3681820413941155,0.10815939278937381,0.3930819680180732,1.0,5/10,25.99%,ABCA1;APOE;PRKACA;ABCA7;ZDHHC8
prerank,response to molecule of bacterial origin (GO:0002237),0.38369416022001945,1.3679818808033744,0.038461538461538464,0.44620417068893165,1.0,19/69,15.14%,TIRAP;S100A9;S100A8;SNCA;NOS3;IL12A;CD24;HNRNPA0;IFNAR1;TRIM6;CYRIB;SLPI;GGT7;F2R;GGT1;TAB2;PELI1;GCH1;MAPKAPK2
prerank,histone lysine methylation (GO:0034968),-0.4396700838124743,-1.3664089470595218,0.09021113243761997,0.3966144235370227,1.0,17/33,33.03%,PRDM5;KMT2D;SMYD3;SETD3;KDM6A;N6AMT1;SETDB1;KMT2A;EZH2;PRDM9;PAXIP1;CXXC1;SMYD1;WDR5;SETDB2;WDR5B;DPY30
prerank,central nervous system development (GO:0007417),0.3178798463984248,1.36595607366819,0.014084507042253521,0.44991637518985517,1.0,58/250,14.97%,PAX8;ADGRL3;CNTNAP2;SPOCK1;GRIN1;SLC6A17;SLC2A1;MAL;MBP;PROX1;ASIC2;SH3GL2;PBX2;GRIN2A;SH3GL3;DNER;AHI1;CDH2;GRIK1;CNTN6;GRIN2B;MFSD2A;ADAM22;ADAM23;GRIN2D;MOG;AATK;PITPNM1;DSCAML1;NPAS2;CYP26C1;NRCAM;MTF1;IL1RAPL2;ROBO2;UBE3A;RELN;TPPP;ADGRL2;PHGDH;FOXJ1;HAP1;CNTN4;NPTX1;ITGAM;SH3GL1;VCAN;HAPLN3;DLL1;PTPRZ1;ADGRG1;NHEJ1;LSR;DCX;PPT1;HPCAL4;HAPLN4;ELP3
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.5051103686191122,-1.365568448226579,0.0851063829787234,0.39785790676012645,1.0,11/19,39.29%,PRKN;DNM1L;VDAC1;FBXW7;PARK7;HTRA2;USP36;HTT;SREBF1;FZD5;HAX1
prerank,regulation of histone methylation (GO:0031060),-0.5492259893539657,-1.3653799690870358,0.10076045627376426,0.3974950077632212,1.0,8/13,35.50%,NSD1;MTHFR;CTR9;JARID2;PIH1D1;NNMT;AASS;TTLL12
prerank,protein ubiquitination (GO:0016567),-0.29626124385714264,-1.3645305830430396,0.0,0.39872440724740876,1.0,148/471,24.04%,RNF220;PDZRN3;FBXL7;SASH1;RNF152;FBXL17;PELI2;SMURF2;UBE2N;RNF43;TNKS2;UBE2E2;UBR2;TRIM44;SPSB1;PRKN;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;TRIP12;RNF115;RNF146;RNF217;HUWE1;USP7;UBR5;UHRF2;RBBP6;RNF213;DTX4;RC3H1;SH3RF1;OS9;BCL2;RNF19A;UBE4B;WWP1;UBE2H;ASB2;ZSWIM8;FBXL4;RNF8;FBXL12;FBXO10;ANAPC7;CTR9;UBE2K;HLTF;RNFT1;DDB2;VCPIP1;ANAPC16;NUB1;TNFAIP1;LZTR1;SELENOS;HERC2;RNF103-CHMP3;TRAF2;UBR1;UBE2R2;HIF1A;RFWD3;RTF1;TRIM5;PSMF1;FBXL19;UBR3;FBXL18;TRIM11;NPEPPS;CUL3;FBXW7;FBXO30;TRIM25;KLHL22;DTX3L;NHLRC3;TRPC4AP;SH3RF2;PSMB2;PRKDC;UBE2B;SMURF1;TRIM39;FBXO45;SH3RF3;CUL2;TOPORS;ERCC8;LNPEP;CDC27;UBE2E1;MSL2;ARRB1;RNF181;RNF20;BFAR;DERL1;ASB5;KLHL18;FBXO22;UBE2S;MYLIP;SYVN1;FBXW11;FBXW5;HERC6;EIPR1;AREL1;SDE2;TRAF6;VCP;RNF14;SPSB4;UBE2D3;TPP2;LRSAM1;CDC73;DTX2;RNF11;NFX1;PCNA;ANAPC11;CUL1;TRIM63;PSMC1;HIF3A;ARIH2;CUL7;FBXW4;DET1;ARRDC4;WAC;CAND2;PSMB6;UBE2V2;RNF144A;RMND5A;PSMA3;SIAH2;USP9X;RNF6;PSMA4;CNOT4
prerank,phospholipid homeostasis (GO:0055091),-0.5821951852553933,-1.3640741375220284,0.10095238095238095,0.3990199110143037,1.0,3/11,11.11%,ABCA1;TLCD2;RCN3
prerank,heart trabecula morphogenesis (GO:0061384),-0.5093134945466002,-1.3638103095397704,0.09549549549549549,0.39881819327214657,1.0,7/18,4.49%,TGFBR3;TGFBR1;BMPR1A;RBPJ;BMP5;BMP7;RBP4
prerank,relaxation of muscle (GO:0090075),-0.5487963597831247,-1.363794117349745,0.1036468330134357,0.3980573791640975,1.0,4/13,7.68%,ATP1A2;GSN;CAMK2D;KCNJ2
prerank,regulation of protein processing (GO:0070613),-0.4917227606895074,-1.363768108476864,0.09514563106796116,0.39731641415929564,1.0,4/21,6.91%,CCBE1;LRRK2;GAS1;RUNX1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4772704392161864,1.3637204765328992,0.1127348643006263,0.4538567670284547,1.0,5/22,10.29%,SLA2;THY1;PTPRJ;GPS2;LPXN
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4849042751154341,-1.363642747500034,0.09315589353612168,0.39677707672941553,1.0,6/20,10.95%,ATP1A2;CACNA1C;ANK2;SLC9A1;CAMK2D;ATP2A2
prerank,cilium organization (GO:0044782),-0.320720532638086,-1.3635687762569784,0.015384615384615385,0.39616346580651834,1.0,61/209,21.17%,PARVA;GSN;PKD1;PCM1;ASAP1;GBF1;BBS9;CDC14A;WDPCP;ODF2;DCDC2;FLNA;NUDCD3;CYS1;ARL3;PIBF1;IFT43;ATP6V0D1;PDE6D;ARL13B;IFT81;CFAP44;CEP162;DYNC2I1;ABLIM3;PCNT;EHD2;MARK4;RFX2;RAB3IP;IFT88;FAM161A;RPGR;RP2;EXOC2;IFT80;RAB11A;PKD2;CC2D2A;POC1B;ARMC9;SNX10;RILPL2;TTC17;CDC14B;DZIP1L;EHD3;CCDC57;CCDC66;TCTN1;WDR11;PTPDC1;CPLANE1;DYNC2I2;EHD4;RILPL1;AVIL;CEP89;GALNT11;KIFAP3;TRAPPC14
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5178083053661091,1.3633869468491764,0.11226611226611227,0.4530620623146857,1.0,4/16,13.23%,CXCL12;CLU;TPT1;RPS3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.511134547358792,-1.3629261697586221,0.10136452241715399,0.3969182391855953,1.0,6/18,6.50%,ROCK2;ROCK1;RIPOR2;BCAS3;RAP1B;ARFGEF1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5624982537989954,-1.3623615830090703,0.12962962962962962,0.3973773746726491,1.0,3/12,2.75%,ANK2;DIAPH1;ANXA6
prerank,actin filament organization (GO:0007015),-0.33213978932283267,-1.362331459873745,0.013592233009708738,0.3966356470902198,1.0,44/151,20.83%,DPYSL3;CGNL1;GSN;TPM1;SVIL;MCU;MPRIP;MYO1B;BAIAP2L1;SHROOM2;FAT1;FLNA;DLG1;RND3;SHROOM3;TMOD3;FHOD1;CORO7;INPPL1;CDC42;ARHGAP17;WASL;RHOA;TPM3;ABI1;RHOBTB2;MYO1F;ZBED3;WHAMM;CARMIL1;EFS;RHOBTB1;RHOH;RHOC;TRIOBP;AVIL;LMOD1;VILL;MARCKS;TPM2;GAS2;BAIAP2;ARHGAP12;PLS1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5833720262595028,1.3618066502900847,0.11702127659574468,0.45532522187619395,1.0,3/10,6.24%,NETO1;SHANK3;NPTN
prerank,angiogenesis involved in wound healing (GO:0060055),0.5829879879476378,1.3617640821484813,0.13473684210526315,0.45377861246872225,1.0,4/11,8.97%,KDR;NDNF;CD34;ADIPOR2
prerank,MAPK cascade (GO:0000165),0.31130514794482744,1.3615186397204047,0.007633587786259542,0.4528068549276501,1.0,56/295,11.67%,CAMK2A;DLG2;GRIN1;KITLG;TEK;RIT2;ERBB4;MBP;LRRC7;RASGRP3;SPTBN4;NRG2;NRG1;SPTB;SHANK3;DUSP6;RASAL3;FGF13;YWHAB;IL2RG;GRIN2B;TNIK;KDR;FGF10;PSMA1;FRS3;FLT3;LYPLA1;PEBP1;RASGEF1A;PAK1;NCAM1;PRKG2;PRKCQ;FGF5;IL5;RPS27A;UBC;RASGRF1;UBB;PSMD12;GOLGA7;PSMA6;WDR83;PSMB3;SPTBN5;CCL2;TAOK2;DAB2IP;PDGFB;SHC2;MEN1;SCG2;CALM1;SPTBN1;MAPK8
prerank,actin crosslink formation (GO:0051764),-0.5710492470507154,-1.3610702130528163,0.08823529411764706,0.3988209602038232,1.0,7/12,27.00%,DPYSL3;BAIAP2L1;FLNA;GAS2;BAIAP2;GAS2L3;GAS2L1
prerank,female gonad development (GO:0008585),-0.5038857622796703,-1.3609490032225058,0.10714285714285714,0.3983228966875787,1.0,12/19,38.28%,NR2F2;KIT;VEGFA;INHBA;EIF2B4;EIF2B5;INHBB;INHA;CEBPB;ANG;COL9A3;LHCGR
prerank,organelle assembly (GO:0070925),-0.3000689539654156,-1.3606584039985494,0.0019646365422396855,0.3983130109267391,1.0,109/384,20.57%,PARVA;GSN;PKD1;INO80;PCM1;ASAP1;SH3PXD2B;GBF1;NCOR1;BBS9;CDC14A;WDPCP;PRRC2C;YTHDF3;DCDC2;FLNA;NUDCD3;CYS1;ARL3;UBXN2B;DDX6;PIBF1;IFT43;CEP63;ATP6V0D1;EIF4ENIF1;PDE6D;ARL13B;IFT81;CFAP44;VPS4B;RC3H1;UBQLN1;TMOD3;CEP162;DYNC2I1;ABLIM3;ZFYVE1;PCNT;TUBGCP6;CHMP4B;CHMP4A;EHD2;ATXN2L;TUBGCP2;UBAP2L;CHMP5;RB1CC1;CHMP3;CSDE1;RFX2;RAB3IP;IFT88;VPS37C;LSM14A;FAM161A;RPGR;WIPI1;RP2;LIMD1;EXOC2;ATP2A2;IFT80;ULK2;RAB11A;CC2D2A;POC1B;ARMC9;BECN1;SNX10;MAPRE1;SYNPO;ATG2A;RILPL2;PIK3C3;CDC14B;EDC3;RCC1;DDX3X;DZIP1L;EHD3;FARP2;ATG9A;CCDC57;DYNC1H1;WDR45B;AUP1;ATG2B;CCDC66;TCTN1;WDR11;AMBRA1;PTPDC1;CPLANE1;ATG5;SQLE;DYNC2I2;CSNK1D;EHD4;HPS1;NEK6;TUBGCP4;RILPL1;AVIL;LMOD1;CEP89;SNF8;GALNT11;WIPI2
prerank,regulation of membrane depolarization (GO:0003254),-0.5208004127857575,-1.3605653424517656,0.0970873786407767,0.3977425421307206,1.0,4/18,7.01%,FHL1;LRRK2;PTPN3;CAMK2D
prerank,negative regulation of protein processing (GO:0010955),-0.5615356221028247,-1.360428541737142,0.12296564195298372,0.3972613073382973,1.0,5/12,24.68%,LRRK2;THBS1;GAS1;SERPINE1;SNX12
prerank,gene expression (GO:0010467),0.3086990694536367,1.3601593351838357,0.00597609561752988,0.4547271342488668,1.0,90/348,14.48%,PAX8;ADARB2;BICD1;RPS6;LMF2;RPS19;RPS20;RPL38;RPL29;PTMA;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;NUP210;HOXD3;RPL10A;NXT1;RPS24;RPL27A;RPS17;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;XAB2;DHX38;RPL41;RPLP0;RPL30;RPL7A;RBM15B;GLE1;MRPL13;RPL13;MRPS18A;TSPAN17;RPL12;MRPS7;RPS15;ALYREF;NUP62;POLR2J;EIF4EBP2;POLR2B;RPL14;MRPS14;RPL5;FARSB;RPS4X;RPL21;THAP1;DKC1;RPS7;POLR2I;TSPAN14;RPL23A;EEF1A2;RPL8;BCL3;MAGOHB;MAGOH;MED20;HSPD1;DROSHA;MRPL36;NUP205;MRPL23;SORL1;TASP1;RPS14;GALNT2;RPS3;CPSF2;RPS2;DDX20;RPS5;EEF1A1;RPL18A;RPS28;POLR3A;THOC1
prerank,DNA geometric change (GO:0032392),-0.4685596861754918,-1.3599376567434904,0.07969639468690702,0.39758204907467437,1.0,10/24,16.79%,HMGB1;NBN;ANXA1;DHX9;DHX36;WRN;MCM9;ASCC3;MRE11;ZRANB3
prerank,skeletal muscle organ development (GO:0060538),-0.4658937567257128,-1.3598012556068064,0.10934393638170974,0.39714048724213025,1.0,5/26,6.08%,LARGE1;SVIL;CFLAR;DISP1;IGSF8
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5493144862593318,-1.359628665335715,0.11070110701107011,0.39681283687130775,1.0,10/14,33.67%,OPA1;PRKN;LRRK2;SELENOS;SYVN1;PARK7;TMBIM6;HERPUD1;HSPA1A;CREB3L1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.3145765364699343,-1.3593195254569521,0.002036659877800407,0.396824682345987,1.0,76/259,20.60%,PARVA;VCL;GSN;PKD1;MYLK;PCM1;ASAP1;GBF1;BBS9;CDC14A;KIT;WDPCP;DCDC2;FLNA;NUDCD3;CYS1;ARL3;PIBF1;ITGB1;IFT43;ATP6V0D1;PDE6D;ARL13B;RAP1B;IFT81;CFAP44;MAP4K4;NRP1;CEP162;DYNC2I1;ABLIM3;PCNT;EHD2;ACTN2;RFX2;RAB3IP;IFT88;FAM161A;RPGR;RP2;EXOC2;IFT80;EMP1;ARFIP2;RAB11A;CC2D2A;POC1B;ARMC9;FGD1;SNX10;P2RY12;EMP3;RILPL2;FGD4;CDC14B;DZIP1L;RAPGEF2;EHD3;WHAMM;CARMIL1;CCDC57;ARHGEF6;FXYD5;CCDC66;TCTN1;WDR11;PTPDC1;CPLANE1;DYNC2I2;INPP5K;EHD4;RILPL1;AVIL;CEP89;GALNT11;SPEF1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.3440287492707174,-1.3592404393152206,0.02111324376199616,0.3962172466045287,1.0,21/122,9.33%,SAMD4A;PLD1;IGF1;EGFR;SORBS1;NFKB1;GLI2;PDGFRB;VIM;ZCCHC4;YTHDF3;IRS1;THBS1;DHX9;MTOR;SLC6A9;BRPF3;HNRNPD;AR;IGF2;PLXNB2
prerank,regulation of type I interferon production (GO:0032479),-0.365495490376194,-1.358997383405202,0.04693877551020408,0.39597695487524553,1.0,46/84,34.85%,NFKB1;EP300;TAX1BP1;TBK1;DTX4;CREBBP;DHX9;DHX36;PCBP2;PTPN22;RNF216;MAVS;TRIM25;IRF1;ILRUN;PRKDC;NLRP4;MRE11;TRAF3;IKBKE;UBA7;POLR2H;IRAK1;XRCC6;NLRX1;POLR2K;DDX41;POLR3D;NFKB2;POLR2E;POLR3H;GPATCH3;DHX58;TNFAIP3;POLR3E;CGAS;POLR1C;IFIH1;DHX33;UFD1;POLA1;IRF5;OTUD5;MYD88;ZBP1;IRF8
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4613166742412892,-1.3582094944385077,0.09073724007561437,0.3970663236763124,1.0,12/27,18.70%,PID1;GRB10;ENPP1;TNS2;IRS1;PIP4K2C;PTPN2;PRKCD;NCK1;PRKCZ;PTPN1;INPP5K
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.554242569237622,-1.3581477681316403,0.10469314079422383,0.3964179837782388,1.0,7/13,10.58%,BMP7;BMP4;NR3C2;NR3C1;AR;MED1;CALCOCO1
prerank,negative regulation of transposition (GO:0010529),-0.5166789817156365,-1.3580701508242121,0.1104868913857678,0.39584607377875314,1.0,4/16,16.94%,UBR2;MOV10;TUT4;MYBL1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5964642058321752,-1.357993170602989,0.12737642585551331,0.3952855979446125,1.0,3/10,8.85%,LYN;NBR1;MAP2K1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.35642995902801733,-1.3579658950924556,0.0390625,0.39458232397685966,1.0,29/92,17.71%,ROCK2;FOXP1;DOCK5;SASH1;ANGPT1;FGF1;BMP4;ABL1;SPARC;RREB1;CTSH;THBS1;BCAS3;MAP4K4;NRP1;FOXC2;MTOR;PLCG1;HIF1A;ADAM9;RAB11A;ANXA3;VEGFA;GLIPR2;ATOH8;DOCK1;PIK3CD;WNT5A;PRKD1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.3024755564460447,-1.3576383454321415,0.004149377593360996,0.39464651218254115,1.0,68/348,11.68%,BMP6;SLC24A3;ROCK2;IGF1;PID1;AFDN;SMAD3;TGFBR1;ANK2;RBMS3;FOXD1;ANGPT1;GSN;RBPJ;NTRK3;LIMS1;CELF1;FGF1;BMP7;ROCK1;BMP4;ROBO1;SMO;PRKN;TNRC6B;OSR1;WNT6;GSK3B;YAP1;TNRC6A;RESF1;CTSH;MOV10;UBR5;HOXA5;PLSCR1;ANXA2;STAT3;DTNBP1;MED26;EIF2AK3;MTOR;F3;BRAF;ECE1;AR;FUBP1;DHX36;PPARGC1A;GJA1;MAP2K1;MED1;PTPN22;ATF2;ITGB8;NGF;GABPA;TADA3;HIF1A;MPHOSPH8;HCFC1;CALCOCO1;RPL11;ATF7IP;ID2;TLE1;ADAM19;MEF2C
prerank,sensory perception (GO:0007600),0.41345151764347876,1.3566112970219444,0.084070796460177,0.4620959880241994,1.0,15/45,19.09%,PCDH15;MME;GNAL;CCL2;OPRM1;RETREG1;TTC8;P2RX7;PNOC;KCNA2;OPRK1;OPRL1;NTSR2;TMEM150C;ADORA2A
prerank,positive regulation of reproductive process (GO:2000243),0.4333782676502944,1.3565478115770249,0.11328976034858387,0.4606152132471773,1.0,6/31,9.30%,GLRA1;PGAM4;PLCB1;TACR1;CFAP69;TACR3
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3696662358364465,-1.356191313748243,0.05,0.3972042977946598,1.0,29/76,22.83%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;GSK3B;RNF217;AXIN1;RNF19A;NUB1;CSNK1E;FBXW7;TRIB2;SH3RF2;SMURF1;CBFA2T3;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;COP1;ZYG11B;ARIH2;CDK5RAP3;DET1;RNF144A
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.4351290001186772,-1.3558756684712319,0.07442748091603053,0.3971762730188997,1.0,15/34,26.06%,IGF1;PDGFRB;NSMCE2;ANAPC5;ANAPC7;IGF2;ANAPC4;CUL3;RB1;CDC27;PHIP;ANAPC11;CDC16;EDN3;EGF
prerank,cyclooxygenase pathway (GO:0019371),-0.6089814226675184,-1.3555572900482828,0.11174242424242424,0.39711638865953064,1.0,4/10,10.32%,PTGDS;PTGIS;PTGS1;PTGES
prerank,maintenance of blood-brain barrier (GO:0035633),0.4559755985229264,1.355353711659757,0.06326530612244897,0.4621429586485649,1.0,9/30,7.13%,CLDN5;ACTB;MBP;MFSD2A;JAM2;SLC1A1;OCLN;ESAM;PECAM1
prerank,activation of protein kinase activity (GO:0032147),-0.35115376142456767,-1.3548954627230263,0.030303030303030304,0.39794325974486006,1.0,40/106,19.83%,IGF1;ADCY9;ADCY5;ANGPT1;NTRK3;FGF1;STK3;GHR;ABL1;TGFBR2;OSBPL8;NRK;MAPKAP1;PIBF1;AXIN1;PAK2;MAP4K4;TAOK3;ADCY1;MTOR;ADCY6;PDPK1;PRRC1;TRAF2;PRKCD;RICTOR;CARD14;COPS8;TXN;VEGFA;ADRA2A;IL18;PRKACA;WNT5A;TRAF6;PARK7;ITGB3;IRAK1;TAOK1;ADCY7
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5405529721581068,-1.3546803197772694,0.11632653061224489,0.3976819719987273,1.0,6/14,26.18%,MOXD1;DAGLA;NOS1;SLC5A7;DAGLB;SLC22A2
prerank,calcium ion homeostasis (GO:0055074),0.35456051939688416,1.3545521225850703,0.04339250493096647,0.46246267248182626,1.0,14/95,8.10%,TMTC2;SLC24A4;SLC24A2;GRIN1;CXCL12;RYR2;HTR2C;SNCA;SLC8A1;ATP2B3;SLC30A1;NPTN;CIB2;TPT1
prerank,positive regulation of lipid localization (GO:1905954),-0.5736768675185782,-1.3541891269055737,0.1308411214953271,0.3979937968526134,1.0,2/11,1.19%,LRP1;NFKB1
prerank,renal system development (GO:0072001),-0.392359325918431,-1.353554418431646,0.05973025048169557,0.39870098435428475,1.0,20/52,17.02%,SULF1;TGFBR1;PKD1;WNT4;GLI2;FOXC1;BMP4;PCSK5;RBP4;ARL3;SULF2;PYGO1;IFT88;TBX18;AGTR1;STAT1;VEGFA;GREB1L;SALL1;SIX1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.5837228660265565,-1.3532575061847192,0.12686567164179105,0.3985777093249759,1.0,5/11,20.38%,PRKN;UBQLN1;REST;PARK7;P4HB
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.38912865805538027,-1.3528435837796542,0.060546875,0.3988160863589906,1.0,25/57,31.80%,DCN;MCU;PRKN;GSK3B;DNM1L;DDHD1;FAM162A;PPARGC1A;RALA;PARK7;FIS1;BMF;BNIP3;ZNF205;HIP1R;HTRA2;PDCD5;CHCHD10;MUL1;PLAUR;GPER1;BAK1;PPIF;BCL2L11;HTT
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5067347249129693,-1.3526268993164794,0.125,0.398575896552284,1.0,3/16,1.01%,ATP1A2;CACNA1C;ANK2
prerank,glycogen biosynthetic process (GO:0005978),0.5504802156319051,1.3524798859616525,0.1277533039647577,0.46441237622067094,1.0,4/12,16.80%,PGM2L1;GYS1;PER2;GBE1
prerank,glucan biosynthetic process (GO:0009250),0.5504802156319051,1.3524798859616525,0.1277533039647577,0.46441237622067094,1.0,4/12,16.80%,PGM2L1;GYS1;PER2;GBE1
prerank,dicarboxylic acid transport (GO:0006835),-0.4537029269208547,-1.3524037133550826,0.08737864077669903,0.39845130643244453,1.0,7/28,10.70%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6;GIPC1
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.4896518888059117,-1.3523051727287263,0.10344827586206896,0.39791641403544514,1.0,8/19,17.43%,TBK1;DHX9;DHX36;SETD2;MAVS;STAT1;DDX3X;TLR4
prerank,ceramide metabolic process (GO:0006672),0.40515518672423106,1.3519234661855206,0.05197505197505198,0.4642591515230672,1.0,8/49,5.78%,ST6GALNAC3;SGMS1;ACER2;FA2H;DEGS2;ORMDL1;ORMDL2;PPP2R1A
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.3265335963207619,-1.351414597344065,0.017142857142857144,0.3992901418190879,1.0,50/166,23.06%,SAMD4A;PLD1;IGF1;EGFR;SMAD3;SORBS1;GLI2;PDGFRB;VIM;ARNT;ZCCHC4;YTHDF3;IRS1;THBS1;DHX9;MTOR;ZEB2;SLC6A9;BRPF3;HNRNPD;PPARGC1A;IGF2;LDLR;PLXNB2;PTPN2;NR1H3;HIF1A;GIPC1;PKD2;APPL1;GLI1;SLC27A1;PRKDC;CTC1;DDX3X;P2RX4;UPF3A;TLR4;PARK7;PCNA;UPF3B;FGFR4;ASS1;STN1;AKT2;FGF2;ZNF205;PYM1;CHP1;PTH1R
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.4726891537557226,-1.3509558031867162,0.10986964618249534,0.39958756047923144,1.0,9/24,19.37%,GRB10;ARNT;VTN;NIBAN2;HIF1A;EMILIN1;ITGA5;PTPN1;ITGB3
prerank,respiratory tube development (GO:0030323),-0.44328641455538864,-1.350626552619487,0.10256410256410256,0.3996137880294058,1.0,10/28,15.98%,GLI2;FGF1;BMP4;PDPN;PCSK5;RBP4;FGFR2;CCDC39;VEGFA;LOXL3
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.46825702960909055,-1.3503362610256908,0.0914396887159533,0.39947282722363053,1.0,9/24,17.54%,TRIM44;TRAF3IP2;PTPN22;PARP9;MAVS;EIF2AK4;DTX3L;STAT1;ZDHHC1
prerank,intestinal lipid absorption (GO:0098856),-0.580335367043217,-1.349660041781164,0.11330935251798561,0.4002997081166256,1.0,3/11,11.74%,LIMA1;LDLR;UGCG
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.5048077010780598,-1.3494805534144143,0.10200364298724955,0.3999981857071353,1.0,9/18,14.18%,IL6ST;JAK1;YAP1;STAT3;CTR9;FER;SMAD4;IL6R;STAT1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.506480057498176,1.349387626923434,0.125,0.46904177564301297,1.0,4/17,10.77%,ANK3;AKAP6;KCNAB1;RNF207
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5366203343376746,-1.3484836922442356,0.13358778625954199,0.4017160570678916,1.0,10/14,37.29%,FUS;WDR48;PARP1;MMS19;ARID2;ACTR2;FANCB;TIMELESS;ERCC6;MRNIP
prerank,electron transport chain (GO:0022900),0.5117724071822796,1.3478012769886674,0.11060948081264109,0.47135290353729836,1.0,6/15,13.39%,CYB561;NDOR1;ENOX2;ETFB;ETFA;ETFDH
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5712209862627389,-1.3475997398839834,0.11368015414258188,0.4029808639783992,1.0,6/12,25.95%,IRS1;ABCD2;PPARGC1A;AKT2;TWIST1;PPARA
prerank,sulfur compound catabolic process (GO:0044273),-0.41179582877878734,-1.3466225438379251,0.07183364839319471,0.4045786944990134,1.0,14/38,24.80%,DCN;BGN;FMOD;GNS;OGN;PRELP;LUM;HEXA;GALNS;CHAC2;OMD;TXN2;CSPG4;GGT5
prerank,histone H3-K9 demethylation (GO:0033169),-0.5782040048054125,-1.3464834067302835,0.11317254174397032,0.4041965845361741,1.0,7/11,27.07%,KDM7A;KDM4B;PHF8;KDM3B;KDM3A;KDM1A;JMJD1C
prerank,positive regulation of response to wounding (GO:1903036),-0.4705097860475199,-1.3462743311123062,0.10780669144981413,0.4039940114745983,1.0,6/24,7.02%,PTN;MYLK;VTN;ITGB1;ARFGEF1;ANXA1
prerank,aerobic electron transport chain (GO:0019646),0.37423675009976715,1.346148962400876,0.044715447154471545,0.47419822189961325,1.0,30/68,21.30%,NDUFC1;SDHC;NDUFA4;COX4I1;NDUFA1;COX6A1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;COX6B1;NDUFB2;COX7C;NDUFAF1;UQCRH;NDUFB9;UQCC3;NDUFAB1;NDUFA7;COX10;NDUFA12;COX8A;NDUFB4;NDUFB8;NDUFA10;NDUFS3;UQCRC2;NDUFA6;COX5B;NDUFB7
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.4397562092256384,-1.3457824088379875,0.10555555555555556,0.40443972359368213,1.0,11/32,20.79%,AUTS2;PLCE1;RREB1;WASF2;CDC42;BRK1;NCKAP1;ARPC2;CARMIL1;AVIL;PIK3R1
prerank,granulocyte chemotaxis (GO:0071621),0.39460380168993364,1.3456619530145781,0.06326530612244897,0.4737033090882859,1.0,14/55,20.51%,BSG;PDE4B;S100A9;S100A8;TGFB2;CCL2;SCG2;EDN1;CCL25;PPIA;NCKAP1L;CKLF;CCL13;CCL19
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.40744590883606246,-1.3451573334283873,0.060263653483992465,0.4052212130103975,1.0,19/47,21.76%,MEDAG;BMP7;TMEM64;RREB1;CREBL2;ZBTB16;ID2;NAPEPLD;TRPM4;SOX13;WDFY2;CMKLR1;SIX1;HNRNPU;SYAP1;BMP2;METRNL;FRZB;CCDC71L
prerank,positive regulation of B cell activation (GO:0050871),0.398719128954253,1.3449362636336608,0.07465618860510806,0.47399603100354964,1.0,15/50,18.99%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;SHLD3;CD40;XBP1;NFATC2;SH3KBP1;CD38;BTK;NCKAP1L;NOD2
prerank,regulation of chromosome segregation (GO:0051983),-0.5165689667771568,-1.344796842644963,0.11962616822429907,0.405376541735191,1.0,6/16,15.45%,NUMA1;PUM2;SMC6;PUM1;SMC5;CSNK2A1
prerank,histone H2B ubiquitination (GO:0033523),-0.5869854469846553,-1.3447226897239624,0.13627992633517497,0.40479345190342403,1.0,7/10,22.39%,RNF8;CTR9;DTX3L;UBE2E1;RNF20;CDC73;WAC
prerank,regulation of autophagosome assembly (GO:2000785),-0.4371077818932411,-1.34468345137606,0.09177820267686425,0.40413187117116844,1.0,12/33,19.39%,LRRK2;NUPR1;RAB3GAP1;SEC22B;CHMP4B;CHMP4A;PIP4K2C;IFT88;MTMR3;NPRL3;FEZ2;LRSAM1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.5177745155612253,-1.3446182967118987,0.11775362318840579,0.40351185532421285,1.0,10/16,30.13%,AUTS2;BCOR;CTR9;SMAD4;PIH1D1;KMT2A;PAXIP1;KDM1A;WDR5;SNW1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.6019213493245834,-1.3442235113804537,0.10338345864661654,0.40379291622102786,1.0,5/10,16.75%,IMPACT;BAG3;JUN;NCK1;CITED2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.46417169057190655,-1.3440805330118728,0.11732851985559567,0.4034163205437747,1.0,7/25,10.06%,VPS4B;CHMP4B;CHMP4A;LEPROTL1;CHMP5;LEPROT;CHMP3
prerank,negative regulation of macroautophagy (GO:0016242),-0.4661850974954821,-1.3439284009799068,0.11214953271028037,0.40305190770810045,1.0,7/26,7.80%,SMG1;LRRK2;NUPR1;MTOR;SEC22B;CHMP4B;CHMP4A
prerank,cellular component maintenance (GO:0043954),0.5546279908876743,1.3436472090987377,0.13733905579399142,0.4760512484268674,1.0,1/12,0.11%,IGF1R
prerank,response to ATP (GO:0033198),0.49884571490569335,1.3433060117339168,0.12026726057906459,0.4753461183222865,1.0,5/18,11.50%,RYR3;KCNJ11;P2RY1;CIB2;P2RX7
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.44931779970114016,1.3432062528447135,0.09898989898989899,0.47398865716384203,1.0,6/30,4.46%,FLT1;CSF1R;ARMC6;FST;KDR;FLT3
prerank,regulation of DNA replication (GO:0006275),-0.39167982418146574,-1.3427620785764351,0.06224899598393574,0.4049733110450658,1.0,21/49,29.76%,EGFR;ANKRD17;GLI2;RBBP6;DHX9;BRPF3;PDS5A;GLI1;ESCO1;CTC1;S100A11;CDAN1;PCNA;PPP2CA;STN1;ATR;ATAD5;EGF;OBI1;WAPL;ZBTB38
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.34310924000173315,1.3427529395776125,0.04184100418410042,0.47356489331021234,1.0,20/110,11.17%,ADGRL4;ADGRL3;ADGRB3;ADCY8;ADCY3;RAMP2;ADGRB1;ADRB1;S1PR5;GPR101;LGR5;ADCYAP1;GPR26;GNG2;GNAL;ADRA1D;ADRA1A;ADGRL2;ADCY4;CNR1
prerank,relaxation of cardiac muscle (GO:0055119),-0.5410431770573929,-1.3427163325329747,0.13152804642166344,0.40433367064074804,1.0,4/13,7.68%,ATP1A2;GSN;CAMK2D;KCNJ2
prerank,regulation of coagulation (GO:0050818),0.5727039763202505,1.3424254816452428,0.1277533039647577,0.4727867784560115,1.0,3/11,11.24%,HS3ST5;F2R;PROC
prerank,neurotransmitter uptake (GO:0001504),-0.5538305195702469,-1.342420388251018,0.12686567164179105,0.4043546872894372,1.0,2/12,0.95%,ATP1A2;SLC1A3
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5302634360898055,-1.3423462674616884,0.11923076923076924,0.4037979272577231,1.0,4/15,12.21%,LARGE1;OGA;RENBP;MGAT3
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.4370357849108993,-1.342030188659767,0.09778597785977859,0.4038905747856065,1.0,16/30,25.26%,FOXP1;DDX5;DAB2;EP300;NCOR1;AR;SAFB2;PRMT2;HDAC1;HEYL;RNF14;PARK7;RNF6;TRIM68;KDM1A;ZBTB7A
prerank,negative regulation of lipid storage (GO:0010888),-0.4926735411986455,-1.3418506472498841,0.11198428290766209,0.40358701260754803,1.0,6/19,10.23%,ABCA1;ITGAV;OSBPL8;ABHD5;PTPN2;NR1H3
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.43550198040327104,-1.341812302655165,0.099609375,0.40293422774399756,1.0,14/32,19.91%,PHLDB2;ARHGAP6;JAG1;THBS1;BCAS3;HOXA7;MAP4K4;SEMA3E;APOD;RASA1;SERPINE1;FAM107A;MYOC;NF2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.48817957285640284,-1.341496871212603,0.09929078014184398,0.40293410546615926,1.0,6/21,5.26%,ROCK2;EPHA3;VCL;ROCK1;SLC9A1;SLK
prerank,endochondral bone morphogenesis (GO:0060350),-0.5663299906748193,-1.3410522859924812,0.12382739212007504,0.40330432735997696,1.0,5/11,11.68%,FOXC1;BMP4;INPPL1;COL13A1;MEF2C
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.4026125450350354,-1.3405726322492288,0.07436399217221135,0.40376671259522223,1.0,20/48,22.02%,DOCK5;LIMS1;ABL1;CUX1;FBXW8;RREB1;FLNA;NRP1;OBSL1;CDC42;S100A10;PRKDC;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CUL7;CRKL
prerank,activation of phospholipase C activity (GO:0007202),-0.44306324994169866,-1.340558508563017,0.10153256704980843,0.40308644156868245,1.0,5/29,9.48%,EGFR;LPAR1;ARHGAP6;EDNRA;PLCG1
prerank,regulation of nervous system process (GO:0031644),0.49468707787773586,1.3402516105045192,0.12108559498956159,0.4767814320537254,1.0,5/18,4.75%,DLGAP1;TMEM108;HTR2C;NOS3;DLGAP2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3854735566964985,-1.3396383862240901,0.058935361216730035,0.4045362433085908,1.0,26/56,25.25%,EGFR;ANKRD17;UBE2E2;RPTOR;VPS4B;RAD51B;NSMCE2;ANXA1;ANAPC5;ANAPC7;ANAPC4;RAB11A;CUL3;RB1;CCND3;DDX3X;CDC25B;CDC27;ADAMTS1;KLHL18;EIF4G1;ANAPC11;RAD51C;CDC16;KMT2E;PHB2
prerank,regulation of steroid metabolic process (GO:0019218),-0.46379225540082275,-1.3393669927593663,0.13214990138067062,0.4044297291214274,1.0,13/23,41.25%,PANK2;RORA;APOE;EPHX2;ARV1;ACADVL;NR1H4;ASAH1;STAR;ACADL;ABCG1;RORC;FMO5
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.3539819572927443,-1.3392330683079763,0.046875,0.4040134841914716,1.0,37/102,21.34%,RHOQ;SORBS1;NFKB1;ADCY9;ADCY5;KAT2B;ENPP1;IRS1;SLC39A14;INSIG2;SLC30A10;RAB10;ADCY1;RAB12;ADCY6;PDPK1;VAMP2;SELENOS;FER;PRKCD;DENND4C;PARP1;PCK2;PRKDC;CPEB1;NR4A1;PRKACA;NR4A2;LPIN2;SYAP1;LPIN3;INPP5K;ADCY7;PKM;PIK3R1;USF1;AKT2
prerank,myoblast fusion (GO:0007520),0.5476396719089353,1.3390960918884505,0.13894736842105262,0.47816397755973994,1.0,4/12,6.90%,ADGRB3;ADAM12;JAM2;KCNH1
prerank,cellular response to amino acid starvation (GO:0034198),-0.363182663132852,-1.33899596811584,0.06049149338374291,0.4038514120431274,1.0,20/71,17.78%,RNF152;ATP6V1B2;TFEB;RPTOR;ATP6V0D1;EIF2AK3;MTOR;MAP3K5;GCN1;SESN1;IMPACT;ATF2;WDR59;CASTOR2;EIF2AK4;EIF2AK2;DAP;TCIRG1;PRKD1;NPRL3
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.3765271917718532,-1.338770333762935,0.05788423153692615,0.40364576673076835,1.0,29/64,28.25%,MLLT3;GTF2H2;CCNT2;CCNH;CCNT1;CDK7;CTR9;CDK13;CCNK;SETD2;MNAT1;AFF4;RTF1;ERCC3;NELFB;POLR2H;CDC73;GTF2F1;POLR2K;GTF2H1;EAF2;CTDP1;POLR2E;NCBP2;GTF2H4;POLR2D;NELFA;CDK9;NELFE
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.5252613702097624,-1.3378853509714093,0.10687022900763359,0.40507342766549004,1.0,10/15,21.57%,FGF1;JAK1;PDPK1;BMPER;VEGFA;ITGA5;PKM;S100A1;SMAD1;FGF2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3308925893891083,-1.3373086724877563,0.03262955854126679,0.40566445602077966,1.0,43/140,18.98%,AKAP13;ARHGAP29;ARHGAP10;ARHGAP6;RHOQ;CGNL1;PLCE1;ARHGAP28;ITGAV;ARHGAP20;TIAM2;ARHGEF17;ARAP1;RHOJ;MYO9A;ARHGAP24;BCR;INPP5B;GMIP;ARHGAP21;PLEKHG2;CDC42;VAV2;ARHGAP17;TRIP10;RHOA;ARHGEF12;RHOT1;ARHGEF18;ARHGAP32;SOS2;FGD1;ARHGDIB;FGD4;NGEF;ARHGAP18;ARHGEF11;TRIO;ARHGEF6;ARHGEF1;ARHGAP15;RHOH;RHOC
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5829089093221166,-1.337299976697691,0.13271028037383178,0.4049736747097099,1.0,3/10,14.18%,TGFBR2;FGFR2;STAT1
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.38049875969613156,-1.3371732550725404,0.07100591715976332,0.4044982287252155,1.0,15/64,10.27%,ROCK2;PLEKHA2;EPHA3;VCL;ROCK1;JAG1;GSK3B;SLC9A1;SLK;THBS1;HOXA7;MAP4K4;JUP;SEMA3E;RHOA
prerank,bone morphogenesis (GO:0060349),-0.5349611898166119,-1.3363342125658109,0.14757281553398058,0.40578105504195844,1.0,4/14,6.61%,LRP6;CYP26B1;SKI;FGFR2
prerank,mammary gland epithelium development (GO:0061180),0.5187097565091634,1.3363252968106356,0.13846153846153847,0.48387909387959543,1.0,5/14,7.97%,ERBB4;CSF1R;IRF6;WNT7B;AKT1
prerank,homocysteine metabolic process (GO:0050667),-0.5554256899972629,-1.3362000550401332,0.12730627306273062,0.4053953048324974,1.0,3/11,7.13%,MMUT;NOX4;MTHFR
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5424004699373395,-1.3360261473132178,0.12897196261682242,0.40505658169548087,1.0,3/12,11.51%,FOXP1;LYN;FNIP1
prerank,tRNA methylation (GO:0030488),-0.42705690381749567,-1.3355919679372898,0.07330827067669173,0.40526627928236847,1.0,20/34,33.29%,NSUN6;METTL2A;METTL2B;METTL1;NSUN2;THUMPD3;TRMT1L;FTSJ1;DALRD3;LCMT2;WDR6;GTPBP3;TRMT1;MTO1;TRMT44;TRMT61B;TRMT10C;TYW3;ALKBH8;TRMT12
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.47205555816295464,1.3349790619422484,0.13829787234042554,0.4856949278985682,1.0,7/22,8.71%,TMEM108;SH3GL2;MAGI2;NTRK2;AKT1;RAB35;STMN2
prerank,endomembrane system organization (GO:0010256),-0.3200430522245009,-1.334951097112745,0.03067484662576687,0.40610638211320105,1.0,60/178,24.59%,GBF1;LRRK2;FBXW8;CSNK1A1;RAB30;A4GALT;ATL3;UBXN2B;HUWE1;DNM1L;ATP8B1;BCAS3;MYOF;GOLGB1;SEC23IP;ARFGEF1;RAB22A;EIF2AK3;ARHGAP21;OBSL1;CDC42;TLCD2;USP6NL;SEC31A;ATP8B2;ATL2;TBC1D20;DMPK;COG3;COG7;SNX10;SURF4;USP50;DOP1B;TJAP1;TMED3;MIA3;PRKD1;SEC16B;CSNK1D;SMPD4;TMED5;TMED4;TMCC1;PLEKHF1;TRIP11;SEC16A;STX17;CUL7;COG4;PLEKHM2;ALS2;TOR1A;PI4K2B;VAPA;WASHC4;LMAN1;SPTSSB;BAG5;ARFGEF2
prerank,nuclear export (GO:0051168),-0.36662341870034737,-1.3348417331420206,0.0499001996007984,0.405648376933908,1.0,27/80,23.70%,RANBP3L;PKD1;ATXN1;XPO4;CASC3;U2AF2;SRSF6;NUP42;PHAX;SLU7;EIF4E;NUP214;TPR;SRSF1;SMURF1;NXF1;RANBP3;SRSF7;SRSF11;SRRM1;UPF3B;DESI1;SRSF2;CHP1;WASHC4;XPO5;XPO1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.5534240158099734,-1.3345889803931252,0.12867647058823528,0.4055218972731873,1.0,5/11,12.51%,RESF1;MPHOSPH8;ATF7IP;TPR;SETDB1
prerank,lung development (GO:0030324),-0.4253344995792615,-1.334240349588585,0.09839357429718876,0.40565935120628793,1.0,12/33,15.98%,ERRFI1;PKD1;GLI2;FGF1;BMP4;PDPN;RBP4;FGFR2;RCN3;CCDC39;VEGFA;LOXL3
prerank,microtubule anchoring at centrosome (GO:0034454),-0.582041554561533,-1.3339375123202757,0.12075471698113208,0.40570591033560455,1.0,3/10,4.74%,PCM1;NIN;NINL
prerank,regulation of stem cell proliferation (GO:0072091),-0.49945143106732315,-1.332797792468674,0.10877862595419847,0.4076868564411524,1.0,8/17,25.24%,FBLN1;YAP1;GJA1;EIF2AK2;HNRNPU;TERT;SOX11;KDM1A
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.44080766126018006,-1.332387967840925,0.09424083769633508,0.40793456756981034,1.0,18/30,29.73%,GTF2H2;CCNH;CDK7;CAVIN1;TAF1D;TBP;MNAT1;ERCC3;TTF1;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;TAF1A;POLR1C
prerank,regulation of secretion (GO:0051046),0.5441846196370148,1.332331863124359,0.11471861471861472,0.4911247805079688,1.0,6/13,16.58%,NRG1;FGF10;MYO6;OPRK1;ACSL3;GPLD1
prerank,histone methylation (GO:0016571),-0.4517237986287691,-1.3321887291268624,0.11923076923076924,0.4076907623497176,1.0,11/26,21.59%,CREBBP;NSD3;NSD1;SMYD3;PRMT2;N6AMT1;EHMT1;PRMT5;PRMT8;NTMT1;EZH2
prerank,protein deacetylation (GO:0006476),-0.40421841761132493,-1.331955426472721,0.09125475285171103,0.40752126603681627,1.0,9/41,5.05%,PRDM5;MIDEAS;HDAC4;TBL1X;TBL1XR1;FLNA;RCOR1;BAZ2A;RCOR3
prerank,cellular response to starvation (GO:0009267),-0.3263861064594508,-1.3318536376006163,0.02574257425742574,0.40705284338985315,1.0,51/147,23.65%,PRKAG2;RNF152;FOXO3;ATP6V1B2;LRRK2;TFEB;PRKAA2;RPTOR;ATP6V0D1;EIF2AK3;ZFYVE1;MTOR;MAP3K5;WRN;LAMP2;GCN1;SESN1;IMPACT;ATF2;BRSK1;USP33;WIPI1;FNIP1;WDR59;SIK1;CASTOR2;EIF2AK4;MTMR3;BECN1;EIF2AK2;PIK3C3;PIK3R4;DAP;WDR45B;TCIRG1;PRKD1;NPRL3;PRKAA1;ATG5;RRP8;WIPI2;PRKAG3;LARS1;TBL2;ATG14;SIK2;ATP6V1G2;SZT2;MAP1LC3A;DAPL1;NUAK1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.30896547526678453,-1.3317742264254366,0.010570824524312896,0.4065433059254852,1.0,94/241,28.06%,SRRM2;DDX5;HNRNPH1;PABPN1;HNRNPR;SYNCRIP;PCF11;WDR33;CASC3;IK;SRSF10;RBM6;DDX46;FUS;HNRNPM;U2AF2;DHX9;SF3B1;CPSF3;SRSF6;HNRNPUL1;HNRNPD;RBM10;PRPF6;PCBP2;RNPC3;DDX42;CDC5L;PRCC;SLU7;GEMIN5;HNRNPK;PRPF3;SF3A1;SF3B6;YTHDC1;USP39;SF3A3;RSRC1;ZCRB1;SNRNP70;CCAR1;DNAJC8;DDX23;YBX1;CWC22;RBM5;SRSF1;CWF19L1;EFTUD2;GEMIN7;SNU13;MTREX;SFPQ;PPIH;UBL5;PRPF40B;PPWD1;WBP11;CSTF3;HNRNPU;ZMAT5;POLR2H;SNRPF;HNRNPA3;RBM4;SRSF7;SRSF11;SRRM1;UPF3B;SRSF2;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;DDX41;SMU1;DHX15;NONO;PRPF38A;POLR2E;CPSF1;NCBP2;PRPF8;CRNKL1;LSM6;RBM22;RBM19;CACTIN;SUGP1;POLR2D;HNRNPL;ISY1
prerank,regulation of telomere capping (GO:1904353),-0.4664599607655499,-1.3316134860998114,0.10845588235294118,0.4062852575787907,1.0,8/23,19.61%,SMG6;TNKS2;USP7;NBN;HNRNPD;NABP2;MAP2K7;TERF2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.39742814784450353,1.3316046408018225,0.07014028056112225,0.4914645166563568,1.0,7/48,12.68%,SLC7A5;PDE4B;ISG15;IL12A;CYRIB;PDE4D;HSPD1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3593480687393836,-1.3312759059630535,0.06538461538461539,0.40642539057126165,1.0,31/80,25.13%,PLPP3;GBF1;UVRAG;STX18;SEC22B;KDELR1;COPB1;COPZ2;ARCN1;ARFGAP1;ARFGAP3;COG3;COG7;KDELR3;RINT1;COPB2;KIF1C;SURF4;COPG2;TMED3;NAPA;COPG1;RER1;KIFAP3;COPE;COG4;ERGIC1;NSF;KIF3A;ATP9A;KIF23
prerank,response to reactive oxygen species (GO:0000302),-0.39144708355028857,-1.3306352027837838,0.05263157894736842,0.4071235662368042,1.0,17/54,18.24%,EGFR;PDGFRA;TPM1;COA8;PTPRK;FER;JUN;HIF1A;ADAM9;PKD2;APOD;APTX;ERCC6L2;APOE;TXNRD2;GLRX2;SOD2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4892921975692624,1.3304151542895293,0.13636363636363635,0.49300618359996945,1.0,5/18,3.46%,RIMS1;NLGN1;RIMS2;PREPL;RIMS3
prerank,negative regulation of developmental process (GO:0051093),0.3667412404286151,1.3297129959626626,0.050100200400801605,0.4932772992476894,1.0,17/69,13.72%,TFRC;ARHGEF15;DCC;OMA1;MIF;HEY1;SPRY3;GAS6;THY1;NOS3;NOTCH1;FOXJ1;GRIN3A;WDR77;HOPX;VAT1;DLL1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.4978698762713609,-1.3296967943779197,0.12546125461254612,0.4087910855933108,1.0,9/18,20.74%,HDAC4;FRS2;CCN3;BHLHE41;FZD7;SOX6;HDAC1;BMP2;TMEM119
prerank,protein sumoylation (GO:0016925),-0.3898565253200072,-1.3295863959079701,0.08531746031746032,0.40837568915295147,1.0,13/49,15.42%,EYA1;PIAS1;SAE1;RANBP2;NSMCE2;NUP42;PIAS3;UBE2I;NUP214;TPR;PIAS4;TRPM4;TOPORS
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3271307634497557,-1.3293906484447298,0.029411764705882353,0.40815900564882307,1.0,48/151,19.26%,BMP6;EGFR;SMAD3;TGFBR1;SOX5;APPL2;BMPR1A;ADAMTS12;WNT4;NTRK3;LIMS1;WWOX;FOXC1;BMP7;BMP4;TGFBR2;CLEC3B;NR3C1;GAREM1;NRP1;SHC1;GAS1;ANXA1;PDPK1;MED1;PLCG1;PTPN12;SMAD4;MEF2C;PDE3A;APPL1;CPNE3;SOX6;VEGFA;ACVR1;ERN1;ACAP2;RAPGEF2;EMD;RUNX2;NR4A1;WNT5A;PRKD1;STAT5B;SYAP1;INPP5K;BMP2;PTPN11
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.33771227387180486,1.3287524034312457,0.047524752475247525,0.4942946009649365,1.0,26/124,10.81%,CNTNAP2;GPRIN1;FRY;PLP1;CSF1R;TMEM108;NLGN1;GPM6A;SH3GL2;GPM6B;MAP2;STMN1;STX3;PPP1R9A;GPRIN3;ADCYAP1;STMN4;RASGRF1;BICDL1;CAMSAP1;RAB35;STMN2;IQCG;PTPRM;MICALL2;CNTN4
prerank,response to metal ion (GO:0010038),0.3735529177331941,1.3286302618245458,0.0547945205479452,0.49297774792711513,1.0,18/67,14.52%,MT2A;AQP9;KHK;SNCA;MT1X;MT1A;ATP5F1D;HOMER1;MTF1;SLC30A3;CALM1;SLC30A5;TRPC1;SNCB;CALM2;NDRG1;CALM3;PPP3CA
prerank,water transport (GO:0006833),0.5577510163175791,1.328543047483428,0.14583333333333334,0.49159703527375226,1.0,4/12,15.98%,AQP9;AQP11;AQP4;CFTR
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3941768589000387,1.3282569648516998,0.08456659619450317,0.4907337321681607,1.0,9/47,13.00%,SPOCK2;SPOCK1;SPOCK3;BIN1;TIMP1;AKT1;SERPINB8;TIMP4;SORL1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.3469934528082904,-1.3280241722109192,0.0390625,0.41057611069132455,1.0,29/101,19.93%,NFKB1;VIM;AXL;PABPN1;LBP;HMGB1;SBNO2;LYN;CTR9;PTPN22;CHMP5;SELENOS;UPF1;NR1H3;RHOA;ADAM9;MEF2C;TNIP2;IL18;PDCD4;SERPINE1;TLR4;WNT5A;CX3CR1;TRAF6;IRAK1;SHPK;CDC73;CARD16
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.33140847760678294,1.3272646023879553,0.03711340206185567,0.49168947531536905,1.0,19/138,5.87%,FLT1;PTPRG;IGF1R;TEK;MPZL1;PTPRD;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;PTPRT;AHI1;KDR;NTRK2;FLT3;SRMS;ALK
prerank,nucleotide metabolic process (GO:0009117),-0.4678711308120767,-1.3269843351924846,0.12830188679245283,0.4122667202760156,1.0,8/23,14.94%,FHIT;NMNAT2;NUDT5;ENPP3;ME1;CTPS2;NMNAT3;NMNAT1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.5362250472510139,1.3269427773100864,0.15419501133786848,0.49099556617278317,1.0,4/13,9.08%,ADCY8;SHANK3;SHISA7;RELN
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.5044403951448199,-1.3266626673097843,0.10916179337231968,0.41227095265058267,1.0,7/18,18.77%,SMAD3;PDPN;RUNX1;RB1;EFEMP2;EMILIN1;BMP2
prerank,negative regulation of hippo signaling (GO:0035331),-0.5575018550203527,-1.3253337777713758,0.11132075471698114,0.4147349868820389,1.0,9/12,25.76%,WWC2;VGLL4;WTIP;MARK3;LIMD1;WWC1;AJUBA;DLG5;MAPK14
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.4093847169065884,-1.325315567456,0.09320388349514563,0.4140862079258469,1.0,16/43,19.26%,PID1;SORBS1;GRB10;ENPP1;TNS2;IRS1;PIP4K2C;IGF2;PTPN2;PRKCD;OGT;NCK1;PRKCZ;PTPN1;INPP5K;PTPN11
prerank,selective autophagy (GO:0061912),-0.38686549774828477,-1.32465642992501,0.07824427480916031,0.4148348121932059,1.0,22/56,18.94%,UBE2N;VIM;PRKN;ARL13B;UBQLN1;UFL1;PCNT;UBA5;NBR1;TEX264;RB1CC1;IFT88;ULK2;DYNC1LI1;BECN1;ATG2A;DYNC1H1;AUP1;ATG2B;AMBRA1;ATG5;PARK7
prerank,embryonic organ development (GO:0048568),-0.37362843106675014,-1.3244174158470279,0.06578947368421052,0.4147053897630366,1.0,18/61,12.15%,PBX1;GLI3;TEAD1;BMPR1A;RBPJ;GLI2;RARB;TGFBR2;PCSK5;KIT;RBP4;PBX3;FGFR2;COL13A1;TEAD3;NES;ERCC3;TEAD2
prerank,camera-type eye morphogenesis (GO:0048593),-0.590247756211397,-1.3238688167083528,0.122568093385214,0.415275653118681,1.0,5/10,17.05%,LRP6;SHROOM2;SKI;VEGFA;TBX2
prerank,oligosaccharide metabolic process (GO:0009311),0.39685493672930605,1.323020617067767,0.0841683366733467,0.5000633574937658,1.0,11/46,12.68%,ST6GALNAC3;ST8SIA4;ST3GAL6;NEU2;ST8SIA1;FUT9;B3GALT5;GLA;ST8SIA6;ST8SIA3;ST6GAL2
prerank,protein-containing complex assembly (GO:0065003),-0.3047612580181694,-1.322781497434632,0.010245901639344262,0.41711129171546113,1.0,93/259,24.50%,FBXL7;AFDN;TCF7L2;TEAD1;SEC24D;OPA1;MCU;MDM4;SH3PXD2B;EP300;LRRK2;CSNK1A1;TRAPPC9;DLG4;GSK3B;YAP1;SLC9A1;KMT2D;CTSC;BCL9L;DNM1L;SNX9;AXIN1;TFG;SEC23IP;DNAJB14;PYGO1;CREBBP;SEC23A;TRRAP;DHX9;SEC22B;TUBGCP2;PPARGC1A;VAMP2;SEC31A;GEMIN5;TBC1D20;MNAT1;WASL;TRAF2;TLE4;TLE1;CAPZA1;WIPF1;HES1;TEAD2;TRAPPC6B;CUL3;TCF7L1;GSDMD;FN1;CDC123;STX5;PARD3;HDAC1;RANBP9;WASF1;REPS2;FARP2;STOML2;GOSR2;PPIH;PICALM;SEC16B;NAPA;CSNK1D;GPAA1;TUBGCP4;CDC73;TERT;PML;SEC16A;TLE3;CUL1;FANCC;KIFAP3;CLDN1;KMT2A;PPID;DET1;CAND2;LAMC1;F5;NSF;TRAPPC2;LMAN1;HSF1;USO1;PREB;TFAP4;SAR1B;MCFD2
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.36453753703440855,-1.3220506466749662,0.04426559356136821,0.4180835271820411,1.0,18/72,16.32%,AKAP13;COL3A1;LPAR1;KANK2;ABCA1;ROBO1;ABL1;RIPOR2;BCR;NRP1;TNFAIP1;ABL2;ARHGEF18;CUL3;ARHGDIB;APOE;GPR4;ARRB1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.3442911128533263,-1.321860393097845,0.05357142857142857,0.417811211242344,1.0,30/101,23.38%,SAMD4A;PLD1;VIM;CYFIP2;BTRC;ZCCHC4;YTHDF3;VGLL4;THBS1;MTOR;HNRNPD;ASPH;DACT1;PLXNB2;NR1H3;AGTR1;OGT;PRKDC;DDX3X;UPF3A;FBXW11;EIF4G1;INHBA;UPF3B;FGFR4;TBC1D10A;MSN;PYM1;PERP;HDAC2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.5588525040018903,-1.321567479252617,0.14548802946593,0.41776870704590385,1.0,6/11,16.82%,KHDRBS1;DHX9;AKAP8L;SETD2;TPR;NSUN2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5038272087279208,-1.3213645492946233,0.14624505928853754,0.41753524359970495,1.0,5/16,19.78%,NFAT5;ST3GAL4;RHOA;TRAF6;IRAK1
prerank,transcription by RNA polymerase I (GO:0006360),-0.4232385633992326,-1.3212772117357872,0.0944741532976827,0.41704095966016597,1.0,19/34,29.73%,GTF2H2;CCNH;CDK7;CAVIN1;TAF1D;TBP;MNAT1;ERCC3;TTF1;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;TAF1A;RRN3;POLR1C
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5547172636301576,-1.3210803868815504,0.14606741573033707,0.4168840815309029,1.0,7/12,21.69%,INSIG2;OS9;KDELR1;KDELR3;GPAA1;RER1;TAPT1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.4409575544923832,-1.3203996595401395,0.11090573012939002,0.4178784623450531,1.0,11/29,17.09%,KANK2;YAP1;KMT2D;STRN3;AXIN1;UFL1;RUNX1;UBA5;CNOT2;LATS1;CNOT1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5504602150017393,-1.3202017242542416,0.1323529411764706,0.4176385234555065,1.0,6/12,21.90%,LRP6;CYP26B1;SKI;PTCH1;MEGF8;FBXW4
prerank,motor neuron axon guidance (GO:0008045),0.502490399728064,1.3200235225167136,0.12875536480686695,0.5063215225203863,1.0,5/15,10.68%,TMEFF1;SLIT1;LHX1;NTN1;CHN1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.5189804938599657,-1.3199017085909264,0.1350844277673546,0.41768269432676136,1.0,8/15,25.70%,STXBP4;CUL3;GLI1;KLHL18;CDC73;EZH2;PHB2;ATAD5
prerank,smooth muscle cell differentiation (GO:0051145),0.5605470286026184,1.3194896681958619,0.14465408805031446,0.5060773139505714,1.0,5/12,7.29%,MRTFA;HEY1;TMEM204;MRTFB;APLNR
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.40518525030315133,-1.3191374577416464,0.09477756286266925,0.41868844247741166,1.0,8/41,6.61%,TGFBR3;BMPR1A;TPM1;RBPJ;BMP4;JAG1;TGFBR2;FGFR2
prerank,protein heterooligomerization (GO:0051291),0.49509985820150837,1.3182593732280767,0.12978723404255318,0.5079480627801524,1.0,5/17,13.62%,GRIN1;KCNC2;GRIN2B;FARSB;MAT2A
prerank,DNA methylation or demethylation (GO:0044728),-0.4788725160831083,-1.3172831230633082,0.12840466926070038,0.4218236737688403,1.0,5/19,12.83%,PPM1D;BAZ2A;DNMT3A;ATF7IP;EHMT1
prerank,DNA alkylation (GO:0006305),-0.4788725160831083,-1.3172831230633082,0.12840466926070038,0.4218236737688403,1.0,5/19,12.83%,PPM1D;BAZ2A;DNMT3A;ATF7IP;EHMT1
prerank,regulation of interleukin-2 production (GO:0032663),0.4013703889857071,1.3172745504612506,0.09690721649484536,0.5090499813291305,1.0,8/43,13.23%,NAV3;PDE4B;IL17F;CD34;HOMER2;SPTBN1;PDE4D;RPS3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5275756146875291,1.3168374331751818,0.13871635610766045,0.5085755916365462,1.0,6/13,16.47%,ELOVL7;ELOVL4;TECR;HACD3;HACD1;TECRL
prerank,macroautophagy (GO:0016236),-0.3363542006321871,-1.3168019478003425,0.0390625,0.422231514253421,1.0,39/118,22.01%,PRKAG2;PRKN;PRKAA2;UVRAG;VPS4B;UBQLN1;VTI1B;VAMP7;ZFYVE1;CHMP4B;CHMP4A;LIX1L;NBR1;LAMP2;VDAC1;RB1CC1;CHMP3;VPS39;VPS37C;WIPI1;PRKAB2;MTMR3;BECN1;ILRUN;PIK3C3;CSNK2A1;PIK3R4;TCIRG1;AMBRA1;PRKAA1;ATG5;VCP;SNF8;TOMM7;WIPI2;STX17;PRKAG3;PRKAB1;ATG14
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5807640513606718,-1.3167068096306578,0.1487603305785124,0.4217833411199122,1.0,9/10,39.67%,MLLT3;UFL1;HOXB4;LMBR1L;BATF;SP7;TP53;SFRP1;ACE
prerank,cellular response to oxidative stress (GO:0034599),-0.3341482740878732,-1.316057927164615,0.04678362573099415,0.4226543037810256,1.0,51/118,30.10%,EGFR;PDGFRA;TPM1;FOXO3;ABL1;ARNT;LRRK2;PRKAA2;PLA2R1;NOX4;PPARGC1A;PTPRK;SELENOS;FER;JUN;PRKCD;HIF1A;STX4;PARP1;SOD3;MGAT3;PKD2;ADNP2;ERCC6L2;TXNRD2;GPX8;CYBA;DAPK1;PRKD1;PRKAA1;SOD2;PARK7;NCF2;PRDX2;FANCC;WNT16;ZFAND1;GPX7;NUDT2;CCS;GSR;MAPK9;SLC25A24;HTRA2;LONP1;BRF2;MT3;NFE2L2;TXNRD1;CYCS;SRXN1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5589866543810675,1.315854825408604,0.14052953156822812,0.5095933146173615,1.0,4/11,22.08%,KLRC1;SMAD7;HFE;CEACAM1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5015446318198744,1.3157467608563265,0.13478260869565217,0.5082780550061269,1.0,3/14,6.82%,TIRAP;HNRNPC;HNRNPA0
prerank,regulation of ion transmembrane transport (GO:0034765),0.42500858887385906,1.3156756947169705,0.10993657505285412,0.506834083774045,1.0,8/33,12.77%,KCNJ3;CHRM3;KCNJ6;AKAP6;KCNJ11;KCNJ10;P2RX7;KCNJ8
prerank,endothelial cell migration (GO:0043542),-0.4175216158524999,-1.3148240383979368,0.10139165009940358,0.4250562799045906,1.0,14/37,17.06%,FSTL1;ABL1;DPP4;ADGRA2;NRP1;CYP1B1;CCN3;RHOA;GIPC1;FAP;STAT1;VEGFA;PLXND1;NR4A1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.32436038805988665,-1.3144237671507668,0.043137254901960784,0.4252151675947348,1.0,48/136,25.25%,TCF7L2;PKD1;BMP7;PTGIS;HDAC4;TAX1BP1;BTRC;WWP2;NUPR1;FLNA;IRAK3;TAF3;ANXA4;USP7;UFL1;IRAK2;PARP10;CEBPG;SP100;CYP1B1;PRMT2;GLIS2;ID2;HES1;PKD2;SUFU;SIK1;RB1;EIF2AK4;PTCH1;CMKLR1;ARRB1;DAP;TRAF3;HEYL;LRRC14;SFRP4;MDFI;IRAK1;CDK5RAP3;WFS1;CHP1;COMMD7;HDAC2;NLRC3;PAXIP1;KDM1A;PHB2
prerank,potassium ion import across plasma membrane (GO:1990573),0.39895936844665014,1.314384261004698,0.09607843137254903,0.5087217872527187,1.0,13/41,13.24%,KCNJ3;KCNJ6;SLC12A6;KCNJ11;HCN2;KCNJ10;ATP1A3;KCNK9;SLC12A3;ATP1A4;ATP1A1;KCNJ8;ATP1B1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.43545630274391317,1.3143492513609025,0.12474012474012475,0.507231017804352,1.0,11/28,17.02%,MAP1B;MAP2;STMN1;MAPRE3;STMN4;CAMSAP1;STMN2;STMN3;FKBP4;CAMSAP3;CLASP2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5280925462537297,1.3142947411463424,0.1590909090909091,0.5057816461956854,1.0,6/13,18.99%,KDR;TLR2;CCL2;NAMPT;EDN1;NOD2
prerank,platelet degranulation (GO:0002576),-0.3304602779646831,-1.3137582754955492,0.05060728744939271,0.4260898437641512,1.0,36/118,19.37%,IGF1;TIMP3;VCL;PHACTR2;SERPING1;SPARC;PROS1;TLN1;FLNA;NHLRC2;CLEC3B;ANXA5;THBS1;CD9;VTI1B;STXBP1;LYN;ISLR;BRPF3;LAMP2;IGF2;ACTN2;TEX264;GTPBP2;CD109;FN1;VEGFA;VEGFD;TGFB3;ECM1;SERPINE1;SYTL4;TMX3;CHID1;LGALS3BP;ITGB3
prerank,sodium-independent organic anion transport (GO:0043252),0.568823830662461,1.3131957375248586,0.15217391304347827,0.5071457567921951,1.0,4/10,9.69%,SLCO1C1;SLCO4C1;SLCO5A1;SLCO2B1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3514731468571707,-1.313117726672557,0.05736137667304015,0.4269328618442042,1.0,13/79,6.97%,SULF1;CRIM1;BMPR1A;ADAMTS12;SMAD6;SMURF2;NBL1;HTRA3;NIBAN2;SULF2;THBS1;SKI;SKIL
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.5792437456936697,-1.313099424368146,0.14727272727272728,0.42627991745424554,1.0,4/10,12.87%,USP7;SELENOS;ZNF692;OGT
prerank,regulation of mast cell degranulation (GO:0043304),-0.5242326674254523,-1.312784454406274,0.1525096525096525,0.4262710181295585,1.0,11/14,42.26%,GAB2;LYN;FER;CD84;CD300A;SYK;SPHK2;FES;FGR;STXBP2;UNC13D
prerank,regulation of lamellipodium organization (GO:1902743),-0.5238514201133222,-1.3127325627894793,0.13018867924528302,0.4257111516584382,1.0,7/14,26.26%,PDPN;CDC42;FER;CAPZB;CARMIL1;TWF1;TWF2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.46905653356089594,-1.3123880301193556,0.12475633528265107,0.4258177991554038,1.0,8/22,26.85%,ROCK2;ROCK1;GSK3B;BOD1L1;PTPA;CRY2;MASTL;BOD1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3643480722022638,1.3122389686823326,0.07128712871287128,0.507971675044248,1.0,19/72,11.23%,NAV3;KANK3;SHANK3;MAP2;STMN1;FGF13;SNCA;PFDN5;HSPA8;CLU;PFDN6;TUBB4A;CAMSAP1;STMN2;CYRIB;ARHGEF2;MID1IP1;CORO1A;APC
prerank,primary miRNA processing (GO:0031053),-0.5726853067491022,-1.3122331238011937,0.14076782449725778,0.42549883158157015,1.0,3/10,6.96%,SMAD3;SMAD2;PUS10
prerank,negative regulation of RNA splicing (GO:0033119),-0.47023680980094373,-1.312057702508132,0.1343570057581574,0.42521515527103915,1.0,5/19,7.39%,SFSWAP;SRSF10;U2AF2;PTBP3;SRSF6
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.48069096146482915,1.3118620278278785,0.13389121338912133,0.507264471123368,1.0,3/17,7.54%,SLA2;THY1;PTPRJ
prerank,cellular biogenic amine metabolic process (GO:0006576),0.554095995792821,1.311722427783691,0.14942528735632185,0.506074179201651,1.0,3/12,4.60%,SMS;DDC;TRH
prerank,negative regulation of growth (GO:0045926),0.33456500985478693,1.3116157833697333,0.05165289256198347,0.5047988809692322,1.0,37/121,17.97%,MT2A;MINAR1;SIRT1;GNG4;APBB1;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;SCGB3A1;NOTCH1;PPP2R1A;TGFB2;SLIT3;WFDC1;PTPRJ;ACVRL1;ING4;TMPRSS4;APBB2;SOX17;NDUFA13;BMPR2;SMARCA2;CDKN1A;PPT1;RTN4;NPR1;CDKN1B;DNAJB2;PNPT1;CDKN2AIP;RERG
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.40844249126224186,-1.3115015260959644,0.11090225563909774,0.4259303953240639,1.0,20/38,32.52%,PRKN;LRRK2;SAE1;HUWE1;ABLIM3;LEPROT;NPEPPS;FBXW7;UBL5;ATP5IF1;UBE2D3;TOMM7;ARIH2;PARL;LMAN1;HTRA2;USP36;UBE2L3;RNF31;SREBF1
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.40321591819490565,-1.3111936015010397,0.09161793372319688,0.4258765868547461,1.0,6/39,7.79%,TCF7L2;MCU;NLGN2;RBP4;GLUD1;NNAT
prerank,cellular iron ion homeostasis (GO:0006879),0.376497271533342,1.3109292036795144,0.09473684210526316,0.5051543575185418,1.0,12/55,10.62%,TFRC;ALAS2;TMPRSS6;SLC40A1;ABCG2;FTH1;SLC22A17;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3776708667469511,1.3107915884473067,0.08879492600422834,0.5039983430022495,1.0,12/53,20.07%,MTNR1B;CHRM3;HTR2C;MTNR1A;CCL2;OPRM1;CNR1;CHRM2;CALCRL;HTR1B;HTR4;AGT
prerank,activation of protein kinase B activity (GO:0032148),-0.43111044870116394,-1.3107377174877104,0.09523809523809523,0.42629668193823284,1.0,13/29,18.94%,IGF1;NTRK3;FGF1;OSBPL8;MAPKAP1;MTOR;PDPK1;RICTOR;TXN;ADRA2A;IL18;WNT5A;PARK7
prerank,regulation of Notch signaling pathway (GO:0008593),-0.35850078543909286,-1.3101472671415901,0.052845528455284556,0.42691220327636664,1.0,23/76,16.43%,EGFR;ZMIZ1;RBPJ;KAT2B;IL6ST;EP300;JAG1;WWP2;TSPAN5;NIBAN2;YAP1;CREBBP;STAT3;POFUT1;CCN3;MMP14;NOTCH3;MAML2;FBXW7;MAML1;BMP2K;ARRB1;TSPAN15
prerank,carnitine metabolic process (GO:0009437),-0.5495891456871799,-1.3100037816699808,0.16176470588235295,0.4265643114987047,1.0,6/12,18.84%,ACADM;CPT1C;TMLHE;CPT2;BBOX1;CPT1A
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5590733202841313,1.309222151660163,0.14705882352941177,0.5065160676496561,1.0,5/10,12.59%,PDE2A;PDE11A;APLNR;RNF157;PDE4D
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.5748218469149688,1.3092203091005779,0.15212981744421908,0.5049813055875025,1.0,3/10,14.31%,GPR35;CALM1;CALM3
prerank,stem cell development (GO:0048864),0.4954779422615212,1.3085974378450569,0.15126050420168066,0.5050830533814356,1.0,3/16,6.01%,NRG1;CDH2;CYP26C1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.45914992427715007,1.308535761703787,0.10897435897435898,0.5036907232432186,1.0,3/23,3.78%,CD33;GIT1;GAS6
prerank,negative regulation of viral transcription (GO:0032897),0.5242298119975497,1.3082784192006656,0.1390728476821192,0.5027991379923313,1.0,4/13,10.91%,TRIM13;TRIM62;IFITM3;MID2
prerank,positive regulation of interleukin-4 production (GO:0032753),0.4938946974144688,1.3079946053084237,0.1492842535787321,0.5020646769004168,1.0,2/17,6.50%,SLC7A5;PRKCQ
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5312971887281774,-1.3073286325869444,0.15482695810564662,0.43229966076986953,1.0,4/13,12.21%,LARGE1;OGA;RENBP;MGAT3
prerank,regulation of translation (GO:0006417),-0.311658268428386,-1.3065328524448856,0.02240325865580448,0.4335392205465283,1.0,46/173,20.56%,SAMD4A;PLD1;IGFBP5;EIF4G3;VIM;FOXO3;ZCCHC4;YTHDF3;SYNCRIP;EIF4A2;DDX6;EIF4ENIF1;THBS1;EIF2AK3;DHX9;MTOR;LARP1;HNRNPD;DHX36;IMPACT;GEMIN5;PLXNB2;EIF4E;UPF1;CSDE1;LSM14A;NSUN3;CNOT8;ALKBH1;EIF2AK4;YBX1;EIF2AK2;PRKDC;DDX3X;DAPK1;CNOT1;UPF3A;SHFL;PAIP1;MIF4GD;EIF4G1;CNOT10;MTG2;RBM4;EIF2B4;UPF3B
prerank,phospholipid catabolic process (GO:0009395),0.4521036769028991,1.30649237918534,0.12184873949579832,0.5045807911041899,1.0,8/24,19.73%,GPCPD1;ENPP2;SMPDL3A;SMPD1;PNPLA6;PLA2G4E;PLBD2;PRDX6
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.42712414683648925,1.306355765927141,0.10278372591006424,0.5034210937166642,1.0,5/29,10.48%,CXCL12;GAS6;JAM2;IL12A;AIF1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.38174816135564893,-1.3054732163337877,0.07020872865275142,0.4353332257635087,1.0,24/52,34.78%,ME2;MTHFR;MTHFD2L;ADHFE1;D2HGDH;ME1;MDH1;DLST;ALDH1L1;ALDH18A1;SDHA;NIT2;ASS1;ACOT8;DGLUCY;ME3;GCLC;GOT1;SLC25A32;MDH2;IDH2;SLC19A1;GOT2;SDHAF3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.34573289740961094,-1.304771423469925,0.07115384615384615,0.4363801556977818,1.0,28/88,16.32%,MYO1B;VPS13A;DNAJC6;GBF1;CCDC93;ARL3;GOLGB1;RAB10;OSBPL5;DTNBP1;VAMP7;CORO7;AP4E1;PUM1;MON2;VAMP2;ACBD3;KIF16B;RP2;EXOC2;STX4;SCAMP2;ARF1;AP4S1;VPS13C;DOP1B;TXNDC5;ARRB1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.316284467955746,-1.3045608006979403,0.04592901878914405,0.4362450010443324,1.0,45/158,22.70%,WLS;AKAP13;ROR1;LPAR1;PELI2;ANKRD17;UBE2N;CFLAR;MAP3K3;PRKN;FLNA;TBK1;TFG;ALPK1;TRIM8;TRAF3IP2;DHX36;GJA1;MIER1;TRAF2;RHOA;ZDHHC13;MAVS;LGALS1;TRIM5;TRIM25;PPM1A;LTBR;MAP3K14;TNIP2;ECM1;IKBKE;PRKD1;CC2D1A;TRAF6;RHOC;TMED4;NEK6;IRAK1;CARD16;SHARPIN;CXXC5;TRAF5;TICAM1;VAPA
prerank,response to interleukin-6 (GO:0070741),-0.5750549988819145,-1.3044648971131627,0.163003663003663,0.43578656496012347,1.0,4/10,5.53%,PID1;NFKB1;PTGIS;SBNO2
prerank,sulfur compound biosynthetic process (GO:0044272),-0.33468489965295145,-1.3038584398314264,0.05304518664047151,0.43659246840731475,1.0,29/104,19.07%,UST;DSE;ST3GAL4;ANGPT1;DCN;B4GALT1;BGN;FMOD;SLC35B3;OGN;GLCE;SLC26A2;SLC10A7;PRELP;CHST15;ST3GAL3;TPK1;AKR1A1;LUM;GGTA1;CHST11;CHPF2;CHSY1;CHAC2;B4GALT5;GSTT1;MGST1;OMD;CHST12
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4511476822546892,1.3027991094733848,0.12448132780082988,0.5114224140790672,1.0,6/24,10.54%,TEK;RAMP2;GAS6;KDR;NDNF;SCG2
prerank,negative regulation of locomotion (GO:0040013),0.5446055839498603,1.30279210591452,0.16414686825053995,0.5099259293827053,1.0,2/12,0.66%,SPOCK3;FRMD5
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.48518768943466944,-1.3022989819477941,0.12867647058823528,0.439755422629231,1.0,7/18,24.99%,PTN;CAMK1D;LYN;IL6R;SLC8B1;EDN3;SLIT2
prerank,cellular response to amyloid-beta (GO:1904646),0.42013127149219365,1.3019627209685602,0.108,0.5106881713423697,1.0,6/35,3.72%,IGF1R;GRM5;GRIN1;CACNA1A;GRIN2A;CACNA2D1
prerank,retina homeostasis (GO:0001895),0.4553711957973094,1.301677264128373,0.13725490196078433,0.5099574146186109,1.0,3/23,8.42%,POTEF;ACTB;HSPB1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5623137249472805,-1.3015135849716823,0.16071428571428573,0.4410889661800375,1.0,7/11,29.50%,KMT2D;CTR9;OGT;KMT2A;PRDM9;TET2;TET3
prerank,cellular response to nitrogen compound (GO:1901699),-0.4700352825616376,-1.3007977532994155,0.15037593984962405,0.4421375711526257,1.0,9/20,29.42%,ROCK2;SPIDR;DDI2;RIOK3;HSF1;PDE12;ATRX;TIMELESS;NR1H4
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4164020431500897,1.300380811291488,0.1407563025210084,0.5118508180798079,1.0,8/34,9.89%,FLT1;SEMA6A;RAMP2;KDR;MT1G;NOTCH1;HSPB1;DAB2IP
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5205442360301867,-1.3001077566313761,0.16098484848484848,0.44313092579135704,1.0,4/13,9.15%,DDO;ASPA;GLUD1;GLUL
prerank,keratan sulfate metabolic process (GO:0042339),-0.4187015977308692,-1.2991769056406157,0.12660550458715597,0.44479407348908145,1.0,12/31,18.91%,ST3GAL4;B4GALT1;FMOD;GNS;OGN;PRELP;ST3GAL3;LUM;HEXA;GALNS;B4GALT5;OMD
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5463133091917414,1.2989326985337202,0.15271966527196654,0.514235636735727,1.0,3/11,10.77%,AKAP6;LRRC55;RNF207
prerank,regulation of T cell mediated immunity (GO:0002709),-0.561411562255519,-1.2986084773335598,0.14642857142857144,0.4454970468003401,1.0,3/10,12.95%,HMGB1;ZBTB1;TRPM4
prerank,arachidonic acid secretion (GO:0050482),-0.5667422181094599,-1.2967443612320766,0.16697588126159554,0.44854041563072744,1.0,3/10,15.56%,ANXA1;PNPLA8;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.5667422181094599,-1.2967443612320766,0.16697588126159554,0.44854041563072744,1.0,3/10,15.56%,ANXA1;PNPLA8;BDKRB2
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.28879169183838566,-1.2964014149567804,0.01556420233463035,0.4487222042677329,1.0,154/336,33.67%,FOXP1;INO80;SETD7;RNF169;UBE2E2;ABL1;KMT5B;RBBP8;UVRAG;TRIP12;YAP1;SPIDR;CEP63;SMC6;CBX1;UBR5;CBX5;RBBP6;NBN;STXBP4;WDR48;RAD51B;UFL1;TAOK3;TRRAP;BCL2;LYN;RNF8;PDS5A;WRN;NCOA6;XIAP;DDB2;VCPIP1;ZBTB1;ATF2;CCNK;CSNK1E;SMC5;BRSK1;HERC2;UPF1;MNAT1;SUSD6;MCM9;NIPBL;USP47;RFWD3;PARP1;RAD51D;PDS5B;ERCC3;PAXX;ALKBH1;WDR76;NABP2;CASP2;KMT5C;APTX;SLF1;STK33;DTX3L;PARP4;MMS19;PHF1;PRKDC;HINFP;UBE2B;MSH3;FBXO45;TOPORS;ERCC8;MTREX;BOD1L1;NOP53;MRE11;SPRTN;HELB;ZRANB3;IKBKE;UBA7;BAZ1B;VCP;NEK4;TANK;ZDHHC16;PARK7;MSH6;TAOK1;MAP2K6;PML;SMC1A;FANCC;RPAIN;ATR;SIRT4;WAC;MACROD1;PLK5;SMARCAL1;NSMCE4A;RAD51C;ERCC1;GTF2H1;AATF;BRAT1;USP28;MASTL;POLE2;UBQLN4;RECQL5;BCL2L2;KIN;MAPK14;OGG1;HTRA2;ENDOV;RAD54L;GTF2H4;SHPRH;POLH;TIMELESS;CGAS;ZBTB4;DCUN1D5;IGHMBP2;E2F1;NUDT1;PARP3;BAK1;MGMT;SAMHD1;HIC1;ZBTB38;GNL1;BATF;UBA1;FANCG;BCL2L11;PARP2;FAAP20;TNFRSF1B;BCL6;RAD9A;PNKP;RMI2;RAD51;PSME4;POLA1;ALKBH8;DDB1;TIGAR;BRCA1;PCLAF
prerank,gas transport (GO:0015669),0.5466254747064843,1.2955442268011959,0.15145228215767634,0.5215962366036617,1.0,2/10,9.12%,CA2;MB
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4756481891585929,1.2953303625314956,0.12320328542094455,0.5206603214781219,1.0,5/19,9.08%,LRP8;PTPRD;IL1RAPL1;CDKL5;RELN
prerank,heart contraction (GO:0060047),0.39852402281306515,1.2952208648005001,0.11354581673306773,0.5194543798356731,1.0,9/41,10.09%,SGCZ;RYR2;GPX1;MYH6;GRK2;SLC8A1;SCN4B;TCAP;SGCG
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.4057384036862711,-1.295149027985933,0.11948529411764706,0.45121735756302866,1.0,16/37,27.86%,PRKAG2;CEMIP;BMP7;RPTOR;AXIN1;UBE2K;PARD3;INPP5K;EIF4G1;SPRED2;CAB39;SPHK1;IRGM;EGF;TNKS1BP1;APP
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.47241314305865717,-1.2948916420682426,0.16789667896678967,0.45113550991030904,1.0,6/20,15.61%,WNT4;EP300;NCOR1;CLK2;SIK1;C1QTNF3
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5537909779178984,1.2948040294172358,0.17547568710359407,0.5190313702885183,1.0,4/10,19.94%,ANK3;KCNAB1;KCNRG;SUMO1
prerank,regulation of protein localization to membrane (GO:1905475),-0.42757121213656035,-1.2946438591215852,0.13255360623781676,0.4510905882771701,1.0,10/28,12.97%,GPC6;GSN;SLC5A3;PRKN;GPC4;GPC3;VTI1B;AR;MMP14;APPL1
prerank,regulation of microtubule polymerization (GO:0031113),0.4030515669240701,1.2942778920696227,0.13135593220338984,0.5189120690256668,1.0,12/40,13.23%,NAV3;MAP2;STMN1;SNCA;OCLN;PAK1;MAPRE3;TUBB4A;CAMSAP1;STMN2;DCTN1;RPS3
prerank,aortic valve morphogenesis (GO:0003180),-0.4332186596829551,-1.2942174580599497,0.11731843575418995,0.45146324809084765,1.0,7/30,3.07%,ROCK2;SMAD6;ROCK1;BMP4;ROBO1;ELN;JAG1
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.43640278190472603,-1.2941221045930311,0.14258188824662812,0.45099018989520556,1.0,8/27,18.15%,KAT2B;EP300;KAT6B;CREBBP;TRRAP;KAT8;TAF6L;MSL3
prerank,phospholipid translocation (GO:0045332),0.4355033728137684,1.2940894141439065,0.12955465587044535,0.5179195791631286,1.0,10/28,11.50%,TMEM30A;ATP8A1;ATP11A;ATP10A;MFSD2A;ATP10B;ATP11C;ATP8A2;ABCB4;P2RX7
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.515938228210888,-1.2937357075844178,0.16544117647058823,0.451235917440351,1.0,11/14,35.29%,SEC24D;SEC23A;SEC31A;TBC1D20;SEC23B;MIA3;SCAP;SEC24A;SEC24C;SEC13;SEC31B
prerank,fatty acid elongation (GO:0030497),0.5214282826380123,1.2936521978608237,0.15991471215351813,0.517540933474948,1.0,5/13,13.74%,ELOVL7;ELOVL4;TECR;HACD3;HACD1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5589482615611462,-1.2935674136871145,0.14882032667876588,0.45093050043173044,1.0,4/12,8.57%,IGF1;SORBS1;IRS1;IGF2
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.4821908273022831,-1.2934763954520951,0.13931297709923665,0.450476799671334,1.0,6/18,12.22%,DCN;MCU;PRKN;DNM1L;DDHD1;RALA
prerank,primary alcohol metabolic process (GO:0034308),-0.4435107190910248,-1.2932982537953026,0.14100185528756956,0.4502243452483493,1.0,5/25,11.18%,IGF1;RBP4;DHRS3;CYP1B1;NAPEPLD
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.49428954150031545,-1.2927929161123335,0.1553398058252427,0.45078359412556,1.0,4/17,2.69%,ROCK2;VCL;PPP1R12A;ROCK1
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4269472886607699,-1.2926309776409728,0.1261595547309833,0.4504988353237179,1.0,11/31,17.31%,RANBP3L;CRIM1;SMAD6;TMEM64;SKI;NBR1;LIMD1;SUFU;TRPM4;PTCH1;TWIST2
prerank,catecholamine biosynthetic process (GO:0042423),0.5534764255397756,1.2924038302562033,0.1762208067940552,0.5194837025631446,1.0,3/11,5.82%,DDC;SNCA;TGFB2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5679053214835442,-1.2919641186081448,0.1614678899082569,0.45137610428644503,1.0,3/10,13.02%,GLI3;BMP4;IRF1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.43244399208106155,-1.2918746112321269,0.1233140655105973,0.4509179417934166,1.0,4/26,4.33%,IGF1;FHL2;GSK3B;SLC9A1
prerank,generation of neurons (GO:0048699),0.31107701449208414,1.2914749524394658,0.03969754253308128,0.5203098256729032,1.0,43/190,16.99%,ADGRL3;SPOCK1;MYT1L;PTPRD;IRX2;IL1RAPL1;GPM6A;HEY1;DNER;MAP1B;FGF13;NTRK2;ASTN1;NEUROD6;FUT9;TGFB2;TAFA1;SNPH;NRCAM;LHX1;WNT7B;ITM2C;NDNF;CDKL5;RELN;RNF112;ASTN2;BRSK2;FZD4;PER2;HES6;BHLHE40;POMGNT2;CIT;DLL1;ATP2B2;DCX;ELP3;ACSL3;LMX1B;DDIT4;HES5;CTNNB1
prerank,regulation of cytokinesis (GO:0032465),-0.3490251253633088,-1.290769872487367,0.05576923076923077,0.4529603916942355,1.0,19/78,15.52%,SVIL;KIF13A;BIRC6;CDC14A;KLHL13;UVRAG;CSPP1;CDC42;SETD2;RHOA;GIPC1;RAB11A;CUL3;BECN1;PIK3C3;CDC14B;MAP9;CDC25B;PIK3R4
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.42718030443514127,-1.2907612846750396,0.10114503816793893,0.4522941661912398,1.0,15/33,26.62%,PABPN1;PCF11;WDR33;SCAF8;CPSF3;SSU72;SLBP;CSTF3;SNRPF;CSTF1;CPSF4;NUDT21;CPSF1;NCBP2;LSM11
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3717644115826707,1.290492423693769,0.07835051546391752,0.5215587007139663,1.0,15/57,16.22%,RGS1;ADCY8;ADCY3;GRM7;CHRM3;GRM8;PDE2A;MTNR1A;GNAL;OPRM1;ADCY4;OPRK1;CHRM2;OPRL1;GNAI1
prerank,regulation of mitochondrial fission (GO:0090140),-0.44688614286423545,-1.290368803929969,0.1237721021611002,0.4525809622596147,1.0,6/24,6.92%,DCN;MCU;PRKN;LRRK2;DNM1L;DDHD1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.538020794051966,-1.290214415139611,0.1657754010695187,0.45229965979274134,1.0,4/13,8.57%,IGF1;SORBS1;IRS1;IGF2
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.31481725223923557,-1.2900984327695757,0.050880626223091974,0.4518722308800085,1.0,36/150,15.41%,PTPN13;PRKAG2;PID1;ERRFI1;LDLRAD4;LRP6;NTRK3;SMAD6;FBLN1;PLPP3;PRKN;ENPP1;LRRK2;PPM1E;IBTK;DEPTOR;IGFBP3;PAK2;DTNBP1;LYN;PDPK1;IMPACT;PMEPA1;PRKCD;DNAJC3;RB1;RASSF2;FKBP8;TRIB2;PARD3;PRKDC;EMILIN1;ZBED3;NCK1;PRKCZ;NCK2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.29209742604685746,-1.2879557639640218,0.014141414141414142,0.4565501843429627,1.0,131/314,30.21%,FBXL7;FBXL17;SMURF2;UBR2;SPSB1;PRKN;RAD23B;BTRC;TBL1X;WWP2;TBL1XR1;ECPAS;KLHL15;UBXN2B;HUWE1;DNAJB14;UBQLN1;OS9;UBE4B;WWP1;ZSWIM8;FBXL4;ANAPC5;FBXL12;ANAPC7;PCBP2;UBE2K;JKAMP;EDEM1;MAEA;ANAPC4;ANAPC16;TNFAIP1;RNF216;FAM8A1;SELENOS;RNF103-CHMP3;UBR1;SPOPL;MAN1B1;GID4;RHBDD2;KCTD5;ERLIN1;PSMF1;FBXL19;UBR3;FBXL18;AMN1;CUL3;RB1;FBXW7;TRIM25;KLHL22;NHLRC3;PSMB2;CDC26;UBE2B;SMURF1;FBXO38;FBXO45;CUL2;TOPORS;ERCC8;FAF2;CDC27;UBE2E1;ARRB1;FEM1A;AUP1;BFAR;DERL1;UBE2S;SYVN1;PPP2R5C;FBXW11;FBXW5;AREL1;VCP;SPSB4;UBE2D3;IFI27;CDK2;COP1;PML;ANAPC11;CUL1;PSMC1;UBXN4;APPBP2;SHARPIN;KCTD17;GID8;ECRG4;FBXW4;DCAF12;WFS1;PSMB6;RMND5A;PSMA3;SIAH2;ARMC8;PSMA4;BAG6;DNAJC18;CDC16;FBXL14;FBXO4;ANAPC1;PCNP;TMUB2;SPSB2;PSME1;SEL1L;PSMD13;FZR1;USP19;CDC34;DERL2;PSMB10;PSMA5;SPSB3;FBXL3;PSMB9;LTN1;KBTBD7;RBX1;NFE2L2;FBXL8;UBA52;ZFAND2B
prerank,ERAD pathway (GO:0036503),-0.3498651552399076,-1.2875069445847709,0.07251908396946564,0.4570290206139437,1.0,36/83,29.11%,PRKN;UGGT2;ECPAS;DNAJB14;UBQLN1;OS9;UBE4B;JKAMP;EDEM1;FAM8A1;SELENOS;ERLEC1;RNF103-CHMP3;MAN1B1;RCN3;RHBDD2;ERLIN1;POMT2;TRIM25;USP13;FAF2;AUP1;DERL1;SYVN1;GET4;VCP;UBXN4;TOR1A;WFS1;BAG6;DNAJC18;TMUB2;SEL1L;USP19;DERL2;CCDC47
prerank,positive regulation of phospholipase activity (GO:0010518),-0.45401937352112176,-1.2871642046492355,0.14366729678638943,0.4571549165942823,1.0,9/22,12.26%,PDGFRA;NTRK3;PDGFRB;KIT;FGFR2;PDPK1;PLCG1;ABL2;AGTR1
prerank,DNA recombination (GO:0006310),-0.39639609217313976,-1.2871322226906698,0.1274131274131274,0.45656956559475514,1.0,23/37,39.79%,HMGB1;RAD51B;WRN;RAD21;RAD51D;MSH3;DMC1;MRE11;RPAIN;RAD51C;ERCC1;RECQL5;RAD54L;IGHMBP2;SUPV3L1;HDAC10;RAD51;LIG4;GEN1;MSH2;RAD52;XRCC3;EXO1
prerank,protein secretion (GO:0009306),-0.37690275537359763,-1.286945378123504,0.09487666034155598,0.4563666618018173,1.0,17/56,18.94%,WLS;ABCA1;STEAP3;TANGO6;PCSK5;CYB5R4;RAB10;ANXA1;RAB12;CAMK2G;ARFGAP3;RCN3;MON1A;COPG2;MIA3;COPG1;PARK7
prerank,synaptic vesicle endocytosis (GO:0048488),0.40538150515365,1.286399363064686,0.1419491525423729,0.5312244234113922,1.0,14/33,18.86%,DNM3;SYT1;NLGN1;SNCA;SNAP91;AMPH;SYT2;SNCB;NLGN3;PACSIN1;DNM1;GAK;SYNJ1;SYT5
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5330403475571536,1.2863280167029674,0.17248459958932238,0.5298873162488738,1.0,2/12,0.98%,DSCAM;PROM1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5314883847291633,1.286242840382406,0.16885964912280702,0.5285845319946374,1.0,5/12,8.71%,MAP2;STMN1;SNCA;TUBB4A;STMN2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.534913343089201,1.2858983804711437,0.16810344827586207,0.5280387221316654,1.0,3/11,7.40%,ITM2A;NECAB2;ITM2C
prerank,positive regulation of neuron migration (GO:2001224),0.5222620126261893,1.2857001940013246,0.18807339449541285,0.5270501230131102,1.0,4/11,9.89%,SEMA6A;SHTN1;ARHGEF2;DAB2IP
prerank,regulation of lipid metabolic process (GO:0019216),-0.34163418240745036,-1.2850915025966334,0.07874015748031496,0.4601912807396894,1.0,37/88,26.87%,PRKAG2;CHD9;NR1D2;NCOR1;TBL1X;TBL1XR1;CREBBP;NCOA6;NFYC;NCOA1;MED1;PANK2;ID2;NPC2;RORA;TGS1;MBOAT7;LACTB;C1QTNF2;CCDC3;RXRA;NFYB;HMGCR;SQLE;CYP51A1;ABCA7;FGFR4;NFYA;SC5D;FDFT1;SMARCD3;MVK;PPARA;EDF1;ZFP69;BBS4;HDAC3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5359989561090919,-1.2849598733207843,0.17407407407407408,0.4598523392800543,1.0,9/13,27.56%,BMP7;RREB1;NAPEPLD;SOX13;SIX1;HNRNPU;METRNL;ZBTB7B;PIM1
prerank,ovarian follicle development (GO:0001541),-0.5257273018950536,-1.2847392890918328,0.16911764705882354,0.45972870108687164,1.0,10/13,38.28%,KIT;VEGFA;INHBA;EIF2B4;EIF2B5;INHBB;INHA;CEBPB;ANG;LHCGR
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3438385932761748,-1.2845953593955097,0.07782101167315175,0.4593490097780757,1.0,15/85,7.81%,EYA1;ROR1;PIEZO2;COL1A1;CEMIP;COL4A3;CDC14A;TBL1X;GSDME;RIPOR2;DCDC2;EML2;ADGRV1;ATP6V0A4;CACNA1D
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.47053930894897994,-1.284497457331012,0.13575525812619502,0.4589086406946561,1.0,14/20,42.18%,MBTPS2;APOE;MBTPS1;EPHX2;LPCAT3;ARV1;ACADVL;NR1H4;SREBF1;RAN;ACADL;FMO5;LDLRAP1;KPNB1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.4839240104708953,1.2844157664911962,0.14380530973451328,0.5289382040899908,1.0,2/16,4.90%,CADM1;IL12A
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4363501778599446,-1.2842551396637216,0.13214990138067062,0.45881868446722013,1.0,7/25,13.20%,CCNT2;SETD5;CCNT1;SCAF8;CCNK;WDR43;HTATSF1
prerank,retinoic acid metabolic process (GO:0042573),-0.4991686747341303,-1.283918976275863,0.17594254937163376,0.4589613902005528,1.0,2/14,3.51%,ALDH1A2;CYP26B1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.5037226983307777,-1.283744537058811,0.1720226843100189,0.45872219317504226,1.0,4/14,7.39%,SFSWAP;SRSF10;U2AF2;SRSF6
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4811610495215352,-1.2834229924382463,0.14583333333333334,0.4588733976332364,1.0,11/17,30.48%,PID1;HDAC4;NCOR1;NUPR1;PARP1;CBFA2T3;FIS1;PPARA;PDE12;MLXIPL;PPIF
prerank,regulation of MAPK cascade (GO:0043408),-0.31364175738397193,-1.2833571966989705,0.030303030303030304,0.45835458391249356,1.0,30/157,8.85%,ROCK2;TGFBR3;IGF1;ROR1;EGFR;LPAR1;DAG1;EPHA7;NTRK3;PELI2;KSR1;STK3;ROCK1;ADRA1B;GSDME;KIT;STYX;RYK;NRK;HMGB1;LBH;PAK2;MAP4K4;TAOK3;FGFR2;SHC1;LYN;NBR1;IGF2;MAP2K1
prerank,regulation of exocytosis (GO:0017157),0.38449986035283606,1.283130284480603,0.11270491803278689,0.5309216153866294,1.0,11/46,10.81%,SYT1;IL1RAPL1;CADPS;RIMS2;RAB3C;LGI3;SNCA;STXBP5L;CPLX1;ATP6AP1;HAP1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.4002019093298495,-1.2826645798744614,0.13584905660377358,0.45930224159638144,1.0,21/37,33.45%,PCM1;IFT43;IFT81;DYNC2I1;IFT88;IFT80;DYNC2LI1;DYNLRB1;DYNC2I2;TRIP11;KIFAP3;IFT27;KIF3A;SSX2IP;IFT140;TTC21B;IFT122;WDR35;DYNC2H1;IFT52;IFT74
prerank,regulation of dendritic spine development (GO:0060998),0.4739105711594748,1.2822880914735517,0.1554192229038855,0.5318161481961645,1.0,6/19,13.71%,NLGN1;SHANK3;KIF1A;GRIN3A;PPFIA2;PSEN1
prerank,regulation of cell motility (GO:2000145),0.3254267914595238,1.2819470118103538,0.06768558951965066,0.5313457162335624,1.0,23/121,9.97%,SPOCK2;SPOCK3;FRMD5;ERBB4;CSF1R;PLXNB3;TMSB4X;NRG2;NRG1;TMSB10;ROBO4;FGF10;ENPP2;MEAK7;PKN1;FGF5;AKT1;PLXNA4;SGK3;SST;SPATA13;CYRIB;NTN1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5284024988511905,-1.28188450682186,0.16515426497277677,0.4605354857588091,1.0,5/12,16.75%,FOXP1;DAB2;NCOR1;HDAC1;HEYL
prerank,positive regulation of type I interferon production (GO:0032481),-0.3508129680406132,-1.2815877692970696,0.10119047619047619,0.4605976393486278,1.0,34/73,31.05%,NFKB1;EP300;TBK1;CREBBP;DHX9;DHX36;PTPN22;SETD2;MAVS;RIOK3;IRF1;STAT1;PRKDC;DDX3X;MRE11;OAS2;TLR4;POLR2H;PTPN11;IRAK1;XRCC6;POLR2K;DDX41;POLR3D;NFKB2;POLR2E;POLR3H;DHX58;POLR3E;CGAS;POLR1C;TLR3;IFIH1;DHX33
prerank,phospholipid biosynthetic process (GO:0008654),0.4126996167789689,1.28137446360246,0.13518886679920478,0.531409444359222,1.0,15/36,19.21%,SGMS1;MBOAT1;CPNE1;MVD;GPAM;CRLS1;FADS1;DHDDS;FAR1;IDI1;PIP5K1A;SAMD8;CPNE7;FDPS;PCYT2
prerank,mitotic recombination (GO:0006312),-0.4897925918180843,-1.2813469366090677,0.14673913043478262,0.4605620278566316,1.0,6/15,15.93%,SMC6;NSMCE2;SMC5;RAD51D;MSH3;DMC1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.47603191914270937,1.2811262363793845,0.14660831509846828,0.5305500790807647,1.0,2/17,4.90%,CADM1;IL12A
prerank,regulation of cellular metabolic process (GO:0031323),-0.39004684007915336,-1.2811055763191892,0.10784313725490197,0.4605178202604434,1.0,10/45,12.82%,PID1;PRKN;TBC1D16;MKLN1;CYP1B1;PANK2;KIF16B;NPC2;ARF1;MBOAT7
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4364140484324065,-1.2808437644808017,0.15398886827458255,0.46044246692010443,1.0,4/25,7.56%,ERRFI1;CBLB;SNX6;SLC6A9
prerank,negative regulation of protein depolymerization (GO:1901880),0.44861775075259924,1.2803433728371747,0.16198704103671707,0.5312421666165186,1.0,12/24,19.69%,NAV3;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.33765621517389965,-1.2799435406984485,0.0796812749003984,0.46199471635090683,1.0,33/85,24.46%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;NUPR1;GSK3B;RNF217;RNF19A;RNFT1;NUB1;CSNK1E;TMEM259;FBXW7;TRIB2;SH3RF2;USP13;CBFA2T3;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;COP1;ZYG11B;TMTC3;ARIH2;DET1;RNF144A;BAG6;NKD2
prerank,protein localization to organelle (GO:0033365),-0.32132987025085824,-1.2797908988812472,0.06525911708253358,0.4617147412644506,1.0,38/133,19.21%,ANK2;COL1A1;ZNF423;TRAM2;BMP7;BMP4;GBF1;BBS9;LRRK2;LMNA;PACSIN2;CNTLN;ARL3;DHX9;OBSL1;DCP1A;LAMP2;VAMP2;TULP3;RPL11;COG3;COG7;RAB11A;STX5;SNX10;YBX1;UBAC2;DDX3X;YWHAE;EMD;TOPORS;SIX1;AUP1;LAMP1;GBP2;GET4;CSNK1D;ABCA7
prerank,Golgi ribbon formation (GO:0090161),-0.5098330785971543,-1.2794458197854106,0.155893536121673,0.46189400613592585,1.0,6/13,19.84%,VTI1A;STX16;PRMT5;VAMP4;TMED5;TRIP11
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.29471753202585205,-1.2784111944464964,0.019189765458422176,0.4636205081244508,1.0,102/264,28.06%,SRRM2;DDX5;HNRNPH1;PABPN1;HNRNPR;SYNCRIP;PCF11;WDR33;DDX17;CASC3;IK;SRSF10;RBM6;DDX46;FUS;HNRNPM;U2AF2;DHX9;SF3B1;CPSF3;SRSF6;HNRNPUL1;HNRNPD;RBM10;PRPF6;PCBP2;RNPC3;DDX42;CDC5L;CDK13;PRCC;SLU7;GEMIN5;HNRNPK;PRPF3;SF3A1;SF3B6;YTHDC1;USP39;SCAF11;SF3A3;TGS1;RSRC1;ZCRB1;SNRNP70;CCAR1;DNAJC8;STRAP;DDX23;YBX1;CWC22;COIL;RBM5;SRSF1;CWF19L1;EFTUD2;GEMIN7;SNU13;MTREX;PRMT5;SFPQ;PPIH;UBL5;PRPF40B;PPWD1;WBP11;CSTF3;HNRNPU;ZMAT5;POLR2H;SNRPF;HNRNPA3;RBM4;SRSF7;SRSF11;GEMIN2;SRRM1;UPF3B;SRSF2;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;DDX41;SMU1;DHX15;NONO;PRPF38A;POLR2E;CPSF1;NCBP2;PRPF8;CRNKL1;LSM6;RBM22;RBM19;CACTIN;SUGP1;POLR2D;HNRNPL;ISY1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.4001900292846984,-1.2772011564340493,0.11646586345381527,0.46606819893027945,1.0,5/37,3.78%,NFKB1;ITGAV;NCOR1;PRKN;DLG4
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3937534560799842,-1.277121754976784,0.13345521023765997,0.4656082693769359,1.0,11/39,15.58%,VCL;PDGFRA;PLPP3;MEGF11;TLN1;FLNA;STXBP1;GNAS;FN1;P2RY12;FIBP
prerank,negative regulation of blood coagulation (GO:0030195),-0.3996870953450974,-1.2765377464132561,0.12195121951219512,0.4663673769893165,1.0,6/38,7.35%,PDGFRA;SERPING1;VTN;PLAT;TFPI;F3
prerank,dopamine metabolic process (GO:0042417),-0.4720421941962313,-1.2764769528172815,0.1586998087954111,0.4658207517970991,1.0,4/18,8.28%,MOXD1;PRKN;SNCAIP;COMT
prerank,osteoclast differentiation (GO:0030316),-0.4526519058260098,-1.2760822876293323,0.1569767441860465,0.4661709190150969,1.0,7/22,15.24%,FOXP1;GAB2;SBNO2;ANXA2;SNX10;GLO1;FARP2
prerank,regulation of cytoskeleton organization (GO:0051493),-0.325478775906353,-1.2756804314105592,0.058704453441295545,0.46651494245859854,1.0,33/108,20.60%,PHLDB2;ROCK2;LRP1;RHOQ;EPHA3;DIAPH1;PDGFRB;ROCK1;ABL1;PRKAA2;GSK3B;RND3;PAK2;MTOR;CLIC4;ARHGAP17;IQGAP2;RHOA;PRKCD;RHOBTB2;RICTOR;PLXNB1;SORBS3;ARHGAP18;FAM107A;PRKAA1;RHOBTB1;RHOH;RHOC;CDK10;TAOK1;BAIAP2;SPEF1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.42522754556318343,-1.2756097174329264,0.16314779270633398,0.4660251801903159,1.0,14/28,29.54%,PDK1;PRKN;FOXK1;PANK2;RORA;APOE;FOXK2;EPHX2;BCKDK;ARV1;PPARA;ACADVL;NR1H4;PDK3
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.32851215867113204,-1.2755376727801664,0.059961315280464215,0.46549071581747303,1.0,19/113,7.39%,BMP6;NOTCH2;IGF1;EGFR;TCF7L2;TGFBR1;PTN;BMP5;FGF1;BMP4;ARNT;OSR1;RREB1;YAP1;STXBP4;NRP1;FGFR2;F3;SRSF6
prerank,protein phosphorylation (GO:0006468),-0.27875116975935554,-1.27547845779169,0.008456659619450317,0.4649867684883416,1.0,154/479,22.14%,PRKAG2;ROCK2;TGFBR3;GRK5;EGFR;TGFBR1;EFEMP1;BMPR1A;EPHA3;PDGFRA;CDK8;PKD1;TLK1;PDK1;PDGFRB;STK3;FAM20A;ROCK1;BMP4;SMG1;ERC1;MAP3K3;CAMK1D;ABL1;BIRC6;LRRK2;JAK1;PRKAA2;TGFBR2;CSNK1A1;FRK;CCNH;TOP1;GSK3B;KIT;CCNT1;STK17B;RYK;TBK1;IRAK3;NRK;IGFBP3;MARK3;CDK16;BCR;CDK7;SLK;SMAD2;EIF2AK1;PAK2;MAP4K4;TAOK3;EEF2K;FGFR2;EIF2AK3;LYN;CAMK2D;MTOR;MERTK;BRAF;GRK4;MAP3K5;PDPK1;EPHA4;DCLK1;MARK4;MAP2K1;CDK13;GRK3;WNK4;CLK2;MAP3K20;WNK1;CSNK1E;HIPK1;BRSK1;FER;PRKCD;ABL2;DMPK;FAM20C;CLK3;CDK11B;ULK2;ABI1;MKNK2;TEC;SIK1;COPS2;EIF2AK4;RICTOR;MAML1;GMFB;STK33;TBCK;TRIB2;COPS8;MAPK6;TYK2;EIF2AK2;EPHA8;PRKDC;BMP2K;ACVR1;ERN1;LATS1;CDC25B;PRKCZ;DDR1;CSNK2A1;PIK3R4;GRK6;MARK1;DAPK1;SIK3;IKBKE;DAPK2;PIK3CD;TLR4;PRKACA;PXK;PRKD1;MORC3;BAZ1B;PRKAA1;NEK4;CSNK1D;STK16;MAP3K1;BMP2;MUSK;CDK10;CDK2;NEK6;FASTK;IRAK1;TAOK1;MAP2K6;NRBP2;FGFR4;CAB39;BCKDK;PRKAG3;PKDCC;CDK6;MAST2;PPP4R1;AKT2;PRKAB1;MKNK1;ATR;MAP3K12;PRKCA;SIK2
prerank,mitochondrion morphogenesis (GO:0070584),-0.5499339375390597,-1.2751661361890525,0.188212927756654,0.46504105365850823,1.0,6/11,28.80%,PID1;DNM1L;WASF1;FIS1;MYH14;SUPV3L1
prerank,visual system development (GO:0150063),-0.40463962646479656,-1.2747876827412763,0.1378026070763501,0.46532982546187274,1.0,6/37,5.76%,PBX1;SMOC1;FOXC1;SH3PXD2B;RBP4;PBX3
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5400113597400261,-1.2742267064289863,0.17416829745596868,0.4660778996903964,1.0,6/11,24.20%,DAB2;PRKN;RAB21;EIPR1;MSN;PTPN23
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.49143010340879784,-1.2742216577379755,0.16988416988416988,0.46543017465220227,1.0,7/16,16.99%,KMT5B;SHLD2;PARP9;KMT5C;DTX3L;PRKDC;SMCHD1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.41433101154016394,-1.274126902956776,0.13111545988258316,0.4650196244167915,1.0,11/31,12.58%,BOC;CDON;CTNNA1;ABL1;MEF2A;FGFR2;CDC42;IGF2;ID2;MEF2C;TCF3
prerank,central nervous system neuron development (GO:0021954),0.4887727685239058,1.273824966606517,0.18144329896907216,0.5472119566558685,1.0,4/15,8.37%,MAP2;NTRK2;HSP90AB1;B4GALT6
prerank,respiratory system development (GO:0060541),-0.40929214428522176,-1.2731957669143656,0.13141683778234087,0.46652236821781623,1.0,14/32,21.57%,GLI2;FGF1;BMP4;PDPN;DISP1;RBP4;FGFR2;CHD7;CCDC39;VEGFA;LOXL3;SMCHD1;ZIC3;FGF2
prerank,regulation of fat cell differentiation (GO:0045598),-0.353890411270148,-1.2730530421413364,0.10384615384615385,0.466172211322724,1.0,21/74,18.77%,SMAD3;MEDAG;FTO;TMEM64;ENPP1;YAP1;CREBL2;ZBTB16;RUNX1T1;ID2;RORA;TRPM4;TRIB2;WDFY2;ANKRD26;TAF8;CMKLR1;TRIO;WNT5A;SYAP1;BMP2
prerank,regulation of cilium assembly (GO:1902017),-0.3588970174611381,-1.2726105305377733,0.10674157303370786,0.46653279670560066,1.0,30/62,28.25%,TBC1D16;YAP1;DCDC2;TBC1D19;TBC1D24;MARK4;USP6NL;TBC1D2B;TBC1D20;IFT88;ODF2L;TBC1D22B;DYNC2LI1;ATG5;TBC1D17;CDK10;RABGAP1;TBC1D7;TBC1D10A;KCTD17;TAPT1;TCHP;ARHGAP35;IFT140;TBC1D10B;BBS4;ATG3;TESK1;TBC1D9B;RABEP2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.34168389071416605,1.2725348654607003,0.09274193548387097,0.5491916410423145,1.0,36/87,21.30%,OMA1;NDUFC1;CHCHD4;NDUFAF5;NDUFA1;NDUFA2;TIMM21;NDUFC2;COA5;DMAC2;FASTKD3;COX16;NDUFA13;NDUFA3;TMEM126A;DMAC1;NDUFB2;ECSIT;COX17;NDUFAF1;NDUFB9;BCS1L;UQCC3;NDUFAF6;NDUFAB1;NDUFA7;NDUFA12;COA3;OXA1L;NDUFB4;NDUFB8;NDUFA10;NDUFS3;SCO1;NDUFA6;NDUFB7
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.5328576105235787,-1.2724882552165078,0.19666048237476808,0.4662088665737415,1.0,7/12,28.25%,RNF8;NELFB;TCERG1;HNRNPU;RECQL5;NELFA;NELFE
prerank,positive regulation of cell aging (GO:0090343),0.5334710974943409,1.2724663485864267,0.15894039735099338,0.5478896148734885,1.0,3/11,4.97%,SIRT1;HMGA2;YPEL3
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.30595698418704415,-1.2724622643842265,0.05761316872427984,0.46561350950132546,1.0,39/170,15.50%,ROCK2;PRDM6;IGF1;FOXP1;PRDM5;ZNF462;TRIM44;AFF3;TFEB;TBC1D16;AFF1;CDH1;ZUP1;MKLN1;REST;HNRNPD;FUBP1;PCBP2;KDM6A;LDLR;HNRNPK;KIF16B;HIF1A;AFF4;NFKBIZ;TRIM5;TRIM11;ARF1;YBX3;ADNP2;CGGBP1;MTMR3;YBX1;ATRAID;APOE;HINFP;PRDM2;TRIM39;RASA1
prerank,histone H3-K4 methylation (GO:0051568),-0.43760785379630385,-1.2724094328859887,0.14484126984126985,0.46507354941767004,1.0,14/26,33.03%,KMT2C;KMT2D;CTR9;KDM6A;OGT;KMT2A;PRDM9;PAXIP1;CXXC1;TET2;TET3;WDR5;WDR5B;DPY30
prerank,iron ion homeostasis (GO:0055072),0.3618113512009875,1.2723571902373374,0.12017167381974249,0.5467173312239265,1.0,12/58,10.62%,TFRC;ALAS2;TMPRSS6;SLC40A1;ABCG2;FTH1;SLC22A17;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.4997753407901915,-1.272301527397813,0.1727447216890595,0.46470107048226567,1.0,6/14,16.11%,PIAS1;JAK1;PTPN2;PARP9;STAT1;IFNGR1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.5648976381773719,-1.2721137543997145,0.18024263431542462,0.4645154554015846,1.0,3/10,2.52%,LRP6;BMP5;BMP7
prerank,ion transport (GO:0006811),0.32797069484568114,1.2720070678043716,0.07024793388429752,0.5461522580511506,1.0,20/111,10.90%,SLC24A4;SLC24A2;GRIN1;SLC4A1;GABRB1;GLRA1;KCNN2;AQP11;SLC17A6;SLC1A1;SLC8A1;SLC12A6;SLC15A3;KCNN1;SLC1A2;KCNN3;SLC12A3;SLC36A1;VDAC2;ATP1A4
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.518126753602173,-1.2717096417318174,0.166351606805293,0.4641925266336049,1.0,2/12,4.00%,FHL2;GSK3B
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.518126753602173,-1.2717096417318174,0.166351606805293,0.4641925266336049,1.0,2/12,4.00%,FHL2;GSK3B
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.480633925371346,-1.2716991324591083,0.18091451292246521,0.46357164545622737,1.0,8/18,31.90%,KAT2B;NCOR1;PTBP3;TERT;TMBIM6;ESR1;ZC3H10;NUDT16
prerank,positive regulation of lyase activity (GO:0051349),-0.5048268804938593,-1.2713672614738039,0.1867704280155642,0.46368828713832166,1.0,7/14,22.09%,CACNA1C;STIM1;CACNA1D;PARK7;NOS1;FXN;ORAI1
prerank,sprouting angiogenesis (GO:0002040),-0.373026839994487,-1.2710361000045554,0.107421875,0.46384782477478753,1.0,18/51,17.48%,PARVA;ANGPT1;EFNB2;CCBE1;BMP4;ROBO1;THBS1;RSPO3;RNF213;ADGRA2;NRP1;RECK;SEMA3E;BMPER;VEGFA;VEGFD;NR4A1;MIA3
prerank,catecholamine metabolic process (GO:0006584),-0.49876810187791265,-1.271004876073511,0.16129032258064516,0.4632764990984989,1.0,3/14,8.28%,PRKN;SNCAIP;COMT
prerank,intracellular lipid transport (GO:0032365),-0.4621630350220182,-1.2704935396501755,0.17300380228136883,0.46385723016198394,1.0,9/21,14.23%,PRKAG2;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;NPC2;ABCD4;PLEKHA8
prerank,regulation of cell communication (GO:0010646),-0.4106995501963546,-1.2702406193783602,0.12857142857142856,0.4638437035116058,1.0,16/35,19.19%,GRK5;ANK2;CXADR;CAMK2D;ANXA1;GRK4;GRK3;TBX18;UGCG;CDC42SE2;SRI;IGFBP7;GRK6;GLRX2;PTPN1;MGLL
prerank,mesenchymal to epithelial transition (GO:0060231),0.5577355808843644,1.2701657275482976,0.1873536299765808,0.5497055436947222,1.0,3/10,8.33%,PAX8;PAX2;BASP1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.48594694269916294,-1.2693560302387767,0.1544256120527307,0.4654701250407474,1.0,6/17,7.78%,NTRK3;ABL1;BAIAP2L1;BCAS3;NRP1;CDC42
prerank,positive regulation of macrophage activation (GO:0043032),-0.4791977063108492,-1.2690794370859846,0.1694915254237288,0.4655088798545915,1.0,6/17,20.00%,LBP;THBS1;TNIP2;TLR4;WNT5A;KARS1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.44390468800856603,-1.268619415181929,0.1669902912621359,0.4659365882727955,1.0,6/22,13.54%,CCNT2;CCNT1;SCAF8;CDK13;CCNK;TCERG1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5014799019604297,-1.2684863705029903,0.15827338129496402,0.4656486271676646,1.0,10/14,33.55%,AUTS2;CTR9;SMAD4;KMT2A;PRDM9;PAXIP1;KMT2E;WDR5;SNW1;BRCA1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4864256599651685,-1.2679815757518977,0.16789667896678967,0.46621963626518925,1.0,8/17,14.80%,FCHSD2;WASF2;BRK1;NCKAP1;ARFIP2;ARF1;GMFB;WASF1
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.4148357559107354,-1.2678480213335144,0.14587332053742802,0.4659025270588711,1.0,14/29,20.37%,TCF7L2;EP300;KMT2D;BCL9L;PYGO1;CREBBP;TRRAP;TLE4;TLE1;TCF7L1;HDAC1;CDC73;TERT;TLE3
prerank,response to chemokine (GO:1990868),-0.5088530335615632,-1.26768590370501,0.18689788053949905,0.46562563804418844,1.0,6/13,14.52%,FOXC1;RIPOR2;WNK1;SLC12A2;RHOA;DUSP1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5068565913912608,-1.2672927550461985,0.16970802919708028,0.4659159948254269,1.0,4/14,10.34%,ANKRD17;PUM2;PUM1;DDX60
prerank,lamellipodium assembly (GO:0030032),-0.43604372589243245,-1.2672127616985973,0.15163147792706333,0.4654485526397482,1.0,9/26,16.70%,VCL;KIT;ITGB1;ABLIM3;ARFIP2;P2RY12;WHAMM;CARMIL1;ARHGEF6
prerank,cellular response to heat (GO:0034605),-0.400289740353422,-1.266701976938356,0.1391941391941392,0.4659881679622477,1.0,16/35,27.98%,FGF1;THBS1;DHX36;SLU7;BAG3;TPR;YWHAE;PRKACA;ANO1;VCP;HSBP1;ZFAND1;HSF1;HTRA2;TCIM;POLR2D
prerank,mitochondrial protein processing (GO:0034982),0.5335984097167379,1.2660889107356088,0.19913419913419914,0.5596253153750603,1.0,3/11,7.90%,OMA1;PMPCA;ATP23
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.417616549203085,-1.265685426006175,0.1455223880597015,0.46787311727774994,1.0,15/30,31.38%,SAE1;HUWE1;ABLIM3;LEPROT;NPEPPS;FBXW7;UBL5;UBE2D3;TOMM7;ARIH2;HTRA2;PDCD5;USP36;UBE2L3;RNF31
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.42694522582364036,-1.265555910253251,0.1525096525096525,0.46756937482169697,1.0,10/25,15.44%,CACNA1C;ANK2;DLG1;CXADR;CAMK2D;JUP;ATP2A2;TBX18;TRPM4;AKAP9
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.4137402794696996,-1.2655503963858632,0.12589928057553956,0.4669428727770531,1.0,18/32,29.73%,GTF2H2;CCNH;CDK7;CAVIN1;TAF1D;TBP;MNAT1;ERCC3;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;TAF1A;RRN3;POLR1C
prerank,regulation of exosomal secretion (GO:1903541),-0.4727617642418128,-1.2650173024546032,0.166,0.4675733191076829,1.0,8/19,25.12%,PRKN;VPS4B;CHMP3;SDC4;SNF8;RAB7A;SDC1;ATP9A
prerank,negative regulation of organelle assembly (GO:1902116),-0.40406637901534137,-1.264832888699155,0.14794007490636704,0.46734419844038894,1.0,13/35,22.38%,KAT2B;LRRK2;NUPR1;YAP1;SEC22B;CHMP4B;CHMP4A;SMAD4;ODF2L;FEZ2;CDK10;TBC1D7;TCHP
prerank,intracellular protein transport (GO:0006886),-0.2845646307781372,-1.2646808312334288,0.02448210922787194,0.46706063928358,1.0,109/304,26.40%,WLS;RANBP3L;APPL2;TRAK1;PKD1;TLK1;KIF13A;KIF13B;XPO4;TBC1D16;SGSM2;EIF4ENIF1;SNX9;FUT10;SNX6;SEC23IP;STAT3;STX16;RAB22A;STXBP1;VPS26C;SIL1;AP3B1;AP4E1;NUP42;LAMP2;COPZ2;USP6NL;SEC31A;SLU7;ARCN1;ARFGAP3;BAG3;TBC1D2B;HERC2;TBC1D8B;GGA3;NUP214;RPGR;RPL11;GIPC1;IPO13;COG7;STX4;ARFIP2;ARF1;TPR;AP4S1;APPL1;STX5;COPB2;SURF4;TBCK;RAB21;CTTN;GRTP1;TBC1D22B;CTSA;DNAJC27;SMURF1;FAM91A1;TBC1D9;COX18;SNX8;FAM53C;TMED3;WDR11;NAPA;TBC1D17;RANBP3;TMED5;TMED4;RABGAP1;SNF8;SEC16A;DESI1;STX17;RPAIN;TBC1D10A;RAB24;AKT2;GGA2;STX8;IFT27;IPO9;RABL3;VPS26B;CHP1;TNPO3;ARL5A;XPO5;NSF;LMAN1;USO1;XPO1;AP2A1;PREB;SAR1B;PPP1R10;SYK;RAB7A;STX12;PHB2;RAB5A;CLIP3;STX1A;VPS45;TBC1D10B;NUP93
prerank,actin filament depolymerization (GO:0030042),-0.5481447831120542,-1.2643226282181692,0.16506717850287908,0.46725170292669854,1.0,3/11,3.91%,MICAL3;GSN;MICAL2
prerank,bile acid and bile salt transport (GO:0015721),0.44103027026311303,1.2640365277433188,0.1722689075630252,0.563893648395434,1.0,4/24,10.49%,SLCO1C1;NCOA2;SLCO2B1;ABCC4
prerank,digestive tract morphogenesis (GO:0048546),-0.5043232745274439,-1.26395121809595,0.14450867052023122,0.46757468332339974,1.0,8/14,25.77%,PDGFRA;FGFR2;ID2;NIPBL;GLI1;RBPMS2;SOX11;EPHB3
prerank,negative regulation of bone mineralization (GO:0030502),-0.503474894696475,-1.263599418042836,0.1702127659574468,0.4677822758545508,1.0,4/13,16.44%,BCOR;ENPP1;TRPM4;ECM1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.462436767288127,-1.263236517648305,0.14794007490636704,0.46803279596469843,1.0,8/20,18.77%,WNT4;BMP5;WDTC1;ERLIN1;SIK1;FBXW7;SLC27A1;BMP2
prerank,midbody abscission (GO:0061952),-0.4810336437928459,-1.262585021319122,0.17748091603053434,0.46885205481728826,1.0,5/17,10.06%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.5313179059184283,-1.2623203942892416,0.19649805447470817,0.4688803881234952,1.0,5/11,26.43%,GFPT1;UAP1;RENBP;UAP1L1;PGM3
prerank,polyol metabolic process (GO:0019751),-0.3754088533697234,-1.2622745036487883,0.1490125673249551,0.4683824718572474,1.0,11/46,10.26%,PLCE1;SLC5A3;NUDT4;PLCD3;INPP5B;INPP5A;ISYNA1;INPPL1;PLCG1;PLCB3;PLCD1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3838859292224843,-1.261704058749159,0.13142857142857142,0.46912746789965076,1.0,8/43,10.03%,EGFR;ERRFI1;CBLB;RNF115;SNX6;PTPN3;CDC42;PTPN2
prerank,negative regulation of cell population proliferation (GO:0008285),-0.27838668870863614,-1.2614430361512112,0.01680672268907563,0.46906732401000323,1.0,102/351,20.88%,TGFBR3;ALDH1A2;ZBTB7C;APPL2;KANK2;SMAD6;IGFBP5;CELF1;COL4A3;FBLN1;BMP5;MDM4;DIS3L2;KAT2B;BMP4;PDPN;PPM1D;PTPN14;TNS2;PODN;BRD7;FRK;NUPR1;LMNA;GSDME;CLMN;NIBAN2;VGLL4;RBP4;RARG;IGFBP3;TGFB1I1;IGFBP6;OGN;SKI;SPEG;TMEM127;NOX4;LYN;TES;REST;PARP10;WNT9A;P3H3;AR;PTPRK;MAP2K1;CYP1B1;BTG3;MN1;COL18A1;NGF;PTPN2;CCN3;ABI1;ROR2;PDS5B;FAP;HES1;PKD2;APOD;IRF1;ATRAID;FKTN;COPS8;IGFBP7;EIF2AK2;ING5;CD164;RBM5;CBFA2T3;RAPGEF2;EMD;NCK2;MNT;TGFB3;PLXNB1;DUSP10;ADAMTS1;WNT5A;ARID2;MORC3;S100A11;PPP2R5C;SFRP4;SOD2;FGFBP1;IFI35;BMP2;CDK10;INHBA;B4GALT7;PBRM1;CDC73;NF2;IFIT3;PML;FRZB;CDKN1C;NME1;ZBTB49;CDK6
prerank,response to estradiol (GO:0032355),-0.41031934421414074,-1.2613496502457533,0.14953271028037382,0.4687037715711197,1.0,5/31,7.02%,EGFR;LCOR;STRN3;STAT3;ANXA1
prerank,response to UV (GO:0009411),-0.3326522945764821,-1.2611099858090091,0.08745247148288973,0.46864276030963375,1.0,35/95,24.06%,EGFR;INO80;SCARA3;EP300;GTF2H2;CREBBP;UBE4B;DHX36;WRN;PTPRK;DDB2;ZBTB1;BRSK1;PRKCD;USP47;PARP1;ERCC3;EIF2AK4;REV1;UBE2B;ERCC8;MAP2K7;SPRTN;ZRANB3;SDE2;DCUN1D3;MFAP4;MSH6;PCNA;USF1;BMF;ATR;CCAR2;PRIMPOL;USP28
prerank,negative regulation of cell migration (GO:0030336),-0.31171376156841835,-1.260937689107109,0.06387225548902195,0.4684273461979154,1.0,25/137,9.27%,PHLDB2;SULF1;COL3A1;DPYSL3;AFDN;LRP1;DAG1;BMPR1A;VCL;LDLRAD4;TPM1;IGFBP5;FOXO3;ROBO1;JAG1;PODN;IGFBP3;CDH1;HOXA7;CLIC4;EPHA4;RECK;GJA1;PTPRK;CYP1B1
prerank,sulfation (GO:0051923),-0.5434041397744316,-1.2605646584928718,0.17902350813743217,0.4687758403326501,1.0,2/11,10.52%,UST;SULT1A1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.5128556395200625,-1.2604920623701894,0.20186915887850468,0.4683065488993639,1.0,7/13,28.25%,RNF8;NELFB;TCERG1;HNRNPU;RECQL5;NELFA;NELFE
prerank,cellular response to ATP (GO:0071318),0.5057070254028653,1.260377373738464,0.18510158013544017,0.572736977434042,1.0,4/14,11.50%,RYR3;P2RY1;CIB2;P2RX7
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5368153886394876,-1.2597891198223805,0.16911764705882354,0.46931609582008865,1.0,2/11,11.86%,PTGIS;FAP
prerank,regulation of macrophage differentiation (GO:0045649),-0.49167916495115555,-1.259517936171238,0.15917602996254682,0.46933392535064206,1.0,6/15,23.41%,IL34;PTPN2;ID2;INHBA;PRKCA;HSF1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4894055698535925,-1.2594739025857193,0.1948529411764706,0.46882777326446795,1.0,10/16,22.70%,ANK2;GBF1;LRRK2;BCAP29;UBAC2;MIA3;SEC16B;SEC16A;TAPT1;VAPA
prerank,negative regulation of translational initiation (GO:0045947),-0.4997793964039762,-1.2592413359096073,0.19047619047619047,0.46879087571677985,1.0,6/13,24.31%,EIF2AK1;LARP1;TPR;EIF2AK4;RBM4;EIF4EBP1
prerank,response to peptide hormone (GO:0043434),-0.38152400112538276,-1.2590448837067205,0.12570356472795496,0.46864830368794147,1.0,13/43,17.75%,ROCK2;TGFBR3;IGFBP5;ROCK1;IRS1;STAT3;ANXA1;OGT;SLC27A1;STAT1;ZBED3;STAT5A;STAT5B
prerank,sensory perception of sound (GO:0007605),-0.33586763041055434,-1.2587118981415282,0.09320388349514563,0.4688151227633275,1.0,15/88,7.81%,EYA1;ROR1;COL1A1;CEMIP;COL4A3;CDC14A;TBL1X;GSDME;KIT;RIPOR2;DCDC2;EML2;ADGRV1;ATP6V0A4;CACNA1D
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3363552347277593,-1.258647889453475,0.09386973180076628,0.4683627151405712,1.0,19/86,15.36%,BMP6;IGF1;EGFR;EPHA7;ANGPT1;GHR;ABL1;VTN;PAK2;NRP1;IGF2;PRKCD;TEC;IL6R;VEGFA;ACVR1;PRKCZ;PDCL3;ITGA5
prerank,response to steroid hormone (GO:0048545),-0.4126139197953428,-1.2585174388347526,0.16304347826086957,0.468067172941937,1.0,8/31,10.23%,ATP1A2;YAP1;NR3C1;THBS1;TFPI;AR;MED1;NR1H3
prerank,post-translational protein modification (GO:0043687),-0.27965601541872626,-1.2583307601416462,0.02663934426229508,0.46791845392566084,1.0,122/332,29.48%,FSTL1;CP;FBN1;FBXL7;LTBP1;IGFBP5;SDC2;BMP4;SPSB1;FBXW8;KLHL13;BTRC;GPC3;ASB3;IGFBP3;STT3A;ZBTB16;WDTC1;ITIH2;OBSL1;ASB2;FBXL4;FBXL12;FBXO10;IGFBP4;ASB13;KTN1;DDB2;TNC;NUB1;DCAF10;HIF1A;FAM20C;DNAJC3;DCAF6;SERPIND1;LGALS1;PSMF1;FBXL19;FBXL18;RAB11A;LRRC41;CUL3;COPS2;FBXW7;FBXO30;WSB2;FN1;DCAF8;KLHL22;MXRA8;CCN1;COPS8;IGFBP7;APOE;PSMB2;ESCO1;MSLN;MBTPS1;CUL2;ERCC8;KLHL11;DCAF4;FEM1A;ASB5;FBXO22;MIA3;RABGGTB;FBXW11;ATG5;FBXW5;RCN1;DCUN1D3;CHM;SPSB4;COP1;SPP1;P4HB;CUL1;PSMC1;HIF3A;CHML;CUL7;NAE1;FBXW4;SUMF1;WFS1;BTBD1;LAMB2;LAMC1;PSMB6;F5;PSMA3;CALU;PSMA4;RAB8A;FBXL14;KCTD7;FBXO4;PNPLA2;RAB5A;FBXW9;FBXO11;CCDC8;EVA1A;SPSB2;PSME1;PSMD13;MGAT4A;APP;GPS1;KCTD6;PSMB10;PSMA5;SPSB3;ASB6;FBXL3;PSMB9;ICMT;KBTBD7;RBX1;PENK
prerank,neuron differentiation (GO:0030182),0.3064594051159848,1.2579144843820356,0.05973025048169557,0.5782979755135598,1.0,36/165,16.99%,PHOX2A;SPOCK1;MYT1L;PTPRD;IRX2;IL1RAPL1;TENM2;PBX2;TENM1;EPHA5;NTRK2;TENM4;NEUROD6;FUT9;TGFB2;ALK;SNPH;LHX1;WNT7B;TENM3;ITM2C;RNF112;ERCC2;ATP8A2;BRSK2;FZD4;RORB;XBP1;ATP2B2;PPT1;ACSL3;SOX4;LMX1B;PBX4;DDIT4;CTNNB1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5090498941635214,1.2577944643510675,0.19088937093275488,0.577072661512951,1.0,7/12,20.31%,SEPHS2;PHGDH;MTHFD1;GGT1;SEPHS1;SERINC3;SRR
prerank,negative regulation of inclusion body assembly (GO:0090084),0.5376266353761753,1.2572322011507657,0.18,0.5771489488652723,1.0,4/10,16.45%,SACS;DNAJA4;SORL1;DNAJB2
prerank,nucleic acid metabolic process (GO:0090304),-0.3496985002919207,-1.2567423754703098,0.11089494163424124,0.4711482526125238,1.0,33/69,33.62%,RBFOX2;HNRNPH1;ENPP1;HNRNPR;WTAP;HNRNPM;HNRNPD;PCBP2;WRN;HNRNPK;DUSP11;XRN2;MMS19;HNRNPU;POLR2H;HNRNPA3;GTF2F1;POLR2K;DNASE2;POLR2E;RECQL5;NCBP2;PDE12;DNASE1L1;POLR2D;HNRNPL;KPNA2;LSM1;WDR74;PCBP1;RBMX;HNRNPA2B1;RAN
prerank,positive regulation of protein secretion (GO:0050714),-0.35029390283794537,-1.2567122145762861,0.09163346613545817,0.47060744747578603,1.0,12/69,10.53%,BMP6;WLS;IGF1;TCF7L2;MCU;NLGN2;RBP4;DNM1L;GLUD1;NNAT;UNC13B;ADAM9
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.47798060864938946,-1.2566750099771113,0.20342205323193915,0.4700680617751027,1.0,5/17,7.81%,ATP1A2;CACNA1C;ANK2;KCNJ2;CACNA1D
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4344704091147369,1.255805695343893,0.18789144050104384,0.5796589603860784,1.0,8/23,15.73%,FAR2;ELOVL7;DGAT2;TECR;ACOT7;HACD1;FAR1;ACSL3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4974371000663509,1.2551320653357778,0.19134396355353075,0.58008197488407,1.0,4/13,13.00%,TMEM30A;SAR1A;BRSK2;SORL1
prerank,activation of GTPase activity (GO:0090630),-0.33244936974590417,-1.2545957087346755,0.10694183864915573,0.4743633431865953,1.0,28/89,21.64%,ARHGAP29;ARHGAP42;SIPA1L1;NTRK3;TIAM2;TBC1D16;DOCK7;ARHGAP24;BCR;SGSM2;BCAS3;GMIP;USP6NL;TBC1D2B;TBC1D8B;TBCK;GRTP1;TBC1D22B;TBC1D9;NGEF;TBC1D17;SIPA1L3;RALGAPB;RABGAP1;TBC1D7;TBC1D10A;RALGAPA2;SCRIB
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.4654972745174438,-1.2541835194746591,0.19433962264150945,0.4746691438596945,1.0,8/18,31.48%,VGLL4;CTSC;DACT1;APOE;ATP5IF1;MSN;CD81;RDX
prerank,chromatin organization (GO:0006325),-0.31154237184030936,-1.2537151793201426,0.0745697896749522,0.47526238493777107,1.0,52/132,29.13%,HDAC8;INO80;SETD7;BRWD1;KAT2B;HDAC4;SETD5;TOP1;EZH1;BAZ1A;BAZ2A;KDM4B;SMARCC2;NUDT5;KDM5B;MYSM1;ZBTB1;KDM6A;SETD2;HCFC1;MCM3AP;SETDB1;TCF7L1;RB1;EHMT1;PHF1;HDAC1;JARID2;SMARCD2;BAZ2B;BAZ1B;TAF6L;HMG20A;BPTF;CDAN1;PBRM1;PIH1D1;EZH2;HMGN3;SMARCD3;HDAC2;SNAI1;FAM50A;INO80C;ZBTB7A;HDAC3;MPND;ATRX;SAFB;ESR1;SUPV3L1;RUVBL2
prerank,regulation of intracellular signal transduction (GO:1902531),-0.27332004238459257,-1.252546418530887,0.014056224899598393,0.4774878974681985,1.0,122/420,20.84%,AKAP13;PTPN13;PRKAG2;ARHGAP29;EGFR;ARHGAP10;ARHGAP6;RHOQ;NTRK3;ZFAND6;ARHGAP28;ARAF;MDM4;ITGAV;FGF1;ARHGAP20;STK3;EP300;TIAM2;LRRK2;WWC2;PRKAA2;ARHGEF17;ARAP1;BRD7;RHOJ;RBBP8;MYO9A;AKAP12;NRK;MAPKAP1;TAF3;ARHGAP24;BCR;INPP5B;USP7;DLG1;LBH;PAK2;NBN;UFL1;MAP4K4;TAOK3;TMBIM4;TMEM127;GMIP;LYN;ARHGAP21;MTOR;PLEKHG2;CDC42;VAV2;PDPK1;PIP4K2C;TTI1;WRN;TAF4;TBP;ARHGAP17;XIAP;PTPN22;CHD4;HIPK1;CHD3;TRIP10;TRAF2;RHOA;RPL11;ARHGEF12;RHOT1;PRKAB2;ARHGEF18;RCN3;WWC1;ARHGAP32;SOS2;TELO2;CASTOR2;RASSF2;EHMT1;RICTOR;FGD1;TBCK;ARHGDIB;ING5;FGD4;VEGFA;USP2;HDAC1;CSNK2A1;TAF13;NGEF;PRMT5;CMKLR1;ARHGAP18;NOP53;MRE11;ARHGEF11;TRAF3;TRIO;ARHGEF6;TTC5;DAPK2;WNT5A;ARHGEF1;PRKAA1;PPP2R5C;ARHGAP15;TRAF6;RHOH;MYOC;RHOC;KMT5A;CDK2;TAOK1;NF2;MAP2K6;PML;GPAT3;TAF12;ARHGAP12;PRKAG3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5132634111955188,-1.252051297961432,0.18857142857142858,0.47806193067977615,1.0,5/13,17.09%,TNRC6B;TNRC6A;EIF4ENIF1;TNRC6C;CNOT1
prerank,positive regulation of axon extension (GO:0045773),0.438632775182544,1.2515721810917932,0.16666666666666666,0.5886439203064165,1.0,5/22,9.97%,DSCAM;SEMA7A;SHTN1;CDKL5;NTN1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.473924095869873,-1.251429502029495,0.18850987432675045,0.4789821096839369,1.0,5/17,3.07%,NOTCH2;SMAD6;BMP4;ROBO1;JAG1
prerank,regulation of embryonic development (GO:0045995),-0.4112579680551445,-1.2509837817442895,0.1540041067761807,0.47940236183812085,1.0,9/34,14.74%,PHLDB2;DAG1;TRIP12;WDPCP;NIBAN2;DHX36;NIPBL;EHMT1;ZBED3
prerank,brain development (GO:0007420),0.31341994870303624,1.2506593017239651,0.08835341365461848,0.5896035605385408,1.0,26/136,10.81%,ADGRL3;CNTNAP2;GRIN1;CTNNA2;SLC6A17;PROX1;PBX2;GRIN2A;SHANK3;CDH2;PAX2;GRIN2B;MFSD2A;GRIN2D;AATK;PITPNM1;DSCAML1;ROBO2;UBE3A;RELN;ADGRL2;PHGDH;FOXJ1;SPEF2;HAP1;CNTN4
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5320991899985046,1.250604265942826,0.19222462203023757,0.5881891262309059,1.0,3/10,11.89%,DLGAP1;DLGAP2;NPTX1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.525212759893154,-1.250264338594483,0.1718146718146718,0.4805475045043028,1.0,3/12,17.43%,RBP4;STRAP;TLR4
prerank,positive regulation of neuron projection development (GO:0010976),0.33852646675164655,1.2502383738675165,0.11287128712871287,0.5876878590336706,1.0,21/85,9.89%,RIT2;LRP8;LRRC7;PLXNB3;S100A9;ITGA6;MAGI2;TOX;NTRK2;SCARF1;FUT9;ALK;NPTN;PLPPR5;TENM3;NDNF;SCARB2;STMN2;ZDHHC15;RELN;DAB2IP
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.484055948276574,1.250106963808623,0.17525773195876287,0.5865442464411948,1.0,1/15,0.37%,PLTP
prerank,mitotic spindle assembly (GO:0090307),-0.37584088407070126,-1.2499253791150051,0.15031315240083507,0.48068636903731043,1.0,24/42,36.82%,FLNA;PIBF1;SPICE1;STAG1;RHOA;LSM14A;RAB11A;ABRAXAS2;TOGARAM1;MAP9;STAG2;SMC1A;BCCIP;KIF23;ABRAXAS1;KIF11;RACGAP1;MZT1;KIF2A;PRC1;SMC3;MISP;TPX2;KIFC1
prerank,modulation by symbiont of host process (GO:0044003),0.5307121057788418,1.2498489976675191,0.19736842105263158,0.5856767032948261,1.0,6/10,19.23%,RPS27A;UBC;TLR2;UBB;B2M;HGS
prerank,regulation of monooxygenase activity (GO:0032768),0.43472260253590256,1.249179202219009,0.15942028985507245,0.5859981905031922,1.0,9/23,18.04%,NOSTRIN;SNCA;NOS3;LYPLA1;AKT1;CALM1;HSP90AA1;NOSIP;DDAH1
prerank,fluid transport (GO:0042044),0.5151143125748102,1.248882027213301,0.21875,0.5854011646703395,1.0,3/12,12.21%,AQP9;AQP11;AQP4
prerank,response to glucocorticoid (GO:0051384),-0.42840777154635257,-1.2488719623234095,0.18352059925093633,0.48260038871630373,1.0,11/26,30.89%,NR3C1;ANXA1;REST;ADAM9;FAM107A;HNRNPU;SLIT2;ZFP36L2;GOT1;UBE2L3;BCL2L11
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.4616300653183397,-1.2486425516706123,0.17540687160940324,0.482577419571431,1.0,12/18,35.10%,ABL1;POR;ABL2;AGTR1;RFK;PARK7;FXN;SIRT3;EDN3;GDNF;ATP7A;PDP2
prerank,modulation by host of viral genome replication (GO:0044827),-0.504046051465171,-1.2468144242977108,0.18700787401574803,0.4862364980119511,1.0,6/13,22.70%,PRKN;CCNK;TBC1D20;EIF2AK4;IFI27;VAPA
prerank,fat cell differentiation (GO:0045444),-0.3590207288715168,-1.2465065534272977,0.13872832369942195,0.4863688431375154,1.0,24/57,28.24%,PID1;TCF7L2;SMAD6;EP300;BBS9;WNT5B;OSBPL8;OSBPL11;PPARGC1A;MED1;FAM120B;C1QTNF3;NR4A1;NR4A2;METRNL;AKT2;SENP2;MAFB;ZBTB7A;BSCL2;CLIP3;BBS4;ERAP1;BBS2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3411875947706808,1.2463255240209845,0.11134903640256959,0.5911655448225178,1.0,19/76,15.06%,GRM5;GRM1;HTR2C;TACR1;GPR35;P2RY1;HOMER1;GPR17;ADRA1D;ADRA1A;TRHR;OPRM1;F2RL2;F2R;GRPR;OPRK1;CCKBR;CHRM2;OPRL1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5068181038045613,1.2463057842161056,0.20496894409937888,0.5896828763377371,1.0,6/13,14.31%,ANK3;SLC8A1;CALM1;PDE4D;CALM2;CALM3
prerank,positive regulation of protein catabolic process (GO:0045732),-0.3332669216410504,-1.246195978889993,0.10526315789473684,0.48655767796923904,1.0,23/84,18.42%,SMURF2;PRKN;WWP2;GSK3B;VGLL4;GPC3;HUWE1;SNX9;AXIN1;WWP1;SEC22B;DACT1;NRDC;ADAM9;STX5;APOE;SMURF1;CSNK2A1;ADRA2A;ASB5;WNT5A;AREL1;VCP
prerank,regulation of potassium ion transport (GO:0043266),0.41142466690566454,1.246182890053053,0.15478615071283094,0.5885111018025797,1.0,7/31,7.96%,DPP10;KCNIP4;KCNN2;ANK3;KCNIP1;DPP6;KCNAB1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.44445884856703377,-1.2460669996830402,0.18579234972677597,0.4862720235746642,1.0,8/20,25.49%,HOXA5;ZBTB16;CTR9;HSPA9;CDC73;CDK6;MAFB;LDB1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5342853308897513,-1.2458697414382007,0.20185185185185187,0.4861219211922309,1.0,8/10,36.86%,RIOK3;SEC14L1;GPATCH3;DHX58;C1QBP;UFD1;TKFC;TSPAN6
prerank,microtubule depolymerization (GO:0007019),0.47269201085836443,1.2457993842619521,0.20638297872340425,0.5882182569006184,1.0,6/17,18.20%,STMN1;STMN4;STMN2;KIF19;STMN3;KIF18A
prerank,lymphocyte differentiation (GO:0030098),-0.34415486207952417,-1.2457959307776065,0.12770137524557956,0.48566925379347753,1.0,24/68,26.70%,PBX1;LEPR;AXL;HDAC4;KIT;ITGB1;DCAF1;CEBPG;PTPN22;PTPN2;TCF3;CHD7;ITGA4;KLF6;PIK3CD;BLNK;RHOH;RABL3;VCAM1;GPR89B;GPR89A;ZBTB7A;LMBR1L;NFIL3
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.5378360050333937,-1.2457883860903667,0.21014492753623187,0.4850603537217422,1.0,6/10,26.22%,DHX36;CPEB1;CDC73;NUDT21;HSF1;NCBP2
prerank,regulated exocytosis (GO:0045055),0.30315694685000605,1.245582262565584,0.06693711967545639,0.5873336454136271,1.0,35/173,12.38%,SYT1;PCYOX1L;RIMS1;PCLO;SYT6;STEAP2;SYT7;TMSB4X;RIMS2;SYT12;SYT11;SNAP25;RIMS3;GAS6;SNCA;PCDH7;FERMT3;TGFB2;WDR1;CLU;PECAM1;SYT10;ITIH3;TIMP1;SELENOP;CYRIB;SCG3;PDGFB;ABCC4;CPLX1;CALM1;SYT2;ITGA2B;TUBA4A;VWF
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4743084465310683,1.245496597453474,0.21336206896551724,0.5860819472168405,1.0,4/16,10.83%,MRAP2;NECAB2;GRP;PDE6H
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.4525694928552505,-1.24539443240108,0.19845857418111754,0.4847099128538137,1.0,8/20,24.26%,ACADSB;IVD;HIBCH;MCCC2;ALDH6A1;BCKDK;HIBADH;AUH
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.4525694928552505,-1.24539443240108,0.19845857418111754,0.4847099128538137,1.0,8/20,24.26%,ACADSB;IVD;HIBCH;MCCC2;ALDH6A1;BCKDK;HIBADH;AUH
prerank,mesenchyme development (GO:0060485),-0.4814156026109375,-1.2450670954175227,0.18846153846153846,0.4848474221642656,1.0,5/15,12.34%,TGFBR1;BMP7;BMP4;FGFR2;PKD2
prerank,negative regulation of protein modification process (GO:0031400),-0.3368966642661836,-1.24448284837381,0.11026615969581749,0.485607901421823,1.0,13/79,4.83%,PTPN13;PID1;LRP6;NTRK3;FBLN1;PLPP3;PRKN;LRRK2;PRKAA2;IBTK;GSK3B;SNTA1;IGFBP3
prerank,regulation of signal transduction (GO:0009966),-0.29662153144851017,-1.2444269041898484,0.047325102880658436,0.4851122796118069,1.0,55/190,18.48%,SULF1;GRK5;ZIC1;PLCE1;IGFBP2;FBXL17;IGFBP5;MDFIC;LRRK2;ELF1;CD55;DCDC2;IGFBP3;IGFBP6;RSPO3;AXIN1;PLSCR1;IFT81;CREBBP;DTNBP1;FGFR2;GAS1;RUNX1;IRAK2;GRK4;DHRS3;POFUT1;IGFBP4;SP100;GRK3;USP33;PTPN2;TULP3;RORA;TRIM5;UGCG;TCF7L1;CDC42SE2;CASTOR2;OGT;GLI1;IGFBP7;ACVR1;NCK1;NCK2;PTCH1;GRK6;TSPAN15;FOXL1;GLRX2;RIC8B;WDR11;PRKD1;PTPN1;SLC8A3
prerank,T cell activation (GO:0042110),-0.3410485662978668,-1.244289321514206,0.12601626016260162,0.48483780070246496,1.0,19/69,23.39%,LEPR;KIF13B;KIT;CXADR;DPP4;PTPN22;PTPN2;EIF2AK4;CHD7;NCK1;NCK2;CTPS1;PIK3CD;RHOH;MSN;SCRIB;GPR89B;GPR89A;NLRC3
prerank,positive regulation of nervous system process (GO:0031646),0.4477608375838241,1.2431946716027311,0.17849462365591398,0.5913252625017216,1.0,5/18,9.18%,RIMS1;RIMS2;TENM4;ATPSCKMT;TPPP
prerank,pyroptosis (GO:0070269),-0.4920510306848713,-1.242971153708821,0.1857707509881423,0.48725376990607766,1.0,9/15,41.55%,GSDME;DHX9;GSDMD;APIP;ZBP1;CASP1;CASP4;TREM2;NLRC4
prerank,regulation of peptidase activity (GO:0052547),-0.4523630381830112,-1.2426440346437648,0.20411985018726592,0.4874280180362189,1.0,9/19,34.04%,CTSH;NRDC;RCN3;HDAC1;ECM1;PSMA3;CAV1;PSMB8;FURIN
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.45821841815424935,-1.242508894884113,0.1836734693877551,0.48714711576273284,1.0,11/19,35.44%,DDO;ASPA;DLST;ALDH7A1;PIPOX;PHYKPL;GOT1;GCDH;HYKK;GOT2;AASS
prerank,liver development (GO:0001889),-0.40188325606640274,-1.2422061121599348,0.17425742574257425,0.4872848478130975,1.0,12/32,21.31%,TGFBR3;WNT4;ANXA1;CEBPG;PHF2;ARID5B;PKD2;PCK2;CCDC39;CITED2;ZIC3;CDK5RAP3
prerank,regulation of presynapse organization (GO:0099174),0.4564408905262649,1.2421748777096737,0.1735357917570499,0.5912438040449193,1.0,6/18,8.22%,PTPRD;LRFN5;IL1RAPL1;SNCA;LRRC4B;IL1RAPL2
prerank,regulation of presynapse assembly (GO:1905606),0.4564408905262649,1.2421748777096737,0.1735357917570499,0.5912438040449193,1.0,6/18,8.22%,PTPRD;LRFN5;IL1RAPL1;SNCA;LRRC4B;IL1RAPL2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4586840381963686,-1.2421004013451808,0.16390423572744015,0.4869068921491544,1.0,7/19,16.50%,WNT4;VIM;BMP4;RUNX1;EMILIN1;TGFB3;SUCO
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.543442457020246,1.2415153069596994,0.2234762979683973,0.5915822280430809,1.0,3/10,10.17%,SIRT1;SNCA;SET
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.36166094767433327,-1.2413286849961058,0.1504950495049505,0.4881296399792884,1.0,9/52,5.12%,EGFR;LRP1;SORBS1;EPHA3;EPB41L2;NUMA1;PTPN9;DLG1;ITGB1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3785981796330156,-1.241119862388193,0.11776061776061776,0.4880371498697853,1.0,17/44,22.49%,GSN;FCHSD2;BAIAP2L1;SNX9;VASP;CDC42EP5;FER;NCKAP1;CTTN;NCK1;WHAMM;CARMIL1;NCK2;CDC42EP4;LMOD1;BAIAP2;CDC42EP1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3929224897563549,1.2395176108330543,0.15665236051502146,0.595721744504074,1.0,8/35,4.44%,SEMA3C;PLXNB3;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,regulation of macroautophagy (GO:0016241),-0.3216955312688085,-1.2394664260090826,0.09741550695825049,0.4915566528787834,1.0,17/105,11.15%,PRKAG2;DCN;SMG1;ATP6V1B2;LRRK2;PRKAA2;RPTOR;TBK1;ATP6V0D1;SNX6;UBQLN1;MTOR;LARP1;SESN1;RB1CC1;PRKAB2;PAFAH1B2
prerank,negative regulation of reproductive process (GO:2000242),-0.4650396721679606,-1.239425416042486,0.17475728155339806,0.4910312966789463,1.0,5/17,14.52%,SULF1;IGF1;GJA1;ARHGDIB;DUSP1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.4958142937445856,-1.2391513283716677,0.2007366482504604,0.4910552998901933,1.0,5/14,14.36%,SMURF2;YTHDF3;GJA1;ARHGDIB;VEGFA
prerank,ephrin receptor signaling pathway (GO:0048013),0.33094572880738815,1.238768720106143,0.11479028697571744,0.5964887654112281,1.0,23/82,14.65%,GRIN1;ANKS1B;ACTB;EPHA6;EPHB1;GIT1;EPHA5;AP2M1;VAV3;GRIN2B;EFNB3;PSENEN;PAK1;EFNA2;EPHA10;AP2B1;CHN1;KALRN;EPHA1;HRAS;PSEN1;ARHGEF7;PAK3
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.3497383097989315,-1.238352816472434,0.13250517598343686,0.4924715502966389,1.0,30/63,28.60%,TIMP3;LEPR;EIF4G3;ROCK1;NUPR1;ZKSCAN3;STAT3;BCL2;PTPN3;MTOR;FOXK1;PTPN22;EIF4E;KLHL22;ATRAID;FOXK2;DAP;RUBCN;EIF4G1;TIMP2;CDK5RAP3;BMF;RGP1;WDR6;DAPL1;RRAGA;HGF;RIC1;MET;MT3
prerank,positive regulation of kinase activity (GO:0033674),0.31995936920504847,1.238319209337981,0.09940357852882704,0.596329322169947,1.0,19/107,9.08%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;MMD2;EPHB1;TIE1;EPHA5;GAS6;KDR;NTRK2;FLT3;ALK;MAPRE3;ADCYAP1;EPHA10;RELN
prerank,negative regulation of neurogenesis (GO:0050768),0.3950052479364356,1.2381906805235605,0.18395303326810175,0.5951731944369313,1.0,12/34,14.97%,MAG;MCF2;THY1;EFNB3;OMG;NOTCH1;LINGO1;RTN4R;SORL1;B2M;RTN4;GDI1
prerank,cellular response to dsRNA (GO:0071359),-0.48619547438648725,-1.238043699144498,0.188715953307393,0.4925549270488319,1.0,11/15,38.69%,DHX9;MAVS;RIOK3;PDE12;MUL1;CGAS;IFIH1;CAV1;ZCCHC3;NPM1;FLOT1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5099553123878146,-1.237984439901276,0.20297951582867785,0.49208614638448933,1.0,2/12,0.78%,NOTCH2;DOCK11
prerank,neuron remodeling (GO:0016322),0.5242041076838169,1.2379548262414268,0.2224622030237581,0.5944058395238546,1.0,2/10,5.01%,ADGRB3;SCARF1
prerank,regulation of tube diameter (GO:0035296),-0.5035447462547191,-1.2379178590867104,0.226691042047532,0.4910449584656252,1.0,4/13,12.26%,ROCK2;ROCK1;ADCY6;AGTR1
prerank,vascular process in circulatory system (GO:0003018),-0.5035447462547191,-1.2379178590867104,0.226691042047532,0.4910449584656252,1.0,4/13,12.26%,ROCK2;ROCK1;ADCY6;AGTR1
prerank,regulation of spindle assembly (GO:0090169),-0.43168698471062783,-1.2378937502829563,0.17810760667903525,0.4904906437094,1.0,10/25,20.16%,NUMA1;VPS4B;CHMP4B;SENP6;CHMP5;CHMP3;TPR;DYNC1H1;HNRNPU;EML3
prerank,response to fatty acid (GO:0070542),-0.46879123792797106,-1.2372197036239783,0.20272904483430798,0.49154077773312777,1.0,3/17,4.52%,PID1;FOXO3;IRS1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.41091555791018053,-1.2371473677188676,0.15338645418326693,0.4910984108942876,1.0,13/29,23.13%,VTI1A;VTI1B;COPB1;COPZ2;COG3;GOSR1;COPB2;COPG2;GOSR2;NAPA;COPG1;COPE;NSF
prerank,actomyosin structure organization (GO:0031032),-0.33663090415769825,-1.235808692723306,0.12915851272015655,0.49382866246486057,1.0,16/75,12.57%,ROCK2;PHACTR1;SORBS1;FRMD6;TPM1;EPB41L5;EPB41L2;ROCK1;ITGB1;TMOD3;ITGB5;ACTN2;TNFAIP1;RHOA;ZYX;CUL3
prerank,calcium ion transmembrane transport (GO:0070588),0.32824002707263344,1.235496655070829,0.12237093690248566,0.5998789688247823,1.0,15/86,6.45%,SLC24A4;SLC24A2;GRIN1;TRPC5;CACNA1A;GRIN2A;RYR3;GRIN2B;CACNA2D1;GAS6;GRIN2D;SLC8A1;ATP2B3;SLC25A23;TRPM2
prerank,mitotic sister chromatid segregation (GO:0000070),-0.3213536278021365,-1.2354570382626615,0.09274193548387097,0.49413134753526644,1.0,25/98,15.45%,INO80;EML4;DIS3L2;PIBF1;VPS4B;PHF8;SMC4;AKAP8L;CHMP4B;CHMP4A;PDS5A;CHMP5;CHMP3;NIPBL;RAD21;PDS5B;RAB11A;CUL3;RB1;KLHL22;BECN1;NUDC;MCPH1;ZWINT;CSNK2A1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5308944207879485,-1.235269210942063,0.2261682242990654,0.4940138243559404,1.0,3/10,6.91%,HMGB1;SH3RF1;RUNX1
prerank,cellular response to peptide (GO:1901653),0.3593529047751323,1.2350979989585806,0.14198782961460446,0.5995614226613822,1.0,14/56,13.89%,IGF1R;GRM5;GRIN1;CACNA1A;GRIN2A;RPL23;CACNA2D1;ATP1A3;DDX11;ARHGEF2;NOD1;XBP1;PSEN1;CD36
prerank,secretory granule organization (GO:0033363),-0.5377213380407633,-1.2349785431201628,0.224105461393597,0.4941208129325128,1.0,2/10,6.34%,ABCA1;DTNBP1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.36278471777021976,-1.2349759937956144,0.14959016393442623,0.49351592644370185,1.0,23/52,28.16%,SAMD4A;PAN3;DDX6;RC3H1;TUT4;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9;CNOT2;PAN2;CNOT1;CNOT10;EXOSC3;CNOT4;TNKS1BP1;LSM6;PNLDC1;PDE12;DIS3;POLR2D;PARN
prerank,protein kinase B signaling (GO:0043491),0.442892074567889,1.2347953582460784,0.1740041928721174,0.599006394589937,1.0,6/23,11.13%,PAX2;GAS6;KDR;AKT1;CCL2;PIK3R3
prerank,diol metabolic process (GO:0034311),0.4551929533445459,1.234297284776835,0.1858974358974359,0.5989935948499248,1.0,9/19,17.88%,DEGS2;NOS3;PRKG2;SGPP2;AKT1;CALM1;GCH1;HSP90AA1;SGPP1
prerank,negative regulation of wound healing (GO:0061045),-0.410721152371772,-1.2339553946322661,0.15311909262759923,0.4953684584942075,1.0,7/28,17.01%,PHLDB2;VTN;TFPI;SLC12A2;CD109;APOE;SERPINE1
prerank,autophagosome assembly (GO:0000045),-0.3676657253363233,-1.2337657238936417,0.12573673870333987,0.49523088370012674,1.0,24/52,26.45%,UBXN2B;UBQLN1;RB1CC1;WIPI1;ATP2A2;ULK2;BECN1;ATG2A;PIK3C3;SMURF1;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;WIPI2;STX17;ATG14;MAP1LC3A;RAB7A;IRGM;STX12;MFN2;ATG3
prerank,erythrocyte development (GO:0048821),0.5282823911027519,1.2336161246944348,0.2267818574514039,0.5994312653129015,1.0,1/10,0.29%,ALAS2
prerank,regulation of axonogenesis (GO:0050770),0.3605078958100728,1.2336068221940293,0.1434108527131783,0.5979840087949102,1.0,16/51,11.20%,LRRC4C;MAG;PLXNB3;MCF2;CDH2;NTRK2;THY1;EFNB3;OMG;PAK1;LINGO1;PLXNA4;ROBO2;RTN4R;CHN1;BRSK2
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3503972140043286,-1.2332954092898702,0.11573236889692586,0.4957409786643516,1.0,23/66,21.31%,ZIC1;SMAD3;YAP1;FLNA;UBR5;CCT6A;CDH1;EIF2AK3;JUP;BAG3;PRKCD;PARP9;MAVS;CCT8;TPR;DTX3L;CCT5;EFCAB7;PARK7;ORMDL3;TERT;PIK3R1;CDK5RAP3
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.4073648456122976,1.2332907012014438,0.17453798767967146,0.597467414741059,1.0,10/30,14.52%,DACH1;HNRNPC;TERF1;ACVRL1;TEN1;PIF1;MEN1;BMPR2;TINF2;CDKN1A
prerank,regulation of microtubule-based process (GO:0032886),-0.3826751413306044,-1.2332878525421447,0.15324165029469547,0.49515466820343307,1.0,6/36,4.00%,PHLDB2;EPHA3;DIAPH1;ROCK1;PRKAA2;GSK3B
prerank,spinal cord development (GO:0021510),-0.5069623936221995,-1.2331280352756109,0.22700587084148727,0.4949065790217225,1.0,5/12,15.98%,PKD1;GLI2;VIT;PKD2;LOXL3
prerank,telomere maintenance via recombination (GO:0000722),-0.5130323450373476,-1.232566361852058,0.20825852782764812,0.4956916005803325,1.0,4/11,11.74%,SMC6;NSMCE2;SMC5;RAD51D
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4781329030074041,-1.2318353386989294,0.20257826887661143,0.4968048106361873,1.0,5/15,13.44%,EGFR;RBPJ;PTPN12;FER;RHBDF1
prerank,aortic valve development (GO:0003176),-0.39937917764707254,-1.231762584978549,0.18484288354898337,0.4963630395574473,1.0,7/34,3.07%,ROCK2;SMAD6;ROCK1;BMP4;ROBO1;ELN;JAG1
prerank,positive regulation of cartilage development (GO:0061036),-0.4724309653597176,-1.2317325311988314,0.18689788053949905,0.49584075079334766,1.0,7/17,21.69%,SOX5;BMP4;ZBTB16;SOX6;BMP2;PKDCC;TAPT1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.26281991172231395,-1.2308935018424056,0.008403361344537815,0.4971985615556467,1.0,138/509,22.26%,WLS;AKAP13;ROCK2;IGF1;ROR1;EGFR;LPAR1;SASH1;NFAT5;TCF7L2;GAB2;TGFBR1;PDGFRA;ANGPT1;NTRK3;DCN;LIMS1;PELI2;ANKRD17;UBE2N;ITGAV;CFLAR;KSR1;FGF1;PDGFRB;TRIM44;AXL;EP300;ROCK1;MAP3K3;PRKN;NR3C2;NUPR1;ADRA1B;GSDME;KIT;RPTOR;OSBPL8;PUM2;FLNA;RYK;TBK1;IRS1;HMGB1;ITGB1;DNM1L;THBS1;TFG;ALPK1;ADGRV1;FGFR2;SHC1;BCL2;LYN;TRIM8;TRAF3IP2;F3;PUM1;PDPK1;DHX36;IGF2;GJA1;MIER1;FRS2;TRAF2;PDGFC;RHOA;DDX60;ZDHHC13;KL;MAVS;BCLAF1;WWC1;FNIP1;LGALS1;ROR2;TRIM5;WDR59;TRIM25;FN1;RICTOR;PPM1A;PIK3AP1;BECN1;LTBR;P2RY12;EIF2AK2;EPHA8;TXN;VEGFA;DDX3X;RAPGEF2;P2RX4;MAP3K14;PLXNB1;TNIP2;IAPP;ECM1;ADRA2A;IL18;PDCD4;IKBKE;PIK3CD;TLR4;WNT5A;PRKD1;CC2D1A;CX3CR1;TRAF6;GCNT2;IFI35;BMP2;PARK7;MYOC;RHOC;TMED4;HBEGF;NRG4;GAB1;PTPN11;NEK6;IRAK1;CARD16;FIS1;TRIP6;FGFR4;PIK3R1;SHARPIN;CDK5RAP3;AKT2;LARS1;BMF;FGF2;CXXC5;DLG5;WNT16;TRAF5;SPHK1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.493663265522345,-1.230713416886645,0.22304832713754646,0.4970457293973883,1.0,6/14,19.13%,FOXC1;NRP1;VEGFA;VEGFD;PIK3CD;GAB1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.49569402910989485,-1.2306993088583373,0.21521335807050093,0.49647370530559526,1.0,3/13,6.91%,GLI3;TGFBR2;RUNX1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.44056313357660004,1.230616657972283,0.1987179487179487,0.6039268765056972,1.0,5/23,11.40%,KIF1A;HOOK1;MAP6D1;MYO10;CCDC88A
prerank,protein localization to membrane (GO:0072657),0.29554278912476145,1.230506573573897,0.07942973523421588,0.6027630633242446,1.0,27/187,7.35%,BSG;DLG2;DPP10;EFR3B;NRXN1;LRRC7;MRAP2;KCNIP4;SPTBN4;NLGN1;RAMP2;MAGI2;ANK3;SHANK3;RAB3C;FGF13;LIN7A;TNIK;GAS6;MAP7;THY1;NRXN2;DPP6;ZDHHC22;P2RY1;EPB41L3;CACNB2
prerank,regulation of actin filament polymerization (GO:0030833),-0.33975843227985436,-1.2303315111201412,0.12133072407045009,0.49678613105405106,1.0,35/69,30.42%,ARHGAP28;FCHSD2;BAIAP2L1;SNX9;ARFGEF1;PLEKHG2;VASP;CDC42EP5;FER;PRKCD;NCKAP1;CTTN;NCK1;LATS1;CARMIL1;NCK2;RASA1;ARHGAP18;CDC42EP4;MYADM;LMOD1;BAIAP2;CDC42EP1;HIP1R;GBA2;SLIT2;ABITRAM;KANK1;TWF1;TWF2;SSH3;SSH2;PFN2;KANK4;ARF6
prerank,regulation of leukocyte migration (GO:0002685),-0.4704037820846676,-1.2302287487814076,0.22456813819577734,0.49638815439869566,1.0,5/16,18.46%,HOXA7;ANXA1;VEGFA;MIA3;RHOH
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.4005390200596103,-1.2300255580060047,0.15399239543726237,0.4962630845359102,1.0,5/31,1.51%,TGFBR3;TGFBR1;BMPR1A;TPM1;RBPJ
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.4153911279389793,-1.2295600027523252,0.1840607210626186,0.4968130116628584,1.0,14/25,31.44%,SRSF10;SF3B1;PRPF6;SLU7;PRPF3;SCAF11;SF3A3;DDX23;GEMIN2;SRRM1;PRPF8;MPHOSPH10;LSM1;SF3B4
prerank,mitochondrion localization (GO:0051646),-0.45595932199830463,-1.2294585880262159,0.19001919385796545,0.49648859746865576,1.0,6/19,15.68%,TRAK1;LRRK2;MEF2A;NECTIN2;ZBED3;MARK1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4926601354864317,-1.2291422475511629,0.1958568738229755,0.49661319549851735,1.0,3/13,7.27%,IGF1;SOAT1;RAMP1
prerank,regulation of DNA metabolic process (GO:0051052),-0.3698444963214931,-1.2291399378041716,0.1580952380952381,0.4960191791313506,1.0,10/44,13.02%,SMG6;HDAC8;UBE2N;SMG1;NBN;YLPM1;HNRNPD;UPF1;MPHOSPH8;KDM1B
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5135592473710878,1.2291346833136574,0.25162689804772237,0.6053221760097517,1.0,4/11,16.96%,EXOSC5;FBL;DKC1;EXOSC4
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.49175462051665,-1.2289567021343364,0.21442495126705652,0.4959096863895451,1.0,6/15,20.62%,LRP1;PDPN;DPP4;FAP;DDR1;FGFR4
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4405481079428373,1.22871717899883,0.21794871794871795,0.6050617441288437,1.0,6/20,15.73%,FAR2;DGAT2;SCD;FAR1;PPT1;ACSL3
prerank,regulation of gluconeogenesis (GO:0006111),-0.4160877039985247,-1.2283435331685297,0.18198198198198198,0.496782706926435,1.0,10/27,15.61%,EP300;USP7;PPARGC1A;CLK2;SELENOS;PTPN2;ZNF692;SIK1;OGT;C1QTNF3
prerank,regulation of proteolysis (GO:0030162),-0.3604589827987066,-1.2283021797756597,0.1606425702811245,0.4962738209662447,1.0,21/48,32.61%,DNAJC1;CYFIP2;BTRC;PLAT;ASPH;SPOPL;OGT;TRAF3;FBXW11;FGFR4;TBC1D10A;PARL;PERP;HDAC2;BAG6;CLN8;PLAUR;BAK1;CAV1;CLN6;LTBP4
prerank,visual perception (GO:0007601),-0.3307882393132308,-1.2281536664607937,0.10305343511450382,0.4960369168889374,1.0,20/84,18.22%,EFEMP1;COL1A1;OPA1;EYA4;ZIC2;SLC4A10;MYO9A;EML2;ADGRV1;DHRS3;PITPNA;COL18A1;RPGR;RP2;ATF6;IMPG2;OAT;ATXN7;RABGGTB;POU6F2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.49778875667445255,-1.2276847540507771,0.21526418786692758,0.49655607853563527,1.0,7/13,17.05%,TGFBR3;BMPR1A;RBPJ;FGFR2;MEF2C;GLI1;TBX2
prerank,ribosomal large subunit assembly (GO:0000027),0.41606159075922816,1.2274065454573144,0.17418032786885246,0.6074380196254571,1.0,9/24,19.14%,RPF2;RPL10;RPLP0;RPL5;RPL23A;NOP2;MDN1;PPAN;RPL3
prerank,carbohydrate derivative transport (GO:1901264),0.45711702252344116,1.2272790867471821,0.20985010706638116,0.6063515464416511,1.0,7/18,18.88%,PLTP;MFSD2A;SLC15A3;CPTP;SCARB1;SLC15A2;VLDLR
prerank,neuron projection regeneration (GO:0031102),-0.5379890949618905,-1.2268990370468098,0.23605947955390336,0.4978400194432649,1.0,2/10,1.86%,PTN;NREP
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.32301500007729406,-1.2266257814781565,0.11462450592885376,0.4978989979706811,1.0,20/88,17.09%,SAMD4A;NFKB1;IGFBP5;DNAJC1;SYNCRIP;PLAT;DDX6;EIF4ENIF1;EIF2AK3;LARP1;DHX36;LSM14A;CNOT8;YBX1;ATRAID;EIF2AK2;APOE;DDX3X;DAPK1;CNOT1
prerank,hepaticobiliary system development (GO:0061008),-0.44726571187528236,-1.22649510099092,0.19696969696969696,0.4975700366488215,1.0,7/20,12.34%,TGFBR3;WNT4;CEBPG;PHF2;NIPBL;ARID5B;PKD2
prerank,positive regulation of protein acetylation (GO:1901985),-0.5199453290097501,-1.2262595835991397,0.19736842105263158,0.4975466032230902,1.0,7/12,19.80%,PRKAA2;RAPGEF3;FAM161A;DDX3X;CEP295;PRKAA1;TAOK1
prerank,negative regulation by host of viral process (GO:0044793),-0.53434866235939,-1.2259056973933111,0.21946564885496184,0.4978503611663386,1.0,4/10,22.70%,PRKN;CCNK;EIF2AK4;VAPA
prerank,myelination in peripheral nervous system (GO:0022011),-0.5024524363658445,-1.2251196927382932,0.20864661654135339,0.4992131870404038,1.0,7/13,23.63%,DICER1;SKI;PARD3;LGI4;MYOC;ADGRG6;PRX
prerank,nucleoside catabolic process (GO:0009164),-0.5372777826291087,-1.2248151314474673,0.21178637200736647,0.4993624109801859,1.0,5/11,14.78%,DERA;UPP2;NT5M;UPB1;DPYD
prerank,cellular protein metabolic process (GO:0044267),0.27219899198203124,1.224796307781665,0.027624309392265192,0.6122610403047984,1.0,87/396,14.10%,ST8SIA4;RPS6;CHRM3;RPS19;OMA1;TMEM132A;RPS20;RPL38;RPL29;ST3GAL6;CDH2;RPL23;RPL17;LCMT1;RPL35A;RPL37;QPCT;PHEX;GAS6;RPS27;SLC35A1;RPL7;PDIA6;MRPS12;RPS12;RPS21;RPL15;RPL10;RPL10A;PSENEN;RPS24;RPL27A;RPS17;AMELX;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;MELTF;RPL30;RPL7A;TIMP1;ATP23;MSRB2;MRPL13;RPL13;MRPS18A;FBXL2;RPL12;MRPS7;RPS15;FDX2;DAB2IP;SCG3;EIF4EBP2;RPL14;MRPS14;VWA1;MEN1;SCG2;RPL5;FARSB;PROC;RPS4X;RPL21;RPS7;CSNK1G3;RPL23A;SERP1;EEF1A2;RABGGTA;SPARCL1;RPL8;MRPL36;MRPL23;RPS14;VCAN;RPS3;VGF;RPS2;PSEN1;RPS5;EEF1A1;RPL18A
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5351082627507134,-1.2245468647561624,0.23540489642184556,0.4993865616684382,1.0,4/10,16.48%,ATP1A2;VDAC1;YWHAE;ADRA2A
prerank,regulation of interleukin-17 production (GO:0032660),0.4005095473872889,1.2244692133225594,0.18144329896907216,0.6117885040980345,1.0,3/31,6.50%,SLC7A5;IL12A;PRKCQ
prerank,regulation of mitotic cell cycle (GO:0007346),-0.29477008379257985,-1.224330777514062,0.07847082494969819,0.49931439615643936,1.0,68/171,29.12%,SMAD3;FOXC1;GBF1;BTRC;ASAH2;GAS1;PTPN3;OBSL1;ANAPC5;ANAPC7;MAEA;CDK13;ANAPC4;ANAPC16;BTG3;EIF4E;CDK11B;PSMF1;ERCC3;SIK1;RB1;TTL;PSMB2;CDC26;USP2;RCC1;CDC25B;TMEM8B;CDC27;UBE2E1;CCDC57;PRMT5;AFAP1L2;TTC28;RNF20;UBE2S;HNRNPU;CDK10;NEK6;CDKN1C;ANAPC11;CUL1;PSMC1;CUL7;CDK5RAP3;SCRIB;PRKCA;SPHK1;PSMB6;ANGEL2;PSMA3;HSF1;BORA;TFAP4;PSMA4;EIF4EBP1;CDC16;ANAPC1;NEK7;CCDC8;PSME1;PSMD13;APP;FZR1;CDK9;PSMB10;PSMA5;PSMB9
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.4800959694781925,-1.2242524831481636,0.23076923076923078,0.49891862061068226,1.0,5/16,9.94%,CHMP4B;CHMP4A;LEPROTL1;CHMP5;LEPROT
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.36151874070220147,-1.2241664086398294,0.140625,0.4985209584883247,1.0,16/49,16.40%,LDLRAD4;SMAD6;EP300;GSK3B;HMGB1;CDC42;IMPACT;DACT1;PMEPA1;RIOK3;PPM1A;ANKRD27;DDX3X;PRKCZ;NOP53;IAPP
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.44858920413945175,-1.224137937380026,0.19734345351043645,0.4980128044907337,1.0,10/20,21.37%,RBPJ;EP300;HIF1A;SMAD4;VEGFA;CARF;RUNX2;BMP2;SMAD9;SMAD1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.533910510364406,-1.2237145858246874,0.2391304347826087,0.4984540267629378,1.0,3/10,6.72%,DCN;LRRK2;BCL2
prerank,regulation of insulin secretion (GO:0050796),-0.31674960615251185,-1.223336968756364,0.09411764705882353,0.49879851658676005,1.0,18/101,7.83%,ITPR1;CACNA1C;TCF7L2;ITPR2;ADCY5;MCU;PRKN;NLGN2;RBP4;IRS1;CDK16;DPP4;STXBP4;GLUD1;REST;NNAT;CACNA1D;RAPGEF3
prerank,cilium assembly (GO:0060271),-0.277584293491796,-1.2232469807592872,0.05357142857142857,0.49843941629832,1.0,82/296,21.17%,PARVA;GSN;PKD1;PCM1;ASAP1;GBF1;BBS9;CDC14A;ALMS1;WDPCP;ODF2;DCDC2;FLNA;NUDCD3;CYS1;NINL;ARL3;PIBF1;IFT43;CEP63;ATP6V0D1;PDE6D;ARL13B;CEP135;IFT81;CFAP44;CEP162;DYNC2I1;ABLIM3;PCNT;SPATA6;EHD2;MARK4;CSNK1E;RFX2;RAB3IP;IFT88;FAM161A;RPGR;RP2;EXOC2;IFT80;RAB11A;CC2D2A;POC1B;ARMC9;SNX10;C2CD3;MAPRE1;TOGARAM1;CCDC39;RILPL2;CDC14B;YWHAE;DZIP1L;DYNC2LI1;EHD3;AKAP9;CCDC57;DYNC1H1;CEP76;CCDC66;TCTN1;PRKACA;WDR11;CFAP74;PTPDC1;CPLANE1;DYNLRB1;DYNC2I2;CEP57;CSNK1D;EHD4;GORAB;RILPL1;AVIL;TRIP11;CEP89;GALNT11;NPHP1;KIFAP3;TRAPPC14
prerank,RNA stabilization (GO:0043489),-0.3958212264473749,-1.2230933970880975,0.1755424063116371,0.49822435971945517,1.0,11/33,18.07%,TENT2;EIF4ENIF1;FUS;LARP1;DHX36;PHAX;YBX1;NSUN2;TENT5A;HNRNPU;PAIP1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.4183922898970246,-1.2230031814488846,0.18640776699029127,0.4978387348898646,1.0,10/27,20.28%,FBXL17;PER3;FBXL12;CRTC1;ID2;SIK1;USP2;PPP1CB;RBM4;PML
prerank,negative regulation of developmental growth (GO:0048640),0.4012705501601752,1.2223787530388621,0.18609406952965235,0.616238519903478,1.0,9/30,16.15%,DCC;MAG;MAP2;FGF13;RTN4R;DIP2B;CDKN1A;RTN4;CDKN1B
prerank,receptor internalization (GO:0031623),0.3719582128214314,1.2223734376865711,0.154,0.6147834541368192,1.0,6/44,4.64%,TFRC;DNM3;RAMP2;AP2M1;SNCA;GRK2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.3498468251627458,-1.2219799304921823,0.14516129032258066,0.49974819966841033,1.0,14/60,10.77%,TCF7L2;NFKB1;CDK8;PPM1D;TNRC6B;TNRC6A;MED15;MOV10;MED17;MED26;MED12;DHX36;MED1;ATF7IP
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.47451129370738115,-1.2218743955329088,0.22606924643584522,0.49942044768658556,1.0,7/16,13.56%,TGFBR3;IGF1;BMPR1A;RBPJ;FGFR2;MEF2C;GLI1
prerank,establishment of spindle orientation (GO:0051294),-0.4039707031725044,-1.2218235615103328,0.18236472945891782,0.4989509379030157,1.0,6/28,8.60%,NUMA1;MAP4;UBXN2B;ITGB1;NDEL1;GJA1
prerank,regulation of interleukin-1 production (GO:0032652),-0.47017580711947593,-1.2214002730637092,0.21178637200736647,0.4994427556357047,1.0,3/15,7.02%,FOXP1;HMGB1;ANXA1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.35899146503147483,-1.221217339251329,0.14457831325301204,0.499303313310846,1.0,9/48,5.51%,EGFR;NFKB1;MDM4;ITGAV;ROCK1;FLOT2;FLNA;IRAK3;EIF2AK1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.4995254993273597,-1.2211899691468913,0.2260536398467433,0.49878406633276173,1.0,2/13,4.33%,ATP1A2;SLC9A1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3867909014430523,-1.2201390130152951,0.18007662835249041,0.5007931047067754,1.0,23/39,33.80%,ABCA1;STEAP3;TANGO6;RAB10;RAB12;ARFGAP3;RCN3;MON1A;COPG2;MIA3;COPG1;RAB3D;PREB;RAB8A;TVP23B;AFM;SEL1L;PPY;RAB8B;MIA2;LTBP2;TVP23A;RAB15
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5038643683696562,1.2199191488077463,0.2565789473684211,0.6204159733808094,1.0,3/12,6.58%,PAX8;PAX2;LHX1
prerank,response to UV-B (GO:0010224),0.4919821154856179,1.2196803138315697,0.24472573839662448,0.6196457856744424,1.0,2/12,4.90%,MME;IL12A
prerank,calcium ion transport (GO:0006816),0.3098706519115124,1.2190918973066256,0.09108910891089109,0.6198682389569087,1.0,27/113,14.43%,CAMK2A;SLC24A4;SLC24A2;TRPC5;CACNA1A;CACNA1B;RAMP2;RYR2;RYR3;CACNA2D1;GAS6;SLC8A1;CACNA1E;TRPM2;CACNB2;TPT1;CACNG3;GRIN3A;CACNG8;P2RX7;TRPC1;TMCO1;MCOLN2;PSEN1;ATP2B4;ATP2B2;CACNA1I
prerank,protein localization to cilium (GO:0061512),-0.3963850069649896,-1.2186976321796756,0.16366906474820145,0.5036768068391335,1.0,17/32,33.89%,ZNF423;BBS9;ARL3;TULP3;SNX10;TCTN1;CSNK1D;INVS;IFT140;TTC21B;BBS4;RABEP1;IFT122;EHD1;TULP1;WDR35;TMEM107
prerank,regulation of heart contraction (GO:0008016),-0.32303888380865087,-1.2185537907150112,0.12525252525252525,0.5034206927302664,1.0,26/90,21.31%,ATP1A2;ITPR1;CELF2;STIM1;ANK2;ITPR2;TPM1;TMEM65;ASB3;CAMK2D;ASPH;DMPK;ATP2A2;ATP2B1;SRI;P2RX4;TBX2;NPR2;PRKACA;SLC8A3;ATP1B3;NOS1;ATP2A3;DES;S100A1;AHCYL1
prerank,RNA polyadenylation (GO:0043631),-0.4161813060027811,-1.2183004044978345,0.18297101449275363,0.5028645662847815,1.0,10/26,21.31%,TENT2;PCF11;WDR33;SCAF8;CPSF3;SSU72;PAPOLG;CSTF3;CDC73;AHCYL1
prerank,mRNA polyadenylation (GO:0006378),-0.4161813060027811,-1.2183004044978345,0.18297101449275363,0.5028645662847815,1.0,10/26,21.31%,TENT2;PCF11;WDR33;SCAF8;CPSF3;SSU72;PAPOLG;CSTF3;CDC73;AHCYL1
prerank,regulation of cell size (GO:0008361),-0.425307463698117,-1.2180487162921445,0.17702448210922786,0.5029532021514528,1.0,6/23,10.27%,RPTOR;DEPTOR;RARG;MTOR;VAV2;RHOA
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.42959275524942675,-1.2177026300457328,0.18281535648994515,0.503196318604254,1.0,8/23,15.61%,EP300;HDAC4;NCOR1;NUPR1;CLK2;SIK1;CBFA2T3;C1QTNF3
prerank,negative regulation of mRNA processing (GO:0050686),-0.47389530362079507,-1.2175478212077682,0.21292775665399238,0.503034671031432,1.0,4/15,7.39%,SFSWAP;SRSF10;U2AF2;SRSF6
prerank,cell cycle G2/M phase transition (GO:0044839),-0.30160658051602884,-1.2174950489879064,0.09904761904761905,0.5025743860437157,1.0,38/129,19.50%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;KHDRBS1;NINL;CDK7;CEP63;CEP135;PHLDA1;PCNT;AKAP8L;FBXL12;CSNK1E;BRSK1;MNAT1;NES;MAPRE1;TPD52L1;YWHAE;LATS1;CDC25B;PPP1CB;AKAP9;CCDC57;DYNC1H1;CEP76;PRKACA;FBXW11;CEP57;CSNK1D;AJUBA;CDK2
prerank,regulation of fibrinolysis (GO:0051917),-0.5076942266187482,-1.217483996892728,0.2164750957854406,0.5020229492564748,1.0,4/13,21.30%,THBS1;FAP;SERPINE1;USF1
prerank,protein localization to centrosome (GO:0071539),-0.46900057904849696,-1.2169050503025471,0.2053742802303263,0.5028062949589033,1.0,7/17,13.29%,PCM1;NUDCD3;PIBF1;GOLGB1;CCDC14;SNX10;C2CD3
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.5170007194757368,-1.2163464881578299,0.21523809523809523,0.5036098064246182,1.0,7/12,33.62%,CLCN2;MBTPS2;MBTPS1;H6PD;LPCAT3;SREBF1;RAN
prerank,natural killer cell activation (GO:0030101),-0.42591907977321486,-1.2160522158292795,0.22075471698113208,0.5037407615739923,1.0,3/23,6.72%,PBX1;AXL;ELF4
prerank,mRNA catabolic process (GO:0006402),-0.36742155081180533,-1.2158983712439975,0.18548387096774194,0.5035645328780496,1.0,21/44,33.70%,DDX5;DIS3L2;RC3H1;TUT4;UPF1;XRN1;XRN2;EXOSC9;ERN1;EXOSC10;CNOT10;AGO1;LSM6;PDE12;ZFP36L2;SUPV3L1;THRAP3;NUDT16;NUDT16L1;HSPA1A;MRTO4
prerank,actin polymerization or depolymerization (GO:0008154),-0.35954964745961054,-1.215797986694584,0.1489795918367347,0.503249128003622,1.0,16/50,19.90%,ARHGAP6;MICAL3;GAS7;GSN;SVIL;DIAPH1;MICAL2;CORO7;WASL;ABI1;TTC17;WASF1;FAM107A;MICAL1;AVIL;VILL
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.3603654219164719,-1.2157222349645587,0.15355086372360843,0.5028934404269189,1.0,13/49,14.36%,IGF1;IL6ST;IL31RA;GHR;KIT;PIBF1;STAT3;LYN;PARP14;PARP9;HES1;IL6R;VEGFA
prerank,dendritic spine morphogenesis (GO:0060997),0.47855391484814225,1.2147401322603526,0.2345679012345679,0.6312576225605142,1.0,3/15,3.04%,EPHB1;CTNND2;SHANK3
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.47360470712664726,-1.2142319624957756,0.22179732313575526,0.5060009800486893,1.0,5/15,16.48%,SNX9;NRDC;ADAM9;APOE;ADRA2A
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.4543553545285509,-1.2138933757174057,0.19734345351043645,0.5062661881140935,1.0,10/17,33.62%,FGF1;MBTPS2;ERLIN1;APOE;MBTPS1;PRKAA1;LPCAT3;SCAP;SREBF1;RAN
prerank,cellular response to organic substance (GO:0071310),-0.3086322165846993,-1.2136872000226933,0.11728395061728394,0.5062365582774534,1.0,24/116,10.27%,PTPN13;DPYSL3;NFAT5;PID1;SMAD3;TGFBR1;BMPR1A;IGFBP5;GHR;LRRK2;PTPN14;TGFBR2;TBK1;CLEC3B;PTPN9;STAT3;ASAH2;SHC1;RAMP1;NCOA1;CYP1B1;PTPN12;PTPN2;RHOA
prerank,positive regulation of cyclase activity (GO:0031281),-0.4734424845895634,-1.2136483061408538,0.2198852772466539,0.5057430216515754,1.0,3/14,7.81%,CACNA1C;STIM1;CACNA1D
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.4894042766726016,-1.2125813298378867,0.24521072796934865,0.5077662627858583,1.0,5/13,26.43%,GFPT1;UAP1;RENBP;UAP1L1;PGM3
prerank,regulation of cell-cell adhesion (GO:0022407),0.38095912425559125,1.2117264172869873,0.1765873015873016,0.6387999701865067,1.0,10/39,12.16%,PTPRG;PTPRR;PODXL;MAGI1;FERMT3;FUT9;TENM3;CELSR2;SMAD7;MEGF10
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5194144746030388,-1.2108723075306809,0.21956087824351297,0.5113799922928929,1.0,2/11,5.41%,BMPR1A;THBS1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.45810161205072786,-1.2107472863110569,0.21484375,0.5111209420028239,1.0,9/18,33.43%,GSK3B;ACAA2;TMEM14A;ZNF205;HIP1R;CHCHD10;MUL1;BAK1;HSPA1A
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4115268237109102,-1.2104523305336479,0.1937269372693727,0.5113040292633905,1.0,6/26,11.70%,PRKAG2;PRKAA2;WDTC1;NR1H3;PRKAB2;ERLIN1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.5378640470437347,-1.2104519821437314,0.22813688212927757,0.5107236614662696,1.0,3/10,10.27%,MYO9A;CDC42;RHOA
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.503775972593145,-1.2101880904065272,0.22960151802656548,0.5107770521989333,1.0,4/12,4.53%,DOCK5;TPM1;IGFBP5;DOCK7
prerank,dendritic cell differentiation (GO:0097028),0.42680492374232054,1.2098578720747524,0.20204081632653062,0.6428978012264855,1.0,5/22,7.11%,GAS6;CAMK4;FLT3;TRPM2;BATF2
prerank,regulation of defense response to virus (GO:0050688),-0.47949316455664215,-1.2095507070456977,0.21631878557874762,0.5117144687969495,1.0,5/14,16.57%,DHX9;PCBP2;RNF216;ILRUN;TRAF3
prerank,positive regulation of cell growth (GO:0030307),0.3173883250780628,1.2091714664139102,0.150390625,0.6433575817688748,1.0,21/96,11.21%,SYT1;RIMS1;S100A9;S100A8;RIMS2;AKAP6;MFSD2A;CPNE9;SEMA4D;SEMA7A;UNC13A;TGFB2;RPS6KA1;AKT1;RNF157;SHTN1;H3-3A;CDKL5;NTN1;CEP43;SYT2
prerank,regulation of actin nucleation (GO:0051125),-0.5035273724695111,-1.208482424230681,0.2430939226519337,0.5137351584922971,1.0,4/12,15.29%,GSN;ARFIP2;ARF1;WHAMM
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.45611167207216297,-1.20824798394202,0.2140221402214022,0.5136933835656852,1.0,6/17,16.50%,WNT4;VIM;BMP4;RUNX1;TGFB3;SUCO
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.4125527048542003,-1.2073723586289753,0.20747663551401868,0.5151610979700318,1.0,9/25,19.36%,FOXO3;ARNT;STAT3;MED1;HIF1A;STAT1;PRKDC;STAT5B;INHBA
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.32797051720216797,-1.2073194942500307,0.16533864541832669,0.5146878079719688,1.0,17/80,17.35%,SAMD4A;ROCK2;PLD1;VIM;ZCCHC4;YTHDF3;THBS1;MTOR;HNRNPD;EPHA4;PLXNB2;PRKCD;PRKDC;DDX3X;IFNGR1;UPF3A;PICALM
prerank,mesenchymal cell development (GO:0014031),0.44094558694134195,1.2070454202390402,0.2,0.6482187958224512,1.0,4/18,6.01%,NRG1;CDH2;NOTCH1;CYP26C1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2826978526544548,-1.206989020259648,0.06625258799171843,0.5148947583801825,1.0,61/208,23.39%,WLS;AKAP13;ROR1;LPAR1;PELI2;ANKRD17;ZFAND6;UBE2N;CFLAR;MAP3K3;PRKN;FLNA;TBK1;TFG;ALPK1;UFL1;MAPKBP1;TRIM8;TRAF3IP2;PDPK1;DHX36;GJA1;MIER1;TRAF2;RHOA;ZDHHC13;MAVS;TLE1;LGALS1;RORA;TRIM5;RIOK3;TRIM25;PPM1A;LTBR;STAT1;TRIM39;MAP3K14;TNIP2;ECM1;TRAF3;IKBKE;WNT5A;PRKD1;CC2D1A;TRAF6;RHOH;TANK;RHOC;TMED4;NEK6;IRAK1;CARD16;SHARPIN;CXXC5;TRAF5;NLRX1;TICAM1;VAPA;GPR89A;NLRC3
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.4479372304808047,-1.2069164307758753,0.20226843100189035,0.5144885286208932,1.0,7/18,24.68%,DAB2;MAP2K1;CHMP3;RAB21;MSN;PTPN23;SNX12
prerank,early endosome to late endosome transport (GO:0045022),-0.4414276081432824,-1.2062893222166533,0.21851851851851853,0.5155054694286026,1.0,12/20,25.62%,EEA1;KIF16B;WDR91;BECN1;PIK3C3;ANKRD27;SNF8;WDR81;STX8;PTPN23;RAB7A;RAB5A
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.3406572503484918,-1.2062536140310156,0.14619883040935672,0.5149951237327525,1.0,18/59,17.61%,TCF7L2;NFKB1;CDK8;PPM1D;TNRC6B;TNRC6A;MED15;MOV10;MED17;MED26;MED12;MED1;JUN;BCLAF1;MED8;RUNX2;TNRC6C;MED27
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4192993270766505,-1.2062476815609282,0.19483101391650098,0.5144231198311288,1.0,5/23,5.70%,MCU;CAMK1D;RIPOR2;DNM1L;DPP4
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.4562592437720998,1.2060758674885648,0.22690763052208834,0.6496185807395125,1.0,4/15,12.04%,FST;MAGI2;CSNK2B;SMAD7
prerank,positive regulation of microtubule polymerization (GO:0031116),0.4037626512434794,1.205789904236115,0.2153846153846154,0.6489756693918051,1.0,11/28,21.50%,NAV3;GIT1;OCLN;PAK1;DCTN1;RPS3;MECP2;CLASP1;RAC1;CDK5R1;CDK5RAP2
prerank,negative regulation of biosynthetic process (GO:0009890),-0.4723882439898959,-1.2049602717455532,0.22857142857142856,0.5169182640579754,1.0,10/16,39.25%,COA8;SLC30A10;ABCD2;EMILIN1;PARK7;PPARA;GPER1;CIITA;SLC18A2;TRAP1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3642774079777948,-1.2045778304387544,0.188212927756654,0.517246654581791,1.0,13/47,15.61%,ROCK2;NFKB1;WNT4;EP300;PTGIS;WDTC1;CLK2;ERLIN1;SIK1;FBXW7;SLC27A1;RAPGEF2;C1QTNF3
prerank,thyroid hormone generation (GO:0006590),-0.5372514874993032,-1.2045476786378189,0.23626373626373626,0.5167539569741584,1.0,2/10,11.33%,CPQ;SLC5A5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5109030513099323,1.204540546123615,0.22810590631364563,0.6499721441317843,1.0,2/10,6.76%,MBP;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5109030513099323,1.204540546123615,0.22810590631364563,0.6499721441317843,1.0,2/10,6.76%,MBP;KLF4
prerank,apical protein localization (GO:0045176),0.5189586822241685,1.2042212430334343,0.2548596112311015,0.6494265550521691,1.0,5/10,14.24%,ACTB;MAL;INSC;VANGL2;JAM3
prerank,vasculature development (GO:0001944),-0.4736478275961828,-1.2039518914341045,0.22900763358778625,0.5176218824753217,1.0,3/16,2.43%,ERRFI1;PDGFRA;PDGFRB
prerank,transport across blood-brain barrier (GO:0150104),0.32473292377181423,1.2036316933355582,0.14807302231237324,0.6498032579160409,1.0,24/83,14.15%,SLCO1C1;TFRC;SLC7A5;SLC6A6;SLC6A17;SLC2A1;ATP8A1;SLC2A3;SLC7A1;ABCG2;MFSD2A;SLC1A1;SLC1A2;SLC7A8;SLCO2B1;ABCC4;ATP1A4;FABP5;KCNJ8;SLC16A1;SLC27A4;INSR;CD36;ATP2B4
prerank,photoperiodism (GO:0009648),-0.41199718374190114,-1.2024298371763753,0.20396039603960395,0.5208424615022264,1.0,10/28,20.28%,FBXL17;PER3;FBXL12;CRTC1;ID2;SIK1;USP2;PPP1CB;RBM4;PML
prerank,epithelial tube morphogenesis (GO:0060562),0.390037418393073,1.2018303380344382,0.20396039603960395,0.6536129357075379,1.0,8/32,7.56%,CSF1R;PODXL;RYR2;FGF10;CSNK2B;PAK1;LHX1;ACVRL1
prerank,regulation of multicellular organism growth (GO:0040014),-0.4621302012180215,-1.201778198185438,0.21584158415841584,0.5219149409822035,1.0,5/15,17.75%,IGF1;GHR;PTCH1;STAT5A;STAT5B
prerank,ameboidal-type cell migration (GO:0001667),0.3549215185050786,1.201750838257249,0.17558886509635974,0.6523459929504192,1.0,10/51,7.97%,ERBB4;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;PKN1;AKT1
prerank,regulation of kinase activity (GO:0043549),0.3190473625902078,1.2011252742874918,0.12266112266112267,0.6527916047113749,1.0,13/89,5.87%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK
prerank,positive regulation of protein processing (GO:0010954),-0.43590285725800443,-1.2011101057180371,0.21176470588235294,0.5229916636161245,1.0,3/19,4.69%,GSN;CCBE1;CLEC3B
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3254746111761596,-1.2008749515966788,0.13948919449901767,0.5229455973142456,1.0,20/80,13.84%,DPYSL3;AUTS2;DOCK11;RHOQ;PLCE1;ARAP1;RIPOR2;WASF2;BCAS3;NRP1;CDC42;BRK1;NDEL1;MARK4;CDC42EP5;WASL;NCKAP1;RALA;ARPC2;P2RY12
prerank,regulation of leukocyte activation (GO:0002694),0.46789307511440215,1.2004316031618922,0.24048096192384769,0.6533876565710101,1.0,2/14,2.15%,CD33;MIF
prerank,DNA repair (GO:0006281),-0.2732701714653262,-1.200120740873516,0.05454545454545454,0.5241775310502003,1.0,127/284,33.55%,EYA1;INO80;UBE2N;FTO;GTF2H2;ABL1;KMT5B;RAD23B;RBBP8;UVRAG;WDR33;HUWE1;KDM4B;NBN;WDR48;RAD51B;TDP2;MLH1;TRRAP;APEX2;BRCC3;RNF8;PDS5A;WRN;TEX264;DDB2;VCPIP1;ZBTB1;CSNK1E;SETD2;HERC2;UPF1;MNAT1;PARP9;USP47;ASCC3;RFWD3;XRCC4;PARP1;RAD21;RAD51D;PDS5B;ERCC3;ALKBH1;NABP2;PIAS4;FANCE;KMT5C;APTX;DTX3L;PARP4;MMS19;ERCC6L2;PRKDC;FANCM;HINFP;UBE2B;BRCA2;MSH3;FANCI;ERCC8;NOP53;MRE11;SPRTN;ZRANB3;BAZ1B;VCP;DCLRE1A;PARK7;MGME1;MSH6;PCNA;POLN;SMC1A;FANCC;RPAIN;FAAP100;ATR;UBE2V2;SMARCAL1;NSMCE4A;RAD51C;ERCC1;GTF2H1;PRIMPOL;EYA3;POLE2;ACTR5;RECQL5;SLC30A9;OGG1;TNKS1BP1;ENDOV;ABRAXAS1;RAD54L;GTF2H4;FANCB;MPG;POLH;TIMELESS;IGHMBP2;NUDT1;KPNA2;PARP3;MGMT;MAD2L2;UBA52;FANCD2;FANCG;MDC1;PARP2;POLD2;FAAP20;NEIL3;NSD2;RPA2;EME2;RAD9A;PNKP;EXO5;RMI2;RAD51;PSME4;POLA1;DDB1;LIG4;BRCA1
prerank,negative regulation of cellular process (GO:0048523),-0.25673029351000604,-1.1994265328271825,0.016359918200409,0.5253340557336245,1.0,152/521,22.10%,PLXNA2;TGFBR3;ALDH1A2;SMAD3;ZBTB7C;APPL2;KANK2;ANGPT1;DCBLD2;SMAD6;CELF1;COL4A3;FBLN1;BMP5;MDM4;CCN2;FHL1;DIS3L2;UBR2;KAT2B;BMP7;BMP4;ANXA6;PDPN;PRKN;PPM1D;ENPP1;PTPN14;TNS2;PODN;BRD7;FRK;NUPR1;LMNA;GSDME;CLMN;NIBAN2;RIPOR2;VGLL4;RARG;IGFBP3;TGFB1I1;IGFBP6;PLSCR1;SKI;VPS4B;SPEG;CD9;TMEM127;EIF2AK3;BCL2;NOX4;LYN;TES;SRSF6;REST;WNT9A;P3H3;CHMP4B;AR;GJA1;SP100;PTPRK;IMPACT;MAP2K1;TXNIP;CYP1B1;PLXNB2;BTG3;COL18A1;NGF;PTPN2;CCN3;NR1H3;SMAD4;ABI1;ROR2;PDS5B;PKD2;RB1;VPS13C;ADNP2;IRF1;BECN1;CCN5;FKTN;CCN1;COPS8;ARHGDIB;IGFBP7;EIF2AK2;ING5;CD164;RBM5;EMILIN1;CRLF3;DUSP1;NCK1;DDX3X;CBFA2T3;RAPGEF2;NCK2;PLXND1;RASA1;ANP32B;MNT;TGFB3;PLXNB1;ADAMTS1;PDCD4;MYBL1;NR4A1;CCN4;MIA3;OSGIN2;ARID2;PRKD1;S100A11;PPP2R5C;SFRP4;ATG5;SOD2;NDRG3;FGFBP1;DACT3;NME6;IFI35;BMP2;DCUN1D3;PARK7;CDK10;INHBA;PBRM1;CDC73;NF2;IFIT3;PML;ING1;FRZB;NOS1;SPEF1;NME1;ZBTB49;CDK6;PPP2CA;BNIP3;FGF2;TGFBI;DLG5;LPCAT3;PTHLH;WNT16
prerank,aminoglycan biosynthetic process (GO:0006023),-0.34956104292830187,-1.1994067668613497,0.166015625,0.524798488540662,1.0,18/49,19.51%,GPC6;SDC2;B3GALT1;HS3ST3A1;GPC4;GPC3;EXT1;HSPG2;HS2ST1;NDST1;NDST2;HEXA;PXYLP1;SDC4;HS6ST1;XYLT2;GCNT2;B4GALT7
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.4501847360740883,1.199223383538149,0.2208067940552017,0.6555983582347401,1.0,5/18,9.08%,LRP8;ADCY8;EPHA5;RPS6KA5;RELN
prerank,regulation of stem cell population maintenance (GO:2000036),-0.4498168379656796,-1.1981668950917954,0.2265625,0.5272399279521935,1.0,8/18,22.73%,PTN;REST;WDR43;CNOT2;TAF5L;CNOT1;TAF6L;ZC3H13
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.38167157098701954,-1.1980453127851687,0.18664047151277013,0.5269747462858768,1.0,19/33,30.05%,DDX5;EP300;AXIN1;UFL1;RUNX1;AR;UBA5;SAFB2;PRMT2;LATS1;RNF14;PARK7;RNF6;TRIM68;KDM1A;ESR1;KCTD6;UFM1;CALR
prerank,double-strand break repair (GO:0006302),-0.28865707484544684,-1.1978002723243852,0.09851301115241635,0.5270337814381293,1.0,69/158,33.55%,EYA1;INO80;UBE2N;RBBP8;SPIDR;HMGB1;KDM4B;SMC6;NBN;RAD51B;TDP2;NSMCE2;BRCC3;RNF8;WRN;SMC5;HERC2;PARP9;MCM9;RFWD3;XRCC4;PARP1;RAD21;RAD51D;PAXX;POLM;NABP2;PIAS4;APTX;DTX3L;PRKDC;BRCA2;KDM2A;SFPQ;MRE11;ZSWIM7;BAZ1B;VCP;DCLRE1A;POLN;XRCC6;UBE2V2;SMARCAL1;RAD51C;ERCC1;PAXIP1;EYA3;ACTR5;RECQL5;IFFO1;TNKS1BP1;ABRAXAS1;SFR1;HELQ;KPNA2;PARP3;MAD2L2;SAMHD1;MDC1;ZFYVE26;PARP2;RNF138;NSD2;RPA2;EME2;RAD51;POLA1;LIG4;BRCA1
prerank,hemidesmosome assembly (GO:0031581),0.5020082116296255,1.1977627316974968,0.2603938730853392,0.658398878122864,1.0,2/11,4.92%,ITGA6;DST
prerank,regulation of cell migration (GO:0030334),0.2681037368389973,1.1972980438587382,0.049079754601226995,0.6583722676656494,1.0,78/382,13.89%,FLT1;CAMK2A;CLDN5;IGF1R;PRR5L;LEF1;NAV3;LIMCH1;CTNNA2;FRMD5;SRGAP1;ERBB4;PTP4A1;SEMA3C;CSF1R;PODXL;PLXNB3;TMSB4X;SEMA6A;MIF;ITGA6;DACH1;TMSB10;CXCL12;MAGI2;SEMA4A;PTPRT;MCTP1;SEMA4F;ROBO4;PPM1F;SEMA6D;KDR;FGF10;SEMA4D;SEMA7A;THY1;FERMT3;ENPP2;MEAK7;HSPA5;NOTCH1;PAK1;FGF5;PECAM1;PTPRJ;ACVRL1;AKT1;GPNMB;PLXNA4;SGK3;SST;NTNG1;NTNG2;SPATA13;CYRIB;PDGFB;AIF1;F2R;CEP43;PIK3R3;TMEFF2;APC;TJP1;SMAD7;RET;SRGAP3;SRGAP2;DOCK10;EPHA1;BCAR1;SORL1;ACTN4;RFFL;HRAS;XBP1;INSR;CIB1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5210570827825399,-1.1972704973734785,0.24319066147859922,0.5277786593736348,1.0,4/10,21.93%,GFPT1;PFKP;PFKM;PFKL
prerank,positive regulation of developmental process (GO:0051094),-0.2910859848367452,-1.19694024478314,0.09036144578313253,0.5280690229849101,1.0,28/164,8.60%,PHLDB2;SOX5;PTN;DAG1;BMPR1A;FOXD1;DCN;SMURF2;MCU;BMP5;CCN2;BMP7;BMP4;PRKN;KMT5B;NUMA1;DLG4;LMNA;RREB1;NIBAN2;ADGRL1;DNM1L;ZBTB16;DDHD1;REST;RAPGEF3;AR;GJA1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.26552726552624367,-1.196913936444146,0.060903732809430254,0.527533982124078,1.0,115/390,20.91%,ROCK2;SULF1;IGF1;ROR1;EGFR;RHOQ;SORBS1;RBFOX2;EPHA7;COL4A6;SIPA1L1;EPHA3;COL1A1;PDGFRA;ANGPT1;NTRK3;EFNB2;SDC2;FLRT2;HNRNPH1;FOXC1;GRB10;ITGAV;FGF1;PDGFRB;AXL;IL31RA;ROCK1;GHR;ATP6V1B2;CYFIP2;FRK;GSK3B;KIT;SHOC2;RYK;WASF2;IRS1;PLAT;SULF2;ATP6V0D1;SLC39A14;SHB;PAK2;STAT3;NRP1;HNRNPM;FGFR2;EIF2AK3;SHC1;FOXC2;LYN;ATP6V0A4;MERTK;CDC42;VAV2;BRK1;EPHA4;IGF2;FRS2;NGF;NCSTN;WASL;FER;PTPN2;PDGFC;RHOA;KIF16B;KL;YES1;ABI1;NFATC4;NCKAP1;ROR2;ANGPT2;MMP2;ARPC2;FLRT1;APPL1;EPHA8;VEGFA;NCK1;RAPGEF2;VEGFD;DDR1;NCK2;CYBA;RASA1;BDKRB2;FIBP;NGEF;EFS;DOCK1;STYK1;ZFYVE27;TCIRG1;PHIP;PRKD1;BLNK;FGFBP1;CEP57;POLR2H;MUSK;GAB1;PTPN11;ITGB3;NCF2;MVP;RAPGEF1;SPRED2;GFRA2;BAIAP2;FGFR4;PIK3R1;AAMP
prerank,somite development (GO:0061053),-0.5093509915785865,-1.1968199407781528,0.25735294117647056,0.5271952762099665,1.0,4/11,15.98%,SMO;MEOX2;PTCH1;LOXL3
prerank,aggrephagy (GO:0035973),-0.4113320444543233,-1.196382693515078,0.21521335807050093,0.5277653118506004,1.0,12/27,21.16%,UBE2N;VIM;PRKN;ARL13B;UBQLN1;PCNT;IFT88;DYNC1LI1;DYNC1H1;ATG5;PARK7;WDR81
prerank,cellular response to alkaloid (GO:0071312),0.4532596585588178,1.1963746996482765,0.23265306122448978,0.6595401837589804,1.0,3/17,4.70%,RYR2;RYR3;SLC8A1
prerank,positive regulation of calcium ion transport (GO:0051928),0.38061619462621726,1.1962758921446954,0.1927710843373494,0.6583588933511192,1.0,8/36,11.50%,CAMK2A;GRIN1;CXCL12;CACNB2;CCL2;PDGFB;F2R;P2RX7
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.41608455470981465,1.1961686324992464,0.21621621621621623,0.6572044480136038,1.0,8/22,15.63%,RPS20;RPL23;RPL37;UBB;RPS15;RPS7;ATM;CHD5
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4167897069438403,-1.1961431025725653,0.2015810276679842,0.5277682011332645,1.0,10/24,12.22%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;BCAS3;NRP1;CDC42;WASL;RALA
prerank,membrane assembly (GO:0071709),0.38541451510462177,1.1957230621680055,0.19915254237288135,0.6571361158525971,1.0,6/34,5.91%,NRXN1;PTPRD;IL1RAPL1;NLGN1;ANK3;NRXN2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.403023934163128,-1.1957113470199856,0.19694072657743786,0.5282919739416726,1.0,4/26,5.66%,LARGE1;ST3GAL4;GK5;RRM2B
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.31793671674867807,-1.1956421427939767,0.13916500994035785,0.5278874139547086,1.0,23/84,20.17%,SAMD4A;IGF1;IGFBP5;ROCK1;SYNCRIP;DDX6;EIF4ENIF1;EIF2AK3;LARP1;DHX36;GGA3;LSM14A;CNOT8;YBX1;EIF2AK2;APOE;DDX3X;DAPK1;CNOT1;ABCA7;CNOT10;RBM4;ORMDL3
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.49955814692193945,-1.1954096797297167,0.2438095238095238,0.5278823445104015,1.0,4/12,9.06%,THRB;KLF9;CTSH;MED1
prerank,recombinational repair (GO:0000725),-0.32319862167854524,-1.1953320136219985,0.1519230769230769,0.5274960308015264,1.0,19/77,17.04%,INO80;UBE2N;RBBP8;SPIDR;SMC6;NBN;RAD51B;NSMCE2;WRN;SMC5;MCM9;RFWD3;PARP1;RAD51D;NABP2;BRCA2;SFPQ;MRE11;ZSWIM7
prerank,cellular protein localization (GO:0034613),-0.270781757663842,-1.1952620907675469,0.07102803738317758,0.527074165427468,1.0,103/285,27.93%,WLS;EGFR;ANK2;VCL;ANGPT1;TLK1;KIF13A;SH3PXD2B;LRRK2;TBC1D16;FBLN5;CNTLN;FLNA;SGSM2;PIGK;SNX9;SNX6;SEC23IP;STX16;RAB22A;STXBP1;VPS26C;SIL1;AP3B1;GJA1;COPZ2;PTPRK;USP6NL;SEC31A;SLU7;ARCN1;ARFGAP3;TBC1D2B;HERC2;TBC1D8B;GGA3;RPGR;WIPI1;COG3;TM9SF2;COG7;NIPBL;STX4;ARFIP2;ARF1;STX5;USP4;COPB2;TBCK;RAB21;CTTN;GRTP1;TM9SF1;TBC1D22B;CTSA;DNAJC27;SMURF1;FAM91A1;TBC1D9;COX18;ATG9A;SNX8;WDR45B;TMED3;WNT5A;WDR11;NAPA;TBC1D17;TMED5;TMED4;RABGAP1;WIPI2;STX17;TBC1D10A;NPHP1;RAB24;GGA2;STX8;IFT27;RABL3;VPS26B;ARL5A;NSF;USO1;AP2A1;SAR1B;STX12;PRRT1;RAB5A;CD63;STX1A;VPS45;RRAGA;TBC1D10B;BBS4;MFN2;GAS8;STX7;TMED2;TBC1D9B;FERMT2;ARL4C;RIC1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5206708569011487,-1.1949996821016171,0.26459143968871596,0.5271466027350729,1.0,5/11,25.95%,COA8;SLC30A10;ABCD2;PARK7;PPARA
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.40807606415919084,-1.194889012182581,0.21218074656188604,0.5268220110968971,1.0,12/26,30.84%,FBN1;HOXA7;PTPN2;TLR4;GPR137B;INHBA;TCTA;CDK6;MAFB;INHA;TLR3;FSTL3
prerank,regulation of defense response (GO:0031347),-0.3224298267425051,-1.1942741040189766,0.15476190476190477,0.5277548137285528,1.0,46/76,37.78%,FOXP1;APPL2;ADAMTS12;CELF1;NR1D2;SBNO2;UFL1;ANXA1;CASP12;XIAP;PTPN22;PTGES;AGTR1;APPL1;IRF1;PIK3AP1;APOE;TRAF3;WNT5A;AREL1;PARK7;MGLL;SHPK;DAGLB;USP18;IL1RL2;DHX58;ERAP1;GRN;BIRC3;SAMHD1;BCL6B;ACE2;BCL6;TKFC;HCK;MYD88;ZBP1;LACC1;FGR;CASP1;FCGR2B;CASP4;SETD6;LRRC19;CCR2
prerank,endocrine system development (GO:0035270),-0.42251827505418466,-1.1941698993002097,0.21011673151750973,0.5274755617785112,1.0,4/21,2.97%,TGFBR1;WNT4;GLI2;DKK3
prerank,regulation of cellular protein localization (GO:1903827),-0.3608673306491938,-1.194076385388911,0.18,0.5271387420569948,1.0,18/45,22.48%,GPC6;GBF1;PRKAA2;GPC4;GPC3;SPIDR;NDEL1;VCPIP1;CSNK1E;SETD2;PARP1;CCDC66;PRKAA1;PTPN1;VCP;DVL3;TOR1A;GPC1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4434971393112031,-1.1940296107228863,0.2144177449168207,0.5266851398329572,1.0,7/18,14.89%,MDFIC;CTNNA1;GSK3B;SUFU;APOD;ILRUN;LATS1
prerank,hyaluronan catabolic process (GO:0030214),-0.45398292713384725,-1.1939796849137838,0.25585585585585585,0.5262338093787455,1.0,7/18,22.57%,CEMIP;SLC9A1;CEMIP2;GUSB;HEXA;FGF2;CHP1
prerank,response to insulin (GO:0032868),-0.3311592533230433,-1.1935559995016272,0.15180265654648956,0.5267421376802183,1.0,29/80,21.34%,RHOQ;SORBS1;KAT2B;ENPP1;IRS1;SLC39A14;INSIG2;RAB10;RAB12;PDPK1;VAMP2;SELENOS;FER;DENND4C;PARP1;OGT;PCK2;SLC27A1;PRKDC;ZBED3;CPEB1;LPIN2;SYAP1;LPIN3;INPP5K;PKM;PIK3R1;USF1;AKT2
prerank,response to iron ion (GO:0010039),-0.503643569280307,-1.1933394987664854,0.26346153846153847,0.5266971761109507,1.0,4/12,14.13%,BMP6;BCL2;HIF1A;ACO1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.29641023788424553,-1.1933113965217046,0.11641221374045801,0.5261907193101977,1.0,42/128,22.93%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;KHDRBS1;NINL;CDK7;CEP63;CEP135;PHLDA1;PCNT;FBXL12;CSNK1E;BRSK1;MNAT1;NES;MAPRE1;TPD52L1;YWHAE;LATS1;CDC25B;PPP1CB;AKAP9;CCDC57;DYNC1H1;CEP76;PRKACA;FBXW11;CEP57;CSNK1D;AJUBA;CDK2;CUL1;TAF2;HAUS7;HAUS8;ACTR1A
prerank,response to thyroid hormone (GO:0097066),-0.48629959307607695,-1.1932810718214377,0.2376425855513308,0.5257046198118885,1.0,4/13,9.06%,THRB;KLF9;CTSH;MED1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3267680123321842,-1.1931150239936343,0.15779467680608364,0.5255634119308583,1.0,30/67,28.25%,PLD1;TBC1D16;DCDC2;ATP8B1;TBC1D19;TBC1D24;CDC42;USP6NL;TBC1D2B;TBC1D20;FER;IFT88;CAPZB;TBC1D22B;DYNC2LI1;P2RX4;ATG5;TBC1D17;RABGAP1;TBC1D10A;ABITRAM;RAB5A;IFT140;FXR1;TWF1;TWF2;TBC1D10B;ATG3;TBC1D9B;RABEP2
prerank,chromatin remodeling (GO:0006338),-0.30939799697867215,-1.1930312799030793,0.1276595744680851,0.52522385591084,1.0,40/100,28.18%,INO80;KAT2B;ARID1B;HDAC4;TOP1;EZH1;BAZ1A;BAZ2A;KDM4B;SMARCC2;NUDT5;CHD8;KDM5B;MYSM1;MBD2;ZBTB1;KDM6A;CHD4;CHD3;HCFC1;RB1;HDAC1;JARID2;SMARCD2;BAZ2B;BAZ1B;TAF6L;BPTF;PBRM1;PIH1D1;SMARCD3;HDAC2;MBD3;INO80C;ZBTB7A;ACTR5;MPND;CECR2;ATRX;ESR1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4200870443809576,-1.1930267805814068,0.22242990654205608,0.5246840304013235,1.0,3/21,1.01%,ATP1A2;CACNA1C;ANK2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.4312147747783681,-1.1927611792083392,0.2409867172675522,0.5247489919971493,1.0,4/20,2.70%,TGFBR3;TGFBR1;RBPJ;BMP4
prerank,response to acidic pH (GO:0010447),-0.4947917974365067,-1.1925951982824916,0.22524271844660193,0.5245736436605434,1.0,8/13,41.30%,SLC9A1;IMPACT;GPR4;CHP1;PKD2L1;PKD1L3;LGMN;RAB11FIP5
prerank,regulation of cardiac conduction (GO:1903779),-0.3419000788975091,-1.192306228368877,0.1511627906976744,0.5247151524895761,1.0,17/54,21.31%,ATP1A2;ITPR1;STIM1;ANK2;ITPR2;TMEM65;ASPH;DMPK;ATP2A2;ATP2B1;NPR2;PRKACA;SLC8A3;ATP1B3;NOS1;ATP2A3;AHCYL1
prerank,mononuclear cell differentiation (GO:1903131),0.41512509655326474,1.1920129417313328,0.21663019693654267,0.6668579181625284,1.0,6/24,6.45%,CSF1R;PPARG;GAS6;FLT3;MT1G;TRPM2
prerank,prostanoid biosynthetic process (GO:0046457),-0.462238074461181,-1.1916671427980627,0.2490272373540856,0.5257741937352238,1.0,6/15,12.46%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,regulation of neuroblast proliferation (GO:1902692),-0.458249014187456,-1.191590822498582,0.2427536231884058,0.5253894730272622,1.0,6/15,25.24%,PTN;LRRK2;VEGFA;CX3CR1;SMARCD3;KDM1A
prerank,negative regulation of DNA binding (GO:0043392),0.3957682693666611,1.1909345323742813,0.19327731092436976,0.6686462967501023,1.0,7/28,13.26%,LEF1;HEY1;HMGA2;CPNE1;PER2;SIN3A;NFKBIA
prerank,histone H4 deacetylation (GO:0070933),-0.5165757987603571,-1.1905208122171516,0.24304267161410018,0.5273919393370199,1.0,5/10,14.63%,HDAC8;HDAC4;RCOR1;REST;HDAC1
prerank,lipid phosphorylation (GO:0046834),0.5050828921283486,1.190413672420301,0.267260579064588,0.6687230700034795,1.0,3/10,7.01%,DGKI;DGKH;DGKB
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.31917728335038187,-1.1903951335058667,0.15841584158415842,0.5271397371122989,1.0,25/84,17.71%,ROCK2;FOXP1;SASH1;ANGPT1;PLPP3;FGF1;BMP4;ABL1;SPARC;HMGB1;THBS1;BCAS3;NRP1;FOXC2;PDPK1;PLCG1;HIF1A;ANXA3;VEGFA;P2RX4;ATOH8;STAT5A;PIK3CD;WNT5A;PRKD1
prerank,covalent chromatin modification (GO:0016569),-0.4720782568498383,-1.190319929762079,0.2397003745318352,0.526745905906626,1.0,6/14,18.94%,HLCS;SETD5;UFL1;MBD2;HDAC1;PARK7
prerank,lipid droplet organization (GO:0034389),-0.42066399083824635,-1.189591624034109,0.22905027932960895,0.5280266598203847,1.0,10/22,31.17%,RAB3GAP1;ZFYVE1;FAF2;AUP1;SQLE;CDS2;PPID;BSCL2;PLA2G4C;FITM2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.38648657485687105,1.1895853297479093,0.22384937238493724,0.6697396721052722,1.0,11/32,16.35%,AKAP6;SNCA;THY1;APLNR;HAP1;F2R;CALM1;TRPC1;CALM2;CALM3;NPSR1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.46268240575744046,-1.188268274854756,0.22820037105751392,0.5307663974083451,1.0,5/14,22.93%,ANXA1;NFKBIZ;PRKCZ;IL18;CD80
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3717584693384293,1.1882539868764508,0.19658119658119658,0.6723575740005997,1.0,7/38,10.22%,GRM5;LRP8;CSF1R;GAS6;THY1;RELN;PDGFB
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.27807359124419223,-1.186900505806147,0.08299595141700405,0.5335977461023554,1.0,53/199,21.14%,ROCK2;ALDH1A1;EGFR;LDLRAD4;RBPJ;SMAD6;ZNF423;LGR4;BMP5;ROCK1;BMP4;ROBO1;NPR3;WWC2;NFIB;GSK3B;DOCK7;ADAMTS5;HOXA7;TWSG1;FOXC2;SRSF6;GJA1;LAMA4;NRDC;NR1H3;ATP2B1;WWC1;TBX18;MEF2C;IL17RD;RB1;ACOT11;ARHGDIB;BRCA2;IL17D;PTCH1;LNPEP;DUSP10;IFNGR1;VASN;PLCL1;TLR4;HMGCR;CHSY1;BMP2;ABHD6;CYP51A1;MAP2K6;SPRED2;TLE3;PPP2CA;SFMBT1
prerank,early endosome to Golgi transport (GO:0034498),-0.5142739724878544,-1.186850124503179,0.2616279069767442,0.5331646102543843,1.0,5/11,23.33%,STX5;SURF4;EHD3;SNX8;LMAN1
prerank,amino sugar biosynthetic process (GO:0046349),-0.4921272205569801,-1.1864875044818535,0.25595238095238093,0.5334621849521684,1.0,5/12,26.43%,GFPT1;UAP1;RENBP;UAP1L1;PGM3
prerank,regulation of plasminogen activation (GO:0010755),-0.4946356853283367,-1.1863093112185856,0.24577861163227016,0.5333265103608693,1.0,4/12,17.01%,CLEC3B;THBS1;RUNX1;SERPINE1
prerank,regulation of protein catabolic process (GO:0042176),-0.3113668815372472,-1.1863063845374322,0.12981744421906694,0.5327665201095506,1.0,27/99,19.02%,EGFR;SMURF2;MDM4;PRKN;WWP2;GSK3B;FLNA;IRAK3;GPC3;HUWE1;AXIN1;WWP1;SEC22B;DACT1;WDR91;STX5;GFAP;CTSA;SMURF1;CSNK2A1;CENATAC;ASB5;WNT5A;HMGCR;AREL1;VCP;CYP51A1
prerank,regulation of complement activation (GO:0030449),-0.36594579762404733,-1.1861177605120148,0.18687872763419483,0.5326041770650952,1.0,5/40,3.68%,CFH;SERPING1;VTN;PROS1;CD55
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.4665162180569985,-1.1859199987124014,0.25946969696969696,0.5324949826943478,1.0,2/14,3.11%,ZEB1;OSR1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.46951062029434365,-1.1858671246384862,0.24907063197026022,0.5320833308618577,1.0,5/14,19.61%,ANK2;ACTN2;AKAP9;LRRC38;ATP1B3
prerank,synaptic vesicle recycling (GO:0036465),0.38049694454547583,1.185701342017686,0.19469026548672566,0.6787306071852507,1.0,12/31,18.86%,SYT1;NLGN1;SYT7;SNCA;AMPH;SYT2;PLD2;SNCB;NLGN3;PACSIN1;SYNJ1;SYT5
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3883030779118961,-1.1856044531543761,0.21372549019607842,0.5321229625097785,1.0,12/31,20.88%,KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;PKD2;RB1;FAM107A;DCUN1D3;CDC73;CDK6
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.32120764887429204,-1.1854650945695757,0.1580952380952381,0.531880512970219,1.0,13/78,7.97%,EGFR;PID1;LRP1;RHOQ;SORBS1;EPHA3;DAB2;PTPN9;DLG1;ITGB1;VTI1B;PDPK1;AR
prerank,fatty acid beta-oxidation (GO:0006635),-0.3447564190128262,-1.1851841581983333,0.1596958174904943,0.5320592472035265,1.0,21/51,24.26%,ABCD3;IVD;ACADM;ACAD10;ABCD2;ACAD11;CPT2;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ACOX1;ECI1;DECR2;AMACR;MECR;ACOT8;ACOX3;AUH
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.4583617229893654,-1.1851009165371567,0.24214417744916822,0.5316822984407839,1.0,6/16,16.50%,WNT4;VIM;BMP4;RUNX1;TGFB3;SUCO
prerank,antibacterial humoral response (GO:0019731),0.4515051166153803,1.1850142804077626,0.2484472049689441,0.679280201894999,1.0,4/16,21.92%,SLPI;DEFA6;RNASE3;RNASE7
prerank,embryonic hemopoiesis (GO:0035162),0.4952134523685695,1.1849627430822203,0.24330357142857142,0.6779093220984427,1.0,4/12,9.01%,KITLG;KDR;TAL1;TPO
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3165609996926026,-1.1848019507163061,0.16569200779727095,0.5318583669763142,1.0,19/86,13.81%,AKAP13;NOTCH2;IGF1;DENND4A;PLCE1;KANK2;SHOC2;MAPKAP1;BCR;SHC1;LYN;ARHGAP17;ARFGAP1;LZTR1;NGF;ARHGEF18;DENND4C;OGT;ARHGDIB
prerank,regulation of axon extension (GO:0030516),0.3757459398933558,1.1845873009489534,0.19753086419753085,0.6775583166994923,1.0,12/37,15.90%,MAG;MAP2;SEMA7A;NRCAM;SHTN1;CDKL5;RTN4R;NTN1;DIP2B;SIN3A;RTN4;MACF1
prerank,negative regulation of cell motility (GO:2000146),0.30761000795448357,1.1841739575576624,0.156,0.6773032060775961,1.0,13/108,4.49%,CLDN5;NAV3;LIMCH1;SPOCK3;FRMD5;SRGAP1;PLXNB3;MIF;DACH1;MAGI2;PTPRT;MCTP1;THY1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.43541341061609473,-1.1837475473055508,0.2427007299270073,0.5339373799530582,1.0,4/19,11.49%,NFAT5;PLCE1;INPP5A;NFATC4
prerank,proteoglycan metabolic process (GO:0006029),-0.4044993713664701,-1.1835451022043502,0.24171539961013644,0.5338788222954837,1.0,4/26,4.87%,SULF1;IGF1;ADAMTS12;SULF2
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.4601518228404914,1.1835020029720393,0.2661122661122661,0.6779522050899967,1.0,5/16,13.88%,IGF1R;ETF1;GLE1;OGFOD1;INSR
prerank,pulmonary valve development (GO:0003177),-0.4484506313979319,-1.1831568847589278,0.2261029411764706,0.5342874367298405,1.0,5/18,3.07%,NOTCH2;SMAD6;BMP4;ROBO1;JAG1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.4361691109545822,1.182645647336832,0.23931623931623933,0.6788992563223817,1.0,2/19,1.77%,CD33;GIT1
prerank,cytoskeleton organization (GO:0007010),-0.30256582424793266,-1.1817180456851628,0.14951456310679612,0.5373726429864752,1.0,40/114,21.25%,ARHGAP10;MICAL3;PLCE1;TPM1;BRWD1;DIAPH1;SYNE3;MICAL2;WDPCP;PACSIN2;WTIP;RND3;LRCH3;OBSL1;PALLD;RANBP10;RHOA;LIMD1;ZMYM4;RHOBTB2;FGD1;ZMYM3;CAPZB;APOE;FGD4;NECTIN2;RANBP9;MARK1;PHIP;MICAL1;RHOBTB1;RHOH;RHOC;SIPA1L3;AJUBA;CNN2;SPRYD3;DES;MAST2;PPP2R3C
prerank,presynapse organization (GO:0099172),0.498225425811212,1.1814838083349295,0.25813449023861174,0.6808990937729632,1.0,4/10,15.65%,LRRTM3;NLGN1;DVL1;NLGN3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5099502896929394,-1.180663206777497,0.2591240875912409,0.5393912482154113,1.0,5/11,24.08%,PRKN;REST;HIF1A;PARK7;NONO
prerank,response to nutrient levels (GO:0031667),-0.4591518714235886,-1.1797860137888871,0.24545454545454545,0.5410815972487063,1.0,7/17,22.37%,PRKAA2;RPTOR;MTOR;FAM107A;PRKAA1;EIF4G1;KCNB1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5099858880736684,1.1796829016038026,0.24579831932773108,0.6848262481720767,1.0,1/10,1.24%,KLRC1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4749590902288795,-1.1794830034235408,0.26570915619389585,0.5412751290219876,1.0,8/13,31.31%,UBQLN1;RNFT1;TMEM259;USP13;BAG6;NFE2L2;CAV1;HERPUD1
prerank,secondary palate development (GO:0062009),-0.4688307631343229,-1.1794629791915432,0.2729007633587786,0.5407694666218303,1.0,8/14,17.55%,TGFBR3;TGFBR2;SMAD2;SMAD4;CHD7;TGFB3;LRRC32;WNT5A
prerank,regulation of autophagosome maturation (GO:1901096),-0.4746419687157728,-1.17915302048876,0.26618705035971224,0.5409864369970133,1.0,5/13,27.39%,UVRAG;RUBCN;IRGM;UBQLN4;ADRB2
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.35979387146677905,-1.178953736015694,0.19029126213592232,0.5409210529952652,1.0,17/41,28.64%,ACSL1;DAGLA;PTGS1;CYP1B1;PLA2G4A;PNPLA8;EPHX1;ACOX1;DECR2;MGLL;ELOVL1;ACOT8;DAGLB;GSTM2;ALOX12;ELOVL5;PLA2G4C
prerank,neuron maturation (GO:0042551),0.43621773787917867,1.1785225075215722,0.25346534653465347,0.6867628933750336,1.0,4/18,8.37%,ADGRB3;SCARF1;SRRM4;B4GALT6
prerank,regulation of protein secretion (GO:0050708),0.3006371592528382,1.1777115968780796,0.13953488372093023,0.6877910594690366,1.0,16/119,6.27%,CD33;CACNA1A;SLC2A1;MTNR1B;SYT7;KCNC2;SNAP25;HADH;APBB1;RHBDF2;IL12A;KCNJ11;STXBP5L;APBB3;TGFB2;CACNA1E
prerank,heart process (GO:0003015),0.46473561227939786,1.1776062177832782,0.24945770065075923,0.6866108824355628,1.0,3/14,10.09%,SGCZ;GPX1;SGCG
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2919589158914733,1.1774310918533364,0.13636363636363635,0.685648705411952,1.0,32/149,14.06%,CAMK2A;TFRC;TIRAP;PRKCH;S100A9;S100A8;TRIM13;TRAF1;RPS6KA5;ALK;CLU;PRKCQ;RTKN2;TRIM37;RPS27A;UBC;TRIM62;TLR2;UBB;TRIM6;PSMA6;ARHGEF2;NOD1;TERF2IP;MID2;BCL10;CD40;RPS3;NFKBIA;CD36;CIB1;TAB2
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4779029474034956,-1.1772328283019153,0.26136363636363635,0.5445624620424081,1.0,7/13,19.15%,PKD1;FLNA;PKD2;SUFU;LATS1;GET4;MDFI
prerank,neutrophil activation involved in immune response (GO:0002283),0.2595382303611096,1.1770834051712302,0.06862745098039216,0.6852439888005533,1.0,91/428,17.90%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;DNASE1;SLCO4C1;HRNR;MME;RAB4B;SLC2A3;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;SNAP25;ENPP4;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PECAM1;BRI3;TLR2;PTPRJ;EPX;FTL;HSP90AB1;PSMD12;GOLGA7;ARSA;HEBP2;LAIR1;ALDOC;SLPI;BIN2;GLA;GGH;ACTR10;CCT2;FABP5;PDAP1;TSPAN14;ITGAM;CTSB;VAT1;LCN2;HGSNAT;PSEN1;CD36;EEF1A1;ATP11B;SNAP29;PTGES2;COTL1;B2M;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMC3;PSMA2;RAP1A;STK11IP;XRCC5;RAP2B;HSP90AA1;RAB31;ATP6V0A1;GLB1;ARL8A;TMBIM1;C3AR1;PPIA;EEF2;HEXB
prerank,regulation of immune effector process (GO:0002697),-0.3581681003903504,-1.1770089859538169,0.20388349514563106,0.5445268258009889,1.0,5/41,3.68%,CFH;SERPING1;VTN;PROS1;CD55
prerank,L-amino acid transport (GO:0015807),0.39465464845115195,1.1768019238103946,0.21206225680933852,0.6845743808374979,1.0,6/28,9.57%,SLC7A5;SLC7A1;SLC1A1;SLC1A2;SLC7A8;SLC36A1
prerank,positive chemotaxis (GO:0050918),0.4399623461643175,1.1766794971957844,0.2551440329218107,0.6834454584018139,1.0,6/17,10.67%,PLXNB3;FGF10;PTPRJ;GPNMB;SCG2;CORO1A
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5090201666982408,1.1762705069127541,0.24786324786324787,0.6833153028014779,1.0,4/11,13.24%,KCNJ3;KCND3;ATP1A1;ATP1B1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3524347605602659,1.1757921271004765,0.22755741127348644,0.6833555295049206,1.0,7/46,4.15%,PTPRR;SEMA6A;SPRY3;CNKSR3;DUSP6;CAMK2N1;WNK2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.4619470815161653,1.1754581599080955,0.24561403508771928,0.6829380467758324,1.0,3/13,7.89%,TMEM35A;STX3;HSP90AB1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.4553064013138392,-1.1752802754696359,0.24904942965779467,0.5482999546724833,1.0,4/16,9.95%,MOV10;RC3H1;DHX36;UPF1
prerank,regulation of interleukin-13 production (GO:0032656),0.4711653428680662,1.1752713001167154,0.2608695652173913,0.6821063777806181,1.0,2/13,11.19%,LEF1;TNFRSF21
prerank,DNA double-strand break processing (GO:0000729),-0.4406823851367994,-1.175193449300496,0.24909090909090909,0.5479477775411808,1.0,3/18,5.93%,UBE2N;RBBP8;NBN
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5223399829776483,-1.1751742495402349,0.283609576427256,0.54742658147701,1.0,3/10,7.01%,ATP1A2;OSR1;CAMK2D
prerank,lipid homeostasis (GO:0055088),-0.3354650380753896,-1.1745410169285517,0.20616570327552985,0.5483785314084147,1.0,15/57,17.82%,ZBTB20;RBP1;ABCA1;NR1D2;PRKAA2;ABHD5;TLCD2;NR1H3;RCN3;PNPLA8;FBXW7;APOE;DDX3X;ACOX1;PRKAA1
prerank,vascular transport (GO:0010232),0.3184066791293605,1.174478040975284,0.18775510204081633,0.6831714571610972,1.0,12/81,4.33%,SLCO1C1;TFRC;SLC7A5;SLC6A6;SLC6A17;SLC2A1;ATP8A1;SLC2A3;SLC7A1;ABCG2;MFSD2A;SLC1A1
prerank,heterochromatin organization (GO:0070828),0.46205092353952554,1.174429736598669,0.2531914893617021,0.6818461334120204,1.0,3/14,3.68%,MECOM;SIRT1;HMGA2
prerank,hyaluronan metabolic process (GO:0030212),-0.41976278976331477,-1.1743826032589957,0.2537037037037037,0.5482163977671304,1.0,8/23,22.57%,CEMIP;SLC9A1;ABCC5;CEMIP2;GUSB;HEXA;FGF2;CHP1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.38450808358059535,1.1736750511982723,0.22844827586206898,0.6827257771089815,1.0,4/29,12.48%,CADM1;IL12A;CYRIB;ITGAM
prerank,B cell activation involved in immune response (GO:0002312),-0.49231755638361674,-1.1735701991766914,0.2784090909090909,0.5496474909662203,1.0,8/13,37.27%,RNF8;MSH6;EXOSC3;BATF;GPR183;LIG4;FCGR2B;MSH2
prerank,positive regulation of cell migration (GO:0030335),-0.2720943194038678,-1.1735617272009526,0.10121457489878542,0.5491021909487193,1.0,72/253,19.13%,SYNE2;ROCK2;IGF1;EGFR;DOCK5;TGFBR1;COL1A1;PDGFRA;NTRK3;SMURF2;MYLK;CEMIP;SEMA3D;FGF1;PDGFRB;DAB2;PDPN;SMO;VTN;WNT5B;KIT;RREB1;ITGB1;CTSH;THBS1;STAT3;MAP4K4;NRP1;MTOR;F3;PLCG1;SEMA3E;CXCL16;FER;PDGFC;MMP14;HIF1A;ADAM9;NIPBL;STX4;ROR2;RAB11A;FN1;CCAR1;MAPRE1;CPNE3;CCN1;SH3RF2;SEMA3B;VEGFA;SEMA4B;NUMB;ACVR1;RAPGEF2;GLIPR2;CARMIL1;DOCK1;ADRA2A;PIK3CD;TWIST2;CCN4;MIA3;FAM107A;S100A11;MYADM;SOD2;GCNT2;BMP2;MYOC;RHOC;HBEGF;GAB1
prerank,intracellular sterol transport (GO:0032366),-0.4767698108780391,-1.1733499779220582,0.26737967914438504,0.5490891085062624,1.0,3/13,11.63%,ABCA1;RELCH;NPC2
prerank,mitochondrial membrane organization (GO:0007006),-0.3831195228858408,-1.1733354847823434,0.2519230769230769,0.5485613918978067,1.0,12/32,30.48%,OPA1;BCL2;MICOS10;MTX3;RCC1L;HSPA9;BNIP3;APOO;MFN2;SAMM50;BAK1;PPIF
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.47272198437852286,-1.1726560127607222,0.26678765880217786,0.5497005009670146,1.0,2/13,2.90%,DCN;BGN
prerank,protein targeting to peroxisome (GO:0006625),-0.39192162329567276,-1.1724548830655737,0.23062015503875968,0.5496356075529333,1.0,11/29,20.65%,ZFAND6;ABCD3;PXMP4;ABCD2;LONP2;PEX6;SLC25A17;PEX7;FIS1;PXMP2;PEX26
prerank,positive regulation of viral process (GO:0048524),-0.3334988271832712,-1.1723373526364238,0.18216318785578747,0.5493807260927744,1.0,27/60,31.73%,MDFIC;AXL;CCNT1;KPNA6;DHX9;LARP1;TBC1D20;NELFB;DDX3X;PPIH;POLR2H;PPID;GTF2F1;POLR2K;RAB7A;CTDP1;POLR2E;PPARA;PDE12;POLR2D;NELFA;CDK9;NELFE;KPNA2;ADARB1;NR5A2;TYRO3
prerank,purine nucleotide catabolic process (GO:0006195),0.4719797975158509,1.1721403669956318,0.2735229759299781,0.6859975348543792,1.0,3/13,12.85%,GPX1;NT5C;HINT1
prerank,carboxylic acid transport (GO:0046942),0.3427588229991092,1.1721018936938297,0.21473684210526317,0.6846662821234192,1.0,10/55,10.55%,SLC7A5;SLC6A6;SLC6A17;SLC7A1;AQP9;SLC1A1;SLC7A8;SLC66A1;SLC36A1;SLC16A4
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.4133108558930674,-1.1720214600973293,0.2546816479400749,0.5496109215372313,1.0,4/21,7.81%,ANK2;FLNA;SNTA1;CACNA1D
prerank,cardiac atrium morphogenesis (GO:0003209),0.45225324023112035,1.1716855122886116,0.24480369515011546,0.6844809284572538,1.0,4/16,5.82%,PROX1;MYH6;NOTCH1;TGFB2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4241531624787943,-1.1716049543856244,0.24236641221374045,0.5500680832490425,1.0,5/20,10.53%,TGFBR1;ZMIZ1;PRKN;UBQLN1;HIF1A
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.3185060068525374,-1.1715105125331362,0.1774193548387097,0.5497673705509455,1.0,41/80,35.65%,ANGPT1;UBE2N;LRRK2;HUWE1;AXIN1;UBQLN1;XIAP;CUL3;FBXW7;FANCM;FANCI;TOPORS;SPRTN;DERL1;FAM107A;TRAF6;DCUN1D3;SPSB4;TBC1D7;CDK5RAP3;SPHK1;ARRDC4;SENP2;WFS1;MAGEC2;PAXIP1;KDM1A;FBXO4;HDAC3;DCUN1D5;BIRC3;RBX1;PEF1;UBE2L3;CAV1;DCUN1D4;BRCA1;PSMD10;CENPX;RIPK2;PIN1
prerank,fatty acid catabolic process (GO:0009062),-0.32448287415927485,-1.1714609343791365,0.17647058823529413,0.5493373981402092,1.0,24/67,24.49%,PCCA;ABCD3;ACADM;MMUT;ACAD10;ABCD2;ACAD11;CPT2;ABHD3;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ACOX1;LPIN2;ECI1;LPIN3;MECR;MCEE;ACOT8;AUH;ILVBL
prerank,regulation of macrophage chemotaxis (GO:0010758),0.41361512460863536,1.1713757489133751,0.24358974358974358,0.6839498329987147,1.0,3/21,4.74%,CSF1R;MIF;MTUS1
prerank,membrane organization (GO:0061024),0.2727696521804831,1.1709062888139399,0.11777301927194861,0.6840244513736959,1.0,48/227,15.25%,TFRC;DNM3;ACTB;SYT1;RIMS1;SGCZ;SH3GL2;AP2M1;ANK3;REEP1;BIN1;LPCAT2;SLC18A3;CERT1;HIP1;ATP10B;HSPA8;FNBP1L;AMPH;FCHO1;NAPG;RPS27A;UBC;DYSF;UBB;SCARB2;AP2B1;SAR1A;SUN1;SYT2;SPTBN1;CCDC88A;FZD4;PLEKHA3;SERP1;LEMD2;CNTN2;CPTP;SGIP1;TTPA;CLTB;SNAP29;NECAP1;SH3KBP1;PPT1;CHRM2;CORO1C;REEP3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4607201904507478,1.170678868845601,0.2494802494802495,0.6833123995860346,1.0,2/13,3.31%,MIF;SIRT1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.49335982117281546,1.1706223925487675,0.2755741127348643,0.682045429062912,1.0,3/11,7.35%,CACNA2D1;BIN1;CACNB2
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3393285994902453,-1.1705190787134552,0.15714285714285714,0.5510690179137301,1.0,14/59,14.02%,EGFR;PDGFRA;TPM1;ABL1;ANXA1;MAP3K5;PTPRK;IMPACT;CYP1B1;FER;JUN;PRKCD;PKD2;ERCC6L2
prerank,regulation of cholesterol efflux (GO:0010874),0.3820141255822209,1.170373563369718,0.2192622950819672,0.6813768416415656,1.0,5/30,8.56%,PLTP;SIRT1;NAXE;PPARG;GPS2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.38027573897460837,-1.1702966812510947,0.2381852551984877,0.5511146341918166,1.0,15/33,21.57%,FGF1;JAK1;RHOJ;THBS1;PDPK1;GLUL;ADAMTS9;BMPER;CEMIP2;VEGFA;ITGA5;PKM;S100A1;SMAD1;FGF2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3848017978464484,1.1699308269433497,0.21875,0.6812237573008424,1.0,7/31,11.12%,LRP8;NLGN1;SHANK3;KIF1A;ZDHHC15;RELN;PPFIA2
prerank,smooth muscle tissue development (GO:0048745),-0.5056188416079916,-1.1698575221034448,0.2718631178707224,0.5516163511458921,1.0,5/10,15.46%,MYLK;BMP4;SMO;EFEMP2;PTCH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.5036905927061566,-1.1693141698611416,0.2669172932330827,0.551855940929911,1.0,3/10,12.14%,FTO;ASCC3;ALKBH1
prerank,DNA dealkylation (GO:0035510),-0.5036905927061566,-1.1693141698611416,0.2669172932330827,0.551855940929911,1.0,3/10,12.14%,FTO;ASCC3;ALKBH1
prerank,regulation of phospholipase activity (GO:0010517),-0.5103134069948515,-1.168655317559274,0.2616279069767442,0.5529054968512154,1.0,3/10,7.95%,LRP1;FGFR2;PDPK1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.4566069818327426,-1.1685953138167409,0.275797373358349,0.5524741895261249,1.0,4/16,11.70%,APPL2;NCOR1;WDTC1;ERLIN1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3181329927979096,-1.1682502636519196,0.18762475049900199,0.552791406711746,1.0,26/78,22.83%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;GSK3B;RNF217;UBQLN1;RNF19A;NUB1;CSNK1E;TRIB2;SH3RF2;CBFA2T3;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;COP1;ZYG11B;ARIH2;DET1;RNF144A
prerank,positive regulation of ruffle assembly (GO:1900029),0.46677444807922314,1.1682188384072902,0.27419354838709675,0.6850180386589464,1.0,4/13,13.64%,NLGN1;FAM98A;HRAS;PFN1
prerank,mRNA 3'-end processing (GO:0031124),-0.3226393946884727,-1.1678292807880077,0.18832391713747645,0.5532968131732416,1.0,31/78,27.98%,TENT2;PABPN1;PCF11;WDR33;CASC3;SCAF8;U2AF2;CPSF3;SRSF6;SSU72;SLU7;RPRD2;SLBP;SRSF1;PAPOLG;CSTF3;SRSF7;CDC73;SRSF11;SRRM1;UPF3B;SRSF2;AHCYL1;CSTF1;CPSF4;NUDT21;CPSF1;NCBP2;LSM11;APP;POLR2D
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.4128486677270162,-1.1678172975046273,0.2684310018903592,0.5527702938884386,1.0,9/21,23.49%,SMO;DCDC2;TTC23;EVC;ARMC9;GLI1;PDCL;DLG5;KIF7
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.43479638178054514,-1.1674417471538143,0.2572533849129594,0.5531930823848441,1.0,4/17,5.36%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,substantia nigra development (GO:0021762),0.37620705488630074,1.166728289149001,0.21063394683026584,0.6879756758112318,1.0,11/37,14.31%,ACTB;MBP;PLP1;HSPA5;DYNLL1;BASP1;CALM1;COX6B1;CALM2;INA;CALM3
prerank,protein dephosphorylation (GO:0006470),-0.2923637571164204,-1.166664018397301,0.1442687747035573,0.5546426536172067,1.0,34/135,15.20%,EYA2;PTPN13;EYA1;EYA4;PPP1R12A;PPM1D;PTPN14;PPM1E;TNS2;BTRC;PTPN9;PTPRS;PTPN21;DUSP16;PTPN3;SSU72;PTPRK;DAPP1;PTPN22;PPP4R2;PPP2CB;PPM1H;PTPN12;PTPN2;DUSP11;PPP2R5E;PPM1M;MTMR3;PPM1A;PPP2R5D;DUSP1;CDC14B;NCK1;PPP1CB
prerank,cellular response to estradiol stimulus (GO:0071392),-0.427074450311681,-1.166202011918585,0.2581818181818182,0.555278332586051,1.0,2/18,5.19%,EGFR;LCOR
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.528892112924495,1.1659663634023685,0.275,0.6890173022577886,1.0,3/10,8.88%,PODXL;FERMT3;SKAP1
prerank,substrate-dependent cell migration (GO:0006929),-0.46574904042679977,-1.1658280730063277,0.2673992673992674,0.5556829691400468,1.0,4/14,13.96%,ITGA11;NRP1;P2RY12;EPHA8
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.49293247962257924,-1.1657779838760922,0.298372513562387,0.5552355998632176,1.0,6/12,17.48%,NBL1;BMP5;WASL;CCN3;DUSP1;MIA3
prerank,gland development (GO:0048732),-0.3323369943562811,-1.165597497125809,0.204,0.5551318910659073,1.0,17/59,17.02%,TGFBR3;TGFBR1;WNT4;GLI2;DKK3;FGFR2;ANXA1;CEBPG;ZBTB1;PHF2;ARID5B;HES1;PKD2;TGFB3;SALL1;CITED2;SIX1
prerank,protein autophosphorylation (GO:0046777),0.28156746704263946,1.164983508772113,0.1523046092184369,0.6905777954109451,1.0,23/157,9.10%,FLT1;CAMK2A;IGF1R;TEK;ERBB4;CSF1R;EPHB1;HTATIP2;TNIK;MEX3B;KDR;CAMK4;NTRK2;WNK2;FLT3;AATK;SRMS;ALK;PAK1;MELK;AKT1;CDKL5;TAOK2
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.4978735619469959,-1.1646043884375248,0.28544776119402987,0.557065018379273,1.0,4/11,23.41%,IL34;ID2;PRKCA;HSF1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4280106741626617,-1.1642590633987777,0.2485207100591716,0.557355401990247,1.0,4/19,5.36%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,protein localization to cell-cell junction (GO:0150105),-0.46206506968966726,-1.164053248372133,0.2404040404040404,0.5572951336898067,1.0,5/15,10.94%,CGNL1;MPP7;JAK1;PAK2;ARHGEF18
prerank,chemokine-mediated signaling pathway (GO:0070098),0.35628151222543863,1.1638444348402488,0.2288659793814433,0.6926196764138179,1.0,11/42,21.31%,CXCL12;GPR35;CCL2;THPO;GPR75;STK39;CIB1;CCL25;CCL13;CCL19;RBM15
prerank,negative regulation of cell projection organization (GO:0031345),0.3413147495242731,1.1631998825264045,0.19678714859437751,0.6932024154968778,1.0,20/48,19.42%,SPOCK1;DCC;MINAR1;MAG;SPRY3;GRIN2B;ITM2C;STMN2;RTN4R;CIB1;PRAG1;RTN4RL1;FKBP4;CRMP1;STX1B;RAB29;FYN;GAK;TRPV4;PTPRO
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3184251901466201,1.1631222485786712,0.20077972709551656,0.6919905525993011,1.0,11/70,9.41%,MBOAT1;MFSD2A;LPCAT2;PCYT1B;CHKA;ENPP2;CSNK2B;PLAAT1;TMEM86B;SLC44A5;PLA2G12A
prerank,cellular response to alcohol (GO:0097306),-0.3519888641792547,-1.1630611612446107,0.23196881091617932,0.5591786806588086,1.0,12/42,9.18%,ADCY5;LRP6;KLF9;CTNNA1;SMO;SPIDR;GRAMD1C;CDH1;ADCY1;LARP1;ADCY6;JUP
prerank,peptidyl-proline modification (GO:0018208),-0.40029376470566097,-1.162440634928486,0.2529411764705882,0.5602052394928263,1.0,11/25,30.48%,FKBP5;FKBP10;FKBP7;PPIH;PPWD1;NKTR;NTMT1;PPID;PPIC;PPIL1;PPIF
prerank,negative regulation of defense response to virus (GO:0050687),-0.5168262910995113,-1.1621629458099796,0.2782101167315175,0.5603322587489348,1.0,8/10,41.27%,PCBP2;ILRUN;MUL1;C1QBP;TSPAN6;TRAF3IP1;TARBP2;RNF26
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.44567631053994944,-1.1620980218351347,0.25092936802973975,0.5599122880049535,1.0,7/16,30.64%,VAMP7;CEBPG;VAMP2;PLEKHM2;KIF5B;ULBP1;RAET1E
prerank,amino acid import (GO:0043090),0.41182345844339246,1.1619591268411618,0.2616033755274262,0.6940931652367315,1.0,6/21,9.57%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;SLC7A8;SLC36A1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.519259913972506,-1.1618099122655032,0.2722419928825623,0.5600902924304786,1.0,6/10,27.07%,EMC2;EMC7;EMC9;EMC4;EMC10;EMC3
prerank,protein-containing complex disassembly (GO:0032984),-0.3355948705391433,-1.161726305244832,0.2057142857142857,0.559743597228646,1.0,12/54,10.06%,LRP6;CSNK1A1;UVRAG;GSK3B;AXIN1;UBQLN1;FZD2;VTI1B;VAMP7;LIX1L;LAMP2;CHMP3
prerank,T cell differentiation in thymus (GO:0033077),-0.4577532256201099,-1.161682349399092,0.2862190812720848,0.5593124534233255,1.0,1/14,0.85%,GLI3
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3195654679132245,1.1613211015576452,0.199203187250996,0.6947647754168432,1.0,12/72,7.74%,FLT1;IGF1R;TEK;SIRT1;KDR;NTRK2;SEMA4D;FLT3;TGFB2;PIK3R5;UNC5B;EPO
prerank,response to muscle stretch (GO:0035994),0.46050609495870165,1.1611758665318674,0.2679738562091503,0.6937477076759934,1.0,4/15,9.53%,RYR2;CDH2;SLC8A1;TCAP
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.44383671805902164,1.1610653292248805,0.2857142857142857,0.6926816090650681,1.0,2/14,3.31%,PRKAR2B;SIRT1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4571789515505157,-1.1609439109751567,0.27617328519855594,0.5604650785524818,1.0,8/16,18.78%,FTO;BMP7;RREB1;NAPEPLD;SOX13;SIX1;HNRNPU;METRNL
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.3216257712321015,-1.1608658735145558,0.2011605415860735,0.5601037006359553,1.0,27/69,29.30%,CCNT2;CCNT1;INTS4;CDK7;PHAX;TBP;CCNK;RPRD2;NABP2;SNAPC3;TAF8;TAF13;GTF2B;ICE1;INTS6;POLR2H;INTS14;GTF2F1;POLR2K;SNAPC1;POLR2E;NCBP2;SNAPC5;GTF2E2;POLR2D;CDK9;INTS7
prerank,membrane lipid biosynthetic process (GO:0046467),0.33525848569948613,1.1602292057911527,0.19801980198019803,0.6938811208118136,1.0,18/58,18.02%,SGMS1;ACER2;FA2H;DEGS2;CERT1;SPNS2;ELOVL7;SGPP2;ELOVL4;HACD3;ST8SIA6;HACD1;PPM1L;SAMD8;PRKD3;KDSR;SGPP1;SPTLC2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3984927404935533,1.1597516604160918,0.2543478260869565,0.6939137150091637,1.0,11/26,21.50%,NAV3;OCLN;PAK1;STMN2;DCTN1;RPS3;TRPV4;CLASP1;RAC1;CDK5R1;CDK5RAP2
prerank,positive regulation of double-strand break repair (GO:2000781),-0.36105096618923027,-1.159388444459846,0.229126213592233,0.5632810440646409,1.0,14/39,17.67%,KMT5B;SPIDR;FUS;WDR48;SHLD2;PARP9;PARP1;KMT5C;SLF1;DTX3L;MMS19;PRKDC;SMCHD1;ARID2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.39823051029407475,-1.1587522484837827,0.242,0.5643403530281655,1.0,6/26,16.48%,ATP1A2;UBQLN1;PKD2;SRI;YWHAE;ADRA2A
prerank,cortical cytoskeleton organization (GO:0030865),-0.3519883022890621,-1.1578611474562401,0.22718446601941747,0.5660647111979958,1.0,12/41,18.98%,ROCK2;RHOQ;ROCK1;DLG1;RND3;FHOD1;RHOA;NCKAP1;RHOBTB2;RHOBTB1;RHOH;RHOC
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3620530445815664,-1.1572690921616657,0.22580645161290322,0.567032201927278,1.0,15/36,24.29%,FHIT;USP7;RPL11;GIPC1;PSMF1;OGT;TRIM39;NOP53;PSME3IP1;PARK7;WAC;CCAR2;EIF3H;BAG5;BAG6
prerank,nitric oxide mediated signal transduction (GO:0007263),0.43225924308767844,1.157200116905043,0.27896995708154504,0.7001786797590573,1.0,6/16,20.07%,KCNC2;NOS3;NDNF;CD36;DDAH1;AGT
prerank,replicative senescence (GO:0090399),0.47729030012969664,1.1571852904425808,0.28541666666666665,0.6988028758316397,1.0,2/12,1.59%,CHEK1;MME
prerank,plasma membrane organization (GO:0007009),-0.32896541813655955,-1.156862034941101,0.19959266802443992,0.5674235553191934,1.0,16/61,11.74%,ANK2;COL5A1;ANXA6;A4GALT;PLSCR4;PLSCR2;PACSIN2;SNX9;MYOF;PLSCR1;CHMP4A;EHD2;ABCD2;TLCD2;STX4;UGCG
prerank,regulation of chromosome organization (GO:0033044),-0.41660538800037117,-1.1568603229562653,0.25343811394891946,0.5668685869897584,1.0,7/22,12.66%,SMG6;HDAC8;SMG1;YLPM1;HNRNPD;UPF1;RB1
prerank,neutrophil degranulation (GO:0043312),0.2547997885987956,1.156580530215042,0.08203125,0.6993023249137514,1.0,90/425,17.90%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;SLCO4C1;HRNR;MME;RAB4B;SLC2A3;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;SNAP25;ENPP4;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PECAM1;BRI3;TLR2;PTPRJ;EPX;FTL;HSP90AB1;PSMD12;GOLGA7;ARSA;HEBP2;LAIR1;ALDOC;SLPI;BIN2;GLA;GGH;ACTR10;CCT2;FABP5;PDAP1;TSPAN14;ITGAM;CTSB;VAT1;LCN2;HGSNAT;PSEN1;CD36;EEF1A1;ATP11B;SNAP29;PTGES2;COTL1;B2M;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMC3;PSMA2;RAP1A;STK11IP;XRCC5;RAP2B;HSP90AA1;RAB31;ATP6V0A1;GLB1;ARL8A;TMBIM1;C3AR1;PPIA;EEF2;HEXB
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4041565478644152,1.1561522556342907,0.22807017543859648,0.6991772545059738,1.0,3/22,9.29%,SLC7A5;TRIM6;TRIL
prerank,peptide metabolic process (GO:0006518),-0.31526849905334486,-1.1560478537003909,0.20204081632653062,0.5683938151421263,1.0,26/75,23.52%,CPQ;AEBP1;PCSK5;HM13;ANPEP;SEC11C;MGAT3;NPEPPS;NLN;CPM;CPXM2;LNPEP;GSTT2;GLRX2;CTNS;CPXM1;SEC11A;GSTT1;ETHE1;CARNMT1;SPPL3;CLN5;DNPEP;PARL;GSTM2;APEH
prerank,positive regulation of translational initiation (GO:0045948),-0.4274646110542301,-1.1558038471567533,0.2781818181818182,0.5684091810671731,1.0,6/18,14.85%,YTHDF3;KHDRBS1;MTOR;LARP1;CDC123;DDX3X
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.40357433787054964,1.155709326140866,0.25925925925925924,0.6990066098072488,1.0,6/23,16.28%,CHEK1;BUB1;WEE2;NABP1;CHFR;PLK2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.454796414572878,1.1556343099259014,0.2809917355371901,0.6978646212515982,1.0,4/15,5.70%,IGF1R;KDR;AATK;SRMS
prerank,negative regulation of leukocyte migration (GO:0002686),-0.4994833528851116,-1.1555406884635258,0.283609576427256,0.5684888496085698,1.0,5/10,24.99%,BMP5;HOXA7;EMILIN1;CD300A;SLIT2
prerank,regulation of osteoblast proliferation (GO:0033688),-0.4385850903395887,-1.1554061467905243,0.2624521072796935,0.5682657100590861,1.0,10/17,20.74%,NPR3;FGFR2;MN1;RHOA;ATRAID;CCN1;EIF2AK2;PLXNB1;BMP2;TMEM119
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.28617952085188086,1.1553322831970938,0.17057569296375266,0.6973966133235033,1.0,31/152,16.95%,ADGRL4;ADGRL3;ADGRB3;RGS1;ADCY8;ADCY3;RAMP2;ADGRB1;GRM8;S1PR5;PDE2A;LGR5;MTNR1A;ADCYAP1;GPR26;GNAL;ADRA1D;ADGRL2;ADCY4;CNR1;PTGER2;OPRK1;ADGRG1;CHRM2;OPRL1;GNAI1;GNAQ;CALCRL;ADCYAP1R1;ADGRE1;PTGER4
prerank,response to UV-A (GO:0070141),0.45163551350487535,1.1553030049429753,0.3036093418259023,0.6960918430013208,1.0,4/14,7.97%,MME;CCND1;TIMP1;AKT1
prerank,Notch signaling involved in heart development (GO:0061314),-0.49599718067434556,-1.1552374494684536,0.2949907235621521,0.5681072143656352,1.0,3/11,3.07%,NOTCH2;RBPJ;JAG1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.47034451885466266,1.1544324102358665,0.27802690582959644,0.697344143974466,1.0,3/12,9.70%,ACTB;AHI1;VANGL2
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.29738461841613917,-1.154356970362209,0.2,0.5697450589196241,1.0,46/110,24.95%,TRABD2B;GSN;ABCA1;MPP7;EP300;GSK3B;SPIDR;STXBP1;CDC42;BRK1;IMPACT;TRAF2;HCFC1;ATF7IP;HJURP;FNIP1;RIOK3;RB1;SLF1;EIF2AK2;GFAP;APOE;VEGFA;DDX3X;LATS1;PRKCZ;FARP2;NOP53;IAPP;ICE1;VCP;NAPA;PARK7;RHOC;PTPN11;AJUBA;KIF9;FBLIM1;PIH1D1;BMF;HSF1;PREB;SAR1B;GNL3L;SYK;IRGM
prerank,amide transport (GO:0042886),0.3895425465193691,1.1542560371777622,0.27139874739039666,0.6964819862995951,1.0,4/26,4.27%,PLTP;ABCG2;AQP11;CERT1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.39530430419115486,-1.1539173353524577,0.2485089463220676,0.5703252739257587,1.0,8/26,17.98%,APPL2;LGR4;FLOT2;IRAK3;APPL1;IRF1;OTUD4;LRRC14
prerank,regulation of neuron projection arborization (GO:0150011),0.4385859161514623,1.153453472233563,0.2915766738660907,0.6975479904053258,1.0,7/15,11.92%,SPRY3;MFSD2A;GRIP1;NTNG1;NTNG2;FZD4;DVL1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.31789971315780813,-1.1533537294050307,0.21357285429141717,0.5711487905460721,1.0,24/72,26.64%,RBFOX2;FLRT2;HNRNPH1;FGF1;SHOC2;HNRNPM;FGFR2;FRS2;KIF16B;KL;FLRT1;FIBP;FGFBP1;CEP57;POLR2H;PTPN11;SPRED2;FGFR4;FGF2;GTF2F1;POLR2K;POLR2E;NCBP2;FGFRL1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.386845374645099,-1.15333435390012,0.24778761061946902,0.5706299459296822,1.0,12/29,24.11%,UBE2N;ABL1;AXIN1;FBXW7;DTX3L;TOPORS;FEM1A;DCUN1D3;PARK7;ARRDC4;MAGEC2;BAG5
prerank,snRNA transcription (GO:0009301),-0.3179867729529215,-1.1532705798028515,0.2153846153846154,0.5702306067695155,1.0,27/70,29.30%,CCNT2;CCNT1;INTS4;CDK7;PHAX;TBP;CCNK;RPRD2;NABP2;SNAPC3;TAF8;TAF13;GTF2B;ICE1;INTS6;POLR2H;INTS14;GTF2F1;POLR2K;SNAPC1;POLR2E;NCBP2;SNAPC5;GTF2E2;POLR2D;CDK9;INTS7
prerank,epithelial cell differentiation (GO:0030855),-0.30909530684992687,-1.1530994375970425,0.1828793774319066,0.5701558458093078,1.0,29/88,21.64%,FSTL1;MAF;DAB2;BMP4;JAG1;ANXA4;RAB10;FGFR2;ANXA7;ANXA1;CNN3;VDAC1;SCUBE1;FZD7;PGK1;PCK2;GLI1;VEGFA;HDAC1;LATS1;BDH2;SIX1;TAGLN;CPT1A;PCNA;PIH1D1;AKT2;GATA6;SCRIB
prerank,cellular component assembly (GO:0022607),-0.26415770070895594,-1.1528603647337083,0.12311015118790497,0.5701774643473704,1.0,68/253,21.48%,CALD1;DPYSL3;PARVA;PAWR;RHOQ;TEAD1;GSN;LIMS1;MDM4;MYO1B;LIMA1;BAIAP2L1;SHROOM2;RHOJ;NLGN2;DLG4;MYO9A;YTHDF3;YAP1;FLNA;DNM1L;SNX9;CREBBP;CDC42;TUBGCP2;PPARGC1A;VAMP2;VASP;TLCD2;VCPIP1;GEMIN5;FLNC;MNAT1;WASL;TRAF2;RHOA;NCKAP1;RAD21;CAPZA1;WIPF1;HES1;TEAD2;TOGARAM1;PARD3;RANBP9;WASF1;REPS2;PPIH;ZFYVE27;PICALM;WNT5A;FAM107A;CFAP74;MICAL1;RHOH;FZD1;GPAA1;TUBGCP4;CDAN1;PML;BAIAP2;SPEF1;FBLIM1;PLS1;FANCC;KIFAP3;KMT2A;PPID
prerank,positive regulation of phosphorylation (GO:0042327),-0.26750750735052675,-1.15258857243913,0.12083333333333333,0.5703299309819909,1.0,38/240,8.57%,ZBTB20;ROCK2;IGF1;ROR1;EGFR;LMO4;EPHA7;LEPR;EPHA3;IL34;PDGFRA;ANGPT1;SLCO3A1;NTRK3;PELI2;FGF1;PDGFRB;AXL;DAB2;FAM20A;BMP4;ABL1;ARNT;LRRK2;PRKAA2;KIT;RYK;THBS1;AXIN1;NBN;NRP1;FGFR2;PFKFB4;LYN;MERTK;AR;EPHA4;IGF2
prerank,cellular response to cAMP (GO:0071320),0.38297989870122656,1.1521837438535032,0.27070707070707073,0.6999916948870225,1.0,5/30,6.29%,HCN1;AQP9;AKAP6;PDE2A;HCN2
prerank,Golgi to lysosome transport (GO:0090160),-0.4896063993474583,-1.1520049716895475,0.2886405959031657,0.5712574222286204,1.0,4/11,17.98%,CCDC91;EHD3;LAMP1;ANKFY1
prerank,negative regulation of cell growth (GO:0030308),0.2938773077725108,1.1518705519801282,0.16049382716049382,0.6995328539825634,1.0,28/121,16.45%,DCC;MINAR1;MAG;MAP2;SIRT1;GNG4;FGF13;APBB1;SCGB3A1;PPP2R1A;TGFB2;SLIT3;WFDC1;PTPRJ;ACVRL1;RTN4R;APBB2;SOX17;DIP2B;NDUFA13;BMPR2;SMARCA2;CDKN1A;PPT1;RTN4;NPR1;CDKN1B;DNAJB2
prerank,vasculogenesis (GO:0001570),0.3735396675471983,1.151864122475207,0.23651452282157676,0.6981691054474334,1.0,7/32,7.29%,EGFL7;RAMP2;KDR;TGFBR3L;NOTCH1;WNT7B;APLNR
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.30441238854885033,-1.151834569208669,0.20300751879699247,0.5710860013519046,1.0,26/94,21.54%,ITPR1;FHIT;DDX5;PDK1;ABL1;BCL2;MAP3K5;AIFM1;CYP1B1;TRAF2;PRKCD;PRODH;CUL3;CASP2;PRKDC;ERN1;DDX3X;CUL2;TOPORS;IKBKE;RRP8;MSH6;PML;ATP2A3;CUL1;BNIP3
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.342806391904578,-1.1516532092954943,0.224,0.5709645756391528,1.0,18/49,24.77%,KAT2B;EP300;TNRC6B;KMT2C;TNRC6A;KMT2D;MOV10;THBS1;RUNX1;MEF2C;PITHD1;HDAC1;TNRC6C;KMT2A;AGO1;CNOT4;KMT2E;RAB7B
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5033570106861579,-1.1516196868945776,0.2874015748031496,0.5705099268960787,1.0,4/11,14.18%,IL6ST;JAK1;STAT3;STAT1
prerank,amino acid import across plasma membrane (GO:0089718),0.39777387031198935,1.151405242646972,0.2723404255319149,0.6981829324944889,1.0,8/24,9.57%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;SLC1A2;SLC6A5;SLC7A8;SLC36A1
prerank,glycerolipid catabolic process (GO:0046503),0.421130830182912,1.1512841604411683,0.2713347921225383,0.6971707499146409,1.0,2/19,2.01%,GPCPD1;ABHD2
prerank,acylglycerol biosynthetic process (GO:0046463),-0.39971812781417865,-1.151200679473317,0.25,0.5709760268692767,1.0,8/23,20.39%,AGMO;PLCE1;GPAT4;PLA2G4A;MOGAT3;LPIN2;LPIN3;GPAT3
prerank,regulation of cell population proliferation (GO:0042127),-0.2423623969948866,-1.1510836142828584,0.05942622950819672,0.5707468085282519,1.0,178/691,21.77%,BMP6;IGF1;GRK5;EGFR;ALDH1A2;TCF7L2;GAB2;TGFBR1;ZBTB7C;RBFOX2;PTN;BMPR1A;IL34;PDGFRA;KANK2;NTRK3;LIMS1;EFNB2;SMAD6;CELF1;COL4A3;BMP5;MDM4;ITGAV;DIS3L2;KSR1;FGF1;PDGFRB;KAT2B;PIAS1;IL6ST;IL31RA;BMP4;HDAC4;PDPN;PPM1D;ELN;BIRC6;JAG1;NPR3;PTPN14;TGFBR2;TNS2;PODN;BRD7;FRK;NUPR1;LMNA;GSDME;KIT;CLMN;NIBAN2;YAP1;IRS1;RARG;IGFBP3;TGFB1I1;KMT2D;CTSH;IL13RA1;IGFBP6;THBS1;DPP4;GAREM1;SKI;SPEG;STAT3;UFL1;TMEM127;FGFR2;SHC1;BCL2;NOX4;RUNX1;LYN;TES;REST;WNT9A;P3H3;AR;ACER3;IGF2;PTPRK;XIAP;MAP2K1;CDK13;JUP;CYP1B1;BTG3;COL18A1;NGF;FER;PTPN2;EGLN3;PDGFC;RHOA;JUN;ID2;STX4;ABI1;CNOT8;ROR2;PDS5B;HES1;AGTR1;PKD2;CUL3;IL6R;FN1;CCAR1;TRPM4;CDC123;IRF1;GLI1;FKTN;COPS8;IGFBP7;EIF2AK2;ING5;STAT1;CD164;PRKDC;RBM5;VEGFA;HDAC1;CIAO1;CBFA2T3;CDC25B;RAPGEF2;VEGFD;NCK2;CSNK2A1;MNT;TGFB3;ADRA2A;ADAMTS1;SIX1;STAT5A;TBX2;TCIRG1;CACUL1;PHIP;ARID2;STAT5B;S100A11;PPP2R5C;SFRP4;PTGFR;SOD2;DHPS;SQLE;FGFBP1;GCNT2;IFI35;BMP2;HBEGF;CDK10;INHBA;CDK2;PBRM1;CDC73;NF2;IFIT3;PML;FRZB;FGFR4;NME1;ZBTB49;CDK6;FXN;TRAPPC14;XRCC6;AKT2;GID8;FGF2;EZH2;ECRG4;DLG5
prerank,protein tetramerization (GO:0051262),0.3235715791583782,1.1510116357773323,0.21020408163265306,0.6965814288422825,1.0,15/67,15.56%,HCN1;GRIN1;RYR3;GRIN2B;SNCA;TRPM2;KCNC3;HPRT1;HOMER1;KCNC1;FARSB;AQP4;GOLGA2;B2M;GLS
prerank,sphingolipid biosynthetic process (GO:0030148),0.3217435936944394,1.1508016788959354,0.20486815415821502,0.6958504193469676,1.0,22/71,18.02%,SGMS1;ACER2;FA2H;DEGS2;CERT1;SPNS2;ST8SIA1;ELOVL7;SGPP2;ELOVL4;B4GALT6;SMPD1;HACD3;ST8SIA3;HACD1;PPM1L;SAMD8;PRKD3;TLCD3B;KDSR;SGPP1;SPTLC2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3591070242580751,1.1507206106452574,0.22384937238493724,0.6947297516724885,1.0,17/38,24.15%,MAGI2;SIRT1;PHLPP1;TRIB3;PTPRJ;AKT1;CIB1;PPP2R5B;PDCD6;ARRB2;HYAL2;RACK1;EPHA2;PHLDA3;DDIT3;FLCN;PIK3CB
prerank,methylguanosine-cap decapping (GO:0110156),-0.5057461677125356,-1.1505311852511146,0.29182156133828996,0.5715672824180444,1.0,3/10,14.66%,DCP1A;DCP1B;EDC3
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3132850326655549,-1.1502083250509578,0.20388349514563106,0.571841366046813,1.0,23/76,17.56%,NTRK3;FCHSD2;ABL1;BAIAP2L1;NUMA1;BCAS3;SNX9;NRP1;CDC42;VASP;CDC42EP5;SYNPO2;FER;NES;NCKAP1;SYNPO;CTTN;NCK1;CARMIL1;NCK2;DYNC1H1;SORBS3;CDC42EP4
prerank,positive regulation of translation (GO:0045727),-0.30489995387760693,-1.1499329759936976,0.1894093686354379,0.5719644973717551,1.0,18/94,14.85%,SAMD4A;PLD1;VIM;ZCCHC4;YTHDF3;KHDRBS1;THBS1;DHX9;MTOR;LARP1;HNRNPD;DHX36;PLXNB2;RCC1L;YBX3;CDC123;PRKDC;DDX3X
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.38986881690602887,1.1494950379317392,0.24476987447698745,0.6970035099890075,1.0,10/27,17.12%,TIRAP;RPS27A;UBC;TLR2;UBB;HSPD1;CD36;TAB2;TNIP1;BTK
prerank,regulation of cardiac muscle contraction (GO:0055117),0.36056936555868035,1.1492121630862386,0.23137254901960785,0.6964252673233106,1.0,11/34,14.31%,PDE4B;RYR2;SLC8A1;ADRA1A;RNF207;CALM1;SMAD7;PDE4D;ATP1B1;CALM2;CALM3
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.4026422614840591,-1.1486993558449368,0.2634508348794063,0.5744471228249036,1.0,3/24,3.72%,EPHA7;FOXO3;NUPR1
prerank,positive regulation of histone modification (GO:0031058),-0.37011595716087353,-1.1484947426861791,0.2375249500998004,0.5744116465557132,1.0,15/33,29.45%,UBE2N;BRD7;AKAP8L;PPARGC1A;NIPBL;ARRB1;SAP30BP;NOS1;PAXIP1;RPS6KA4;KDM1A;ZBTB7B;CDK9;RUVBL2;GLYR1
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5014856314603519,-1.1480286306527296,0.30612244897959184,0.5750231449212114,1.0,4/10,14.47%,KAT2B;EP300;CREBBP;ESCO1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.36980508934446715,-1.147787787175688,0.24271844660194175,0.5750615353862472,1.0,13/33,22.89%,KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;PKD2;RB1;FAM107A;DCUN1D3;CDC73;CDK6;PLK5
prerank,regulation of response to external stimulus (GO:0032101),-0.29092283341500813,-1.1474193158076944,0.18238993710691823,0.5754369698839245,1.0,37/121,24.16%,FOXP1;APPL2;ADAMTS12;PDGFRA;EFNB2;CELF1;NR1D2;NMT2;CD55;SBNO2;ADGRA2;UFL1;ANXA1;GRK4;CASP12;XIAP;PTPN22;PTGES;TRIM5;AGTR1;APPL1;IRF1;PIK3AP1;P2RY12;P2RX4;TRAF3;WNT5A;AREL1;PARK7;MGLL;SHPK;GATA6;CAMKMT;DAGLB;USP18;FNTA;IL1RL2
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.3895691713982489,-1.147358914571984,0.24615384615384617,0.5750593199629699,1.0,9/26,18.91%,ST3GAL4;B4GALT1;FMOD;OGN;PRELP;ST3GAL3;LUM;B4GALT5;OMD
prerank,striated muscle tissue development (GO:0014706),-0.37874062797684566,-1.147227860063164,0.2589118198874296,0.5748443558253058,1.0,6/29,6.08%,SVIL;BMP5;CFLAR;BMP7;RBP4;IGSF8
prerank,calcium ion import (GO:0070509),0.3807346292940738,1.1470204293091562,0.24836601307189543,0.7017610798099597,1.0,6/28,7.35%,CACNA1A;CACNA1B;SLC8A1;SLC25A23;CACNA1E;CACNB2
prerank,neutrophil mediated immunity (GO:0002446),0.25215413154222405,1.146775963410135,0.0872093023255814,0.7011436444236775,1.0,90/432,17.90%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;SLCO4C1;HRNR;MME;RAB4B;SLC2A3;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;SNAP25;ENPP4;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PECAM1;BRI3;TLR2;PTPRJ;EPX;FTL;HSP90AB1;PSMD12;GOLGA7;ARSA;HEBP2;LAIR1;ALDOC;SLPI;BIN2;GLA;GGH;ACTR10;CCT2;FABP5;PDAP1;TSPAN14;ITGAM;CTSB;VAT1;LCN2;HGSNAT;PSEN1;CD36;EEF1A1;ATP11B;SNAP29;PTGES2;COTL1;B2M;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMC3;PSMA2;RAP1A;STK11IP;XRCC5;RAP2B;HSP90AA1;RAB31;ATP6V0A1;GLB1;ARL8A;TMBIM1;C3AR1;PPIA;EEF2;HEXB
prerank,regulation of DNA binding (GO:0051101),-0.347989979840719,-1.1460819307085375,0.21828358208955223,0.5772369653027049,1.0,14/44,14.00%,IGF1;FOXC1;SMO;PRKN;HMGB1;SKI;CEBPG;SP100;NGF;JUN;HJURP;HES1;ILRUN;TXN
prerank,negative regulation of catalytic activity (GO:0043086),0.3949721073680438,1.1460688554796148,0.2668112798264642,0.7019151238801948,1.0,4/24,7.73%,CAMK2A;SIRT1;NOTCH1;TIMP1
prerank,regulation of hydrolase activity (GO:0051336),0.3138872947544727,1.1455589446706083,0.23076923076923078,0.7021062552556161,1.0,15/71,10.93%,CAMK2A;PLXNB3;EPHA5;CHN2;VAV3;NTRK2;PRKG1;RAP1GAP;SCARB2;PLXNA4;FGD5;CFAP100;DAB2IP;CHN1;FGD3
prerank,positive regulation of GTPase activity (GO:0043547),-0.27343774620773803,-1.1452446547099153,0.15187376725838264,0.5788987014709179,1.0,32/188,9.98%,ARHGAP29;ARHGAP42;DOCK11;AFDN;ASAP3;SIPA1L1;NTRK3;LIMS1;TIAM2;ARAP1;TBC1D16;GSK3B;DOCK7;ARHGAP24;BCR;SGSM2;ITGB1;BCAS3;SNX9;MAP4K4;RAB3GAP1;MMUT;GMIP;RAPGEF3;ZC3H15;S100A10;RSU1;NDEL1;USP6NL;TBC1D2B;TBC1D20;TBC1D8B
prerank,ERBB signaling pathway (GO:0038127),-0.31952946953747025,-1.1450677176981856,0.22077922077922077,0.5788080689443877,1.0,23/64,22.04%,EGFR;EFEMP1;PLCE1;SLC30A10;GAREM1;SHC1;BRAF;PDPK1;PLCG1;PTPN12;KIF16B;CPNE3;REPS2;NCK2;HBEGF;NRG4;GAB1;PTPN11;MVP;PIK3R1;AAMP;DGKD;PRKCA
prerank,blood vessel morphogenesis (GO:0048514),0.3382208912576881,1.1450634490071392,0.2445759368836292,0.7022371944067655,1.0,10/54,7.29%,FLT1;EGFL7;PROX1;RAMP2;CDH2;KDR;SLC1A1;TGFBR3L;ID1;APLNR
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.4572199244910834,-1.1448952262406291,0.2788104089219331,0.5787073830977556,1.0,6/14,15.89%,ADK;GMPS;PPAT;ATIC;RFK;PAICS
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.30832845002114573,-1.1447803568188328,0.22444889779559118,0.5784479675842085,1.0,31/88,25.02%,TRABD2B;SMAD3;MPP7;BMP7;GSK3B;SPIDR;VPS4B;STX18;BRK1;SYNPO2;FNIP1;TPR;SLF1;SYNPO;VEGFA;EMILIN1;SDC4;ICE1;VCP;PARK7;RHOC;AJUBA;SNF8;PIH1D1;BMF;PRKCA;ERCC1;GNL3L;SYK;RAB7A;SDC1
prerank,regulation of chemotaxis (GO:0050920),-0.38231070032370146,-1.1445013688907457,0.2648221343873518,0.5786506134936542,1.0,10/30,15.21%,PDGFRA;EFNB2;PDGFRB;THBS1;ADGRA2;ZSWIM8;PTPN2;STX4;P2RY12;P2RX4
prerank,histone mRNA catabolic process (GO:0071044),-0.44617774877296057,-1.1442638364101314,0.2802303262955854,0.5786704619296527,1.0,5/15,15.99%,TENT2;TUT4;UPF1;XRN1;EXOSC10
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.3995130615925635,-1.1442149264500732,0.26145038167938933,0.5782454284385716,1.0,5/23,10.84%,TGFBR3;TPM1;FGFR2;ADAMTS9;ID2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4097628182864854,1.1439141002051423,0.275626423690205,0.7042284614156967,1.0,2/21,2.10%,SLC39A10;PRKCH
prerank,regulation of developmental growth (GO:0048638),-0.38431276539460435,-1.1436509622409514,0.25,0.5790990565711405,1.0,12/29,19.00%,IGF1;GHR;ABL1;GSK3B;NIPBL;CTTN;APOE;LATS1;SIX1;STAT5A;STAT5B;MUSK
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.36457367044073596,1.1434562391173035,0.24893617021276596,0.7042788855389793,1.0,9/35,14.53%,FAR2;HPGD;GGT7;SCD;GGT1;HMGCLL1;BDH1;FAR1;PPT1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.44950620671472624,-1.1430660235876873,0.2925430210325048,0.5800504865050286,1.0,3/15,2.99%,IGF1;OPA1;PRKN
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.36566193410681613,-1.1430351770902474,0.24105461393596986,0.5795802055149454,1.0,11/33,19.36%,FOXO3;ARNT;HOXA5;STAT3;MED1;HIF1A;STAT1;PRKDC;PITHD1;STAT5B;INHBA
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4210139262003903,-1.1427219658928638,0.26746506986027946,0.5798697131513821,1.0,4/18,5.36%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3987461746688994,-1.1427093379633508,0.2821497120921305,0.5793464166731334,1.0,2/22,1.50%,ALDH1A2;RBP1
prerank,regulation of centrosome duplication (GO:0010824),-0.38097659918373183,-1.1425100458851822,0.2606924643584521,0.5793080760660181,1.0,19/29,36.32%,ALMS1;VPS4B;SPICE1;CHMP4B;CHMP5;CHMP3;CENATAC;CEP295;CEP76;FBXW5;NAT10;STIL;CEP295NL;CCNF;CHMP1B;CHMP1A;NPM1;GEN1;CEP131
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.42313805433983115,-1.142373917722297,0.2808349146110057,0.5791303767166363,1.0,2/19,0.80%,BMP6;AFDN
prerank,proton transmembrane transport (GO:1902600),0.3560135401821596,1.1411930566272117,0.25738396624472576,0.7096749554740596,1.0,14/36,18.00%,UCP2;ATP1A3;SLC25A14;SLC25A27;ATP6V1F;ATP6V1A;SLC36A1;ATP1A4;ATP1A1;ATP5F1B;ATP5MF;DMAC2L;NNT;ATP6V0E2
prerank,regulation of humoral immune response (GO:0002920),-0.3452951878519753,-1.1411212639446537,0.23904382470119523,0.5817142912408332,1.0,5/44,3.68%,CFH;SERPING1;VTN;PROS1;CD55
prerank,negative regulation of cell adhesion (GO:0007162),0.31541219885228716,1.1410036154327934,0.23721881390593047,0.7089205395444655,1.0,12/72,8.51%,DSCAM;SPOCK1;PODXL;PLXNB3;SEMA6A;ACER2;ADAM22;SEMA4D;NOTCH1;ACVRL1;PLXNA4;NEXMIF
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.4215088567854903,-1.1409608599335495,0.27289048473967686,0.581599755746487,1.0,7/19,20.16%,VPS4B;CHMP4B;CHMP5;CHMP3;TPR;HNRNPU;EML3
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.37139060693706905,-1.140814968288063,0.25665399239543724,0.5814618890599448,1.0,14/30,24.29%,FHIT;STYX;USP7;RPL11;GIPC1;OGT;TRIM39;NOP53;PARK7;WAC;CCAR2;EIF3H;BAG5;BAG6
prerank,neural tube development (GO:0021915),-0.4430816666189144,-1.1408103666699227,0.2870036101083033,0.5809254842749637,1.0,6/15,15.46%,ALDH1A2;PKD1;ARL13B;DACT1;PKD2;PTCH1
prerank,cell differentiation in spinal cord (GO:0021515),0.48721073586018215,1.1402644986043873,0.2966804979253112,0.709798184276189,1.0,2/10,6.58%,MDGA2;LHX1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4242187335581613,-1.1398109077021377,0.2916666666666667,0.5829395450054188,1.0,3/17,3.94%,AKAP13;ADCY9;ADRA1B
prerank,response to alcohol (GO:0097305),0.3837315200112721,1.139589178937,0.2546972860125261,0.710585072488263,1.0,6/27,10.09%,GRIN1;GLRA1;GRIN2A;GRIN2B;SLIT3;GRIN3A
prerank,negative regulation of synaptic transmission (GO:0050805),0.3968295816895835,1.139251194388128,0.27056277056277056,0.7102965097162856,1.0,4/23,9.15%,SLC24A2;SYT11;SLC30A1;SHANK2
prerank,positive regulation of telomere maintenance (GO:0032206),-0.37227545433908615,-1.1391952825726799,0.24427480916030533,0.5839647674629832,1.0,13/31,27.53%,TNKS2;NBN;HNRNPD;DHX36;NABP2;MAP2K7;MRE11;PML;ERCC1;PPP1R10;NEK7;GNL3;ATRX
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3981495702560698,1.1385797227422922,0.303347280334728,0.7109473457102723,1.0,3/22,13.36%,SLC7A5;PRKCQ;RFTN1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.39785003269659125,1.1379016915171594,0.2766393442622951,0.7116032039073231,1.0,7/20,10.22%,PROX1;CCND1;MAPRE3;HSP90AB1;AKT1;CCNY;PDGFB
prerank,regulation of cilium movement (GO:0003352),-0.49370877541532676,-1.1378091747162,0.3333333333333333,0.5869831505305501,1.0,9/10,46.73%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,ERBB2 signaling pathway (GO:0038128),0.37047399033566564,1.1378024783346776,0.2811791383219955,0.7105545897334702,1.0,5/31,6.84%,ERBB4;PTPRR;NRG2;NRG1;PTPN18
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3971677745596241,-1.137757182751793,0.2622641509433962,0.5865607672803393,1.0,8/23,16.11%,PIAS1;JAK1;PTPN2;NR1H3;PARP14;PARP9;STAT1;IFNGR1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.467467461686308,1.1377030895104379,0.3066132264529058,0.7094905340823779,1.0,3/12,10.48%,CXCL12;JAM2;AIF1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.41511606990146355,1.137667295462143,0.28361344537815125,0.708251699486445,1.0,5/19,5.98%,HS6ST3;HS3ST5;HS6ST2;CSGALNACT1;NDST4
prerank,hexose metabolic process (GO:0019318),0.3478776097969612,1.1375114357229092,0.27253668763102723,0.7074160860998213,1.0,7/39,10.71%,OMA1;KHK;KCNJ11;SLC37A4;PMM1;ALDOC;GDPGP1
prerank,C-terminal protein amino acid modification (GO:0018410),0.4709880580282578,1.137351872870892,0.31788079470198677,0.7065465053480833,1.0,2/11,3.17%,AGBL4;LCMT1
prerank,import into cell (GO:0098657),-0.3527925375277514,-1.1372463243239117,0.2535211267605634,0.5873243952766036,1.0,12/41,14.17%,ATP1A2;SLC6A13;SLC1A3;SLC47A1;SLC5A3;SLC39A14;SLC12A7;LRRC8D;GLUL;SLC5A6;SLC22A4;SLC27A1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.48191924419024823,-1.1371712555141635,0.32044198895027626,0.5869927113743496,1.0,5/12,16.89%,DPYSL3;CTPS2;ALDH6A1;DPYD;CTPS1
prerank,regulation of cell cycle (GO:0051726),-0.2613028949986617,-1.1370951180691529,0.13,0.5866460663288735,1.0,76/271,21.36%,NOTCH2;GRK5;TCF7L2;SMAD3;TGFBR1;SON;PKD1;LRP6;FBXL17;ANKRD17;KAT2B;BMP7;EP300;BMP4;GBF1;ABL1;CDC14A;NUPR1;CDK7;THBS1;UHRF2;NBN;STAT3;FGFR2;ASAH2;PUM1;FBXL12;MAEA;PTPRK;XIAP;MAP2K1;PRCC;MAP3K20;JUN;HCFC1;ID2;CDK11B;FAP;PKD2;SIK1;RB1;CDC123;IRF1;CDC26;CRLF3;DUSP1;CDC14B;ERN1;TMEM8B;WHAMM;CSNK2A1;NOP53;AFAP1L2;CITED2;PDCD4;TTC28;NR4A1;WDR12;RNF20;PRKACA;RASSF1;HNRNPU;RRP8;BMP2;DCUN1D3;CDK10;INHBA;NEK6;NF2;MAP2K6;PML;ZBTB49;CDK6;CDK5RAP3;AKT2;GATA6
prerank,positive regulation of vacuole organization (GO:0044090),-0.5013482465287802,-1.1370755534908872,0.3252788104089219,0.5861644214362113,1.0,3/10,8.27%,ANXA2;RAB3GAP1;PIP4K2C
prerank,endoplasmic reticulum organization (GO:0007029),-0.3160749341709488,-1.1369405700984867,0.22030651340996169,0.585971376921369,1.0,25/72,23.67%,TRAM2;LRRK2;ATL3;DNM1L;RAB10;EIF2AK3;STX18;VAMP2;VCPIP1;SEC31A;ATL2;STX5;DOP1B;ZBED3;EMD;MIA3;GET4;SEC16B;SMPD4;TMCC1;SEC16A;LPCAT3;VAPA;LMAN1;SPTSSB
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.39637054812803474,-1.136841775614274,0.278,0.5856777013076061,1.0,5/23,8.60%,NUMA1;UBXN2B;ITGB1;NDEL1;GJA1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.38804340084922473,-1.1367233797731982,0.2661596958174905,0.5854189434503378,1.0,4/24,3.96%,ITPR1;ITPR2;ANXA6;IBTK
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4713353666412885,1.1366369763071642,0.29791666666666666,0.707358801676915,1.0,2/12,2.58%,GRIN1;ADGRB1
prerank,necroptotic process (GO:0070266),-0.43078485798486804,-1.1359543865198483,0.2903225806451613,0.5868975775648188,1.0,8/16,32.33%,DNM1L;TLR4;TRPM7;MLKL;TICAM1;TLR3;LY96;ITPK1
prerank,regulation of blood circulation (GO:1903522),-0.3613930121153146,-1.1358999266982401,0.26436781609195403,0.586495403864547,1.0,11/34,20.94%,CELF2;TPM1;CAMK2D;ECE1;DMPK;AGTR1;SRI;BDKRB2;TBX2;DES;S100A1
prerank,embryonic axis specification (GO:0000578),-0.4400598822266031,-1.1357682144180457,0.29724770642201837,0.5862974193550761,1.0,6/15,30.07%,SMAD6;SMAD2;PTCH1;CXXC4;COBL;STIL
prerank,positive regulation of viral life cycle (GO:1903902),-0.40425560547411254,-1.1354591775141774,0.2732447817836812,0.5865350315575912,1.0,5/22,12.13%,AXL;KPNA6;CHMP3;LGALS1;TRIM11
prerank,myofibril assembly (GO:0030239),-0.34794346080527183,-1.135312420553998,0.23562152133580705,0.586325237160846,1.0,7/42,8.81%,PDGFRA;TPM1;CFLAR;PDGFRB;TMOD3;OBSL1;ACTN2
prerank,positive regulation of catabolic process (GO:0009896),-0.3180208687624688,-1.1348421667704591,0.2530612244897959,0.5869571149041971,1.0,17/65,18.42%,SMURF2;PRKN;WWP2;GSK3B;GPC3;HUWE1;AXIN1;WWP1;SEC22B;DACT1;STX5;SMURF1;CSNK2A1;ASB5;WNT5A;AREL1;VCP
prerank,positive regulation of vascular permeability (GO:0043117),-0.46990911223321785,-1.134581820105214,0.3285968028419183,0.5870425419666959,1.0,2/12,1.37%,BMP6;ANGPT1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.49393848724030365,1.1345748388563788,0.30462184873949577,0.7122539562991994,1.0,3/10,5.63%,B3GAT1;B3GAT2;CSGALNACT1
prerank,protein destabilization (GO:0031648),-0.367646055187722,-1.1344421607773536,0.28709055876685935,0.5868295584103642,1.0,11/32,19.87%,GSN;EP300;PRKN;BTRC;CTSH;CREBBP;GGA3;CUL3;DERL1;FBXW11;CDC73
prerank,protein localization to phagophore assembly site (GO:0034497),-0.4887017761931079,-1.1343563166475956,0.3088512241054614,0.5865213070692786,1.0,7/11,32.98%,WIPI1;ATG9A;WDR45B;WIPI2;STX17;MFN2;WDR45
prerank,plasma membrane invagination (GO:0099024),-0.37214647725272665,-1.134141135989975,0.251953125,0.5865179182295548,1.0,6/29,10.27%,GULP1;GSN;SNX9;VAMP7;CDC42;RHOA
prerank,lung epithelium development (GO:0060428),-0.4975486250692616,-1.1340508230328183,0.3170731707317073,0.5861973512461208,1.0,3/10,2.70%,ERRFI1;PKD1;BMP4
prerank,autophagy of peroxisome (GO:0030242),-0.47018825919235424,-1.1339656635396,0.32092198581560283,0.5858773740823436,1.0,4/12,15.52%,NBR1;RB1CC1;PIK3C3;PIK3R4
prerank,regulation of lipid storage (GO:0010883),-0.4032412148533351,-1.1337187982523032,0.29887218045112784,0.585944698841201,1.0,7/22,19.37%,NFKB1;FTO;ITGAV;PTPN2;FBXW7;IKBKE;ITGB3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.4845444539267856,1.1336241857543112,0.31702544031311153,0.7138067978192086,1.0,3/10,9.89%,SEMA6A;IL12A;DAB2IP
prerank,regulation of programmed cell death (GO:0043067),0.2780384571687732,1.1336085442791126,0.18269230769230768,0.7125281065651063,1.0,38/161,17.04%,PAX8;MECOM;LRP8;OMA1;HTATIP2;LCMT1;ACER2;SIRT1;PAX2;FLT3;HIP1;NME2;ALK;PHLPP1;CLU;AKT1;TPT1;NUP62;TRIM24;APEX1;RABGGTA;BCL3;CTSB;TNFRSF25;BCAR1;ACTN4;RPS3;MADD;ANP32A;NDRG1;ATM;USP42;RTN4;GLS2;FANK1;RAF1;MAGED1;HSP90AA1
prerank,regulation of cell morphogenesis (GO:0022604),-0.37540259090256123,-1.1334770136620604,0.2773279352226721,0.5860283174600667,1.0,9/30,13.57%,PDPN;SPARC;MYO9A;WTIP;MOV10;BCL9L;ZMYM4;ZMYM3;CAPZB
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.40813675151145057,-1.133409349426823,0.30275229357798167,0.5856787581503139,1.0,3/20,2.59%,PID1;RHOQ;DAB2
prerank,positive regulation of transferase activity (GO:0051347),0.28235252155970536,1.1333107970247533,0.1794871794871795,0.7121570830712557,1.0,43/142,18.94%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK;PRKCQ;KLF4;TRIB3;HSP90AB1;EPHA10;SERINC1;CCT2;DKC1;RET;EPHA1;CCT4;SORL1;RPS2;INSR;PARM1;DBI;RFC4;DCUN1D2;DDR2;PTGES3;XRCC5;RFC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;FGFR3;RFC2;TCP1
prerank,negative regulation of cell communication (GO:0010648),0.3931009602181864,1.1330542580583138,0.29067245119305857,0.7115907540950852,1.0,4/21,11.28%,GLRA1;SRMS;OPRM1;UBASH3B
prerank,cellular response to glucose stimulus (GO:0071333),0.3697993814149521,1.132881021347,0.2657952069716776,0.710783324329042,1.0,5/30,3.78%,IGF1R;PTPRN2;ADCY8;PAX2;GAS6
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.40399720786763266,-1.1327205014426676,0.27380952380952384,0.586935805714199,1.0,7/20,22.55%,LBP;LYN;PTPN22;IL18;TLR4;IRAK1;TICAM1
prerank,negative regulation of peptidase activity (GO:0010466),0.3358663738417429,1.1325432359901944,0.24789915966386555,0.7104366038398672,1.0,7/47,12.00%,SPOCK2;SPOCK1;SPOCK3;TIMP1;AKT1;SERPINB8;TIMP4
prerank,regulation of primary metabolic process (GO:0080090),-0.2866639499115326,-1.1322837905074454,0.1895551257253385,0.5875181910145986,1.0,48/126,29.31%,ROCK2;CHD9;NR1D2;NCOR1;TBL1X;TBL1XR1;CREBBP;NCOA6;NFYC;NCOA1;MED1;LDLR;PRKAB2;ID2;PSMF1;TGS1;LACTB;APOE;PSMB2;C1QTNF2;RXRA;NFYB;HMGCR;SQLE;CYP51A1;ABCA7;FGFR4;NFYA;PSMC1;PRKAB1;SC5D;FDFT1;PSMB6;PSMA3;SMARCD3;MVK;PSMA4;PPARA;EDF1;ZFP69;BBS4;HDAC3;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;PLPP1
prerank,cellular response to hormone stimulus (GO:0032870),-0.3126747526299636,-1.132138277334161,0.21875,0.5873437977200535,1.0,15/69,11.68%,ATP1A2;THRB;KLF9;GHR;NR3C1;CTSH;BCAS3;TFPI;STAT3;RAMP1;AR;NCOA1;MED1;SLC5A5;MEF2C
prerank,regulation of protein binding (GO:0043393),-0.2891206034439954,-1.132117246567743,0.18618042226487524,0.5868548583056188,1.0,40/114,25.24%,TCF7L2;LRP1;PKD1;DAB2;STK3;ROCK1;BMP4;HDAC4;PRKN;LRRK2;VTN;GSK3B;STYX;MARK3;IFIT2;DACT1;CSNK1E;USP33;NES;PRKCD;RPL11;DTX3L;RAPGEF2;PSME3IP1;DERL1;PRKACA;PRMT8;BMP2;PARK7;CARD16;SPPL3;TERT;PPP2CA;BTBD1;GTF2F1;HIP1R;TMBIM6;GNL3L;CFHR2;KDM1A
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.38539232951464153,-1.1314069452886235,0.2957486136783734,0.588052903200011,1.0,10/27,20.47%,AHNAK;ANK2;JPH1;CAMK2D;SELENON;YWHAE;CACNB1;ADRA2A;PRKACA;NOS1
prerank,positive regulation of phospholipid transport (GO:2001140),0.48102434123786286,1.1310602733629305,0.3202479338842975,0.713560770534651,1.0,3/10,14.67%,TMEM30A;ABCB4;DBI
prerank,regulation of Golgi organization (GO:1903358),-0.4202197856131776,-1.1308313940817152,0.2998236331569665,0.5889562217129113,1.0,7/17,15.44%,STX18;MAP2K1;USP6NL;STX5;ARMH3;EHD3;AKAP9
prerank,regulation of mitochondrion organization (GO:0010821),-0.3349069502382289,-1.1305706997653622,0.2709551656920078,0.5890723404110145,1.0,10/47,12.70%,PID1;EP300;PRKN;LRRK2;GSK3B;DNM1L;PPARGC1A;VDAC1;RHOT1;FBXW7
prerank,cellular response to insulin stimulus (GO:0032869),-0.28752721789687125,-1.130271690681641,0.21507352941176472,0.589327195315042,1.0,41/124,21.34%,RHOQ;SORBS1;GRB10;KAT2B;ATP6V1B2;ENPP1;GSK3B;IRS1;ATP6V0D1;SLC39A14;INSIG2;RAB10;SHC1;FOXC2;ATP6V0A4;RAB12;PDPK1;VAMP2;IGF2;SELENOS;FER;PTPN2;DENND4C;PARP1;APPL1;PCK2;SLC27A1;PRKDC;CPEB1;TCIRG1;PHIP;LPIN2;SYAP1;LPIN3;INPP5K;GAB1;PKM;BAIAP2;PIK3R1;USF1;AKT2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3997065118298605,-1.1294632541553975,0.28091872791519434,0.590798441745519,1.0,7/23,18.63%,UACA;BMP7;CCN3;PPM1A;DDX3X;C1QTNF3;IFI35
prerank,regulation of macrophage cytokine production (GO:0010935),0.45351850084275624,1.1294440205554768,0.3008849557522124,0.7171046703445227,1.0,3/13,5.82%,SIRT1;SEMA7A;TGFB2
prerank,negative regulation of cellular component organization (GO:0051129),-0.3073937471850214,-1.1287719649810377,0.23061224489795917,0.5920167118995547,1.0,23/74,19.61%,BMP6;EPHA3;EP300;GSK3B;IRAK3;CDC42;RAPGEF3;AR;IMPACT;WASL;FAP;RIOK3;VEGFA;DDX3X;PRKCZ;CARMIL1;NOP53;IAPP;RUBCN;PRKD1;ABCA7;LRSAM1;TERF2
prerank,glycogen metabolic process (GO:0005977),-0.3750699779273735,-1.1287422423549538,0.2553606237816764,0.5915699396936266,1.0,6/27,9.55%,PRKAG2;PHKB;GSK3B;PYGB;PHKA1;AGL
prerank,sensory organ development (GO:0007423),-0.3325763497707446,-1.1286216594043612,0.2424812030075188,0.5913262354344387,1.0,14/51,19.04%,PBX1;SMOC1;FOXC1;SH3PXD2B;SHROOM2;RBP4;PBX3;ECE1;HIPK1;ATF6;CHD7;SMCHD1;ZDHHC16;SIPA1L3
prerank,negative regulation of programmed cell death (GO:0043069),-0.25076453473298765,-1.1285203502035037,0.13320079522862824,0.5910764894193956,1.0,50/355,10.02%,FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;ARHGAP10;SON;NFKB1;KANK2;ANGPT1;SMAD6;OPA1;ZFAND6;ARAF;CFLAR;AXL;IL6ST;DAB2;IL31RA;BMP4;ERC1;PDPN;TAX1BP1;BIRC6;OSR1;PRKAA2;NUPR1;GSK3B;NIBAN2;FLNA;ANXA4;ANXA5;CTSH;THBS1;PAK2;SH3RF1;MAP4K4;TMBIM4;SHC1;BCL2;ANXA1;BRAF;VDAC1;XIAP;MED1;HNRNPK;BAG3;NGF;ANKLE2
prerank,regulation of endopeptidase activity (GO:0052548),0.3184714052224229,1.1285113151131874,0.2682926829268293,0.7186998690623653,1.0,7/59,9.80%,SPOCK2;SPOCK1;SPOCK3;PSENEN;TIMP1;AKT1;SERPINB8
prerank,organonitrogen compound catabolic process (GO:1901565),-0.31534588747935427,-1.1284558336065127,0.24696356275303644,0.5907311088250972,1.0,16/57,24.03%,CPQ;MTOR;ANPEP;RENBP;PLA2G4A;PDXDC1;GGACT;PNPLA8;NPEPPS;LNPEP;LRSAM1;CLN5;BCKDK;SMPD2;TXN2;CLPX
prerank,cellular response to ketone (GO:1901655),-0.35355411672843223,-1.1283341318534517,0.27715355805243447,0.5904823534151576,1.0,8/35,7.97%,ROCK2;ADCY5;KLF9;NR3C1;ADCY1;LARP1;ADCY6;AR
prerank,regulation of JNK cascade (GO:0046328),0.2913913006956832,1.1280823268942444,0.2192622950819672,0.7187301763860118,1.0,22/101,13.62%,IGF1R;MECOM;TIRAP;EPHB1;MAPK8IP2;MAP4K2;TRAF1;PLCB1;TNFRSF19;PHLPP1;WNT7B;ANKRD6;GPS2;MAPK8IP1;TAOK2;DAB2IP;MEN1;HIPK2;PJA2;DUSP15;MAP3K11;HRAS
prerank,long-chain fatty acid transport (GO:0015909),-0.3767346363130458,-1.127902204167172,0.2803030303030303,0.591009975345194,1.0,10/30,14.17%,PRKAG2;ACSL1;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;ABCD4;APOE;SLC27A1
prerank,inositol phosphate metabolic process (GO:0043647),-0.33626206229977407,-1.1275437894927502,0.26268115942028986,0.5913579112332581,1.0,10/46,10.26%,PLCE1;NUDT4;PLCD3;INPP5B;INPP5A;ISYNA1;INPPL1;PLCG1;PLCB3;PLCD1
prerank,protein targeting to mitochondrion (GO:0006626),0.3284808779191704,1.1273276822440363,0.2629310344827586,0.7197456545605518,1.0,14/52,19.77%,GDAP1;CHCHD4;TIMM21;DNAJC15;PMPCA;PITRM1;TIMM22;NDUFA13;HSPD1;TSPO;HSP90AA1;TOMM70;TIMM10B;DNAJC19
prerank,peptidyl-lysine methylation (GO:0018022),-0.3821280188327263,-1.127271739114134,0.2776659959758551,0.5915115873482408,1.0,9/26,19.36%,SETD7;SMYD3;SETD3;SETD2;N6AMT1;EHMT1;METTL21A;EEF2KMT;KMT5A
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4554873675493386,1.1267122158044705,0.31890660592255127,0.7203032778249702,1.0,2/13,4.08%,RPP40;RPS21
prerank,mitotic cell cycle phase transition (GO:0044772),-0.2632845106866004,-1.1264103261961451,0.16569200779727095,0.5932169424042883,1.0,69/203,25.40%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;KHDRBS1;NINL;CDK7;CEP63;CEP135;PHF8;PHLDA1;PCNT;CHMP4B;FBXL12;ANAPC7;CSNK1E;BRSK1;EIF4E;MNAT1;NES;CUL3;RB1;MAPRE1;TPD52L1;HINFP;CRLF3;ACVR1;CCND3;RCC1;YWHAE;LATS1;CDC25B;PPP1CB;CUL2;AKAP9;CDC27;CCDC57;DYNC1H1;NASP;CEP76;CACUL1;UBE2S;PRKACA;FBXW11;CEP57;CSNK1D;AJUBA;INHBA;CDK2;CUL1;CDK6;TAF2;HAUS7;HAUS8;ACTR1A;BORA;DBF4;EIF4EBP1;CDC16;CCNE2;CCNJ;MASTL;CTDP1;ANAPC1
prerank,regulation of cell killing (GO:0031341),-0.42372867030994765,-1.1262272522889678,0.30174081237911027,0.5931335060290257,1.0,6/16,17.55%,CFH;CD55;FZD7;CR1L;CYBA;WNT5A
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3149876001370308,-1.1261827184713598,0.23742454728370221,0.5927090608470486,1.0,19/65,17.28%,FOXP1;GAB2;IL31RA;EP300;BMP4;TGFBR2;KIT;SBNO2;RUNX1;CDC42;PARP1;SNX10;GLO1;VEGFA;CBFA2T3;FARP2;RXRA;PIR;PIK3CD
prerank,fatty acid biosynthetic process (GO:0006633),0.3192145318167761,1.1261471694316618,0.2489451476793249,0.7206408716356147,1.0,16/63,17.68%,ABHD2;ELOVL7;CYP2E1;ELOVL4;TECR;HPGD;HACD3;SCD;ACOT7;FADS1;XBP1;HACD1;LTA4H;TECRL;NDUFAB1;LIAS
prerank,regulation of fibroblast proliferation (GO:0048145),-0.334695373929179,-1.1261188483302198,0.23295454545454544,0.5923625531408656,1.0,17/45,23.39%,IGF1;PDGFRA;SKI;DHX9;PARP10;PDGFC;S100A6;FN1;EMD;WNT5A;MORC3;B4GALT7;CDC73;CDK6;SPHK1;CD300A;NLRC3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.49170047642471765,-1.125817598475219,0.3264150943396226,0.5920490921124639,1.0,3/10,3.72%,HDAC4;NCOR1;NUPR1
prerank,negative regulation of glycolytic process (GO:0045820),-0.49170047642471765,-1.125817598475219,0.3264150943396226,0.5920490921124639,1.0,3/10,3.72%,HDAC4;NCOR1;NUPR1
prerank,nitrogen compound transport (GO:0071705),0.28296489060928276,1.125046621460552,0.202,0.7225349673725179,1.0,18/141,9.57%,SLC7A5;SLC6A6;LRP1B;TMEM30A;SLC7A1;AQP9;RAMP2;ABCG2;CERT1;SLC52A2;SLC15A3;SLC6A2;SLC6A8;SLC7A8;SLC52A3;SCARB2;SLC43A2;SLC36A1
prerank,negative regulation of complement activation (GO:0045916),-0.4793157241062014,-1.1248004889466447,0.32947976878612717,0.5940237916548408,1.0,3/10,14.01%,SERPING1;CD55;CR1L
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4705517307464671,1.1245628780352341,0.32891832229580575,0.7226500698500946,1.0,5/10,19.18%,RUVBL1;PIH1D2;ZNHIT6;NAF1;NUFIP1
prerank,cellular amide metabolic process (GO:0043603),-0.2909700729180887,-1.1236922197802817,0.22134387351778656,0.5962502092071714,1.0,29/102,23.25%,AEBP1;PCCA;PLPP3;HLCS;ASAH2;MCCC2;MTHFR;GPAT4;MTHFD2L;PANK2;ACSF2;SLC5A6;NAPEPLD;ACSL6;NLN;CPM;ACOT11;CPXM2;ACOT9;CPXM1;ALDH1L1;NIT1;ORMDL3;PPP2CA;SMPD2;ACOT8;ST6GAL1;DNPEP;ACOT6
prerank,heart morphogenesis (GO:0003007),-0.32901278102974235,-1.123602337515523,0.275797373358349,0.5959810450951087,1.0,14/50,19.53%,TGFBR3;TGFBR1;BMPR1A;FLRT2;MDM4;NIPBL;HES1;CHD7;VEGFA;ACVR1;HEYL;TBX2;BMP2;MEGF8
prerank,positive regulation of neuron death (GO:1901216),-0.33163034273196357,-1.1232864537771095,0.25287356321839083,0.5962336902354548,1.0,7/46,7.74%,EPHA7;EFNB2;FOXO3;NUPR1;GSK3B;REST;MAP3K5
prerank,error-prone translesion synthesis (GO:0042276),0.4015260799326303,1.1227351405189694,0.30666666666666664,0.7268925982761616,1.0,9/21,19.15%,RPA3;RPS27A;UBC;POLK;UBB;RFC4;RFC5;RFC2;POLI
prerank,regulation of vasoconstriction (GO:0019229),0.38019999439846747,1.1223043291491739,0.3075313807531381,0.7268890205720647,1.0,8/27,12.87%,CHRM3;KCNMB2;KCNMB4;ADRA1D;ADRA1A;F2R;PER2;BMPR2
prerank,glycerophospholipid metabolic process (GO:0006650),0.3091936611286067,1.1220763117554564,0.25252525252525254,0.7262116573943119,1.0,23/75,20.45%,GPCPD1;CSF1R;PGP;PLCB1;DGKH;PLAAT1;CPNE1;PIGM;SERINC1;CRLS1;FAR1;PIP5K1A;GPLD1;PIGW;PNPLA3;PNPLA6;CPNE7;PLA2G4E;PIGG;SYNJ1;ACP6;PRDX6;ABCA3
prerank,regulation of glucose metabolic process (GO:0010906),-0.363451948205971,-1.121956343580731,0.2804642166344294,0.5989740909652673,1.0,10/34,15.77%,PDK1;PRKN;IRS1;USP7;FOXK1;SELENOS;RORA;ZNF692;OGT;FOXK2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3632286245068104,-1.1219214279317598,0.2946768060836502,0.5985308143973651,1.0,16/33,26.62%,EGFR;ANKRD17;UBE2E2;RPTOR;STXBP4;ANXA1;GLI1;CCND3;DDX3X;ADAMTS1;EIF4G1;CDC73;EZH2;KMT2E;PHB2;LSM11
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3108954144988906,-1.121747799648043,0.23552123552123552,0.5984200648097658,1.0,13/75,5.60%,ROCK2;SULF1;WNT4;DCN;COL4A3;FOXC1;ROCK1;SPARC;NIBAN2;HSPG2;THBS2;THBS1;HOXA5
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.4817691406291941,-1.1212282353375849,0.31309297912713474,0.598659788978809,1.0,3/11,5.92%,INPP5B;SYNJ2;INPP5A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4817691406291941,-1.1212282353375849,0.31309297912713474,0.598659788978809,1.0,3/11,5.92%,INPP5B;SYNJ2;INPP5A
prerank,muscle tissue morphogenesis (GO:0060415),-0.44130092551645533,-1.1211345815442308,0.3315018315018315,0.5983721302797395,1.0,3/16,2.70%,TGFBR3;MYLK;BMP4
prerank,fatty acid transmembrane transport (GO:1902001),-0.420621643598031,-1.1211293162019034,0.28875968992248063,0.5978540171340013,1.0,8/19,14.17%,PRKAG2;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;ABCD4;SLC27A1
prerank,ncRNA transcription (GO:0098781),-0.4516063523527284,-1.1210275049977876,0.3371212121212121,0.5975686435149619,1.0,9/13,38.98%,CAVIN1;BRF1;SNAPC3;SPIN1;GTF3C1;POLR1G;GTF3A;ANG;SNAPC2
prerank,apoptotic cell clearance (GO:0043277),-0.36966286611307836,-1.120814364225709,0.3176691729323308,0.5975767304625003,1.0,11/30,19.37%,LRP1;ITGAV;HMGB1;THBS1;ANXA1;NR1H3;RHOBTB2;TXNDC5;RHOBTB1;RHOH;ITGB3
prerank,positive regulation of vasculogenesis (GO:2001214),0.4882046395822627,1.1208056566684366,0.3022774327122153,0.7288225328824831,1.0,4/10,16.16%,KDR;CD34;RIN2;RAP1A
prerank,negative regulation of apoptotic process (GO:0043066),-0.24445148089685695,-1.1205370873917568,0.10950413223140495,0.5977580950775614,1.0,99/444,18.35%,FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;ARHGAP10;SON;NFKB1;ANGPT1;SMAD6;OPA1;ZFAND6;ARAF;CFLAR;AXL;IL6ST;DAB2;IL31RA;BMP4;ERC1;PDPN;TAX1BP1;PRKN;BIRC6;OSR1;PRKAA2;NUPR1;GSK3B;NIBAN2;YAP1;FLNA;ANXA4;ANXA5;ITGB1;CTSH;THBS1;SLC30A10;SNX6;RNF213;PAK2;SH3RF1;MAP4K4;TMBIM4;ASAH2;SHC1;BCL2;ANXA1;MERTK;BRAF;PPARGC1A;VDAC1;MAEA;XIAP;MED1;HNRNPK;BAG3;NGF;ANKLE2;PRKCD;DNAJC3;USP47;TLE1;NFATC4;FNIP1;MEF2C;YME1L1;HSPA9;RB1;CASP2;CARD14;SH3RF2;APOE;GLO1;PRKDC;NAA15;VEGFA;HDAC1;DDX3X;YWHAE;ITGA5;TOPORS;CSNK2A1;RASA1;TXNDC5;TGFB3;SFPQ;MRE11;CITED2;SIX1;BFAR;WNT5A;PHIP;NR4A2;PRKAA1;CX3CR1;SOD2;AREL1;TRAF6
prerank,cellular response to fatty acid (GO:0071398),-0.4644182089094393,-1.1205335676778116,0.3102803738317757,0.5972402500151208,1.0,2/12,4.52%,PID1;IRS1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.37617242508379756,1.120454472101727,0.29065040650406504,0.7286273374008254,1.0,5/29,6.76%,RPS19;RPP40;RPS21;RPS8;RPS16
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.31297823362257227,1.1203443440067538,0.258,0.7276545534226888,1.0,9/67,5.70%,FLT1;IGF1R;TEK;ERBB4;CSF1R;KDR;FLT3;AATK;SRMS
prerank,regulation of DNA recombination at telomere (GO:0072695),0.41100405182856736,1.1197398101063658,0.3249475890985325,0.7268749127614417,1.0,7/19,17.14%,TERF1;POLR2J;TERF2IP;POLR2B;POLR2I;TINF2;POLR2G
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.41100405182856736,1.1197398101063658,0.3249475890985325,0.7268749127614417,1.0,7/19,17.14%,TERF1;POLR2J;TERF2IP;POLR2B;POLR2I;TINF2;POLR2G
prerank,programmed necrotic cell death (GO:0097300),-0.4160961616263674,-1.1197292763070745,0.3081395348837209,0.5988065285460881,1.0,9/18,32.33%,DNM1L;TLR4;TRPM7;MLKL;TICAM1;PPIF;TLR3;LY96;ITPK1
prerank,regulation of calcium ion import (GO:0090279),0.4011430699617772,1.119512044567696,0.2961460446247465,0.7262487291526757,1.0,5/21,10.22%,CXCL12;SLC30A1;PLPP4;CCL2;PDGFB
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.45771476219082546,-1.119226656562528,0.31238095238095237,0.5996038842120217,1.0,8/13,28.67%,ABCA1;ITGB1;CD9;LDLR;SYK;FCER1G;LPL;CD81
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.3400248638873229,-1.1188987451902082,0.2845849802371542,0.5999081152417925,1.0,10/45,16.54%,EGFR;NFKB1;DDX5;BMP4;U2AF2;MAP2K1;WDR43;DIMT1;ERN1;BUD23
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.4107077207897318,-1.1188641467024407,0.29927007299270075,0.5994743604086314,1.0,4/20,7.62%,DICER1;PUM2;ZC3H7A;PUM1
prerank,vasodilation (GO:0042311),0.4415306924125014,1.1185807917571642,0.3319672131147541,0.7276943266835261,1.0,4/13,17.01%,ADRB1;NOS3;KLF2;KCNMA1
prerank,protein oxidation (GO:0018158),-0.4713982668896787,-1.1183195817248752,0.3177570093457944,0.6002931923101693,1.0,5/11,22.11%,LOXL1;LOX;LOXL3;TMX3;SUMF1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.31019141646786047,-1.117489387620309,0.2537313432835821,0.6018824355125498,1.0,27/69,28.48%,ECPAS;DNAJB14;UBQLN1;OS9;UBE4B;JKAMP;EDEM1;FAM8A1;SELENOS;RNF103-CHMP3;MAN1B1;RHBDD2;ERLIN1;TRIM25;FAF2;AUP1;DERL1;SYVN1;VCP;UBXN4;WFS1;BAG6;DNAJC18;TMUB2;SEL1L;USP19;DERL2
prerank,negative regulation of protein polymerization (GO:0032272),0.3740650862688806,1.1174657961711978,0.30265848670756645,0.7297171463839687,1.0,7/27,9.43%,KANK3;MAP2;STMN1;SNCA;TUBB4A;STMN2;CYRIB
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3598496420684666,-1.1173656493871085,0.2761061946902655,0.6016799652275774,1.0,7/30,9.79%,NOTCH2;IGF1;ITGAV;SHOC2;SHC1;LYN;NGF
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.2737850858411704,-1.117347457609813,0.1895551257253385,0.60118118374124,1.0,44/144,22.88%,ZIC1;TCF7L2;SMAD3;CEMIP;PCM1;XPO4;GSK3B;FLNA;SAE1;HUWE1;UBR5;BCAS3;CDH1;TFDP2;BCL2;ABLIM3;PCNT;RAPGEF3;VAMP2;JUP;BAG3;LEPROT;PRKCD;MAVS;TPR;NPEPPS;FBXW7;YWHAE;EMD;EFCAB7;ANP32B;ICE1;UBL5;SEC16B;UBE2D3;FIS1;SEC16A;TOMM7;PIK3R1;ARIH2;AKT2;KCNB1;CHP1;ZFAND1
prerank,linoleic acid metabolic process (GO:0043651),-0.41866049857648313,-1.117327158635227,0.31758034026465026,0.6007021315683055,1.0,6/17,27.35%,ACSL1;PNPLA8;ELOVL1;GSTM2;ALOX12;ELOVL5
prerank,neutrophil activation (GO:0042119),0.46778863109507707,1.117141348738723,0.3414141414141414,0.7293848450984156,1.0,2/12,6.96%,DNASE1;PREX1
prerank,organic hydroxy compound transport (GO:0015850),0.35284518549025784,1.1160532058825607,0.2765072765072765,0.7313229870201291,1.0,6/36,13.57%,SLCO1C1;AQP9;NCOA2;SLCO2B1;ABCC4;SLC16A1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3610480061453776,1.1159829758176079,0.27631578947368424,0.7302189759765384,1.0,4/33,7.97%,IGF1R;NYAP2;PIK3R5;AKT1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.416960923290724,-1.1156791798126797,0.30019120458891013,0.6043249729934339,1.0,8/18,30.42%,PABPN1;ENY2;MCM3AP;DDX19B;NXF1;NUP93;THOC2;DDX25
prerank,cellular protein-containing complex assembly (GO:0034622),0.2736379795905811,1.1155298955309307,0.2045929018789144,0.7302879903115984,1.0,34/159,15.33%,NSG2;MAPK8IP2;OMA1;DNAAF3;RPL38;NRG1;ANLN;AP2M1;PDE4DIP;TMEM35A;COX7A1;SNCA;BIN1;HIP1;CSNK2B;CHCHD4;CLU;PFDN6;BBS10;FCHO1;HSP90AB1;DNAAF2;MID1IP1;CCT2;HOPX;CALY;HSPD1;SGIP1;NUP205;HIGD1A;CLTB;HIGD1B;RTN4;NDUFAF1
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.2495282342912967,-1.1153736704345862,0.15853658536585366,0.6045622866832543,1.0,78/308,19.36%,LRP1;SMAD3;TGFBR1;SOX5;APPL2;PTN;BMPR1A;FOXD1;LEPR;COL1A1;ABCA1;SMURF2;FOXC1;GRB10;DAB2;ROCK1;BMP4;GHR;PDPN;ACSL1;SMO;TGFBR2;KMT5B;NUMA1;ALMS1;ADRA1B;PLA2R1;RREB1;NIBAN2;LBP;TGFB1I1;PPARGC1B;SMAD2;BCL9L;ZBTB16;VAMP7;MTOR;REST;PPARGC1A;GJA1;MED1;CPT2;PDGFC;SMAD4;SHLD2;PRKAB2;GNAS;EHMT1;OGT;KMT5C;TRPM4;SOX6;EIF2AK2;APOE;SLC27A1;VEGFA;ACVR1;ZBED3;KDM3A;GLIPR2;C1QTNF3;TGFB3;DYNC1H1;CMKLR1;ADRA2A;IL18;SERPINE1;SIX1;PIK3CD;WNT5A;TRPV2;B4GALT5;GCNT2;INPP5K;BMP2;ABCA7;PTPN11;INHBA
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.39540422014532917,-1.1153736433048533,0.2977867203219316,0.6040324336712619,1.0,3/20,3.72%,CFLAR;FLOT2;NUPR1
prerank,cAMP-mediated signaling (GO:0019933),0.3865790957118714,1.115218450455836,0.3159090909090909,0.7299696101457265,1.0,7/24,12.59%,RIMS2;EPHA5;AKAP6;PDE2A;ADCYAP1;CAP2;PDE4D
prerank,cellular response to cytokine stimulus (GO:0071345),-0.24563294049895643,-1.115083401983708,0.1360824742268041,0.6042549760473759,1.0,94/416,19.26%,PTPN13;COL1A2;DPYSL3;NFAT5;PID1;SMAD3;GAB2;ADAMTS12;LEPR;NFKB1;IL34;ZFAND6;ZEB1;FOXC1;GRB10;VIM;AXL;IL6ST;IL31RA;FOXO3;GHR;PTGIS;JAK1;PTPN14;GSK3B;GSDME;KIT;RIPOR2;SYNCRIP;TBK1;IRAK3;LBP;PTPN9;ITGB1;IL13RA1;SBNO2;RC3H1;STAT3;ASAH2;SHC1;BCL2;IL16;ANXA1;IRAK2;DHX9;F3;INPPL1;UBE2K;WNK1;PTPN12;UPF1;FER;PTPN2;SLC12A2;RHOA;HIF1A;ABL2;GREM2;STX4;CNTFR;RORA;NUMBL;MMP2;TPR;TEC;IL6R;YBX3;FN1;IRF1;TYK2;GBP3;STAT1;VEGFA;DUSP1;DAPK1;IFNGR1;IL18;STAT5A;PIK3CD;GBP7;GBP2;NPR2;TLR4;PRKACA;WNT5A;STAT5B;HNRNPU;NPNT;TRAF6;TANK;INPP5K;SMPD4;GBP6;PTPN11
prerank,cellular response to sterol (GO:0036315),-0.4519830266453385,-1.1149719774737163,0.3055555555555556,0.6039859741496129,1.0,6/13,15.46%,LRP6;SMO;GRAMD1C;INSIG2;RORA;PTCH1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.38708180896426636,-1.114813045936431,0.3041825095057034,0.6038622638732474,1.0,9/24,18.00%,PKD1;CTSC;EPHA4;NUB1;RHBDF1;APOE;LATS1;PRKACA;ATP5IF1
prerank,response to interleukin-1 (GO:0070555),-0.3058824419758326,-1.1147987148262484,0.2554027504911591,0.6033661023555703,1.0,15/73,19.78%,ADAMTS12;NFKB1;PTGIS;HDAC4;IRAK3;RC3H1;ANXA1;IRAK2;UPF1;HIF1A;GBP3;GBP2;TRAF6;TANK;IRAK1
prerank,mRNA export from nucleus (GO:0006406),-0.29217432888899597,-1.1147137643314302,0.2366412213740458,0.6030600979945913,1.0,36/102,26.63%,SMG6;SMG1;PABPN1;WDR33;CASC3;RANBP2;U2AF2;ENY2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.42157040335105067,1.1144913923858684,0.3183673469387755,0.7308410524533758,1.0,2/18,8.61%,CAMK2A;HEBP2
prerank,steroid hormone biosynthetic process (GO:0120178),0.3683902357709878,1.1140064150576534,0.3047034764826176,0.7310353423954365,1.0,10/29,19.40%,SRD5A2;HSD17B7;FDX2;TSPOAP1;TSPO;HSD17B2;DHCR7;STARD3NL;STARD3;SRD5A1
prerank,presynaptic endocytosis (GO:0140238),0.37843959011339234,1.1138488727647715,0.2915766738660907,0.7302237814288834,1.0,10/24,18.86%,SYT1;NLGN1;SNCA;AMPH;SYT2;SNCB;NLGN3;PACSIN1;SYNJ1;SYT5
prerank,prostaglandin biosynthetic process (GO:0001516),-0.41605775124003297,-1.1134082296716286,0.32233009708737864,0.6057557070638335,1.0,6/18,12.46%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,regulation of extracellular matrix organization (GO:1903053),-0.44806959978450894,-1.1133924213854927,0.3303249097472924,0.6052623075443931,1.0,7/15,15.37%,AEBP1;LRP1;RUNX1;FAP;RB1;EFEMP2;DDR1
prerank,polyol biosynthetic process (GO:0046173),-0.4290689322625239,-1.1131600004799669,0.33911368015414256,0.6053247471155346,1.0,7/16,25.71%,CYP27A1;ISYNA1;ACER3;ITPKC;FGF2;CYP2R1;IP6K2
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.2916865856169962,-1.1129105254758682,0.25146198830409355,0.6054212807558967,1.0,23/95,17.04%,INO80;UBE2N;RBBP8;SPIDR;SMC6;NBN;RAD51B;NSMCE2;WRN;SMC5;MCM9;NIPBL;RFWD3;PARP1;RAD21;RAD51D;NABP2;FANCM;MCM6;BRCA2;SFPQ;MRE11;ZSWIM7
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.35887067154262997,-1.112865629284385,0.2935222672064777,0.6049998747760752,1.0,17/34,31.73%,LGR4;IRAK3;PTPRS;LYN;OTUD4;TLR4;LRRC14;CD300A;TICAM1;RAB7B;CACTIN;GRAMD4;TNFAIP3;NLRP2B;TLR3;LY96;TYRO3
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.45789237948406725,-1.112809517288,0.3302063789868668,0.6046185169082863,1.0,4/13,6.88%,CBLB;KPNA4;RANBP2;KPNA6
prerank,endothelial tube morphogenesis (GO:0061154),-0.47867631540469413,-1.1126835334021725,0.35551330798479086,0.6044001189038959,1.0,3/10,10.27%,RBPJ;BMP4;RHOA
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.326578188356861,-1.1125382830530872,0.27920792079207923,0.6042616289870995,1.0,14/55,15.15%,TGFBR1;WWOX;NUPR1;GSDME;DNM1L;PAK2;BCL2;TRAF2;BCLAF1;BECN1;LTBR;ING5;TPD52L1;TRIM39
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.42468325482757874,-1.112385656170875,0.3370998116760829,0.6040893242833658,1.0,5/15,14.53%,DICER1;ZC3H12C;NYNRIN;KHNYN;ZC3H12B
prerank,cellular potassium ion homeostasis (GO:0030007),-0.4597885333971673,-1.112326680576277,0.31153846153846154,0.6037255396379214,1.0,3/13,10.08%,ATP1A2;KCNJ2;SLC12A2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.38525657807256675,-1.1119530858218356,0.3010948905109489,0.6041175010925708,1.0,9/22,28.18%,MED17;MED12;DHX36;MED1;MED16;MED13;MED14;PAXIP1;ESR1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4538132799122247,1.111666994315225,0.3373493975903614,0.7355090294131466,1.0,3/12,6.76%,TIRAP;MBP;KLF4
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.3220026090977723,-1.111322759551464,0.277992277992278,0.6051654687759366,1.0,14/57,14.36%,IGF1;IL6ST;IL31RA;GHR;KIT;PIBF1;STAT3;LYN;PTPN2;PARP14;PARP9;HES1;IL6R;VEGFA
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.27084732821064383,-1.1111675542608526,0.21482889733840305,0.6050001776659247,1.0,56/153,25.76%,ROCK2;TGFBR1;PKD1;TLK1;ROCK1;SMG1;CAMK1D;LRRK2;TGFBR2;CSNK1A1;TOP1;GSK3B;TBK1;MARK3;PAK2;EIF2AK3;CAMK2D;MTOR;PDPK1;WNK1;CSNK1E;HIPK1;BRSK1;PRKCD;DMPK;ULK2;MKNK2;RICTOR;PRKDC;ERN1;LATS1;PRKCZ;CSNK2A1;MARK1;IKBKE;PRKACA;PRKD1;MORC3;CSNK1D;CDK2;NEK6;CAB39;MAST2;AKT2;MKNK1;ATR;MAP3K12;PRKCA;CLSPN;DYRK1B;MAP3K13;CSNK1G2;MASTL;RPS6KA4;MAPK9;MAPK14
prerank,histone deubiquitination (GO:0016578),-0.41534658439690153,-1.1109257658273441,0.3171171171171171,0.6051341767677326,1.0,4/18,7.43%,USP7;TRRAP;ENY2;BRCC3
prerank,thymus development (GO:0048538),-0.45573716881552395,-1.1108167422179087,0.3181818181818182,0.6048839875284587,1.0,6/13,25.77%,TGFBR1;ZBTB1;HES1;SIX1;FOXE1;EPHB3
prerank,establishment of endothelial barrier (GO:0061028),0.3692158563670141,1.1106421277892031,0.3080082135523614,0.7374618701333391,1.0,11/29,16.87%,ROBO4;PDE2A;PPP1R16B;PECAM1;RAB1B;TJP1;MARVELD2;PDE4D;RAP1A;SOX18;RAP2B
prerank,receptor metabolic process (GO:0043112),0.3251185729067808,1.1103102435785641,0.2869022869022869,0.737163314079175,1.0,6/53,4.64%,TFRC;DNM3;RAMP2;AP2M1;SNCA;GRK2
prerank,protein glycosylation (GO:0006486),0.2783109175363162,1.1102921271135158,0.22336065573770492,0.7359284084766277,1.0,30/125,16.10%,ST8SIA4;GAL3ST1;GALNT9;MGAT5B;AQP11;ST3GAL6;EOGT;GALNT6;ST8SIA1;FUT9;ALG3;PMM1;PLOD3;B3GALT5;ALG1;MGAT4C;MPI;SLC39A8;ST8SIA6;B3GNT2;TMEM258;ST8SIA3;SERP1;ALG8;GALNT2;POMGNT2;GOLGA2;POMGNT1;POGLUT1;MGAT1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3468166404541294,1.110179682521975,0.27521008403361347,0.7350092729804201,1.0,11/35,18.89%,LIG3;RPA3;UNG;APEX1;POLG;POLD1;RFC4;POLD3;RFC5;ADPRS;RFC2
prerank,proteasomal protein catabolic process (GO:0010498),-0.26487786424329635,-1.1101211573347434,0.22061855670103092,0.6062066896350348,1.0,77/201,29.56%,FBXL17;SMURF2;SPSB1;PRKN;RAD23B;BTRC;TBL1X;WWP2;TBL1XR1;UBXN2B;HUWE1;UBE4B;WWP1;ZSWIM8;DDI2;PCBP2;UBE2K;MAEA;TNFAIP1;RNF216;ERLEC1;SPOPL;RCN3;GID4;KCTD5;PSMF1;FBXL19;CUL3;FBXW7;KLHL22;NHLRC3;PSMB2;UBE2B;SMURF1;FBXO45;TOPORS;ERCC8;ARRB1;BFAR;DERL1;SYVN1;PPP2R5C;FBXW11;FBXW5;AREL1;VCP;SPSB4;UBE2D3;IFI27;COP1;PML;PSMC1;APPBP2;SHARPIN;KCTD17;GID8;PSMB6;RMND5A;PSMA3;SIAH2;ARMC8;PSMA4;BAG6;PCNP;SPSB2;PSME1;SEL1L;PSMD13;CDC34;PSMB10;PSMA5;SPSB3;CCDC47;PSMB9;KBTBD7;RBX1;NFE2L2
prerank,neuromuscular process (GO:0050905),0.43261135197166567,1.1101171037302195,0.3346456692913386,0.733918621102193,1.0,4/16,18.46%,NRXN1;DCTN1;GCH1;KCNA1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3258508233129593,1.110038399117528,0.27176220806794055,0.7328688431682644,1.0,11/52,8.49%,KHDRBS2;RBFOX3;NOVA2;CELF5;RBFOX1;CELF4;RBM11;KHDRBS3;SRRM4;RBM15B;SRSF12
prerank,metal ion export (GO:0070839),-0.36934887498561497,-1.1100211228585835,0.30919765166340507,0.6059006660695114,1.0,4/31,6.27%,ATP1A2;KCNT2;SLC9A1;KCNK5
prerank,TOR signaling (GO:0031929),0.3697327241005227,1.1099693322950188,0.28450106157112526,0.7317884362254012,1.0,7/26,11.40%,PRR5L;RPS6;MEAK7;RPS6KB2;AKT1;EIF4EBP2;CCDC88A
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3997151207478814,-1.1098444014408364,0.3150684931506849,0.6058358032444005,1.0,4/21,3.09%,ROCK2;ROCK1;BCOR;ENPP1
prerank,protein ADP-ribosylation (GO:0006471),-0.37572799563871406,-1.1096264077923026,0.29296875,0.6058528997285928,1.0,12/28,24.53%,TNKS2;ZC3HAV1;PARP10;PARP14;PARP9;PARP1;SIRT5;PARP4;PARP6;SIRT4;SIRT3;PARP12
prerank,cellular response to interleukin-15 (GO:0071350),-0.45658555459219163,-1.1095807926562993,0.3388888888888889,0.6049300035237747,1.0,6/13,17.75%,JAK1;IL15RA;STAT3;SHC1;STAT5A;STAT5B
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.45658555459219163,-1.1095807926562993,0.3388888888888889,0.6049300035237747,1.0,6/13,17.75%,JAK1;IL15RA;STAT3;SHC1;STAT5A;STAT5B
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3016313026808287,-1.1092247307618515,0.25842696629213485,0.6053060171535362,1.0,15/69,14.15%,IGF1;GAB2;PLCE1;PDGFRA;PI4KA;PDGFRB;PLCD3;IRS1;PLCB3;NGF;PLCD1;RHOA;PITPNM2;OGT;PIK3C3
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.45118717762847993,-1.1089437662629913,0.31684981684981683,0.6054672717497724,1.0,9/14,31.48%,UPP2;NT5M;UPB1;DPYD;DHODH;NT5C1A;UMPS;CAD;ERH
prerank,epithelium development (GO:0060429),-0.2885946662621701,-1.108787053415899,0.25775193798449614,0.6053735688870618,1.0,30/107,18.84%,ALDH1A2;ERRFI1;DAG1;VCL;KANK2;PKD1;WNT4;SMO;OSR1;MEOX2;ANXA4;FGFR2;ANXA7;CNN3;VDAC1;DACT1;RCN3;PKD2;PGK1;STAT1;VEGFA;BDH2;PTCH1;SALL1;LOXL3;SIX1;TBX2;TAGLN;BMP2;CPT1A
prerank,positive regulation of insulin secretion (GO:0032024),-0.35091907103657727,-1.108350786017827,0.2830188679245283,0.6059182225759362,1.0,11/36,20.69%,TCF7L2;MCU;NLGN2;RBP4;GLUD1;NNAT;STX4;TRPM4;ANO1;C2CD2L;ACSL4
prerank,cellular response to UV-A (GO:0071492),0.4638866122111981,1.1080354755127655,0.32112068965517243,0.7363873037754829,1.0,2/11,7.73%,MME;TIMP1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3714118999404307,1.1077852882406143,0.3216494845360825,0.7358756275182854,1.0,6/27,10.86%,GRM1;HTR2C;GPR35;GPR17;F2RL2;F2R
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.35613185055956526,-1.1076687682254034,0.3045186640471513,0.6071219725514724,1.0,7/33,10.53%,SMAD3;TEAD1;FOXO3;NR3C1;STAT3;JUN;HIF1A
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.30981101648712495,-1.1076672765495394,0.2737864077669903,0.6066064242558122,1.0,13/68,16.48%,RHOQ;OPA1;ENPP1;LRRK2;TPST1;AMPD3;GPAT4;ACSF2;SULT1A1;ACSL6;ACOT11;ABHD14B;ACOT9
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.277976859839004,-1.107543614429931,0.241635687732342,0.6064186667583517,1.0,24/121,12.73%,BMP6;IGF1;IL34;ANGPT1;IL6ST;IL31RA;GHR;ABL1;VTN;DLG4;KIT;PIBF1;PAK2;STAT3;NRP1;NOX4;LYN;EPHA4;IGF2;PARP14;PARP9;HES1;TEC;IL6R
prerank,carnitine shuttle (GO:0006853),-0.47522661494131696,-1.1073564892305992,0.34146341463414637,0.6063722293681914,1.0,4/11,10.83%,PRKAG2;PRKAA2;CPT2;PRKAB2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4846373140826138,-1.1070065733186447,0.34629629629629627,0.6067201339879282,1.0,6/10,32.27%,LRRK2;TXN;PARK7;NFE2L2;PDE8A;STK26
prerank,multivesicular body organization (GO:0036257),-0.3598912969840594,-1.1069622307067812,0.3098330241187384,0.6063049080255248,1.0,7/31,12.11%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;VPS37C;RAB11A
prerank,protein localization to Golgi apparatus (GO:0034067),-0.36728208975631543,-1.1069097545329682,0.302504816955684,0.6059065759730216,1.0,6/27,12.89%,VPS13A;GBF1;VPS13D;OBSL1;COG7;VPS13C
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.38817630009242743,1.106651184732088,0.2891304347826087,0.7379475045795405,1.0,6/21,14.11%,USP44;RPL23;UBE2C;RPL5;RPS7;GOLGA2
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.31944333414906856,-1.1064636390999154,0.26095238095238094,0.6065127936737914,1.0,16/59,15.45%,ROCK2;TGFBR1;ROCK1;LRRK2;TGFBR2;GSK3B;TBK1;CAMK2D;PDPK1;MAP2K1;WNK1;HIPK1;PRKCD;PRKDC;ACVR1;CSNK2A1
prerank,positive regulation of cell projection organization (GO:0031346),0.28605695245538687,1.106393182009289,0.2220039292730845,0.7374784709756679,1.0,27/115,12.13%,RIT2;PTPRD;LRRC7;IL1RAPL1;PLXNB3;S100A9;ITGA6;MAGI2;TOX;GRIP1;NTRK2;SCARF1;FUT9;NPTN;PLPPR5;TENM3;NDNF;SCARB2;PLXNA4;ROBO2;STMN2;CDKL5;RELN;DAB2IP;FZD4;DVL1;RET
prerank,cellular response to increased oxygen levels (GO:0036295),0.4607281575659343,1.1063398049597337,0.32409381663113007,0.7363831179255761,1.0,4/11,14.85%,ATP6V1A;ATP6AP1;FOXO1;TMEM199
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.4592194055269953,-1.105961662748261,0.34555984555984554,0.6072725282625927,1.0,5/13,29.38%,GAB2;STX4;LAMP1;SYK;SPHK2
prerank,positive regulation of response to external stimulus (GO:0032103),-0.27928736223750816,-1.1058792088395457,0.2572533849129594,0.6069702664121852,1.0,28/128,17.55%,BMP6;SASH1;PTN;ANKRD17;PDGFRB;PUM2;THBS1;PLSCR1;IL16;DHX9;PUM1;IL17RA;DDX60;NAPEPLD;STX4;NFKBIZ;RIOK3;AGTR1;P2RY12;CYBA;GPR4;FEM1A;IL18;PDCD4;SERPINE1;TLR4;CCN4;WNT5A
prerank,positive regulation of cellular component movement (GO:0051272),0.3938153933150882,1.1058616346272614,0.30962343096234307,0.7365954418466926,1.0,6/24,13.02%,SPOCK2;CSF1R;RPS19;ETS1;NTN1;ACTN4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3370205377582734,1.105813141661058,0.2718052738336714,0.7354850435414046,1.0,9/44,7.97%,PAX2;GAS6;SNCA;GPX1;ARL6IP1;KLF4;BEX3;RPS6KA1;AKT1
prerank,positive regulation of cellular component organization (GO:0051130),0.28505395004627887,1.1056843878856013,0.24116424116424118,0.7345907406280676,1.0,23/107,13.88%,IGF1R;TFRC;NRXN1;TIRAP;TMEM30A;NRG1;SHANK3;ATP10A;SNCA;GPX1;TAL1;TGFB2;CLU;RELN;TPPP;DAB2IP;SMPD1;ABCB4;DCTN1;CALY;RPS3;DLL1;INSR
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2919634054885956,-1.1054918627887391,0.2567049808429119,0.6073995950061514,1.0,34/96,26.63%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,natural killer cell mediated immunity (GO:0002228),-0.4348217542062407,-1.1050970397784794,0.3384321223709369,0.6078473408861386,1.0,5/15,30.64%,CEBPG;PLEKHM2;KIF5B;ULBP1;RAET1E
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2941461600655097,-1.104932745082045,0.2602739726027397,0.6077245487215283,1.0,21/84,14.35%,CELF2;RBFOX2;SON;DDX5;CELF1;RBM39;MBNL2;SFSWAP;DDX17;KHDRBS1;WTAP;SRSF10;U2AF2;SRSF6;REST;HNRNPK;DAZAP1;YTHDC1;CWC22;NSRP1;RBM5
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4143190251724486,-1.1046535254760763,0.3063583815028902,0.6079348941794191,1.0,2/17,0.36%,ATP1A2;CACNA1C
prerank,multivesicular body assembly (GO:0036258),-0.36070959801915053,-1.1046120329986833,0.313543599257885,0.6075489294876647,1.0,7/30,12.11%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;VPS37C;RAB11A
prerank,glial cell development (GO:0021782),0.37753499491937376,1.1043759331132268,0.2980132450331126,0.7371727135319625,1.0,8/25,16.78%,S100A9;TLR2;NSUN5;EIF2B3;TPPP;DLL1;SOX4;HES5
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.42505964353647935,-1.1040494682854265,0.33519553072625696,0.608387658377424,1.0,5/16,14.78%,DPYSL3;UPP2;NT5M;UPB1;DPYD
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3958620049735061,-1.1039204248597807,0.3162705667276051,0.6081945944032093,1.0,3/20,3.94%,AKAP13;ADCY9;ADRA1B
prerank,monosaccharide transmembrane transport (GO:0015749),-0.4268279221742845,-1.1035354370326895,0.32950191570881227,0.6086343999728243,1.0,2/16,6.74%,SLC5A3;SLC2A12
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.4216041850924408,-1.1030536572473149,0.3314393939393939,0.6092878100090585,1.0,10/16,30.28%,PRPF39;SFSWAP;DDX23;SRSF1;WBP11;NCBP2;RBM22;CACTIN;SNRNP200;PSIP1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.37440089158497486,-1.1027489485986899,0.30538922155688625,0.609508793172482,1.0,8/25,19.37%,PARVA;ITGAV;ITGB1;CXADR;JUP;ITGA5;ITGA4;ITGB3
prerank,cholesterol transport (GO:0030301),-0.33289344438709617,-1.102733574786218,0.2965779467680608,0.6090404570770834,1.0,8/45,14.09%,ABCA1;LIMA1;SOAT1;OSBPL5;LDLR;RELCH;NPC2;APOE
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.3970860888130593,-1.1022624766041658,0.3364140480591497,0.6097328462067811,1.0,3/20,2.59%,PID1;RHOQ;DAB2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.3231010731679409,-1.1020832523878634,0.2801556420233463,0.6096693983207232,1.0,8/52,7.95%,EGFR;LRP1;SORBS1;EPHA3;PTPN9;DLG1;ITGB1;PDPK1
prerank,positive regulation of viral transcription (GO:0050434),-0.3826850595839519,-1.1020063518019778,0.31477927063339733,0.609343736490458,1.0,13/25,28.25%,MDFIC;CCNT1;DHX9;NELFB;POLR2H;GTF2F1;POLR2K;CTDP1;POLR2E;POLR2D;NELFA;CDK9;NELFE
prerank,response to peptide (GO:1901652),0.3513539697570168,1.1018806266253525,0.2952586206896552,0.7434233861613426,1.0,3/33,1.58%,CACNA1A;CACNA1B;MMP12
prerank,regulation of actin filament depolymerization (GO:0030834),-0.45572408446842105,-1.1013787874221175,0.3339805825242718,0.6103630070086684,1.0,2/12,5.46%,LIMA1;PLEKHH2
prerank,RNA export from nucleus (GO:0006405),-0.28960042648279444,-1.1012908916613682,0.2524084778420039,0.6100582205696027,1.0,35/100,26.63%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;XPO5;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.35707286425978996,1.1012366992215805,0.3037974683544304,0.7441088963134016,1.0,4/32,4.57%,GRM5;PGAM1;RPL10;NANOS3
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.48360213473326474,-1.101175449907541,0.3446327683615819,0.6098385109226252,1.0,4/10,20.84%,SOX5;ZBTB16;SOX6;PKDCC
prerank,potassium ion export across plasma membrane (GO:0097623),-0.44552118316075423,-1.100460546644595,0.3352272727272727,0.6111938023091081,1.0,2/13,6.27%,KCNT2;KCNK5
prerank,ion homeostasis (GO:0050801),0.36193986689056573,1.1004483969035679,0.31808278867102396,0.7452540612992875,1.0,5/30,7.92%,SLC4A1;KLHL3;WNK2;UNC80;SLC30A3
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.46601544965079045,-1.0999835425965174,0.3719165085388994,0.6113688974485305,1.0,4/11,23.36%,TNRC6A;TNRC6C;RBM4;AGO1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.46601544965079045,-1.0999835425965174,0.3719165085388994,0.6113688974485305,1.0,4/11,23.36%,TNRC6A;TNRC6C;RBM4;AGO1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.43036362690117813,-1.0998519696157703,0.3314285714285714,0.6111964256414215,1.0,4/15,9.06%,FOXC1;BMP4;NUMA1;MED1
prerank,glycosphingolipid metabolic process (GO:0006687),0.33537587790168166,1.099762730744271,0.31004366812227074,0.7460547989871847,1.0,18/42,21.61%,ST6GALNAC3;B4GALNT1;NEU2;ST8SIA1;B4GALT6;ARSA;GLA;SMPD1;ST8SIA3;CPTP;GALC;GLB1;HEXB;NEU1;NEU4;PSAP;ESYT2;SUMF2
prerank,heme biosynthetic process (GO:0006783),0.38891314911526403,1.0997549691954347,0.34810126582278483,0.7448063605062011,1.0,8/22,20.83%,ALAS2;ABCG2;CPOX;TSPO;FECH;COX10;HMBS;ABCB10
prerank,regulation of cell projection organization (GO:0031344),0.44551533598350695,1.0996402392246587,0.35671342685370744,0.7439175672379283,1.0,4/13,8.89%,MFSD2A;SEMA4D;NTNG1;NTNG2
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.3075516467080377,-1.0992331523459389,0.2776659959758551,0.6122508288152254,1.0,23/65,21.54%,MDM4;BMP7;PTGIS;LMNA;UBQLN1;MTOR;FAM162A;EGLN3;HIF1A;RORA;ACAA2;NPEPPS;PGK1;VEGFA;CPEB1;NOP53;SLC8A3;CARD16;TERT;P4HB;GATA6;TBL2;BNIP3
prerank,membrane repolarization (GO:0086009),-0.4355626345178994,-1.0990139090847355,0.3416506717850288,0.612308571497497,1.0,2/15,7.68%,ATP1A2;KCNJ2
prerank,regulation of protein kinase A signaling (GO:0010738),0.3960877458316133,1.0986768358086734,0.32397408207343414,0.7456302329366108,1.0,3/20,3.16%,PRKAR2B;MIF;AKAP6
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3441234335416446,-1.0985843938911872,0.2946768060836502,0.6128924395723507,1.0,13/39,15.01%,ROCK2;ROCK1;SNCAIP;RAP1B;PARP10;TRAF2;HCFC1;HJURP;SPTY2D1;GFAP;APOE;LATS1;RAPGEF2
prerank,peptidyl-methionine modification (GO:0018206),0.44545998402127285,1.0983951671889887,0.3463203463203463,0.7452584005191389,1.0,3/12,15.10%,METAP2;NAA30;NAA60
prerank,secondary alcohol metabolic process (GO:1902652),-0.33323784097258086,-1.0983817932125366,0.31894934333958724,0.6129110100986566,1.0,17/42,34.61%,ABCA1;CYP27A1;SOAT1;OSBPL5;APOE;RXRA;SQLE;FDX1;GBA2;SCAP;CLN8;TSKU;ANGPTL3;CLN6;IDH2;CH25H;LCAT
prerank,apoptotic DNA fragmentation (GO:0006309),-0.42265653892338606,-1.0983768100775362,0.31351351351351353,0.6124101255634445,1.0,6/16,27.42%,DICER1;HMGB1;H1-0;EXOG;DNASE2;CECR2
prerank,regulation of protein localization to nucleus (GO:1900180),-0.3419031453676655,-1.0983098128506803,0.3211009174311927,0.6120866862393233,1.0,14/43,21.31%,CTNNA1;BMP4;GSK3B;YAP1;EIF2AK3;GLUL;PARP9;TPR;ILRUN;DTX3L;LATS1;PARK7;ORMDL3;CDK5RAP3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3470096848328654,1.0982674834069681,0.3093220338983051,0.744427841254932,1.0,12/36,18.04%,NOSTRIN;NOS3;LYPLA1;AKT1;GLA;CALM1;SCARB1;ATP2B4;GCH1;HSP90AA1;NOSIP;DDAH1
prerank,RNA interference (GO:0016246),-0.4199749240660535,-1.0980410889335717,0.344106463878327,0.6122853045905213,1.0,3/17,7.10%,CELF1;DICER1;DHX9
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3412084784721428,-1.09753172616127,0.26356589147286824,0.612991880605179,1.0,7/39,10.03%,EGFR;ERRFI1;RNF115;PTPN3;CDC42;PTPN12;PTPN2
prerank,autophagy of mitochondrion (GO:0000422),-0.3408513104189683,-1.097388656276138,0.29313543599257885,0.6128518302033991,1.0,18/38,26.45%,PRKN;RB1CC1;WIPI1;ULK2;BECN1;ATG2A;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;FIS1;WIPI2;BNIP3;ATG14;MAP1LC3A;PHB2;ATG3
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.38448818730172885,-1.097289577752326,0.34831460674157305,0.6126067844531009,1.0,8/24,12.58%,BOC;CDON;CTNNA1;ABL1;MEF2A;CDC42;MEF2C;TCF3
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.4012129977257205,-1.097230223583388,0.3216374269005848,0.6122265419932303,1.0,8/20,30.48%,FKBP5;PPIH;PPWD1;NKTR;PPID;PPIC;PPIL1;PPIF
prerank,peroxisomal membrane transport (GO:0015919),-0.3725919529012685,-1.096957226088246,0.313953488372093,0.6123663006336334,1.0,14/27,32.19%,ABCD3;PXMP4;ABCD2;PEX6;ABCD4;SLC25A17;PEX7;FIS1;PXMP2;PEX26;PEX11B;PEX10;PEX16;RAB8B
prerank,peptide cross-linking (GO:0018149),-0.38821801599603367,-1.0968336586932215,0.30939226519337015,0.6121693473842681,1.0,4/25,12.79%,COL3A1;THBS1;ANXA1;FN1
prerank,macrophage chemotaxis (GO:0048246),0.47936620858126044,1.096618953316883,0.3436213991769547,0.7481363893911619,1.0,3/10,18.29%,CCL2;EDNRB;CKLF
prerank,protein kinase A signaling (GO:0010737),-0.44524748008976794,-1.0966088526311006,0.3379721669980119,0.6122285476249164,1.0,10/12,53.21%,PRKACA;MYOM1;RDX;TTN;TCP11X2;TCP11;PRKACB;RAB13;LCP1;GAL
prerank,calcium-mediated signaling (GO:0019722),-0.28760391861811163,-1.0964361776451539,0.28893058161350843,0.6121250727586752,1.0,24/93,18.08%,CACNA1C;EGFR;ANK2;PLCE1;MCU;LRRK2;NUDT4;SLC9A1;CCR9;ADGRL1;EIF2AK3;TPCN2;PDPK1;PLCG1;DMPK;ATP2A2;AGTR1;TRPM4;P2RY12;P2RX4;PRKACA;PRKAA1;CX3CR1;PTGFR
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4201172818168944,-1.0964161311444953,0.35580524344569286,0.6116792646780227,1.0,7/15,24.80%,PRODH;GGACT;SARDH;CHAC2;ABHD12;ALDH4A1;GGT5
prerank,protein modification by small protein removal (GO:0070646),-0.25435117760454246,-1.096369549911383,0.18962075848303392,0.6112811213537066,1.0,93/252,29.34%,SMAD3;TGFBR1;INO80;SMURF2;MDM4;USP24;KAT2B;EP300;PRKN;RAD23B;USP7;SMAD2;SENP3;WDR48;SENP7;TRRAP;BRCC3;MYSM1;SENP6;AR;FOXK1;DDB2;VCPIP1;USP33;TRAF2;RHOA;TADA3;HIF1A;HCFC1;SMAD4;SENP1;RHOT1;USP47;WDR20;SENP5;PSMF1;COPS2;OGT;USP12;KDM1B;USP11;USP4;ABRAXAS2;BECN1;USP46;USP35;COPS8;USP50;PSMB2;USP2;OTUD4;USP13;FOXK2;TNIP2;TRAF3;USP34;ATXN7;TRAF6;VCP;DESI1;DESI2;PSMC1;SMAD1;TAF9B;TOR1A;CLSPN;SENP2;PSMB6;PSMA3;USP18;SIAH2;OTUD1;USP9X;PSMA4;USP28;INO80D;INO80C;ACTR5;MBD6;ABRAXAS1;PSME1;ADRB2;PSMD13;USP19;ESR1;TNFAIP3;GPS1;RCE1;PSMB10;PSMA5;PSMB9;BIRC3;FOXO4
prerank,negative regulation of TOR signaling (GO:0032007),-0.34663479680708814,-1.0962668195354945,0.3247232472324723,0.6110370159748101,1.0,12/36,19.75%,RNF152;UBR2;PRKAA2;DEPTOR;TMEM127;SESN1;UBR1;FNIP1;CASTOR2;NPRL3;PRKAA1;TBC1D7
prerank,membrane depolarization during action potential (GO:0086010),-0.3721849617811912,-1.096003428589519,0.3283582089552239,0.6111818284808079,1.0,5/26,7.81%,ATP1A2;CACNA1C;SCN7A;KCNJ2;CACNA1D
prerank,phosphatidic acid metabolic process (GO:0046473),-0.3251851263938049,-1.0959332274440838,0.2842741935483871,0.6108640752110985,1.0,13/48,21.07%,PLD1;GNPAT;DGKA;AGPAT4;DDHD1;ABHD5;GPAT4;PLA2G4A;SLC27A1;GPD1L;LPCAT1;GPAT3;DGKD
prerank,glycolipid metabolic process (GO:0006664),0.32748511359544186,1.0958743719559887,0.3205944798301486,0.749080556249462,1.0,18/47,21.61%,ST6GALNAC3;ST3GAL6;B4GALNT1;NEU2;ARSA;GLA;SMPD1;ST8SIA6;CPTP;GALC;PIGW;GLB1;HEXB;NEU1;NEU4;PSAP;ESYT2;SUMF2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.4145200251204487,1.0956830878587542,0.36026200873362446,0.7484117878940196,1.0,6/17,14.31%,CD33;MAGI2;HSP90AB1;CALM1;CALM2;CALM3
prerank,histone H4-K16 acetylation (GO:0043984),-0.40518473748090295,-1.0955085582367439,0.32037037037037036,0.6114112936905363,1.0,9/19,23.98%,KANSL2;HCFC1;OGT;KAT8;MSL2;MSL3;KANSL3;KMT2A;JADE2
prerank,insulin secretion (GO:0030073),0.39838588647755113,1.0951472291640212,0.3466666666666667,0.748767343414076,1.0,3/19,7.52%,PTPRN2;RIMS2;ADCYAP1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.37422744766978905,-1.094708426023737,0.32947976878612717,0.6129557459983401,1.0,3/24,2.59%,PID1;RHOQ;DAB2
prerank,regulation of protein phosphorylation (GO:0001932),-0.24939262096128095,-1.0945725618801327,0.2043222003929273,0.6127822980854356,1.0,72/256,22.02%,PTPN13;ROCK2;EGFR;PID1;PLCE1;EPHA7;LEPR;IL34;ANGPT1;SLCO3A1;LRP6;NTRK3;PELI2;FBLN1;PLPP3;FGF1;BMP7;DAB2;FAM20A;BMP4;ABL1;PRKN;LRRK2;IBTK;IGFBP3;AXIN1;NSD1;EIF2AK3;LYN;AKAP8L;IGF2;IMPACT;PLXNB2;RB1CC1;FER;BMPER;MAVS;FNIP1;PPP2R5E;FN1;FKBP8;CARD14;MOB1B;CCN1;WDFY2;PRKDC;VEGFA;PPP2R5D;CCND3;ZBED3;VEGFD;PDCL3;ARRB1;NOP53;PHIP;MYADM;PPP2R5C;CSNK1D;INPP5K;BMP2;PARK7;MUSK;ITGB3;PML;TMEM119;PPP2CA;CDK5RAP3;AKT2;DVL3;FGF2;ATG14;CRKL
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3958593919058419,-1.094459534251203,0.3386454183266932,0.6125469126522008,1.0,9/21,28.60%,PRKN;COA8;SLC30A10;ABCD2;SIRT5;PARK7;AATF;PPARA;MT3
prerank,cell junction organization (GO:0034330),0.3033485256924803,1.0943447409766438,0.294478527607362,0.7499970772709188,1.0,22/71,15.67%,GRM5;ACTB;CTNND2;SNCA;OCLN;PPFIA3;TGFB2;ELFN1;WNT7B;RAB39B;VMP1;APBB2;PPFIA2;TJP1;DVL1;MARVELD2;PPFIA4;SNCB;PSEN1;PAK3;NLGN3;CBLN2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4774602211621822,-1.0942797330792322,0.3684210526315789,0.6124634496857619,1.0,5/10,34.02%,PTPRS;NLRC3;SIRPA;CACTIN;PYCARD
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.46902797354543263,1.0942606082189688,0.36210526315789476,0.7490221521279975,1.0,3/10,11.23%,KNSTRN;SPAG5;APC
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.3291472610814726,-1.093925265157962,0.2880324543610548,0.6128227214775926,1.0,13/46,21.07%,PLD1;GNPAT;DGKA;AGPAT4;DDHD1;ABHD5;GPAT4;PLA2G4A;SLC27A1;GPD1L;LPCAT1;GPAT3;DGKD
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.43021081240633796,1.0936393869056893,0.34151785714285715,0.7497152262682738,1.0,3/15,6.58%,PAX8;PAX2;LHX1
prerank,erythrocyte differentiation (GO:0030218),-0.33280223119866453,-1.0931259553252644,0.3269230769230769,0.614315130181331,1.0,15/44,19.36%,TGFBR3;KIT;ACIN1;UFL1;LYN;CEBPG;UBA5;MED1;PTPN2;ID2;HSPA9;VEGFA;SLC25A38;ATP5IF1;INHBA
prerank,regulation of mRNA processing (GO:0050684),-0.35544078656780476,-1.0928091950092758,0.31297709923664124,0.6145976968014917,1.0,11/32,13.34%,SON;RBM39;PABPN1;KHDRBS1;SRSF10;DHX9;SAFB2;HNRNPK;CDK11B;YTHDC1;CWC22
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3629385781882581,-1.092615393414267,0.32062391681109187,0.6145670608671389,1.0,8/29,11.94%,GTF2H2;RAD23B;CCNH;CDK7;DDB2;MNAT1;PARP1;ERCC3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.37558419105369506,1.0926112238420496,0.3340122199592668,0.7514553992992006,1.0,4/23,3.16%,PROX1;ATP11A;NRG1;AKAP6
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.4563990872030651,1.0925355962778143,0.31519274376417233,0.7492050846944065,1.0,2/10,8.95%,AP2M1;AP2B1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.4563990872030651,1.0925355962778143,0.31519274376417233,0.7492050846944065,1.0,2/10,8.95%,AP2M1;AP2B1
prerank,superoxide anion generation (GO:0042554),-0.4392433525516189,-1.092464031906884,0.349609375,0.6144194119916054,1.0,4/13,27.15%,NOX4;CYBA;NCF2;ALOX12
prerank,platelet aggregation (GO:0070527),-0.34963839598851026,-1.0924113482424622,0.3231597845601436,0.6140670674089167,1.0,9/33,15.58%,VCL;PDGFRA;TLN1;FLNA;STXBP1;GNAS;FN1;P2RY12;FIBP
prerank,regulation of angiogenesis (GO:0045765),0.2622187479021096,1.0922702391224528,0.24898785425101214,0.7487694562558166,1.0,27/192,8.42%,FLT1;CLDN5;TEK;IL17F;MINAR1;ADAM12;TIE1;SEMA6A;RAMP2;ADGRB1;HTATIP2;SIRT1;NAXE;TSPAN12;HMGA2;PPARG;PPP1R16B;KDR;NOS3;TGFB2;ETS1;KLF4;APLNR;NINJ1;GPNMB;CD34;HSPB1
prerank,superoxide metabolic process (GO:0006801),-0.3598921115654945,-1.0922205783278724,0.3333333333333333,0.6140562538040758,1.0,12/29,28.60%,SH3PXD2B;CYB5R4;NOX4;SH3PXD2A;SOD3;CYBA;SOD2;NCF2;PRDX2;CCS;ALOX12;MT3
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2703426885425227,1.092038186471116,0.2459349593495935,0.7482088654750194,1.0,23/140,11.50%,GRIN1;CACNA1A;ADCY8;GRM1;RYR2;HTR2C;CACNA2D1;SLC8A1;CD24;TACR1;NPTN;GPR35;P2RY1;CIB2;ADCYAP1;ACKR4;GPR17;ADRA1D;ADRA1A;F2RL2;F2R;JPH3;P2RX7
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2804829010271324,1.0918175417144105,0.2774451097804391,0.7476110933821046,1.0,18/100,10.86%,FLT1;IGF1R;TEK;PIP5K1B;SIRT1;PPP1R16B;KDR;NTRK2;SEMA4D;FLT3;TGFB2;PIK3R5;UNC5B;EPO;FBXL2;DAB2IP;PDGFB;F2R
prerank,mRNA transport (GO:0051028),-0.28583274813941134,-1.091633167779532,0.28,0.6149825795377366,1.0,34/101,26.63%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,protein trimerization (GO:0070206),-0.429116370687161,-1.0910119140061356,0.34724857685009486,0.615454789066226,1.0,4/14,3.98%,CLYBL;SLC1A5;DISP1;SCARA5
prerank,protein homotrimerization (GO:0070207),-0.429116370687161,-1.0910119140061356,0.34724857685009486,0.615454789066226,1.0,4/14,3.98%,CLYBL;SLC1A5;DISP1;SCARA5
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.3745012651622667,-1.0904649247670433,0.3181818181818182,0.6163257507453611,1.0,13/26,24.56%,EIF4E;HES1;CUL3;TTL;USP2;CDC25B;CCDC57;KLHL18;PRKCA;SPHK1;HSF1;EIF4EBP1;PPP1R10
prerank,protein heterotetramerization (GO:0051290),0.43590467623620155,1.0904260566990678,0.33832976445396146,0.7505311579469457,1.0,3/13,11.07%,GRIN1;GRIN2B;FARSB
prerank,peptidyl-threonine modification (GO:0018210),-0.3066881846884757,-1.0903879074328715,0.2865384615384615,0.6160033956426939,1.0,23/66,23.10%,ROCK2;TGFBR1;ROCK1;LRRK2;TGFBR2;GSK3B;TBK1;CAMK2D;PDPK1;MAP2K1;WNK1;HIPK1;PRKCD;PRKDC;ACVR1;CSNK2A1;PRKD1;GALNT1;CDK10;GALNT11;MAP3K12;PRKCA;CDC42BPG
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2590428525929639,1.0901856251940656,0.2448559670781893,0.7500093361458994,1.0,34/214,10.86%,TEK;ERBB4;TIRAP;PTPRR;CSF1R;EPHB1;NECAB2;SEMA6A;MIF;SPRY3;CNKSR3;DUSP6;HTR2C;CAMK2N1;GAS6;KDR;FGF10;NTRK2;WNK2;SEMA7A;NOTCH1;P2RY1;ZDHHC17;ADCYAP1;GPNMB;ADRA1A;CCL2;THPO;OPRM1;DAB2IP;PDGFB;LMO3;ATP6AP1;F2R
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.36560746555682205,1.0899535003906013,0.3306122448979592,0.749496992527157,1.0,6/27,7.53%,SLC7A5;SLC7A1;SLC1A1;SLC1A2;SLC6A5;SLC7A8
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.31565439871714024,1.089881692035602,0.30353430353430355,0.7485197588207443,1.0,14/54,14.15%,TMSB4X;SIRT1;PPARG;KDR;NOS3;CSNK2B;ETS1;ACVRL1;AKT1;HSPB1;PDGFB;ATP5F1B;CD40;ATP2B4
prerank,fatty acid oxidation (GO:0019395),-0.3099132643677388,-1.0896836034930133,0.2982107355864811,0.6172829503960434,1.0,15/57,18.00%,ABCD3;ACADM;ACAD10;ABCD2;PPARGC1A;ACAD11;CPT2;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ACOX1;ECI1
prerank,regulation of microtubule nucleation (GO:0010968),0.48333745089761254,1.089664634160444,0.37188208616780044,0.747918620583247,1.0,5/10,19.28%,GIT1;PAK1;DCTN1;ARHGEF7;MECP2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4823000221095251,1.08857994611793,0.36160714285714285,0.7500388613967577,1.0,6/10,16.45%,ISG15;RPS27A;UBC;UBB;CHFR;NEDD8
prerank,regulation of protein acetylation (GO:1901983),-0.45351018906296575,-1.0884041644799607,0.3697632058287796,0.6198752907038099,1.0,7/12,19.80%,GSK3B;RAPGEF3;FAM161A;DDX3X;CEP295;PARK7;TAOK1
prerank,striated muscle cell development (GO:0055002),0.42720432297105065,1.0883781403366823,0.34598214285714285,0.7493960514763301,1.0,3/14,8.44%,MYH6;PGM5;TMOD1
prerank,nucleosome organization (GO:0034728),-0.31926264847475966,-1.088236111634351,0.30297397769516726,0.619786935278792,1.0,28/55,37.35%,INO80;KAT6B;SMARCC2;RNF8;SETD2;MCM3AP;SPTY2D1;ANP32B;ANP32E;NASP;SMARCD2;ARID2;BPTF;H1-0;PRDM9;NAP1L4;SMARCD3;NAP1L1;ACTR6;ATRX;DMAP1;NAP1L2;CHAF1A;NAP1L3;SMARCA4;NPM1;ARID1A;SART3
prerank,sulfate transport (GO:0008272),-0.4479499012959165,-1.0880864440481137,0.36278195488721804,0.6197073521053348,1.0,3/14,7.01%,SLC13A4;SLC26A7;SLC26A2
prerank,glycoprotein catabolic process (GO:0006516),-0.4203054787308626,-1.0879839532476432,0.3605313092979127,0.6194516013804822,1.0,5/17,9.28%,ADAMTS12;NGLY1;OGA;EDEM1;ADAMTS9
prerank,regulation of cell growth (GO:0001558),0.258718778708619,1.0879087050874865,0.26356589147286824,0.7495539947614187,1.0,41/204,14.84%,NRG3;TFRC;SPOCK1;MINAR1;S100A9;S100A8;AKAP6;SIRT1;GNG4;APBB1;OGFR;MFSD2A;PAK5;SCGB3A1;PPP2R1A;TGFB2;SLIT3;PRKCQ;WFDC1;MELTF;PTPRJ;ACVRL1;RPS6KA1;AKT1;SGK3;H3-3A;TAOK2;NET1;APBB2;IL17RB;CEP43;SOX17;NDUFA13;BMPR2;BCAR1;CIB1;LGI1;SMARCA2;CDKN1A;PPT1;RTN4
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.35126142354075046,-1.0869956624164807,0.3182640144665461,0.6214115882115968,1.0,9/34,17.55%,SMAD3;ENPP1;YAP1;RUNX1T1;RORA;TRIB2;ANKRD26;TRIO;WNT5A
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.4388301457263303,-1.0869478662250556,0.3479923518164436,0.6210477421799867,1.0,6/13,19.26%,SORBS1;IRS1;IGF2;PRKCZ;ECHDC3;PTPN11
prerank,sodium ion import across plasma membrane (GO:0098719),-0.40285913382157,-1.0869365806512437,0.3723608445297505,0.6205841183220715,1.0,5/17,12.95%,SLC9A1;SLC9A2;SLC12A2;SLC6A1;TRPM4
prerank,bicellular tight junction assembly (GO:0070830),0.33131296043697467,1.086901406204407,0.33805668016194335,0.751279236991184,1.0,9/46,12.08%,CLDN5;RAMP2;OCLN;CLDN14;ESAM;PECAM1;MICALL2;APC;MARVELD2
prerank,striated muscle cell differentiation (GO:0051146),-0.4164415886137203,-1.0857124031055885,0.34935304990757854,0.6231821944558203,1.0,4/16,12.53%,AKAP13;SKI;MEF2C;SIK1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4722838275697934,-1.0856391686583802,0.3651376146788991,0.6228817423074885,1.0,3/11,11.68%,EFNB2;DHX36;MEF2C
prerank,cardiac muscle contraction (GO:0060048),-0.34757591307432023,-1.0852318292843073,0.330078125,0.6234351790663025,1.0,3/34,1.44%,ATP1A2;GSN;TPM1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.42581925640786966,1.0851615632728224,0.35874439461883406,0.7554434224991015,1.0,4/13,18.22%,SYT1;SYT10;CACNA1I;SYT4
prerank,protein targeting to lysosome (GO:0006622),0.3796620621206616,1.085153260743587,0.3333333333333333,0.7542529669044655,1.0,10/20,20.67%,HSPA8;CLU;SCARB2;NCOA4;SORL1;M6PR;AP3M1;HGS;VPS4A;SNX16
prerank,muscle cell development (GO:0055001),0.3597648600025225,1.0846573687628858,0.3353658536585366,0.754497722639431,1.0,9/30,12.16%,SGCZ;RAMP2;BIN1;MYH6;SLC8A1;DYSF;NRAP;TCAP;MEGF10
prerank,arachidonic acid metabolic process (GO:0019369),-0.34768088232476124,-1.0842096093221059,0.34701492537313433,0.6254911965454052,1.0,10/35,15.83%,PTGDS;PTGIS;DAGLA;PTGS1;CYP1B1;PLA2G4A;PTGES;PNPLA8;EPHX1;EPHX2
prerank,actin filament polymerization (GO:0030041),-0.3593969857612762,-1.083989407203906,0.33874239350912777,0.6255808943350751,1.0,9/29,17.57%,ARHGAP6;GAS7;GSN;DIAPH1;CORO7;WASL;TTC17;WASF1;FAM107A
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.41410120477940565,-1.0836524100856693,0.3560606060606061,0.6259348952584934,1.0,8/16,32.69%,KAT2B;EP300;CREBBP;NAA15;NAA16;NAA80;NAA25;NAA40
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3427494059842929,-1.0833015778550528,0.3104125736738703,0.6262940345099658,1.0,10/36,16.04%,NCOR1;PRKN;DLG1;TAOK3;DACT1;PTPN22;FKTN;SH3RF2;DUSP1;DUSP10
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4149401570058189,1.0832050353730327,0.35517970401691334,0.7575386653282209,1.0,8/17,21.28%,NDUFA4;COX4I1;COX6A1;COX6B1;COX7C;COX10;COX8A;COX5B
prerank,T cell mediated immunity (GO:0002456),-0.4497094268405868,-1.0829632308717754,0.35940409683426444,0.626639305211081,1.0,3/13,5.14%,JAG1;CD55;CTSH
prerank,response to glucagon (GO:0033762),0.39866230403554237,1.0826711675342924,0.38114754098360654,0.7580087762441996,1.0,3/19,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,regulation of urine volume (GO:0035809),-0.47605895966184963,-1.0825211914481183,0.4003690036900369,0.6271852085262657,1.0,4/10,24.90%,NPR3;ADCY6;INPP5K;ADM
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3439281913917093,1.0821461068171918,0.35157894736842105,0.7583808879777427,1.0,7/33,10.31%,PTPRG;PTPRR;ADGRB1;ACVRL1;DNAJA4;DAB2IP;PTPRM
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.467572742364889,-1.0819074072022086,0.38113207547169814,0.6282858994021785,1.0,8/10,33.56%,ZEB2;GIPC1;APPL1;RAPGEF2;CTNS;OPN3;CDH3;ATP7A
prerank,negative regulation of catabolic process (GO:0009895),-0.32621802699035146,-1.0818378998781748,0.3013698630136986,0.6279608005952472,1.0,7/47,4.50%,EGFR;MDM4;HDAC4;NCOR1;NUPR1;FLNA;IRAK3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.447808262216359,1.081729096779827,0.3717391304347826,0.7584121056239367,1.0,2/13,3.17%,USP44;LCMT1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.32681975468543223,-1.0816391557205283,0.30078125,0.6279363260486441,1.0,17/46,21.48%,JAK1;RAP1B;ANXA2;PAK2;CDC42;PITPNA;CAPZA1;ARF1;RALA;HSPA9;TYK2;PDCD4;AIP;SOD2;CNN2;P4HB;MSN
prerank,regulation of translational initiation (GO:0006446),-0.3009244349526682,-1.081451717359303,0.29904761904761906,0.6279099984285101,1.0,20/63,19.58%,EIF4G3;YTHDF3;KHDRBS1;EIF4A2;EIF2AK3;LARP1;IMPACT;CSDE1;DNAJC3;ALKBH1;TPR;EIF2AK4;CDC123;NCK1;DDX3X;NCK2;PAIP1;MIF4GD;EIF4G1;RBM4
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.454366882145129,-1.081127082684439,0.368836291913215,0.6282277693114064,1.0,7/12,32.24%,DHX9;MAVS;MUL1;CGAS;IFIH1;CAV1;ZCCHC3
prerank,sensory perception of light stimulus (GO:0050953),-0.2883577182303501,-1.080927740098079,0.29750479846449135,0.6282380864899655,1.0,20/87,18.22%,EFEMP1;COL1A1;OPA1;EYA4;ZIC2;SLC4A10;MYO9A;EML2;ADGRV1;DHRS3;PITPNA;COL18A1;RPGR;RP2;ATF6;IMPG2;OAT;ATXN7;RABGGTB;POU6F2
prerank,autophagosome organization (GO:1905037),-0.32133661796113827,-1.080881037129514,0.3116370808678501,0.6278576897057426,1.0,21/50,26.45%,UBXN2B;UBQLN1;RB1CC1;WIPI1;ATP2A2;ULK2;BECN1;ATG2A;PIK3C3;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;WIPI2;ATG14;MAP1LC3A;RAB7A;IRGM;STX12;ATG3
prerank,negative regulation of cell cycle (GO:0045786),-0.29590733139981773,-1.0806282595176333,0.3235294117647059,0.6279908691141209,1.0,23/73,23.94%,NR2F2;SMAD3;FOXC1;BMP7;BMP4;NUPR1;GAS1;PTPN3;PTPRK;BTG3;RB1;CDK5RAP1;DUSP1;LATS1;PDCD4;NR4A1;BMP2;INHBA;CDKN1C;CDK6;SCRIB;ANGEL2;TFAP4
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4464484228672372,-1.080598065967913,0.3689839572192513,0.6275811180714549,1.0,7/13,31.94%,LRRK2;TXN;PARK7;HGF;MET;NFE2L2;PDE8A
prerank,cellular response to chemical stress (GO:0062197),-0.2813381766302516,-1.0800259702719348,0.29766536964980544,0.6285013809719805,1.0,39/96,30.10%,FOXO3;ABL1;LRRK2;PRKAA2;NOX4;LRRC8D;PPARGC1A;SELENOS;STX4;PARP1;SOD3;MGAT3;PKD2;ADNP2;TXNRD2;DDX3X;GPX8;CYBA;PRKD1;PRKAA1;SOD2;PARK7;NCF2;PRDX2;FANCC;ZFAND1;GPX7;NUDT2;CCS;GSR;SLC25A24;HTRA2;LONP1;BRF2;MT3;NFE2L2;TXNRD1;CYCS;SRXN1
prerank,positive regulation of immune effector process (GO:0002699),-0.3665362022233053,-1.079989868861256,0.33992094861660077,0.6280984589477241,1.0,4/27,10.34%,APPL2;ANKRD17;LBP;DDX60
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3732643109386289,1.0797405805716065,0.3404255319148936,0.7632192359419901,1.0,7/25,11.89%,AKAP6;SNCA;THY1;APLNR;CACNB2;F2R;TRPC1
prerank,positive regulation of ATPase activity (GO:0032781),0.3359693229030506,1.0794398229723603,0.3237113402061856,0.7628863111551986,1.0,11/41,17.70%,DNAJC9;RYR2;DNAL4;FGF10;DYNLL1;VMP1;ATP1B1;PFN1;DYNLL2;DNAJB2;AHSA1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.4530715201956255,-1.0794071975914568,0.3679060665362035,0.6290695019287736,1.0,2/12,7.55%,GMDS;GFPT1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.36633416973848426,1.0791992040754126,0.3709016393442623,0.7624308268455926,1.0,10/25,18.04%,CLU;KLF4;HSP90AB1;AKT1;KLF2;INSR;CD36;EDN1;HSP90AA1;DDAH1
prerank,response to lipid (GO:0033993),0.28218635635950867,1.0788814707674663,0.2865853658536585,0.7621644533559284,1.0,25/105,15.14%,TIRAP;S100A9;S100A8;ACER2;PPARG;SNCA;NOS3;IL12A;HNRNPA0;IFNAR1;TRIM6;SLPI;GGT7;F2R;SCD;GGT1;FOXO1;CD36;TAB2;PAQR8;RXRG;PELI1;HSD17B2;GCH1;MAPKAPK2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4183765706468053,-1.0786132953708256,0.37174721189591076,0.6305358788458761,1.0,7/15,28.33%,DAB2;SMAP1;WASL;BMP2K;DGKD;HIP1R;NEU3
prerank,cellular response to hexose stimulus (GO:0071331),0.3734971466356025,1.0786105451837427,0.34841628959276016,0.7617178563065474,1.0,5/23,3.78%,IGF1R;ADCY8;SLC2A5;PAX2;GAS6
prerank,regulation of apoptotic process (GO:0042981),-0.22693802190684872,-1.078540773791861,0.16265060240963855,0.6302102031763444,1.0,153/676,19.06%,AKAP13;FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;PAWR;ARHGAP10;SON;NFKB1;ANGPT1;SMAD6;OPA1;ZFAND6;STEAP3;ARAF;CFLAR;AXL;IL6ST;DAB2;IL31RA;FOXO3;STK3;BMP4;TIAM2;ERC1;PDPN;ABL1;TAX1BP1;PRKN;BIRC6;OSR1;PRKAA2;ARHGEF17;NUPR1;GSK3B;STK17B;NIBAN2;FLNA;RARG;IGFBP3;ANXA4;ANXA5;HMGB1;ITGB1;CTSH;SLK;DNM1L;THBS1;HOXA5;PAK2;CREBBP;SH3RF1;MAP4K4;TMBIM4;PHLDA1;SHC1;BCL2;IFIT2;GAS1;ANXA1;BRAF;REST;PLEKHG2;MAP3K5;FAM162A;VAV2;CALHM2;FBXO10;AIFM1;WRN;DDX42;VDAC1;ACTN2;XIAP;ADAMTSL4;MED1;UNC13B;HNRNPK;CYP1B1;MAP3K20;BAG3;NGF;NCSTN;PRMT2;ANKLE2;EGLN3;TRAF2;JUN;ARHGEF12;DNAJC3;ARHGEF18;USP47;BCLAF1;LGALS1;MEF2C;ERCC3;YME1L1;SOS2;HSPA9;RASSF2;CCAR1;CASP2;FGD1;CARD14;ATF6;SH3RF2;ING5;GLO1;STAT1;FGD4;PRKDC;NAA15;RBM5;VEGFA;HDAC1;DDX3X;LATS1;TOPORS;RASA1;ANP32B;ANP32E;TXNDC5;TGFB3;DAPK1;NGEF;PTPA;NOP53;MRE11;IAPP;ARHGEF11;TRIO;ARHGEF6;CITED2;BFAR;DAPK2;TMEM219;WNT5A;PHIP;ARHGEF1;PRKAA1;SFRP4;RABGGTB;AREL1;TRAF6;VCP;TMEM14A;BMP2;DCUN1D3;PARK7;CHM;APIP
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.4366683489600133,1.0784269548288576,0.3572984749455338,0.7610416774886368,1.0,2/12,3.31%,MIF;SIRT1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.47178162678407043,-1.0782624815487853,0.3882783882783883,0.6303989401808509,1.0,4/10,12.63%,LRP1;PTPN12;PTPN2;APOD
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.4581123039318208,-1.0782082453436745,0.38764044943820225,0.6300467101675631,1.0,2/11,7.02%,RC3H1;ANXA1
prerank,regulation of cell division (GO:0051302),-0.2967210363403453,-1.0781940041124134,0.3181818181818182,0.6295854863507461,1.0,15/72,16.05%,MLLT3;KIF13A;FGF1;BIRC6;KLHL13;UVRAG;CSPP1;FGFR2;TXNIP;SETD2;RAB11A;BECN1;PIK3C3;PIK3R4;PRDM15
prerank,steroid biosynthetic process (GO:0006694),-0.30458992178031336,-1.0778613246325504,0.3191489361702128,0.6299174108506143,1.0,15/56,23.09%,PRKAG2;CYP7B1;CYP27A1;INSIG2;OSBPL9;HMGCR;SQLE;CYP51A1;AMACR;DHRS11;SC5D;ACOT8;FDFT1;OSBPL3;LBR
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.3522487573681027,1.0774749335450975,0.3474576271186441,0.7627479501375656,1.0,10/29,17.73%,TERF1;HSP90AB1;PIF1;TERF2IP;DKC1;NHP2;TINF2;PTGES3;HSP90AA1;PPIA
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.4649398677350033,-1.0772705283472135,0.37407407407407406,0.6308461723682349,1.0,4/10,25.24%,VEGFA;CX3CR1;SMARCD3;KDM1A
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.4604415818513204,-1.0771706579845521,0.3706422018348624,0.6306123925568471,1.0,8/11,31.89%,WNT4;BMP5;BMP2;FGFR4;EGR1;NR1H4;ASAH1;STAR
prerank,amino acid transport (GO:0006865),0.3190306994378732,1.077054965331759,0.30833333333333335,0.7628369273335219,1.0,7/49,9.57%,SLC7A5;SLC6A6;SLC6A17;SLC7A1;SLC7A8;SLC43A2;SLC36A1
prerank,regulation of cell differentiation (GO:0045595),-0.26440871144152306,-1.0769642669666892,0.2980561555075594,0.6306272547590347,1.0,33/148,17.47%,PHLDB2;SMOC1;TGFBR1;DAG1;EPHA3;DDX5;NREP;NR1D2;ZFHX3;CCN2;ROCK1;FLOT2;DDX17;CREBBP;TRIP4;FGFR2;RUNX1;REST;ST7;AR;IGF2;NGF;ID2;SIK1;CDK5RAP1;TRPS1;EIF2AK2;TAF8;ANP32B;RUNX2;NSUN2;SIX1;PRKACA
prerank,positive regulation of MAPK cascade (GO:0043410),-0.2461331695249811,-1.0769622120824645,0.22745901639344263,0.6301384693909569,1.0,52/245,16.48%,ROCK2;NOTCH2;IGF1;ROR1;EGFR;LPAR1;IL34;PDGFRA;ANGPT1;NTRK3;PELI2;CCN2;KSR1;FGF1;PDGFRB;ROCK1;ROBO1;LRRK2;ADRA1B;GSDME;KIT;RYK;HMGB1;SLC30A10;GAREM1;TAOK3;NRP1;FGFR2;SHC1;BRAF;MID1;IGF2;MAP2K1;PTPN22;PDGFC;BMPER;WWC1;ROR2;TRIM5;FBXW7;EIF2AK2;EPHA8;APOE;TPD52L1;VEGFA;RAPGEF2;PRKCZ;GLIPR2;MAP2K7;ARRB1;IAPP;ADRA2A
prerank,acidic amino acid transport (GO:0015800),-0.4069893302196663,-1.076859308407536,0.3442622950819672,0.6298955402620001,1.0,6/17,11.00%,SLC6A13;SLC1A3;LRRC8D;GJA1;GIPC1;SLC6A1
prerank,peripheral nervous system development (GO:0007422),0.3792982264616682,1.0767619417709227,0.34949494949494947,0.762520789774771,1.0,3/23,6.54%,ASIC2;ADGRB1;NFASC
prerank,mitochondrion disassembly (GO:0061726),-0.3426806331549592,-1.076714525169176,0.3438077634011091,0.6297898742239104,1.0,15/34,23.01%,PRKN;RB1CC1;WIPI1;ULK2;BECN1;ATG2A;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;FIS1;WIPI2;BNIP3;MAP1LC3A
prerank,homologous chromosome segregation (GO:0045143),0.38739057325855775,1.0765244067022526,0.33402489626556015,0.7620334945228755,1.0,2/20,4.07%,MEI4;FMN2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.4034037939679422,-1.076512615325339,0.3745247148288973,0.6297913753070173,1.0,11/18,37.88%,RNFT1;TMEM259;ERN1;NCK1;USP13;PIK3R1;BAG6;BAK1;BCL2L11;FCGR2B;RNF185
prerank,plasma membrane repair (GO:0001778),0.4308313046113508,1.0764035592389996,0.3665254237288136,0.7612101941822585,1.0,4/13,10.84%,SYT7;SYT11;DYSF;SMPD1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4726381843797065,-1.076103068634741,0.3671875,0.6303070134490582,1.0,4/10,29.41%,ADGRV1;IFT88;PLS1;TSKU
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.405363878285933,-1.076082866438298,0.38122605363984674,0.6298510396374079,1.0,4/17,8.83%,FSTL1;SULF1;TWSG1;XIAP
prerank,regulation of phospholipase C activity (GO:1900274),-0.43029838874234716,-1.0760102058235894,0.3634651600753296,0.6295210937971144,1.0,7/15,10.56%,PDGFRA;NTRK3;PDGFRB;ABL1;KIT;PLCG1;ABL2
prerank,synaptic membrane adhesion (GO:0099560),0.4237562272340836,1.0758734915875339,0.3674321503131524,0.7616380432899073,1.0,5/14,8.89%,PTPRD;LRRC4C;LRFN5;LRRC4B;NTNG1
prerank,histone H2A monoubiquitination (GO:0035518),-0.40609050919299,-1.075832936260382,0.37777777777777777,0.6294485948073858,1.0,4/17,11.85%,BCOR;DDB2;PCGF2;PCGF6
prerank,histone mRNA metabolic process (GO:0008334),-0.36854711702493337,-1.075787394385699,0.3371868978805395,0.6290731332539939,1.0,8/27,18.75%,TENT2;CPSF3;TUT4;UPF1;SLBP;XRN1;EXOSC10;SNRPF
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.41726782410970104,-1.0756307428905951,0.3785310734463277,0.6289686809449444,1.0,5/15,17.09%,TNRC6B;TNRC6A;EIF4ENIF1;TNRC6C;CNOT1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3344787487847647,-1.075252612646619,0.343811394891945,0.6294603462644722,1.0,16/37,24.29%,FHIT;USP7;RPL11;GIPC1;OGT;TRIM39;PDCL3;CSNK2A1;NOP53;PARK7;PML;WAC;CCAR2;EIF3H;BAG5;BAG6
prerank,response to cAMP (GO:0051591),0.34363046104954004,1.0752465670951963,0.3469387755102041,0.7623538459883048,1.0,5/37,6.29%,HCN1;AQP9;AKAP6;PDE2A;HCN2
prerank,protein localization to cell junction (GO:1902414),-0.3812163956592305,-1.0749671612291851,0.336996336996337,0.6297385726150376,1.0,5/22,5.83%,CGNL1;JAK1;NLGN2;DLG4;PAK2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.44136810453001957,1.074782976500791,0.3788546255506608,0.7625628525048709,1.0,4/12,16.46%,SNAP25;STX3;SNAP29;STX1B
prerank,negative regulation of signaling (GO:0023057),0.3570842100278293,1.0737851629580821,0.34801762114537443,0.7643196096676339,1.0,7/25,20.00%,GLRA1;SRMS;OPRM1;UBASH3B;OPTN;BRAP;KIF26A
prerank,macromolecule catabolic process (GO:0009057),-0.3601829953213972,-1.0737245551544372,0.3422562141491396,0.6322680627951953,1.0,15/26,38.10%,UVRAG;MTOR;KIF16B;BECN1;SMURF1;PIK3R4;LRSAM1;CLN5;CLPX;CLN8;CLN6;SNX25;IDE;NEDD4;LGMN
prerank,ventricular septum morphogenesis (GO:0060412),-0.3726701514209664,-1.0734690828260776,0.3532608695652174,0.6323691897469459,1.0,6/27,3.24%,TGFBR3;TGFBR1;BMPR1A;BMP4;ROBO1;TGFBR2
prerank,cellular protein catabolic process (GO:0044257),-0.30045152540517667,-1.0726550898044913,0.3215613382899628,0.6338834786186843,1.0,21/59,27.56%,ADAMTS12;PRKN;CTSC;CTSH;AFG1L;RAB12;FAP;YME1L1;CLPP;TCIRG1;MYLIP;CTSF;BNIP3;CTSL;MAGEC2;SIAH2;AP2A1;CLPX;RAB7A;HTRA2;LONP1
prerank,morphogenesis of an epithelium (GO:0002009),-0.37364520549691205,-1.0724300555428317,0.373046875,0.6339666070666399,1.0,6/25,11.59%,DAG1;VCL;LRP6;FGFR2;LAMA3;TBX18
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.42329511068088965,1.0724250831470876,0.36129032258064514,0.7671534269802711,1.0,5/14,13.24%,ANK3;WNK2;GLRX;ACTN4;ATP1B1
prerank,dendrite morphogenesis (GO:0048813),0.33662643518710156,1.0724242708185276,0.34623217922606925,0.7659572174837411,1.0,10/35,12.47%,CTNNA2;EPHB1;CTNND2;MAPK8IP2;SHANK3;MAP2;TAOK2;CELSR2;DVL1;DOCK10
prerank,negative regulation of immune effector process (GO:0002698),-0.4379336927449927,-1.0719229965116583,0.37962962962962965,0.6347045132367418,1.0,5/13,12.97%,CD55;RC3H1;FER;ENPP3;APPL1
prerank,diacylglycerol metabolic process (GO:0046339),0.37145997512453577,1.0709603784423665,0.3595505617977528,0.7691800192000323,1.0,6/23,10.43%,DGKI;LIPE;DGAT2;DGKH;DGKB;GPAM
prerank,GPI anchor biosynthetic process (GO:0006506),-0.3555583203672509,-1.0706436246423656,0.37169811320754714,0.6374219687367827,1.0,14/30,32.32%,PIGN;PIGK;DPM1;PIGS;GPAA1;PIGH;MPPE1;PIGC;DPM3;PIGA;PIGZ;PIGP;PIGF;PIGO
prerank,protein localization to cell periphery (GO:1990778),0.2708482710654494,1.0702784392000604,0.3136842105263158,0.7700126870292113,1.0,19/133,7.35%,BSG;DPP10;EFR3B;MRAP2;KCNIP4;SPTBN4;RAMP2;ANK3;RAB3C;FGF13;LIN7A;TNIK;GAS6;MAP7;DPP6;ZDHHC22;P2RY1;EPB41L3;CACNB2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4085133165437902,1.0700126845095752,0.36400817995910023,0.7695962334661168,1.0,5/17,13.89%,PODXL;TGFB2;SKAP1;RET;CIB1
prerank,cell cycle checkpoint signaling (GO:0000075),0.4316810301879877,1.0698032356257658,0.3893617021276596,0.7690302502931723,1.0,5/12,16.28%,BUB1;WEE2;NABP1;CHFR;PLK2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.446449665263496,1.069485286163552,0.3827433628318584,0.7687978078692186,1.0,2/11,3.31%,MIF;SIRT1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3418156640036254,-1.0691461632257429,0.3539651837524178,0.6407054349074123,1.0,10/33,18.24%,TPM1;IGFBP5;IGFBP3;OGN;MEF2C;APOD;EFEMP2;TGFB3;PDCD4;SOD2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4193780584508555,1.0689518857753024,0.3674321503131524,0.7691516177959129,1.0,3/15,8.42%,TMSB4X;KDR;HSPB1
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.24252772229823621,-1.068508296175058,0.2897959183673469,0.641819651244745,1.0,71/291,20.08%,ROCK2;EGFR;PID1;NFKB1;EPHA3;PDGFRA;TPM1;IGFBP5;PTK7;VIM;AXL;PABPN1;WNT5B;WNT6;RPTOR;IRS1;LBP;HMGB1;LCOR;SBNO2;RAP1B;LYN;MTOR;WNT9A;ADCY6;RAPGEF3;DHX36;CTR9;PTPRK;IMPACT;CHMP5;SELENOS;UPF1;FER;NR1H3;RHOA;JUN;PRKCD;ADAM9;ABL2;SLC5A5;RORA;MEF2C;PDE3A;PKD2;FZD7;ADNP2;P2RY12;ERCC6L2;RAPGEF2;P2RX4;AKAP9;DAPK1;GNB1;TNIP2;CPEB1;PDCD4;SERPINE1;TLR4;WNT5A;PRKD1;CX3CR1;TRAF6;VCP;INPP5K;CDK2;IRAK1;SHPK;CDC73;CARD16;RAPGEF1
prerank,detection of mechanical stimulus (GO:0050982),-0.39301330273268736,-1.0683347901443485,0.37832699619771865,0.6417292206839131,1.0,4/19,12.34%,PIEZO2;PKD1;JUP;PKD2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.4012238574858858,-1.0679558432489042,0.37243947858473,0.6421500104589742,1.0,5/20,12.97%,ITGAV;GSK3B;BCL2;CASP2;APPL1
prerank,positive regulation of cellular process (GO:0048522),0.22941549688145088,1.067739809749158,0.21689059500959693,0.7715352745780737,1.0,92/565,14.28%,FLT1;CLDN5;IGF1R;LEF1;SLC6A6;CHEK1;GRIN1;KITLG;FRMD5;ERBB4;PROX1;CSF1R;RPS6;RPS19;S100A9;S100A8;IL7;NRG1;AQP11;CXCL12;CCND1;COPS9;RYR2;RPL23;AKAP6;ACER2;SIRT1;TRIM13;IL2RG;HMGA2;MFSD2A;GAS6;KDR;FGF10;NTRK2;FLT3;TENM4;IL12A;STX3;NOTCH1;TAL1;TGFB2;PAK1;SPAG5;ETS1;MLC1;RTKN2;FGF5;TLR2;PTPRJ;TIMP1;EPO;RPS6KA1;HSP90AB1;MVD;AKT1;ADRA1D;H3-3A;CNOT6L;THPO;NAMPT;SHANK2;TPPP;LIFR;PDGFB;AIF1;FAM98A;HMGN5;F2R;WDR77;CEP43;APC;RPS4X;P2RX7;TJP1;MAPK8;NOP2;DUSP26;EPHA1;ACTN4;AGPAT1;BMPR1B;HRAS;XBP1;DLL1;INSR;CD36;CIB1;ADGRG1;CCKBR;ATM;LGI1
prerank,positive regulation of cell death (GO:0010942),-0.30058854738715957,-1.0674784838703417,0.3359223300970874,0.6428232047116309,1.0,11/59,10.88%,SLC6A13;LRP1;EFNB2;CELF1;BMP4;LRRK2;GSK3B;RARG;MAP3K5;MARK4;PRODH
prerank,ventricular septum development (GO:0003281),-0.34206021303001,-1.067422160823448,0.3389830508474576,0.6424720247663429,1.0,13/37,16.75%,TGFBR3;TGFBR1;BMPR1A;MDM4;ROBO1;TGFBR2;SMAD4;HES1;ACVR1;SALL1;HECTD1;HEYL;CITED2
prerank,cobalamin metabolic process (GO:0009235),-0.39743562062579185,-1.0672507312221287,0.3686200378071834,0.6424124961397191,1.0,4/17,16.51%,TCN2;MMUT;ABCD4;CUBN
prerank,cellular response to glucagon stimulus (GO:0071377),0.41338569337489167,1.0667149699476532,0.4184549356223176,0.773405841433076,1.0,3/17,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,cGMP-mediated signaling (GO:0019934),0.43084291631151905,1.0666680984258674,0.3757828810020877,0.7723479960781131,1.0,3/13,3.45%,KCNC2;PDE2A;HTR2C
prerank,cellular response to organic cyclic compound (GO:0071407),-0.26342973005124937,-1.0665657604962213,0.29979879275653926,0.6436346146256562,1.0,29/141,12.34%,ATP1A2;ROCK2;EGFR;ADCY5;IGFBP5;DIAPH1;CTNNA1;LRRK2;SPIDR;NR3C1;LCOR;TFPI;RAP1B;CDH1;ADCY1;LARP1;ADCY6;RAPGEF3;AR;IMPACT;MED1;JUP;CYP1B1;SLC5A5;RORA;MEF2C;RIOK3;PDE3A;PKD2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.41908801613179136,-1.066256883459994,0.37153419593345655,0.6439408166176719,1.0,3/14,5.41%,SULF1;SULF2;THBS1
prerank,regulation of TOR signaling (GO:0032006),-0.2963018703675754,-1.0662063585471573,0.34205607476635513,0.6435807232617815,1.0,19/67,21.42%,ARAF;UBR2;PRKAA2;RPTOR;DEPTOR;TMEM127;TTI1;UBR1;FNIP1;TELO2;WDR59;RICTOR;TBCK;NPRL3;PRKAA1;TBC1D7;GPAT3;PIH1D1;LARS1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.41664675628437203,-1.0658241309350012,0.3815028901734104,0.6440078790311603,1.0,3/15,10.08%,ATP1A2;SLC9A1;SLC12A2
prerank,regulation of wound healing (GO:0061041),-0.3323942445541522,-1.0658188426480433,0.3300970873786408,0.6435315565496368,1.0,12/42,21.57%,MYLK;VTN;ITGB1;ARFGEF1;ANXA1;SRSF6;CD109;ADRA2A;SERPINE1;HBEGF;CLDN1;FGF2
prerank,cellular response to nutrient levels (GO:0031669),-0.30134251567744946,-1.0654849675688134,0.2972972972972973,0.6438195872446777,1.0,24/62,27.05%,LRRK2;TFEB;PRKAA2;RPTOR;ZFYVE1;MTOR;WRN;LAMP2;USP33;WIPI1;FNIP1;WDR45B;FAM107A;PRKAA1;EIF4G1;WIPI2;ATG14;KCNB1;MAP1LC3A;PPARA;LPL;RRAGA;GAS2L1;VPS41
prerank,mitotic metaphase plate congression (GO:0007080),-0.31567444847350123,-1.0654460556684366,0.34833659491193736,0.6434251753852149,1.0,11/51,14.26%,EML4;PIBF1;VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;RAB11A;CUL3;BECN1;NUDC
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.3561535215117281,-1.0650996922308738,0.3649906890130354,0.643758340327072,1.0,8/26,20.94%,NPR3;POR;HIF1A;APOE;PARK7;TERF2;TERT;S100A1
prerank,positive regulation of cell motility (GO:2000147),0.25374329556507724,1.0650418574994704,0.2908366533864542,0.7760290234673235,1.0,42/205,14.52%,SPOCK2;FLT1;IGF1R;LEF1;PTP4A1;SEMA3C;CSF1R;PODXL;SEMA6A;ITGA6;CXCL12;SEMA4A;SEMA4F;PPM1F;SEMA6D;KDR;SEMA4D;SEMA7A;FERMT3;HSPA5;NOTCH1;PAK1;PECAM1;GPNMB;NTN1;PDGFB;AIF1;F2R;CEP43;PIK3R3;APC;TJP1;RET;EPHA1;BCAR1;ACTN4;HRAS;XBP1;INSR;CIB1;ATM;PPP3CA
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.3301738333598627,1.065022432307556,0.33537832310838445,0.7748842742906026,1.0,8/39,13.15%,TEK;RAMP2;GAS6;KDR;NDNF;CCL2;SCG2;CD40
prerank,regulation of innate immune response (GO:0045088),-0.30839374454442625,-1.064795369475892,0.31746031746031744,0.6440282648570379,1.0,27/57,32.35%,APPL2;IRAK3;TRAFD1;PLSCR1;DHX9;XIAP;PTPN22;PARP9;RIOK3;APPL1;IRF1;PTPN1;IFI35;PTPN11;USP18;NLRC3;POLR3D;DHX58;CACTIN;ERAP1;MUL1;TNFAIP3;BIRC3;SAMHD1;TYRO3;PTPN6;TKFC
prerank,blood circulation (GO:0008015),-0.3178320476583545,-1.0644302505727312,0.3667953667953668,0.6444694784918652,1.0,12/49,15.56%,ROCK2;COL4A3;ROCK1;ELN;SERPING1;MEOX2;MYOF;ADCY6;GUCY1A1;AGTR1;STAT1;BDKRB2
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.39367573350251256,-1.0644155143553258,0.37547892720306514,0.6440104132991741,1.0,5/20,13.71%,ST3GAL4;B4GALT1;B3GALT1;ST3GAL3;ST6GALNAC5
prerank,cellular amino acid catabolic process (GO:0009063),-0.2815771390360849,-1.064380604801463,0.3136094674556213,0.6436055649038808,1.0,25/87,26.77%,DDO;ACADSB;ABAT;ASPA;IVD;HIBCH;GLUD1;MCCC2;GLUL;PRODH;ALDH6A1;DLST;SARDH;ALDH7A1;CARNMT1;NOS1;BCKDK;ALDH4A1;AMT;HIBADH;AUH;PIPOX;CBS;HNMT;PHYKPL
prerank,negative regulation of telomere maintenance (GO:0032205),-0.4159486609213695,-1.0640177112474822,0.37362637362637363,0.643971768932334,1.0,4/15,11.62%,SMG6;TNKS2;NBN;PARP1
prerank,response to exogenous dsRNA (GO:0043330),-0.39508719485228505,-1.063903008814011,0.3787575150300601,0.6437641036678814,1.0,10/18,32.24%,IRAK3;DHX9;MAVS;TICAM1;MUL1;CGAS;TLR3;IFIH1;CAV1;ZCCHC3
prerank,mesonephros development (GO:0001823),-0.45380095244599633,-1.0635484689882144,0.39285714285714285,0.6441296311991284,1.0,5/11,5.92%,FGF1;BMP7;BMP4;OSR1;ZBTB16
prerank,cholesterol efflux (GO:0033344),-0.3849171396747996,-1.063371205444351,0.36727272727272725,0.6440921758831045,1.0,5/20,19.21%,ABCA1;SOAT1;NPC2;APOE;ABCA7
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.38840027131111476,-1.062925434337383,0.3663551401869159,0.6447252837035398,1.0,4/20,10.08%,ATP1A2;SLC9A1;KCNJ2;SLC12A2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3808223508266372,-1.0629034071582661,0.3622641509433962,0.6442964510018648,1.0,4/21,8.85%,IGF1;ITGAV;CTSH;MAP2K1
prerank,negative regulation of histone methylation (GO:0031061),-0.46037334997256474,-1.0625774900687848,0.38420107719928187,0.6445603157290609,1.0,7/10,35.44%,BCOR;PHF1;JARID2;KDM1A;WDR5;BRCA1;AASS
prerank,regulation of blood coagulation (GO:0030193),-0.36439682006579144,-1.062532608429161,0.349146110056926,0.6441764348171454,1.0,7/27,17.01%,ST3GAL4;VTN;THBS1;TFPI;FAP;APOE;SERPINE1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.40814889394218024,1.0622808170420088,0.3554083885209713,0.782000707514198,1.0,5/15,12.04%,USP44;RPL23;RPL5;RPS7;SMAD7
prerank,regulation of cell adhesion (GO:0030155),-0.26632947905952553,-1.06153703965537,0.3070362473347548,0.6462039834236667,1.0,31/129,17.89%,PLXNA2;ROCK2;EPHA7;ANGPT1;TPM1;FBLN1;ZFHX3;ITGAV;PPP1R12A;ROCK1;ABL1;RIPOR2;LYN;EPHA4;RSU1;PLXNB2;ABL2;STX4;ARHGDIB;EPHA8;CD164;VEGFA;DUSP1;PPP1CB;PLXND1;RASA1;PLXNB1;GPR4;IL18;MIA3;MYADM
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.2818283513103023,-1.0614704799557415,0.322265625,0.6458797566828186,1.0,26/95,19.93%,NFKB1;VIM;AXL;PABPN1;LBP;HMGB1;SBNO2;CTR9;CHMP5;SELENOS;UPF1;NR1H3;RHOA;ADAM9;MEF2C;TNIP2;PDCD4;SERPINE1;TLR4;WNT5A;CX3CR1;TRAF6;IRAK1;SHPK;CDC73;CARD16
prerank,small GTPase mediated signal transduction (GO:0007264),-0.28043714074786397,-1.0613321926524746,0.322265625,0.6457242361958402,1.0,33/103,24.06%,PLD1;IGF1;PLCE1;KSR1;TIAM2;RREB1;SHOC2;ARL3;BCR;MRAS;SHC1;JUN;ARHGEF18;ARHGAP32;ARFIP2;RALA;SETDB1;RB1;USP50;RAPGEF2;GNB1;ARHGAP18;ADRA2A;PRKD1;RASSF1;PARK7;CDK2;FGF2;CRKL;RIT1;CHP1;SIAH2;USP28
prerank,peptidyl-tyrosine modification (GO:0018212),-0.30970637922166055,-1.0612136602120386,0.3292929292929293,0.6455267030618272,1.0,16/56,13.89%,EGFR;EFEMP1;EPHA3;PDGFRA;PDGFRB;ABL1;TPST1;KIT;FGFR2;LYN;EPHA4;FER;ABL2;ABI1;TEC;TTL
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.32558068807439833,-1.0606079602459846,0.3391472868217054,0.6465555100976125,1.0,27/42,37.37%,KLHL15;SPIDR;FUS;WDR48;PPP4C;PPP4R2;SETD2;SHLD2;PARP1;MMS19;HELB;SMCHD1;ARID2;KDM1A;UBQLN4;ACTR2;FANCB;TIMELESS;CGAS;MAD2L2;RPA2;RMI2;RAD51;PARPBP;ERCC6;MRNIP;SIRT6
prerank,lipid transport (GO:0006869),0.27545698214924447,1.0601913835747512,0.3514056224899598,0.7871350650961959,1.0,21/97,13.89%,SLCO1C1;PLTP;ATP8A1;MFSD2A;NCOA2;CERT1;CHKA;PITPNM1;SPNS2;PRELID3A;SLCO2B1;ABCC4;FABP5;PLEKHA3;PRELID2;CPTP;ABCG4;TTPA;SCARB1;SLC27A4;CD36
prerank,regulation of filopodium assembly (GO:0051489),-0.3268872041996142,-1.059936739878219,0.36363636363636365,0.647706625933202,1.0,12/38,13.57%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;BCAS3;NRP1;CDC42;WASL;PRKCD;RALA;CAPZB
prerank,positive regulation of chromatin organization (GO:1905269),0.4389415773938702,1.0598830101570627,0.3721881390593047,0.7868660636829561,1.0,6/12,14.35%,TAL1;TERF1;H3-3A;TERF2IP;SIN3A;TINF2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4770914820810819,-1.0598129207701799,0.39779005524861877,0.6475143249931413,1.0,4/10,14.78%,UPP2;NT5M;UPB1;DPYD
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3742852927113172,-1.0597544148152498,0.35700934579439253,0.647143974683555,1.0,3/23,5.68%,ERRFI1;CBLB;SNX6
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.36738658196521956,-1.059604621937996,0.36996336996337,0.6470544724605757,1.0,6/23,18.70%,INPP5B;SYNJ2;MTMR12;MTMR3;SACM1L;INPP5K
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.4345311747667464,-1.0591558845977629,0.4192377495462795,0.6477266032374113,1.0,7/13,22.57%,MDFIC;SP100;TPR;SUFU;APOD;PARK7;CHP1
prerank,establishment of protein localization to membrane (GO:0090150),-0.293836013565544,-1.0588733390456722,0.3403846153846154,0.6479291874590999,1.0,16/66,18.95%,EGFR;AFDN;SYNE3;NACA;RAB10;RAB3GAP1;BRAF;RAB3IP;VPS37C;RAB11A;PARD3;SEC63;COX18;NECTIN3;ZDHHC1;CHM
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.40150929547133113,-1.0586833448670405,0.37218045112781956,0.6478982680032765,1.0,5/17,17.43%,JAG1;CD55;STAT3;IL18;TLR4
prerank,negative regulation of interleukin-8 production (GO:0032717),0.39748883259084794,1.0584997382613557,0.36024844720496896,0.7898783486681348,1.0,3/17,6.76%,CD33;TMSB4X;KLF4
prerank,regulation of interferon-gamma production (GO:0032649),0.29417245909409334,1.0584418552174917,0.334020618556701,0.7888391826187587,1.0,8/71,12.68%,SLC7A5;PDE4B;GAS6;ISG15;IL12A;CYRIB;PDE4D;HSPD1
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.31972894487821324,-1.0576993005328754,0.3699186991869919,0.6498396279131278,1.0,10/45,11.06%,FOXO3;PUM2;ZC3H7A;RC3H1;LARP1;PUM1;GEMIN5;EIF4E;PARP9;YTHDC1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.4591353622781166,-1.0576863298532135,0.40476190476190477,0.6493799854716755,1.0,7/10,46.26%,FBXW7;ADRA2A;HBEGF;EGF;ADAM17;BTC;NCF1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.23529609981818564,-1.0570598379022078,0.2625,0.6504213941004907,1.0,78/348,19.37%,BMP6;PRKAG2;ROCK2;IGF1;EGFR;TGFBR1;BMPR1A;LEPR;IL34;ANGPT1;SLCO3A1;NTRK3;PELI2;RBPMS;CEMIP;ARAF;BMP5;FGF1;BMP7;DAB2;FAM20A;BMP4;GHR;ABL1;LRRK2;VTN;RPTOR;TBK1;DOCK7;CREBL2;SNX9;AXIN1;PAK2;NBN;TWSG1;NRP1;LYN;BRAF;RAPGEF3;UBE2K;IGF2;NGF;RB1CC1;PDGFC;SMAD4;MAVS;FNIP1;TEC;IL6R;RASSF2;CARD14;CCN1;WDFY2;TXN;VEGFA;ACVR1;CCND3;DDX3X;LATS1;RAPGEF2;VEGFD;ITGA5;AKAP9;TGFB3;ARRB1;MRE11;CACUL1;PRKD1;CX3CR1;CSNK1D;BMP2;PARK7;MUSK;MTCP1;PTPN11;EIF4G1;INHBA;ITGB3
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.387168983811464,-1.0563794316162174,0.373134328358209,0.651642972385843,1.0,3/19,5.41%,IL34;CAMK1D;THBS1
prerank,nucleic acid-templated transcription (GO:0097659),0.32095725963184346,1.0562878183693618,0.3653061224489796,0.7941458174815298,1.0,11/42,14.46%,PAX8;PTMA;HOXD3;XAB2;POLR2J;POLR2B;THAP1;POLR2I;BCL3;MED20;POLR3A
prerank,metanephric mesenchyme development (GO:0072075),-0.4557927213306596,-1.0560842881643813,0.41847826086956524,0.6519129359915568,1.0,5/10,17.02%,WNT4;OSR1;PKD2;STAT1;SIX1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4499866728650056,1.0559883528086558,0.3885480572597137,0.7938437944288619,1.0,3/10,23.10%,IL12A;NCKAP1L;DDIT3
prerank,positive regulation of calcium ion import (GO:0090280),0.43899580253913545,1.0559631753478078,0.38074398249452956,0.7927086765721153,1.0,3/12,10.22%,CXCL12;CCL2;PDGFB
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.389675298641128,1.055789569657968,0.37398373983739835,0.7920101230200928,1.0,6/17,10.22%,PROX1;CCND1;MAPRE3;AKT1;CCNY;PDGFB
prerank,SNARE complex assembly (GO:0035493),-0.46996111700436105,-1.0551456839209379,0.4060721062618596,0.6536714957696682,1.0,4/10,17.94%,UVRAG;STXBP1;VAMP2;VAMP4
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.38601021701153343,1.0546270140286127,0.37130801687763715,0.794315880176579,1.0,5/19,11.00%,DLG2;LRRC7;MTCL1;FOXJ1;CRB1
prerank,apoptotic mitochondrial changes (GO:0008637),0.3419706202363535,1.0544066909380316,0.3684210526315789,0.7937852027909904,1.0,3/32,6.46%,CAMK2A;ERBB4;CLU
prerank,long-term memory (GO:0007616),0.3869709381811077,1.0540857350238284,0.38284518828451886,0.7935264974854916,1.0,4/19,12.90%,LRRN4;CAMK4;RASGRF1;PJA2
prerank,proteasome assembly (GO:0043248),-0.44529781193947504,-1.0537665276420398,0.39264990328820115,0.6566726730055403,1.0,5/11,34.30%,PSMG1;PSMD13;ADRM1;PSMD10;OTUD6B
prerank,mucosal immune response (GO:0002385),0.41539524078608636,1.053317220419494,0.40497737556561086,0.794663583922574,1.0,15/15,58.50%,DEFA6;RNASE3;OTUD7B;PLA2G1B;RPL39;PIGR;LTF;FFAR2;DEFB1;BPIFB1;CAMP;IL4;RAB17;NOS2;IFNLR1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3747002945166892,-1.0532069382547202,0.38846153846153847,0.6575990763256079,1.0,7/22,11.96%,UGGT2;MAN1C1;OS9;EDEM3;EDEM1;MAN1B1;MAN1A2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3767100874365249,1.0526258619885975,0.37861915367483295,0.7943426920101704,1.0,6/22,19.52%,ZDHHC22;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;ZDHHC24
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3767100874365249,1.0526258619885975,0.37861915367483295,0.7943426920101704,1.0,6/22,19.52%,ZDHHC22;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;ZDHHC24
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.36493691424746566,1.0524657110285212,0.36041666666666666,0.7936371806072042,1.0,4/25,3.87%,DSCAM;MIF;ITGA6;SNCA
prerank,receptor-mediated endocytosis (GO:0006898),0.26338097576116526,1.051939047139963,0.3168724279835391,0.794037907377492,1.0,31/132,17.14%,TFRC;DNM3;LRP1B;TMEM108;RAMP2;AP2M1;CAV2;SNCA;GRK2;SNAP91;SCARF1;FNBP1L;FCHO1;SCARB2;AP2B1;CD163;ITGAM;SGIP1;SORL1;SCARB1;DLL1;INSR;CD36;CLTB;STAB2;PPT1;NLGN3;M6PR;CALCRL;HSP90AA1;RAB31
prerank,acylglycerol homeostasis (GO:0055090),-0.3865872006567185,-1.0516855918658465,0.38632162661737524,0.6609132467777424,1.0,8/20,30.79%,NR1H3;RORA;PNPLA8;APOE;IL18;LPL;MLXIPL;ANGPTL3
prerank,negative regulation of macrophage activation (GO:0043031),0.400976662083363,1.0516304148989069,0.4168618266978923,0.7937740622807273,1.0,2/16,2.79%,LRFN5;SYT11
prerank,organic cation transport (GO:0015695),-0.3848606022422382,-1.0515990289084343,0.38740458015267176,0.6606423186230747,1.0,8/20,28.93%,SLC47A1;SLC22A5;SLC22A4;SEC14L1;SLC5A7;SLC22A2;SLC44A2;SLC25A29
prerank,activation of protein kinase A activity (GO:0034199),0.4036439430934012,1.0512155160113021,0.40606060606060607,0.793829231859106,1.0,3/16,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.44742557101388136,1.051168288029536,0.3991228070175439,0.7927968162361749,1.0,2/10,4.32%,CHEK1;SMARCB1
prerank,mitotic nuclear division (GO:0140014),-0.2880806868636773,-1.0506579814302925,0.36220472440944884,0.6625331841270884,1.0,19/71,17.46%,INO80;FLNA;PIBF1;SPICE1;KLHDC8B;SMC4;CHMP4B;NDEL1;STAG1;RHOA;LSM14A;RAB11A;KLHL22;ABRAXAS2;TOGARAM1;MAP9;ZWINT;STAG2;UBE2S
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.37245883294713966,1.0499033199833223,0.3983903420523139,0.7954914000781792,1.0,6/21,9.89%,SPRY3;RASAL3;TGFB2;SPRY4;CYRIB;DAB2IP
prerank,positive regulation of cholesterol transport (GO:0032376),0.35377430412709254,1.0498369679671544,0.39323467230443976,0.7945323313917442,1.0,7/27,14.95%,PLTP;SIRT1;PPARG;GPS2;ABCB4;NFKBIA;SCP2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3800411278754552,-1.0497363982843402,0.3747534516765286,0.6643565970125296,1.0,6/22,17.35%,ROCK2;LYN;EPHA4;RANBP9;IFNGR1;PICALM
prerank,microglial cell activation (GO:0001774),0.37574604370197917,1.0496999181892819,0.38155136268343814,0.7937541954599957,1.0,4/21,12.48%,SNCA;CLU;AIF1;ITGAM
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3701243415818962,-1.0495975903130121,0.3822463768115942,0.6642129059932814,1.0,6/22,12.77%,BMP7;GSK3B;REST;MED1;HES1;EIF2AK4
prerank,regulation of hippo signaling (GO:0035330),-0.39909019550596736,-1.0492042809070556,0.4032846715328467,0.664658309945986,1.0,12/17,27.41%,WWC2;VGLL4;WTIP;MARK3;LIMD1;WWC1;AJUBA;NF2;DLG5;SOX11;MAPK14;NEK8
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.26899613311930004,-1.0489193738589873,0.3397312859884837,0.6649413636412279,1.0,22/109,15.52%,PTPN13;PLEKHA2;PI4KA;PDGFRB;INPP5B;SYNJ2;MTMR12;INPPL1;PIP4K2C;PLA2G4A;PLCG1;PLCB3;PLCD1;PITPNM2;ARF1;MBOAT7;MTMR3;PIK3C3;SLC27A1;PLEKHA8;SACM1L;PIK3R4
prerank,cellular calcium ion homeostasis (GO:0006874),0.2620057943046354,1.0488524889352127,0.32796780684104626,0.7951531874605642,1.0,23/133,14.16%,SLC24A4;SLC24A2;TRPC5;ADCY8;CXCL12;RYR2;CAV2;HTR2C;HCRTR1;SLC8A1;ATP2B3;TMEM178A;SLC30A1;NPTN;TPT1;HCRTR2;TRPC1;TMCO1;CD40;ATP1B1;PSEN1;ATP2B4;ATP2B2
prerank,positive regulation of neuron differentiation (GO:0045666),0.3234754936352676,1.048372347728285,0.36231884057971014,0.7954231045730479,1.0,10/40,13.53%,PROX1;MMD2;BRINP1;HOXD3;NRCAM;CPNE1;BRINP3;ARHGEF2;SIN3A;BEND6
prerank,renal filtration (GO:0097205),-0.45200393694674995,-1.0482043130637129,0.4155339805825243,0.666286123018355,1.0,3/10,9.98%,SULF1;SULF2;TBC1D8B
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3661633098287412,-1.0474851225455728,0.3807763401109057,0.6676218336865826,1.0,4/23,6.93%,IL34;BMP5;THBS1;LYN
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.41538245839100846,-1.0472889637875096,0.39436619718309857,0.6675935105403216,1.0,8/15,37.64%,IQGAP2;ARPC2;WHAMM;ACTR2;ARPC5;JMY;ARPC3;ARPC4
prerank,protein K48-linked deubiquitination (GO:0071108),0.36410784657489176,1.0471493212053886,0.4105263157894737,0.7979119447736417,1.0,9/23,18.81%,OTUD7A;YOD1;OTUB2;MINDY1;MINDY2;OTUB1;USP8;ATXN3;OTUD7B
prerank,kinetochore organization (GO:0051383),-0.43139369209703976,-1.0471406860293324,0.4056603773584906,0.6674815400278654,1.0,12/13,53.48%,CENPT;POGZ;CENPE;CENPH;NDC80;CENPF;CENPA;DLGAP5;NUF2;CENPW;CENPC;CDT1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2751706880715606,-1.0465407727095108,0.34393638170974156,0.6685167510560817,1.0,37/91,25.62%,PLD1;ITGAV;STXBP5;ABL1;LRRK2;PACSIN2;STON2;USP7;RAB10;NRP1;GAS1;RAB12;VAMP2;MAP2K1;ARFGAP1;CHMP3;ABL2;STX4;RAB11A;RALA;RINT1;RAB21;MBTPS1;ZFYVE16;PICALM;PTPN1;STON1;SPHK1;BET1L;NSF;RAB3D;HIP1R;RAB8A;SYK;SNX12;ATP9A;RAB5A
prerank,anion transmembrane transport (GO:0098656),0.29134360046845054,1.0463945965415855,0.3722334004024145,0.799054024692449,1.0,12/67,7.95%,SLC7A5;SLC7A1;LRRC8B;SLC35A1;SLC1A1;SLC25A42;MFSD12;SLC1A2;SLC6A5;SLC6A8;SLC7A8;SLC25A14
prerank,signal transduction by p53 class mediator (GO:0072331),-0.3426851531941977,-1.0462959371642935,0.40636704119850187,0.6686347298784873,1.0,4/30,5.93%,FHIT;DDX5;MDM4;NBN
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.36583639790706013,1.0460913305478432,0.3945720250521921,0.7987529509804212,1.0,8/22,14.31%,RYR2;AKAP6;VMP1;HAP1;CALM1;ATP1B1;CALM2;CALM3
prerank,positive regulation of cellular protein localization (GO:1903829),0.292236533755867,1.0460601598029484,0.36043956043956044,0.7976630881787459,1.0,12/69,11.40%,TFRC;BICD1;NECAB2;SYT11;TMEM35A;MEAK7;STX3;HSP90AB1;AKT1;NUP62;APC;CCDC88A
prerank,axon extension (GO:0048675),-0.36997842239721845,-1.045787671511606,0.3883677298311445,0.6694935235288384,1.0,5/23,11.05%,ALCAM;AUTS2;NRP1;SPG11;ULK2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.41531082044881473,-1.0455350392309934,0.4171656686626746,0.6696510124249014,1.0,3/15,6.09%,PIEZO2;KIT;ADGRV1
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.37347214889794483,-1.0452043443392232,0.4140625,0.6699636215318575,1.0,9/22,23.33%,MDFIC;LRRK2;SP100;SUFU;APOD;INPP5K;PARK7;CHP1;LMAN1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3577267060321568,1.0452008560184851,0.3724279835390947,0.7990927167263064,1.0,4/26,4.98%,GRIN1;MBP;GRIN2B;PSENEN
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.36375369871124696,-1.0448229680555599,0.3881453154875717,0.6704520576195919,1.0,4/24,8.41%,PID1;LEPR;GFPT1;PPARGC1A
prerank,DNA modification (GO:0006304),0.36379862232783344,1.0447604272834954,0.4074074074074074,0.7992537471493623,1.0,6/22,16.96%,EXOSC5;TERF1;UNG;TERF2IP;TINF2;EXOSC4
prerank,protein O-linked mannosylation (GO:0035269),-0.39643131773831,-1.0445697593395364,0.4174573055028463,0.6706198875748796,1.0,11/18,23.79%,TMTC1;LARGE1;TMTC4;CRPPA;POMT2;FKTN;DPM1;TMTC3;POMT1;FKRP;DPM3
prerank,regulation of response to biotic stimulus (GO:0002831),-0.34708579064422435,-1.0444955556345286,0.382,0.6703084295754256,1.0,8/28,13.02%,FOXP1;APPL2;CD55;XIAP;PTPN22;TRIM5;APPL1;IRF1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.25835253498572386,-1.044256725056385,0.3383742911153119,0.67038510625431,1.0,48/148,24.24%,PRKAG2;MDM4;EP300;PRKAA2;BRD7;RBBP8;MAPKAP1;TAF3;USP7;NBN;MTOR;PDPK1;WRN;TAF4;TBP;CHD4;HIPK1;CHD3;RPL11;PRKAB2;EHMT1;RICTOR;ING5;USP2;HDAC1;CSNK2A1;TAF13;PRMT5;NOP53;MRE11;TTC5;PRKAA1;PPP2R5C;KMT5A;CDK2;MAP2K6;PML;TAF12;PRKAG3;CDK5RAP3;PRKAB1;TAF9B;TAF2;ATR;HDAC2;NUAK1;BOP1;MBD3
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.36023796778856976,-1.0439508998232747,0.4018348623853211,0.6707161429553025,1.0,9/24,25.37%,PPM1D;DNMT3A;MPHOSPH8;PHF1;JARID2;EPC1;EZH2;PPHLN1;CREBZF
prerank,import into nucleus (GO:0051170),0.2855847676492865,1.0438596677659069,0.37328094302554027,0.8007739800166619,1.0,11/73,10.97%,IPO5;IPO4;MMP12;GEMIN8;HTATIP2;NXT1;AKT1;NUP62;FAM53B;SNRPD2;SNRPD1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.356542361790372,-1.0437245813664608,0.391304347826087,0.6707819222755426,1.0,10/25,25.26%,IGF1;NIBAN2;NSD1;RB1;TRAF6;PARK7;H1-0;TWIST1;SOX11;ZBTB7A
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.44072625728610476,-1.0437095162091188,0.40225563909774437,0.6703280543232948,1.0,5/12,18.03%,JAG1;REST;HES1;NELFB;HNRNPU
prerank,muscle tissue development (GO:0060537),-0.42641617930052234,-1.043466568671286,0.4097087378640777,0.6704350315505141,1.0,4/13,15.46%,BMP4;SMO;CSRP2;PTCH1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.3455665425494143,-1.043461191888074,0.3776908023483366,0.6699559238766104,1.0,9/28,21.31%,PRKN;NUPR1;CTSC;AXIN1;FBXW7;SMURF1;ATP5IF1;TMTC3;CDK5RAP3
prerank,macrophage activation involved in immune response (GO:0002281),-0.42893958567298707,-1.0434036512160605,0.4098671726755218,0.669598624555361,1.0,6/13,28.01%,LBP;SBNO2;CX3CR1;IFI35;SYK;GRN
prerank,regulation of stem cell differentiation (GO:2000736),-0.2756079136888333,-1.0431954197736881,0.356,0.6696136119693951,1.0,30/89,29.12%,PTN;BMPR1A;PDGFRA;ABL1;JAG1;YAP1;RUNX1;HOXB4;PSMF1;HES1;TCF3;NELFB;EIF2AK2;PSMB2;PRKDC;NSUN2;HNRNPU;PSMC1;KMT2A;PSMB6;PSMA3;NUDT21;PSMA4;LDB1;PSME1;PSMD13;ZFP36L2;PSMB10;PSMA5;PSMB9
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.291400622613244,-1.042445506618918,0.3836978131212724,0.6710127601287538,1.0,17/68,17.56%,PCCA;AOX1;ENPP1;HLCS;TCN2;MMUT;MCCC2;MTHFR;MTHFD2L;PANK2;SLC5A6;TPK1;ABCD4;RFK;PDXK;CUBN;ALDH1L1
prerank,regulation of interleukin-8 production (GO:0032677),0.2883298596475321,1.0424146049565624,0.3639921722113503,0.8038160101883657,1.0,10/69,12.26%,CD33;TIRAP;IL17F;TMSB4X;KLF4;TLR2;NOD1;F2R;BCL10;BCL3
prerank,glycerophospholipid catabolic process (GO:0046475),0.3507697612746213,1.0415597142291795,0.4,0.8052813374153804,1.0,2/27,4.79%,GPCPD1;ENPP2
prerank,protein transport (GO:0015031),-0.23525910151751975,-1.0415403807578625,0.3165322580645161,0.6727819590222575,1.0,110/332,27.96%,WLS;LRP1;TLK1;ABCA1;KIF13A;STEAP3;TANGO6;ATP6V1B2;TBC1D16;SGSM2;ATP6V0D1;SNX9;SNX6;SEC23IP;RAB10;STX16;RAB22A;STXBP1;VAMP5;VPS26C;ATP6V0A4;RAB12;RAMP1;SIL1;AP3B1;SLC10A7;LAMP2;VAMP2;COPZ2;USP6NL;SEC31A;TXNIP;SLU7;ARCN1;ARFGAP3;TBC1D2B;HERC2;TBC1D8B;CHMP3;GGA3;RPGR;COG7;RCN3;STX4;ARFIP2;SCAMP2;ARF1;MON1A;STX5;COPB2;TBCK;RAB21;CTTN;GRTP1;APOE;TBC1D22B;CTSA;DNAJC27;FAM91A1;TBC1D9;COPG2;SNX8;TCIRG1;TOM1;TMED3;MIA3;WDR11;VAMP4;NAPA;COPG1;TBC1D17;TMED5;TMED4;LRSAM1;RABGAP1;STX17;TBC1D10A;RAB24;GGA2;STX8;IFT27;ARRDC4;RABL3;VPS26B;ATP6V1G2;ARL5A;NSF;RAB3D;USO1;AP2A1;PREB;RAB8A;KIF3A;SAR1B;TVP23B;RAB7A;STX12;ARRDC2;RAB5A;STX1A;VPS45;TBC1D10B;AFM;STX7;TMED2;SEL1L;TBC1D9B;ARL4C;RIC1;RUFY1
prerank,glycerol metabolic process (GO:0006071),0.44917390864301443,1.041169997482774,0.3925619834710744,0.8052919698156226,1.0,2/10,3.39%,COQ2;PGP
prerank,regulation of protein ubiquitination (GO:0031396),-0.2684889566972559,-1.0404351883296992,0.3570057581573896,0.6750967536605703,1.0,36/108,24.61%,NXN;SASH1;TGFBR1;ANGPT1;HDAC8;UBE2N;PRKN;LRRK2;HUWE1;AXIN1;UBQLN1;UFL1;U2AF2;XIAP;SPOPL;CUL3;FBXW7;OGT;USP4;SH3RF2;FANCI;ARRB1;SPRTN;DERL1;FAM107A;TRAF6;PARK7;TBC1D7;CDK5RAP3;SPHK1;SENP2;WFS1;CHP1;BAG5;PAXIP1;GNL3L
prerank,telomere maintenance via telomerase (GO:0007004),0.34347264504249553,1.0403793241074835,0.3855932203389831,0.8064842095296645,1.0,9/28,17.04%,TERF1;HSP90AB1;PIF1;TERF2IP;DKC1;NHP2;TINF2;PTGES3;HSP90AA1
prerank,regulation of synapse organization (GO:0050807),-0.35434981064828397,-1.0402995718475048,0.3715953307392996,0.6749366758740447,1.0,10/26,19.56%,PDLIM5;ABL1;SETD5;ABHD17B;EPHA4;GRIPAP1;MEF2C;WNT5A;SLITRK4;MDGA1
prerank,positive regulation of T cell activation (GO:0050870),0.29510219383381714,1.040291154051575,0.36105476673427994,0.805592053124153,1.0,10/62,13.68%,TFRC;SLC7A1;IL7;THY1;PRKCQ;CCL2;CYRIB;AIF1;HSPD1;XBP1
prerank,negative regulation of cell death (GO:0060548),-0.27785143549459146,-1.0400353756596459,0.37057728119180633,0.6751246886369258,1.0,31/88,22.46%,KANK2;CCN2;BMP7;BMP4;PRKN;LRRK2;GSK3B;INPP5A;VPS4B;SRSF6;CHMP4B;CHMP4A;PPARGC1A;IMPACT;TRAF2;CCN3;ADNP2;BECN1;CCN5;CCN1;NCK1;CCN4;PRKD1;ATG5;PARK7;EIF4G1;SPEF1;BNIP3;FGF2;WNT16;WFS1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.34738230120508834,1.0400028772528724,0.4036885245901639,0.8053064900819348,1.0,10/26,18.04%,CLU;KLF4;HSP90AB1;AKT1;KLF2;INSR;CD36;EDN1;HSP90AA1;DDAH1
prerank,regulation of postsynapse organization (GO:0099175),0.3432916410866815,1.0397623178455802,0.37280701754385964,0.8048100304092524,1.0,7/28,11.12%,IL1RAPL1;SHANK3;KIF1A;HOMER1;ZDHHC15;CDKL5;PPFIA2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.25651757968610306,1.0394691795343045,0.3576923076923077,0.8044772852266215,1.0,19/151,8.50%,ALAS2;SGMS1;GSTA4;PCSK1;ACER2;FA2H;DEGS2;MFSD2A;LPCAT2;CERT1;PCYT1B;CHKA;CSNK2B;SPNS2;ELOVL7;SGPP2;ELOVL4;GSTM5;SLC44A5
prerank,microtubule nucleation (GO:0007020),-0.38338059804760016,-1.0393729118285793,0.39314516129032256,0.6763318367880905,1.0,8/19,19.56%,TUBGCP6;TUBGCP2;NDEL1;RANBP9;AKAP9;CCDC57;CSNK1D;TUBGCP4
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2709580478633216,1.0392721285016873,0.375,0.8039252601197946,1.0,24/101,14.31%,FLT1;PROX1;CSF1R;TENM1;CCND1;SIRT1;HMGA2;SNCA;FLT3;CD24;DIRAS1;MAPRE3;PIK3R5;AKT1;CCNY;DAB2IP;PDGFB;CALM1;CD40;HRAS;CALM2;CIB1;ATP2B4;CALM3
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.2768311288671209,1.0391710553512485,0.36983471074380164,0.8030580467175225,1.0,18/90,13.89%,IGF1R;GATM;OMA1;KSR2;UCP2;ADRB1;HADH;EPAS1;ADCYAP1;ADIPOR2;APC;SCD;FABP5;PER2;LCN2;ESRRG;EBF2;CD36
prerank,nucleocytoplasmic transport (GO:0006913),0.32178726367919586,1.0381089898423592,0.3821782178217822,0.8051108046447223,1.0,9/40,13.65%,GEMIN8;HTATIP2;NXT1;RBM15B;SNRPD2;SNRPD1;NUP205;ANP32A;DDX20
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3272957061848453,1.0377788185180035,0.38381742738589214,0.8049113435774304,1.0,7/36,11.61%,CAMK2A;LEF1;PLCB1;FZD6;GNG2;CALM1;FZD4
prerank,regulation of intracellular protein transport (GO:0033157),-0.340816521334884,-1.0377028349977395,0.4123314065510597,0.6801064219649714,1.0,11/32,19.45%,PCM1;BMP4;PTPN14;BCAS3;PCNT;NDEL1;VAMP2;TPR;ICE1;PTPN1;IFI27
prerank,anion transport (GO:0006820),0.3253412532447866,1.0376588634920765,0.3630831643002028,0.8041236034935313,1.0,6/33,10.27%,SLC4A1;ABCG2;LRRC8B;SLC17A6;SLCO2B1;VDAC2
prerank,response to prostaglandin E (GO:0034695),-0.45944214262520955,-1.0376547579739464,0.42124542124542125,0.6797215812589393,1.0,3/10,16.03%,TGFBR3;ADCY6;GNB1
prerank,negative regulation of angiogenesis (GO:0016525),-0.2796534038993049,-1.0375834309772736,0.38095238095238093,0.6794090905410883,1.0,16/84,10.08%,ROCK2;SULF1;DCN;COL4A3;FOXC1;ROCK1;SPARC;NIBAN2;HSPG2;THBS2;THBS1;HOXA5;ATF2;ADAMTS9;SEMA3E;SLC12A2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.33758380848355707,1.037130849981002,0.4024640657084189,0.8045877810058891,1.0,7/31,11.45%,DLG2;LRRC7;LIN7A;WDR1;MTCL1;CRB1;ANK1
prerank,oxoacid metabolic process (GO:0043436),-0.3503603798939109,-1.0368748693299479,0.40733590733590735,0.6806943346102075,1.0,7/27,18.99%,DDO;ENPP1;TPST1;SULT1A1;PPA1;ABHD14B;THAP4
prerank,autophagosome maturation (GO:0097352),-0.33594731439038705,-1.0365717139132848,0.3956692913385827,0.6809775473192728,1.0,13/32,23.01%,UVRAG;UBQLN1;VTI1B;VAMP7;LIX1L;LAMP2;CHMP3;ATP2A2;VCP;WIPI2;STX17;ATG14;MAP1LC3A
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.35838303528674553,-1.036246327245311,0.3966165413533835,0.6813449315272158,1.0,10/26,19.31%,EGFR;ANKRD17;UBE2E2;RPTOR;ANXA1;CCND3;DDX3X;ADAMTS1;CDK10;EIF4G1
prerank,axonal transport (GO:0098930),0.3242456121044807,1.0362438746245553,0.3917525773195876,0.8060801469587764,1.0,7/36,12.45%,SYBU;TMEM108;KIF1A;DST;AP3B2;HAP1;DCTN1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4210606225783377,-1.0360817324000144,0.4200743494423792,0.6812374345864454,1.0,4/13,11.49%,BMP4;NFIB;REST;NFATC4
prerank,positive regulation of vasculature development (GO:1904018),0.2745993227323385,1.0358883491361304,0.38065843621399176,0.8059911531487242,1.0,14/94,8.42%,FLT1;TEK;ADAM12;TIE1;RAMP2;SIRT1;HMGA2;KDR;NOS3;ETS1;APLNR;NINJ1;CD34;HSPB1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.31129622512014465,1.035886623473178,0.4025695931477516,0.8048476339616603,1.0,9/47,11.79%,IGF1R;EPHB1;MAPK8IP2;TGFB2;PHLPP1;MAPK8IP1;TAOK2;DAB2IP;FOXO1
prerank,zinc ion transport (GO:0006829),0.3750349125321595,1.0356864991518635,0.40289256198347106,0.8042717524539933,1.0,6/21,11.74%,SLC39A2;SLC30A1;TRPM2;SLC30A3;SLC39A8;SLC30A5
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.31390092987689594,-1.035519562725883,0.4134419551934827,0.6822254790130299,1.0,14/44,23.09%,PRKAG2;CYP7B1;CYP27A1;INSIG2;OSBPL9;HMGCR;SQLE;PARK7;AMACR;SC5D;ACOT8;PSAT1;OSBPL3;LBR
prerank,acyl-CoA metabolic process (GO:0006637),-0.32530217285265234,-1.0354999587189888,0.3783783783783784,0.6817902424157399,1.0,11/35,23.25%,GPAT4;ACSF2;ACSL6;DLST;ACOT11;ACOT9;SUCLA2;MCEE;SUCLG2;ACOT8;ACOT6
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.307881002611598,1.0351967630592285,0.38329764453961457,0.8046480458758031,1.0,12/46,19.77%,GDAP1;CHCHD4;TIMM21;DNAJC15;AKT1;PITRM1;TIMM22;HSPD1;TSPO;TOMM70;TIMM10B;DNAJC19
prerank,regulation of mast cell activation (GO:0033003),-0.4447351045684128,-1.0350394839406776,0.41316270566727603,0.6824313661520758,1.0,4/10,20.55%,PLSCR1;LYN;NECTIN2;CD84
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.43196362001037564,1.0343748649348663,0.4316702819956616,0.8057657650787368,1.0,4/12,13.24%,ANK3;WNK2;GLRX;ATP1B1
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.41893850174757385,-1.0343637389870748,0.43159922928709055,0.6835995829817624,1.0,5/14,21.64%,MYO9A;CDC42;RHOA;MSN;SCRIB
prerank,DNA packaging (GO:0006323),-0.4032584584478425,-1.0338616651208599,0.4195933456561922,0.6844051905832425,1.0,8/16,37.93%,AIFM1;HAT1;CDAN1;H1-0;BANF1;CHAF1A;NAA10;TP53
prerank,carboxylic acid metabolic process (GO:0019752),0.3280242058475993,1.0336465601432918,0.3917525773195876,0.8068174939179805,1.0,4/33,5.63%,SLC2A1;SLC2A3;MIF;CSGALNACT1
prerank,cardiac myofibril assembly (GO:0055003),-0.4076198807871179,-1.033408406493933,0.4254545454545455,0.6850456208132647,1.0,4/15,7.30%,PDGFRA;PDGFRB;MEF2A;OBSL1
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3909829924135084,-1.0324552537384037,0.41448692152917505,0.68693882348549,1.0,6/18,22.73%,FBN1;FBXW7;TLR4;GPR137B;TCTA;MAFB
prerank,sulfur amino acid catabolic process (GO:0000098),-0.45731860406728597,-1.0323325213161672,0.4340659340659341,0.6867593216626187,1.0,9/10,54.30%,TXN2;CBS;CTH;ADO;MPST;BLMH;MTRR;TST;GADL1
prerank,triglyceride biosynthetic process (GO:0019432),-0.38895074318567474,-1.0319718229860289,0.4316831683168317,0.6872090229907426,1.0,7/18,20.39%,AGMO;GPAT4;MOGAT3;PCK2;LPIN2;LPIN3;GPAT3
prerank,positive regulation of histone methylation (GO:0031062),-0.35676243985481504,-1.031665022066193,0.41742286751361163,0.6874594263844184,1.0,6/24,15.69%,AUTS2;CTR9;SMAD4;OGT;PHF1;JARID2
prerank,miRNA metabolic process (GO:0010586),-0.368960607268755,-1.0315814445273037,0.4307400379506641,0.6871960843872482,1.0,4/20,8.00%,DIS3L2;DICER1;DDX17;TUT4
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.3740241262855155,-1.0313224108437902,0.4155597722960152,0.6873794455168424,1.0,9/22,22.44%,PPM1D;PPM1E;DUSP16;PPP2CB;PPM1A;DUSP1;DUSP10;PPP2CA;DUSP7
prerank,positive regulation of cellular metabolic process (GO:0031325),0.2723015587353575,1.0312803615340185,0.38137472283813745,0.8128966343507837,1.0,19/98,16.55%,SLCO1C1;PAX8;MAGI2;AHI1;PPARG;SNCA;KLF4;RAB1B;IFNAR1;AKT1;PDGFB;AGPAT1;NFKBIA;GHITM;INSR;CDKN1A;STARD4;TBC1D5;RAB29
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.32219605788283406,-1.0311178677492747,0.4126679462571977,0.6873403955003822,1.0,9/40,21.34%,PID1;ABL1;LRRK2;BCL2;STOML2;ATP5IF1;VCP;PARK7;AKT2
prerank,cytoplasmic microtubule organization (GO:0031122),-0.30175171832527414,-1.0306997656835832,0.3783783783783784,0.6879417546911996,1.0,13/54,13.89%,PCM1;FIGN;NUMA1;DLG1;SLK;VPS4B;TUBGCP6;TUBGCP2;FIGNL2;RHOA;CLIP4;RAB11A;KATNA1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.43410702225686265,1.0306197727582507,0.4314606741573034,0.8137115795539603,1.0,3/11,12.89%,STMN1;PAK1;BCAR1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.34692086089646956,-1.0300758634556704,0.4101123595505618,0.6890294262578347,1.0,5/28,10.12%,ITPR1;BCL2;MAP3K5;AIFM1;TRAF2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.252827914590287,1.0295821463800348,0.3843058350100604,0.8155350475620946,1.0,23/151,10.86%,TEK;ERBB4;TIRAP;CSF1R;NECAB2;MIF;HTR2C;GAS6;KDR;FGF10;NTRK2;SEMA7A;NOTCH1;P2RY1;ADCYAP1;GPNMB;ADRA1A;CCL2;THPO;OPRM1;PDGFB;ATP6AP1;F2R
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.35661253412398963,1.0295597469839726,0.4246861924686193,0.8144489681184098,1.0,8/24,20.83%,ALAS2;ABCG2;CPOX;TSPO;FECH;COX10;HMBS;ABCB10
prerank,cellular response to interleukin-12 (GO:0071349),-0.3098910746763656,-1.0294996476469063,0.40077821011673154,0.6899475829569874,1.0,17/48,21.48%,JAK1;RAP1B;ANXA2;PAK2;CDC42;PITPNA;CAPZA1;ARF1;RALA;HSPA9;TYK2;PDCD4;AIP;SOD2;CNN2;P4HB;MSN
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.4208627902161339,1.0289887190176756,0.4051172707889126,0.8150410872052433,1.0,1/12,0.11%,IGF1R
prerank,primary neural tube formation (GO:0014020),-0.3399241583230745,-1.028343308696879,0.41681574239713776,0.6924652851982431,1.0,6/30,9.33%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,tube closure (GO:0060606),-0.337023039210117,-1.027955125179735,0.41532976827094475,0.6929786831883761,1.0,6/31,9.33%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2991873904763422,1.0279479551264321,0.4126679462571977,0.8170029028333766,1.0,12/54,12.13%,RPL35A;RPF2;RPL7;RPL10;RPL10A;RPLP0;RPL7A;RPL14;RPL5;RPL23A;NHP2;NOP2
prerank,cellular senescence (GO:0090398),-0.3451977303484928,-1.0279138290898704,0.40074906367041196,0.6925955009192297,1.0,11/27,21.77%,OPA1;SMC6;NSMCE2;MAP2K1;SMC5;PRKCD;ID2;TBX2;TERF2;PML;ECRG4
prerank,regulation of striated muscle contraction (GO:0006942),-0.3465037039825589,-1.027856826429059,0.40038684719535783,0.6922154157236581,1.0,8/27,20.47%,ATP1A2;ANK2;ASB3;SRI;P2RX4;PRKACA;SLC8A3;NOS1
prerank,dephosphorylation (GO:0016311),0.2576466901960905,1.0277802727564187,0.38284518828451886,0.8163502750466246,1.0,31/147,15.17%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PLPPR1;PTPRT;DUSP6;PGP;PPM1F;PPP2R1A;PLPPR5;PTPN18;SGPP2;PTPRJ;PLPPR4;PLPP4;NT5C;MTMR6;PTPRM;DUSP28;DUSP26;DUSP15;CTTNBP2NL;PTPRZ1;PPM1L;PPP3CA;CTDSP2;PDP1;PLPP6;FRA10AC1
prerank,histone monoubiquitination (GO:0010390),-0.3578501756051241,-1.0277447286616217,0.42777777777777776,0.6920304180262142,1.0,8/24,22.39%,BCOR;CTR9;DDB2;DTX3L;UBE2E1;RNF20;CDC73;WAC
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.3666454648519417,-1.0276794270645762,0.4106090373280943,0.6917132493170203,1.0,9/19,23.47%,ELF1;RUNX1;IRAK2;DHX9;PARP9;MAVS;WNT5A;IRAK1;MAPK7
prerank,neuron projection extension (GO:1990138),-0.3320620170823473,-1.0276664105634812,0.4070631970260223,0.6912497701143873,1.0,8/32,12.86%,ALCAM;AUTS2;NRP1;IMPACT;SPG11;ULK2;EIF2AK4;FLRT1
prerank,glycolipid biosynthetic process (GO:0009247),-0.31774654457919027,-1.0275492576278518,0.4180478821362799,0.6910573766345753,1.0,16/38,30.49%,LARGE1;ST3GAL4;A4GALT;PIGN;GBGT1;ST6GALNAC5;DPM1;PIGH;MPPE1;PIGC;DPM3;PIGA;ST3GAL2;PIGZ;PIGP;PIGF
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.3354572905713916,-1.0272350512174477,0.41366223908918404,0.6913752284506859,1.0,14/29,36.26%,EIF4ENIF1;FUS;LARP1;YBX1;TENT5A;HNRNPU;PAIP1;TENT5D;E2F1;THRAP3;GDNF;SLC11A1;RBM24;ELAVL1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3190143384585236,-1.0267635585393902,0.3945841392649903,0.6920811849444978,1.0,25/42,35.32%,INO80;ARID1B;SMARCC2;CHD8;RNF8;MBD2;CHD4;CHD3;SPTY2D1;HDAC1;ANP32E;NASP;SMARCD2;PBRM1;HDAC2;MBD3;ACTR5;ACTR6;CECR2;DMAP1;INO80B;ACTL6B;ACTR8;ERCC6;SMARCA4
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.26348306411018246,-1.0266676701064876,0.40408163265306124,0.6918387013470241,1.0,22/118,11.68%,PHLDB2;PID1;DAG1;SIPA1L1;PDLIM5;SDC2;KIF13B;LRRK2;SPARC;GSK3B;WTIP;BCL9L;PAK2;ADGRA2;RC3H1;FGFR2;EPHA4;SP100;BRSK1;BMPER;ZMYM4;MEF2C
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.30031185105690883,1.026573602929204,0.4063745019920319,0.8187461604387006,1.0,12/50,13.67%,PAX2;GAS6;SNCA;GPX1;ARL6IP1;KLF4;BEX3;RPS6KA1;AKT1;RNF34;RFFL;CAAP1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.30204029725146997,-1.026507153755009,0.39575289575289574,0.6917436485713705,1.0,20/52,24.44%,LMNA;TLN1;ATP6V0D1;SHC1;GFPT1;EDEM1;SEC31A;ARFGAP1;WIPI1;DNAJC3;KDELR3;ERN1;GOSR2;FKBP14;SYVN1;CUL7;WFS1;PREB;CXXC1;HYOU1
prerank,tyrosine metabolic process (GO:0006570),-0.4411478725881687,-1.0264721360188547,0.44508670520231214,0.6913370259828997,1.0,5/11,43.22%,THAP4;TYR;HGD;IL4I1;FAH
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.40967800376844593,1.026348300038224,0.42323651452282157,0.8183111033311625,1.0,5/15,15.25%,REEP1;ARL6IP1;REEP2;RTN4;REEP3
prerank,apoptotic nuclear changes (GO:0030262),-0.36222531782246065,-1.0262980799148609,0.4275092936802974,0.6913066169799936,1.0,9/24,29.16%,DICER1;ACIN1;HMGB1;H1-0;CDK5RAP3;EXOG;DNASE2;CECR2;GPER1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.39988524802398173,-1.0261359148072735,0.4153543307086614,0.6912652851014196,1.0,6/14,27.14%,LIMS1;FLNA;LOXL3;PRKD1;CD63;SLC2A10
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2805779571222291,-1.0257132368367672,0.402321083172147,0.691919433514512,1.0,17/70,16.46%,CYFIP2;ABL1;WASF2;LYN;CDC42;VAV2;BRK1;PLCG1;WASL;PRKCD;YES1;ABI1;NCKAP1;WIPF1;ARPC2;NCK1;DOCK1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3920424144071709,-1.0250181510371363,0.4180790960451977,0.6931631375628101,1.0,4/16,11.62%,SMG6;TNKS2;DHX36;PARP1
prerank,tight junction assembly (GO:0120192),0.3086114158147492,1.0247143707098332,0.4326530612244898,0.8219683101755924,1.0,9/49,12.08%,CLDN5;RAMP2;OCLN;CLDN14;ESAM;PECAM1;MICALL2;APC;MARVELD2
prerank,tetrapyrrole metabolic process (GO:0033013),-0.37762450157619026,-1.0245838532374152,0.41729323308270677,0.6938023955716975,1.0,4/18,16.51%,TCN2;MMUT;ABCD4;CUBN
prerank,phospholipid metabolic process (GO:0006644),0.28389260588343623,1.0245186483094262,0.4268774703557312,0.8214228328278073,1.0,17/71,19.21%,PLPPR1;MBOAT1;PGP;ENPP2;PLPPR5;PLPPR4;GPAM;SMPD1;FADS1;AGPAT1;PIP5K1A;PNPLA3;PLA2G4E;PIP4K2B;PLBD2;ACP6;PCYT2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.41245767621810736,-1.0243785743299885,0.41320754716981134,0.6938258699794606,1.0,5/13,16.00%,PLXNA2;NRP1;PLXNB2;PLXND1;PLXNB1
prerank,retinol metabolic process (GO:0042572),-0.40739928528932345,-1.024181659504242,0.4352517985611511,0.6938282973346194,1.0,3/14,9.27%,RBP4;DHRS3;CYP1B1
prerank,gliogenesis (GO:0042063),0.3883450799060928,1.0222634718314616,0.40757238307349664,0.8271885556818772,1.0,4/15,9.08%,CDH2;PAX2;TGFB2;RELN
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3427994435447863,-1.021790171077084,0.41487279843444225,0.6994534495075687,1.0,5/27,7.01%,SLMAP;SNTA1;DLG1;PTPN3;CAMK2D
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.34719740771614166,-1.0213906832712827,0.4137254901960784,0.6999790371393566,1.0,8/25,30.42%,ITGAV;DLG4;PICALM;ITGB3;ANKRD13B;APP;NEU3;ARF6
prerank,negative regulation of cell activation (GO:0050866),-0.40692746190819856,-1.0212054082161466,0.4222222222222222,0.6999980987820256,1.0,4/14,14.42%,PDGFRA;LDLR;APOE;EMILIN1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.44353196231139747,-1.0211547780178856,0.4444444444444444,0.6996466521769364,1.0,1/10,0.93%,APPL2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.40056418323056897,-1.0209742550940837,0.4296724470134875,0.6996215275831393,1.0,2/15,3.68%,GLI3;CD55
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.43303777223349815,-1.0208152511834812,0.4425925925925926,0.699556261505757,1.0,8/10,43.56%,HMGB1;ATF7IP;THRA;ESR1;TP53;PSMC6;PSMC2;PSMC5
prerank,cardiac muscle cell differentiation (GO:0055007),-0.3629393327781781,-1.0207723776248308,0.4309278350515464,0.699169061987519,1.0,8/21,18.77%,AKAP13;CXADR;MEF2C;SIK1;VEGFA;ACVR1;MYH11;BMP2
prerank,metanephros development (GO:0001656),-0.34419242834313857,-1.020720916040489,0.4198473282442748,0.6988216901060119,1.0,10/26,17.02%,FOXD1;PKD1;BMP7;BMP4;OSR1;CTSH;NIPBL;PKD2;PTCH1;SIX1
prerank,regulation of intracellular transport (GO:0032386),-0.3156743747224132,-1.0205702302522828,0.4088291746641075,0.6987320640493558,1.0,12/38,19.58%,LRRK2;NUMA1;GAS1;NDEL1;GRIPAP1;NUP214;WWC1;RINT1;DYNC1H1;LAMP1;PTPN1;RBM4
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.24692950490849358,-1.0204685276581023,0.403960396039604,0.6984873146244143,1.0,40/150,21.57%,EGFR;TCF7L2;GAB2;TGFBR1;PDGFRA;ANGPT1;FGF1;PDGFRB;AXL;KIT;OSBPL8;IRS1;ITGB1;THBS1;FGFR2;F3;PDPK1;IGF2;FRS2;KL;RICTOR;PIK3AP1;P2RY12;TXN;P2RX4;IAPP;IL18;PIK3CD;CX3CR1;GCNT2;PARK7;MYOC;HBEGF;NRG4;GAB1;PTPN11;FGFR4;PIK3R1;AKT2;FGF2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3537412709471226,-1.0204574391669543,0.4397031539888683,0.6980252109387955,1.0,10/24,24.21%,OPA1;PRKN;LRRK2;SELENOS;NR1H3;SYVN1;PARK7;LPCAT3;WFS1;TMBIM6
prerank,regulation of neuron differentiation (GO:0045664),-0.281021718423402,-1.0201027312983397,0.40080160320641284,0.6984472679040433,1.0,19/76,13.75%,TCF4;NBL1;NREP;ZFHX3;ZEB1;BMP7;ROCK1;LRRK2;REST;IMPACT;MED1;NGF;RHOA;ID2;MEF2C;HES1;TCF3;EIF2AK4;CDK5RAP1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.43147101618590566,1.020006402639668,0.44567627494456763,0.832839073292211,1.0,2/11,5.60%,ATF3;HSPA5
prerank,negative regulation of protein kinase activity (GO:0006469),0.27238145250404106,1.0192062387078646,0.42105263157894735,0.8340558528723347,1.0,29/88,20.39%,PTPRB;PTPRT;CAMK2N1;PPM1F;SNCA;THY1;SLC8A1;TRIB3;AKT1;YWHAG;HSPB1;DAB2IP;CEP43;UBASH3B;DVL1;DUSP26;EPHA1;SORL1;CDKN1A;CORO1C;CDKN1B;GNAQ;PPIA;ADAR;PTPRO;HYAL2;SH3BP5;DBNDD2;GSKIP
prerank,regulation of interleukin-12 production (GO:0032655),-0.3024513411429788,-1.0190852208878818,0.4111969111969112,0.7006128729127269,1.0,6/47,6.73%,FOXP1;IRAK3;PIBF1;HMGB1;THBS1;IL16
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.40356876950877735,1.018967702977665,0.4388646288209607,0.8336130179089087,1.0,4/14,11.59%,SIRT1;CAMK4;SEMA7A;BCL10
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.4151778703148627,-1.018836959802513,0.44028520499108736,0.7007595258684595,1.0,8/13,27.68%,UFL1;NCK1;BFAR;PTPN1;ABCA7;WFS1;ATF6B;PPP1R15B
prerank,organic acid transport (GO:0015849),-0.2673104809785906,-1.0187576588583094,0.4090909090909091,0.7004618147550504,1.0,13/94,9.00%,SLC7A11;SLC7A2;SLC6A13;SLC13A3;PDPN;ACSL1;SLC1A5;SLC26A7;SLC6A12;ATP8B1;LRRC8D;SLC22A6;NCOA1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3787669160372025,1.0187252641427864,0.4340425531914894,0.8331659291912105,1.0,5/17,13.41%,ALG3;MVD;ALG1;ALG8;DHDDS
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3887979922059025,1.0183864222344141,0.432258064516129,0.8330793223686868,1.0,2/16,4.90%,FGF10;IL12A
prerank,sodium ion homeostasis (GO:0055078),-0.36336267516155485,-1.018171465848232,0.4339622641509434,0.7013830274626052,1.0,3/21,10.08%,ATP1A2;SLC9A1;SLC12A2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.41686646970706254,-1.0181286084388819,0.4444444444444444,0.7009947613914838,1.0,2/13,4.04%,DDX5;PLA2R1
prerank,establishment of protein localization to organelle (GO:0072594),0.2784617131912278,1.0180893449220902,0.4214876033057851,0.8328726449195463,1.0,11/72,9.99%,IPO5;IPO4;MMP12;RYR2;NXT1;AKT1;ZDHHC15;TSPAN17;NEURL1B;NUP62;FAM53B
prerank,bicarbonate transport (GO:0015701),0.3514081513651726,1.0180162558736157,0.45217391304347826,0.8319631499214909,1.0,4/25,10.65%,SLC4A1;CA4;CA2;SLC39A8
prerank,positive regulation of metabolic process (GO:0009893),0.2652172189537238,1.017821807687357,0.4149797570850202,0.8313801084405126,1.0,20/103,13.89%,IGF1R;GATM;OMA1;KSR2;UCP2;ADRB1;HADH;EPAS1;ADCYAP1;ADIPOR2;APC;SCD;FABP5;PER2;AGPAT1;LCN2;ESRRG;EBF2;INSR;CD36
prerank,receptor catabolic process (GO:0032801),-0.35059877876728823,-1.017705445806857,0.4262589928057554,0.7015673709540718,1.0,7/24,17.48%,RNF43;UVRAG;KIF16B;BECN1;SMURF1;PIK3R4;MYLIP
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.31681841689310164,1.0176924284689597,0.44123711340206184,0.8306211347154929,1.0,7/39,8.51%,MBP;PODXL;PPM1F;NOTCH1;KLF4;AKT1;NEXMIF
prerank,negative regulation of dephosphorylation (GO:0035305),0.37941475888331355,1.0173627140335046,0.445859872611465,0.8304265958609169,1.0,3/18,4.95%,YWHAB;PPP1R16B;ZCCHC9
prerank,negative regulation of MAPK cascade (GO:0043409),0.27230954759379566,1.0167500526707862,0.43415637860082307,0.8311102497917133,1.0,18/87,13.00%,PTPRR;SEMA6A;SPRY3;CNKSR3;DUSP6;CAMK2N1;WNK2;PEBP1;PTPRJ;SPRY4;DAB2IP;UCHL1;LMO3;SMPD1;P2RX7;FOXO1;DUSP26;SORL1
prerank,positive regulation of cell population proliferation (GO:0008284),-0.22260436754902319,-1.016676576579068,0.3903420523138833,0.7036562364415868,1.0,84/423,18.37%,BMP6;TGFBR3;IGF1;FOXP1;GRK5;EGFR;PID1;TCF7L2;GAB2;TGFBR1;PTN;BMPR1A;IL34;PDGFRA;RBPJ;NTRK3;EFNB2;BMP5;ITGAV;FGF1;PDGFRB;IL6ST;IL31RA;BMP4;HDAC4;MAP3K3;OSR1;TGFBR2;YAP1;IRS1;KMT2D;CTSH;IL13RA1;THBS1;DPP4;GAREM1;UFL1;FGFR2;SHC1;BCL2;LYN;DHX9;AR;ACER3;IGF2;GJA1;CDK13;FER;PDGFC;NES;S100A6;ID2;STX4;CNOT8;MEF2C;HES1;CUL3;IL6R;FN1;CCAR1;TRPM4;CDC123;GLI1;CCN1;STAT1;VEGFA;HDAC1;CIAO1;CDC25B;VEGFD;CSNK2A1;TGFB3;ADRA2A;IL18;TBX2;TCIRG1;CACUL1;CCN4;WNT5A;PHIP;HNRNPU;PTGFR;DHPS;GCNT2
prerank,regulation of receptor recycling (GO:0001919),-0.394864836174724,-1.0160620648056038,0.4479553903345725,0.7046572096751053,1.0,7/16,25.58%,TBC1D16;ANXA2;ECE1;KIF16B;SCRIB;NSF;AP1AR
prerank,protein localization to plasma membrane (GO:0072659),0.2573770773675376,1.015834840574366,0.41922290388548056,0.8325892931779406,1.0,24/129,11.88%,BSG;DPP10;EFR3B;MRAP2;KCNIP4;SPTBN4;RAMP2;ANK3;RAB3C;FGF13;TNIK;GAS6;MAP7;DPP6;ZDHHC22;P2RY1;EPB41L3;CACNB2;TSPAN17;RAB40B;SPTBN1;CCDC88A;ANK1;TSPAN14
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.4234257236837441,-1.0156179779840635,0.4580152671755725,0.7053834556439046,1.0,2/12,16.83%,NUPR1;IL18
prerank,innate immune response in mucosa (GO:0002227),0.44438865177002246,1.0156170280899217,0.4467120181405896,0.8321209643828427,1.0,10/10,55.59%,DEFA6;RNASE3;PLA2G1B;RPL39;LTF;DEFB1;BPIFB1;CAMP;IL4;NOS2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.29703900624853613,1.0155085786283229,0.43121149897330596,0.8313207409036572,1.0,11/51,9.89%,NYAP2;CNTNAP2;GPM6A;TNIK;PAK1;EPB41L3;CNTNAP1;UBB;SHTN1;TAOK2;DAB2IP
prerank,eosinophil migration (GO:0072677),0.4006152687091914,1.0149879810614582,0.425,0.8306146976845487,1.0,14/14,59.97%,CCL2;SCG2;CCL13;CCL24;CCL26;LGALS3;CCL3;CCL1;CCL8;CCL7;CCL4;CCL11;CCL5;CX3CL1
prerank,eosinophil chemotaxis (GO:0048245),0.4006152687091914,1.0149879810614582,0.425,0.8306146976845487,1.0,14/14,59.97%,CCL2;SCG2;CCL13;CCL24;CCL26;LGALS3;CCL3;CCL1;CCL8;CCL7;CCL4;CCL11;CCL5;CX3CL1
prerank,myotube cell development (GO:0014904),-0.4444205727216757,-1.0148654660236502,0.4532627865961199,0.7067716933597976,1.0,4/10,17.02%,IGF1;SKI;SELENON;SIX1
prerank,regulation of mitotic spindle organization (GO:0060236),-0.32494660457359675,-1.014700201678852,0.4230769230769231,0.7066997538784776,1.0,18/35,36.43%,NUMA1;VPS4B;CHMP4B;CHMP5;CHMP3;TPR;MAP9;DYNC1H1;HNRNPU;EML3;BORA;PARP3;CHMP1B;TACC3;HSPA1A;CHMP1A;TPX2;FSD1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3837538601425682,-1.0146927683898659,0.43189964157706096,0.7062262021888407,1.0,9/16,21.57%,FOXD1;FGF1;BMP4;PKD2;SALL1;SIX1;NPNT;BMP2;FGF2
prerank,oogenesis (GO:0048477),0.38875235301299305,1.014204536666047,0.42379958246346555,0.8318268489911596,1.0,3/15,4.57%,MEI4;FMN2;NANOS3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.3034851726315313,-1.014136037479202,0.41254752851711024,0.7071566724488787,1.0,10/48,9.75%,ADCY9;ADCY5;SLC35B3;AMPD3;ADCY1;SLC26A2;ADCY6;GMPS;GUCY1A1;PANK2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.35489351587742113,1.0140337948638938,0.44466403162055335,0.8311992198539311,1.0,4/22,8.88%,MBP;THY1;KLF4;SKAP1
prerank,response to laminar fluid shear stress (GO:0034616),-0.4324060203323411,-1.0133017797734638,0.4409171075837742,0.7088675295887046,1.0,2/10,1.66%,ABCA1;SMAD6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.44719480341157664,-1.013209649470197,0.4277456647398844,0.7081310638616428,1.0,5/10,29.38%,PRKCD;SMPD2;SIRT3;NSMAF;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.44719480341157664,-1.013209649470197,0.4277456647398844,0.7081310638616428,1.0,5/10,29.38%,PRKCD;SMPD2;SIRT3;NSMAF;SPHK2
prerank,chromosome organization (GO:0051276),-0.2675604162261299,-1.012979176271208,0.4387755102040816,0.7082314627005143,1.0,30/99,25.49%,TCF7L2;HDAC8;SETD7;BRWD1;ABL1;RAD23B;EZH1;MTHFR;DDB2;RFWD3;PARP1;TCF7L1;COPS2;EHMT1;COPS8;PHF1;HDAC1;LATS1;MSH3;TOP2B;HMG20A;MSH6;CDAN1;EZH2;HMGN3;HDAC2;CENPT;FAM50A;ZBTB7A;LDB1
prerank,sphingolipid catabolic process (GO:0030149),0.38715163766587685,1.012660537033242,0.46710526315789475,0.8342853063673517,1.0,6/15,14.53%,ACER2;ENPP2;SMPDL3A;GLA;SMPD1;PPT1
prerank,response to X-ray (GO:0010165),-0.4088644527033495,-1.012626912626931,0.43227091633466136,0.7085836045841922,1.0,4/14,11.47%,ANXA1;BRCC3;NIPBL;XRCC4
prerank,regulation of mRNA stability (GO:0043488),-0.250453456595938,-1.0126062313974353,0.4222222222222222,0.7081414757471105,1.0,57/145,31.71%,SAMD4A;ROCK2;CELF1;FTO;VIM;ROCK1;PUM2;YTHDF3;EIF4ENIF1;FUS;RC3H1;LARP1;PUM1;HNRNPD;DCP1A;DHX36;CSDC2;PRKCD;NUP214;XRN1;PSMF1;YBX1;SERBP1;PSMB2;EXOSC9;TENT5A;HNRNPU;PAIP1;EIF4G1;PSMC1;PRKCA;PSMB6;PSMA3;XPO1;EXOSC3;PSMA4;FXR1;PCBP4;PSME1;PDE12;PSMD13;DIS3;TENT5D;PARN;FASTKD1;ZFP36L2;PSMB10;E2F1;PSMA5;PSMB9;UBA52;THRAP3;TBRG4;YWHAZ;GDNF;GIGYF2;TNFSF13
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3847422003248358,-1.0124104005005694,0.4406779661016949,0.7081528828739262,1.0,5/17,12.13%,PTN;IL34;DICER1;ID2;HES1
prerank,mitotic spindle organization (GO:0007052),-0.24723376339205713,-1.012369478186865,0.42441860465116277,0.707773268368145,1.0,81/153,39.56%,EML4;FLNA;MAP4;PIBF1;RANBP2;SPICE1;PCNT;NDEL1;STAG1;RHOA;LSM14A;DYNC1LI1;RAB11A;ABRAXAS2;MAPRE1;TOGARAM1;NUDC;MAP9;ZWINT;RCC1;CENPP;SKA2;DYNC1H1;PTPA;STAG2;PMF1;EFHC1;VCP;NEK6;TAOK1;WDR62;NUP98;SMC1A;NUP43;XPO1;TBCE;BCCIP;ITGB3BP;NUP160;CENPT;KIF23;SUN2;INCENP;ABRAXAS1;KIF11;MZT1;STIL;DSN1;KNL1;MAD2L1;CENPE;KIF2A;CENPU;BUB1B;CKAP5;RAN;PRC1;AHCTF1;NUP133;SEC13;SMC3;TTK;B9D2;MISP;TPX2;CENPI;DCTN6;RCC2;CENPH;KIFC1;SEH1L;NSL1;NDC80;CENPN;CENPF;PAFAH1B1;KIF4A;KNTC1;SPDL1;TUBG2;CENPA
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3364207877623765,1.0122734713597024,0.4364406779661017,0.8343459347967831,1.0,5/30,5.57%,SCN1A;FGF12;RYR2;CACNA2D1;SCN4B
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.44420035149384884,-1.0119974256299809,0.4613899613899614,0.7081830378679701,1.0,9/10,55.61%,PRKCZ;IL18;SPHK2;RARA;TSLP;GATA3;IL4;IRF4;LGALS9
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.24498218415133957,-1.0117934565526963,0.4140786749482402,0.7082329474224806,1.0,49/172,23.00%,PTPN13;PLD1;PLEKHA2;PI4KA;SYNJ2;MTMR12;GNPAT;PLSCR1;DGKA;AGPAT4;DDHD1;INPPL1;ABHD5;PIP4K2C;GPAT4;STARD7;ETNK2;PLA2G4A;ABHD3;PTDSS1;PITPNM2;ARF1;PCYT1A;MBOAT7;MTMR3;CPNE3;PIK3C3;SLC27A1;PLEKHA8;HDHD5;SACM1L;CSNK2A1;PIK3R4;TAMM41;PIK3CD;LPIN2;LPIN3;GPD1L;INPP5K;LPCAT1;GPAT3;PIK3R1;CDS2;DGKD;FGF2;LPCAT3;PLEKHA4;PI4K2B;PTDSS2
prerank,positive regulation of protein kinase activity (GO:0045860),0.2496490862479493,1.0117099382958048,0.43621399176954734,0.8349346342183718,1.0,36/148,17.34%,GRM5;LRP8;CSF1R;MMD2;HMGA2;TNIK;GAS6;SNCA;PAK5;NAB2;TGFB2;PAK1;CLU;MAPRE3;ADCYAP1;HSP90AB1;RELN;TAOK2;DAB2IP;PDGFB;CALM1;CCDC88A;CALM2;PAK6;INSR;CIB1;TAB2;CALM3;CDKN1A;PAK3;STOX1;RAP1A;DDR2;XRCC5;HSP90AA1;RALB
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.37267599417780956,1.0116525456927723,0.4334677419354839,0.8339669995024748,1.0,5/18,15.38%,GINS2;LIG3;MCM3;RFC4;POLD3
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.37273947111899186,-1.0114555643689054,0.4564393939393939,0.7085885536316072,1.0,5/19,8.19%,RPTOR;CHD8;MTOR;AR;DHX36
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4150733835934926,-1.0113837042327543,0.4317343173431734,0.7082735795623974,1.0,3/12,10.23%,ABCA1;ITGAV;NR1H3
prerank,protein localization to nucleus (GO:0034504),-0.26169610480808153,-1.011352632889633,0.3946360153256705,0.707885362340536,1.0,57/102,37.66%,APPL2;COL1A1;BMP7;BMP4;LMNA;TAF3;EIF4ENIF1;STAT3;WRN;NUP214;RPL11;IPO13;TPR;APPL1;YWHAE;TAF8;TOPORS;NOP53;FAM53C;SIX1;GBP2;MORC3;HNRNPU;ABCA7;PML;RPAIN;IPO9;TOR1A;TNPO3;PPP1R10;SYK;PHB2;ZBTB7A;NUP93;BBS4;RRS1;CHCHD10;RANBP17;TNPO2;CALR;SIX4;PINX1;E2F3;ARL2;RAN;IPO11;NUP133;SEC13;NUP88;FAM53A;MSX1;TOR1AIP1;SKP1;NUTF2;TSC2;IPO7;CSE1L
prerank,regulation of MAP kinase activity (GO:0043405),-0.26886851880780455,-1.0112087711514404,0.41935483870967744,0.7077553663670211,1.0,29/92,22.48%,EGFR;IL34;KSR1;FGF1;PDGFRB;BMP7;BMP4;ROBO1;LRRK2;KIT;IRAK3;LYN;PDGFC;PRKCD;TRIB2;APOE;TPD52L1;VEGFA;DUSP1;ADRA2A;PTPN1;INPP5K;IRAK1;SNF8;CDK5RAP3;FGF2;EZH2;DUSP7;CD300A
prerank,histone acetylation (GO:0016573),-0.27817788401787136,-1.0110913076537107,0.42135922330097086,0.7075634189296813,1.0,18/69,18.15%,KAT2B;EP300;KAT6B;CREBBP;TRRAP;BRPF3;ZZZ3;HAT1;ATF2;TADA3;KAT14;KAT8;ING5;BRCA2;TAF5L;EPC1;TAF6L;MSL3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.30420119762644143,-1.0109483592894761,0.4246031746031746,0.7074044120884474,1.0,9/42,9.18%,PLEKHA2;LIMS1;ROCK1;ABL1;GSK3B;MAP4K4;NRP1;S100A10;JUP
prerank,Golgi inheritance (GO:0048313),-0.430914111343978,-1.0109001542467264,0.44660194174757284,0.7070480597560327,1.0,3/11,13.00%,GBF1;VCPIP1;STX5
prerank,ureteric bud morphogenesis (GO:0060675),0.3874048156172313,1.0107644126320134,0.4325581395348837,0.8354607673918987,1.0,2/16,3.56%,PAX8;PAX2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.30785879430755436,-1.0107403076529267,0.43018867924528303,0.7070079170141597,1.0,8/41,12.87%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.44664641225909674,-1.0103480355627505,0.4442307692307692,0.7075238368574951,1.0,2/10,8.69%,MTHFR;MTHFD2L
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4138433002322401,-1.0101607803575217,0.4391634980988593,0.7074874973027291,1.0,5/12,19.26%,SORBS1;IRS1;IGF2;PRKCZ;PTPN11
prerank,DNA duplex unwinding (GO:0032508),-0.29484394287019905,-1.0101126656405763,0.42463235294117646,0.7071345042986811,1.0,25/50,33.13%,GTF2H2;RAD23B;NBN;ANXA1;DHX9;WRN;DDB2;MCM9;ASCC3;PARP1;ERCC3;MCM6;MRE11;SSBP1;GTF2H1;RECQL5;GTF2H4;MCM4;MCMDC2;SUPV3L1;RBX1;UBA52;TWNK;RAD51;DDB1
prerank,B cell mediated immunity (GO:0019724),0.4324148274920974,1.0098673679594794,0.4397590361445783,0.8370027873349021,1.0,1/10,3.14%,SLA2
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3622946638334755,1.009857460895218,0.4216335540838852,0.8359009367981677,1.0,4/21,8.56%,PLTP;SIRT1;PPARG;GPS2
prerank,positive regulation of neurogenesis (GO:0050769),0.28135955380864286,1.0096959222484,0.43548387096774194,0.8352469133289664,1.0,11/68,9.59%,PTPRD;IL1RAPL1;MME;PLXNB3;SHANK3;NTRK2;NPTN;PLXNA4;ROBO2;CDKL5;OPRM1
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.2909076506832355,-1.0092927552712847,0.44061302681992337,0.7087516971000565,1.0,19/54,19.51%,GPC6;SDC2;HS3ST3A1;GPC4;GNS;GPC3;EXT1;HSPG2;HS2ST1;NDST1;NDST2;GUSB;HEXA;PXYLP1;SDC4;HS6ST1;XYLT2;GCNT2;B4GALT7
prerank,positive regulation of apoptotic process (GO:0043065),-0.22912586493390033,-1.0085392181648072,0.415506958250497,0.7102073285669579,1.0,69/293,18.90%,AKAP13;PAWR;TGFBR1;EPHA7;FOXO3;STK3;BMP4;TIAM2;PTGIS;ABL1;ARHGEF17;NUPR1;STK17B;RARG;IGFBP3;HMGB1;ITGB1;DNM1L;HOXA5;PHLDA1;IFIT2;REST;PLEKHG2;MAP3K5;FAM162A;VAV2;CALHM2;AIFM1;ADAMTSL4;UNC13B;CYP1B1;MAP3K20;NGF;NCSTN;PRMT2;JUN;ARHGEF12;ARHGEF18;BCLAF1;FAP;ERCC3;SOS2;SIK1;RASSF2;CCAR1;CASP2;FGD1;ATF6;ING5;TPD52L1;FGD4;RBM5;DDX3X;LATS1;TRIM39;TGFB3;DAPK1;NGEF;PTPA;IAPP;ARHGEF11;TRIO;ARHGEF6;DAPK2;ARHGEF1;SFRP4;TRAF6;BMP2;DCUN1D3
prerank,positive regulation of behavior (GO:0048520),0.4327157147797747,1.008402712501763,0.45621181262729127,0.8380222419913411,1.0,4/10,18.27%,NLGN1;NPAS2;SGIP1;NR4A3
prerank,insulin receptor signaling pathway (GO:0008286),-0.2809815286413727,-1.008151920427553,0.43308550185873607,0.7107233714802227,1.0,14/69,10.03%,RHOQ;SORBS1;GRB10;ATP6V1B2;GSK3B;IRS1;ATP6V0D1;SLC39A14;SHC1;FOXC2;ATP6V0A4;IGF2;FER;PTPN2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.2754206202793137,-1.0080790364915608,0.44140625,0.7104137920972572,1.0,15/71,12.71%,CYFIP2;ABL1;WASF2;LYN;CDC42;VAV2;BRK1;PLCG1;WASL;PRKCD;YES1;ABI1;NCKAP1;WIPF1;ARPC2
prerank,xenobiotic transport (GO:0042908),0.389984482037955,1.0080532419468953,0.43817787418655096,0.8380092667413429,1.0,2/17,2.21%,SLC7A5;ABCG2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.39158816629295495,-1.008036062360044,0.44901960784313727,0.7100332331377831,1.0,4/14,16.83%,TGFBR2;CD55;PTPN22;IL18
prerank,JNK cascade (GO:0007254),0.3156132134116408,1.0078504057242808,0.44680851063829785,0.8375246414957055,1.0,15/40,18.99%,MAP4K2;SH2D3C;TNFRSF19;RPS27A;UBC;UBB;GPS2;NOD1;MAPK8;MAP3K11;TAB2;MAPK10;PTGER4;ADORA2B;NOD2
prerank,regulation of GTPase activity (GO:0043087),-0.2422746931631372,-1.0078365892748915,0.4158004158004158,0.7100610362776855,1.0,30/177,9.97%,PLXNA2;DOCK11;AFDN;ASAP3;SIPA1L1;EPHA3;LIMS1;LRRK2;ARAP1;GSK3B;SGSM2;ITGB1;BCAS3;SNX9;MAP4K4;ARFGEF1;RAB3GAP1;MMUT;GMIP;RAPGEF3;ZC3H15;VAV2;S100A10;EPHA4;RSU1;NDEL1;USP6NL;PLXNB2;WNK1;TBC1D20
prerank,protein polymerization (GO:0051258),-0.29491518783982495,-1.0077977201911805,0.4446601941747573,0.7096763729052351,1.0,11/55,10.06%,ARHGAP6;GAS7;GSN;DIAPH1;PRKN;CORO7;CHMP4B;CHMP4A;UBE2K;WASL;CHMP3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3187603094303014,1.0076278188356225,0.4381338742393509,0.8370698962295672,1.0,7/38,7.35%,KCNJ3;CTNNA3;CACNA2D1;BIN1;SCN4B;KCND3;CACNB2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4201016702291755,-1.006441950244187,0.46511627906976744,0.7125837523437722,1.0,3/12,22.93%,IL17D;IL18;CD80
prerank,protein mannosylation (GO:0035268),-0.35880005195959924,-1.0061305472646846,0.43933823529411764,0.7128695116690091,1.0,11/22,23.79%,TMTC1;LARGE1;TMTC4;CRPPA;POMT2;FKTN;DPM1;TMTC3;POMT1;FKRP;DPM3
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.34072171574168447,-1.0060447200227394,0.43103448275862066,0.7126058279819473,1.0,9/27,22.26%,IGF1;PDGFRA;DHX9;PDGFC;S100A6;FN1;WNT5A;CDK6;SPHK1
prerank,rRNA transcription (GO:0009303),-0.3763670688307036,-1.0059398229396819,0.44320297951582865,0.7123756329139289,1.0,9/17,34.61%,CAVIN1;BRF1;GTF3C4;SPIN1;GTF3C1;GTF3C6;POLR1G;GTF3A;ANG
prerank,negative regulation of secretion (GO:0051048),0.4288165239352546,1.0059146262282883,0.42444444444444446,0.8410806199443107,1.0,1/10,2.45%,NRG1
prerank,endothelial cell proliferation (GO:0001935),0.38130245364224147,1.0051607594287049,0.4551422319474836,0.8423146472674631,1.0,5/17,12.87%,TEK;ACVRL1;CD34;THAP1;BMPR2
prerank,regulation of protein targeting to membrane (GO:0090313),0.3334269809944599,1.0050428858767766,0.45161290322580644,0.8415485253941983,1.0,7/28,14.97%,ANK3;MTCL1;MIEF1;ITGAM;HRAS;CIB1;GDI1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2904044994963491,1.0045617512300473,0.431640625,0.8418562981704293,1.0,12/56,15.14%,S100A9;S100A8;RPS27A;UBC;TLR2;UBB;NOD1;BCL10;CTSB;CD36;TAB2;MAPKAPK2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3911331378504447,-1.0043749209736552,0.4684512428298279,0.7158175781718155,1.0,8/14,30.55%,TNKS2;NABP2;BRCA2;TERF2;TERT;ATR;ATRX;PINX1
prerank,regulation of cell junction assembly (GO:1901888),-0.3371965838635463,-1.0042104628470971,0.4368932038834951,0.7157444955489922,1.0,6/27,6.91%,ROCK2;PDLIM5;ROCK1;SETD5;RAP1B;RUNX1
prerank,regulation of neuron death (GO:1901214),0.273772907139436,1.0040118152207884,0.42369477911646586,0.842386168775911,1.0,16/82,13.00%,DCC;EPHB1;GRID2;TRIM2;GRIN2B;SNCA;CLU;AKT1;UBB;GPNMB;CD34;GPR75;CD200R1;SNCB;ITGAM;SORL1
prerank,regulation of platelet activation (GO:0010543),-0.35507261720087246,-1.0039193501414243,0.4438095238095238,0.7159763442350472,1.0,9/21,25.99%,PDGFRA;LYN;PLA2G4A;TEC;APOE;TLR4;PRKCA;SYK;FCER1G
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.34686089421083377,1.003553538326808,0.46396396396396394,0.8426447546559189,1.0,6/24,13.89%,ANK3;MTCL1;MIEF1;ITGAM;HRAS;CIB1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.41441943883705545,-1.0031881813382144,0.45348837209302323,0.7172958304996117,1.0,5/12,18.87%,AKAP8L;NIPBL;VEGFA;PRKD1;SAP30BP
prerank,regulation of establishment of protein localization (GO:0070201),-0.4081667601297412,-1.0028044481030924,0.4480769230769231,0.7178057724559029,1.0,3/13,16.90%,SPIDR;CEP135;CEP295
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.27392511949509246,-1.0027669282708482,0.4426229508196721,0.7174168674060752,1.0,13/72,10.12%,CFLAR;TRIM44;PIAS1;AXL;TAX1BP1;JAK1;ELF1;IRAK3;RUNX1;IRAK2;HIPK1;PTPN2;TRAF2
prerank,lipoprotein localization (GO:0044872),0.413153580334293,1.0022271169858463,0.4704641350210971,0.8456785749262801,1.0,4/11,13.89%,PPARG;ZDHHC17;VMP1;CD36
prerank,response to retinoic acid (GO:0032526),-0.28614378810342167,-1.0021329861636843,0.4521072796934866,0.7185268204958981,1.0,12/59,13.00%,EPHA3;PTK7;WNT5B;WNT6;RBP4;RARG;CTSH;LYN;WNT9A;ABL2;FZD7;ADNP2
prerank,rRNA modification (GO:0000154),0.355465137480392,1.0020690335414006,0.45708582834331335,0.8449947624701923,1.0,5/21,12.05%,TSR3;TFB1M;FBL;DKC1;NHP2
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.43502178805294633,-1.001777316342858,0.47686832740213525,0.7189601552189612,1.0,6/10,47.71%,GNB1;SAG;PDE6A;CNGB1;PDE6G;PDE6B
prerank,response to light stimulus (GO:0009416),-0.2932073410327528,-1.0014948248049902,0.43378119001919385,0.7191864901015124,1.0,16/55,24.91%,GTF2H2;UBE4B;DDB2;BRSK1;ERCC3;REV1;UBE2B;ERCC8;MAP2K7;SPRTN;ZRANB3;MSH6;USF1;CCAR2;PRIMPOL;CRY2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4011883421101101,1.0014156227760629,0.453027139874739,0.8458052987292287,1.0,2/13,9.43%,IL12A;CYRIB
prerank,nucleotide biosynthetic process (GO:0009165),-0.3673446593556887,-1.000648548771133,0.4576271186440678,0.7208660895751748,1.0,10/18,27.62%,NMNAT2;RRM2B;ME1;PPAT;NMNAT3;NMNAT1;PRPSAP2;RRM1;PRPS1;PRPS1L1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2695461158632188,-1.0004055747678675,0.46215139442231074,0.7210242634843594,1.0,21/76,23.39%,BMP7;PTGIS;TAX1BP1;IRAK3;ANXA4;USP7;UFL1;IRAK2;PARP10;CYP1B1;PRMT2;CMKLR1;ARRB1;DAP;TRAF3;LRRC14;IRAK1;CDK5RAP3;CHP1;COMMD7;NLRC3
prerank,RNA 3'-end processing (GO:0031123),-0.27919116460916726,-1.0001205008931786,0.4740740740740741,0.721242341204919,1.0,21/69,23.25%,TENT2;PABPN1;PCF11;WDR33;CASC3;U2AF2;CPSF3;SRSF6;TUT4;SLU7;RPRD2;SRSF1;CSTF3;SRSF7;SRSF11;SRRM1;UPF3B;SRSF2;CSTF1;CPSF4;NUDT21
prerank,skeletal muscle tissue development (GO:0007519),-0.32602550578259515,-1.0000880801956227,0.4463276836158192,0.7208585632671192,1.0,6/32,11.68%,SVIL;CFLAR;SKI;IGSF8;SELENON;MEF2C
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.27770377148855957,-0.9994916024605043,0.4403846153846154,0.7219033525220132,1.0,12/66,10.24%,EGFR;SASH1;IL34;FGF1;PDGFRB;ROBO1;LRRK2;KIT;TAOK3;MAP3K5;TRAF2;PDGFC
prerank,glial cell differentiation (GO:0010001),0.3327943958322285,0.9991003323830168,0.43621399176954734,0.8516024286652236,1.0,10/28,18.84%,CDH2;PAX2;FGF10;RELN;TPPP;PTPRZ1;SOX4;HES5;METRN;SOX2
prerank,glycoprotein metabolic process (GO:0009100),-0.2949937495875929,-0.9990814406672316,0.4490566037735849,0.7223803817264041,1.0,18/53,19.51%,LARGE1;ST3GAL4;NGLY1;MAN1C1;OGA;GANC;ADAMTS9;MAN2A1;MAN1B1;HIF1A;MAN1A2;ERP44;MANBA;GANAB;MAN2A2;B4GALT5;PARK7;B4GALT7
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3384049387661326,0.9989334465546271,0.4449152542372881,0.8510032127735718,1.0,7/27,12.68%,THY1;ETS1;PRKCQ;SKAP1;CCL2;CYRIB;HSPD1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.36983666759176814,0.99865983498662,0.4605543710021322,0.8506774843522772,1.0,8/17,14.84%,BIN1;NTRK2;CLU;RTN2;HAP1;RTN1;SORL1;RTN4
prerank,fibrinolysis (GO:0042730),-0.4064707464011593,-0.9985212356633432,0.4876660341555977,0.7233300180248816,1.0,9/13,54.56%,PLAT;SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA
prerank,inorganic ion transmembrane transport (GO:0098660),0.41631590414111463,0.9984281548356426,0.4696629213483146,0.8502922701997704,1.0,3/12,12.77%,ASIC2;KCNJ11;KCNJ8
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.37057741374804054,-0.9983957615722212,0.45871559633027525,0.7231911221731137,1.0,8/19,18.77%,BMPR1A;SMAD6;MDM4;TGFBR2;SMAD4;ACVR1;HEYL;BMP2
prerank,regulation of axon regeneration (GO:0048679),-0.41299148096759286,-0.9982253399159412,0.4614003590664273,0.7231298506657532,1.0,3/12,8.09%,PTN;PTPRS;EPHA4
prerank,regulation of platelet aggregation (GO:0090330),-0.3756663781883118,-0.9981558618484545,0.4573055028462998,0.7228125678822154,1.0,8/17,27.15%,PDPN;CD9;LYN;PRKCD;PRKCA;F11R;SYK;ALOX12
prerank,long-chain fatty acid import into cell (GO:0044539),0.4263444403973722,0.9981366481822336,0.4411134903640257,0.8500379504595997,1.0,4/10,15.73%,SLC2A1;SLC27A4;CD36;ACSL3
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3238384161521864,-0.9981243716270192,0.44701348747591524,0.7224048213704243,1.0,9/30,19.07%,DSE;DCN;BGN;CHST15;HEXA;CHST11;CHPF2;CHSY1;CHST12
prerank,myotube differentiation (GO:0014902),0.3816114428488041,0.9978230926305072,0.4796573875802998,0.849793638223878,1.0,4/17,6.90%,ADGRB3;ADAM12;JAM2;KCNH1
prerank,megakaryocyte differentiation (GO:0030219),-0.4294639935641015,-0.9977069251523535,0.4853801169590643,0.7229776001691139,1.0,3/11,9.06%,KIT;UBA5;MED1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.33986187987566674,-0.9973384042119925,0.4588910133843212,0.7234309799849098,1.0,9/27,15.44%,CACNA1C;ANK2;DLG1;CAMK2D;JUP;ATP2A2;TRPM4;SRI;AKAP9
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.33464601674712435,-0.9972608998118778,0.45265151515151514,0.7231525354681463,1.0,15/28,32.72%,PRKAG2;PRKAA2;MED1;PRKAB2;SIRT5;CTNS;CX3CR1;AVIL;FGFR4;SIRPA;NR1H4;FITM2;TNFRSF1B;C3;PDK4
prerank,regulation of mitochondrial fusion (GO:0010635),0.4196004153101234,0.9971917379623465,0.47692307692307695,0.8505033801311892,1.0,2/11,2.11%,TFRC;OMA1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.34158125936264866,0.997164877831251,0.4601593625498008,0.8494580391326397,1.0,5/27,6.35%,B3GAT1;CHST9;B3GAT2;CSGALNACT1;CHSY3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.24564461986558928,-0.9965015902874661,0.4636542239685658,0.7246253548788006,1.0,14/142,6.22%,ATP1A2;CACNA1C;LPAR1;SMAD3;PLCE1;PDGFRA;ADCY5;ABL1;CD55;DLG4;ADRA1B;CCR9;HMGB1;EDNRA
prerank,negative regulation of defense response (GO:0031348),-0.2735000709375901,-0.9960814075436714,0.45149253731343286,0.7251951259116881,1.0,31/77,29.42%,PTGIS;IRAK3;TRAFD1;MAPKBP1;PCBP2;SELENOS;PTPN2;CCN3;NR1H3;ENPP3;PRKCD;RORA;RB1;ILRUN;APOE;C1QTNF3;FEM1A;METRNL;SHARPIN;LPCAT3;NLRC3;MAPK7;MVK;SIRPA;PPARA;DHX58;CACTIN;MUL1;TNFAIP3;GPER1;NR1H4
prerank,DNA catabolic process (GO:0006308),0.41468329586296016,0.9956396671392078,0.4479166666666667,0.8528640726927671,1.0,1/11,1.05%,DNASE1
prerank,Rap protein signal transduction (GO:0032486),-0.4365716830495147,-0.9954519095663144,0.48044692737430167,0.7262771120549458,1.0,4/10,20.08%,RAP1B;RAPGEF3;RAPGEF2;RAPGEF1
prerank,cell-cell junction maintenance (GO:0045217),0.4222334107389578,0.9951371019647439,0.44468085106382976,0.853324437879394,1.0,3/11,11.64%,CSF1R;F2R;TJP1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2694684056161253,-0.9949602290484292,0.4621212121212121,0.7269973861424335,1.0,15/73,12.71%,CYFIP2;ABL1;WASF2;LYN;CDC42;VAV2;BRK1;PLCG1;WASL;PRKCD;YES1;ABI1;NCKAP1;WIPF1;ARPC2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.383493059520131,0.9949171561903519,0.43710021321961623,0.8528898048818653,1.0,7/15,18.94%,RUVBL1;CCT2;DKC1;NHP2;CCT4;NAF1;TCP1
prerank,clathrin-dependent endocytosis (GO:0072583),0.3334293476141535,0.9948900975585617,0.4396551724137931,0.8518612179689108,1.0,8/26,14.07%,AP2M1;SNAP91;FNBP1L;FCHO1;AP2B1;SGIP1;DLL1;CLTB
prerank,cellular response to unfolded protein (GO:0034620),0.3358584095576741,0.994724798277045,0.4578059071729958,0.8512332316343997,1.0,6/26,12.68%,HSPA13;PACRG;HSPA8;HSPA5;DAB2IP;HSPD1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3636735945860302,-0.9946041571301232,0.4528301886792453,0.7273994932993718,1.0,5/20,18.35%,CD55;TRAF2;PRKCZ;IL18;TRAF6
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.34421221277890385,-0.9944434298282108,0.4894837476099426,0.7273287393569147,1.0,6/24,17.01%,NBL1;HMGB1;LYN;CCN3;DUSP1;SERPINE1
prerank,mesenchyme morphogenesis (GO:0072132),0.36843003452325035,0.9937316688534084,0.45751633986928103,0.8531566341241699,1.0,5/17,7.56%,HEY1;NOS3;NOTCH1;TGFB2;ACVRL1
prerank,C4-dicarboxylate transport (GO:0015740),0.39503668561855787,0.9936701200231406,0.45807770961145194,0.8522291355469949,1.0,3/14,7.95%,SLC1A1;SLC1A2;SLC25A14
prerank,mitochondrial fission (GO:0000266),0.37396910826898266,0.9935410058493297,0.47058823529411764,0.8515099114080403,1.0,4/16,12.49%,DNM3;GDAP1;MIEF1;SLC25A46
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3638420884986249,-0.9935284932455818,0.46449136276391556,0.7292775961979755,1.0,5/21,13.71%,ST3GAL4;B4GALT1;B3GALT1;ST3GAL3;ST6GALNAC5
prerank,monocyte differentiation (GO:0030224),0.4203866005451631,0.9928933632272543,0.4820627802690583,0.8523432586974985,1.0,3/10,5.18%,CSF1R;PPARG;MT1G
prerank,peptidyl-serine modification (GO:0018209),-0.24104627377161708,-0.9928671210441595,0.47035573122529645,0.7304276747853774,1.0,52/166,22.40%,ROCK2;TGFBR1;PKD1;TLK1;ROCK1;SMG1;CAMK1D;LRRK2;TGFBR2;CSNK1A1;TOP1;GSK3B;TBK1;MARK3;PAK2;EIF2AK3;CAMK2D;MTOR;PDPK1;WNK1;CSNK1E;HIPK1;BRSK1;PRKCD;DMPK;ULK2;PARP1;MKNK2;POGLUT2;RICTOR;PRKDC;LATS1;PRKCZ;CSNK2A1;MARK1;IKBKE;PRKACA;PRKD1;MORC3;GALNT1;CSNK1D;CDK2;NEK6;NTMT1;CAB39;MAST2;AKT2;MKNK1;ATR;MAP3K12;PRKCA;CLSPN
prerank,response to muramyl dipeptide (GO:0032495),-0.4138139449619198,-0.9927874416052782,0.48237476808905383,0.7301415048808394,1.0,3/12,9.47%,VIM;PTPN22;CHMP5
prerank,glucose homeostasis (GO:0042593),-0.2676888178566696,-0.9924697077779213,0.4647058823529412,0.7304682681758456,1.0,25/83,22.46%,TCF7L2;APPL2;LEPR;MCU;PRKAA2;CYB5R4;RBP4;IRS1;STAT3;LRRC8D;FOXK1;PPARGC1A;PTPN2;HIF1A;FOXK2;ADRA2A;CRTC2;PRKAA1;INPP5K;PARK7;FGFR4;PIK3R1;USF1;KCNB1;WFS1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.39486981753715206,0.992159454346559,0.4788135593220339,0.8534993095165825,1.0,1/14,1.04%,IL17F
prerank,negative regulation of inflammatory response (GO:0050728),0.2395365878152136,0.9921554488165361,0.4816326530612245,0.8524057794931825,1.0,37/182,18.47%,TEK;PRKAR2B;ADCY8;ADCY3;LRFN5;GIT1;RPS19;RAMP2;ADRB1;PPARG;RHBDF2;KLF4;ADCYAP1;GNG2;GPS2;POMC;CD163;GPR176;CD200R1;ADCY4;PROC;GGT1;PTGER2;MFHAS1;OTULIN;PLK2;NPSR1;AOAH;CALCRL;ADCYAP1R1;GPR45;PTGER4;CYSLTR1;TNFRSF1A;FYN;PRKAR1A;ADORA2B
prerank,renal water homeostasis (GO:0003091),0.35566057520473615,0.9915055982384168,0.4789915966386555,0.853161381645616,1.0,3/23,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,hydrogen peroxide catabolic process (GO:0042744),0.4201867674464245,0.9912107168647506,0.4700665188470067,0.8529421898258261,1.0,5/11,23.23%,GPX1;PRDX5;PRDX1;PXDN;GPX3
prerank,protein insertion into ER membrane (GO:0045048),-0.31810535179940097,-0.9910320327250225,0.4596153846153846,0.733665768707343,1.0,19/37,33.21%,EMC2;TRAM2;EMC7;VAMP2;STX5;EMD;EMC9;GET4;EMC4;VAPA;BAG6;EMC10;STX1A;EMC3;APP;CCDC47;GET3;EMC6;WDR83OS
prerank,negative regulation of viral process (GO:0048525),0.28908354400316094,0.9903625857764423,0.4908350305498982,0.8543781185122908,1.0,9/57,10.91%,MBL2;PROX1;TRIM13;ISG15;TRIM62;TRIM6;IFITM3;SLPI;MID2
prerank,endocardial cushion development (GO:0003197),0.3468756988602857,0.9901661449556333,0.48735632183908045,0.8538473344290048,1.0,7/21,12.87%,HEY1;NOS3;NOTCH1;TGFB2;ACVRL1;FOXF1;BMPR2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.32124466512650174,-0.9898063248201487,0.4751908396946565,0.7362638680481954,1.0,12/32,22.44%,MAP3K3;MEOX2;RHOJ;THBS1;FOXC2;ANXA1;RHOA;VEGFA;FGFBP1;FGF2;SRPX2;TBXA2R
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.25766884341444934,-0.9897881615026869,0.4748062015503876,0.7358199840176609,1.0,13/98,7.95%,EGFR;LRP1;SORBS1;EPHA3;CEMIP;SLC5A3;PRKN;PTPN9;DLG1;ITGB1;TFDP2;BCL2;PDPK1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.3971588343661987,0.9895843469948962,0.4688888888888889,0.8545161099683565,1.0,2/12,1.57%,EPHB1;SPTBN4
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.28051945065707407,-0.9895780659826146,0.4713740458015267,0.7358425729321544,1.0,22/62,26.40%,PUM2;WTIP;TNRC6A;RANBP2;STAT3;DHX9;PUM1;NUP42;NUP214;LIMD1;TPR;POLR2H;AJUBA;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;FXR1;NUP93
prerank,lymphocyte mediated immunity (GO:0002449),-0.4185272229085186,-0.9895150069283387,0.4915254237288136,0.7355003899291666,1.0,2/12,3.68%,JAG1;CD55
prerank,proteolysis (GO:0006508),-0.22597928544806928,-0.9894099255651884,0.48065173116089616,0.7352838332105323,1.0,48/252,17.11%,CPQ;TRABD2B;AEBP1;ADAMTS12;PCSK5;TBL1X;XPNPEP1;HTRA3;PLAT;HM13;CTSC;CTSH;DPP4;ADGRV1;DPP8;F3;DDI2;ECE1;SENP6;ANPEP;FBXO3;ADAMTS9;NCSTN;LONP2;MMP14;SENP1;LAP3;ADAM19;FAP;YME1L1;MMP2;SUFU;NPEPPS;ADAM33;NLN;CPM;OGT;CASP2;LACTB;CTSA;CPXM2;MBTPS1;PTCH1;LNPEP;ATG4D;SPRTN;CLPP;CPXM1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.41972922799118734,-0.9890017853019102,0.48816029143898,0.7358110315325768,1.0,4/11,6.65%,IGF1;GHR;IRS1;EIF2AK3
prerank,protein hydroxylation (GO:0018126),-0.39089853311499,-0.9888861034430695,0.4960159362549801,0.7356197146686319,1.0,4/15,10.09%,PLOD2;P3H3;ASPH;EGLN3
prerank,ribonucleoprotein complex assembly (GO:0022618),0.24849568242933737,0.9885529150569031,0.4742063492063492,0.8565134686795846,1.0,34/132,17.88%,RPS19;GEMIN8;RPL38;RPF2;RPS27;RPL10;CELF5;SNRPC;CELF4;XAB2;RPLP0;HSP90AB1;PRMT7;MRPS7;RPS15;LSM4;RPL5;WDR77;SNRPD2;SNRPD1;RPL23A;NOP2;RPS14;DDX20;DDX1;RPS5;RPS28;MDN1;PTGES3;XRCC5;HSP90AA1;NAF1;PPAN;CELF6
prerank,activation of adenylate cyclase activity (GO:0007190),0.30766710911179035,0.9882767877117519,0.44880174291938996,0.8562509438099132,1.0,7/35,11.11%,ADCY8;ADCY3;ADRB1;LGR5;ADCYAP1;CAP2;ADCY4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3613362556633144,0.9880233801966257,0.46284501061571126,0.8558699322994139,1.0,7/19,16.63%,TMEM109;SIRT1;HIPK2;BCL3;AEN;DDIT4;CDIP1
prerank,myelin assembly (GO:0032288),0.4409238518608205,0.9876016801632831,0.46744186046511627,0.8560909745372643,1.0,4/10,9.18%,TENM4;EPB41L3;CNTNAP1;TPPP
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3035086659812796,-0.987255545153235,0.4708097928436911,0.7391591660642248,1.0,15/40,21.31%,ARAF;RAD23B;AXIN1;UFL1;NUB1;RPL11;FBXW7;SMURF1;LATS1;TRIM39;PDCL3;CSNK2A1;PML;DESI1;CDK5RAP3
prerank,cation transmembrane transport (GO:0098655),-0.3024220902129629,-0.9869363294645994,0.4656188605108055,0.739488828870471,1.0,7/44,8.33%,ATP1A2;TRPM3;SLC7A2;TRPM6;SLC22A5;SLC6A9;SFXN2
prerank,myeloid cell development (GO:0061515),-0.3673271703325189,-0.9867137246045047,0.47289719626168225,0.7395646098222218,1.0,4/18,9.06%,FOXP1;KIT;ANXA2;MED1
prerank,protein localization to chromosome (GO:0034502),-0.31329856749485563,-0.9864636489066159,0.4806949806949807,0.7397210587067489,1.0,19/34,37.29%,TNKS2;MCM9;XRCC4;RAD21;RB1;SLF1;TERF2;ATR;IFFO1;BOD1;ATRX;ESR1;PARP3;WAPL;PINX1;RPA2;SLF2;MSH2;MRNIP
prerank,potassium ion homeostasis (GO:0055075),-0.34188170193496775,-0.9864195161844042,0.46303501945525294,0.7393358091628076,1.0,7/23,20.33%,ATP1A2;SLC12A7;KCNJ2;SLC12A2;SLC12A8;ATP1B3;SLC12A9
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.36898423123433344,0.9864127924130706,0.4957627118644068,0.858616013460851,1.0,4/17,8.42%,SIRT1;NME5;AKT1;HSPB1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3182069162679787,-0.9861664353642415,0.5,0.7394600948128901,1.0,13/36,18.05%,TGFBR1;DEPTOR;ASAH2;BCL2;RB1;ING5;TPD52L1;TRIM39;CSNK2A1;DAPK2;NR4A2;BCL2L12;CX3CR1
prerank,positive regulation of intracellular transport (GO:0032388),-0.3052732733644575,-0.9854159176814434,0.45610687022900764,0.7409029105000745,1.0,13/38,18.26%,PCM1;NUMA1;BCAS3;STX18;PCNT;EHD2;VAMP2;ACTN2;TBC1D20;TPR;DYNC1H1;ICE1;EIPR1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.30078717732420557,-0.9853169594399416,0.46435845213849286,0.740667023733836,1.0,14/40,21.31%,TIMP3;EGFR;MDM4;ROCK1;FLNA;IRAK3;PTPN3;SNRNP70;ATRAID;CTSA;HMGCR;CYP51A1;TIMP2;CDK5RAP3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3316438320603824,0.9852943016774911,0.47435897435897434,0.86090727335568,1.0,3/27,4.46%,FLT1;TEK;FLT3
prerank,protein homooligomerization (GO:0051260),0.25699766093554083,0.9851799922830636,0.49382716049382713,0.8601515516529259,1.0,13/114,7.42%,MPP2;HCN1;ADCY8;KCNC2;MIF;AQP11;RYR3;GLRA3;ASIC1;SLC1A2;TRPM2;NINJ1;HPRT1
prerank,iron ion transport (GO:0006826),-0.2897798431353369,-0.9849700631931272,0.4826923076923077,0.7410238846487958,1.0,7/47,7.13%,CP;STEAP3;ATP6V1B2;SCARA5;ATP6V0D1;SLC39A14;ATP6V0A4
prerank,positive regulation of chromosome organization (GO:2001252),-0.3854727936556351,-0.9847727706109155,0.48256880733944957,0.7410045838004334,1.0,8/15,27.53%,NBN;DHX36;RAD21;MRE11;PML;PPP1R10;GNL3;ATRX
prerank,synaptic vesicle transport (GO:0048489),-0.42135358713463766,-0.9847147976850668,0.4715909090909091,0.7406465463991165,1.0,4/11,26.29%,TMEM230;SPG11;TOR1A;KIF5B
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4240510877201859,-0.9844433728494727,0.5009041591320073,0.7408287697292165,1.0,1/10,0.08%,BMP6
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.38960806837043904,0.9842571008954969,0.4634703196347032,0.8617948694217799,1.0,3/13,13.00%,TMEM30A;SAR1A;SORL1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.3182116584535789,0.984071825684245,0.48096192384769537,0.861271430307947,1.0,5/31,13.15%,TIRAP;PLCB1;TLR2;HSPD1;CD40
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.33833118794624906,0.9838306374419618,0.5086206896551724,0.8609154599671454,1.0,3/26,3.87%,GRIN1;ADGRB1;SNCA
prerank,photoreceptor cell development (GO:0042461),0.3859916742865757,0.9837010690089937,0.4799154334038055,0.8602075362170802,1.0,4/14,14.27%,AHI1;MFSD2A;RORB;DCX
prerank,icosanoid metabolic process (GO:0006690),-0.2986965697281419,-0.9836387769913258,0.46950092421441775,0.7424217152503134,1.0,16/40,29.81%,PTGIS;DAGLA;PTGS1;CYP1B1;PLA2G4A;PON2;PNPLA8;EPHX1;MGLL;DAGLB;ABCC10;PON3;GGT5;ALOX12;PLA2G4C;TBXAS1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.34706568966275,0.9835320284381804,0.46764091858037576,0.8596271912877125,1.0,3/21,6.98%,GRIN1;GRIN2B;BEX3
prerank,response to hydroxyurea (GO:0072710),-0.4170312647672679,-0.9833723992563311,0.48713235294117646,0.7425916337649188,1.0,2/11,7.42%,SPIDR;DDI2
prerank,glycoprotein biosynthetic process (GO:0009101),0.27115409201021606,0.9829267587428735,0.4827586206896552,0.8603664303378972,1.0,17/79,14.11%,ST8SIA4;ST3GAL6;CHST9;CSGALNACT1;ST8SIA1;FUT9;ALG3;B3GALT5;ALG1;MPI;ST8SIA6;B3GNT2;ST8SIA3;SERP1;BMPR2;BMPR1B;GOLGA2
prerank,lytic vacuole organization (GO:0080171),-0.3163906546941783,-0.9822798784450698,0.4837476099426386,0.7449053685447005,1.0,6/32,7.41%,ABCA1;LRRK2;TFEB;ZKSCAN3;MTOR;TPCN2
prerank,lipoprotein transport (GO:0042953),0.41843573874924805,0.9821625094860954,0.47468354430379744,0.8615827879312996,1.0,4/10,13.89%,PPARG;ZDHHC17;VMP1;CD36
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.34751043001129744,-0.9819419899636337,0.4912959381044487,0.7452648344378748,1.0,8/22,28.12%,SASH1;RELL1;VEGFA;BMP2;SPHK1;EMC10;GADD45G;MINK1
prerank,T cell migration (GO:0072678),-0.401756452215825,-0.9818153517089522,0.49609375,0.7451060148959935,1.0,9/13,47.48%,CXCL16;SLC12A2;PIK3CD;MSN;GPR183;PIK3CG;CXCL10;MYO1G;ZAP70
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.377541652336148,-0.981693016688915,0.49427480916030536,0.7449629423270625,1.0,9/17,25.23%,EFNB2;ROBO1;NRP1;VEGFA;NR4A1;MIA3;FGF2;SLIT2;EPHB4
prerank,cellular response to light stimulus (GO:0071482),-0.2780659121961909,-0.98164345092328,0.4868913857677903,0.7445894388893503,1.0,29/66,39.14%,INO80;EP300;CREBBP;DHX36;PTPRK;ZBTB1;PRKCD;USP47;PARP1;EIF2AK4;GNB1;SDE2;PCNA;BMF;ATR;USP28;KDM1A;SAG;RUVBL2;BAK1;OPN3;PDE6A;GPR88;NPM1;TRIAP1;NEDD4;TP53;CDC25A;CNGB1
prerank,carboxylic acid catabolic process (GO:0046395),-0.40999593079624935,-0.9811580760048653,0.4836852207293666,0.7453268543731366,1.0,8/12,46.19%,RENBP;BCKDK;ACOT8;PON3;NPL;IL4I1;NAGK;GNPDA1
prerank,cardiac muscle cell contraction (GO:0086003),0.35938974212138847,0.9808239751405771,0.4780701754385965,0.8644828425113159,1.0,4/19,5.57%,SCN1A;FGF12;CACNA2D1;SCN4B
prerank,negative regulation of transport (GO:0051051),0.29112615200542336,0.9805395976082393,0.5,0.86422385606397,1.0,8/51,7.93%,NRG1;SYT11;MCTP1;PPM1F;SNCA;TLR2;DYSF;YRDC
prerank,cardiac muscle cell action potential (GO:0086001),0.32333844700031766,0.9804912337851336,0.49356223175965663,0.8632869557298252,1.0,7/30,6.56%,SCN1A;FGF12;CACNA2D1;SLC8A1;SCN4B;HCN2;KCND3
prerank,acetyl-CoA metabolic process (GO:0006084),0.37910817070515107,0.9803077224524882,0.48132780082987553,0.8627497207852601,1.0,7/15,24.93%,MVD;ACSS1;HMGCS1;PPCS;PMVK;ACAT1;DIP2A
prerank,positive regulation of protein deacetylation (GO:0090312),-0.3919169507763378,-0.980074301618279,0.47128712871287126,0.7475460257154649,1.0,8/14,30.74%,AKAP8L;NIPBL;SAP30BP;FNTA;ZBTB7B;DYRK1A;NNMT;BRMS1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3053547066871771,-0.9800135269298815,0.488,0.7472281444627429,1.0,5/40,7.88%,IGF1;OPA1;PRKN;DNM1L;FAM162A
prerank,response to glucose (GO:0009749),-0.29379753448316726,-0.9800129249404113,0.5045537340619308,0.7467441650457706,1.0,17/46,23.18%,ZBTB20;TCF7L2;PRKAA2;SLC39A14;THBS1;VAMP2;UNC13B;SELENOS;PCK2;ERN1;ZBED3;PRKACA;PRKAA1;EIF2B4;PFKL;KCNB1;EIF2B5
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3007409069827658,-0.9799225984176815,0.48902195608782434,0.7465038401563046,1.0,15/44,22.48%,BMP7;BMP4;IRAK3;LYN;PTPN22;PRKCD;APOE;DUSP1;DUSP10;PDCD4;PTPN1;INPP5K;CDK5RAP3;DUSP7;CD300A
prerank,dorsal/ventral pattern formation (GO:0009953),-0.3476198623383274,-0.9798722346824319,0.4934086629001883,0.7461509011608022,1.0,3/20,1.77%,BMPR1A;GLI2;NBL1
prerank,regulation of protein kinase activity (GO:0045859),0.2540191820784147,0.979722576875919,0.49691991786447637,0.863354803239618,1.0,26/106,16.87%,MMD2;SIRT1;CAMK2N1;GAS6;PPM1F;SNCA;THY1;MAPRE3;TRIB3;ADCYAP1;AKT1;YWHAG;HSPB1;RELN;SMG8;CEP43;UBASH3B;DVL1;EPHA1;TAB2;CDKN1A;RAP1A;GNAQ;DDR2;XRCC5;RAP2B
prerank,sterol transport (GO:0015918),-0.3632288842466246,-0.979315861762123,0.5,0.7470258871596585,1.0,7/19,34.61%,OSBPL5;LDLR;NPC2;ARV1;CAV1;MSR1;LCAT
prerank,acylglycerol metabolic process (GO:0006639),0.2994069034903745,0.9791321367831003,0.4628099173553719,0.8641145270231131,1.0,5/37,7.01%,DGKI;ABHD2;DGAT2;DGKH;DGKB
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3702911709006552,-0.979036585976855,0.4797687861271676,0.7472585944838468,1.0,2/18,7.01%,ATP1A2;CAMK2D
prerank,RNA splicing (GO:0008380),-0.2553616958571227,-0.9787355720395041,0.4782608695652174,0.7475604770436252,1.0,34/95,26.80%,SYNCRIP;SRSF10;FUS;SF3B1;PRPF6;RNPC3;PPARGC1A;SLU7;PRPF3;USP39;SCAF11;SF3A3;RSRC1;ZCRB1;DDX23;TCERG1;SFPQ;ZMAT5;SNRPF;SRSF7;SRSF11;GEMIN2;SRRM1;PPP2CA;SRSF2;USB1;LUC7L3;CCAR2;SMU1;DHX15;NONO;NCBP2;PRPF8;LSM6
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.36208968149123955,-0.9786299043172956,0.4928825622775801,0.7473296591074944,1.0,4/18,12.34%,FLNA;PHF8;EIF2AK3;WDR43
prerank,protein maturation (GO:0051604),0.2575645042105265,0.9786120460715311,0.49166666666666664,0.8646157072519658,1.0,19/95,13.71%,MME;LMF2;PCSK1;PCSK2;METAP2;PHEX;PCSK6;PSENEN;MMP16;PITRM1;PCSK7;TSPAN17;TMPRSS4;TSPAN14;HSPD1;SORL1;TASP1;GALNT2;PSEN1
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.27447657220482025,-0.9780607037834977,0.49101796407185627,0.7482594411046625,1.0,24/64,29.43%,ACSL1;DAGLA;ASAH2;CPT2;CYP1B1;PLA2G4A;ACSL6;PNPLA8;EPHX1;EPHX2;ACOX1;ACAD9;CPT1A;MGLL;ACSL4;ELOVL1;ACOT8;DAGLB;GSTM2;ACSBG1;ALOX12;ELOVL5;PLA2G4C;AIG1
prerank,defense response to tumor cell (GO:0002357),-0.426695398063463,-0.977835330222427,0.5028790786948176,0.7483728680497168,1.0,4/10,22.89%,RBMS3;DAPK1;PRDX2;PLK5
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3527345478168755,0.9772052560845028,0.45267489711934156,0.8676138076772908,1.0,5/19,7.54%,TEK;PPM1F;KDR;THY1;PTPRJ
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.39916599464837915,0.9761682751142623,0.49387755102040815,0.8695213367042711,1.0,3/12,8.88%,FUT9;AKT1;SKAP1
prerank,positive regulation of protein metabolic process (GO:0051247),-0.24874994438592063,-0.9757711373930456,0.508130081300813,0.7530944085022996,1.0,32/110,23.47%,ROCK2;SMURF2;PRKN;WWP2;GSK3B;GPC3;HUWE1;AXIN1;WWP1;SEC22B;SLC6A9;DACT1;NR1H3;AGTR1;STX5;APOE;SMURF1;RANBP9;IL17D;CSNK2A1;IL18;ASB5;WNT5A;AREL1;VCP;EIF4G1;INHBA;SNF8;WFS1;CD80;NSF;MAPK7
prerank,phosphatidylserine metabolic process (GO:0006658),-0.31108621943614756,-0.975666052030665,0.4843137254901961,0.7528690782097246,1.0,10/32,23.00%,OSBPL8;PLSCR1;OSBPL5;PLA2G4A;PTDSS1;SLC27A1;PLA1A;ABHD12;LPCAT3;PTDSS2
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3995303792559164,-0.9752081587339995,0.5100548446069469,0.753473762427152,1.0,6/13,29.28%,RNF152;SESN1;CASTOR2;SZT2;KPTN;CASTOR1
prerank,positive regulation of macrophage migration (GO:1905523),-0.3548899134327239,-0.9750801888483082,0.5046728971962616,0.7533084194683011,1.0,5/19,16.18%,IL34;THBS1;P2RY12;P2RX4;CMKLR1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.39542075055774994,-0.9750634819168577,0.514,0.7528622075062895,1.0,3/13,8.60%,CACNA1C;ANK2;GJA1
prerank,icosanoid secretion (GO:0032309),-0.40235967282857776,-0.9748407509469388,0.4763705103969754,0.7529384629082657,1.0,3/12,15.56%,ANXA1;PNPLA8;BDKRB2
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.30926757185988835,-0.9745701821749572,0.5063063063063064,0.7531312034721489,1.0,10/36,14.09%,NR2F2;DCN;HMGB1;THBS1;SP100;JUP;ADAMTS9;MEF2C;ANGPT2;APOE
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3210391316359844,-0.9743531600028403,0.4781021897810219,0.7531749947176262,1.0,8/28,17.57%,PTN;ABL1;GSK3B;ADCY1;EPHA4;EIF2AK4;APOE;FAM107A
prerank,negative regulation of cellular senescence (GO:2000773),-0.3989257728407717,-0.9742894957799793,0.5009487666034156,0.7528479810504398,1.0,8/13,24.88%,MAP3K3;ZKSCAN3;SLC30A10;YBX1;TERF2;TERT;CDK6;TWIST1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.31450434579529224,-0.9741605150605681,0.491395793499044,0.7526936288947066,1.0,13/29,43.90%,DDO;ACADSB;PRODH;SARDH;ALDH4A1;CBS;KMO;GOT2;BLMH;HGD;IL4I1;FAH;HAAO
prerank,membrane lipid metabolic process (GO:0006643),0.3424354897202682,0.9741559137851526,0.48903508771929827,0.8743900656531076,1.0,4/22,8.57%,GAL3ST1;ST3GAL6;TECR;SERINC1
prerank,regulation of inflammatory response (GO:0050727),-0.23436593661895117,-0.9741512795567554,0.5298969072164949,0.7522365244920897,1.0,55/190,24.16%,FOXP1;ADAMTS12;CELF1;NR1D2;PTGIS;SBNO2;SNX6;DAGLA;UFL1;IL16;ANXA1;DHX9;VAMP2;CASP12;XIAP;IL17RA;SELENOS;PTPN2;CCN3;NR1H3;PTGES;ENPP3;PRKCD;NAPEPLD;NFKBIZ;RORA;AGTR1;RB1;PIK3AP1;APOE;C1QTNF3;GPR4;FEM1A;IL18;PDCD4;SERPINE1;TLR4;CCN4;WNT5A;AREL1;IFI35;METRNL;PARK7;MGLL;SHPK;SHARPIN;LPCAT3;SPHK1;DAGLB;USP18;NLRC3;MAPK7;MVK;SIRPA;IL1RL2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.37335928329234064,0.9735506051211944,0.5192307692307693,0.8751058025946304,1.0,6/16,19.24%,ATP5F1D;ATP5F1B;ATP5ME;ATP5MF;DMAC2L;ATP5MG
prerank,protein acetylation (GO:0006473),-0.32183508337839845,-0.9733853515745816,0.5019305019305019,0.7537020487865573,1.0,8/30,16.29%,KAT2B;EP300;CREBBP;HAT1;ING5;NAA15;ESCO1;GTF2B
prerank,artery development (GO:0060840),-0.33991023763656186,-0.9733410307804629,0.494949494949495,0.7533365694438414,1.0,8/23,16.74%,TGFBR1;ROBO1;NRP1;HES1;PKD2;EFEMP2;VEGFA;HECTD1
prerank,macrophage differentiation (GO:0030225),-0.3970775376169667,-0.973204893308913,0.47718631178707227,0.7532258225026387,1.0,5/13,14.36%,IL31RA;BMP4;CDC42;PARP1;VEGFA
prerank,regulation of protein neddylation (GO:2000434),0.4207332559115446,0.9730556357027761,0.5106382978723404,0.8754783864493463,1.0,4/10,15.73%,COPS9;EPAS1;RPL5;DCUN1D2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.25789354557832606,-0.9728647173933461,0.5270541082164328,0.7536058695332677,1.0,22/87,23.02%,RBFOX2;FLRT2;HNRNPH1;FGF1;SHOC2;HNRNPM;FGFR2;FRS2;KIF16B;KL;FLRT1;FIBP;NR4A1;FGFBP1;CEP57;POLR2H;PTPN11;SPRED2;FGFR4;FGF2;GTF2F1;POLR2K
prerank,regulation of epithelial cell migration (GO:0010632),-0.28605411432899014,-0.9726091769259525,0.503006012024048,0.7537757210529471,1.0,14/51,16.46%,DOCK5;SASH1;PTN;RHOJ;RREB1;CTSH;GLUL;PLCG1;HIF1A;BMPER;RAB11A;GLIPR2;DUSP10;DOCK1
prerank,nucleotide catabolic process (GO:0009166),0.37969748441415446,0.9725275108239457,0.4789356984478936,0.8759656557074829,1.0,3/16,9.52%,NUDT3;GPX1;NT5C
prerank,"wound healing, spreading of cells (GO:0044319)",-0.3379862842592815,-0.9724267916221142,0.49506903353057197,0.7537830299136851,1.0,11/24,23.15%,COL5A1;PDPN;FLNA;ARHGAP24;RHOA;CCN1;ITGA5;DDR1;RHOC;TOR1A;ARHGAP35
prerank,RNA transport (GO:0050658),-0.27341378072188366,-0.9723577309721397,0.5069582504970179,0.753485687677834,1.0,21/71,23.72%,TGFBR2;CASC3;U2AF2;SRSF6;SIDT1;SLU7;EIF4E;SLBP;NUP214;TPR;YBX1;SRSF1;NXF1;SIDT2;SRSF7;SRSF11;SRRM1;UPF3B;SRSF2;XPO5;RTRAF
prerank,plasma membrane tubulation (GO:0097320),-0.39671433092103453,-0.9720433476418016,0.4934086629001883,0.7538212142915086,1.0,5/13,15.29%,PACSIN2;SNX9;CHMP4A;EHD2;WHAMM
prerank,apical junction assembly (GO:0043297),-0.2839689695584134,-0.9720072548239576,0.5078740157480315,0.7534329513125568,1.0,9/53,10.27%,AFDN;VCL;MPP7;PARD6G;CTNNA1;DLG1;PAK2;CLDN11;RHOA
prerank,protein deubiquitination (GO:0016579),-0.2261830745261979,-0.9718532321176424,0.5363457760314342,0.7533446815792508,1.0,46/242,14.79%,SMAD3;TGFBR1;INO80;SMURF2;MDM4;USP24;KAT2B;EP300;PRKN;RAD23B;USP7;SMAD2;WDR48;TRRAP;ENY2;BRCC3;MYSM1;AR;FOXK1;DDB2;VCPIP1;USP33;TRAF2;RHOA;TADA3;HIF1A;HCFC1;SMAD4;RHOT1;USP47;WDR20;PSMF1;OGT;USP12;KDM1B;USP11;USP4;ABRAXAS2;BECN1;USP46;USP35;USP50;PSMB2;USP2;OTUD4;USP13
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.34327814299067705,-0.9715244333799419,0.483271375464684,0.7536325574295406,1.0,5/21,9.10%,ADCY9;ADCY5;ADCY1;ADCY6;GUCY1A1
prerank,pyruvate metabolic process (GO:0006090),0.2860202369523909,0.9715103592996063,0.49798387096774194,0.8779067931100113,1.0,16/52,21.41%,BSG;PGAM4;PGAM1;ALDOC;PDHB;GCK;SLC16A1;PFKFB2;DLAT;GAPDHS;NR4A3;LDHB;LDHA;ENO2;SRR;GPI
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.4300814425338958,-0.9713626204678388,0.5173745173745173,0.7535594565820762,1.0,5/10,27.53%,INO80;STOML2;SSBP1;DBF4;ATRX
prerank,glycolytic process (GO:0006096),0.3251932884567075,0.9709612864774013,0.49176954732510286,0.8785002879680079,1.0,9/28,21.41%,PGAM4;PGAM1;ALDOC;GCK;PFKFB2;GAPDHS;LDHA;ENO2;GPI
prerank,DNA metabolic process (GO:0006259),-0.22187011470882514,-0.9708859923732839,0.5353535353535354,0.754275492276713,1.0,111/270,33.62%,TCF7L2;INO80;UBE2N;KMT5B;RBBP8;UVRAG;TOP1;HMGB1;USP7;UHRF2;NBN;RAD51B;TRRAP;PDS5A;WRN;SP100;DDB2;ZBTB1;CSNK1E;UPF1;MNAT1;PARP1;RAD21;RAD51D;PDS5B;ERCC3;ALKBH1;NABP2;KMT5C;DDX23;PARP4;MMS19;PRKDC;HINFP;UBE2B;MCM6;CTC1;MSH3;DMC1;NOP53;MRE11;GLRX2;HELB;ZRANB3;PRIM2;TOP2B;VCP;PARK7;MSH6;CDK2;TERF2;POLE4;POLA2;TERT;PCNA;SMC1A;FANCC;RPAIN;STN1;XRCC6;ATR;UBE2V2;SMARCAL1;DNASE2;NSMCE4A;RAD51C;ERCC1;GTF2H1;PRIMPOL;DBF4;POLE2;CBS;RECQL5;OGG1;ENDOV;ORC1;RAD54L;LONP1;GTF2H4;DNASE1L1;MCM4;MPG;CDC34;POLH;TIMELESS;IGHMBP2;SUPV3L1;NUDT1;KPNA2;PARP3;MGMT;TOP1MT;SAMHD1;UBA52;FANCG;PARG;PARP2;POLD2;NEIL3;RPA2;RAD9A;PNKP;RMI2;RAD51;PSME4;CDC45;POLA1;DDB1;LIG4;BRCA1;RAN
prerank,respiratory chain complex IV assembly (GO:0008535),0.3532639725085444,0.9705791378603154,0.4892241379310345,0.8784549144652076,1.0,11/21,20.69%,TIMM21;COA5;FASTKD3;COX16;COX17;BCS1L;COA6;COX10;COA3;OXA1L;SCO1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.4103810343843706,0.9705581973758036,0.5010351966873706,0.8774230471984978,1.0,3/11,14.55%,TIRAP;PJA2;MFHAS1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.38459086568965767,0.9704415770368332,0.4883227176220807,0.8766848623486843,1.0,4/14,16.17%,RPF2;RPL7;ZNHIT6;DDX18
prerank,regulation of endothelial cell proliferation (GO:0001936),0.26157781989753276,0.9703505310158206,0.5251046025104602,0.8758716677405636,1.0,14/88,10.54%,EGFL7;TEK;PROX1;PLXNB3;TIE1;SIRT1;CAV2;PPP1R16B;KDR;ACVRL1;AKT1;PDGFB;PTPRM;SCG2
prerank,focal adhesion assembly (GO:0048041),-0.35318487638912355,-0.9701893362065089,0.5009784735812133,0.7555615513902748,1.0,6/21,15.29%,SORBS1;BCR;PTPRK;ACTN2;CTTN;WHAMM
prerank,regulation of endocytosis (GO:0030100),-0.2732457807793866,-0.9701676370952812,0.5037453183520599,0.7551441114989278,1.0,24/61,25.91%,LRP1;EPHA3;DAB2;ROCK1;ABL1;PACSIN2;GPC3;STON2;ARFGAP1;ABL2;APOE;ZFYVE16;RUBCN;PICALM;PRKD1;PTPN1;ABCA7;LRSAM1;STON1;SPHK1;HIP1R;SNX12;RAB5A;CLIP3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4046685394849973,-0.9700231666145949,0.5210727969348659,0.7545219604606055,1.0,2/12,4.33%,IGF1;SLC9A1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4046685394849973,-0.9700231666145949,0.5210727969348659,0.7545219604606055,1.0,2/12,4.33%,IGF1;SLC9A1
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.334631083741297,-0.9699940521219227,0.5080321285140562,0.7541059748272558,1.0,5/25,16.18%,ITPR1;LRRK2;TMBIM4;P2RX4;CMKLR1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.3578384661579,0.9695356006365698,0.525,0.877273116587921,1.0,3/19,5.51%,CLDN5;PRKCH;OCLN
prerank,atrial septum morphogenesis (GO:0060413),-0.42305446588436335,-0.9693272260354167,0.5171790235081374,0.7552648670098677,1.0,1/10,0.31%,NOTCH2
prerank,negative regulation of JNK cascade (GO:0046329),-0.3158419893952074,-0.9690915474307721,0.5,0.7553723815656125,1.0,9/31,16.91%,NCOR1;PRKN;TAOK3;DACT1;PTPN22;FKTN;SH3RF2;DUSP10;PDCD4
prerank,7-methylguanosine RNA capping (GO:0009452),-0.31980779733566644,-0.9686163429701968,0.4880294659300184,0.755548529321557,1.0,14/31,27.98%,GTF2H2;CCNH;CDK7;MNAT1;ERCC3;RNGTT;POLR2H;GTF2F1;POLR2K;GTF2H1;POLR2E;NCBP2;GTF2H4;POLR2D
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.31980779733566644,-0.9686163429701968,0.4880294659300184,0.755548529321557,1.0,14/31,27.98%,GTF2H2;CCNH;CDK7;MNAT1;ERCC3;RNGTT;POLR2H;GTF2F1;POLR2K;GTF2H1;POLR2E;NCBP2;GTF2H4;POLR2D
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2957363340198865,-0.9685822380220136,0.477859778597786,0.755160350235118,1.0,8/41,12.87%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT
prerank,regulation of response to oxidative stress (GO:1902882),0.39143039464454116,0.9682612653358226,0.5074309978768577,0.87997010768646,1.0,4/11,16.06%,MCTP1;HEBP2;GGT7;STOX1
prerank,negative regulation of cilium assembly (GO:1902018),-0.4011928489015858,-0.9679802943250069,0.5054347826086957,0.7562071740922631,1.0,7/12,27.43%,YAP1;MAP4;ODF2L;CDK10;TBC1D7;TCHP;TESK1
prerank,vesicle transport along microtubule (GO:0047496),-0.3336847155583394,-0.9679005859446878,0.4831013916500994,0.7559387875149252,1.0,9/23,26.29%,TRAK1;KIF13A;NDEL1;KIF1C;DYNC1H1;FBXW11;KIFAP3;KIF3A;KIF5B
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.35381031150302844,-0.9678696655181156,0.5067961165048543,0.7555405626752477,1.0,8/19,27.00%,GFPT1;UAP1;PMM2;RENBP;SLC35D1;UAP1L1;PGM3;NANS
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.22371565227007045,-0.9676938662339059,0.5490196078431373,0.7554804857414401,1.0,55/234,18.53%,ROR1;SMAD3;NFKB1;SLCO3A1;LRP6;PLPP3;UBE2N;CFLAR;ZIC2;STK3;EP300;HDAC4;ERC1;CAMK1D;SMO;EDA;FLOT2;KIT;IRAK3;PPARGC1B;FZD2;STAT3;ADCY1;IRAK2;DHX9;TRIM8;CEBPG;CRTC3;AR;PPARGC1A;JUP;ATF2;FER;TRAF2;CRTC1;MAVS;MBTPS2;TRIM5;ARID5B;TCF3;TRIM25;ANXA3;CARD14;EIF2AK2;VEGFA;PRKCZ;IL18;IKBKE;TLR4;CRTC2;WNT5A;PRKD1;CX3CR1;TRAF6;FZD1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3593891366995982,-0.9675986811135916,0.49818840579710144,0.7552513925452554,1.0,8/18,18.77%,BMPR1A;MDM4;BMP4;TGFBR2;ACVR1;HEYL;TBX2;BMP2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.33481838466356434,0.9675004227272642,0.5009940357852882,0.8811227950140866,1.0,4/22,8.73%,PSMA1;ENC1;PSMA6;PSMB3
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.35545214769785055,0.96746911146516,0.49583333333333335,0.8801368582999206,1.0,4/18,8.04%,TRIM13;RPS27A;UBC;UBB
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.40648623524935557,-0.9671701765900103,0.5265225933202358,0.755842730891374,1.0,3/12,4.74%,PCM1;NIN;NINL
prerank,cellular response to hydroxyurea (GO:0072711),-0.41786303040662576,-0.9670725644534783,0.4990825688073395,0.7556234555683422,1.0,2/10,7.42%,SPIDR;DDI2
prerank,monocarboxylic acid transport (GO:0015718),-0.28454538121532547,-0.9669503595573027,0.5141776937618148,0.7554217085654371,1.0,10/51,10.92%,SLC6A13;SLC16A12;SLCO3A1;SLC6A12;SLCO2A1;SLC16A6;ATP8B1;NCOA1;SLC16A9;SLC5A6
prerank,nuclear membrane organization (GO:0071763),-0.3613926043110976,-0.9665547627667973,0.5248091603053435,0.7559106240822114,1.0,7/19,29.16%,UBXN2B;AKAP8L;CHMP4B;EMD;TOR1A;NEMP1;GPER1
prerank,cardiac muscle cell development (GO:0055013),-0.3534864444318174,-0.9659909956109927,0.499009900990099,0.756844674191866,1.0,5/20,7.30%,PDGFRA;PDLIM5;PDGFRB;CXADR;OBSL1
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3585433716229653,-0.9659275459168328,0.5009523809523809,0.7565332318593154,1.0,8/18,23.39%,SKI;PARP10;EMD;MORC3;B4GALT7;CDC73;CD300A;NLRC3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.25612092871964826,0.9654218265349251,0.5161290322580645,0.8850696120428997,1.0,13/93,8.20%,TFRC;SPTBN4;MIF;TENM1;CNKSR3;GAS6;PPM1F;SNCA;SH2D3C;PAK1;HSP90AB1;AKT1;TRIM6
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.4228704371709414,-0.9653576167523934,0.5247349823321554,0.7574432719036029,1.0,5/10,18.94%,PRKAA2;SETD5;KLF15;PRKAA1;PARK7
prerank,carbohydrate homeostasis (GO:0033500),-0.2697275363162202,-0.9648503709171604,0.5075471698113208,0.7581644852799262,1.0,9/67,6.07%,TCF7L2;APPL2;LEPR;MCU;PRKAA2;CYB5R4;RBP4;IRS1;STAT3
prerank,protein catabolic process (GO:0030163),-0.2732457071518199,-0.9647797158239527,0.5243664717348928,0.7578498121463882,1.0,19/59,26.35%,NGLY1;PRKN;RAB12;MTOR;DDI2;OGA;LAMP2;ADAMTS9;APOE;MANBA;VCP;LRSAM1;CLN5;MAGEC2;SIAH2;CLPX;BAG6;HTRA2;CLN8
prerank,positive regulation of angiogenesis (GO:0045766),0.2517994747770897,0.9647743296282627,0.5311871227364185,0.8858633383715733,1.0,22/108,13.93%,FLT1;TEK;ADAM12;TIE1;RAMP2;SIRT1;HMGA2;KDR;NOS3;ETS1;KLF4;APLNR;NINJ1;CD34;HSPB1;HIPK2;TJP1;EPHA1;CD40;XBP1;DLL1;ANGPTL4
prerank,cellular glucose homeostasis (GO:0001678),-0.29444052881097366,-0.9646301045473168,0.5256410256410257,0.7577901960011413,1.0,13/41,17.82%,ZBTB20;PRKAA2;SLC39A14;LRRC8D;FOXK1;PPARGC1A;UNC13B;HIF1A;PCK2;ERN1;FOXK2;PRKACA;PRKAA1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.34876428749653604,0.9645693682703369,0.5010660980810234,0.8853582859573688,1.0,6/20,19.22%,FDX2;TSPOAP1;TSPO;STARD3NL;HSD17B10;STARD3
prerank,negative regulation of cellular component movement (GO:0051271),-0.38145825163394054,-0.9642930097184761,0.5059288537549407,0.7581672655740443,1.0,4/15,8.67%,TGFBR3;FBLN1;CD9;SP100
prerank,spliceosomal snRNP assembly (GO:0000387),0.30484588801257306,0.9640713982921544,0.5173116089613035,0.8857086621718586,1.0,11/38,14.80%,GEMIN8;SNRPC;SRSF12;PRMT7;LSM4;WDR77;SNRPD2;SNRPD1;DDX20;LSM2;CD2BP2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.35386812811418816,-0.9640341872896039,0.5213178294573644,0.7583529188001714,1.0,9/20,25.25%,MCU;YME1L1;LETM1;MICU1;STOML2;SLC8A3;PARL;SLC8B1;PHB2
prerank,positive regulation of cell adhesion (GO:0045785),0.26586784065179825,0.963911557708812,0.5178571428571429,0.8850857597339731,1.0,18/74,14.52%,FRMD5;MAGI1;CXCL12;PPM1F;IL12A;STX3;TGFB2;PTPRJ;NDNF;PDGFB;SMAD7;RET;MEGF10;DUSP26;CIB1;ADGRG1;ATM;PPP3CA
prerank,hematopoietic stem cell proliferation (GO:0071425),0.41023679998475626,0.9634285779174482,0.49269311064718163,0.8854231262209534,1.0,2/11,8.25%,MECOM;CD34
prerank,T cell activation involved in immune response (GO:0002286),-0.3958386639059429,-0.9632827062916595,0.5058823529411764,0.7597466497096028,1.0,11/12,58.54%,EIF2AK4;FCER1G;ICAM1;MDK;SLC11A1;LILRB1;LCP1;ITGAL;F2RL1;IFNK;TNFSF18
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.2572716664764915,-0.9631603780810396,0.5326315789473685,0.7595466924981821,1.0,37/87,35.11%,FBXL7;KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;USP47;PSMF1;PKD2;RB1;PSMB2;FAM107A;DCUN1D3;CDC73;CUL1;CDK6;PSMC1;PSMB6;PSMA3;PSMA4;AVEN;PSME1;PSMD13;ZFP36L2;PSMB10;PSMA5;PSMB9;RBX1;CDK2AP2;PINX1;PSME4;MYO16;PSMB8;PSMD10;CDKN2C;RBL2
prerank,positive regulation of blood coagulation (GO:0030194),-0.37281142702516423,-0.9630716323209294,0.4786821705426357,0.7592918936315218,1.0,3/17,7.35%,ST3GAL4;THBS1;F3
prerank,regulation of JUN kinase activity (GO:0043506),-0.3086456449929038,-0.9630427631242393,0.5199240986717267,0.7588953061389894,1.0,11/33,26.77%,SASH1;TAOK3;MAP3K5;PTPN22;TRAF2;DUSP10;PDCD4;TRAF6;DVL3;DVL2;AIDA
prerank,regulation of cholesterol transport (GO:0032374),-0.34397916930592465,-0.963028505043972,0.5121951219512195,0.7584538568946465,1.0,2/20,1.19%,LRP1;NFKB1
prerank,regulation of protein kinase B signaling (GO:0051896),0.227493724372854,0.9628835717998578,0.5650406504065041,0.8859429387780846,1.0,23/193,9.13%,IGF1R;KITLG;TEK;ERBB4;NRG2;NRG1;MAGI2;SIRT1;GAS6;FGF10;NTRK2;FLT3;HIP1;PHLPP1;CPNE1;FGF5;PIK3R5;TRIB3;PTPRJ;HSP90AB1;AKT1;THPO;MYORG
prerank,negative regulation of binding (GO:0051100),-0.2602090652266381,-0.9621740612054493,0.5502846299810247,0.760165679902218,1.0,16/81,10.43%,ARHGAP28;DAB2;ROCK1;SMO;LRRK2;GSK3B;STYX;IFIT2;SP100;DACT1;CSNK1E;BTAF1;USP33;NES;JUN;PRKCD
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.2887424549176728,-0.9618059684464524,0.512621359223301,0.7606530113584817,1.0,9/45,9.77%,SMAD3;FOXC1;BMP7;BMP4;GAS1;PTPN3;PRCC;BTG3;TOM1L2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.33658336023390345,0.961613914353434,0.502127659574468,0.8885449272533152,1.0,4/22,10.79%,PDE4B;GPR35;CACNB2;CACNB4
prerank,cellular response to retinoic acid (GO:0071300),-0.29060788018688627,-0.9615694330166308,0.5170454545454546,0.7607901780057783,1.0,9/42,13.00%,EPHA3;PTK7;WNT5B;WNT6;LYN;WNT9A;ABL2;FZD7;ADNP2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.2989434361203773,0.9614993450766683,0.5084388185654009,0.8877971734779712,1.0,6/39,5.95%,PAX8;TIE1;PAX2;KDR;FGF10;PAK1
prerank,synaptic vesicle membrane organization (GO:0048499),0.36246016961708777,0.9609288830824226,0.48187633262260127,0.8883437726899329,1.0,4/17,16.46%,SNAP25;STX3;SNAP29;STX1B
prerank,regulation of multicellular organismal development (GO:2000026),-0.3310716509404673,-0.9608145035985809,0.504725897920605,0.7622095721346183,1.0,7/25,16.92%,PTN;TRIP12;MYSM1;DHX36;NIPBL;EHMT1;OAS2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2943239521571665,-0.960728270879437,0.493801652892562,0.7619549676854339,1.0,21/40,35.65%,WRN;MCM9;RFWD3;FANCM;MSH3;BOD1L1;ZRANB3;PCNA;ATR;SMARCAL1;PRIMPOL;DONSON;TIPIN;ATRX;CDK9;TIMELESS;EME2;RAD51;POLE;CENPX;GEN1
prerank,negative regulation of hemostasis (GO:1900047),-0.40587295585307853,-0.9606013921085823,0.5134615384615384,0.761796239999003,1.0,4/12,17.01%,VTN;TFPI;APOE;SERPINE1
prerank,positive regulation of protein modification process (GO:0031401),-0.2262034557087028,-0.9605877956065249,0.5684647302904564,0.7613556485942388,1.0,37/203,15.02%,TRABD2B;ROCK2;EGFR;LEPR;IL34;ANGPT1;SLCO3A1;NTRK3;PELI2;UBE2N;FGF1;DAB2;FAM20A;BMP4;ABL1;LRRK2;AXIN1;RAB3GAP1;LYN;RAMP1;RAPGEF3;PPP1R7;IGF2;RB1CC1;ANKLE2;FAM161A;PRKCD;MAVS;FNIP1;CARD14;CCN1;WDFY2;TXN;VEGFA;CCND3;DDX3X;VEGFD
prerank,establishment of mitotic spindle localization (GO:0040001),-0.3211440862708691,-0.9604637265152447,0.5317460317460317,0.7611856522551241,1.0,5/28,8.60%,NUMA1;UBXN2B;ITGB1;NDEL1;GJA1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.31366675201610694,0.9602794595932332,0.5022123893805309,0.8891373153090566,1.0,10/30,21.36%,HSPA13;HSPA8;CHCHD4;HSPA5;CCT2;PTGES3;ST13;GAK;BAG1;ENTPD5
prerank,purine nucleotide metabolic process (GO:0006163),0.3317930025975156,0.960013083272849,0.5233050847457628,0.8888502914324347,1.0,6/24,12.98%,GPX1;GART;HPRT1;MTHFD1;NT5C;GUK1
prerank,positive regulation of JNK cascade (GO:0046330),0.26522523412921545,0.9595865966452878,0.5273109243697479,0.8890088068636745,1.0,16/70,14.55%,TIRAP;MAP4K2;TRAF1;PLCB1;TNFRSF19;WNT7B;ANKRD6;MAPK8IP1;TAOK2;DAB2IP;HIPK2;PJA2;DUSP15;MAP3K11;HRAS;MFHAS1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.2613764534413165,0.9593320286614226,0.5295315682281059,0.8886893299089548,1.0,11/75,10.54%,EGFL7;TEK;PROX1;PLXNB3;SIRT1;PPP1R16B;KDR;APLNR;AKT1;PDGFB;SCG2
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3920035665190402,0.9591702625618168,0.5175983436853002,0.8880627342819446,1.0,3/12,9.38%,GART;HPRT1;MTHFD1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.328989291348967,-0.9591276735432981,0.5143953934740882,0.7639860318228917,1.0,4/23,10.12%,SASH1;TAOK3;MAP3K5;TRAF2
prerank,positive regulation of catalytic activity (GO:0043085),-0.30276845046978257,-0.9591091987182152,0.5040322580645161,0.7635537695643417,1.0,14/37,22.11%,SLC5A3;ABL1;BCAS3;WRN;IGF2;NCSTN;ABL2;STX4;XRCC4;MSH3;MSH6;FGFR4;FXN;SSBP1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.26327645474539946,-0.9588144301960683,0.5211267605633803,0.7637785539532059,1.0,19/73,18.42%,SMAD3;COL4A3;CFLAR;ROBO1;EIF2AK3;F3;FAM162A;AIFM1;CASP12;NGF;EGLN3;TRAF2;SENP1;CASP2;ANP32B;DAP;HSPE1;BCL2L13;VCP
prerank,positive regulation of nuclear division (GO:0051785),-0.3281941673992511,-0.9586533944250207,0.5083179297597042,0.7637167061521226,1.0,3/25,8.57%,IGF1;PDGFRB;IGF2
prerank,smoothened signaling pathway (GO:0007224),-0.3091937328160873,-0.9584579969771786,0.5327102803738317,0.7637301668933998,1.0,9/32,15.46%,GLI3;GLI2;SMO;ARL13B;EVC2;HIPK1;CC2D2A;GLI1;PTCH1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.3958354027692832,0.958316948508955,0.5225806451612903,0.8895086424646541,1.0,2/12,4.90%,CSF1R;IL12A
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3819953587109391,-0.9581336526541632,0.5352380952380953,0.764072363149228,1.0,6/15,18.60%,PCM1;PIBF1;CCDC14;SNX10;C2CD3;CSNK1D
prerank,protein alkylation (GO:0008213),0.34376244895025465,0.957744197230371,0.5262008733624454,0.8900912533135368,1.0,6/22,15.04%,LCMT1;EEF1AKMT1;ETF1;FAM98A;VCPKMT;METTL22
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3240919688372979,0.9576566052592711,0.5152173913043478,0.8892843819248578,1.0,8/26,15.32%,TIRAP;NINJ1;TLR2;PJA2;WDFY1;MFHAS1;RTN4;RSAD2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.42248203069431345,-0.9573038585804546,0.5210237659963437,0.7656414068208433,1.0,3/10,8.59%,IVD;ACADM;ACAD11
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.35669570103104536,-0.9569573479503732,0.5440900562851783,0.7660585648420546,1.0,6/17,22.30%,TAOK3;LYN;MID1;EIF2AK2;TAOK1;KLHDC10
prerank,B cell differentiation (GO:0030183),-0.2841498562527843,-0.9568487704270683,0.5287128712871287,0.7658704234483968,1.0,12/46,18.29%,HDAC4;KIT;ITGB1;DCAF1;CEBPG;PTPN2;FNIP1;TCF3;ITGA4;KLF6;SYVN1;BLNK
prerank,regulation of cell death (GO:0010941),-0.252060840572212,-0.9562778027487481,0.5644859813084112,0.7668891309272037,1.0,31/94,22.57%,LRP1;CELF1;CCN2;BMP7;BMP4;PRKN;LRRK2;TBK1;VPS4B;SRSF6;CHMP4B;ACER3;IMPACT;CCN3;PRODH;ADNP2;BECN1;CCN5;CCN1;NCK1;CCN4;PRKD1;ATG5;PARK7;EIF4G1;RILPL1;SPEF1;BNIP3;FGF2;WNT16;CHP1
prerank,cellular response to interleukin-7 (GO:0098761),-0.36032973923251144,-0.956256178951017,0.5447761194029851,0.7660013864947278,1.0,4/17,6.07%,BRWD1;JAK1;IRS1;STAT3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.36032973923251144,-0.956256178951017,0.5447761194029851,0.7660013864947278,1.0,4/17,6.07%,BRWD1;JAK1;IRS1;STAT3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3398423064675987,0.956101528725063,0.5182012847965739,0.8925819682128603,1.0,2/21,3.53%,PROX1;TOX
prerank,cardiac cell development (GO:0055006),0.4138875443595522,0.95584449117734,0.5098039215686274,0.892304905620109,1.0,4/11,9.53%,MYH6;SLC8A1;NOTCH1;TCAP
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.41952609558432713,-0.9557607827323367,0.5281954887218046,0.7667766667801387,1.0,3/10,13.02%,DNMT3A;IGF2;KDM1B
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3465052776086607,-0.9553749986731135,0.5441441441441441,0.7672172578305203,1.0,3/20,5.41%,SULF1;SULF2;THBS1
prerank,female gamete generation (GO:0007292),-0.31330553398956645,-0.9553093236123188,0.5414258188824663,0.7669074146845689,1.0,3/29,4.94%,DIAPH2;PTN;KMT2D
prerank,positive regulation of lipid kinase activity (GO:0090218),0.31453910085607373,0.9551875643457581,0.5053995680345572,0.8931644288628011,1.0,3/29,4.46%,FLT1;TEK;FLT3
prerank,positive regulation of axonogenesis (GO:0050772),0.29210276918469685,0.9549143181598947,0.5316973415132924,0.8929024097761891,1.0,9/43,9.97%,PLXNB3;NTRK2;SEMA4D;SEMA7A;SHTN1;PLXNA4;ROBO2;CDKL5;NTN1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.402907894797427,0.9545926456031084,0.5414012738853503,0.8927501955666199,1.0,2/11,3.31%,HCAR2;SIRT1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.3730240698327699,0.9545426228564573,0.5166666666666667,0.8918293511250944,1.0,4/14,14.50%,GAS6;GPS2;RFFL;TRAIP
prerank,epiboly involved in wound healing (GO:0090505),-0.3699352940218005,-0.954157064505715,0.5158102766798419,0.7691707803066576,1.0,8/16,23.15%,PDPN;FLNA;RHOA;CCN1;DDR1;RHOC;TOR1A;ARHGAP35
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4146115668572797,-0.9537357855042177,0.5311871227364185,0.7697452654205205,1.0,7/10,46.19%,RENBP;ST6GAL1;GNE;NANP;NPL;NAGK;GNPDA1
prerank,response to unfolded protein (GO:0006986),0.2831564289624094,0.9536735825417266,0.5212765957446809,0.8933200961174969,1.0,8/48,9.89%,HSPA13;PACRG;HSPA8;HSPA5;HSPA4L;HSP90AB1;HSPB1;DAB2IP
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.42002253139821044,-0.9536130954924545,0.5355086372360844,0.7695910210764498,1.0,3/10,9.06%,FOXC1;NUMA1;MED1
prerank,response to growth factor (GO:0070848),-0.29164541038336766,-0.9535889158831317,0.5470249520153551,0.7691839591417575,1.0,16/41,26.32%,TGFBR1;BMPR1A;TGFBR2;SHC1;CPNE3;ACVR1;EMD;STAT5B;TBC1D7;NOS1;GATA6;SPHK1;PLK5;MAPK7;TWF2;HTRA2
prerank,endothelial cell differentiation (GO:0045446),0.401815709254628,0.9533803643971025,0.5089686098654709,0.8930891482854095,1.0,4/12,7.56%,PROX1;TIE1;KDR;ACVRL1
prerank,protein lipidation (GO:0006497),-0.2738722078456848,-0.9528550593646354,0.5253623188405797,0.7705217809429263,1.0,26/59,34.10%,PIGN;GLUL;WIPI1;ZDHHC13;UGCG;PIK3C3;DPM1;WDR45B;ZDHHC1;ATG5;ZDHHC16;HHAT;PIGH;WIPI2;MPPE1;PIGC;DPM3;PIGA;ZDHHC8;PIGZ;PIGP;ATG10;PIGF;PIGO;WDR45;ATG12
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2715789975171287,-0.952615358830778,0.5528301886792453,0.7706470636093591,1.0,23/61,24.47%,CCNH;KHDRBS1;CDK7;PHF8;EIF4E;MNAT1;CUL3;RB1;HINFP;CRLF3;ACVR1;RCC1;LATS1;CUL2;NASP;CACUL1;INHBA;CDK2;CUL1;CDK6;DBF4;EIF4EBP1;CCNE2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.24315726341093932,0.952048100348947,0.5894308943089431,0.8958582004137893,1.0,25/117,19.09%,PRKAR2B;ADCY8;ADCY3;RAMP2;ADRB1;RHBDF2;ADCYAP1;GNG2;POMC;CD163;GPR176;ADCY4;GGT1;PTGER2;PLK2;NPSR1;CALCRL;ADCYAP1R1;GPR45;PTGER4;CYSLTR1;FYN;PRKAR1A;ADORA2B;ADORA2A
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3496805866827799,-0.951920661426425,0.5135135135135135,0.7718276142208503,1.0,10/20,29.45%,PRKAA2;BRD7;PPARGC1A;ARRB1;PRKAA1;NOS1;PAXIP1;RPS6KA4;RUVBL2;GLYR1
prerank,Fc receptor signaling pathway (GO:0038093),-0.24447348693403878,-0.9515803838491177,0.560081466395112,0.7721963079908376,1.0,36/110,29.12%,GAB2;NFKB1;BTRC;KIT;MAP2K4;PAK2;SHC1;LYN;VAV2;PDPK1;PLCG1;FER;JUN;PSMF1;TEC;PSMB2;MAP2K7;FBXW11;TRAF6;MAP3K1;NFATC3;CUL1;PIK3R1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;MAPK9;FCER1G;SOS1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3956583219602855,-0.9511509094965862,0.5,0.7727745020319794,1.0,5/12,26.52%,AR;SELENOS;HDAC2;AP2A1;TAF7
prerank,protein-containing complex subunit organization (GO:0043933),-0.2430151693349072,-0.9511444702313944,0.5782442748091603,0.7723240025357088,1.0,35/109,22.67%,TEAD1;MDM4;DLG4;YAP1;DNM1L;SNX9;CREBBP;TUBGCP2;PPARGC1A;VAMP2;GEMIN5;MNAT1;WASL;TRAF2;CAPZA1;WIPF1;HES1;TEAD2;TPR;PARD3;RANBP9;WASF1;REPS2;PPIH;PICALM;GPAA1;TUBGCP4;PML;NUP98;FANCC;KIFAP3;KMT2A;PPID;DET1;LAMC1
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.36629630377402533,-0.9511004424220855,0.5368217054263565,0.7719657948957307,1.0,10/16,38.61%,WRN;MCM6;SSBP1;RECQL5;MCM4;MCMDC2;TWNK;RAD51;MCM2;MCM7
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.37044511286813875,-0.9509369864971277,0.5370018975332068,0.771888902281104,1.0,4/16,12.87%,AUTS2;ARHGAP24;ARHGAP17;OGT
prerank,regulation of lipid catabolic process (GO:0050994),0.3522818116243387,0.9504834685903059,0.5347368421052632,0.89926253532858,1.0,2/19,5.87%,HCAR2;ALK
prerank,axoneme assembly (GO:0035082),0.31324802194558793,0.950456754306024,0.5405405405405406,0.8982702778243373,1.0,6/30,16.18%,SPAG16;DNAAF3;FOXJ1;DNAAF2;DCX;SPAG1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.24548328199002512,-0.9497508955260096,0.5402061855670103,0.7743726392957503,1.0,25/108,17.29%,UACA;SMAD3;GSN;COL4A3;CFLAR;ROBO1;HMGB1;EIF2AK3;F3;REST;MAP3K5;FAM162A;AIFM1;CASP12;NGF;EGLN3;TRAF2;SENP1;CASP2;DDX3X;ANP32B;DAPK1;DAP;HSPE1;BCL2L13
prerank,regulation of pseudopodium assembly (GO:0031272),-0.41904376067543064,-0.9493278489976723,0.5332068311195446,0.7744435437493382,1.0,4/10,22.49%,CDC42;CDC42EP5;CDC42EP4;CDC42EP1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.41904376067543064,-0.9493278489976723,0.5332068311195446,0.7744435437493382,1.0,4/10,22.49%,CDC42;CDC42EP5;CDC42EP4;CDC42EP1
prerank,regulation of lymphocyte activation (GO:0051249),-0.3863672493441954,-0.9490214388398283,0.5256410256410257,0.7747159341872979,1.0,1/12,3.42%,PAG1
prerank,tRNA 5'-leader removal (GO:0001682),0.38470974212754,0.9490131889377721,0.543859649122807,0.9015012981673332,1.0,3/13,12.31%,RPP40;RPP30;POP5
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.24219797012536468,0.948602708885447,0.5647773279352226,0.901614471393244,1.0,25/116,19.09%,PRKAR2B;ADCY8;ADCY3;RAMP2;ADRB1;RHBDF2;ADCYAP1;GNG2;POMC;CD163;GPR176;ADCY4;GGT1;PTGER2;PLK2;NPSR1;CALCRL;ADCYAP1R1;GPR45;PTGER4;CYSLTR1;FYN;PRKAR1A;ADORA2B;ADORA2A
prerank,modulation by symbiont of entry into host (GO:0052372),0.3584758560196703,0.9484678684288702,0.5403726708074534,0.9009647084819912,1.0,3/16,8.20%,HS3ST5;TRIM62;TRIM6
prerank,prostaglandin metabolic process (GO:0006693),-0.3249901008861125,-0.9481767918189697,0.519455252918288,0.7763322479747865,1.0,6/26,12.46%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,response to organic cyclic compound (GO:0014070),-0.27631074127321514,-0.9475453290582762,0.5460122699386503,0.7773897903653277,1.0,7/52,9.27%,IGFBP5;LRRK2;HLCS;STRN3;STAT3;ANXA1;CYP1B1
prerank,regulation of TORC1 signaling (GO:1903432),-0.3120891981920033,-0.9474869310701929,0.5392156862745098,0.7770592278974678,1.0,12/33,26.25%,RNF152;SESN1;TELO2;CASTOR2;KLHL22;SIK3;GPR137B;PIH1D1;LARS1;SZT2;KPTN;RRAGA
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.40349639887121275,-0.947143708340601,0.5294117647058824,0.7774379861269012,1.0,4/11,15.61%,EP300;CLK2;SIK1;C1QTNF3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.30020167421794774,-0.9468165710457312,0.5477582846003899,0.777829310767519,1.0,5/37,4.00%,PHLDB2;EPHA3;ROCK1;PRKAA2;GSK3B
prerank,positive regulation of telomere capping (GO:1904355),-0.3577334038664781,-0.9467697164471353,0.5299625468164794,0.7774556885391829,1.0,4/17,15.75%,TNKS2;HNRNPD;NABP2;MAP2K7
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3555881176507707,0.9466411951259897,0.5345911949685535,0.9052163652663797,1.0,4/17,14.35%,TERF1;UNG;TERF2IP;TINF2
prerank,neural tube closure (GO:0001843),-0.307026783874972,-0.9465135361358591,0.5439560439560439,0.777593544922324,1.0,6/34,9.33%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.31617758903849524,-0.9463756323438609,0.5503731343283582,0.7774516769297787,1.0,10/27,26.17%,NFKB1;ABCA1;ITGAV;NR1H3;AGTR1;IL18;ITGB3;MAPK9;PPARA;LPL
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.36830365497114226,-0.9458512266592802,0.5388888888888889,0.7782160063201633,1.0,6/16,20.81%,PDK1;PRKN;FOXK1;RORA;FOXK2;BCKDK
prerank,positive regulation of chemotaxis (GO:0050921),0.28966942220999997,0.945470157645668,0.5323275862068966,0.9075265669823638,1.0,8/43,10.48%,DSCAM;TMSB4X;PPM1F;KDR;STX3;HSPB1;PDGFB;AIF1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3763186675980198,-0.9453849573540727,0.5076628352490421,0.7788365542267353,1.0,4/14,34.36%,IL6ST;PARK7;OSMR;ADAM8
prerank,positive regulation of lipid transport (GO:0032370),-0.3870344081137662,-0.9451616574377695,0.5463137996219282,0.7789213253866827,1.0,3/12,20.22%,LRP1;APOE;SPP1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.25901824597735457,-0.9444290761057336,0.5493230174081238,0.7802865415742162,1.0,28/73,29.73%,KAT2B;EP300;HDAC4;PPM1D;DNMT3A;SF3B1;IGF2;TAF1D;TBP;PHF2;MPHOSPH8;CGGBP1;KDM1B;PHF1;JARID2;EPC1;BAZ1B;POLR2H;EZH2;POLR2K;PPHLN1;POLR2E;CREBZF;TAF1C;POLR1G;TAF1A;SPHK2;POLR1C
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3019290937129151,-0.9441266881541661,0.5475728155339806,0.7805417388717192,1.0,12/35,28.12%,SASH1;DLG1;PTPN22;RELL1;VEGFA;DUSP1;DUSP10;BMP2;SPHK1;EMC10;GADD45G;MINK1
prerank,microtubule anchoring (GO:0034453),-0.3934206512526205,-0.9440851367991401,0.549618320610687,0.7801747614184813,1.0,2/12,1.98%,DAG1;PCM1
prerank,second-messenger-mediated signaling (GO:0019932),0.25058980265402575,0.9437672091100237,0.5744234800838575,0.9114171840789989,1.0,11/82,8.25%,CHRM3;KSR2;RYR2;MCTP1;NOS3;RCAN2;PPP2R1A;PPP1R9A;ACKR4;NDNF;RCAN3
prerank,toll-like receptor signaling pathway (GO:0002224),0.256755171855525,0.943621377777182,0.55,0.9107858447620835,1.0,18/84,17.12%,TIRAP;S100A9;S100A8;RPS27A;UBC;TLR2;UBB;TRIL;BCL10;ITGAM;CTSB;HSPD1;RFTN1;CD36;TAB2;MAPKAPK2;TNIP1;BTK
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.3830499857038425,-0.9436211984671415,0.510556621880998,0.7808476422414343,1.0,4/13,14.36%,TGFBR2;NRP1;SEMA3E;VEGFA
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.37079766868474384,-0.9435591678282959,0.556390977443609,0.7805276504686297,1.0,8/14,33.31%,NMNAT2;ME1;NMNAT3;NMNAT1;CMPK2;AK1;PNP;AK7
prerank,engulfment of apoptotic cell (GO:0043652),0.3563055862791792,0.9434065740558382,0.5468085106382978,0.9103318804190738,1.0,4/15,16.20%,ADGRB1;XKR6;MEGF10;XKR4
prerank,negative regulation of cell aging (GO:0090344),0.36215452232239076,0.9433040326194515,0.555793991416309,0.9095359238651461,1.0,3/16,3.68%,MIF;SIRT1;HMGA2
prerank,entry into host (GO:0044409),-0.3843315819984481,-0.9431373544194914,0.533457249070632,0.7811025164523455,1.0,2/13,6.03%,ITGAV;CDH1
prerank,cellular response to acid chemical (GO:0071229),0.32112729544170326,0.9430014780184457,0.5543710021321961,0.9093329306532885,1.0,9/27,20.80%,IPO5;GLRA1;GLRA2;KLF2;XBP1;LAMTOR2;CAPN2;SPAAR;RRAGD
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.316451073310638,-0.9424441281521327,0.5290806754221389,0.7823250606195777,1.0,8/27,20.64%,NFKB1;BTRC;MAP3K5;MAP3K20;MAP2K7;TNIP2;FBXW11;CUL1
prerank,regulation of dephosphorylation (GO:0035303),-0.37263346156155663,-0.9420660859849342,0.5287356321839081,0.7827919495105533,1.0,5/15,21.31%,SMG6;SMG7;MTMR3;INPP5K;CDK5RAP3
prerank,regulation of calcium ion transport (GO:0051924),0.27562799633821305,0.9419308190443781,0.5883534136546185,0.9113785857918987,1.0,9/54,10.86%,CAMK2A;CD33;CACNA2D1;EPB41;CACNB2;HOMER1;PLPP4;HOMER2;F2R
prerank,positive regulation of hydrolase activity (GO:0051345),-0.2361151431871107,-0.9417074778673449,0.6145610278372591,0.7831772380969462,1.0,24/137,11.11%,DOCK11;AFDN;ASAP3;LIMS1;ARAP1;GSK3B;SGSM2;ITGB1;CTSH;BCAS3;SNX9;MAP4K4;RAB3GAP1;MMUT;RAPGEF3;ZC3H15;S100A10;RSU1;WRN;NDEL1;USP6NL;TBC1D20;RHOA;RCN3
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3913734976138731,-0.9414865218520572,0.5500910746812386,0.783203701660655,1.0,5/12,20.74%,HDAC4;CCN3;BHLHE41;HDAC1;TMEM119
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3648926753523988,-0.9413116737803252,0.5417439703153989,0.7832279845394233,1.0,6/16,20.94%,NPR3;HIF1A;APOE;TERF2;TERT;S100A1
prerank,regulation of rRNA processing (GO:2000232),-0.3607439987576433,-0.9409527275252444,0.5489443378119002,0.7836230549650225,1.0,4/16,16.54%,KAT2B;WDR43;DIMT1;BUD23
prerank,tRNA modification (GO:0006400),-0.2656887942348335,-0.940894475049061,0.5680933852140078,0.7832986412571833,1.0,29/62,33.29%,TRMT9B;PUS10;NSUN6;ALKBH1;QTRT2;METTL2A;METTL2B;TYW5;METTL1;NSUN2;TYW1;THUMPD3;ELP5;FTSJ1;PUS3;CDKAL1;LCMT2;WDR6;DTWD1;GTPBP3;TRMT1;MTO1;DTWD2;TRMT44;TRMT61B;TYW3;PUS1;ALKBH8;TRMT12
prerank,monoacylglycerol metabolic process (GO:0046462),-0.38870191256546016,-0.9408417587589568,0.5489833641404805,0.7829560266763786,1.0,5/13,19.19%,PLA2G4A;MOGAT3;ABHD12;ABHD6;MGLL
prerank,body fluid secretion (GO:0007589),0.3706471818582793,0.9401651225249485,0.5233853006681515,0.9153719995866588,1.0,2/15,7.12%,ERBB4;GUCA1B
prerank,cellular metal ion homeostasis (GO:0006875),-0.24088254726631486,-0.940106514630457,0.5764705882352941,0.7842723511609152,1.0,16/102,13.64%,ATP1A2;SLC24A3;STIM1;ANK2;ATP13A5;SLC41A1;SLC9A1;TPCN2;KCNJ2;SLC10A7;SLC12A2;DMPK;ATP2A2;ATP2B1;ATP13A3;LETM1
prerank,regulation of vasculature development (GO:1901342),0.3193171888453129,0.9395904531772759,0.5460251046025104,0.9159562702554548,1.0,4/26,8.17%,HTATIP2;TSPAN12;ETS1;GPNMB
prerank,positive regulation of dendrite development (GO:1900006),-0.40859410506345517,-0.9393982244783093,0.5476635514018692,0.7855349655540441,1.0,3/10,2.52%,PTN;BMP5;BMP7
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3526053495847414,0.938654155259166,0.5793991416309013,0.917548566733428,1.0,6/17,19.24%,ATP5F1D;ATP5F1B;ATP5ME;ATP5MF;DMAC2L;ATP5MG
prerank,phagosome-lysosome fusion (GO:0090385),0.4096364591192462,0.9384397036345123,0.5410526315789473,0.9171023707604611,1.0,1/10,1.84%,SYT7
prerank,negative regulation of response to stimulus (GO:0048585),0.2694022563151358,0.938352490998441,0.5775862068965517,0.916272004125135,1.0,12/60,11.28%,AQP11;MCTP1;SIRT1;HMGA2;THY1;SRMS;CLU;KLF4;CD34;GGT7;TLE5;UBASH3B
prerank,transferrin transport (GO:0033572),0.30232184170174214,0.938138387816401,0.558282208588957,0.9158310726282192,1.0,13/33,22.73%,TFRC;ATP6V1F;ATP6V1A;ATP6AP1;ATP6V1C1;ATP6V0B;ATP6V0A1;ATP6V0E2;ATP6V1D;REP15;HFE;ATP6V0C;ATP6V1G1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3720209701172187,-0.9377195811287727,0.5377176015473888,0.7892198578450623,1.0,6/14,21.07%,ADGRV1;VEGFA;WNT5A;MYADM;GPD1L;DGKD
prerank,mitotic DNA replication (GO:1902969),-0.39853451084338054,-0.9377116404513088,0.5269230769230769,0.7887589665919759,1.0,7/10,38.61%,MCM6;MCM4;MCMDC2;CDC45;POLA1;GINS1;MCM2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.30078311146787606,0.9375521761377869,0.566079295154185,0.9164663282908142,1.0,9/35,13.89%,RIMS2;EPHA5;AKAP6;PDE2A;HTR2C;ADCYAP1;CAP2;PDE4D;CD36
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.284340172950022,0.9371346405512877,0.5553191489361702,0.9166385559619616,1.0,13/42,19.15%,SIRT1;ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2;POLI
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.30247113675204657,-0.9370807622308517,0.5233644859813084,0.7898298614235979,1.0,16/32,28.00%,FOXN3;NBN;TAOK3;BRCC3;BRSK1;RINT1;CDC14B;TRIM39;NOP53;MRE11;TAOK1;CDK5RAP3;CLSPN;DONSON;ABRAXAS1;FZR1
prerank,estrogen metabolic process (GO:0008210),-0.3616969186742503,-0.9370265015168809,0.5398886827458256,0.7894959707168259,1.0,3/15,10.63%,CYP1B1;SULT1A1;HSD17B11
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.25536758221316747,0.9369203109467642,0.5765407554671969,0.916179558657002,1.0,17/80,12.55%,SIRT1;PAX2;GAS6;PPM1F;SNCA;GPX1;ARL6IP1;KLF4;BEX3;RPS6KA1;AKT1;ACVR1C;NOD1;F2R;BCL10;NDUFA13;TNFSF10
prerank,protein depolymerization (GO:0051261),-0.31504045913505013,-0.9368896422023807,0.564299424184261,0.7893803551044208,1.0,4/27,5.95%,MICAL3;GSN;MICAL2;VPS4B
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.40180285374161473,0.9365591263377367,0.5387931034482759,0.9161711705583799,1.0,3/11,12.26%,PTPRT;SOCS1;BCL3
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2567072558475308,-0.9360612744190892,0.575984990619137,0.7909214557541947,1.0,13/70,14.85%,SMAD3;ITGAV;GSK3B;BCL2;PDPK1;HIPK1;BAG3;NGF;TRAF2;IL6R;CASP2;APPL1;DDX3X
prerank,amyloid-beta metabolic process (GO:0050435),0.3564704068490514,0.9358850942280512,0.5407725321888412,0.9170089467966926,1.0,4/16,13.71%,MME;PSENEN;NAT8;PSEN1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.33101664106369055,-0.9357379307881996,0.5337186897880539,0.7911998236022008,1.0,6/22,12.97%,APPL2;LBP;LYN;PTPN22;NR1H3;APPL1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.34206607331908273,0.9357164369492709,0.5634095634095634,0.9164674109408438,1.0,4/18,8.60%,SLC2A1;OCLN;TRIB3;RTN2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.295345062761184,-0.9354298565074758,0.5627376425855514,0.7914799916868898,1.0,8/36,10.96%,TRIM44;AXL;PRKN;UBE2K;PARP14;HIF1A;PARP9;MAVS
prerank,homeostasis of number of cells (GO:0048872),0.37752142959200374,0.9353706411045002,0.5456475583864119,0.9164196457469258,1.0,4/12,10.86%,NOS3;NOTCH1;OCIAD1;F2R
prerank,glycogen catabolic process (GO:0005980),-0.3585845534006613,-0.9352049450993061,0.5498084291187739,0.7915495721946922,1.0,6/15,14.95%,PHKB;PYGB;PHKA1;AGL;RB1CC1;PYGM
prerank,regulation of amyloid-beta formation (GO:1902003),-0.29634011563784585,-0.9349647491287411,0.5529865125240848,0.7916446259784591,1.0,9/34,19.21%,ROCK2;IGF1;ROCK1;EPHA4;GGA3;APOE;IFNGR1;PICALM;ABCA7
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.292101640631096,0.9349465483517985,0.5573770491803278,0.9165616937965778,1.0,8/41,12.16%,PODXL;MAGI1;ANK3;THY1;SKAP1;TJP1;SMAD7;MEGF10
prerank,regulation of cell cycle phase transition (GO:1901987),-0.24549274862512288,-0.9348343292431618,0.5885826771653543,0.7914926707796599,1.0,40/91,34.19%,BTRC;ANAPC5;ANAPC7;ANAPC4;ANAPC16;MN1;PSMF1;ERCC3;FBXW7;PSMB2;CDC26;TRIM39;CDC27;UBE2E1;UBE2S;ANAPC11;CUL1;PSMC1;PSMB6;PSMA3;TFAP4;PSMA4;DBF4;CDC16;ANAPC1;TCIM;PSME1;PSMD13;FZR1;PSMB10;PSMA5;PSMB9;NEK10;NEK11;MAD2L1;PSME4;BUB1B;DDB1;PSMB8;PSMD10
prerank,positive regulation of immune system process (GO:0002684),0.35580054999068556,0.9346400064112427,0.5247933884297521,0.9163289775452739,1.0,2/16,5.82%,HCAR2;TGFB2
prerank,extracellular matrix assembly (GO:0085029),0.32510289363289663,0.9344290117007401,0.540084388185654,0.9159238273304318,1.0,5/23,8.89%,RAMP2;GPM6B;GAS6;NTNG1;NTNG2
prerank,regulation of macrophage activation (GO:0043030),-0.30915262454916903,-0.934355695400839,0.5428571428571428,0.7921882095733439,1.0,11/30,22.26%,IL31RA;LBP;THBS1;NR1H3;TNIP2;TLR4;WNT5A;GPR137B;SHPK;KARS1;SPHK1
prerank,membrane fusion (GO:0061025),-0.30174250526290586,-0.9338796310848034,0.573055028462998,0.7928226880212306,1.0,14/33,23.62%,OPA1;UBXN2B;HUWE1;DNM1L;MYOF;VTI1B;VAMP2;GCA;SNAP23;NAPA;CHP1;VAPA;NSF;USO1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.22223382970883812,-0.9336537040162003,0.6490196078431373,0.7929167594336596,1.0,79/184,33.80%,APPL2;PKD1;INO80;PCM1;CDC14A;BTRC;ALMS1;ODF2;NINL;CEP63;CEP135;PCNT;ANAPC5;ANAPC7;ANAPC4;ANAPC16;CSNK1E;ID2;PSMF1;ERCC3;CUL3;APPL1;MAPRE1;PSMB2;CDC26;CDC14B;YWHAE;AKAP9;CDC27;UBE2E1;DYNC1H1;CEP76;KLHL18;UBE2S;PRKACA;CEP57;CSNK1D;CDK2;NEK6;ANAPC11;CUL1;PSMC1;HAUS7;PSMB6;HAUS8;PLK5;ACTR1A;PSMA3;TFAP4;PSMA4;CDC16;ANAPC1;HAUS3;PSME1;PSMD13;CEP41;FZR1;ZFP36L2;PSMB10;E2F1;PSMA5;PSMB9;HAUS5;UBA52;HAUS4;PLK4;NEK11;MAD2L1;CEP72;CENPE;PTPN6;SSNA1;CEP164;PSME4;BUB1B;DDB1;RIOK2;CKAP5;PSMB8
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.22027361538459106,-0.933622408086611,0.642023346303502,0.7925159770208362,1.0,29/198,10.72%,PLCE1;EPHA7;PI4KA;PLPP3;ENPP1;LRRK2;NUDT4;GK5;TOP1;PLCD3;INPP5B;PAK2;NUDT5;INPP5A;STAT3;ISYNA1;NADK;DUSP16;PFKFB4;MTOR;GFPT1;INPPL1;PLA2G4A;PLCG1;PLCB3;PANK2;PLCD1;ENPP3;LIMD1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3350073089067623,-0.9333259635852938,0.5286738351254481,0.7923047244431757,1.0,10/21,33.13%,GTF2H2;DDB2;PARP1;ERCC3;ERCC1;GTF2H1;GTF2H4;RBX1;RPA2;DDB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3350073089067623,-0.9333259635852938,0.5286738351254481,0.7923047244431757,1.0,10/21,33.13%,GTF2H2;DDB2;PARP1;ERCC3;ERCC1;GTF2H1;GTF2H4;RBX1;RPA2;DDB1
prerank,neuron apoptotic process (GO:0051402),0.34396040571205483,0.9331323528756286,0.5491452991452992,0.9185552845152758,1.0,4/19,13.42%,TRPC5;TNFRSF21;SCN2A;CIT
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.1993633622782155,-0.9330115645997035,0.756701030927835,0.7925818703034667,1.0,86/532,14.36%,COL1A2;GAB2;APPL2;LEPR;NFKB1;IL34;LIMS1;PELI2;ZEB1;UBE2N;BRWD1;FOXC1;GRB10;VIM;IL6ST;IL31RA;FOXO3;GHR;MAP3K3;EDA;JAK1;BTRC;KIT;YAP1;IRAK3;IRS1;LBP;IL15RA;ITGB1;IL13RA1;RAP1B;ANXA2;PAK2;STAT3;SHC1;BCL2;IL16;IFIT2;CAMK2D;ANXA1;IRAK2;TRIM8;TRAF3IP2;F3;MID1;INPPL1;CDC42;CAMK2G;CTR9;TNFRSF11B;SP100;IL17RA;PITPNA;FER;TRAF2;PRKCD;HIF1A;ABL2;SMAD4;GREM2;STX4;CNTFR;RORA;CAPZA1;TRIM5;UGCG;PSMF1;NUMBL;ARF1;RALA;IRF9;HSPA9;MMP2;TEC;TRIM25;IL6R;FN1;APPL1;IRF1;CARD14;LTBR;TYK2;SLC27A1;STAT1;PSMB2;VEGFA
prerank,ganglion development (GO:0061548),0.39784402179270756,0.9325516826645703,0.540948275862069,0.919147804897327,1.0,4/11,21.62%,UNC5C;TUBB3;CTNNB1;SEMA3A
prerank,T cell proliferation (GO:0042098),0.37715759310515096,0.9323778059869557,0.567032967032967,0.9185864972728799,1.0,1/13,0.98%,CADM1
prerank,organic substance transport (GO:0071702),0.2372173025573554,0.9320378207519788,0.6314741035856574,0.9185240743456485,1.0,11/121,6.79%,PLTP;LRP1B;ATP8A1;AQP9;RAMP2;ABCG2;MFSD2A;CHKA;SPNS2;MFSD12;SLC6A2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.23701679631498443,-0.9315629755445972,0.6168958742632613,0.7956845333524006,1.0,45/119,31.08%,PTPN13;PLEKHA2;PI4KA;SMG1;PIGN;SYNJ2;MTMR12;INPPL1;PIP4K2C;TTC7B;EFR3A;PITPNM2;ARF1;MBOAT7;MTMR3;PIK3C3;SLC27A1;PLEKHA8;DPM1;SACM1L;PIK3R4;SOCS7;PIK3CD;INPP5K;ITPKC;PIGH;MPPE1;PIK3R1;FGF2;PIGC;PLEKHA4;PI4K2B;DPM3;PIGA;RAB5A;IP6K2;PLEKHA1;PIGZ;RUFY1;PIGP;PI4KB;PIGF;CISH;SOCS3;PIP5K1C
prerank,protein-DNA complex disassembly (GO:0032986),0.3469352650067551,0.9313052533538307,0.5501113585746102,0.9195324016418225,1.0,4/16,14.93%,RPL23;SMARCB1;SET;SMARCD1
prerank,fatty acid transport (GO:0015908),0.34992598153620147,0.9309112979215695,0.558695652173913,0.919533800483072,1.0,5/17,13.89%,PPARG;MFSD2A;FABP5;SLC27A4;CD36
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.35854001402213165,-0.9309077069319047,0.5727611940298507,0.7968047669113008,1.0,10/15,35.85%,TSEN2;ERN1;TSEN15;CPSF4;RTRAF;CPSF1;TRPT1;TSEN54;RTCB;FAM98B
prerank,NAD biosynthetic process (GO:0009435),-0.3361348876100067,-0.9308848186120857,0.5486381322957199,0.7963727800721706,1.0,6/20,14.94%,PTGIS;NMNAT2;PARP10;PARP9;NMNAT3;NMNAT1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.29649568975137325,0.9307521852312513,0.5665236051502146,0.9189494534343886,1.0,6/34,11.13%,FLT1;TEK;FLT3;DAB2IP;PDGFB;PIK3R3
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3866257320620411,-0.9306581166260475,0.5441176470588235,0.7964332933878056,1.0,7/12,33.09%,BDH2;CHAC2;GSS;GGCT;GCLC;HAGH;CNDP2
prerank,transcription by RNA polymerase III (GO:0006383),-0.30976818563735725,-0.9303323390161387,0.5625,0.7967776241114918,1.0,16/27,39.93%,TBP;BRF1;SNAPC3;ICE1;GTF3C4;POLR2K;GTF3C1;SNAPC1;POLR3H;GTF3C6;SNAPC5;GTF3A;SNAPC4;POLR2L;SNAPC2;POLR3K
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3308156284169283,-0.9301504970461286,0.5479704797047971,0.7967681285394067,1.0,5/21,7.03%,SULF1;EXT1;SULF2;GLCE;HS2ST1
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.2342922004735371,-0.9301317255784475,0.6189473684210526,0.7963385905830811,1.0,34/117,26.45%,IGF1;ALDH1A2;PCCA;ME2;HLCS;CYP26B1;ACADSB;ABAT;GNPAT;CPT1C;MCCC2;VDAC1;PANK2;ACSF2;ME1;SLC5A6;PNPLA8;ACOT11;GLO1;PDHA1;ECHDC3;CPT1A;AMACR;MECR;ACSL4;ALDH4A1;ACOT6;SCPEP1;GBA2;GGT5;PPARA;LPL;AASDH;ME3
prerank,phosphate ion transport (GO:0006817),0.3577004443054669,0.9300711568989978,0.5642701525054467,0.9198048985207089,1.0,3/16,7.95%,SLC37A4;SLC37A1;SLC25A14
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.2958538525762952,-0.9299230091782701,0.57421875,0.7963553833454524,1.0,10/35,18.00%,SULF1;NR2F2;COL4A3;SPARC;THBS1;MEF2C;APOE;STAT1;ATOH8;ATP5IF1
prerank,positive regulation of response to stimulus (GO:0048584),0.28475750410427036,0.9286935310390994,0.5702127659574469,0.9227190848289664,1.0,11/40,19.56%,SIRT1;HMGA2;YPEL3;TGFB2;HOMER1;B2M;RSAD2;IER5;CDKN2AIP;ILK;EEF1E1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3740643097379278,0.9285541601939893,0.5257270693512305,0.922112521500223,1.0,3/13,13.30%,CSTF2T;CSTF2;CPSF2
prerank,protein localization to chromatin (GO:0071168),-0.34494792486512593,-0.9282568093185514,0.5604606525911708,0.7999570250276147,1.0,10/18,37.29%,MCM9;NIPBL;RAD21;PIH1D1;PPHLN1;ESR1;RUVBL2;WAPL;MSH2;MRNIP
prerank,axonal transport of mitochondrion (GO:0019896),-0.39476369106367987,-0.928078306132184,0.572202166064982,0.7999260121172747,1.0,3/11,10.53%,TRAK1;OPA1;HIF1A
prerank,chemical homeostasis (GO:0048878),-0.26699236728659714,-0.9279566213886831,0.5662650602409639,0.7997511360133217,1.0,12/61,12.70%,ZBTB20;RBP1;NR1D2;SLC4A10;ABHD5;TLCD2;WNK4;WNK1;NR1H3;PNPLA8;SLC4A3;FBXW7
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.26534470496800255,0.9276457663248169,0.5984251968503937,0.9235633477902304,1.0,11/57,12.55%,GRIN1;GRIN2A;SIRT1;GRIN2B;PPM1F;ACVR1C;NOD1;F2R;BCL10;NDUFA13;TNFSF10
prerank,inositol phosphate catabolic process (GO:0071545),-0.384717343146457,-0.9269142705366166,0.5580524344569289,0.8017722756708496,1.0,3/12,5.92%,INPP5B;SYNJ2;INPP5A
prerank,sterol biosynthetic process (GO:0016126),-0.2951065872734526,-0.9268467965636186,0.552434456928839,0.8014534899615727,1.0,11/33,23.77%,PRKAG2;INSIG2;ACAA2;HMGCR;SQLE;CYP51A1;SC5D;FDFT1;ARV1;LBR;MVK
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.3421478670119429,-0.926251761742306,0.5734406438631791,0.8024159803509393,1.0,7/20,18.35%,NFKB1;HM13;NCSTN;ADAM9;MBTPS2;MBTPS1;TRAF6
prerank,regulation of endocytic recycling (GO:2001135),-0.3913108138970832,-0.9262227774024852,0.5541044776119403,0.8020306625229692,1.0,5/11,28.69%,EHD2;ACTN2;EIPR1;ATP9A;EHD1
prerank,positive regulation of hormone secretion (GO:0046887),0.34650451955211825,0.9261192856840083,0.5619834710743802,0.9268439372338343,1.0,3/17,9.75%,HCAR2;NMB;GRP
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.3985346012674415,0.9258673790026588,0.5634095634095634,0.9265551004804405,1.0,2/10,3.78%,CXCL12;GAS6
prerank,interstrand cross-link repair (GO:0036297),-0.2740300150189975,-0.9257303279047413,0.5909980430528375,0.8027838166339697,1.0,25/53,32.53%,WDR48;RNF8;MCM9;RFWD3;FANCE;ERCC6L2;FANCM;FANCI;VCP;DCLRE1A;MSH6;POLN;FANCC;FAAP100;ATR;ERCC1;FANCB;UBA52;FANCD2;FANCG;FAAP20;NEIL3;RPA2;EXO5;RAD51
prerank,protein modification process (GO:0036211),-0.2515004293695764,-0.9256951214759992,0.6072874493927125,0.8023868440610253,1.0,25/76,21.34%,ARAF;ABL1;WWP2;PLOD2;PLAT;UBE2I;PPP4R2;ABL2;GGCX;YES1;PARP1;PARP4;LOX;PRKDC;MANBA;UBL5;FBXO22;UBE2S;UBA7;RPN1;RABGGTB;UBE2D3;B4GALT7;PIGH;AKT2
prerank,transepithelial transport (GO:0070633),0.36290424961602413,0.9253660764809792,0.554140127388535,0.9268738778088657,1.0,3/15,5.81%,ABCG2;SLC1A1;SLC1A2
prerank,negative regulation of heart contraction (GO:0045822),-0.4022931324091695,-0.9252420998231837,0.5727272727272728,0.80302845306505,1.0,1/11,0.03%,ATP1A2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.32429678379169063,-0.92474334356931,0.5644859813084112,0.8036930642681421,1.0,11/22,30.60%,BMP7;ROCK1;BMP4;ANKLE2;INPP5K;INHBA;CDKN1C;PRKRIP1;TESK1;CDA;INHA
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.28581271051447915,0.9246924551267669,0.5752808988764045,0.9277430170573505,1.0,9/39,13.02%,SPOCK1;ACER2;AJAP1;NOTCH1;MELTF;NEXMIF;SPRY4;FZD4;ACTN4
prerank,negative regulation of receptor internalization (GO:0002091),0.3733169730775804,0.9244982070568986,0.5646817248459959,0.9272309360536131,1.0,1/12,1.67%,NECAB2
prerank,positive regulation of cell killing (GO:0031343),-0.3802646282160381,-0.9238875976817527,0.5793650793650794,0.8052499571242705,1.0,5/13,25.22%,FZD7;CYBA;WNT5A;SYK;DVL2
prerank,positive regulation of programmed cell death (GO:0043068),-0.21104658025307033,-0.9237818921091069,0.6959183673469388,0.8050569374992386,1.0,63/272,18.90%,AKAP13;PAWR;FOXO3;STK3;BMP4;TIAM2;ABL1;LRRK2;ARHGEF17;STK17B;RARG;IGFBP3;HMGB1;ITGB1;DNM1L;HOXA5;PHLDA1;IFIT2;REST;PLEKHG2;MAP3K5;FAM162A;VAV2;CALHM2;AIFM1;MARK4;ADAMTSL4;UNC13B;CYP1B1;MAP3K20;NGF;NCSTN;PRMT2;JUN;ARHGEF12;ARHGEF18;BCLAF1;ERCC3;SOS2;RASSF2;CCAR1;CASP2;FGD1;ATF6;ING5;FGD4;RBM5;DDX3X;LATS1;TGFB3;DAPK1;NGEF;PTPA;IAPP;ARHGEF11;TRIO;ARHGEF6;DAPK2;ARHGEF1;SFRP4;TRAF6;BMP2;DCUN1D3
prerank,neuromuscular synaptic transmission (GO:0007274),-0.34362732077385655,-0.9236436385678323,0.580078125,0.8049157537101993,1.0,3/18,7.60%,FCHSD2;ERC1;TBC1D24
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2550616228316048,-0.9236234448653989,0.6215139442231076,0.8044994106074131,1.0,10/71,7.80%,ADAMTS12;NGLY1;FBXL17;PRKN;HM13;CTSC;CTSH;VPS4B;DDI2;CHMP4B
prerank,regulation of centrosome cycle (GO:0046605),-0.3267714820048497,-0.9229078125263875,0.5688259109311741,0.8057408048795871,1.0,5/21,10.06%,VPS4B;CHMP4B;MARK4;CHMP5;CHMP3
prerank,cAMP biosynthetic process (GO:0006171),-0.4076394320606499,-0.9228398990345378,0.5767097966728281,0.805430290098906,1.0,4/10,7.73%,ADCY9;ADCY5;ADCY1;ADCY6
prerank,amino acid transmembrane transport (GO:0003333),0.28270941486319373,0.9221469908335973,0.6063618290258449,0.9327007484667624,1.0,6/45,9.57%,SLC7A5;SLC6A6;SLC7A1;MFSD12;SLC7A8;SLC36A1
prerank,amide biosynthetic process (GO:0043604),0.2752003354759483,0.9214609650461659,0.602510460251046,0.9335524255132152,1.0,4/47,3.33%,SGMS1;PCSK1;FA2H;DEGS2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.38760470375437667,-0.9214219063985293,0.5806451612903226,0.808422419815487,1.0,9/12,37.05%,UPP2;DHODH;TK2;UMPS;CDA;CAD;UCK1;DCK;TK1
prerank,regulation of transposition (GO:0010528),-0.36978315640007914,-0.9213574495315272,0.5764925373134329,0.8080981856759644,1.0,2/13,16.94%,UBR2;MYBL1
prerank,nuclear transport (GO:0051169),0.3532132425394242,0.9207499030688285,0.5851703406813628,0.9345138619823149,1.0,4/16,13.45%,NXT1;RBM15B;NUP205;ANP32A
prerank,pentose-phosphate shunt (GO:0006098),-0.39076991203064226,-0.9205194514204273,0.5795454545454546,0.8096237027296084,1.0,6/11,26.16%,DERA;H6PD;PGLS;SHPK;RBKS;RPE
prerank,positive regulation of heart contraction (GO:0045823),-0.33437036537948933,-0.9203732279532753,0.5458015267175572,0.8095144683309984,1.0,1/19,0.03%,ATP1A2
prerank,phosphate ion transmembrane transport (GO:0035435),0.3767354407363518,0.9202198369539271,0.5831435079726651,0.9349402009374254,1.0,3/12,7.95%,SLC37A4;SLC37A1;SLC25A14
prerank,positive regulation of growth (GO:0045927),-0.2558302678493503,-0.9192985347382964,0.6114519427402862,0.8115781515184955,1.0,16/64,15.45%,EGFR;TGFBR1;INO80;RPTOR;BCL2;HDGFL2;CDC42;CXCL16;MMP14;USP47;N6AMT1;ADNP2;KLHL22;EXOSC9;DDX3X;CSNK2A1
prerank,cellular response to interleukin-2 (GO:0071352),-0.38958207726776267,-0.9192446770554129,0.5634615384615385,0.8107642614316602,1.0,5/11,24.64%,JAK1;SHC1;STAT5A;STAT5B;SYK
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.38958207726776267,-0.9192446770554129,0.5634615384615385,0.8107642614316602,1.0,5/11,24.64%,JAK1;SHC1;STAT5A;STAT5B;SYK
prerank,regulation of myelination (GO:0031641),0.3165593356467424,0.9192132603223109,0.6046511627906976,0.9366725716749827,1.0,7/25,13.73%,JAM2;TENM4;TMEM98;NSUN5;TPPP;TNFRSF21;PTPRZ1
prerank,T-helper cell differentiation (GO:0042093),0.36325294807857067,0.919014976713226,0.5550935550935551,0.9361822048978927,1.0,2/14,5.85%,LEF1;TMEM98
prerank,negative regulation of phagocytosis (GO:0050765),0.3403957489497734,0.9189263025797108,0.5560439560439561,0.935376181754268,1.0,4/17,9.10%,SYT11;TLR2;DYSF;CD300LF
prerank,negative regulation of hydrolase activity (GO:0051346),0.2745192506067904,0.918650001342072,0.6004098360655737,0.9350584537287225,1.0,5/49,6.34%,CAMK2A;PLXNB3;MAP2;ZCCHC9;FICD
prerank,positive regulation of embryonic development (GO:0040019),-0.3448923789797262,-0.9186429486263671,0.5773584905660377,0.8117342674493696,1.0,3/19,4.22%,WNT4;OSR1;NIBAN2
prerank,error-free translesion synthesis (GO:0070987),0.3167447489866575,0.918383557570943,0.5746887966804979,0.9347608018428245,1.0,8/22,18.89%,RPA3;RPS27A;UBC;UBB;POLD1;RFC4;RFC5;RFC2
prerank,cell chemotaxis (GO:0060326),0.2603017429480515,0.9181622552140417,0.5843881856540084,0.9343195961365243,1.0,9/60,10.22%,LEF1;EPHB1;PLXNB3;CXCL12;DOCK4;PRKCQ;ACKR4;PDGFB;BIN2
prerank,base-excision repair (GO:0006284),0.2664156000323447,0.9178565653632863,0.638,0.9341016052081506,1.0,13/48,18.89%,HMGA2;LIG3;RPA3;UNG;APEX1;POLG;POLD1;PRMT6;RFC4;POLD3;RFC5;ADPRS;RFC2
prerank,protein targeting (GO:0006605),0.2368069535664721,0.9177305462568944,0.625,0.9334331067655168,1.0,31/118,19.77%,NLGN1;GDAP1;AQP11;AKAP6;RASSF9;GABARAP;ZDHHC22;AP4B1;GOLGA7;PITRM1;CACNG3;ZDHHC15;TAOK2;HAP1;TIMM22;HACL1;SORL1;TSPO;SRPRA;ZDHHC4;SEC61G;ZDHHC14;HOMER3;VPS37A;RTP4;ARL6;TOMM70;TIMM10B;ZDHHC24;VPS37D;DNAJC19
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.315581538988988,-0.9175533111488535,0.5817490494296578,0.8138680468971532,1.0,14/25,42.82%,DNM1L;FAM162A;BMF;BNIP3;PDCD5;PLAUR;GPER1;PPIF;BCL2L11;PYCARD;BIK;TP53;HRK;PMAIP1
prerank,negative regulation of nuclear division (GO:0051784),-0.3939457009157874,-0.9175510040379247,0.5776965265082267,0.8134016468686647,1.0,3/11,9.77%,BMP7;BMP4;TOM1L2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.3061322580895685,-0.9166712233572787,0.6070038910505836,0.8149716522340875,1.0,9/29,29.39%,LDLRAD4;BMP5;IL17RD;VASN;SPRED2;PPP2CA;USF3;SDHAF2;MAD2L2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.2929722138034509,-0.9166309006286808,0.6012024048096193,0.814592264946016,1.0,6/33,7.95%,TCF7L2;ANGPT1;CAST;NUPR1;YAP1;PDPK1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.31175550982711375,-0.916448082289235,0.5776031434184676,0.8145359971659912,1.0,3/26,3.96%,ITPR1;ITPR2;IBTK
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.39403160524182745,-0.9164205494489511,0.5854126679462572,0.8141234643373404,1.0,4/10,17.48%,RIPOR2;WASL;APOD;MIA3
prerank,negative regulation of double-strand break repair (GO:2000780),-0.30454518583388135,-0.9163335295300495,0.5826612903225806,0.8138542729192139,1.0,19/30,35.08%,RNF169;TRIP12;KLHL15;UBR5;SHLD2;HELB;SMCHD1;HSF1;TWIST1;UBQLN4;OGG1;FANCB;CGAS;MAD2L2;NUDT16L1;RMI2;TFIP11;PARPBP;ERCC6
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.35038610905254075,-0.9155224994689578,0.5743879472693032,0.8152670358336003,1.0,7/17,24.75%,BMP4;VEZF1;ATOH8;SFRP4;FGF2;TMEM100;NKX6-1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.363231453230284,-0.9154474375019961,0.5596868884540117,0.8149747453712827,1.0,5/15,25.02%,VPS4B;SDC4;SNF8;RAB7A;SDC1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.31397646620927455,0.9152920901052647,0.546583850931677,0.9390317789292375,1.0,5/24,7.54%,TEK;PPM1F;KDR;THY1;PTPRJ
prerank,positive regulation of heart rate (GO:0010460),0.34060061259162605,0.914958866800593,0.5961538461538461,0.9388591907084296,1.0,6/17,16.31%,ADRB1;RYR2;ADRA1D;ADRA1A;PDE4D;EDN1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.27466645627279074,-0.9145577134274634,0.6227436823104693,0.8165388667399898,1.0,9/47,17.43%,PID1;PDGFRB;SLC5A3;TGFBR2;THBS1;PRKCD;AGTR1;CYBA;TLR4
prerank,regulation of phosphorylation (GO:0042325),-0.23183300783670793,-0.9144734165918266,0.6660412757973734,0.816279919075305,1.0,23/120,12.91%,PRKAG2;EGFR;BMP7;EP300;ROCK1;BMP4;THBS1;RANBP2;NRP1;LYN;NUP42;AR;PLXNB2;FER;ANKLE2;NUP214;HIF1A;FNIP1;TPR;KCTD20;FN1;OGT;FZD7
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.3814429770155756,-0.9139825063717728,0.5826771653543307,0.8169909023071048,1.0,2/12,1.57%,ADAMTS12;DCN
prerank,inner ear morphogenesis (GO:0042472),0.3234170378664618,0.9139627209989482,0.5608247422680412,0.9407175765728419,1.0,2/22,3.56%,PAX8;PAX2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.26752521027080634,0.9136609116055966,0.598343685300207,0.9405679643117838,1.0,12/48,13.89%,HDAC9;TMSB4X;SIRT1;KDR;NOS3;ETS1;AKT1;HSPB1;PDGFB;ATP5F1B;CD40;CIB1
prerank,regulation of membrane repolarization (GO:0060306),0.3674314298256762,0.9136439386366424,0.5784114052953157,0.939580144242305,1.0,2/13,3.72%,AKAP6;CACNA2D1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.24104300699651435,-0.9134373920341933,0.6585820895522388,0.8177884122060521,1.0,23/83,20.88%,CCNH;KHDRBS1;CDK16;CDK7;TFDP2;PHF8;EIF4E;MNAT1;CUL3;RB1;HINFP;CRLF3;ACVR1;RCC1;LATS1;CUL2;NASP;CACUL1;INHBA;CDK2;PCNA;CUL1;CDK6
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.288200916577864,-0.9133985645671563,0.6046065259117083,0.8174027146551189,1.0,13/36,24.78%,AFDN;KIF13A;RAB10;VAMP5;VAMP2;GGA3;RILPL2;NECTIN3;VAMP4;RILPL1;GGA2;NSF;RAB7A
prerank,regulation of mitochondrial translation (GO:0070129),-0.3279043834705596,-0.9131845220553536,0.5769230769230769,0.8174220931261919,1.0,10/21,31.68%,RCC1L;NSUN3;ALKBH1;MTG2;RMND1;RPUSD4;MPV17L2;TRMT10C;C1QBP;MRPS27
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.29009570558246356,0.9127571650596501,0.6320346320346321,0.9410550471723118,1.0,7/35,9.89%,SPRY3;RASAL3;STMN1;TGFB2;KCTD13;SPRY4;DAB2IP
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.27703110516227997,0.9126211485767168,0.6236559139784946,0.94040319579511,1.0,8/42,13.90%,AARS2;VARS1;VARS2;GARS1;RARS1;FARSB;AIMP2;IARS1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.38821716322178035,0.9122069226062086,0.5602536997885835,0.9405007099016532,1.0,2/10,7.01%,PPM1F;TERF1
prerank,peptide hormone secretion (GO:0030072),-0.3069081649665363,-0.912186625826609,0.6014897579143389,0.8192430472705532,1.0,4/26,8.15%,CYB5R4;CDK16;ANXA1;CAMK2G
prerank,motile cilium assembly (GO:0044458),0.3773553789837436,0.9117840265158799,0.5769230769230769,0.940579766148103,1.0,2/12,10.41%,DNAAF3;BBS5
prerank,translational elongation (GO:0006414),0.23958549784991442,0.9116420068910596,0.6575342465753424,0.9399427348583339,1.0,32/101,23.08%,MRPS25;MRPL14;MRPS12;EEF1B2;MRPL49;TUFM;MRPL13;MRPS18A;EEF1D;MRPS7;MRPS14;MRPL45;EEF1A2;MRPL36;MRPL23;EEF1A1;MRPL54;MRPS5;EEF2;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;RACK1;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,neurotrophin signaling pathway (GO:0038179),0.3263980913200932,0.9116389195308637,0.6,0.9389196327849499,1.0,7/21,19.55%,MAGI2;NTRK2;HAP1;BCAR1;RAP1A;DDIT4;SORT1
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.22077867033380663,-0.9111442930996496,0.71,0.8211758121784807,1.0,47/190,19.75%,UACA;ITPR1;CGNL1;DAG1;UBR2;BMP7;WWC2;PRKAA2;VGLL4;DEPTOR;WTIP;MARK3;THBS1;TMEM127;BCL2;LYN;MAPKBP1;UBR1;CCN3;LIMD1;TLE1;WWC1;FNIP1;RORA;RIOK3;PDE3A;PPM1A;STAT1;DUSP1;UBE2B;DDX3X;TRIM39;C1QTNF3;PRDM15;NOP53;NPRL3;PRKAA1;MYADM;PPP2R5C;RHOH;TANK;GPD1L;IFI35;INPP5K;ABCA7;AJUBA;TBC1D7
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3989645594012664,-0.9109551865719364,0.6053639846743295,0.8211326363402363,1.0,2/10,3.68%,TGFBR2;CD55
prerank,organelle transport along microtubule (GO:0072384),-0.2967772935249938,-0.9107392628180333,0.623015873015873,0.821187522380223,1.0,9/31,18.62%,TRAK1;ARHGAP21;CDC42;NDEL1;RHOT1;COPG2;FBXW11;TMEM201;COPG1
prerank,protein complex oligomerization (GO:0051259),0.24566452173971726,0.9106410252860689,0.651356993736952,0.940623671251177,1.0,21/85,19.16%,MPP2;ADCY8;KCNC2;AQP11;SNCA;GLRA3;KCNC3;NINJ1;HOMER1;KCNC1;RNF112;BCL10;HGSNAT;MAT2A;ZNHIT6;PNPT1;VSTM5;G3BP2;PDCD6IP;OXA1L;LRRC8A
prerank,blood vessel diameter maintenance (GO:0097746),-0.29215859880437783,-0.9105141422364141,0.6124031007751938,0.8212032999766852,1.0,5/34,7.77%,ROCK2;ROCK1;EDNRA;ADCY6;ECE1
prerank,regulation of interleukin-6 production (GO:0032675),0.24008113796400896,0.9103990105599226,0.6431535269709544,0.9402464320969334,1.0,17/96,15.80%,TIRAP;MBP;IL17F;SYT11;GAS6;TLR2;FOXJ1;CD200R1;ARHGEF2;AIF1;F2R;BCL10;POU2AF1;HSPD1;XBP1;MAPKAPK2;POU2F2
prerank,positive regulation of cell cycle (GO:0045787),-0.25726023541296855,-0.9103711526686838,0.6,0.82107597537484,1.0,16/62,16.75%,EGFR;PKD1;LRP6;ANKRD17;NUPR1;FGFR2;EIF4E;CCNYL1;HCFC1;PKD2;TTL;USP2;CCND3;CDC25B;CCDC57;CITED2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.3815074850366598,-0.9098456480966015,0.594392523364486,0.8218772832077186,1.0,6/11,30.06%,UQCRC1;UQCR10;UQCR11;CYC1;UQCRFS1;CYCS
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.2580968231502875,-0.9097867959440803,0.6380597014925373,0.8215520919531046,1.0,30/57,32.29%,FOXN3;NBN;TAOK3;BRCC3;ATF2;BRSK1;RFWD3;RINT1;STK33;PRKDC;CDC14B;TRIM39;NOP53;MRE11;SDE2;CDK2;TAOK1;CDK5RAP3;WAC;CLSPN;DONSON;TIPIN;ABRAXAS1;FZR1;FANCD2;MDC1;NEK11;RPA2;EME2;RAD9A
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.39068817654182636,-0.9094315825129035,0.6153846153846154,0.8219093418864891,1.0,5/11,26.22%,DHX36;ZC3H3;CDC73;AHCYL1;NCBP2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3301304933299713,0.9093582360157252,0.6017316017316018,0.9419876250261615,1.0,4/21,10.29%,SLC39A10;PRKCH;GPS2;LPXN
prerank,replication fork processing (GO:0031297),-0.28220502602358233,-0.909244758156116,0.6080508474576272,0.8218898254073553,1.0,18/38,35.65%,WRN;RFWD3;FANCM;BRCA2;BOD1L1;MRE11;ZRANB3;PCNA;ATR;SMARCAL1;PRIMPOL;ATRX;CDK9;SAMHD1;EME2;RAD51;CENPX;GEN1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.33780457057738716,0.9092046328055251,0.6012658227848101,0.9413801531733205,1.0,5/17,16.89%,MIF;SIRT1;RNF34;RFFL;MDM2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3294470712260643,-0.9087908070029088,0.5589941972920697,0.8224451244989124,1.0,7/21,23.68%,MCU;ANXA6;LETM1;MICU1;SLC8A3;FIS1;SLC8B1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.3807895455769954,0.9086695992129142,0.5907258064516129,0.9417636871994685,1.0,3/12,6.70%,PFDN5;CLU;PFDN6
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.2988222874789623,-0.9086311516418062,0.6211293260473588,0.8223352651550738,1.0,17/31,36.86%,UBE2N;BTRC;AXIN1;FBXW7;CDC14B;TOPORS;UBE2S;DCUN1D3;ARRDC4;MAGEC2;FZR1;DCUN1D5;UBE2L3;DCUN1D4;PIN1;GORASP1;SKP1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3486532899610743,-0.9081642219850928,0.5953757225433526,0.8229639980263902,1.0,6/18,19.93%,NGLY1;DERA;OGA;ADAMTS9;MANBA;NAGA
prerank,phagolysosome assembly (GO:0001845),0.37871407542396757,0.9077874863430101,0.6044624746450304,0.9431212065907065,1.0,2/12,10.67%,SYT7;CORO1A
prerank,cytosolic calcium ion transport (GO:0060401),0.3002387146197777,0.9075821580338483,0.6004415011037527,0.9426684630466834,1.0,7/28,11.22%,RYR2;CACNA2D1;SLC8A1;ATP2B3;SLC25A23;ADRA1A;JPH3
prerank,positive regulation of organelle assembly (GO:1902117),-0.2716753122086899,-0.9073426915481158,0.639921722113503,0.8244281895444183,1.0,16/44,26.41%,ASAP1;NUMA1;RAB3GAP1;STX18;PIP4K2C;MARK4;CNOT2;SDC4;DYNC1H1;CNOT1;LRSAM1;KCTD17;TAPT1;ARHGAP35;SDC1;BBS4
prerank,iron ion transmembrane transport (GO:0034755),0.3867319074664768,0.9073339012667625,0.5807860262008734,0.9423120844294838,1.0,3/10,10.65%,SLC40A1;SLC25A37;SLC39A8
prerank,positive regulation of transport (GO:0051050),-0.24535704916572726,-0.9072737047151099,0.6601178781925344,0.8241546043804613,1.0,26/85,25.99%,LRP1;DAB2;CAMK1D;NUMA1;GSK3B;GPC3;IL15RA;ANXA2;ANXA1;MERTK;NR1H3;APOE;CYBA;RXRA;DYNC1H1;INPP5K;ABCA7;AKT2;KMT2A;ZNF205;CHP1;HIP1R;SIRPA;KCTD7;CLIP3;FCER1G
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3178255929362347,0.9071993060579329,0.577922077922078,0.9416672193088534,1.0,6/22,16.15%,IPO5;CAMK2N1;MEN1;APC;CDKN1A;CDKN1B
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.37817824946845746,-0.9070161741686936,0.6069469835466179,0.8242557183309724,1.0,6/12,24.66%,GLUD1;ACO2;ACO1;ASS1;SIRT4;IREB2
prerank,positive regulation by host of viral transcription (GO:0043923),0.3598015164300288,0.9069595342972524,0.5921908893709328,0.9413006979734828,1.0,2/15,4.32%,LEF1;SMARCB1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.35721437675598156,0.9066032216068896,0.5894736842105263,0.9411893462683055,1.0,1/12,1.66%,HUS1B
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.3948863868080498,0.9052859203701387,0.6022471910112359,0.9436620032273938,1.0,3/10,13.04%,HECW1;HECW2;STK39
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.25200009299639015,-0.9051564388977145,0.651394422310757,0.8281889280058072,1.0,26/70,25.77%,PARVA;ITGAV;LAMC3;RADIL;ARL13B;NRP1;ATRNL1;FER;RHOA;MEF2C;RB1;FN1;RILPL2;ITGA4;TBCD;SIPA1L3;ITGB3;RILPL1;PIK3R1;ANTXR1;LAMB2;LAMC1;ITGA8;DACT2;UNK;EPHB3
prerank,protein localization to lysosome (GO:0061462),0.3014435046508532,0.9050164306999365,0.6094420600858369,0.9433483544893424,1.0,13/28,23.55%,SCARB2;NCOA4;GLMP;SORL1;RTN4;M6PR;AP3M1;HGS;VPS4A;SNX16;LMBRD1;SH3BP4;GCC2
prerank,in utero embryonic development (GO:0001701),-0.31191120431201846,-0.9047793684965557,0.5848670756646217,0.8286058307390618,1.0,9/25,18.77%,TGFBR1;PKD1;FGFR2;IGF2;CHD7;HINFP;VEGFA;TGFB3;BMP2
prerank,protein O-linked glycosylation (GO:0006493),0.23764004168035638,0.9046305492430566,0.6817248459958932,0.9433828407349732,1.0,16/96,13.34%,TMTC2;GALNT9;GALNT15;GALNT13;MGAT5B;EOGT;GALNT14;GALNT6;SLC35C1;PLOD3;GALNT3;ST8SIA6;GALNTL6;B3GNT2;GALNT2;POMGNT2
prerank,calcineurin-mediated signaling (GO:0097720),-0.4072558048407078,-0.9042788742075171,0.5980769230769231,0.8288215413409785,1.0,3/10,18.69%,NFAT5;NFATC4;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4072558048407078,-0.9042788742075171,0.5980769230769231,0.8288215413409785,1.0,3/10,18.69%,NFAT5;NFATC4;NFATC3
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.32447753586702055,-0.9038397081618508,0.618018018018018,0.8293846635147194,1.0,6/22,14.09%,AKAP13;AEBP1;ABL1;PRUNE1;EFEMP2;APOE
prerank,regulation of organelle organization (GO:0033043),-0.24185812502664142,-0.903499468234688,0.6401590457256461,0.8296846122385665,1.0,28/80,25.17%,DIAPH1;EP300;PRKN;DNM1L;PAK2;STX18;ZEB2;CLIC4;USP6NL;RHOT1;MAVS;STX5;ARMH3;SURF4;EHD3;AKAP9;PLXNB1;TAOK1;FIS1;SPEF1;MSN;PARL;F11R;LMAN1;RHOT2;PREB;SAR1B;NEXN
prerank,Golgi to plasma membrane transport (GO:0006893),-0.2716098575268542,-0.9034290996326002,0.6433823529411765,0.8293916542509284,1.0,9/47,10.91%,KIF13A;CCDC93;ARL3;RAB10;OSBPL5;VAMP5;VAMP2;GGA3;EXOC2
prerank,positive regulation of T cell proliferation (GO:0042102),-0.2570871483652385,-0.903357563806576,0.6404040404040404,0.8290888652530054,1.0,6/55,8.57%,IGF1;IGFBP2;IL6ST;HMGB1;ANXA1;IGF2
prerank,retinal metabolic process (GO:0042574),0.37246044334575434,0.9033463411640148,0.5859728506787331,0.945793098540737,1.0,2/12,5.75%,BCO1;DHRS13
prerank,cell junction maintenance (GO:0034331),0.3598524250405084,0.9032882028651098,0.5867237687366167,0.9449210492224603,1.0,5/14,19.82%,CSF1R;F2R;DCTN1;CBLN2;CBLN1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.25847057137506774,0.9032430730811247,0.6428571428571429,0.9440304567018378,1.0,20/60,18.94%,PRKCQ;KLF4;HSP90AB1;PDGFB;CCT2;DKC1;CCT4;ATM;PARM1;RFC4;PTGES3;XRCC5;RFC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;RFC2;TCP1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.26094082257649714,0.9027556451217875,0.6294736842105263,0.9444015207399652,1.0,11/54,13.23%,MINAR1;CAMLG;ADGRB1;IVNS1ABP;COPS9;ISG15;AKT1;RPL5;PER2;SMAD7;RPS3
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3894695694134981,-0.9025312737860275,0.5916824196597353,0.8304740577714356,1.0,6/11,27.39%,GTF2H2;GRK3;ARRB1;ADM;SAG;ADRB2
prerank,leukocyte tethering or rolling (GO:0050901),-0.3436618097695968,-0.9023092716795357,0.5786407766990291,0.8305425818017409,1.0,5/17,23.08%,ROCK1;ITGB1;ITGA4;CX3CR1;VCAM1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.3279417409071369,0.9020765193471627,0.5991189427312775,0.9451768134408811,1.0,3/22,2.63%,KANK3;TMSB4X;TMSB10
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2828189407549419,-0.9018686174806307,0.6087751371115173,0.8311366323353298,1.0,16/40,32.02%,UBE2N;SMG1;ABL1;PRKCD;BCLAF1;RFWD3;WDR76;NEK4;KMT5A;UBE2V2;NSMCE4A;FXR1;CDK9;POLH;PARG;RPA2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.25298408140719414,0.9017891961316424,0.6618556701030928,0.944958894333567,1.0,11/68,13.68%,TIRAP;MBP;IL17F;TLR2;ARHGEF2;AIF1;F2R;BCL10;POU2AF1;HSPD1;XBP1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2958094945821404,-0.9016137089605414,0.6204933586337761,0.8312587883832548,1.0,8/29,20.28%,WWOX;THBS1;PAK2;TRAF2;LTBR;INHBA;PPP2R1B;PML
prerank,positive regulation of isotype switching (GO:0045830),0.34962029244745185,0.9013849821540267,0.587991718426501,0.9450515511297088,1.0,3/15,13.15%,TFRC;SHLD3;CD40
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.35413088393040776,-0.9012391290958534,0.6290322580645161,0.831648377760466,1.0,10/16,33.94%,KLHL15;SHLD2;HELB;SMCHD1;UBQLN4;FANCB;CGAS;MAD2L2;RMI2;PARPBP
prerank,negative regulation of anoikis (GO:2000811),-0.3607510621594293,-0.9011740170454212,0.6123595505617978,0.8313291321900622,1.0,4/14,15.36%,ITGB1;BCL2;TLE1;ITGA5
prerank,regulation of protein dephosphorylation (GO:0035304),0.2821992043143196,0.9011373620892175,0.6209850107066381,0.9447055833206153,1.0,12/37,22.83%,YWHAB;PPP1R16B;SMPD1;CALM1;CALM2;CALM3;MFHAS1;PPIA;CAMTA1;PPP2R5A;PPP1R16A;PPP6R1
prerank,regulation of isotype switching (GO:0045191),0.35941724970726585,0.9000113446477982,0.5947136563876652,0.9466634330142596,1.0,1/14,0.13%,TFRC
prerank,regulation of acute inflammatory response (GO:0002673),0.3356906132289548,0.8997926866879856,0.6117886178861789,0.9462911441524566,1.0,1/18,1.05%,DNASE1
prerank,regulation of T cell cytokine production (GO:0002724),-0.3454352723504155,-0.898731451673992,0.5901328273244781,0.8364757601900563,1.0,4/15,18.35%,CD55;TRAF2;TRPM4;TRAF6
prerank,"phagocytosis, engulfment (GO:0006911)",-0.2821132159548842,-0.898627711329206,0.5909090909090909,0.8362479049534356,1.0,10/36,20.76%,GULP1;GSN;THBS1;VAMP7;CDC42;RHOBTB2;DOCK1;RHOBTB1;RHOH;ARHGAP12
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.31116964826483773,-0.8986196535629701,0.6283018867924528,0.835795812946677,1.0,6/23,20.33%,SLC9A1;SLC12A7;ATP6V0A4;SLC12A2;SLC12A8;SLC12A9
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.24401086619053441,0.8986007378785006,0.6808080808080809,0.9483207340202815,1.0,18/86,16.14%,CHEK1;ATF3;EPAS1;PSMA1;RPS27A;UBC;EPO;UBB;PSMD12;PSMA6;PSMB3;KLF2;HIGD1A;PSME3;ATF4;STOX1;PSMC3;PSMA2
prerank,organophosphate ester transport (GO:0015748),0.3115758795541781,0.898293137439982,0.62217659137577,0.9481472073324929,1.0,8/24,18.19%,PLTP;PITPNM1;PRELID3A;PRELID2;SCARB1;SCP2;MTTP;PITPNB
prerank,regulation of cell development (GO:0060284),0.2869692933098302,0.8982526532452849,0.6030701754385965,0.9472517256831803,1.0,11/36,16.99%,HDAC9;RPS19;HEY1;AKT1;FOXO1;PER2;HES6;BHLHE40;DLL1;HES5;CTNNB1
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.2748075004430257,-0.8982227122770752,0.6367265469061876,0.8362491140907963,1.0,7/40,14.17%,SLC7A11;SLC13A3;ABCC5;SLC38A11;SLC5A6;SLC38A6;SLC27A1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.2818712971656754,-0.8981866570451961,0.6313799621928167,0.8358588112728209,1.0,9/38,17.01%,BMP5;CFLAR;GSK3B;THBS1;SP100;TRAF2;STX4;DDX3X;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),-0.40243968513553785,-0.8981293253995191,0.5846994535519126,0.835064729213475,1.0,2/10,5.41%,ST3GAL4;THBS1
prerank,positive regulation of coagulation (GO:0050820),-0.40243968513553785,-0.8981293253995191,0.5846994535519126,0.835064729213475,1.0,2/10,5.41%,ST3GAL4;THBS1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.3658853074828836,-0.8978667751216298,0.626984126984127,0.8351792749774435,1.0,3/13,12.87%,ADHFE1;D2HGDH;DLST
prerank,apoptotic process (GO:0006915),-0.21063856278806334,-0.8978624489479675,0.7461240310077519,0.83471587686279,1.0,41/203,17.29%,NOTCH2;PAWR;RNF152;CFLAR;STK3;EP300;CYFIP2;TGFBR2;PLSCR1;ZBTB16;BCL2;IFIT2;MTOR;FAM162A;AIFM1;VDAC1;CASP12;TNFAIP1;EGLN3;MAGI3;PRKCD;DMPK;CDK11B;AKAP1;BCLAF1;NCKAP1;PARP1;FAP;ERCC3;OGT;CASP2;IRF1;RFK;DAPK1;IAPP;DAP;GLRX2;ARHGEF6;PDCD4;DAPK2;BCL2L13
prerank,protein import into peroxisome membrane (GO:0045046),-0.3209872684365344,-0.8977479371619725,0.6419047619047619,0.8344873540665837,1.0,7/22,20.65%,ABCD3;PXMP4;ABCD2;SLC25A17;FIS1;PXMP2;PEX26
prerank,negative regulation of cytokine production (GO:0001818),0.220955258165885,0.8964217123038067,0.7232824427480916,0.9510701287519349,1.0,19/163,11.19%,CD33;LEF1;NAV3;HDAC9;TMSB4X;SYT11;GAS6;ISG15;IL12A;RPS6KA5;NPTN;KLF4;GPNMB;CD34;FOXJ1;CD200R1;HOMER2;PPP1R11;TNFRSF21
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.341363917330061,0.8961242852901751,0.594017094017094,0.9508287047944519,1.0,3/16,7.29%,PPP1R16B;IL12A;APLNR
prerank,cardiocyte differentiation (GO:0035051),-0.3950265825042286,-0.8959916367386876,0.5963636363636363,0.8379864945720056,1.0,5/10,21.36%,AKAP13;SIK1;EEF1AKMT4-ECE2;BMP2;GATA6
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.22949852794719533,-0.8958182103423141,0.7305389221556886,0.8379200498176856,1.0,35/109,29.12%,GAB2;NFKB1;BTRC;MAP2K4;PAK2;SHC1;LYN;VAV2;PDPK1;PLCG1;FER;JUN;PSMF1;TEC;PSMB2;MAP2K7;FBXW11;TRAF6;MAP3K1;NFATC3;CUL1;PIK3R1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;MAPK9;FCER1G;SOS1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,type I interferon signaling pathway (GO:0060337),-0.2705973501477748,-0.8956548229136055,0.6428571428571429,0.8373753410188818,1.0,22/41,34.85%,JAK1;IFIT2;SP100;IRF9;IRF1;TYK2;STAT1;OAS2;GBP2;IFI35;IFI27;IRAK1;IFIT3;IRF2;IP6K2;EGR1;SAMHD1;IFITM1;IRF5;PSMB8;MYD88;IRF8
prerank,cellular response to type I interferon (GO:0071357),-0.2705973501477748,-0.8956548229136055,0.6428571428571429,0.8373753410188818,1.0,22/41,34.85%,JAK1;IFIT2;SP100;IRF9;IRF1;TYK2;STAT1;OAS2;GBP2;IFI35;IFI27;IRAK1;IFIT3;IRF2;IP6K2;EGR1;SAMHD1;IFITM1;IRF5;PSMB8;MYD88;IRF8
prerank,innate immune response (GO:0045087),0.21228905776591891,0.8954072021429329,0.7382297551789078,0.951699716218121,1.0,33/217,16.08%,MASP2;PGLYRP1;MBL2;TRIM13;PPARG;SNCA;ISG15;CAPZA2;TRIM43;SRMS;TRIM62;TLR2;TRIM6;IFITM3;TRIM59;SLPI;CYBC1;CORO1A;SMPD1;MID2;BCL10;IRF7;PJA2;CD40;DEFA6;LCN2;TRIM35;POLR3A;MFHAS1;B2M;GCH1;OTULIN;RNASE3
prerank,response to nitric oxide (GO:0071731),0.3612391577823104,0.8953541374103547,0.5967413441955194,0.9508235466001509,1.0,4/13,20.51%,KCNC2;FOXO1;EGLN1;CCL19
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.37162904873726493,-0.8953404046402021,0.6155339805825243,0.8376059900868731,1.0,4/13,19.78%,NFAT5;RHOA;TRAF6;IRAK1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.281422578106986,0.8950308195140125,0.59958071278826,0.9507045761645201,1.0,9/33,17.04%,TERF1;HSP90AB1;PIF1;TERF2IP;DKC1;NHP2;TINF2;PTGES3;HSP90AA1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.38906067399955235,-0.8949221625200612,0.5885509838998211,0.8379903046249473,1.0,5/10,21.04%,PIBF1;PTPN2;PARP14;NF2;PPP2CA
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.30693554154160685,0.8947476463792102,0.6458797327394209,0.9504712545854502,1.0,4/26,6.25%,USP44;LCMT1;UBE2C;HECW2
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.38053177881130096,-0.8945814966483064,0.6162570888468809,0.8382812161101822,1.0,3/12,12.13%,GSN;TRIM5;TRIM11
prerank,cellular component disassembly (GO:0022411),0.2612993309261877,0.8941424843902016,0.6338028169014085,0.9510966234380616,1.0,5/53,8.11%,BSG;TMPRSS6;MMP12;TIMP1;MMP16
prerank,extracellular matrix disassembly (GO:0022617),0.26095258749454453,0.8937228183485385,0.6430020283975659,0.9511638911318121,1.0,5/53,8.11%,BSG;TMPRSS6;MMP12;TIMP1;MMP16
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.31156839841250134,0.8937041906035029,0.6238938053097345,0.9502153634730014,1.0,6/23,15.96%,CYP2E1;HPGD;ACOT7;FADS1;LTA4H;GSTM1
prerank,nuclear membrane reassembly (GO:0031468),-0.2586649196678265,-0.8935540857323611,0.6427255985267035,0.8401701517512412,1.0,23/54,35.08%,LMNA;UBXN2B;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;REEP4;AHCTF1;NUP133;SEC13
prerank,regulation of biomineral tissue development (GO:0070167),-0.30554428286849994,-0.8934712073654094,0.5957446808510638,0.8398902842385639,1.0,4/26,8.44%,ROCK2;ROCK1;ENPP1;NBR1
prerank,vesicle organization (GO:0016050),0.2636686936505597,0.8931321602287784,0.6561181434599156,0.9506782561511878,1.0,14/46,21.05%,CAV2;HOOK1;FNBP1L;CD34;AKTIP;SAR1A;CORO1A;CHMP2B;USP8;DNM1;SORT1;PI4K2A;DNAJC13;SNX11
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.3329240384236885,-0.8924230656211227,0.6408839779005525,0.8417762019863956,1.0,8/18,22.22%,MAP3K3;RHOJ;FOXC2;ANXA1;VEGFA;FGFBP1;FGF2;SRPX2
prerank,regulation of cellular component organization (GO:0051128),0.2275933892986137,0.8922763991662462,0.7086776859504132,0.9518982276236406,1.0,20/135,10.63%,NRG3;TFRC;SPOCK1;RIT2;RAB4B;OGFR;SEMA4D;PAK5;HIP1;HSPA8;PRKCQ;WFDC1;BBS10;MELTF;RAB4A;SGK3;TAOK2;DAB2IP;NET1;IL17RB
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3411903929337979,-0.8916990657651677,0.6182170542635659,0.8429679520921063,1.0,2/17,4.65%,ANK2;SNTA1
prerank,anterograde axonal transport (GO:0008089),0.27591575155022874,0.8916622647613087,0.6652892561983471,0.9524647726169487,1.0,5/37,10.81%,DLG2;KIF1A;AP3B2;HSPB1;HAP1
prerank,positive regulation of protein transport (GO:0051222),0.24758250369454748,0.8916421912244423,0.696,0.9515147148384188,1.0,6/67,5.82%,CD33;PRR5L;TENM1;APBB1;APBB3;TGFB2
prerank,sarcomere organization (GO:0045214),0.2990355347123135,0.8913592660234763,0.610655737704918,0.9512667426464791,1.0,4/27,9.53%,MYH6;FHOD3;WDR1;TCAP
prerank,regulation of centriole replication (GO:0046599),-0.33928997219172013,-0.891357534097976,0.6107899807321773,0.8433079563327547,1.0,5/17,17.08%,KAT2B;ALMS1;SPICE1;CEP295;CEP76
prerank,regulation of epithelial cell differentiation (GO:0030856),0.3346065297064426,0.8913475644241023,0.6230936819172114,0.9502950772158095,1.0,4/17,13.72%,AJAP1;CD24;APOLD1;DLL1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.35483245916405637,-0.8909724671422341,0.6011787819253438,0.8437302407409284,1.0,5/15,15.02%,NTRK3;IL16;F3;VEGFA;VEGFD
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2860701438428366,-0.8904311488870531,0.6380255941499086,0.8445178211241825,1.0,12/34,19.26%,PTPN13;TNS2;PTPN9;PTPRS;DUSP16;PTPN22;PTPN12;PTPN2;DUSP1;DUSP10;PTPN1;PTPN11
prerank,regulation of anoikis (GO:2000209),-0.32674461378025094,-0.8903404161194597,0.6078066914498141,0.844232467617358,1.0,5/19,15.36%,ITGB1;BCL2;TLE1;SIK1;ITGA5
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.38434492154274824,-0.8901994784883379,0.6312949640287769,0.8440825293053116,1.0,4/11,17.35%,ACTN2;LEPROTL1;LEPROT;PICALM
prerank,negative regulation of transferase activity (GO:0051348),-0.3020079185174377,-0.8900619693966928,0.6402321083172147,0.8438901900897346,1.0,8/28,20.48%,ABL1;GSK3B;EIF4A2;DTX3L;HNRNPU;INPP5K;PARK7;CDKN1C
prerank,regulation of actin filament-based movement (GO:1903115),-0.3923118192476608,-0.8892200576003014,0.6238532110091743,0.8453140918145258,1.0,2/10,2.84%,ANK2;PDPN
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.328709424684431,-0.8890851258432516,0.6180698151950719,0.8451598149994204,1.0,3/19,2.75%,DCN;CCBE1;ROBO1
prerank,atrioventricular valve development (GO:0003171),-0.35725466214420815,-0.888929144272048,0.5974264705882353,0.8450415670092005,1.0,3/14,3.24%,BMPR1A;MDM4;TGFBR2
prerank,negative regulation of nervous system development (GO:0051961),-0.3406972857343808,-0.888905437356517,0.5846153846153846,0.8446181728582203,1.0,3/17,7.45%,APPL2;PCM1;REST
prerank,negative regulation of DNA metabolic process (GO:0051053),0.31143600685239603,0.8883672207845892,0.6165254237288136,0.957049194834127,1.0,7/24,16.70%,DACH1;ACVRL1;TERF2IP;BMPR2;RPS3;CDKN1A;XRCC5
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.23225155827005453,0.8882898798585244,0.6967370441458733,0.9562521164112014,1.0,19/94,16.23%,ST18;TOLLIP;PSMA1;RPS6KA5;PLCB1;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;NOD1;NFKBIA;TAB2;PSME3;PELI1;PSMC3;PSMA2;IL1RAP
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3731992573316592,0.8879729311402358,0.598343685300207,0.956075394089394,1.0,2/10,7.89%,CD24;HSP90AB1
prerank,histone H4 acetylation (GO:0043967),-0.2638981401172255,-0.8879622752537258,0.6609195402298851,0.8462852394435467,1.0,17/47,21.38%,EP300;TRRAP;ZZZ3;HAT1;ATF2;KANSL2;TADA3;HCFC1;OGT;KAT8;ING5;BRCA2;MSL2;EPC1;MSL3;KANSL3;KMT2A
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3767432313987872,0.8876444470048993,0.5807860262008734,0.9559204951576165,1.0,4/10,16.69%,DGKH;F2R;PRKD3;GAP43
prerank,negative regulation of blood pressure (GO:0045776),0.36632452003614646,0.8874666710958337,0.6088794926004228,0.955393338270106,1.0,2/13,12.87%,NOS3;BMPR2
prerank,purine-containing compound catabolic process (GO:0072523),0.36370421522964946,0.8874503940444758,0.6136363636363636,0.9544432115124016,1.0,2/13,9.52%,GPX1;NT5C
prerank,regulation of necroptotic process (GO:0060544),-0.3082881396784003,-0.8874145443618657,0.6361829025844931,0.8470343110583318,1.0,4/23,12.87%,CFLAR;FLOT2;YBX3;OGT
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3464087861891808,0.8870174203818594,0.6363636363636364,0.954606366670196,1.0,8/15,26.13%,NME2;ENTPD3;AK5;ENTPD1;ENTPD5;ENTPD7;AK4;ENTPD2
prerank,regulation of cellular response to heat (GO:1900034),0.23926866383115475,0.886611873612423,0.6918103448275862,0.9546451022910489,1.0,27/77,22.09%,CAMK2A;SIRT1;NUP210;HSPA8;RPA3;HSP90AB1;CD34;NUP62;NUP205;ATM;MAPKAPK2;NUP54;FKBP4;PTGES3;CHORDC1;HSP90AA1;MLST8;IER5;MAPK3;NUP85;BAG2;CRYAB;BAG1;RAE1;AKT1S1;NUP107;DNAJC2
prerank,manganese ion transport (GO:0006828),0.353018807779125,0.8863907233056713,0.6242171189979123,0.9541805655611865,1.0,3/14,11.89%,TRPC5;SLC39A8;TRPC1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.32875275854391045,0.8861245977953592,0.6357894736842106,0.9538736164971263,1.0,9/18,20.69%,TIMM21;COA5;FASTKD3;COX16;COX17;BCS1L;COA3;OXA1L;SCO1
prerank,cholesterol metabolic process (GO:0008203),-0.2462692694656734,-0.8859091522428099,0.698292220113852,0.8500066993218436,1.0,23/68,31.11%,ABCA1;CYP27A1;SOAT1;INSIG2;OSBPL5;ACAA2;APOE;RXRA;HMGCR;SQLE;CYP51A1;FDX1;FDFT1;ARV1;LBR;MVK;GBA2;SCAP;CLN8;MT3;TSKU;ANGPTL3;CLN6
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3507699218437601,-0.885610200905265,0.6353591160220995,0.85021452474701,1.0,2/14,9.12%,IGF1;LDLR
prerank,positive regulation of endocytosis (GO:0045807),-0.26936847491281996,-0.885541564796814,0.652,0.849895322574038,1.0,8/45,9.23%,LRP1;APPL2;AXL;DAB2;VTN;GPC3;CDC42;HNRNPK
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.2951380589868378,-0.8854610425782363,0.6288461538461538,0.8491396487700301,1.0,7/29,23.25%,GPAT4;ACSF2;ACSL6;ACOT11;ACOT9;ACOT8;ACOT6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.2951380589868378,-0.8854610425782363,0.6288461538461538,0.8491396487700301,1.0,7/29,23.25%,GPAT4;ACSF2;ACSL6;ACOT11;ACOT9;ACOT8;ACOT6
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.36245672906923365,-0.885344036318861,0.6071428571428571,0.8489120897632647,1.0,3/13,10.62%,RBPJ;TGFBR2;SMAD4
prerank,response to tumor necrosis factor (GO:0034612),-0.23603015563834628,-0.8848703482144955,0.7134268537074149,0.8495352988008167,1.0,17/91,18.79%,PID1;ADAMTS12;ZFAND6;AFF3;GSDME;DHX9;NUB1;CXCL16;ADAM9;YBX3;GBP3;MAP2K7;GBP2;NPNT;TANK;INPP5K;SMPD4
prerank,lysosome localization (GO:0032418),-0.27713643045998393,-0.884837563219796,0.6660117878192534,0.8491454194140358,1.0,18/37,41.59%,TFEB;KIT;NDEL1;SYTL4;PIK3CD;PLEKHM2;SPAG9;KIF5B;S100A13;KLC2;MYH9;RAB34;SNAPIN;MILR1;BORCS6;PIK3CG;HPS6;ARL8B
prerank,hexose biosynthetic process (GO:0019319),-0.2758195188444936,-0.8847683093225888,0.6867924528301886,0.8488377628865742,1.0,10/42,17.45%,RBP4;SLC39A14;AKR1B1;PPARGC1A;CHST15;MDH1;PGK1;PCK2;SLC25A11;CRTC2
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2909751689030889,-0.8845926024004617,0.6492248062015504,0.8487301972368775,1.0,8/28,16.43%,EGFR;WWP2;NIBAN2;MMP14;NOTCH3;FBXW7;ARRB1;TSPAN15
prerank,regulation of mRNA metabolic process (GO:1903311),-0.37251845169738335,-0.884390537685367,0.6107011070110702,0.8487051102992799,1.0,3/11,11.02%,DHX9;SAFB2;CDK11B
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3318354303116975,-0.8841755824949933,0.6237816764132553,0.848698489482271,1.0,4/18,17.35%,ROCK2;EPHA4;IFNGR1;PICALM
prerank,axonemal dynein complex assembly (GO:0070286),0.29789499779021006,0.8840947406997853,0.6206185567010309,0.9580817199453507,1.0,4/27,10.03%,DNAAF3;LRRC49;CFAP100;DNAAF2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.3295405874720534,-0.8840537705404202,0.6375711574952562,0.8484871911173447,1.0,2/17,4.65%,ANK2;SNTA1
prerank,pre-replicative complex assembly (GO:0036388),0.25093166125561756,0.8836207550901685,0.6906187624750499,0.958236167686332,1.0,14/64,19.98%,PSMA1;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;MCM3;PSME3;PSMC3;PSMA2;PSMB7;ORC6;MCM8
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3269722551676608,-0.8835723551621251,0.6445783132530121,0.849086520119928,1.0,9/19,24.64%,ZMIZ1;AXL;ZBTB1;MMP14;PRKDC;RHOH;PPP2R3C;XRCC6;SYK
prerank,quinone biosynthetic process (GO:1901663),0.3498895948047438,0.8835568548732629,0.621676891615542,0.9574126032971292,1.0,2/14,5.43%,COQ2;COQ7
prerank,positive regulation of innate immune response (GO:0045089),-0.2879591887370474,-0.8832505524622696,0.659047619047619,0.8493236044247112,1.0,8/30,18.63%,LBP;PLSCR1;DHX9;UBE2K;MAVS;RIOK3;WNT5A;IFI35
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.3774831412094552,0.8832450440311188,0.6053215077605322,0.957170544694048,1.0,3/10,13.42%,TIRAP;NINJ1;WDFY1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3532408587967539,-0.8830067145126563,0.6222222222222222,0.8494125883355544,1.0,5/15,14.17%,LDLR;NR1H3;SIK1;FBXW7;SLC27A1
prerank,glutathione derivative metabolic process (GO:1901685),0.3142974335729484,0.8826684585409318,0.6572668112798264,0.9567042250561311,1.0,5/20,19.26%,GSTA4;GSTM5;ESD;GSTM1;MGST3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3142974335729484,0.8826684585409318,0.6572668112798264,0.9567042250561311,1.0,5/20,19.26%,GSTA4;GSTM5;ESD;GSTM1;MGST3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.31570603497669397,0.8826351033348393,0.6349514563106796,0.9548182494725539,1.0,10/23,22.02%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;PPP1R13B;BBC3;CASP8;YWHAQ;PPP3CC
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.31570603497669397,0.8826351033348393,0.6349514563106796,0.9548182494725539,1.0,10/23,22.02%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;PPP1R13B;BBC3;CASP8;YWHAQ;PPP3CC
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3229760039004089,-0.882576054456714,0.6201550387596899,0.8498442716992316,1.0,10/20,31.31%,BCL2;CAMK2D;ATP2A2;FIS1;PML;KCTD17;WFS1;CCDC47;BAK1;HERPUD1
prerank,rRNA 3'-end processing (GO:0031125),-0.38782338579059916,-0.8821013834005565,0.6242990654205608,0.850404122003442,1.0,4/10,15.99%,ERI3;ERI2;EXOSC9;EXOSC10
prerank,sulfur compound transport (GO:0072348),-0.3006087946229009,-0.881990756973904,0.6591337099811676,0.8501742153023998,1.0,8/27,18.64%,SLC6A13;SLC13A4;SLC26A7;LRRC8D;SLC5A6;SLC27A1;SLC25A11;MGST1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.31447862726703657,0.8816501457475887,0.6336842105263157,0.956254507740465,1.0,4/20,10.07%,AMPD1;GART;HPRT1;GMPR2
prerank,response to lipopolysaccharide (GO:0032496),0.2217079435057201,0.8815408920920771,0.7445109780439122,0.9555444112944728,1.0,26/138,15.14%,PDE4B;TIRAP;GIT1;S100A9;S100A8;SNCA;NOS3;IL12A;HNRNPA0;IFNAR1;TRIM6;CCL2;DAB2IP;SLPI;GGT7;F2R;BCL10;GGT1;MAPK8;SCARB1;DEFA6;XBP1;TAB2;PELI1;GCH1;MAPKAPK2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.23259835252927893,-0.8814942560449907,0.6968503937007874,0.8508171871397727,1.0,40/88,37.07%,FBXL7;FBXL17;BTRC;FBXL4;FBXL12;PSMF1;FBXL18;AMN1;FBXW7;PSMB2;FBXO38;CUL2;FBXW11;FBXW5;CUL1;PSMC1;FBXW4;PSMB6;PSMA3;PSMA4;FBXL14;FBXO4;PSME1;PSMD13;PSMB10;PSMA5;FBXL3;PSMB9;RBX1;FBXL8;FBXO9;CCNF;PSME4;FBXL13;PSMB8;PSMD10;CUL5;FBXL6;SKP1;PSMD3
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.33238609082353804,0.8810188272563287,0.6132723112128147,0.9559311018898102,1.0,4/18,8.42%,SIRT1;NME5;AKT1;HSPB1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2897673380990453,0.8809333422289229,0.653276955602537,0.9551839174621928,1.0,12/30,19.88%,MVD;HSD17B7;IDI1;DHCR7;PLPP6;HMGCS1;ACAT2;TM7SF2;EBP;MSMO1;FDPS;NSDHL
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3195602427078565,0.8809124367221284,0.6244813278008299,0.9542521727996627,1.0,5/21,12.85%,PDE2A;NUDT3;HPRT1;PDE4D;HINT1
prerank,autonomic nervous system development (GO:0048483),0.33206796967866736,0.8805858536324979,0.6186440677966102,0.9541136266256466,1.0,1/17,0.21%,PHOX2A
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.26951441004310783,0.8805170796970271,0.6767895878524945,0.9533100346658251,1.0,10/37,16.84%,RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;RFC4;POLD3;RFC5
prerank,mammary gland development (GO:0030879),0.31472333002104574,0.8803566404627882,0.6391752577319587,0.9527258700053627,1.0,3/21,6.61%,ERBB4;NRG1;WNT7B
prerank,protein acylation (GO:0043543),-0.27698722768987744,-0.8803092394355948,0.64030131826742,0.8529842330031924,1.0,14/38,28.21%,KAT2B;EP300;CREBBP;GLUL;ZDHHC13;ING5;GTF2B;ZDHHC1;ZDHHC16;HHAT;SPHK1;ZDHHC8;NAT10;NAA80
prerank,glucan catabolic process (GO:0009251),0.34129893607858997,0.8801832642189712,0.6244635193133047,0.9521912449422009,1.0,2/15,1.96%,PHKG1;PGM2L1
prerank,cellular response to osmotic stress (GO:0071470),-0.3188697919491989,-0.8801373820562733,0.6318897637795275,0.8528895060111022,1.0,7/21,22.88%,MYLK;LRRC8D;PKD2;YBX3;DDX3X;CAB39;ZFAND1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.26980521214145886,0.8800729778056005,0.6833333333333333,0.9514934961599881,1.0,5/41,8.91%,CD33;SYT11;GAS6;CD34;POMC
prerank,regulation of T cell proliferation (GO:0042129),0.24992403086255502,0.8800072999067734,0.6832298136645962,0.9506958456444692,1.0,5/61,11.19%,TFRC;SLC7A1;GPNMB;AIF1;TNFRSF21
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3312019286669703,0.8793073412907095,0.6367432150313153,0.9513940141097053,1.0,7/18,16.78%,TENM4;NOTCH1;TMEM98;OPALIN;TNFRSF21;PTPRZ1;HES5
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3521308869207119,0.8792471298424044,0.6049382716049383,0.9505667878560351,1.0,1/14,0.13%,TFRC
prerank,carbohydrate catabolic process (GO:0016052),0.2776169730135783,0.8792401334685226,0.6722338204592901,0.949620184534164,1.0,12/38,21.41%,PGAM4;PGAM1;NEU2;ALDOC;GCK;PFKFB2;GAPDHS;NEU1;LDHA;ENO2;NEU4;GPI
prerank,O-glycan processing (GO:0016266),0.26042759537526444,0.8785793216638123,0.678646934460888,0.9503461516214434,1.0,5/54,5.33%,GALNT9;GALNT15;GALNT13;GALNT14;GALNT6
prerank,glutamate metabolic process (GO:0006536),-0.3183122931081847,-0.8781756391571505,0.6597353497164461,0.8568065369448588,1.0,8/19,28.86%,GLUD1;GLUL;PRODH;OAT;ALDH18A1;DGLUCY;GCLC;GOT1
prerank,protein processing (GO:0016485),-0.2273202305511969,-0.8779254942476213,0.7536231884057971,0.8568799021462533,1.0,30/102,22.50%,AEBP1;PCSK5;HM13;CTSH;F3;DDI2;ECE1;SEC11C;NCSTN;LONP2;MMP14;ADAM19;YME1L1;CPM;OGT;CASP2;CPXM2;STOML2;PTCH1;SPRTN;CPXM1;SEC11A;SDE2;EEF1AKMT4-ECE2;SPPL3;CLN5;FXN;CTSL;MYRF;PARL
prerank,positive regulation of protein depolymerization (GO:1901881),0.36656442051461957,0.8777551120659352,0.6079664570230608,0.9514346820411268,1.0,2/11,8.71%,WDR1;STMN2
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.30826535998789967,-0.8774770424328852,0.6418181818181818,0.8573722844282695,1.0,6/23,10.14%,ABL1;PRKN;LRRK2;SLC9A1;ADCY6;GABPA
prerank,response to progesterone (GO:0032570),0.3174473514851721,0.8774725460837579,0.6331096196868009,0.9511630563806488,1.0,4/18,12.34%,ABHD2;TGFB2;UBE3A;WBP2
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3249298183259418,-0.8773547361064731,0.6429942418426103,0.8571851819736416,1.0,7/18,22.37%,PRKN;IRS1;REST;CCN3;ADRA2A;SIRT4;KCNB1
prerank,acute inflammatory response (GO:0002526),-0.30528503699918774,-0.8772131909636287,0.6685082872928176,0.857032245858853,1.0,4/23,12.73%,LBP;PLSCR1;F3;IL6R
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3315527152627319,-0.8771081677652686,0.6452830188679245,0.8567789546499132,1.0,6/17,18.24%,TPM1;MEF2C;EFEMP2;TGFB3;PDCD4;SOD2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.35460078191621863,-0.877053816141493,0.6038834951456311,0.8564430875798829,1.0,3/14,10.27%,MEOX2;THBS1;RHOA
prerank,mitochondrion transport along microtubule (GO:0047497),0.3498132357101661,0.8770321918647295,0.6412556053811659,0.9512864180851861,1.0,2/13,8.04%,SYBU;UBB
prerank,cochlea morphogenesis (GO:0090103),0.3794687922254939,0.8769957281685133,0.6273684210526316,0.9504196455445613,1.0,1/10,3.56%,PAX2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.24117559328767954,-0.8766027236819796,0.7291242362525459,0.8569565310614472,1.0,21/73,20.47%,EGFR;NTRK3;ARAF;RPTOR;TBK1;DOCK7;CREBL2;AXIN1;BRAF;RAPGEF3;NGF;FNIP1;TXN;VEGFA;LATS1;AKAP9;PRKD1;PARK7;MTCP1;EIF4G1;NOS1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.26794848712738123,0.8764360912270274,0.6344294003868471,0.9508479037020177,1.0,11/39,18.49%,MYO1E;KIF1A;FNBP1L;BICDL1;MYO6;HAP1;PPFIA2;ACTN4;SYT4;MYO5A;MYO19
prerank,ubiquinone biosynthetic process (GO:0006744),0.3422693173233482,0.8761410926254217,0.6389452332657201,0.9506010500621014,1.0,2/15,5.43%,COQ2;COQ7
prerank,isotype switching (GO:0045190),-0.3868639473570545,-0.8760910628490441,0.635036496350365,0.8576544883759418,1.0,6/10,37.27%,RNF8;MSH6;EXOSC3;BATF;LIG4;MSH2
prerank,positive regulation of transporter activity (GO:0032411),-0.36031131673987665,-0.8760393280235527,0.6327985739750446,0.8572848249683087,1.0,10/13,47.42%,NR1H3;RXRA;KMT2A;KCTD7;TRPC6;SGK1;SYNGR3;SGK2;PDZK1;WNK3
prerank,positive regulation of lipid storage (GO:0010884),-0.30721572158029264,-0.8759746629675287,0.6539162112932605,0.8569735009349756,1.0,9/21,32.18%,NFKB1;OSBPL11;PLIN3;IKBKE;LPL;EHD1;FITM2;MSR1;C3
prerank,regulation of phagocytosis (GO:0050764),0.25973010959041093,0.875698782765366,0.6859504132231405,0.9506998283294613,1.0,6/53,7.68%,SYT7;SYT11;IL2RG;GAS6;TLR2;DYSF
prerank,peptidyl-arginine modification (GO:0018195),0.34482209010711146,0.8756490330299658,0.6286307053941909,0.9498736782350581,1.0,3/15,12.85%,NDUFAF5;PRMT7;ART3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.2725791735500234,0.8754300580064313,0.6680244399185336,0.9494563275077692,1.0,16/38,20.38%,CLU;KLF4;HSP90AB1;AKT1;CD34;KHSRP;GLA;KLF2;INSR;CD36;ATP2B4;EDN1;HSP90AA1;DDAH1;CD47;RAC1
prerank,B cell homeostasis (GO:0001782),-0.38927448879916443,-0.8754183461287228,0.634469696969697,0.8577132460637038,1.0,3/10,11.68%,DOCK11;LYN;MEF2C
prerank,negative regulation of mitochondrion organization (GO:0010823),0.28625392242659936,0.8751610260118052,0.6301969365426696,0.9491460561960728,1.0,5/33,7.97%,TFRC;OMA1;GPX1;CLU;AKT1
prerank,piRNA metabolic process (GO:0034587),0.33027805271888155,0.8749044736036237,0.6305732484076433,0.94886175291832,1.0,3/19,19.07%,TDRD12;PIWIL2;TDRKH
prerank,ubiquinone metabolic process (GO:0006743),0.3391564522835797,0.8743133735744409,0.6363636363636364,0.9494064655858045,1.0,2/15,5.43%,COQ2;COQ7
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.32215412286019446,0.8741671165943761,0.6632653061224489,0.9488141894381271,1.0,3/18,9.00%,FLT1;PPARG;CCL2
prerank,endocytic recycling (GO:0032456),-0.2578562558144617,-0.874076801360504,0.7153846153846154,0.8601168277116698,1.0,21/50,36.06%,CCDC93;ANKRD50;VPS26C;EHD2;VPS39;ANKRD27;ACAP2;EHD3;EIPR1;EHD4;SNF8;PTPN23;SNX12;RAB7A;ARL4C;EHD1;ARF6;DENND1B;STX6;MICALL1;CCDC22
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.28945593214020077,-0.8738891029955286,0.6704331450094162,0.8600501297844617,1.0,3/29,6.61%,TGFBR3;TPM1;FGFR2
prerank,negative regulation of insulin secretion (GO:0046676),-0.33397418125662975,-0.8737452544432233,0.6405353728489483,0.8598886713170212,1.0,7/17,22.37%,PRKN;IRS1;REST;CCN3;ADRA2A;SIRT4;KCNB1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.28264551848432223,0.87358989406981,0.6707317073170732,0.9492836308313038,1.0,5/31,9.89%,HSPA13;PACRG;HSPA8;HSPA5;DAB2IP
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.31159222049825575,-0.8735428695509357,0.647834274952919,0.8598669643497014,1.0,3/21,9.11%,PAG1;PIBF1;PTPN22
prerank,cardiac ventricle development (GO:0003231),0.31723286676353807,0.8731534863374973,0.6540084388185654,0.9494010801365308,1.0,3/20,5.70%,HEY1;PDE2A;NOTCH1
prerank,regulation of intracellular pH (GO:0051453),-0.27625631307384,-0.8726382150042093,0.6504672897196262,0.8613596631456295,1.0,5/34,6.17%,LRRK2;SLC4A10;SLC9A1;SLC9A8;SLC9A2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.2752831627718422,0.8725793143698694,0.6778947368421052,0.9498894893601765,1.0,6/33,16.55%,SLA2;THY1;PTPRJ;BCL10;RPS3;RAB29
prerank,protein insertion into membrane (GO:0051205),-0.2868403395772864,-0.8724283043734187,0.6654135338345865,0.861354688504548,1.0,11/32,29.11%,EGFR;TRAM2;VAMP2;STX5;COX18;EMD;GET4;VAPA;STX1A;APP;CCDC47
prerank,regulation of myotube differentiation (GO:0010830),-0.30388326444299585,-0.871997693311089,0.6742857142857143,0.8618254466142391,1.0,13/24,28.18%,HDAC4;CCN3;MMP14;DMPK;SIK1;BHLHE41;MAML1;HDAC1;FBXO22;TMEM119;MAPK14;HDAC3;SMYD1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.25899461272791285,-0.8719444245295542,0.7109826589595376,0.8614762543064501,1.0,13/46,22.74%,PIEZO2;NFKB1;SLC9A1;MAP2K4;CASP2;IRF1;LTBR;MAP3K14;TLR4;MAP3K1;CNN2;BNIP3;F11R
prerank,histone exchange (GO:0043486),-0.27922975542494627,-0.8718563937445931,0.6910112359550562,0.8611954210568259,1.0,21/37,40.11%,RNF8;HJURP;SPTY2D1;CENPP;ANP32E;NASP;ITGB3BP;CENPT;ACTR6;DMAP1;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,defense response to Gram-negative bacterium (GO:0050829),0.266256757518993,0.8714183952337958,0.6940928270042194,0.9517807031644407,1.0,8/42,19.26%,RPS19;ADGRB1;RPL30;DROSHA;DEFA6;RNASE3;OPTN;CHGA
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.36094517407391186,0.8711056432354056,0.621676891615542,0.9515327247693595,1.0,3/12,3.94%,RYR2;CTNNA3;BIN1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.22670814663124317,-0.8710758531681605,0.7766599597585513,0.862437458570612,1.0,38/104,27.81%,LRP6;KSR1;ABL1;CCNT2;UVRAG;CCNH;RPTOR;CCNT1;CDK7;MAP2K1;CCNK;MNAT1;RHOA;TELO2;RB1;TRIB2;SLC27A1;CCND3;DDX3X;CNPPD1;SYAP1;SLC8A3;MTCP1;SNF8;CAB39;PPP2CA;PIH1D1;CDK5RAP3;EZH2;GTF2H1;BCCIP;CCNE2;CCNJ;IRGM;INCENP;ADRB2;TESK1;CAMK1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.3711843067062257,-0.8707841905293665,0.6334586466165414,0.8625832458511898,1.0,2/11,6.93%,RC3H1;LYN
prerank,regulation of cytokine production (GO:0001817),0.2227654695578688,0.8706390652009122,0.7945492662473794,0.95168047003684,1.0,12/126,9.29%,CADM1;IL17F;HDAC9;MIF;BTNL9;SYT11;ISG15;MOG;RPS6KA5;NPTN;GPNMB;TRIL
prerank,response to ionizing radiation (GO:0010212),-0.24227630264785766,-0.8696606771142205,0.736328125,0.8645167413177255,1.0,23/70,26.93%,EYA1;INO80;SPIDR;ANXA1;BRCC3;RNF8;CLK2;BRSK1;RFWD3;XRCC4;NABP2;PRKAA1;TANK;DCUN1D3;COP1;BRAT1;USP28;PAXIP1;EYA3;MAPK14;TNKS1BP1;IKBIP;ABRAXAS1
prerank,regulation of immune response (GO:0050776),0.21826561769328956,0.8694298095101944,0.8080614203454894,0.9536639542707088,1.0,12/135,9.53%,CD33;LRP8;TIRAP;KLRC1;SPPL2B;SLA2;TGFB2;CD34;LAIR1;ICAM2;CD300LF;CD200R1
prerank,actin filament-based transport (GO:0099515),-0.30611148545132827,-0.8689632398373287,0.6458333333333334,0.8655430638187618,1.0,4/21,12.66%,SYNE2;MYO1B;WASL;MYO1F
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.2534574786961663,-0.868695627765169,0.7071290944123314,0.8656159078908288,1.0,8/55,13.51%,PID1;PDGFRB;PRKN;TGFBR2;THBS1;CYP1B1;AGTR1;SIRT5
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.32146104510519896,0.8685522372093973,0.6441048034934498,0.9548153994314253,1.0,6/17,22.82%,NLGN1;SYT10;CACNA1I;SYT4;SLC4A8;RAB3A
prerank,peptidyl-glutamic acid modification (GO:0018200),0.2986699909264083,0.8679065571297733,0.6781115879828327,0.9554052071366606,1.0,2/24,2.52%,TTLL7;AGBL4
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.24283983700429956,0.8678574774408492,0.7166324435318275,0.9545671095770392,1.0,13/75,11.23%,PRKAR2B;IPO5;SPRY3;SIRT1;SLC8A1;PTPRJ;AKT1;SPRY4;DAB2IP;UCHL1;MEN1;SMPD1;APC
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.23868958027037623,-0.8666984143244111,0.7304526748971193,0.8693399084439729,1.0,28/70,35.75%,ITGAV;ITGB5;SEC22B;PSMF1;PSMB2;MFSD6;CYBA;LNPEP;TAP2;SNAP23;NCF2;PSMC1;PSMB6;PSMA3;PSMA4;TAP1;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;CALR;PSME4;PSMB8;PSMD10;TAPBP;FCGR1A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.32328000193417444,-0.8660959830268142,0.6717557251908397,0.8701162200269793,1.0,6/18,25.95%,PAG1;PTPN22;WNK1;MIA3;ASS1;PPARA
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.37554604390200474,-0.8657661549036995,0.634469696969697,0.8703914632167239,1.0,2/10,11.43%,RC3H1;NFKBIZ
prerank,ketone body metabolic process (GO:1902224),-0.3791331669858806,-0.8650380896047869,0.6379647749510763,0.8714369631175268,1.0,3/10,20.34%,ACSS3;BDH2;OXCT1
prerank,regulation of B cell differentiation (GO:0045577),-0.3177945695804728,-0.864807456654464,0.6401515151515151,0.8714420334420147,1.0,8/17,32.49%,MMP14;ID2;INHBA;PPP2R3C;SYK;ZFP36L2;INHA;CD27
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2507032741526716,-0.8643055712740922,0.7267441860465116,0.8720687969418993,1.0,14/53,20.68%,PKD1;ARAF;PRKN;RAD23B;NUPR1;UFL1;PSMF1;FBXW7;RHBDF1;APOE;PSME3IP1;PRKACA;TMTC3;DESI1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3424776730599753,-0.8642368293876953,0.66796875,0.8717596230788149,1.0,4/13,13.05%,SRSF10;PRPF6;PRPF3;USP4
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.23423387677723537,-0.8639697911924332,0.7494908350305499,0.8718783020080761,1.0,15/78,15.73%,NR2F2;EGFR;PKD1;CCNT2;CCNH;CCNT1;CDK7;CCNK;MNAT1;CCNYL1;PKD2;CDK5RAP1;CCND3;LATS1;CNPPD1
prerank,response to hexose (GO:0009746),-0.29614057138775995,-0.8635648696587978,0.674074074074074,0.8722365202349454,1.0,9/25,26.17%,TCF7L2;THBS1;VAMP2;SELENOS;ZBED3;EIF2B4;PFKL;EIF2B5;LPL
prerank,glutathione metabolic process (GO:0006749),0.26739961896781506,0.8633417442197335,0.7045951859956237,0.9643779871714915,1.0,6/38,11.62%,GSTA4;GPX1;GSTM5;GGT7;NAT8;GGT1
prerank,response to interferon-beta (GO:0035456),-0.30392560946267366,-0.8632917813264855,0.6584905660377358,0.8723368329145268,1.0,9/22,28.23%,PLSCR1;UBE2K;IRF1;STAT1;IKBKE;SHFL;IRGM;HTRA2;CDC34
prerank,positive regulation of T cell differentiation (GO:0045582),-0.2654894370154294,-0.86328953794563,0.7055555555555556,0.8718690024889473,1.0,3/36,1.70%,GLI3;ZMIZ1;GLI2
prerank,tRNA processing (GO:0008033),-0.2456469479008923,-0.8632098728855709,0.7410207939508506,0.8715729567046139,1.0,23/61,26.39%,FARS2;TRMT9B;TSEN2;NSUN6;QTRT2;TSEN15;TYW5;METTL1;NSUN2;ELP5;KARS1;FTSJ1;PUS3;CDKAL1;LCMT2;CPSF4;TRNT1;DTWD1;RTRAF;TRMT1;CPSF1;ELAC2;DTWD2
prerank,alpha-amino acid metabolic process (GO:1901605),-0.2628137007866015,-0.8631550615654577,0.7091254752851711,0.8712252957029644,1.0,11/45,20.78%,ASPA;MMUT;NOX4;GLUD1;MTHFR;GLUL;ASPG;OAT;ALDH18A1;THAP4;ASS1
prerank,regulation of viral entry into host cell (GO:0046596),0.28741493410128804,0.8630928254965252,0.69375,0.964034127503707,1.0,7/30,14.35%,HS3ST5;TRIM62;TRIM6;IFITM3;TMPRSS4;MID2;LY6E
prerank,regulation of protein transport (GO:0051223),-0.2921097875257827,-0.8630181927289516,0.6691871455576559,0.8710183464232367,1.0,5/27,8.46%,DNAJC1;STXBP5;WWP2;DISP1;NDEL1
prerank,mitotic cytokinesis (GO:0000281),-0.25631228513464144,-0.8629895347034269,0.7058823529411765,0.8706124340148937,1.0,7/47,7.80%,ROCK2;SON;ROCK1;ARL3;SNX9;KLHDC8B;CHMP4B
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2376417312325489,0.8625867578261943,0.7394789579158316,0.9642722789987254,1.0,9/73,11.59%,TIRAP;IL17F;MIF;CLU;TLR2;PTPRJ;HSPB1;ARHGEF2;BCL10
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.2958541650619073,-0.8623768206294148,0.6850828729281768,0.8714385561612319,1.0,6/25,9.42%,ANK2;COA8;SLC6A9;ACTN2;WNK4;WNK1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.2641209999132439,0.8622224854000357,0.720173535791757,0.9641724192350717,1.0,5/43,8.91%,CD33;SYT11;GAS6;CD34;POMC
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3258911605518496,0.8613965057325499,0.6577319587628866,0.965280631488187,1.0,2/16,1.96%,PHKG1;PGM2L1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.3574102946620206,-0.8612926402914525,0.6382978723404256,0.8732375371919093,1.0,10/12,61.39%,IL18;SLC11A1;CCR2;IL12RB1;IL23A;IL23R;IL12B;XCL1;IL1B;IL18R1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3693881743911882,-0.8608355655313078,0.6606822262118492,0.8737301361737089,1.0,2/11,4.07%,PDPN;RREB1
prerank,gastrulation (GO:0007369),-0.34296530213888,-0.8607339992689076,0.6623376623376623,0.8734942784905493,1.0,2/15,5.30%,GPC3;SMAD2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3039687206751049,-0.8606323700932847,0.6940298507462687,0.8732497310770418,1.0,6/23,14.43%,GHR;KIT;PIBF1;CYP1B1;HES1;CRLF3
prerank,basement membrane organization (GO:0071711),-0.3461175770510154,-0.8603497379174322,0.6395348837209303,0.8733572093650898,1.0,3/14,5.97%,NID1;FLRT2;NID2
prerank,regulation of oxidoreductase activity (GO:0051341),-0.3496816352907528,-0.8598419027727513,0.6482142857142857,0.8739475899940629,1.0,6/13,33.56%,ABL1;ABL2;SIRT4;SZT2;MT3;ATP7A
prerank,regulation of chromatin binding (GO:0035561),-0.37551240460046,-0.8594496671872679,0.6351851851851852,0.874284161432514,1.0,3/10,13.47%,BTAF1;PARP9;DTX3L
prerank,granulocyte differentiation (GO:0030851),0.31414386650933335,0.8593526445967447,0.6517311608961304,0.9691586902214081,1.0,2/18,5.80%,LEF1;TAL1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.2544707204754606,-0.8592363979725823,0.7200772200772201,0.8742812838194662,1.0,8/48,9.20%,ZMIZ1;KAT2B;EP300;ARID1B;SF3B1;TAF1D;TBP;PHF2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3098188066506279,0.8591602196846502,0.659043659043659,0.9686571468427737,1.0,8/19,14.84%,BIN1;NTRK2;CLU;RTN2;HAP1;RTN1;SORL1;RTN4
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.2871557085721745,-0.859065451078366,0.6862745098039216,0.8741796673342674,1.0,8/28,16.33%,ARHGAP28;FCHSD2;PLEKHG2;BRK1;CTTN;LATS1;RASA1;ARHGAP18
prerank,organelle fission (GO:0048285),0.29561658068426294,0.8590476075728672,0.7136465324384788,0.9679710123699626,1.0,2/24,1.86%,DNM3;GDAP1
prerank,negative regulation of protein secretion (GO:0050709),-0.2647528016412292,-0.8588339328010349,0.7416829745596869,0.874187035887492,1.0,14/38,22.37%,PRKN;IRS1;REST;CCN3;NR1H3;SERGEF;RHBDF1;APOE;ADRA2A;HMGCR;CYP51A1;DPH3;SIRT4;KCNB1
prerank,immunoglobulin mediated immune response (GO:0016064),-0.3791493479854179,-0.8587317364050329,0.6716417910447762,0.8739481234774369,1.0,6/10,51.98%,FCER1G;CD81;CD27;FCGR2B;TLR8;CARD9
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.23261330701001265,0.8586747056898697,0.757201646090535,0.9678943839440951,1.0,9/86,6.46%,NAV3;PROX1;TENM1;BIN1;GPX1;OCLN;PAK1;WDR1;CLU
prerank,membrane protein proteolysis (GO:0033619),-0.27307473262684057,-0.8584965579207225,0.701010101010101,0.8739708723229012,1.0,12/37,20.20%,DAG1;NFKB1;HM13;CTSH;NCSTN;ADAM9;MBTPS2;ADAM19;MBTPS1;CLPP;TRAF6;SPPL3
prerank,negative regulation of cation channel activity (GO:2001258),0.29294926937749544,0.8584274675350348,0.634453781512605,0.9675040509486721,1.0,6/26,14.31%,GPR35;EPO;KCNAB1;CALM1;CALM2;CALM3
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3362215106423053,0.8583189587374078,0.6591836734693878,0.9668241617677381,1.0,15/15,66.41%,KYAT1;KYNU;GSTZ1;TAT;QDPR;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;FAH;IL4I1;HGD;KMO
prerank,telomere capping (GO:0016233),-0.3262967410235171,-0.8582891520564188,0.6573556797020484,0.8738988797190399,1.0,7/16,21.10%,NBN;PRKDC;CTC1;MRE11;DCLRE1A;TERF2;STN1
prerank,cAMP metabolic process (GO:0046058),-0.35400570729951786,-0.8581797864008349,0.664804469273743,0.8736420779050065,1.0,4/13,7.73%,ADCY9;ADCY5;ADCY1;ADCY6
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.32347874387958936,-0.8576401243287765,0.6636528028933092,0.8742790066180208,1.0,11/18,34.80%,RIPOR2;TNFAIP1;ABL2;CUL3;MYOC;ARHGAP35;KANK1;SCAI;MET;CCDC125;KCTD10
prerank,myeloid cell differentiation (GO:0030099),0.2571496372850921,0.8572052189267142,0.7133620689655172,0.9685045735761142,1.0,9/47,14.55%,ALAS2;TIRAP;RPS19;TAL1;EPO;HIPK2;RPS14;SNRK;MFHAS1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.3337588476783737,-0.8571368571337309,0.6375968992248062,0.8749114490037438,1.0,4/15,11.01%,OSBPL8;OSBPL11;ABHD5;PLIN3
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.28877998108244296,0.8566325962961742,0.6651982378854625,0.9688635121044697,1.0,3/25,5.60%,HSPA13;HSPA8;HSPA5
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3155840890604186,0.8564583614277376,0.676595744680851,0.9683178300714194,1.0,7/18,18.94%,RUVBL1;CCT2;DKC1;NHP2;CCT4;NAF1;TCP1
prerank,histone H3 acetylation (GO:0043966),-0.26222520673759225,-0.8561751615761172,0.7024029574861368,0.8764566570997464,1.0,13/40,25.49%,KAT2B;KAT6B;BRPF3;TADA3;KAT14;ING5;BRCA2;TAF5L;TAF6L;TAF12;YEATS2;JADE2;LDB1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.35521021281659854,0.8560540796662728,0.6531914893617021,0.9682644469491365,1.0,1/11,0.45%,ST18
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.2990324292858213,0.8551197260690455,0.682092555331992,0.969544755046193,1.0,5/21,16.57%,CNKSR3;PPM1F;SMAD7;PDE4D;DDIT4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.30012824386402476,-0.8551084913276608,0.6653771760154739,0.8781923218860425,1.0,7/21,19.07%,DCN;BGN;CHST15;CHST11;CHPF2;CHSY1;CHST12
prerank,histone H4-K8 acetylation (GO:0043982),-0.34187093828003745,-0.8549561734594022,0.6495412844036698,0.8775763615792678,1.0,6/15,23.98%,KANSL2;HCFC1;OGT;KAT8;KANSL3;JADE2
prerank,histone H4-K5 acetylation (GO:0043981),-0.34187093828003745,-0.8549561734594022,0.6495412844036698,0.8775763615792678,1.0,6/15,23.98%,KANSL2;HCFC1;OGT;KAT8;KANSL3;JADE2
prerank,Rac protein signal transduction (GO:0016601),-0.31597743432993386,-0.8545916518306093,0.6830601092896175,0.8778312793278634,1.0,5/18,18.46%,BRK1;NCKAP1;WASF1;FARP2;RHOH
prerank,negative regulation of calcium ion transport (GO:0051926),0.3379352187853534,0.8540373822179954,0.6652977412731006,0.9710981068964736,1.0,3/15,7.74%,CD33;SLC30A1;EPO
prerank,response to ketone (GO:1901654),0.2855849862018347,0.8540307972716793,0.6895787139689579,0.970174068709443,1.0,6/24,12.34%,ABHD2;TGFB2;SLIT3;UBE3A;ABCB4;WBP2
prerank,telomere organization (GO:0032200),0.2564321145918138,0.8537488304189527,0.7346072186836518,0.9698648246932535,1.0,12/43,16.70%,HUS1B;RPA3;TERF1;H3-3A;TERF2IP;APEX1;POLD1;ATM;TINF2;POLD3;PTGES3;XRCC5
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.27871080696293565,0.8533988432314528,0.7035490605427975,0.9697019914274428,1.0,10/32,18.25%,MAGI2;PPP1R16B;HSP90AB1;SMPD1;CALM1;DUSP26;CALM2;CALM3;PPIA;CAMTA1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.2503806425571182,-0.8532577645322442,0.7462962962962963,0.880000955235338,1.0,8/48,12.87%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3518520318356652,-0.8531645407015925,0.6705653021442495,0.879726966832394,1.0,5/12,27.35%,ACSL1;ACOX1;ELOVL1;ACOT8;ELOVL5
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.27877186817842586,0.8529776322683732,0.7024793388429752,0.9697418763762737,1.0,5/32,8.50%,MFSD2A;PCYT1B;CHKA;CSNK2B;SLC44A5
prerank,maturation of SSU-rRNA (GO:0030490),0.2767360934990628,0.8527268434675129,0.6878850102669405,0.9693680813501263,1.0,4/34,6.76%,TSR3;RPS19;RPS8;RPS16
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.24016076854559187,0.852720660838754,0.7707006369426752,0.968444074965108,1.0,10/62,9.76%,CXCL12;SIRT1;NME5;CLU;RTKN2;EPO;AKT1;TPT1;HSPB1;ARHGEF2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3325574183427422,0.8523734959612952,0.7036247334754797,0.9683413456222735,1.0,3/15,5.82%,STOX2;CELF4;TGFB2
prerank,negative regulation of GTPase activity (GO:0034260),-0.30115454410541087,-0.8510325182763547,0.6933867735470942,0.8835604952524067,1.0,5/22,9.42%,LRRK2;BCAS3;ARFGEF1;GMIP;WNK1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.22249253488165746,-0.8507089304848336,0.7895716945996276,0.883751063637837,1.0,28/94,22.93%,PCM1;ALMS1;ODF2;NINL;CEP63;CEP135;CEP162;PCNT;MARK4;CSNK1E;RAB3IP;RAB11A;CC2D2A;C2CD3;MAPRE1;YWHAE;AKAP9;DYNC1H1;CEP76;TCTN1;PRKACA;CEP57;CSNK1D;CEP89;NPHP1;HAUS7;HAUS8;ACTR1A
prerank,regulation of cellular component size (GO:0032535),-0.28444005732836875,-0.850702391938025,0.6992337164750958,0.8833000204862913,1.0,5/30,7.90%,RPTOR;RARG;RAB22A;MTOR;VAV2
prerank,endodermal cell fate commitment (GO:0001711),-0.3663134164718518,-0.8502094315787376,0.6811320754716981,0.8838161078486848,1.0,3/10,19.87%,CTR9;RTF1;CDC73
prerank,positive regulation of ion transport (GO:0043270),0.253110940282326,0.850190517249328,0.7541322314049587,0.9723826973639186,1.0,7/48,11.50%,CAMK2A;CNKSR3;ANK3;SCN4B;CACNB2;F2R;P2RX7
prerank,lysosome organization (GO:0007040),-0.2663168086108075,-0.850138764832543,0.7137330754352031,0.8835036178838396,1.0,6/36,7.41%,ABCA1;LRRK2;TFEB;ZKSCAN3;MTOR;TPCN2
prerank,regulation of phosphatase activity (GO:0010921),-0.2926651264114642,-0.8498844593494697,0.6994328922495274,0.8835488425905141,1.0,12/24,37.52%,SH3RF2;PTPA;GPATCH2;BMP2;CDK5RAP3;CHP1;PPP1R2;PPP6R2;HTT;SH2D4A;URI1;PPP1R26
prerank,maturation of LSU-rRNA (GO:0000470),0.2932752635724225,0.849469162483206,0.702355460385439,0.9731461476161866,1.0,8/26,16.17%,RPF2;RPL7;RPL10A;RPL7A;NHP2;NOP2;ZNHIT6;DDX18
prerank,myelin maintenance (GO:0043217),0.3634753232616267,0.8490601079485698,0.6794582392776524,0.9731436031533277,1.0,2/10,7.03%,CLU;EPB41L3
prerank,regulation of axon guidance (GO:1902667),-0.37639268473635923,-0.8489823355570894,0.6805807622504537,0.8849553933770185,1.0,3/10,14.36%,NRP1;ZSWIM8;VEGFA
prerank,RNA methylation (GO:0001510),-0.2403735100364855,-0.8488643853426148,0.7509578544061303,0.8847353540632128,1.0,25/60,33.29%,ZCCHC4;WTAP;NSUN6;NSUN3;TGS1;DIMT1;METTL2A;METTL2B;BUD23;METTL1;NSUN2;THUMPD3;FTSJ1;ZC3H13;LCMT2;WDR6;GTPBP3;MTO1;TRMT44;TRMT61B;TRMT10C;TYW3;MRM2;ALKBH8;TRMT12
prerank,regulation of cellular senescence (GO:2000772),-0.2815327248418868,-0.848855020265082,0.6937269372693727,0.8842915131699539,1.0,14/28,28.57%,MAP3K3;ZKSCAN3;SLC30A10;YBX1;NEK4;NEK6;TERF2;TERT;CDK6;NUAK1;TWIST1;RSL1D1;VASH1;CGAS
prerank,cellular response to hypoxia (GO:0071456),-0.21346159302026163,-0.848745691462833,0.824847250509165,0.8840330598639723,1.0,45/126,29.47%,MDM4;BMP7;EP300;PTGIS;ARNT;LMNA;CREBBP;UBQLN1;MTOR;FAM162A;EGLN3;HIF1A;LIMD1;RORA;PSMF1;ACAA2;NPEPPS;PGK1;PSMB2;VEGFA;CUL2;CPEB1;NOP53;SLC8A3;CARD16;TERT;P4HB;PSMC1;HIF3A;GATA6;TBL2;BNIP3;PSMB6;PSMA3;PSMA4;HYOU1;TWIST1;PSME1;PSMD13;PSMB10;MT3;EGLN2;PSMA5;PSMB9;RBX1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.33180598736800954,0.8484933881587021,0.6652267818574514,0.9735583651225186,1.0,3/14,9.89%,HSPA5;FICD;DAB2IP
prerank,chromosome condensation (GO:0030261),-0.27127287032951325,-0.8484931685207805,0.7048872180451128,0.8840426819470736,1.0,11/36,21.83%,ACIN1;PHF8;SMC4;AKAP8L;AIFM1;RB1;MCPH1;CSNK2A1;KMT5A;H1-0;NCAPD3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.23408858236947863,0.8483961240173044,0.7799145299145299,0.972848677275743,1.0,20/72,18.89%,COPS6;LIG3;RPA3;RPS27A;UBC;XAB2;POLK;UBB;ERCC2;POLR2J;POLR2B;POLR2I;POLD1;RFC4;POLD3;RFC5;POLR2G;AQR;TCEA1;RFC2
prerank,N-glycan processing (GO:0006491),0.3135310895716414,0.8480601900581412,0.6801801801801802,0.9726723788381005,1.0,4/18,11.96%,ST8SIA4;ST8SIA1;ST8SIA6;ST8SIA3
prerank,modulation by host of symbiont process (GO:0051851),0.2805735526356533,0.8480015781703784,0.7006237006237006,0.9718768285954714,1.0,3/31,4.32%,LEF1;HMGA2;SMARCB1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.27419900073629677,-0.8476216050020831,0.6939571150097466,0.8853108059967804,1.0,8/33,14.09%,MEOX2;HMGB1;THBS1;JUP;RHOA;MEF2C;ANGPT2;APOE
prerank,establishment of melanosome localization (GO:0032401),-0.3056198992594093,-0.8475629831086648,0.6915708812260536,0.8849699584563291,1.0,6/19,28.24%,SHROOM2;RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.293553110958994,-0.8472329032281245,0.6814671814671814,0.8851504209306728,1.0,7/23,31.00%,AXL;HMGB1;TLR4;INHBA;NR1H4;INHA;C1QBP
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.357684691540782,-0.8470426030692768,0.6788461538461539,0.8850778828755412,1.0,3/11,22.55%,SCARA3;TNIP2;TICAM1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.2528816362759711,-0.8467534570499758,0.7281553398058253,0.8851910106247003,1.0,15/45,17.36%,JAK1;CAMK2D;TRIM8;MID1;CAMK2G;SP100;PRKCD;TRIM5;IRF9;TRIM25;IRF1;STAT1;IFNGR1;OAS2;GBP2
prerank,cellular response to virus (GO:0098586),-0.2770202616118031,-0.8463617197688951,0.7288135593220338,0.885506431200288,1.0,6/30,14.85%,GBF1;GSDME;HIF1A;RIOK3;ARF1;DDX3X
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.28621106584655204,-0.846221364071808,0.7098540145985401,0.8853348598746689,1.0,8/27,21.57%,SMG6;PDGFRB;NIBAN2;NABP2;PARP4;TERF2;FGFR4;FGF2
prerank,stabilization of membrane potential (GO:0030322),0.32145359222977665,0.845847051834334,0.7130801687763713,0.975728308472291,1.0,4/16,8.42%,KCNK13;KCNK10;KCNK9;KCNK1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.37059510592414047,-0.8456239498281479,0.6821561338289963,0.886105604202232,1.0,4/10,25.56%,COMT;SARDH;ALDH7A1;HNMT
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.3503515641408711,-0.8456168624074916,0.6745886654478976,0.885654847428391,1.0,1/11,0.80%,AFDN
prerank,t-circle formation (GO:0090656),-0.37112248102873713,-0.8455804578563255,0.6666666666666666,0.8843260268657952,1.0,4/10,23.40%,NBN;WRN;SMARCAL1;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.37112248102873713,-0.8455804578563255,0.6666666666666666,0.8843260268657952,1.0,4/10,23.40%,NBN;WRN;SMARCAL1;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.37112248102873713,-0.8455804578563255,0.6666666666666666,0.8843260268657952,1.0,4/10,23.40%,NBN;WRN;SMARCAL1;ERCC1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3351071272507703,0.8454150400884215,0.6868475991649269,0.9757619506798255,1.0,3/13,12.40%,ALG3;ALG1;ALG8
prerank,negative regulation of platelet activation (GO:0010544),-0.3330502630670996,-0.8453850894446203,0.6951456310679611,0.8842386535381563,1.0,4/16,14.09%,PDGFRA;CD9;PRKCD;APOE
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3740969088457725,0.8453751297169952,0.6914660831509847,0.9749119710817278,1.0,5/10,22.93%,MFSD2A;DNAJC19;ABCA3;MTMR9;MTMR2
prerank,dopaminergic neuron differentiation (GO:0071542),0.30672018362989995,0.845251178952608,0.6937901498929336,0.9742512053343354,1.0,1/19,0.21%,PHOX2A
prerank,exit from mitosis (GO:0010458),0.3437466961686285,0.8450819993603872,0.6629464285714286,0.9736687824967538,1.0,7/12,22.75%,UBE2C;CLASP2;CLASP1;CHMP2A;CHMP7;SIRT7;EPS8
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.343749526013182,-0.8449644069787968,0.6907020872865275,0.8846206476040902,1.0,4/13,10.96%,TRIM44;AXL;DHX9;MAVS
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.3133025158732726,-0.8445701911449609,0.6785046728971963,0.8849336337244704,1.0,7/18,27.02%,CEP135;CCT6A;CCT8;CCT5;CEP295;CHP1;CCT3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.28269542371185297,-0.8444052585831021,0.7123552123552124,0.8848167806385586,1.0,14/28,32.56%,KMT5B;SHLD2;PARP9;KMT5C;DTX3L;PRKDC;SMCHD1;HSF1;ACTR2;PARP3;MAD2L2;NUDT16L1;PNKP;TFIP11
prerank,regulation of glycogen metabolic process (GO:0070873),0.35121627952577156,0.8430473031044802,0.6617647058823529,0.9771679620126421,1.0,2/12,7.97%,KHK;AKT1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3475478072370654,0.8428447767437317,0.6693711967545639,0.9766773899290881,1.0,4/12,14.31%,CALM1;PDE4D;CALM2;CALM3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.22214097371745595,-0.8427830823398246,0.8032128514056225,0.8875941563568498,1.0,26/93,22.30%,SASH1;CCN2;HMGB1;AXIN1;SH3RF1;TAOK3;MID1;MAP3K5;RELL1;TRAF2;RASSF2;FZD7;LTBR;EIF2AK2;SH3RF2;TPD52L1;VEGFA;SH3RF3;TRAF3;TRAF6;BMP2;TAOK1;WNT16;TRAF5;SPHK1;KLHDC10
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.21707415983052625,0.8427279017262083,0.8253012048192772,0.9760167081220981,1.0,22/114,18.95%,ST18;TMSB4X;PSMA1;TRAF1;TNFRSF9;TNFSF13B;PSMD12;PSMA6;PSMB3;TNFRSF12A;TNFRSF25;ACTN4;CD40;NFKBIA;PSME3;PSMC3;PSMA2;CDIP1;TNFRSF1A;ILK;PSMB7;RIPK1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3652002064274927,0.8424746482913724,0.6862745098039216,0.9756614123038995,1.0,3/10,15.24%,HSPA5;CCL2;ATF4
prerank,neuromuscular junction development (GO:0007528),-0.2953028714549764,-0.8423783325272904,0.7058823529411765,0.887952426050422,1.0,4/24,9.26%,PDZRN3;LRRK2;UNC13B;UNC13C
prerank,negative regulation of viral genome replication (GO:0045071),0.2595901121997252,0.8420764180120228,0.7198364008179959,0.9756241672219627,1.0,6/40,10.04%,PROX1;HMGA2;ISG15;TRIM6;IFITM3;SLPI
prerank,regulation of histone acetylation (GO:0035065),0.26992689442886114,0.8420320884144235,0.6983471074380165,0.9747800372391285,1.0,5/33,10.17%,CHEK1;SNCA;RPS6KA5;IWS1;SET
prerank,B cell activation (GO:0042113),-0.2329386572424081,-0.8419900090801677,0.7762096774193549,0.8882113587372621,1.0,14/68,18.29%,HDAC4;KIT;ITGB1;DCAF1;BCL2;CEBPG;PTPN2;MEF2C;TCF3;ITGA4;KLF6;CTPS1;PIK3CD;BLNK
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.23361500635988683,-0.8411232518638477,0.8040665434380776,0.8894305171650246,1.0,9/65,10.03%,EGFR;ERRFI1;ARAP1;RNF115;PTPN3;CDC42;PTPN12;FER;PTPN2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.2399748572412237,-0.84017081569694,0.7614107883817427,0.8908672626088394,1.0,21/55,34.19%,FBXL7;FHL1;USP47;PSMF1;PSMB2;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;AVEN;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;RBX1;PINX1;PSME4;PSMB8;PSMD10
prerank,regulation of cellular pH (GO:0030641),0.2732446120151382,0.8397182277570885,0.6864406779661016,0.9790358674720773,1.0,5/29,11.41%,SLC4A1;CA2;ATP6AP1;ATP1A4;ATP5F1B
prerank,inorganic anion transport (GO:0015698),0.2429704864130297,0.8396652916561153,0.7766179540709812,0.9782275972135963,1.0,7/53,10.99%,SLC4A1;GLRA1;CLIC5;ANO5;SLC25A14;ANO4;CLCN1
prerank,response to estrogen (GO:0043627),-0.2721663202734538,-0.8396058484553385,0.6978131212723658,0.8915319314254103,1.0,6/31,16.75%,EP300;KMT2D;BCAS3;AR;TRIM25;CITED2
prerank,protein polyglutamylation (GO:0018095),0.3527752462226989,0.8395516587421892,0.6769596199524941,0.9775324939911695,1.0,1/11,2.40%,TTLL7
prerank,protein palmitoylation (GO:0018345),0.27485593607000486,0.83932238188848,0.720682302771855,0.9770632605190881,1.0,8/30,19.52%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;PORCN;ZDHHC24
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3316678435484445,-0.8390267124357749,0.6867030965391621,0.8921729264327765,1.0,6/14,23.77%,EHHADH;ACOX1;DECR2;AMACR;ACOT8;ACOX3
prerank,regulation of myoblast fusion (GO:1901739),-0.3608258729889169,-0.8387938248707466,0.6863117870722434,0.8921657729877607,1.0,3/11,7.99%,CFLAR;RIPOR2;EHD2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2720285703716989,-0.8381918236275216,0.7334593572778828,0.8928975993211787,1.0,3/32,2.67%,FHIT;DDX5;EP300
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.333481974600594,0.8374727765417251,0.6997840172786177,0.9801835979514157,1.0,3/13,9.50%,TOX;CAMK4;FOXJ1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3180383314303712,-0.8373226777828957,0.6808905380333952,0.8941067927872466,1.0,8/17,36.76%,DNM1L;BCL2;SOD2;FIS1;GGCT;BAK1;SFN;TIMM50
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3528671640434211,-0.8372692477371884,0.6942909760589319,0.8937441087003744,1.0,4/12,15.89%,GMPS;PPAT;ATIC;PAICS
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.25519808494463425,0.837163939949462,0.7740492170022372,0.9799376184223372,1.0,10/39,16.84%,RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;RFC4;POLD3;RFC5
prerank,tRNA 5'-end processing (GO:0099116),0.32778719636018616,0.8371273169074659,0.6875,0.9790949964344741,1.0,3/15,12.31%,RPP40;RPP30;POP5
prerank,telomere maintenance (GO:0000723),-0.2448829985341397,-0.8370491626438487,0.768642447418738,0.8937212855935112,1.0,17/50,21.95%,SMC6;NBN;NSMCE2;WRN;SP100;SMC5;PARP1;RAD51D;PRKDC;CTC1;MRE11;TERF2;TERT;PCNA;STN1;XRCC6;ATR
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3370330285311314,0.837033207583059,0.6721649484536083,0.9783710374836881,1.0,4/13,14.60%,NAXE;NUDT12;NAMPT;NAXD
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2479889236746704,-0.836977817272491,0.7481343283582089,0.8934019016237679,1.0,9/48,13.52%,ANK2;CEMIP;DIAPH1;JPH1;CAMK2D;PDPK1;PLCG1;SELENON;SRI
prerank,regulation of T cell differentiation (GO:0045580),0.2706664644295243,0.8367357180337844,0.75,0.9780931951880331,1.0,7/33,14.36%,IL7;CAMK4;PRDM1;FANCA;TCF7;XBP1;NFATC2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.2985926778891428,0.8366516162027735,0.7098901098901099,0.9773708008409675,1.0,4/22,10.86%,ERBB4;NOTCH1;OCIAD1;F2R
prerank,cognition (GO:0050890),0.2541919673791049,0.8363036263803901,0.735655737704918,0.9772096774571031,1.0,7/42,13.20%,GRM5;PTCHD1;MFSD2A;NSUN5;TTC8;DGCR2;GPR155
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2704166116796428,-0.8357697993551758,0.7302904564315352,0.8952766831815404,1.0,7/31,14.71%,DIS3L2;DDX6;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9
prerank,positive regulation of DNA recombination (GO:0045911),-0.28466040712018004,-0.8356840491146226,0.7186234817813765,0.8949753794902011,1.0,14/27,29.39%,KMT5B;FUS;WDR48;SHLD2;PARP1;KMT5C;MMS19;ARID2;PRDM9;PAXIP1;ACTR2;FANCB;TIMELESS;MAD2L2
prerank,ear morphogenesis (GO:0042471),-0.29964499389173593,-0.835558640425463,0.7062146892655368,0.894743627990224,1.0,6/20,17.02%,ZIC1;OSR1;FGFR2;NIPBL;CHD7;SIX1
prerank,regulation of transport (GO:0051049),-0.26330761173282335,-0.8351782623961167,0.73767258382643,0.8950169333511541,1.0,8/36,15.13%,LEPR;PRKN;LRRK2;NRP1;VAMP2;WWC1;RAB11A;MBTPS1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.3494313346424775,0.8350734499539088,0.6646341463414634,0.9789929573436494,1.0,2/11,10.46%,NOVA2;ZNF445
prerank,peptidyl-amino acid modification (GO:0018193),-0.3644756203165911,-0.834897372615923,0.686046511627907,0.8950867748326468,1.0,3/10,15.93%,TTLL4;FKBP10;FKBP7
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.33566272068092706,-0.8347921052245281,0.6948176583493282,0.8948145871553856,1.0,6/14,29.16%,THBS1;PLCG1;ITGA4;PDCD4;PRKCI;GPER1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.28012823188437763,-0.834756474408889,0.7322834645669292,0.894425464338293,1.0,16/29,30.32%,LIMA1;PRKN;PLEKHH2;ARFGEF1;PRKCD;SMAD4;MYADM;HIP1R;SLIT2;KANK1;TWF1;TWF2;SSH3;SSH2;PFN2;KANK4
prerank,vitamin D metabolic process (GO:0042359),-0.3322912805743946,-0.834708314250389,0.6903353057199211,0.8940663415043596,1.0,10/13,55.88%,PIAS4;CUBN;CYP2R1;LGMN;LRP2;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,regulation of protein polymerization (GO:0032271),-0.26543698890440726,-0.8346106844711751,0.7641681901279708,0.8937938710838813,1.0,9/35,16.33%,ARHGAP28;FCHSD2;ABL1;PLEKHG2;PRUNE1;CTTN;LATS1;RASA1;ARHGAP18
prerank,negative regulation of response to wounding (GO:1903035),0.3019874738578976,0.834577956018196,0.7190775681341719,0.979104474954027,1.0,3/19,8.96%,GIT1;AJAP1;RTN4R
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.24224054422872143,-0.8340441987432048,0.7684824902723736,0.8943969822079385,1.0,13/52,21.13%,SAE1;HUWE1;TFDP2;BCL2;ABLIM3;LEPROT;NPEPPS;FBXW7;YWHAE;UBL5;UBE2D3;TOMM7;ARIH2
prerank,cristae formation (GO:0042407),0.2860853279959915,0.8340381709375339,0.7295081967213115,0.9793514737068297,1.0,8/27,19.24%,ATP5F1D;ATP5F1B;ATP5ME;ATP5MF;DMAC2L;UQCC3;CHCHD6;ATP5MG
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3314557102532343,-0.83392700689086,0.7007434944237918,0.8941517113631143,1.0,2/14,5.41%,IL34;THBS1
prerank,positive regulation of peptidase activity (GO:0010952),-0.301312089711201,-0.8336391141912333,0.7074148296593187,0.8942229778076217,1.0,7/20,28.01%,CTSH;NCSTN;RCN3;VCP;TANK;PSME1;GRN
prerank,positive regulation of cytokine production (GO:0001819),-0.18861965340738188,-0.8330139576269453,0.9508840864440079,0.8949411728917113,1.0,49/292,17.55%,ROCK2;SULF1;FOXP1;NFKB1;CCBE1;IL6ST;EP300;ARNT;PLA2R1;TBK1;LBP;SULF2;PIBF1;HMGB1;CREBBP;STAT3;EIF2AK3;IL16;RUNX1;ANXA1;DHX9;F3;CEBPG;DHX36;IL17RA;PTPN22;CYP1B1;TRAF2;HIF1A;MAVS;RORA;IL6R;APPL1;IRF1;EIF2AK2;PRKDC;PRKCZ;IL17D;STOML2;CYBA;C1QTNF3;MRE11;ADRA2A;AFAP1L2;IL18;SERPINE1;PIK3CD;TLR4;WNT5A
prerank,vesicle transport along actin filament (GO:0030050),0.3078209163331382,0.832708030933099,0.7019438444924406,0.9812151381777636,1.0,6/19,18.49%,MYO1E;FNBP1L;MYO6;ACTN4;MYO5A;MYO19
prerank,negative regulation of viral life cycle (GO:1903901),-0.3306241341626829,-0.8321666451180723,0.6814671814671814,0.8960926081433251,1.0,3/15,12.13%,GSN;TRIM5;TRIM11
prerank,maintenance of protein location in nucleus (GO:0051457),-0.29774037281371196,-0.8320353194299391,0.7234432234432234,0.8958586423314878,1.0,11/20,28.02%,TAF3;SP100;TAF8;TOPORS;MORC3;HNRNPU;PARK7;PML;SUN2;BBS4;CHCHD10
prerank,regulation of tumor necrosis factor production (GO:0032680),0.2132908866263139,0.831709843756608,0.8302658486707567,0.9823744454081382,1.0,12/112,9.76%,CD33;TIRAP;MIF;SYT11;GAS6;CLU;TLR2;PTPRJ;CD34;HSPB1;POMC;ARHGEF2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.32309067970352073,0.8311032560171913,0.6882845188284519,0.982747822216172,1.0,6/15,22.18%,NTRK2;HAP1;BCAR1;DDIT4;SORT1;BDNF
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.34567823919253726,0.831086714242181,0.6830357142857143,0.9818551004794126,1.0,5/11,23.69%,TIMM22;NDUFA13;TOMM70;TIMM10B;ROMO1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.280867389306431,-0.830873741265931,0.7549407114624506,0.8976274015491642,1.0,9/30,26.50%,UGGT2;STT3A;DPM1;RPN1;ST6GAL1;LMAN1;DPM3;MCFD2;ASGR1
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.24441906711550238,-0.8307297212937117,0.7453874538745388,0.8969917573424321,1.0,22/51,35.08%,LMNA;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;REEP4;AHCTF1;NUP133;SEC13
prerank,mitotic nuclear membrane organization (GO:0101024),-0.24441906711550238,-0.8307297212937117,0.7453874538745388,0.8969917573424321,1.0,22/51,35.08%,LMNA;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;REEP4;AHCTF1;NUP133;SEC13
prerank,cholesterol biosynthetic process (GO:0006695),0.2715303891764628,0.8306969745890476,0.7627118644067796,0.981777338418631,1.0,12/31,19.88%,MVD;HSD17B7;IDI1;DHCR7;PLPP6;HMGCS1;ACAT2;TM7SF2;EBP;MSMO1;FDPS;NSDHL
prerank,cardiolipin metabolic process (GO:0032048),0.335746293199903,0.830531454916381,0.6892177589852009,0.9812042394694664,1.0,3/13,11.47%,HADHA;CRLS1;PTPMT1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.27997480739714464,-0.8302027097500012,0.7585551330798479,0.8975413814520536,1.0,8/26,20.15%,ADCY5;CDK16;STXBP4;STX4;TRPM4;ADRA2A;ANO1;C2CD2L
prerank,striated muscle contraction (GO:0006941),-0.2390358195676151,-0.8301784612584234,0.8153846153846154,0.8971240427380522,1.0,2/53,1.44%,ATP1A2;TPM1
prerank,myeloid dendritic cell activation (GO:0001773),-0.3448001387149363,-0.8299368152927595,0.6847014925373134,0.8971199530500276,1.0,2/12,5.03%,TGFBR2;HMGB1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3097749602110189,0.8298747481463413,0.7041036717062635,0.9816296159000252,1.0,2/17,4.81%,HDAC9;PCSK6
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.326699301736671,-0.8298414900410797,0.7080867850098619,0.8968226342259566,1.0,8/15,34.32%,EIF2AK2;USP50;DDX3X;TLR4;NLRC3;NLRP2B;DHX33;MYD88
prerank,positive regulation of protein maturation (GO:1903319),-0.3514198085843012,-0.8298344607343541,0.7169811320754716,0.896371430955341,1.0,1/11,2.47%,CCBE1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3551206914825097,-0.8291268974280954,0.6934579439252336,0.8972135073091739,1.0,6/11,28.54%,MSH3;ZRANB3;SMARCAL1;DONSON;TIPIN;TIMELESS
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.3272583358573296,-0.8289834466731836,0.683111954459203,0.8970345665365573,1.0,9/14,35.85%,TSEN2;TSEN15;CPSF4;RTRAF;CPSF1;TRPT1;TSEN54;RTCB;FAM98B
prerank,ruffle organization (GO:0031529),-0.3182517040716663,-0.8289527867401555,0.6924643584521385,0.8966285458241637,1.0,9/16,31.46%,TPM1;LIMA1;ARFIP2;CARMIL1;INPP5K;AIF1L;PLEKHA1;ARF6;CORO1B
prerank,negative regulation of endocytosis (GO:0045806),-0.28449501571630764,-0.8288487636712477,0.7406716417910447,0.8963511692328545,1.0,8/24,22.48%,EPHA3;NR1H3;RUBCN;PICALM;PRKD1;ABCA7;LRSAM1;CD300A
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3308303238850662,0.827700434874899,0.7083333333333334,0.9851974429048173,1.0,2/14,4.66%,CHKA;PISD
prerank,cellular copper ion homeostasis (GO:0006878),0.32585946427943596,0.8276639226476469,0.7002141327623126,0.9843588002040311,1.0,1/14,0.94%,MT2A
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.33571387865934343,-0.8273873895994693,0.7088846880907372,0.89865319361157,1.0,5/13,22.55%,AXL;ZBTB1;IL18;LAMP1;TICAM1
prerank,cholesterol homeostasis (GO:0042632),-0.23273499765131744,-0.8269778292842396,0.7967145790554415,0.8989356410714059,1.0,11/64,16.83%,ABCA1;CYP7B1;LIMA1;SOAT1;LDLR;NR1H3;NPC2;RORA;APOE;EPHX2;IL18
prerank,regulation of mitotic nuclear division (GO:0007088),-0.23980475699120465,-0.8267191650642594,0.789179104477612,0.8989403983311033,1.0,13/55,18.55%,IGF1;PDGFRB;BMP7;BMP4;OBSL1;IGF2;CDK13;TOM1L2;DUSP1;RCC1;PRMT5;PHIP;NME6
prerank,aerobic respiration (GO:0009060),0.2921489607647764,0.8266801960742347,0.6975717439293598,0.985500679046802,1.0,3/20,7.95%,SDHC;ATP5F1D;SLC25A14
prerank,lymphocyte migration (GO:0072676),0.26908885808047756,0.8262053775596871,0.7380952380952381,0.9855381201500429,1.0,7/32,20.51%,CCL2;RET;CCL25;CKLF;S1PR1;CCL13;CCL19
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.21171965917864108,-0.8258136987406954,0.8670520231213873,0.9001559518005958,1.0,32/113,24.64%,TRABD2B;ABCA1;MPP7;ASAP1;GTF2H2;GSK3B;SPIDR;RAP1B;BRK1;DDB2;UNC13B;FNIP1;PARP1;ERCC3;SLF1;USP50;VEGFA;DDX3X;ICE1;TLR4;VCP;PARK7;RHOC;AJUBA;EIF4G1;PIH1D1;BMF;ATR;ERCC1;GTF2H1;GNL3L;SYK
prerank,regulation of neurogenesis (GO:0050767),-0.24099144466534783,-0.8255726468478202,0.7819548872180451,0.9001515539364076,1.0,12/55,18.05%,APPL2;PCM1;YAP1;DOCK7;REST;PRUNE1;NUMBL;HES1;BHLHE41;NUMB;HEYL;CX3CR1
prerank,negative regulation of neuron death (GO:1901215),0.22006814810628547,0.8249350887176714,0.8379446640316206,0.9872494259059149,1.0,19/93,15.24%,MAG;FOXQ1;SNCA;NTRK2;VSTM2L;UNC5B;NDNF;AKT1;GPNMB;CD34;CCL2;CD200R1;RETREG1;SET;F2R;SORL1;PTPRZ1;PPT1;ATF4
prerank,positive regulation of protein polymerization (GO:0032273),-0.2327101687812651,-0.8246559265379488,0.8086785009861933,0.9014255123669291,1.0,15/65,15.44%,FCHSD2;BAIAP2L1;NUMA1;SNX9;VASP;CDC42EP5;FER;NCKAP1;MAPRE1;TOGARAM1;CTTN;NCK1;CARMIL1;NCK2;AKAP9
prerank,regulation of interferon-beta production (GO:0032648),-0.24345284111978122,-0.8236847616259434,0.7844990548204159,0.9027456275769735,1.0,17/46,27.37%,TBK1;PTPRS;DHX9;RNF216;MAVS;RIOK3;IRF1;DDX3X;TRAF3;OAS2;TLR4;PTPN11;NLRC3;POLR3D;SIRPA;DHX58;CACTIN
prerank,response to organophosphorus (GO:0046683),0.3132900967246805,0.8236567674361475,0.6820083682008368,0.9889363131321689,1.0,3/16,13.32%,KCNJ11;P2RX7;VGF
prerank,positive regulation of histone acetylation (GO:0035066),-0.2868289066394662,-0.823079737689106,0.7377049180327869,0.9034003311024957,1.0,11/23,29.45%,BRD7;PPARGC1A;SMAD4;ARRB1;NOS1;PIH1D1;PAXIP1;RPS6KA4;RUVBL2;SPHK2;GLYR1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.3454811531111076,0.8230088944829175,0.7013274336283186,0.9893137073681904,1.0,2/11,13.68%,SIRT1;XBP1
prerank,response to interferon-alpha (GO:0035455),0.3145391541872031,0.8228318451684415,0.7325349301397206,0.9887449867458755,1.0,7/16,21.37%,GAS6;IFNAR1;IFITM3;ADAR;KLHL20;BST2;RO60
prerank,sterol homeostasis (GO:0055092),-0.23103649797560621,-0.8225427272652313,0.8105906313645621,0.9039303741360467,1.0,11/65,16.83%,ABCA1;CYP7B1;LIMA1;SOAT1;LDLR;NR1H3;NPC2;RORA;APOE;EPHX2;IL18
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.2955666777925794,0.8222137953471025,0.7342799188640974,0.989116015710028,1.0,5/19,14.35%,HNRNPC;TERF1;TEN1;PIF1;TINF2
prerank,negative regulation of protein transport (GO:0051224),0.2843249379518914,0.821907249902572,0.7169042769857433,0.9888317025534453,1.0,3/25,4.90%,RHBDF2;PPM1F;IL12A
prerank,neural crest cell differentiation (GO:0014033),0.30570276920579104,0.8217981228166905,0.7255717255717256,0.9881607332688971,1.0,3/18,6.01%,NRG1;CDH2;CYP26C1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.34453008329406365,-0.8217859730300677,0.6870229007633588,0.9048796579065316,1.0,6/12,22.89%,RFWD3;PRKDC;SDE2;CDK2;WAC;PLK5
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.294239553268863,0.8214881722715007,0.7366167023554604,0.9878734550395754,1.0,4/23,12.27%,METAP2;GUCA1B;CALM1;NMT1
prerank,negative regulation of protein binding (GO:0032091),-0.2282668099755303,-0.8214880758081344,0.8259187620889749,0.9049706244495397,1.0,12/71,10.95%,DAB2;ROCK1;LRRK2;GSK3B;STYX;IFIT2;DACT1;CSNK1E;USP33;NES;PRKCD;ATP2A2
prerank,cell-substrate junction assembly (GO:0007044),-0.2679383986758347,-0.8213970906294601,0.7129277566539924,0.9046658130795923,1.0,8/33,15.29%,SORBS1;BCR;PTPRK;ACTN2;LAMA3;FN1;CTTN;WHAMM
prerank,positive regulation of rRNA processing (GO:2000234),-0.3481338182942853,-0.8213178197493772,0.728440366972477,0.9043613119502252,1.0,3/10,16.54%,WDR43;DIMT1;BUD23
prerank,negative regulation of histone modification (GO:0031057),0.3236831819305427,0.8213088682302456,0.6987179487179487,0.987351623501937,1.0,3/14,13.54%,SNCA;SET;PRMT6
prerank,tRNA aminoacylation (GO:0043039),0.25626869921409456,0.8212752335858835,0.7713097713097713,0.9865093568718725,1.0,8/37,14.30%,VARS1;GARS1;RARS1;FARSB;AIMP2;GATB;IARS1;GATC
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.343994947665009,-0.8212653947656686,0.7125984251968503,0.9040007382324787,1.0,9/13,37.05%,MMS19;CIAO1;NFU1;YAE1;GLRX5;BOLA2;LTO1;CIAO2B;GLRX3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.3410132774536505,-0.8211923016534873,0.6990654205607477,0.903696884829144,1.0,3/12,12.63%,CBLB;F3;APOD
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.3348335798606097,-0.821010879714557,0.7162162162162162,0.9035732170129658,1.0,2/13,2.72%,ZMIZ1;ARID1B
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.35187068270288313,-0.820806956679015,0.7215686274509804,0.9034938644985768,1.0,2/11,2.72%,ZMIZ1;ARID1B
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.350487218017398,-0.8202499768986653,0.720616570327553,0.9040226485986476,1.0,7/11,48.75%,P2RX4;PLCG2;TREM2;P2RX5;TRAT1;CCL4;NEUROD2
prerank,regulation of double-strand break repair (GO:2000779),-0.2525199759812633,-0.8202006344815016,0.7634615384615384,0.9036474385791717,1.0,9/39,13.24%,RNF169;TRIP12;SPIDR;UBR5;PPP4C;PPP4R2;SETD2;SHLD2;SLF1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.24858043846910252,-0.8199470458988148,0.7941176470588235,0.9036606449893545,1.0,16/46,24.09%,PARVA;ITGAV;LAMC3;RADIL;NRP1;ATRNL1;FER;RHOA;FN1;ITGA4;ITGB3;PIK3R1;ANTXR1;LAMB2;LAMC1;ITGA8
prerank,regulation of T cell activation (GO:0050863),0.24760961518201052,0.8191081905155528,0.8017057569296375,0.9899475575192583,1.0,6/42,12.68%,THY1;PRKCQ;GPNMB;CCL2;CYRIB;HSPD1
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.29425841390664925,-0.8188203320723815,0.7351851851851852,0.9052076756716643,1.0,5/21,22.19%,CYP26B1;ACOX1;LPIN2;LPIN3;ACOT8
prerank,mitochondrial translational elongation (GO:0070125),0.21998637644039762,0.818198457507067,0.8450704225352113,0.9908550921169567,1.0,26/88,23.08%,MRPS25;MRPL14;MRPS12;MRPL49;TUFM;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3144952327748518,0.8178851922475869,0.7331887201735358,0.9906101669715034,1.0,3/16,18.04%,SLC2A5;BMPR2;DDAH1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.288512142511006,0.8176876203117766,0.749003984063745,0.990100534437503,1.0,7/21,21.90%,PGM2L1;TALDO1;GCK;TKT;RPIA;GPI;G6PC3
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3381351055312797,-0.8174313402637957,0.7297297297297297,0.9072476551594796,1.0,2/12,6.07%,NCOR1;STAT3
prerank,GPI anchor metabolic process (GO:0006505),-0.2804222659425277,-0.8172704601358757,0.7601547388781431,0.9070846073531766,1.0,11/26,32.32%,PIGN;DPM1;PIGH;MPPE1;PIGC;DPM3;PIGA;PIGZ;PIGP;PIGF;PIGO
prerank,regulation of ATP metabolic process (GO:1903578),-0.23693576132847188,-0.8169207243786484,0.7949709864603481,0.9072595130809978,1.0,22/54,35.09%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT;ATP5IF1;FIS1;NUP98;NUP43;NUP160;ZBTB7A;NUP93;JMJD8;SPHK2;COX7A2L;ATP7A;NUP133;SEC13;NUP88
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2905958908013616,-0.8167033667389364,0.7441441441441441,0.9071882632970005,1.0,5/22,11.94%,GTF2H2;RAD23B;DDB2;PARP1;ERCC3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.22962501685557005,-0.8166872536499952,0.8097014925373134,0.9067579455758908,1.0,20/63,28.75%,MDM4;EP300;TFDP2;RFWD3;CNOT8;CASP2;PRKDC;CNOT2;CNOT1;SDE2;CNOT10;CDK2;PML;PCNA;WAC;CNOT4;TNKS1BP1;CRADD;PCBP4;E2F1
prerank,fatty acid metabolic process (GO:0006631),-0.20916152055703596,-0.816506977455353,0.8703339882121808,0.90661595227713,1.0,31/115,26.25%,ACSL1;ACADSB;ABCD3;GNPAT;ACADM;CPT1C;ABCD2;PPARGC1A;CPT2;ACSF2;PON2;ACSL6;PNPLA8;ACOT11;ACOX1;ECHDC3;LPIN2;ACAD9;LPIN3;CPT1A;CBR4;MECR;ACSL4;ACOT8;ACOT6;PON3;GGT5;ACSBG1;PPARA;LPL;AASDH
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.335770184417173,0.8162246921677028,0.7161572052401747,0.9922207070495346,1.0,3/11,11.90%,CXCL12;GAS6;IRF7
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.3285653796738468,-0.816114370410674,0.7332123411978222,0.9068340835680241,1.0,6/13,22.46%,NUPR1;EIF2AK3;NR1H3;MBTPS2;LPCAT3;WFS1
prerank,regulation of protein localization to centrosome (GO:1904779),0.35310600170994644,0.8160245556834221,0.7130977130977131,0.9916830535358352,1.0,3/10,11.23%,BICD1;NUP62;APC
prerank,regulation of receptor binding (GO:1900120),-0.3575012722274402,-0.8158772923295784,0.7206703910614525,0.9068029027119124,1.0,4/10,30.08%,ATP2A2;GREM2;ATP2A3;PTPRF
prerank,regulation of cell-substrate adhesion (GO:0010810),0.25125706551034493,0.815704477254368,0.7793240556660039,0.9914122578080785,1.0,7/42,11.61%,SPOCK1;PPM1F;THY1;NOTCH1;NDNF;PDGFB;FZD4
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.28708600697275866,0.81562227265047,0.734065934065934,0.9906749375144078,1.0,3/23,6.58%,PAX8;PAX2;LHX1
prerank,response to organonitrogen compound (GO:0010243),0.25558278594551725,0.8155400971077746,0.7525150905432596,0.9899245406440942,1.0,6/38,11.20%,GLRA1;GLRA3;MEAK7;TRPM2;GLRA2;BRSK2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.28882260155701633,0.8154342761318925,0.7198364008179959,0.9892252280266816,1.0,4/22,11.08%,NDOR1;IBA57;ISCU;ISCA2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.32961581268977524,0.8152764753790769,0.704312114989733,0.9886466853353663,1.0,3/13,13.72%,NOTCH1;EID2B;DLL1
prerank,secretion (GO:0046903),0.3252233959402676,0.8151630275597695,0.740343347639485,0.9879541254758287,1.0,2/14,7.12%,RIMS1;GUCA1B
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.3349419861639066,0.8142791213113629,0.7053941908713693,0.9888084038196896,1.0,5/12,19.22%,FDX2;TSPOAP1;TSPO;STARD3NL;STARD3
prerank,negative regulation of interleukin-6 production (GO:0032715),0.274618010514864,0.814267836851086,0.7741228070175439,0.9879295878969587,1.0,4/27,9.53%,SYT11;GAS6;FOXJ1;CD200R1
prerank,DNA replication (GO:0006260),-0.20600315456827453,-0.8141669842118884,0.8814531548757171,0.909395520792395,1.0,42/105,34.63%,RBMS1;RBBP8;TOP1;BAZ1A;NBN;NT5M;WRN;UPF1;MCM9;REV1;ING5;MCM6;MRE11;HELB;CDK2;POLA2;RPAIN;ATR;CLSPN;DBF4;NAP1L1;DONSON;POLE2;RECQL5;KIN;ORC1;TIPIN;MCM4;TIMELESS;IGHMBP2;TOP1MT;POLD2;RPA2;RAD9A;PNKP;RMI2;CDC45;POLA1;BRCA1;PCLAF;RFC1;POLE
prerank,acute-phase response (GO:0006953),0.33065360134930794,0.8140964969018447,0.7115384615384616,0.9873865993999399,1.0,1/12,0.95%,MBL2
prerank,ether lipid metabolic process (GO:0046485),-0.32421202163353224,-0.8133592922342958,0.7126654064272212,0.9103933042114001,1.0,2/14,5.34%,AGMO;GNPAT
prerank,regulation of protein localization (GO:0032880),-0.23116674512411625,-0.8132195056512735,0.8085106382978723,0.910181950367994,1.0,23/58,27.95%,AFDN;WDPCP;DLG1;UFL1;CSNK1E;PARP1;TRIM5;TPR;FBXW7;TRIM25;DZIP1L;PICALM;ITGB3;DVL3;PLEKHM2;BORA;RAB9A;TRIM68;KDM1A;RSL1D1;TESK1;CAMK1;TRIM46
prerank,cytoplasmic translational initiation (GO:0002183),-0.3069106969760522,-0.8128088978276379,0.7164179104477612,0.9104499756595131,1.0,5/17,19.58%,EIF4A2;DENR;EIF3A;EIF4G1;RBM4
prerank,cellular lipid catabolic process (GO:0044242),-0.2747615418461389,-0.8123764097663349,0.7572254335260116,0.9107249329147128,1.0,12/27,36.46%,CYP1B1;ACOX1;LPIN2;ABHD12;LPIN3;ACOT8;MT3;ANGPTL3;SMPDL3B;NUDT19;FAAH;ACADL
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.33770968049532746,-0.81230601513534,0.7278225806451613,0.9103985592150288,1.0,3/11,9.70%,STX18;VCPIP1;ATL2
prerank,proteoglycan biosynthetic process (GO:0030166),0.2665028044583604,0.811978829947468,0.7690763052208835,0.9905572135186393,1.0,4/31,5.63%,B3GAT1;CHST9;B3GAT2;CSGALNACT1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.24946103561070337,0.8119618139303613,0.776908023483366,0.9896877935462949,1.0,10/40,15.77%,BICD1;MAGI2;AHI1;HIP1;CLU;SGIP1;INSR;PPT1;B2M;TBC1D5
prerank,regulation of cellular protein metabolic process (GO:0032268),0.24028972966987044,0.8119512532393098,0.78125,0.9888178027552392,1.0,5/47,7.97%,GRM5;RPL10;NANOS3;KLF4;AKT1
prerank,regulation of lymphocyte migration (GO:2000401),0.35692244998451805,0.8119137284906833,0.693304535637149,0.9879865477658231,1.0,2/10,7.97%,JAM2;AKT1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3190094411722468,-0.8119048026646192,0.7140077821011673,0.910660675108881,1.0,8/15,28.69%,RIPOR2;RAPGEF3;EHD2;ADAM9;MAPK14;CD53;CAMK1;EHD1
prerank,regulation of keratinocyte migration (GO:0051547),-0.33929476448755214,-0.8118683252145451,0.7345794392523365,0.9102681449981929,1.0,3/12,10.53%,MAP4K4;MTOR;ADAM9
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3252198340642325,0.8117337636567298,0.7289915966386554,0.9874302546950282,1.0,4/12,16.97%,MFSD2A;ACSL3;SOAT2;MTTP
prerank,positive regulation of integrin activation (GO:0033625),-0.34551540565511807,-0.8117272724166947,0.6988636363636364,0.9100419185917842,1.0,2/11,13.84%,RAP1B;P2RY12
prerank,endothelial cell development (GO:0001885),0.2788771672617235,0.8116986155390484,0.7367303609341825,0.9866124551500993,1.0,8/25,16.51%,ROBO4;PDE2A;PPP1R16B;PECAM1;MARVELD2;PDE4D;RAP1A;SOX18
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.2912813393600977,0.8111276600947512,0.7664543524416136,0.9868352523260313,1.0,3/22,5.92%,PROX1;TOX;TAFA1
prerank,peptidyl-asparagine modification (GO:0018196),-0.2726367605769943,-0.8110809456666799,0.776908023483366,0.910677375860076,1.0,9/31,26.50%,UGGT2;STT3A;DPM1;RPN1;ST6GAL1;LMAN1;DPM3;MCFD2;ASGR1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2763910733434226,0.8109039105533464,0.7252747252747253,0.9863712218109834,1.0,7/25,14.84%,HIP1;AKT1;NUP62;HAP1;PDE6H;CCDC88A;RTN4
prerank,intermediate filament organization (GO:0045109),-0.30059626975564635,-0.8097844460952369,0.7557251908396947,0.9124311074327974,1.0,6/17,36.24%,VIM;GFAP;DES;BFSP1;TCHH;KLHL24
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.1947086119111374,0.8096509532584407,0.9375,0.9878345488449087,1.0,32/163,18.40%,PDE4B;BTNL9;SLA2;VAV3;PSMA1;THY1;MOG;PAK1;PRKCQ;PTPRJ;PSMD12;EIF2B3;PSMA6;PSMB3;SKAP1;TNFRSF21;BCL10;PDE4D;BCAR1;RFTN1;TAB2;PSME3;NFATC2;PAK3;CD38;PSMC3;PSMA2;BTK;SH2B2;NCKAP1L;FYN;PSMB7
prerank,regulation of microtubule-based movement (GO:0060632),0.33725089306367395,0.8091637789570225,0.7232704402515723,0.987888611532672,1.0,2/11,10.81%,MAP2;HAP1
prerank,positive regulation of secretion by cell (GO:1903532),0.2249327191084075,0.8089202016602473,0.8240917782026769,0.9874724649479986,1.0,7/70,5.82%,CD33;CADPS;APBB1;SNCA;GRK2;APBB3;TGFB2
prerank,positive regulation of inflammatory response (GO:0050729),0.2164724414985697,0.8088018702169696,0.8875502008032129,0.9868080313088515,1.0,8/86,7.50%,RPS19;S100A9;S100A8;PDE2A;SNCA;ETS1;NINJ1;TLR2
prerank,neuron projection fasciculation (GO:0106030),0.3518032507977332,0.8087802016391518,0.708803611738149,0.9859654479330218,1.0,5/10,21.74%,NRCAM;CNTN4;RTN4;CDK5R1;AMIGO1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3454216945552126,0.8086383088206607,0.7056277056277056,0.9853141811129796,1.0,3/10,14.24%,ACER2;NEXMIF;JAM3
prerank,establishment of vesicle localization (GO:0051650),-0.3063746054273502,-0.8085616192995849,0.7518796992481203,0.914077224511123,1.0,7/18,27.43%,TMEM230;SPG11;RAB11A;CCDC186;TOR1A;KIF5B;TESK1
prerank,mitochondrion organization (GO:0007005),-0.19600400411910823,-0.8082344260878355,0.9260700389105059,0.9142028111192251,1.0,64/165,33.56%,PID1;TRAK1;OPA1;PRKN;LRRK2;MEF2A;DNM1L;CXADR;VPS13D;AFG1L;MIGA2;IFIT2;AIFM1;PPARGC1A;MTX3;GABPA;HCFC1;RHOT1;PARP1;NRF1;YME1L1;VPS13C;SIRT5;WASF1;STOML2;AIP;PARK7;MGME1;FIS1;TERT;TOMM7;PYROXD2;WDR81;FMC1;BNIP3;SIRT4;SSBP1;RHOT2;SIRT3;CLUH;PHB2;TIMM13;MFN2;SAMM50;TIMM44;LONP1;HIGD2A;MYH14;CHCHD10;MUL1;SUPV3L1;TOMM5;POLRMT;MIGA1;CYCS;FANCG;TWNK;HK2;TIMM9;PTCD2;AFG3L2;MTFR2;COX7A2L;ATP7A
prerank,regulation of tissue remodeling (GO:0034103),-0.297589876882116,-0.8079818997715258,0.7504725897920604,0.9141597911915542,1.0,4/18,16.83%,LEPR;RUNX1;SUCO;IL18
prerank,lipoxygenase pathway (GO:0019372),0.31691103792533576,0.8071601393551446,0.7178899082568807,0.9872135416401381,1.0,2/14,9.46%,GPX1;HPGD
prerank,regulation of exit from mitosis (GO:0007096),-0.2543072822238782,-0.806570249158572,0.7855750487329435,0.9160760626506268,1.0,14/38,25.40%,CDC14A;ANAPC5;ANAPC7;ANAPC4;ANAPC16;CDC26;CDC14B;CDC27;UBE2E1;UBE2S;ANAPC11;CDC16;PHB2;ANAPC1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.32546652684819416,-0.8064854510215406,0.7495291902071564,0.9157731145658531,1.0,5/13,30.89%,RHOT1;BMF;BNIP3;RHOT2;BCL2L11
prerank,cellular response to interferon-beta (GO:0035458),-0.32801954996656973,-0.8063118497918652,0.7283236994219653,0.9156225904892379,1.0,6/14,28.23%,UBE2K;IRF1;STAT1;IRGM;HTRA2;CDC34
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.34770577646287004,0.8061394333299481,0.7430406852248393,0.9882293358300023,1.0,2/10,9.89%,NELL1;DAB2IP
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.24338023745484344,-0.8061048714520445,0.8007662835249042,0.9155294573539827,1.0,19/43,28.00%,FOXN3;NBN;TAOK3;BRCC3;BRSK1;NABP2;RINT1;CDC14B;TRIM39;NOP53;MRE11;TAOK1;CDK5RAP3;NAE1;CLSPN;DONSON;ORC1;ABRAXAS1;FZR1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3127080322440428,0.8058490731623651,0.7324561403508771,0.9878935202255376,1.0,3/15,8.42%,TMSB4X;NOTCH1;HSPB1
prerank,regulation of mRNA catabolic process (GO:0061013),0.20741174306919272,0.8058156147134025,0.8866396761133604,0.987067139928683,1.0,17/121,10.80%,PRR5L;EXOSC5;YWHAB;PSMA1;HSPA8;RPS27A;UBC;AKT1;UBB;PSMD12;HSPB1;PSMA6;PSMB3;PABPC1;KHSRP;SET;APEX1
prerank,regulation of fibroblast migration (GO:0010762),0.28904948382884765,0.8056243181192456,0.75,0.9865517595516871,1.0,8/20,20.38%,PRR5L;RFFL;ARHGEF7;CORO1C;DDR2;GNA12;HYAL2;RAC1
prerank,macrophage activation (GO:0042116),0.26032921175313606,0.8054878544163216,0.7721518987341772,0.9859372685301541,1.0,6/34,12.48%,CD93;SNCA;CLU;DYSF;AIF1;ITGAM
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3137908729522533,0.805371252329859,0.7295597484276729,0.9852682718834858,1.0,2/15,3.31%,MIF;SIRT1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.3093023320282753,-0.8051049673913309,0.7247706422018348,0.916772549438368,1.0,6/16,21.04%,PIBF1;LEPROT;PTPN2;PARP14;NF2;PPP2CA
prerank,lysine catabolic process (GO:0006554),-0.32944494973035765,-0.804113979093004,0.7341772151898734,0.9175516828805008,1.0,8/12,40.50%,DLST;ALDH7A1;PIPOX;PHYKPL;GCDH;HYKK;AASS;DLD
prerank,lysine metabolic process (GO:0006553),-0.32944494973035765,-0.804113979093004,0.7341772151898734,0.9175516828805008,1.0,8/12,40.50%,DLST;ALDH7A1;PIPOX;PHYKPL;GCDH;HYKK;AASS;DLD
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3341297648284356,-0.8040698643426808,0.7316176470588235,0.9171673819644429,1.0,6/12,30.89%,ATF6;ERN1;PTPN1;PIK3R1;BAK1;BCL2L11
prerank,negative regulation of B cell activation (GO:0050869),-0.2862129468041814,-0.8040693510359235,0.7683823529411765,0.9167103083760731,1.0,11/21,39.23%,RC3H1;LYN;ID2;INHBA;CD300A;TNFAIP3;PARP3;INHA;FCGR2B;BANK1;SFRP1
prerank,negative regulation of response to external stimulus (GO:0032102),-0.20879048523773902,-0.8039194269151914,0.8975791433891993,0.9165051512194502,1.0,37/105,29.42%,PTGIS;IRAK3;TRAFD1;PTPRS;MAPKBP1;EPHA4;PCBP2;SELENOS;PTPN2;CCN3;NR1H3;ENPP3;PRKCD;CD109;RORA;RB1;ILRUN;APOE;C1QTNF3;FEM1A;SERPINE1;METRNL;CARD16;SHARPIN;FGF2;LPCAT3;NLRC3;MAPK7;MVK;SIRPA;PPARA;DHX58;CACTIN;MUL1;TNFAIP3;GPER1;NR1H4
prerank,positive regulation of vasoconstriction (GO:0045907),0.3234737820995165,0.8036925076169987,0.707983193277311,0.9875819629480279,1.0,3/13,10.86%,ADRA1D;ADRA1A;F2R
prerank,DNA damage checkpoint signaling (GO:0000077),-0.26495339763982767,-0.8035216167780243,0.7677543186180422,0.9167351331814511,1.0,12/28,29.30%,CEP63;NBN;CDC5L;MAP3K20;STK33;HINFP;ATR;CLSPN;USP28;DONSON;E2F1;INTS7
prerank,"phototransduction, visible light (GO:0007603)",-0.3185780302743445,-0.8033844042034439,0.7463503649635036,0.9165129456681994,1.0,8/14,47.71%,ABCA4;GNB1;SAG;PDE6A;CNGB1;PDE6G;GNA11;PDE6B
prerank,regulation of nervous system development (GO:0051960),-0.2555308457759977,-0.8032485581674678,0.7842003853564548,0.9162998831739183,1.0,9/37,18.12%,PTN;YAP1;DOCK7;PRUNE1;HES1;BHLHE41;HEYL;CX3CR1;LGI4
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.31464740392800084,-0.8023352911955278,0.7471910112359551,0.9173993806457227,1.0,7/14,31.68%,RCC1L;RMND1;RPUSD4;MPV17L2;TRMT10C;C1QBP;MRPS27
prerank,cGMP biosynthetic process (GO:0006182),-0.34808336961299496,-0.8022246611012965,0.7527675276752768,0.917139242893329,1.0,2/10,17.38%,GUCY1A1;NPR2
prerank,integrated stress response signaling (GO:0140467),0.3166926951694995,0.8021205265833791,0.7468619246861925,0.9896913082445183,1.0,3/14,9.00%,OMA1;HSPA5;CCL2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3151091599628526,0.8016366001731745,0.7180616740088106,0.9897086529834319,1.0,3/14,13.30%,CSTF2T;CSTF2;CPSF2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23295872266854542,-0.8016049797720737,0.8330206378986866,0.9178104886585913,1.0,19/51,28.16%,SMG6;TNKS2;CCT6A;XRN1;CCT8;CTC1;CCT5;MAP2K7;EXOSC10;HNRNPU;TERF2;STN1;ATR;GNL3L;FBXO4;NEK7;NAT10;CCT3;PARN
prerank,lipid catabolic process (GO:0016042),0.292838016379239,0.8014658514334306,0.7525354969574036,0.9891340616190107,1.0,3/18,14.53%,LIPE;HSD11B1;PPT1
prerank,transition metal ion homeostasis (GO:0055076),-0.26915697654373494,-0.8012417062474629,0.7684824902723736,0.9179733794993679,1.0,4/28,8.83%,CP;PRKN;SLC39A14;XIAP
prerank,cellular response to UV (GO:0034644),-0.22064417835444672,-0.8007003880447285,0.8670309653916212,0.9184031486417767,1.0,24/76,25.45%,INO80;EP300;CREBBP;DHX36;PTPRK;IMPACT;DDB2;ZBTB1;PRKCD;USP47;PARP1;MMP2;EIF2AK4;SDE2;MFAP4;CARD16;PCNA;BMF;PPID;ATR;ERCC1;USP28;KDM1A;ACTR5
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.33400288745213746,0.8006500179861069,0.7019438444924406,0.9897754817364962,1.0,11/11,66.62%,LPO;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;PKD1L3;PKD2L1
prerank,amyloid fibril formation (GO:1990000),0.23196931989224845,0.7997201732690481,0.8281853281853282,0.9906005820439764,1.0,12/51,14.59%,SNCA;PSENEN;RPS27A;UBC;UBB;H3-3A;NAT8;TSPAN14;SORL1;CD36;SERF1A;B2M
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.3550178253022337,-0.7989133964799733,0.7430167597765364,0.9208777958538195,1.0,3/10,14.42%,DPP4;FAP;EMILIN1
prerank,regulation of cellular response to stress (GO:0080135),-0.2048953792105861,-0.7987775206043963,0.8976833976833977,0.9206431957008073,1.0,17/115,11.12%,ROCK2;EP300;SMG1;ABL1;PRKN;NUPR1;GSK3B;RPTOR;RANBP2;CREBBP;CAMK2D;MTOR;NUP42;CAMK2G;BAG3;NUP214;MBTPS2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.20394005714269572,0.7987253139751264,0.9083820662768031,0.9915200448135139,1.0,25/124,18.40%,CAMK2A;LEF1;AP2M1;PSMA1;PLCB1;FZD6;GNG2;PSMD12;PSMA6;PSMB3;AP2B1;VANGL2;CELSR2;CALM1;FZD4;DVL1;PFN1;PSME3;PPP3CA;PSMC3;PSMA2;CTNNB1;AGO4;PRICKLE2;PSMB7
prerank,chromatin assembly or disassembly (GO:0006333),-0.34233310355832525,-0.798668838196548,0.7349624060150376,0.920357391656188,1.0,1/11,1.47%,HDAC8
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.3112682624678001,-0.7973949089182002,0.747148288973384,0.9219953563242737,1.0,8/16,29.89%,PID1;PPARGC1A;PARP1;VCP;PPARA;SPHK2;ANTKMT;ENO1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.29148458772374497,-0.7972364319998698,0.7561436672967864,0.9218178431853771,1.0,12/20,33.85%,PLOD2;PLSCR1;PTDSS1;SLC27A1;CHAC2;GSS;PTDSS2;GGCT;GCLC;HAGH;CNDP2;GAMT
prerank,inflammatory response (GO:0006954),-0.18927179823364457,-0.7970745618732308,0.9542743538767395,0.9216263375578085,1.0,34/195,19.19%,NFKB1;HDAC4;TPST1;KIT;TBK1;HSPG2;HMGB1;THBS1;STAT3;ADCY1;NOX4;ANXA1;TRAF3IP2;ABCF1;NFATC4;AGTR1;SCUBE1;PARP4;IL17D;CYBA;BDKRB2;LOXL3;CMKLR1;AFAP1L2;IL18;PTGDR;PIK3CD;TLR4;PXK;PTGFR;BLNK;NFATC3;BMP2;MGLL
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3360050081632017,0.7969493528528558,0.7461024498886414,0.9938047859840834,1.0,4/11,12.95%,TERF1;CCT2;DKC1;CCT4
prerank,negative regulation of cell cycle process (GO:0010948),-0.22790675256824178,-0.7967907116652417,0.8615384615384616,0.9216279694877181,1.0,24/61,33.55%,BMP7;BMP4;RBBP8;CBX5;TFDP2;TOM1L2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1;NME6;TERF2;EZH2;PPP1R10;APAF1;E2F1;GPER1;FOXO4;WAPL;ZFYVE19;RAD51;E2F6;BRCA1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3325017156451075,-0.7964457095025214,0.7586912065439673,0.9217044996941096,1.0,4/13,12.13%,TRIM8;CHMP3;TRIM5;TRIM11
prerank,DNA replication checkpoint signaling (GO:0000076),0.30244364517989597,0.7961400333342302,0.7404063205417607,0.9943343782770593,1.0,1/16,1.66%,HUS1B
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.233643625927884,-0.796121811278398,0.8330206378986866,0.921321768627372,1.0,17/50,27.98%,PUM2;TNRC6A;RANBP2;PUM1;NUP42;NUP214;TPR;POLR2H;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;NUP93;POLR2D
prerank,regulation of gene silencing by RNA (GO:0060966),-0.233643625927884,-0.796121811278398,0.8330206378986866,0.921321768627372,1.0,17/50,27.98%,PUM2;TNRC6A;RANBP2;PUM1;NUP42;NUP214;TPR;POLR2H;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;NUP93;POLR2D
prerank,microvillus organization (GO:0032528),-0.3220901788838595,-0.7956463410763694,0.7309160305343512,0.9216403699692695,1.0,4/13,17.01%,RAP1B;MAP4K4;RAPGEF2;FXYD5
prerank,neuron fate commitment (GO:0048663),0.31769819357963874,0.7955343906446302,0.7526205450733753,0.9945205170245727,1.0,1/14,0.68%,MYT1L
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.23460920444110459,-0.7953920862346749,0.8314393939393939,0.9215907829175262,1.0,9/51,17.01%,PTN;IL34;HMGB1;THBS1;IL6R;VEGFA;VEGFD;CMKLR1;SERPINE1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.29346987868994334,0.7952016367288516,0.75054704595186,0.9942247162959296,1.0,5/18,18.01%,SLA2;BCAR1;GPLD1;C3AR1;SH2B2
prerank,glutathione biosynthetic process (GO:0006750),-0.3385555870636981,-0.7950279857816729,0.7276119402985075,0.9217600951837263,1.0,6/11,33.09%,CHAC2;GSS;GGCT;GCLC;HAGH;CNDP2
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3522763503896104,-0.7945094661823323,0.7342007434944238,0.9221462187409497,1.0,3/10,10.53%,MAP4K4;MTOR;ADAM9
prerank,regulation of amyloid fibril formation (GO:1905906),0.3173981667535029,0.7943156460125468,0.7521008403361344,0.9949614458666644,1.0,6/15,20.46%,PFDN5;CLU;PFDN6;PSEN1;PFDN1;CRYAB
prerank,tryptophan metabolic process (GO:0006568),0.33569769631535995,0.7939581230515452,0.7317073170731707,0.994742310229367,1.0,11/11,66.45%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO;ATP7A
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2659898731305947,0.793560201514122,0.7886710239651417,0.9945798664177036,1.0,3/27,6.39%,CHKA;PISD;PLAAT1
prerank,cellular response to pH (GO:0071467),-0.2978606804099927,-0.7934038310953874,0.770949720670391,0.9234993605657861,1.0,11/17,42.57%,SLC9A1;IMPACT;CHP1;MCOLN1;GPR68;PKD2L1;PKD1L3;HVCN1;KCNK4;RAB11FIP5;HYAL1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.25184147939998985,0.7932368682069599,0.7884615384615384,0.9942517169403308,1.0,12/35,21.89%,ERBB4;NOTCH1;SOCS1;OCIAD1;F2R;BCL3;HES5;HGS;DOT1L;NLK;PIGU;IL10RB
prerank,ATP transport (GO:0015867),0.3383931865938408,0.7930897992622393,0.7218390804597701,0.9936209035776394,1.0,5/10,25.69%,SLC25A42;CD47;ABCC6;SLC25A5;SLC25A4
prerank,RNA modification (GO:0009451),0.2327325441415817,0.7926220819212174,0.8295687885010267,0.9935680277868497,1.0,6/54,8.12%,TSR3;AARS2;QTRT1;NSUN5;TFB1M;RBM15B
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.32379409794964054,-0.7924277966523436,0.7490636704119851,0.9246220679286314,1.0,4/13,13.96%,OS9;EDEM1;ERLEC1;UBAC2
prerank,coenzyme A biosynthetic process (GO:0015937),0.3292581666809134,0.7911149362546287,0.743421052631579,0.9936263904840651,1.0,6/11,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3292581666809134,0.7911149362546287,0.743421052631579,0.9936263904840651,1.0,6/11,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3292581666809134,0.7911149362546287,0.743421052631579,0.9936263904840651,1.0,6/11,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.2917411874798634,-0.7907640958891067,0.7562380038387716,0.9268463335186709,1.0,11/19,32.96%,TAF3;TAF8;TOPORS;MORC3;HNRNPU;PML;TAPT1;BBS4;CHCHD10;HK2;ARL2
prerank,negative regulation of DNA replication (GO:0008156),-0.31863324687080646,-0.7907197967401484,0.7649402390438247,0.9264639280219894,1.0,9/13,44.86%,PDS5A;S100A11;CDAN1;ATR;WAPL;GMNC;TSPYL2;GMNN;CDC6
prerank,development of primary male sexual characteristics (GO:0046546),0.24874569529954937,0.7905738442058444,0.8081896551724138,0.9937049619289394,1.0,3/34,5.82%,KITLG;SRD5A2;TGFB2
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.32229303420290095,-0.7904238245981269,0.762,0.9265048161026003,1.0,5/13,11.39%,MOV10;RC3H1;ZC3HAV1;UPF1;CNOT8
prerank,protein methylation (GO:0006479),-0.24426351507780253,-0.790373582966516,0.8307086614173228,0.9261282313271433,1.0,14/40,22.32%,NSD3;NSD1;SETD3;PRMT2;N6AMT1;EHMT1;PCMT1;METTL21A;PRMT5;PRMT8;EEF2KMT;NTMT1;EZH2;CAMKMT
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.2797053832263681,-0.7900822043027067,0.7662835249042146,0.9261270527105144,1.0,9/22,27.79%,ERI3;ERI2;URB1;EXOSC9;EXOSC10;WDR12;EXOSC3;PES1;RRS1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.3373519779213624,0.7899441348141565,0.7239130434782609,0.9939159288112425,1.0,2/10,7.97%,SNCA;AKT1
prerank,microtubule polymerization (GO:0046785),-0.26118076851214433,-0.7897968463505781,0.7941176470588235,0.9261018613231327,1.0,9/28,19.56%,TUBGCP6;TUBGCP2;NDEL1;RANBP9;AKAP9;CCDC57;CSNK1D;MAP7D3;TUBGCP4
prerank,DNA integrity checkpoint signaling (GO:0031570),0.24834735793403523,0.7896437132330859,0.7954545454545454,0.9935851345623595,1.0,2/36,1.66%,CHEK1;HUS1B
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.30375609142195226,-0.7894075495167598,0.7551789077212806,0.9262423679511225,1.0,6/16,25.46%,ABHD5;LDLR;NR1H3;SLC27A1;DAGLB;PNPLA2
prerank,copper ion transport (GO:0006825),0.3278746548988325,0.7893556250377084,0.7361702127659574,0.9932053045519207,1.0,3/11,15.26%,STEAP2;ATOX1;COX17
prerank,L-glutamate transmembrane transport (GO:0015813),0.34552694955773683,0.789264693525285,0.7407407407407407,0.9924839674652309,1.0,2/10,5.81%,SLC1A1;SLC1A2
prerank,nucleotide-excision repair (GO:0006289),0.20481482648125243,0.7891088650608268,0.8974358974358975,0.9918828885493347,1.0,24/101,18.89%,HUS1B;SIRT1;COPS6;LIG3;RPA3;RPS27A;UBC;XAB2;POLK;UBB;ERCC2;POLR2J;POLR2B;POLR2I;BRIP1;POLD1;RFC4;POLD3;RFC5;POLR2G;AQR;TCEA1;ATXN3;RFC2
prerank,negative regulation of kinase activity (GO:0033673),0.2235223228239503,0.7886918733797172,0.8638297872340426,0.9916883459016417,1.0,12/62,12.84%,CAMK2N1;PPM1F;SNCA;THY1;TRIB3;AKT1;YWHAG;HSPB1;CEP43;UBASH3B;DVL1;EPHA1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.34599886612024894,-0.7886916128405786,0.7226148409893993,0.9269029176577346,1.0,2/10,10.23%,ABCD2;NR1H3
prerank,tryptophan catabolic process (GO:0006569),0.33613709120582513,0.7883518296134242,0.75,0.991373287041423,1.0,11/11,66.41%,KYAT1;KYNU;AFMID;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,positive regulation of dephosphorylation (GO:0035306),0.26690792294282517,0.787756062289213,0.8004158004158004,0.9915301105168333,1.0,9/27,20.82%,PPP1R16B;SMPD1;CALM1;CALM2;CALM3;PPIA;CAMTA1;PPP2R5A;MTMR9
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.32090388814881454,0.7870653460201903,0.7433035714285714,0.9918676288252282,1.0,1/12,1.19%,ADCY8
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3384843471838591,-0.7868274874383097,0.7547169811320755,0.9294349028888724,1.0,3/11,14.52%,NBL1;CCN3;DUSP1
prerank,triglyceride metabolic process (GO:0006641),-0.2287852241567322,-0.7863302995692282,0.8519269776876268,0.9297559497965749,1.0,12/48,27.49%,AGMO;GK5;GPAT4;MOGAT3;APOE;LPIN2;LPIN3;GPAT3;LMF1;PNPLA2;LPL;SEL1L
prerank,regulation of microglial cell activation (GO:1903978),0.30269029207664505,0.7859055454408037,0.7637969094922737,0.9929901269516902,1.0,1/15,2.79%,SYT11
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.23474852642228414,-0.7857782584983165,0.8502772643253235,0.9301432887363805,1.0,22/48,34.02%,EP300;ABL1;BCL2;HIPK1;CASP2;PRKDC;TOPORS;IKBKE;MSH6;PML;USP28;BAG6;BCL2L2;HTRA2;E2F1;BAK1;HIC1;SNW1;BCL2L11;TNFRSF1B;BRCA1;PYCARD
prerank,zymogen activation (GO:0031638),-0.24009523408739236,-0.7850687132855148,0.8256704980842912,0.9307924568301522,1.0,6/39,13.42%,CYFIP2;PLAT;CTSH;ASPH;MMP14;PGK1
prerank,organophosphate catabolic process (GO:0046434),0.33201462143392957,0.7844962474841518,0.7399577167019028,0.9945924222380698,1.0,1/11,4.79%,ENPP2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3360600657937065,0.7844551714709231,0.7435897435897436,0.9937771112216195,1.0,2/10,13.61%,SIRT1;DNMT1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.29027512600959315,-0.7841078239332855,0.7664092664092664,0.9317976284528444,1.0,5/18,23.08%,ROCK1;ITGB1;ITGA4;CX3CR1;VCAM1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.26433484149533526,0.7838833356174016,0.8161157024793388,0.9938485207106753,1.0,6/29,13.15%,RPS27A;UBC;UBB;CD300LF;IRF7;CD40
prerank,blood vessel endothelial cell migration (GO:0043534),-0.27889773505231785,-0.782998535612838,0.7915057915057915,0.9330287633577752,1.0,9/22,25.23%,EFNB2;ROBO1;NRP1;VEGFA;NR4A1;MIA3;FGF2;SLIT2;EPHB4
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.31927554571065503,-0.782980604152922,0.7849056603773585,0.9325985320592632,1.0,3/13,18.04%,NIBAN2;EMILIN1;PTPN1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.3264682804566737,-0.7827004494255118,0.7659963436928702,0.932580207625101,1.0,5/12,23.94%,REST;JUN;HDAC1;INPP5K;TFAP4
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.288731162121924,0.78262035862735,0.7595744680851064,0.9950807717525256,1.0,3/19,12.48%,TIRAP;TRIL;ITGAM
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.29580927296344767,-0.7823023123439485,0.7709090909090909,0.9327302599703212,1.0,10/17,32.83%,EMC2;EMC7;EMC9;GET4;EMC4;BAG6;EMC10;EMC3;GET3;EMC6
prerank,mitochondrial translational termination (GO:0070126),0.21039534460506767,0.7821238790355025,0.8975903614457831,0.9950547800341646,1.0,25/88,23.08%,MRPS25;MRPL14;MRPS12;MRPL49;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,regulation of neuron apoptotic process (GO:0043523),0.20693763730035689,0.7820573018310092,0.9163346613545816,0.9943066113588043,1.0,13/96,10.86%,MAG;GRID2;TRIM2;FOXQ1;NTRK2;TGFB2;VSTM2L;UNC5B;NDNF;CCL2;RETREG1;SET;F2R
prerank,renal absorption (GO:0070293),-0.3474075425277704,-0.7819374818846213,0.7436893203883496,0.9328743429880373,1.0,2/10,9.05%,GSN;WNK4
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2525339684300532,-0.7818776699952,0.8288973384030418,0.9325020621831444,1.0,9/33,19.26%,TBK1;DHX9;MAVS;RIOK3;IRF1;DDX3X;OAS2;TLR4;PTPN11
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.2708566892997555,-0.7817965201787934,0.8133595284872298,0.9321714457186411,1.0,10/24,26.73%,TNKS2;XRN1;PARP1;CTC1;EXOSC10;HNRNPU;TERF2;STN1;GNL3L;NAT10
prerank,heterochromatin assembly (GO:0031507),-0.28581529219757196,-0.781689898838213,0.796078431372549,0.931874292743202,1.0,6/20,18.55%,EZH1;BAZ2A;MBD2;HDAC1;SMCHD1;RRP8
prerank,protein import into mitochondrial matrix (GO:0030150),0.28961908704076883,0.7814172784906551,0.7743362831858407,0.994497130840624,1.0,6/18,23.69%,TIMM21;DNAJC15;TOMM70;DNAJC19;TIMM17B;ROMO1
prerank,regulation of protein localization to cell surface (GO:2000008),0.2502430403118086,0.7811880680904333,0.8297872340425532,0.9940071545088962,1.0,4/33,7.89%,GPM6B;TMEM35A;STX3;HSP90AB1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.25471078803654323,-0.7808924209943967,0.8260869565217391,0.9326333544721719,1.0,7/31,14.79%,USP7;BRCC3;USP33;ABRAXAS2;USP50;OTUD4;USP13
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3183677065664175,0.780454554331547,0.75,0.9934880532756828,1.0,4/12,15.14%,MELTF;SPRY4;ACTN4;CORO1C
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3183677065664175,0.780454554331547,0.75,0.9934880532756828,1.0,4/12,15.14%,MELTF;SPRY4;ACTN4;CORO1C
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.29528792484075816,-0.779923227613915,0.7479838709677419,0.9336809412939052,1.0,3/15,8.56%,RAB10;RAB3GAP1;EDEM1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.23010622984440302,-0.7794354825441902,0.8648648648648649,0.9339768301468234,1.0,18/51,37.53%,HMGB1;STAT3;IL16;GSDMD;USP50;TLR4;WNT5A;TMEM106A;LPL;S100A13;APP;EGR1;PYCARD;MYD88;RIPK2;CASP1;FZD5;AGER
prerank,epithelial cell development (GO:0002064),-0.2800216000786804,-0.7792335174179342,0.7941747572815534,0.9338296713987888,1.0,15/20,51.44%,WNT5B;RILPL2;SIPA1L3;RILPL1;DACT2;BFSP1;EXPH5;ACTA2;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;RAB25;ROS1
prerank,regulation of nuclear division (GO:0051783),-0.28122635372327753,-0.7787357797933215,0.8142076502732241,0.9341350599972047,1.0,7/20,26.58%,OBSL1;CDK13;RCC1;PRMT5;CUL7;BORA;CCDC8
prerank,microtubule-based transport (GO:0099111),0.31814187068424354,0.7785693376093454,0.7640692640692641,0.9956561998544122,1.0,12/12,68.21%,DNAAF2;SPEF2;DYNC1I2;DYNC1I1;DNAAF4;CCDC40;SPA17;SPAG17;ADCY10;ROPN1L;CABYR;HTT
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.33593356532547863,0.7784767635655986,0.7510638297872341,0.9949628834210047,1.0,5/10,24.41%,TERF2IP;APEX1;RTEL1;ACD;DCLRE1B
prerank,embryonic heart tube morphogenesis (GO:0003143),0.23695189429597646,0.7779369614946469,0.8410041841004184,0.9950028644799448,1.0,8/43,13.72%,RYR2;AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,regulation of hormone secretion (GO:0046883),-0.3081244935209343,-0.7776084378913458,0.7565543071161048,0.9354569859938284,1.0,3/15,8.49%,SNX6;ANXA1;VAMP2
prerank,cranial nerve development (GO:0021545),0.3281665115796804,0.7775989896183901,0.7962184873949579,0.9947085017387163,1.0,2/11,13.08%,PAX2;TMEM126A
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.29837213298988785,-0.7774077640541359,0.7422480620155039,0.9352930979390396,1.0,7/16,26.25%,TELO2;KLHL22;SIK3;GPR137B;PIH1D1;LARS1;RRAGA
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.31208676475826824,-0.776096487550149,0.7852998065764023,0.9367990868606821,1.0,6/14,25.95%,IRS1;ABCD2;LONP2;AKT2;TWIST1;PPARA
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.3348511834484696,-0.7755363968058738,0.7606177606177607,0.937198533853827,1.0,2/10,6.93%,KIT;LYN
prerank,cellular response to interferon-gamma (GO:0071346),-0.20611146510910933,-0.7754742947002191,0.9119373776908023,0.9368390516984281,1.0,21/88,17.55%,JAK1;SYNCRIP;CAMK2D;TRIM8;MID1;CAMK2G;SP100;PRKCD;TRIM5;IRF9;TRIM25;IRF1;GBP3;STAT1;DAPK1;IFNGR1;OAS2;GBP7;GBP2;TLR4;WNT5A
prerank,regulation of spindle organization (GO:0090224),-0.29509391106547356,-0.7752870452645668,0.8023255813953488,0.9366626664860561,1.0,10/18,39.21%,NUMA1;SENP6;MAP9;DYNC1H1;BORA;PARP3;TACC3;TPX2;FSD1;RNF4
prerank,synaptonemal complex organization (GO:0070193),-0.30183465229018286,-0.7750042832340773,0.7780040733197556,0.936189658028939,1.0,8/15,47.00%,RAD21;BAG6;P3H4;TEX11;REC8;SYCE2;TEX12;STAG3
prerank,synaptonemal complex assembly (GO:0007130),-0.30183465229018286,-0.7750042832340773,0.7780040733197556,0.936189658028939,1.0,8/15,47.00%,RAD21;BAG6;P3H4;TEX11;REC8;SYCE2;TEX12;STAG3
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.32500907474482255,-0.7749088139496426,0.7514231499051234,0.935875827007998,1.0,3/12,12.66%,HDAC8;RAD21;RB1
prerank,B cell proliferation (GO:0042100),-0.2923912835352145,-0.7746279591451478,0.7922330097087379,0.9358370454963483,1.0,3/17,16.89%,BCL2;MEF2C;CTPS1
prerank,iron-sulfur cluster assembly (GO:0016226),0.2678020270405097,0.7741467587453194,0.7823408624229979,0.9994156901497673,1.0,4/24,11.08%,NDOR1;IBA57;ISCU;ISCA2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.23913615156261603,0.7739132634189788,0.8582834331337326,0.9989653902315369,1.0,5/38,9.89%,OTUD7A;SIRT1;CARD19;TRIM59;DAB2IP
prerank,regulation of DNA recombination (GO:0000018),-0.25253132985906956,-0.7738225495166462,0.825925925925926,0.9365419477581125,1.0,10/32,20.12%,SPIDR;PPP4C;PPP4R2;SETD2;SHLD2;MSH3;MRE11;ZRANB3;MSH6;H1-0
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.26023824639535326,0.7737577077415028,0.8291139240506329,0.9983376770699622,1.0,6/30,13.15%,RPS27A;UBC;UBB;CD300LF;IRF7;CD40
prerank,actin-myosin filament sliding (GO:0033275),0.23314315259305365,0.7735888751229647,0.8467908902691511,0.9968873718614918,1.0,5/38,9.53%,MYH6;MYL1;TMOD1;MYL6;TCAP
prerank,muscle filament sliding (GO:0030049),0.23314315259305365,0.7735888751229647,0.8467908902691511,0.9968873718614918,1.0,5/38,9.53%,MYH6;MYL1;TMOD1;MYL6;TCAP
prerank,regulation of viral life cycle (GO:1903900),-0.27983428203196037,-0.7731345800660621,0.8107569721115537,0.9371066215557594,1.0,5/21,14.33%,AXL;KPNA6;TRIM5;TRIM25;NECTIN2
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.2786248468729615,-0.7731036391578465,0.8046875,0.9366984312397006,1.0,5/21,11.32%,DAG1;HM13;NCSTN;ADAM9;ADAM19
prerank,reverse cholesterol transport (GO:0043691),-0.3137144181794409,-0.7728797933780863,0.771484375,0.9365602412466517,1.0,2/13,14.09%,ABCA1;APOE
prerank,cellular response to arsenic-containing substance (GO:0071243),0.29668377899749276,0.7728654331947513,0.7575757575757576,0.9971886985410356,1.0,1/15,0.80%,ATF3
prerank,global genome nucleotide-excision repair (GO:0070911),-0.26529896621718174,-0.7726124628518597,0.8119349005424955,0.9365079793211296,1.0,5/26,11.94%,GTF2H2;RAD23B;DDB2;PARP1;ERCC3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.27150089034816094,-0.7724005490725862,0.7813620071684588,0.9363803741796424,1.0,13/25,29.48%,YAP1;ARHGAP24;PRKCD;ODF2L;CAPZB;CDK10;TBC1D7;TCHP;SLIT2;KANK1;ARHGAP44;TESK1;PFN2
prerank,regulation of histone deacetylation (GO:0031063),-0.31888510257000857,-0.7723407149369537,0.7678916827852998,0.9360135896404258,1.0,6/13,29.38%,CAMK2D;AKAP8L;NIPBL;SAP30BP;ZBTB7B;SPHK2
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.34933965188517346,-0.772291664902825,0.7575187969924813,0.9356373844954544,1.0,4/10,26.77%,PTPN22;DUSP10;PDCD4;AIDA
prerank,positive regulation of defense response (GO:0031349),0.2060653893385879,0.7721208071866557,0.934560327198364,0.9974962382466837,1.0,8/89,7.50%,S100A9;S100A8;PDE2A;SNCA;NPAS2;ETS1;NINJ1;TLR2
prerank,placenta development (GO:0001890),0.31953339472330866,0.7719491999572994,0.7510729613733905,0.9969174748008798,1.0,2/12,12.29%,PPARG;E2F7
prerank,non-motile cilium assembly (GO:1905515),-0.25473411720306727,-0.7716396789507665,0.8080614203454894,0.9361563373237689,1.0,9/30,19.92%,PCM1;PIBF1;ARL13B;IFT88;C2CD3;TOGARAM1;CSNK1D;GORAB;CEP89
prerank,male gonad development (GO:0008584),0.24164270380758424,0.7715698677821063,0.8405172413793104,0.9966512679380298,1.0,3/34,5.82%,KITLG;SRD5A2;TGFB2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.24386629904005547,0.7712618028092196,0.8291666666666667,0.9962902425708856,1.0,6/33,11.40%,HIP1;AKT1;NUP62;HAP1;PDE6H;CCDC88A
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2657564881186227,0.771232136387027,0.8294243070362474,0.9954847164532821,1.0,4/23,8.04%,COPS6;RPS27A;UBC;UBB
prerank,negative regulation of protein ubiquitination (GO:0031397),0.22545331616088088,0.770786765670662,0.8589743589743589,0.995334265367389,1.0,9/50,13.23%,MINAR1;CAMLG;ADGRB1;IVNS1ABP;ISG15;AKT1;PER2;SMAD7;RPS3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.24645613419886023,-0.7704464606960229,0.8472998137802608,0.9374778219555261,1.0,4/33,10.84%,IL34;ACIN1;RUNX1;ID2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.20672099765501886,0.7702819326807495,0.9211538461538461,0.99524563713355,1.0,16/85,16.14%,MAGI2;AP2M1;PSMA1;FZD6;PSMD12;PSMA6;PSMB3;AP2B1;VANGL2;CELSR2;FZD4;DVL1;PFN1;PSME3;PSMC3;PSMA2
prerank,gonad development (GO:0008406),-0.23508463615219471,-0.7702606404883011,0.8542435424354243,0.9372972362663183,1.0,5/41,10.07%,NR2F2;WNT4;KIT;AR;CSDE1
prerank,regulation of pH (GO:0006885),-0.33267345714488716,-0.7698995522969463,0.7745454545454545,0.9373641588856435,1.0,2/11,7.13%,SLC9A1;ATP6V0A4
prerank,cellular response to oxygen levels (GO:0071453),0.3410661921795304,0.7695131061338777,0.7676991150442478,0.9956272193151767,1.0,3/10,14.85%,ATP6V1A;ATP6AP1;TMEM199
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.30839696597901883,0.7690502536550885,0.7928118393234672,0.9954890550255662,1.0,1/13,2.83%,PTPRT
prerank,regulation of receptor internalization (GO:0002090),-0.2444458071990658,-0.7690377841755269,0.8214285714285714,0.9381342330366012,1.0,10/35,26.06%,ANGPT1;DLG4;MKLN1;ARF1;VEGFA;ARRB1;SFRP4;ANKRD13B;CD63;EGF
prerank,indolalkylamine catabolic process (GO:0046218),0.33611599297012285,0.7690130635529235,0.7839506172839507,0.9946956209733391,1.0,10/10,66.41%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.3026385528100726,-0.7689451680613297,0.783427495291902,0.9373530910787787,1.0,4/15,17.09%,TNRC6B;DHX36;TNRC6C;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.3026385528100726,-0.7689451680613297,0.783427495291902,0.9373530910787787,1.0,4/15,17.09%,TNRC6B;DHX36;TNRC6C;CNOT1
prerank,neurogenesis (GO:0022008),-0.2322968529170401,-0.7687969370637044,0.8265895953757225,0.9371220236941333,1.0,5/43,7.02%,LPAR1;TRAK1;RYK;DAGLA;ANXA1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2616252114556723,0.7685130505423619,0.8261758691206544,0.994629174111584,1.0,5/25,10.07%,AMPD1;GART;HPRT1;MTHFD1;GMPR2
prerank,acylglycerol catabolic process (GO:0046464),0.24812488918638453,0.7680400738640097,0.8441295546558705,0.9945175247358081,1.0,3/30,11.76%,ABHD2;LIPE;FABP5
prerank,regulation of protein modification process (GO:0031399),-0.2261687953164354,-0.7678241032913017,0.8795180722891566,0.9380636247046783,1.0,16/50,22.96%,KAT2B;LYN;IGF2;PLXNB2;FER;FNIP1;FN1;FKTN;NOP53;PHIP;SPRED2;PML;PPP2CA;ATG14;RABL3;CCAR2
prerank,bile acid biosynthetic process (GO:0006699),-0.2618564250739403,-0.7677512542796948,0.8249027237354085,0.9377145630625661,1.0,6/24,22.49%,CYP7B1;CYP27A1;OSBPL9;AMACR;ACOT8;OSBPL3
prerank,regulation of macrophage migration (GO:1905521),0.32833493470883945,0.7675300603853021,0.7483870967741936,0.9944719808273235,1.0,2/10,9.53%,MTUS1;CD200R1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.3453085773743892,-0.7669252199094523,0.7720588235294118,0.9384307778913155,1.0,2/10,4.82%,RARB;RARG
prerank,protein localization to mitochondrion (GO:0070585),0.3292044117706097,0.7668811092952668,0.7516059957173448,0.9945941615078526,1.0,3/11,11.37%,ISG15;AKT1;MTCH2
prerank,regulation of viral transcription (GO:0046782),-0.2388337917711199,-0.7668182747697626,0.8697318007662835,0.9381516174944656,1.0,15/39,28.25%,MDFIC;CCNT1;DHX9;UBP1;TRIM11;NELFB;POLR2H;GTF2F1;POLR2K;CTDP1;POLR2E;POLR2D;NELFA;CDK9;NELFE
prerank,cellular response to amino acid stimulus (GO:0071230),-0.24726344918774296,-0.7668071398395471,0.859344894026975,0.9377161650276791,1.0,8/33,16.18%,UBR2;RPTOR;MTOR;SESN1;UBR1;CASTOR2;KLHL22;CPEB1
prerank,copper ion homeostasis (GO:0055070),0.2825622025355932,0.7667758080256953,0.7810526315789473,0.9939297854427339,1.0,1/17,0.94%,MT2A
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.24286574682000447,-0.7665146994635961,0.8503787878787878,0.9376923305446618,1.0,13/32,37.01%,CDK16;TFDP2;ID2;RB1;HINFP;PCNA;NPAT;ORC1;E2F1;CDC45;POLA1;CDK15;CDK18
prerank,cellular response to fluid shear stress (GO:0071498),-0.3186259412397715,-0.766412065968128,0.7701375245579568,0.9373762495592317,1.0,7/12,29.56%,MEF2C;PKD2;ASS1;MAPK7;MTSS1;HDAC3;NFE2L2
prerank,regulation of lipase activity (GO:0060191),0.3064070660031112,0.7659812522332683,0.7830578512396694,0.9943285031021181,1.0,2/13,4.81%,SNCA;PCSK6
prerank,protein import into nucleus (GO:0006606),0.21555298956905436,0.765239774864205,0.9208333333333333,0.9946402836746181,1.0,8/66,9.99%,IPO5;IPO4;MMP12;RPL23;NXT1;AKT1;NUP62;FAM53B
prerank,protein-DNA complex assembly (GO:0065004),-0.1983298128578827,-0.7650637610319241,0.9458413926499033,0.938832646949873,1.0,43/116,34.77%,TCF4;GTF2H2;KAT6B;RAD23B;CCNH;CDK7;DDB2;MNAT1;PARP1;PSMF1;ERCC3;SPTY2D1;PSMB2;MCM6;ANP32B;DMC1;PSMC1;NAP1L4;PSMB6;PSMA3;GTF2H1;PSMA4;NAP1L1;ORC1;PSME1;ATRX;GTF2H4;PSMD13;MCM4;PSMB10;PSMA5;PSMB9;RBX1;UBA52;NAP1L2;RPA2;RAD51;PSME4;DDB1;CHAF1A;PSMB8;PSMD10;NAP1L3
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.3316477974181819,-0.7646649317416797,0.7781885397412199,0.9389343470716598,1.0,2/10,21.64%,RC3H1;SCRIB
prerank,positive regulation of cell development (GO:0010720),-0.25195992375370097,-0.7643025596646558,0.8566037735849057,0.9389772379060402,1.0,11/31,30.13%,BMP4;NIBAN2;NUMBL;PDE3A;NUMB;CX3CR1;NKX6-1;SOX11;NAP1L1;GPER1;SNW1
prerank,translational termination (GO:0006415),0.20301413282786468,0.7639731999567447,0.9282868525896414,0.9956987810512254,1.0,26/95,23.08%,MRPS25;MRPL14;MRPS12;MRPL49;ETF1;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.3205346414531339,-0.7636497065985818,0.7641509433962265,0.9394172014438091,1.0,1/12,5.93%,NBN
prerank,rRNA catabolic process (GO:0016075),0.2844418779671962,0.7635793848665314,0.7816326530612245,0.9954431321371675,1.0,1/16,0.97%,EXOSC5
prerank,microvillus assembly (GO:0030033),-0.30417518575923425,-0.7626172908720358,0.7678916827852998,0.9403943288302377,1.0,4/14,17.01%,RAP1B;MAP4K4;RAPGEF2;FXYD5
prerank,protein localization to kinetochore (GO:0034501),-0.30320723517408854,-0.7622094247068246,0.8038095238095239,0.9404990733138823,1.0,8/14,44.99%,IK;CENPT;KNL1;TTK;RCC2;SPDL1;CDK1;MTBP
prerank,nucleoside salvage (GO:0043174),0.3285899845489094,0.7621152689479326,0.7597402597402597,0.9967665990824359,1.0,2/10,7.42%,UCKL1;HPRT1
prerank,sphingosine metabolic process (GO:0006670),-0.2827585841173199,-0.7615803363060893,0.8128440366972477,0.9409410940064034,1.0,3/17,8.43%,PLPP3;ASAH2;ACER3
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2617644181827885,0.7612722802984127,0.8256513026052105,0.9971659007621445,1.0,6/24,14.06%,RPS27A;UBC;UBB;RNF34;NOD1;TAB2
prerank,androgen metabolic process (GO:0008209),0.28644735512027514,0.7612028989788435,0.8220338983050848,0.9964305746444229,1.0,5/18,20.66%,SRD5A2;HSD17B7;HSD17B10;SRD5A1;HSD17B4
prerank,mitotic chromosome condensation (GO:0007076),0.25251267777344705,0.7610965755595926,0.8254620123203286,0.9957671263147412,1.0,5/26,10.27%,CSNK2B;TENT4A;NUSAP1;SET;NCAPH2
prerank,positive regulation of TOR signaling (GO:0032008),-0.23240125953423307,-0.7610251151349523,0.8529980657640233,0.9412683923103381,1.0,21/40,41.44%,RPTOR;FNIP1;TELO2;WDR59;RICTOR;KLHL22;SIK3;GPR137B;PIH1D1;LARS1;RRAGA;HDAC3;RRAGC;SEC13;MIOS;LAMTOR4;LAMTOR5;SEH1L;WDR24;TREM2;HTR6
prerank,regulation of astrocyte differentiation (GO:0048710),0.31277243803855115,0.7601269620141657,0.7593360995850622,0.9963674742107412,1.0,2/12,5.70%,BIN1;NOTCH1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.2604943512896951,0.7595304272938597,0.8311688311688312,0.9964408095632997,1.0,5/25,11.76%,RPL23;HSP90AB1;RPL5;HIPK2;RPS7
prerank,regulation of osteoclast differentiation (GO:0045670),-0.24031585107185274,-0.7594428519961328,0.8495238095238096,0.9429697420638277,1.0,7/33,22.73%,FBN1;MTOR;TLR4;TRAF6;GPR137B;TCTA;MAFB
prerank,sulfur amino acid metabolic process (GO:0000096),-0.25953992681758187,-0.7588270668286413,0.8416988416988417,0.9433332571803589,1.0,12/24,39.18%,MMUT;NOX4;MTHFR;TXN2;CBS;GCLC;CDO1;MTR;CTH;ADO;MPST;AHCY
prerank,translesion synthesis (GO:0019985),0.22813837635038167,0.7586108371117937,0.8587196467991169,0.9969394853005622,1.0,12/42,19.15%,ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2;POLI
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.2255170951008495,-0.7584825430963315,0.8752598752598753,0.9433551498748964,1.0,10/49,18.94%,LBP;HMGB1;STAT3;F3;MAVS;IL17D;AFAP1L2;SERPINE1;TLR4;PARK7
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.24373136116980185,-0.7574711989477474,0.8481973434535104,0.9443084149285239,1.0,15/33,35.63%,GLUD1;GLUL;PRODH;OAT;ALDH18A1;NIT2;ALDH4A1;SIRT4;DGLUCY;GCLC;GOT1;CAD;PYCR2;GOT2;PYCR3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2428490042845648,0.7565856094102079,0.8588957055214724,0.9988679570629528,1.0,1/34,0.20%,SLC7A5
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.1903907062280836,-0.7564490543609995,0.969639468690702,0.9452363783650333,1.0,64/125,40.47%,EML4;MAP4;RANBP2;PCNT;NDEL1;SETD2;DYNC1LI1;MAPRE1;NUDC;ZWINT;RCC1;CENPP;SKA2;DYNC1H1;PTPA;PMF1;EFHC1;NEK6;TAOK1;WDR62;NUP98;NUP43;XPO1;TBCE;BCCIP;ITGB3BP;NUP160;CENPT;SUN2;INCENP;KIF11;STIL;DSN1;KNL1;MAD2L1;CENPE;KIF2A;CENPU;BUB1B;TACC3;CKAP5;RAN;AHCTF1;NUP133;SEC13;TTK;B9D2;CENPI;DCTN6;RCC2;CENPH;SEH1L;NSL1;NDC80;CENPN;CENPF;PAFAH1B1;KIF4A;KNTC1;SPDL1;TUBG2;CENPA;CENPQ;SGO1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3090122836500976,0.7562284958020631,0.7799145299145299,0.9985721342839334,1.0,2/12,8.88%,THY1;SKAP1
prerank,protein import (GO:0017038),0.20455560799888284,0.7562229705941775,0.9356846473029046,0.9977466311745495,1.0,9/84,9.99%,IPO5;IPO4;MMP12;GDAP1;NXT1;CLU;AKT1;NUP62;FAM53B
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.30833367059448885,-0.7555354155462304,0.7961335676625659,0.946048350443928,1.0,3/13,16.42%,ENPP1;ENPP3;ENTPD6
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.21271564386202177,-0.7547938624565662,0.893574297188755,0.9465948701590744,1.0,4/59,4.06%,ALDH1A2;CYP7B1;CYP27A1;ABCD3
prerank,positive regulation of RNA splicing (GO:0033120),-0.24552823386756925,-0.754562346623473,0.845724907063197,0.9464525758305806,1.0,12/29,33.43%,U2AF2;DAZAP1;ERN1;NUP98;PIK3R1;RBM22;DYRK1A;SNW1;THRAP3;SF3B4;RBMX;HSPA1A
prerank,cellular response to inorganic substance (GO:0071241),0.2647357534322303,0.7543755767731808,0.7791666666666667,0.9994917327142351,1.0,3/21,11.79%,KCNC2;DDX11;FOXO1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.2766982653296071,-0.7543659990729279,0.8260038240917782,0.9462532276259235,1.0,12/20,38.26%,TXNIP;TXN;P2RX4;IL18;SUGT1;PSTPIP1;APP;C3;PYCARD;CASP1;NT5E;ANO6
prerank,negative regulation of DNA recombination (GO:0045910),-0.22921873177263224,-0.7543462468477165,0.8767395626242545,0.9458322125812554,1.0,19/43,29.39%,KLHL15;SHLD2;MSH3;HELB;ZRANB3;SMCHD1;POLR2H;MSH6;TERF2;H1-0;POLR2K;POLR2E;UBQLN4;ATRX;FANCB;POLR2D;CGAS;PARP3;MAD2L2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.206189545822947,0.7542073565515633,0.9247104247104247,0.9989016406636474,1.0,10/74,8.73%,EPAS1;PSMA1;NOTCH1;RPS27A;UBC;EPO;UBB;PSMD12;PSMA6;PSMB3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.30912234878559636,0.7539642136927225,0.7732181425485961,0.9984075511036684,1.0,3/12,11.30%,SIRT1;TRIB3;ERLIN2
prerank,mitochondrial transport (GO:0006839),0.21757395237597163,0.7537152776286878,0.9089068825910931,0.9978998755883886,1.0,19/53,25.69%,GDAP1;PITRM1;TIMM22;TMEM14C;TSPO;BCS1L;HSP90AA1;TOMM70;OXA1L;STARD3;TIMM10B;DNAJC19;ABCB10;TIMM17B;BCAP31;SLC25A5;MFF;TOMM22;SLC25A4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2514625423821835,-0.7535067011112437,0.8606403013182674,0.94647622757432,1.0,14/29,35.50%,YTHDF3;UBE2K;PTPN2;MAVS;WNT5A;PTPN1;PTPN11;USP18;CACTIN;MUL1;SAMHD1;PTPN6;ZBP1;TTLL12
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.240123496820978,-0.7531779155763793,0.8538899430740038,0.9464727880766227,1.0,10/37,21.43%,NUPR1;GSDME;DNM1L;BCL2;BCLAF1;BECN1;NCK1;SFPQ;FIS1;BMF
prerank,ESCRT III complex disassembly (GO:1904903),-0.3325588331951955,-0.7531283165864178,0.78125,0.9456377950053751,1.0,2/10,9.47%,VPS4B;CHMP5
prerank,ESCRT complex disassembly (GO:1904896),-0.3325588331951955,-0.7531283165864178,0.78125,0.9456377950053751,1.0,2/10,9.47%,VPS4B;CHMP5
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.20919215652838943,-0.7527659420048957,0.9158316633266533,0.9456511315220425,1.0,25/67,35.75%,ITGAV;ITGB5;SEC22B;PSMF1;PSMB2;CYBA;TAP2;SNAP23;NCF2;PSMC1;PSMB6;PSMA3;PSMA4;TAP1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;CALR;PSME4;PSMB8;PSMD10;TAPBP;FCGR1A
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24430729062772555,0.7520115199725409,0.8646464646464647,0.9993943789912194,1.0,1/31,0.13%,TFRC
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.286086122797333,0.7518319461380144,0.8041666666666667,0.998808282591068,1.0,5/17,16.57%,CALM1;SMAD7;CALM2;CALM3;DDIT4
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.27014276695699907,-0.7515676006327534,0.837573385518591,0.9467598621333005,1.0,5/22,18.35%,CD55;ZBTB1;TRAF2;FBXO38;TRAF6
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.24486669927120977,-0.7513534196830653,0.8698224852071006,0.9465740971985768,1.0,5/30,17.43%,PIBF1;HMGB1;STAT3;PRKCZ;TLR4
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.20836354097347182,0.7511397548738962,0.9181286549707602,0.9989253064460101,1.0,10/69,10.86%,MAG;FOXQ1;NTRK2;VSTM2L;UNC5B;NDNF;CCL2;RETREG1;SET;F2R
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2516305454765333,-0.750991343283613,0.8574181117533719,0.9465570895393162,1.0,11/27,29.87%,RRM2B;CTPS2;AK6;DTYMK;CTPS1;NUDT13;NME1;RRM1;GSR;AK1;TXNRD1
prerank,lipid biosynthetic process (GO:0008610),-0.19989636072514927,-0.7508258315330338,0.9304174950298211,0.9462842457003102,1.0,25/77,32.52%,ACSL1;PRKAA2;ABCD3;GNPAT;AGPAT4;PDSS2;GPAT4;ACSL6;HMGCR;PRKAA1;CYP51A1;CBR4;LPCAT1;DHRS11;FDFT1;MVK;LPL;CLN8;OXSM;DOLPP1;PDSS1;FITM2;STAR;MCAT;SREBF1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2510431166120332,-0.750751275434458,0.8764044943820225,0.945925477156389,1.0,10/30,22.48%,PIBF1;PTPN2;PRKCD;PARP14;PRKCZ;SH3BP5L;NF2;MVP;PPP2CA;CD300A
prerank,mitochondrial translation (GO:0032543),0.19597581245076265,0.7502859047847038,0.958498023715415,0.9993103651878301,1.0,24/104,20.09%,MRPS25;MRPL14;MRPS12;MRPL49;TUFM;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;GATB;GATC;MRPL54;MRPS5;NDUFA7;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2
prerank,membrane repolarization during action potential (GO:0086011),0.3059065941522835,0.7502004956281788,0.7768052516411379,0.9986149356918141,1.0,3/13,13.24%,KCND3;ATP1A1;ATP1B1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.23714769846876377,0.750178085910959,0.8438133874239351,0.9978177093906023,1.0,7/35,14.59%,BICD1;HIP1;SNAP91;CLU;SGIP1;PPT1;B2M
prerank,UV protection (GO:0009650),0.31781624669287595,0.7501537187542834,0.7947598253275109,0.9970270056363049,1.0,2/10,9.45%,GPX1;ERCC2
prerank,tRNA wobble base modification (GO:0002097),-0.29740363807969294,-0.7488368376585085,0.8101010101010101,0.9479407349561866,1.0,10/14,44.32%,TRMT9B;ALKBH1;DPH3;GTPBP3;MTO1;ALKBH8;MOCS3;ADAT2;CTU2;CTU1
prerank,folic acid metabolic process (GO:0046655),-0.2742932446774035,-0.7487701622772575,0.8265682656826568,0.9475725190439436,1.0,3/18,17.56%,MTHFR;MTHFD2L;ALDH1L1
prerank,bile acid metabolic process (GO:0008206),-0.2512730214360014,-0.7480244170125572,0.8485436893203884,0.9480922558388374,1.0,7/27,24.71%,CYP7B1;CYP27A1;OSBPL9;AMACR;ACOT8;OSBPL3;GBA2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3082206785378338,0.7476663567576246,0.7910112359550562,0.999609658172648,1.0,2/11,9.62%,SMARCB1;DDX11
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3167432773156611,-0.7476655599423132,0.8018518518518518,0.9480897601988385,1.0,6/12,27.04%,CCT6A;CCT8;CCT5;GNL3L;CCT3;GNL3
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.3129643858577301,0.7473679343754758,0.8251748251748252,0.9992054942093488,1.0,2/11,11.56%,SEMA6A;KLF2
prerank,T cell receptor signaling pathway (GO:0050852),0.18348911843630272,0.7470551819751741,0.9801980198019802,0.9988091384274086,1.0,23/138,16.14%,PDE4B;BTNL9;PSMA1;THY1;MOG;PAK1;PRKCQ;PTPRJ;PSMD12;EIF2B3;PSMA6;PSMB3;SKAP1;TNFRSF21;BCL10;PDE4D;BCAR1;RFTN1;TAB2;PSME3;PAK3;PSMC3;PSMA2
prerank,skeletal muscle contraction (GO:0003009),0.27903033347987166,0.7469238233911529,0.8087912087912088,0.9981603747714698,1.0,19/19,72.13%,TCAP;STAC2;STAC;TNNI3;STAC3;MYH8;MYH3;MYH7;CHRNA1;TNNT1;JSRP1;TNNC2;TNNI2;RCSD1;CCDC78;TNNC1;TNNI1;TNNT3;MYH14
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.18303603534745883,-0.7465609987651887,0.9860834990059643,0.9490330406019064,1.0,67/145,38.71%,FBXL7;PCM1;FHL1;ALMS1;ODF2;NINL;CEP63;CEP135;VPS4B;RAD51B;PCNT;CSNK1E;USP47;PSMF1;RAB11A;MAPRE1;PSMB2;YWHAE;CDC25B;AKAP9;DYNC1H1;CEP76;PRKACA;CEP57;CSNK1D;CDK2;CUL1;PSMC1;HAUS7;PSMB6;HAUS8;ACTR1A;PSMA3;RAD51C;PSMA4;AVEN;HAUS3;PSME1;PSMD13;CEP41;PSMB10;PSMA5;PSMB9;RBX1;HAUS5;HAUS4;PINX1;PLK4;CEP72;SSNA1;CEP164;PSME4;CKAP5;PSMB8;PSMD10;TUBA1A;TPX2;CEP131;RCC2;SKP1;PSMD3;NEDD1;CENPF;PAFAH1B1;CDC25A;DTL;HMMR
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.3120405108269993,-0.7462496895463449,0.821917808219178,0.9489677561305339,1.0,6/12,30.13%,CYP26B1;DHRS3;CNOT1;EZH2;CALR;SNW1
prerank,membrane raft organization (GO:0031579),0.2879146279246231,0.7462348788237766,0.792016806722689,0.998264099119937,1.0,4/15,14.53%,FA2H;NAXE;RFTN1;PPT1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2882247358892625,-0.7454394646389033,0.8247232472324724,0.9495189807055165,1.0,7/16,30.49%,PIGN;PIGH;PIGC;PIGA;PIGZ;PIGP;PIGF
prerank,ceramide catabolic process (GO:0046514),0.2921519887008483,0.7448553688051678,0.7983014861995754,0.999275876250435,1.0,6/14,20.72%,ACER2;NEU2;GLA;HEXB;NEU1;NEU4
prerank,nucleosome assembly (GO:0006334),-0.24457106986726912,-0.7446290881333109,0.8461538461538461,0.9500421892344381,1.0,7/31,16.45%,KAT6B;UBN1;HAT1;CABIN1;SPTY2D1;ANP32B;NASP
prerank,regulation of cell cycle process (GO:0010564),-0.1918663750347296,-0.7444340688014933,0.9720558882235529,0.9498334927313717,1.0,20/104,16.15%,KIF13A;BIRC6;KLHL13;NUMA1;UVRAG;OBSL1;CDC42;MARK4;CDK13;SETD2;RAB11A;BECN1;TTL;PIK3C3;MAP9;RCC1;CSNK2A1;PIK3R4;DYNC1H1;PRMT5
prerank,mesoderm development (GO:0007498),0.2769987112183933,0.7443262121492225,0.8101010101010101,0.9991435556561309,1.0,1/18,1.78%,TIE1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.27871026733884263,0.7439381086673283,0.84,0.9988646408823514,1.0,7/16,25.35%,SCD;PPT1;ACSS1;PPCS;ACAT1;DIP2A;HSD17B8
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.2917465077952786,-0.7439088458877582,0.8133086876155268,0.9500185586104875,1.0,4/15,13.19%,NLGN2;STXBP1;SYN3;USP46
prerank,spermatid development (GO:0007286),0.2447993621862724,0.7434672483865246,0.8683127572016461,0.9986475730125008,1.0,5/32,15.12%,JAM2;NME5;IQCG;CIB1;ING2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.25811202696193447,-0.7430163063127172,0.8153564899451554,0.9506573516517257,1.0,9/24,23.64%,JPH1;CAMK2D;SELENON;PKD2;SRI;PRKACA;NOS1;GSTM2;JPH2
prerank,axonal fasciculation (GO:0007413),-0.30776858968518017,-0.742196442386786,0.7984934086629002,0.9512507356441996,1.0,5/12,25.77%,EPHA3;EPHA4;MEGF8;ARHGAP35;EPHB3
prerank,negative regulation of lipid metabolic process (GO:0045833),0.26744556560175786,0.7416954591725496,0.8272921108742004,1.0,1.0,2/22,5.87%,HCAR2;ALK
prerank,synaptic vesicle localization (GO:0097479),0.29086820101978955,0.7408582044126288,0.8148148148148148,1.0,1.0,1/13,1.68%,NLGN1
prerank,mesoderm formation (GO:0001707),-0.2795599808734974,-0.740255021694496,0.8207547169811321,0.9531440830869243,1.0,5/17,24.76%,ITGB1;SMAD2;ITGB3;ITGA8;SNAI1
prerank,negative regulation of innate immune response (GO:0045824),-0.2402548376979736,-0.7399649516013062,0.8870056497175142,0.9530373833861797,1.0,13/34,29.59%,SERPING1;YTHDF3;IRAK3;TRAFD1;PTPN2;USP18;NLRC3;DHX58;CACTIN;GRN;MUL1;TNFAIP3;SAMHD1
prerank,prostanoid metabolic process (GO:0006692),-0.3037762326654161,-0.73970420551553,0.8070500927643784,0.9529067330669201,1.0,6/13,34.21%,PTGS1;PTGES;ACOX1;CYP2S1;PTGR2;PTGR1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.25129705731674223,-0.738537123870256,0.8449304174950298,0.953902147379479,1.0,5/25,12.61%,B3GALT1;EXT1;HS2ST1;NDST1;NDST2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.2897240730479003,0.7377045178900278,0.7969094922737306,1.0,1.0,1/14,0.89%,TIRAP
prerank,negative regulation of ATPase activity (GO:0032780),0.2852460186829022,0.7374695248887752,0.797979797979798,1.0,1.0,4/16,22.80%,SIRT1;VCPKMT;OXA1L;TNNI3
prerank,protein N-linked glycosylation (GO:0006487),0.20323782510988955,0.7368230611537747,0.9322381930184805,1.0,1.0,12/66,16.10%,GAL3ST1;MGAT5B;ALG3;PMM1;ALG1;MGAT4C;SLC39A8;TMEM258;ALG8;OSTC;OST4;MGAT1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.30904861590780286,0.7367913509113043,0.7973856209150327,1.0,1.0,2/13,4.58%,TMSB4X;NOS3
prerank,actin filament network formation (GO:0051639),0.3190040122701698,0.736783199488305,0.7938144329896907,1.0,1.0,2/11,7.33%,FHOD3;SPIRE2
prerank,B cell receptor signaling pathway (GO:0050853),0.23613989727228343,0.7346125417442001,0.8845360824742268,1.0,1.0,8/32,18.22%,VAV3;BCAR1;RFTN1;NFATC2;CD38;BTK;SH2B2;NCKAP1L
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.22865722789644138,-0.7346023475460829,0.9114391143911439,0.9581320544792175,1.0,5/39,7.81%,ANK2;FHL1;WWP2;PTPN3;CACNA1D
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.21388241674251046,-0.7341025213453881,0.8973384030418251,0.9582594771429932,1.0,22/54,38.04%,MDM4;EP300;TFDP2;CNOT8;CASP2;CNOT2;CNOT1;CNOT10;PML;PCNA;CNOT4;TNKS1BP1;CRADD;PCBP4;E2F1;PLAGL1;RBL2;GADD45A;SFN;TRIAP1;TP53;PLK3
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3162530627196672,-0.7340536142700761,0.8061224489795918,0.9578832190334384,1.0,6/11,39.93%,WNK1;WNT5A;ADAM10;CCR2;ADAM17;CXCL10
prerank,mRNA stabilization (GO:0048255),-0.2241782311489328,-0.7337263244232763,0.9139579349904398,0.9578264953501424,1.0,10/40,18.07%,SYNCRIP;EIF4ENIF1;FUS;DHX9;LARP1;YBX3;YBX1;TENT5A;HNRNPU;PAIP1
prerank,defense response to protozoan (GO:0042832),0.2996419155327121,0.7331621636095749,0.8133047210300429,1.0,1.0,3/12,13.15%,BATF2;GBP4;CD40
prerank,response to gamma radiation (GO:0010332),0.2532421116612499,0.7331357643158164,0.8861788617886179,1.0,1.0,9/24,20.96%,TMEM109;TRIM13;MEN1;HRAS;ATM;XRCC5;MDM2;CRYAB;TSPYL5
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.27707440823384094,-0.7328459439756762,0.8404669260700389,0.9583794450545307,1.0,7/18,25.99%,LBP;SBNO2;ENPP3;IFI35;KARS1;SYK;FCER1G
prerank,regulation of viral release from host cell (GO:1902186),0.2642004061517201,0.7328380997908929,0.8506224066390041,1.0,1.0,8/21,21.05%,TRIM13;TRIM62;MID2;TRIM35;CHMP2B;VPS4A;CHMP2A;TRIM21
prerank,nucleus organization (GO:0006997),0.2207723752710526,0.7328045086093146,0.921443736730361,1.0,1.0,14/47,21.20%,SYNE1;RPS19;BIN1;SUN1;LEMD2;NUP205;REEP3;NUP54;CHMP2B;PITPNB;PDCD6IP;VPS4A;CHMP2A;CHMP7
prerank,regulation of phosphate metabolic process (GO:0019220),0.28240042212204686,0.7327825797933958,0.8300653594771242,1.0,1.0,5/16,19.82%,PGAM1;CD24;PSEN1;BARD1;SMG5
prerank,positive regulation of receptor internalization (GO:0002092),0.2618967777542298,0.7325851068532062,0.8568329718004338,1.0,1.0,2/22,3.00%,MAGI2;AHI1
prerank,protein autoprocessing (GO:0016540),0.2790163392544817,0.7325769131763629,0.8329809725158562,1.0,1.0,1/17,2.11%,OMA1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.22705396612152795,-0.7324254278960849,0.8869731800766284,0.958420102860378,1.0,11/39,22.47%,PI4KA;SMG1;PIP4K2C;TTC7B;EFR3A;PIK3C3;SOCS7;PIK3CD;ITPKC;PIK3R1;PI4K2B
prerank,defense response to virus (GO:0051607),-0.1907638660799531,-0.7322656796594822,0.9590163934426229,0.9581514610640407,1.0,30/100,30.86%,FLNA;MOV10;PLSCR1;BCL2;IFIT2;SETD2;MAVS;AKAP1;TRIM5;IRF1;EIF2AK2;STAT1;MAP3K14;OAS2;ZDHHC1;SHFL;MLKL;IFI27;IFIT3;BNIP3;IRF2;NCBP3;PHB2;ABCC9;PDE12;CGAS;ZMYND11;SAMHD1;TLR3;IFIH1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.3004292425412748,0.7317160322404374,0.8070539419087137,1.0,1.0,5/11,19.78%,IPO4;H3-3A;HIRA;RBBP4;ASF1A
prerank,magnesium ion transport (GO:0015693),0.3052317245719148,0.7315618933622752,0.8009153318077803,1.0,1.0,5/12,18.64%,NIPA1;NIPAL3;NIPAL4;MMGT1;MAGT1
prerank,sister chromatid segregation (GO:0000819),-0.24270359146583032,-0.7315250069602481,0.8740458015267175,0.9585792799557733,1.0,8/31,20.41%,INO80;SMC4;RB1;KLHL22;ZWINT;LATS1;TOP2B;SMC1A
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2111164165708158,0.7314132466783556,0.9272727272727272,0.9994472003647168,1.0,14/56,16.70%,ANLN;ANK3;STMN1;TRIM36;SPIRE2;RAB35;NUSAP1;APC;SPTBN1;CIT;EFHC2;BIN3;MYH10;USP8
prerank,glucose metabolic process (GO:0006006),0.2123582984432056,0.7313232253391551,0.9406593406593406,0.9987532002476615,1.0,9/58,15.24%,OMA1;PGAM1;KCNJ11;SLC37A4;ALDOC;GDPGP1;PER2;ADPGK;ATF4
prerank,cellular respiration (GO:0045333),0.22159232068020623,0.7308230743402762,0.9050632911392406,0.9985537053562682,1.0,11/41,20.63%,SDHC;ATP5F1D;SLC25A14;ETFB;ETFA;ETFDH;UQCRH;NR4A3;COX10;OXA1L;UQCRC2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.26712718924588913,-0.7302561743437743,0.8584070796460177,0.9595784378605084,1.0,6/20,23.07%,PLCE1;SETD3;ATP2B1;CTTN;SPHK1;NMU
prerank,regulation of cholesterol esterification (GO:0010872),-0.319822131755707,-0.7301485091421034,0.8089668615984406,0.9592556561182757,1.0,2/10,14.09%,AGTR1;APOE
prerank,stress-activated MAPK cascade (GO:0051403),0.21238025127790794,0.7299999093456092,0.940677966101695,0.998766839431528,1.0,17/61,18.99%,MAP4K2;SH2D3C;TNFRSF19;RPS27A;UBC;UBB;GPS2;TAOK2;NOD1;MAPK8;MAP3K11;TAB2;MAPK10;PTGER4;MAPK3;ADORA2B;NOD2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2123761517263763,0.7294388323351098,0.9221311475409836,0.9986520809327989,1.0,9/50,16.15%,ACTB;CCND1;CAMK2N1;HSP90AB1;CDK5R2;CCNB2;CDKN1A;STOX1;CDKN1B
prerank,endoderm development (GO:0007492),0.29027717255381447,0.7290553329938677,0.8177676537585421,0.9983300982755259,1.0,3/13,15.20%,LHX1;SOX17;SOX7
prerank,respiratory electron transport chain (GO:0022904),0.2801489353068175,0.7290260824991841,0.8185745140388769,0.997568163866986,1.0,4/14,15.96%,ETFB;ETFA;ETFDH;GPD2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.28412936885636697,-0.7285400857598868,0.8339483394833949,0.9606757126040626,1.0,7/16,24.38%,AMPD3;GMPS;PPAT;ATIC;PAICS;AMPD2;NUDT2
prerank,regulation of adaptive immune response (GO:0002819),0.2691337713243928,0.727878731967715,0.8301486199575372,0.9981138658415922,1.0,3/18,11.90%,SIRT1;SKAP1;IRF7
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.26768812434494016,0.7278261333063119,0.8547717842323651,0.9973704100512146,1.0,2/17,10.48%,CXCL12;AIF1
prerank,positive regulation of phosphatase activity (GO:0010922),0.2607199932448928,0.7258778150759245,0.8588709677419355,0.9989282537872073,1.0,6/21,16.58%,MAGI2;HSP90AB1;CALM1;CALM2;CALM3;GPLD1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.21479320981631292,-0.7258371134599387,0.9178082191780822,0.9633764157110198,1.0,19/49,30.25%,MDM4;ABL1;CEP63;NBN;CDC5L;MAP3K20;STK33;HINFP;ATR;CLSPN;USP28;PAXIP1;DONSON;MAPK14;ATRX;E2F1;INTS7;MAD2L2;BATF
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.29030479561693673,-0.7257463864927514,0.8524904214559387,0.9630256426613573,1.0,2/15,11.25%,MOXD1;SAT1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3131494714616144,-0.7257317892947729,0.8263254113345521,0.9625918849497349,1.0,2/10,12.46%,PLA2G4A;PNPLA8
prerank,pore complex assembly (GO:0046931),-0.2727199561125027,-0.7253811772350182,0.8453038674033149,0.9625265969274295,1.0,3/19,12.60%,AFDN;TPR;GSDMD
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.2599294595923638,0.7251701369905489,0.8606060606060606,0.9989510045084455,1.0,6/22,14.31%,GPNMB;TAOK2;PDGFB;CALM1;CALM2;CALM3
prerank,transcription preinitiation complex assembly (GO:0070897),-0.305224794937501,-0.7248093903953072,0.8413926499032882,0.9627243891327532,1.0,4/12,26.52%,TBP;GTF2B;TAF12;TAF7
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.2379419360044954,0.7245560879829697,0.8858350951374208,0.9988960769904259,1.0,10/30,19.16%,GPX1;NOS3;ARHGEF2;RNF34;TNFSF10;RFFL;FAIM2;TMBIM1;RIPK1;FAIM
prerank,phospholipid dephosphorylation (GO:0046839),0.22981211645562405,0.7243799265928114,0.8863157894736842,0.9982899787488774,1.0,6/37,10.19%,PLPPR1;PLPPR5;SGPP2;PLPPR4;PLPP4;MTMR6
prerank,intracellular protein transmembrane transport (GO:0065002),0.2231519912446377,0.7233292981615067,0.9224137931034483,0.9986919509049236,1.0,11/42,21.63%,CHCHD4;HSPA5;TIMM21;DNAJC15;RTN2;HSPD1;SEC61G;TOMM70;DNAJC19;SEC61A2;TIMM17B
prerank,cellular response to chemokine (GO:1990869),-0.21723532133954254,-0.7232876178035362,0.9227722772277228,0.963964711283754,1.0,5/46,10.27%,FOXC1;RIPOR2;WNK1;SLC12A2;RHOA
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.1997393439204267,-0.7228853555449749,0.9569672131147541,0.9639526504206254,1.0,20/70,29.12%,FOXC1;ABL1;YAP1;RUNX1;PSMF1;TCF3;EIF2AK2;PSMB2;PRKDC;PSMC1;KMT2A;PSMB6;PSMA3;PSMA4;LDB1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.3142321731893858,-0.7225670384870161,0.8339350180505415,0.9638591452170385,1.0,3/11,11.52%,ENPP3;TPK1;CTPS2
prerank,triglyceride homeostasis (GO:0070328),0.2439035252986572,0.7224470868400237,0.8621399176954733,0.9989094023849914,1.0,5/26,13.93%,SIRT1;DGAT2;SCARB1;XBP1;ANGPTL4
prerank,heart looping (GO:0001947),0.22369836056436643,0.7222483442567917,0.9214876033057852,0.9983349450599028,1.0,7/39,13.72%,AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,histone H3 deacetylation (GO:0070932),0.2791704566729968,0.7217075869206093,0.8659574468085106,0.9981700716560066,1.0,2/15,3.31%,HDAC9;SIRT1
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.22992895014884604,-0.7208289546232671,0.9103053435114504,0.965294939700031,1.0,8/36,16.89%,RBBP8;CBX5;TFDP2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1
prerank,regulation of T cell migration (GO:2000404),0.2700815831653019,0.720510616289041,0.8629032258064516,0.9987882247430505,1.0,5/18,19.29%,CXCL12;CD200R1;AIF1;DOCK8;LRCH1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.2813293106793586,0.7195486287583542,0.840958605664488,0.9990651696109527,1.0,5/15,20.79%,ORMDL1;ORMDL2;SAMD8;TNFRSF1A;RACK1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.30736881747426553,0.7195237676031002,0.8377192982456141,0.997505674368097,1.0,10/10,69.28%,CEP250;GRM6;RPE65;CACNA2D4;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.30736881747426553,0.7195237676031002,0.8377192982456141,0.997505674368097,1.0,10/10,69.28%,CEP250;GRM6;RPE65;CACNA2D4;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.21560668593200688,-0.7194387983485412,0.9043824701195219,0.9663917015679107,1.0,13/49,21.43%,NUPR1;GSDME;DNM1L;UBQLN1;EIF2AK3;BCL2;BCLAF1;BECN1;DDX3X;DAPK2;FIS1;P4HB;BMF
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.25106006662210323,0.7192047511756106,0.8813186813186813,0.9970628142598863,1.0,6/24,15.62%,ATF3;HSPA5;NOTCH1;KLF2;ATF4;CHD6
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.31656011564558667,-0.7190633488047043,0.8278985507246377,0.9663414620719151,1.0,6/10,37.57%,RFWD3;WDR76;CCAR2;RPA2;FEM1B;ETAA1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.21304728697184455,-0.7186792599844657,0.940959409594096,0.9663045433832969,1.0,16/49,28.80%,NGLY1;PRKN;RAB12;OGA;HNRNPD;ADAMTS9;XRN2;MTREX;MANBA;SIDT2;MAGEC2;SIAH2;PABPC4;HTRA2;DNASE1L1;SUPV3L1
prerank,purine-containing compound salvage (GO:0043101),0.29418010420619545,0.718672130992759,0.8290598290598291,0.996919130462837,1.0,3/12,10.07%,AMPD1;HPRT1;GMPR2
prerank,aspartate family amino acid metabolic process (GO:0009066),0.26639196195634923,0.7185426442387735,0.8426501035196687,0.9962798610833222,1.0,3/18,9.38%,SMS;ASNS;MTHFD1
prerank,organelle fusion (GO:0048284),-0.25897586132593287,-0.7183809117136347,0.8681318681318682,0.9661703600954501,1.0,4/22,11.22%,OPA1;EEA1;MIGA2;STX4
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.27869861577154664,-0.7181140572888834,0.8406072106261859,0.9655604792799584,1.0,3/15,14.84%,DTNBP1;AP3B1;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.27869861577154664,-0.7181140572888834,0.8406072106261859,0.9655604792799584,1.0,3/15,14.84%,DTNBP1;AP3B1;BLOC1S5
prerank,adipose tissue development (GO:0060612),-0.30024913763425276,-0.7172391196312948,0.8458646616541353,0.9660467973919329,1.0,3/11,11.76%,SH3PXD2B;PGRMC2;ARID5B
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.20085069264859548,-0.7169659538478542,0.9512670565302144,0.9658947721690845,1.0,21/59,31.38%,ROCK2;ROCK1;ERC1;TBK1;IRAK2;TRAF2;MAP3K14;TLR4;TRAF6;TANK;SHARPIN;TICAM1;NKIRAS1;NLRC3;IRAK1BP1;TRADD;BIRC3;UBA52;TLR3;LY96;RNF31
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.19908969623609152,0.7168479158613777,0.9421157684630739,0.9973690163947262,1.0,7/69,9.76%,TIRAP;MIF;CLU;TLR2;PTPRJ;HSPB1;ARHGEF2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.2563539356476866,0.7162758479251775,0.8729508196721312,0.997242286007536,1.0,3/21,9.52%,MBOAT1;PLA2G12A;OSBPL10
prerank,negative regulation of coagulation (GO:0050819),0.2819310478065464,0.7159762015926917,0.8707627118644068,0.9967733139971735,1.0,5/14,19.96%,HS3ST5;CD34;PROC;EDN1;PROCR
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3098997384380604,0.715795821125985,0.8084677419354839,0.9961810528775044,1.0,2/10,10.98%,KLF4;TLE5
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.23632088374514887,-0.7155204346666232,0.9011627906976745,0.9669518967286984,1.0,7/30,17.46%,ACSL1;ABCD3;ABCD2;ACSL6;ABCD4;HACD4;ACOX1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.2092548541201196,0.7154481006310298,0.95,0.9957659703337022,1.0,12/50,21.87%,PSMA1;PSMD12;PSMA6;PSMB3;PSME3;PSMC3;PSMA2;PSMB7;ODC1;OAZ1;AZIN1;PSMD7
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.2555759223334171,0.714860417583055,0.8908296943231441,0.9955792968276417,1.0,4/20,13.04%,HECW1;HECW2;EPO;STK39
prerank,vacuolar acidification (GO:0007035),-0.25626832680155776,-0.7134837558066079,0.8802395209580839,0.9685885624067908,1.0,11/21,40.42%,ATP6V0D1;ATP6V0A4;TCIRG1;CLN5;DMXL1;GRN;ATP6V0D2;CLN6;SLC11A1;TMEM9;ATP6V1H
prerank,pre-miRNA processing (GO:0031054),-0.2821285084095485,-0.7134569322058492,0.8648648648648649,0.9681672138905661,1.0,2/14,8.00%,DICER1;TUT4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.3016904879463582,-0.7126426706424277,0.8487712665406427,0.9686098944607187,1.0,2/11,12.74%,NUPR1;YBX3
prerank,regulation of immunoglobulin production (GO:0002637),-0.24983495846234394,-0.7123373757341798,0.872865275142315,0.9684807095133913,1.0,2/23,11.22%,RBP4;STX4
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.22951333703079593,0.7120666697048006,0.9030172413793104,0.9978856775110911,1.0,7/33,14.24%,ACER2;FERMT3;TGFB2;NEXMIF;RET;CIB1;JAM3
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2722573770432335,0.711205915838637,0.8555798687089715,0.997997718774431,1.0,2/15,7.97%,PPARG;AKT1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.24319014034596736,0.7109276799788501,0.8875255623721882,0.9974900121337688,1.0,1/25,0.20%,SLC7A5
prerank,DNA-dependent DNA replication (GO:0006261),0.18084483029434978,0.7109030270337342,0.9763313609467456,0.9967343525460952,1.0,26/128,20.09%,GINS2;NOC3L;PSMA1;RPA3;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;RECQL;MCM3;POLG;POLD1;PSME3;RFC4;POLD3;PSMC3;PSMA2;RFC5;PSMB7;RFC2;ORC6;WDHD1;MCM8;CDK2AP1
prerank,intestinal absorption (GO:0050892),0.2836444313379328,0.7097839500889562,0.8512931034482759,0.9970850517747348,1.0,1/13,2.66%,SLC2A5
prerank,mitochondrial transcription (GO:0006390),-0.3134256331587412,-0.7095537813994154,0.8649155722326454,0.9708323152294162,1.0,1/10,2.62%,FOXO3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.286040180929907,-0.707763931236285,0.8230088495575221,0.972153198038015,1.0,2/13,6.82%,UPP2;NT5M
prerank,leukocyte cell-cell adhesion (GO:0007159),0.24538023586706972,0.7076808053103092,0.8832997987927566,0.9984335973231029,1.0,3/24,7.13%,SEMA4D;FERMT3;PECAM1
prerank,ncRNA metabolic process (GO:0034660),0.21813255253763983,0.707474184181363,0.907843137254902,0.9978739180589024,1.0,8/37,19.07%,TDRD12;KHSRP;DTD1;DROSHA;BCDIN3D;PIWIL2;MEPCE;TDRKH
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.22479200911829234,-0.7072901791169853,0.90715667311412,0.9721836413824301,1.0,13/35,27.68%,PDGFRB;PPP1R12A;GSK3B;MTOR;BOD1L1;PTPA;CD300A;PPP1R2;NUAK1;CRY2;MASTL;BOD1;PPP1R15B
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.22511185985692944,-0.7072331437344486,0.924812030075188,0.971792574111435,1.0,11/35,28.16%,TNKS2;CCT6A;DHX36;CCT8;CCT5;MAP2K7;ATR;FBXO4;NEK7;CCT3;PARN
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.26097978466699345,-0.7072019607324419,0.8671726755218216,0.9713722068162479,1.0,14/19,56.86%,APOE;SLC5A7;NQO1;CHRNA4;CHRFAM7A;CHRNA7;CHRNB2;ACHE;COLQ;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3
prerank,regulation of chemokine production (GO:0032642),0.22304827568693156,0.707134277151294,0.9256198347107438,0.9974258058362288,1.0,4/36,10.48%,CSF1R;IL7;TLR2;AIF1
prerank,regulation of ruffle assembly (GO:1900027),0.24527868914209733,0.7060427004795187,0.8823529411764706,0.9977686873839525,1.0,5/23,16.73%,NLGN1;FAM98A;HRAS;PFN1;EVL
prerank,triglyceride catabolic process (GO:0019433),0.2547886704766689,0.7059540040357084,0.8811475409836066,0.9970743919047459,1.0,19/19,74.55%,FABP5;PNPLA3;FABP6;APOC3;PNPLA5;FABP2;PNPLA1;LIPI;PNLIPRP2;CPS1;LIPG;FABP3;FABP12;FABP4;LIPC;LIPH;FABP7;LPL;PNPLA2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3038663120571561,0.7052385059170159,0.8586956521739131,0.9970357474741001,1.0,2/11,6.50%,ANK3;PRKCQ
prerank,snRNA 3'-end processing (GO:0034472),0.2527613733308111,0.7051338944122475,0.8713080168776371,0.9963585194389858,1.0,5/19,20.60%,EXOSC5;INTS2;EXOSC4;TOE1;INTS5
prerank,microtubule bundle formation (GO:0001578),0.21475505837855466,0.7051146524839921,0.9412915851272016,0.995605967539285,1.0,7/42,15.27%,SPAG16;MTCL1;TPPP;FOXJ1;DCX;CAPN6;TPPP3
prerank,gluconeogenesis (GO:0006094),-0.222638851569031,-0.7029698001776159,0.946360153256705,0.9750495233375612,1.0,13/39,29.89%,RBP4;SLC39A14;PPARGC1A;MDH1;PGK1;PCK2;SLC25A11;CRTC2;PGM1;ALDOA;ENO3;GOT1;ENO1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.21977405719003995,-0.7028747793202442,0.9400386847195358,0.9746895049387495,1.0,11/36,27.39%,ITGB1;NRP1;HIF1A;FBXW7;HDAC1;ADRA2A;PARK7;HBEGF;HDAC2;EGF;ADRB2
prerank,mitochondrial gene expression (GO:0140053),0.2140832099548229,0.7028012606952686,0.9285714285714286,0.9971971464529514,1.0,14/42,22.12%,MRPS12;MRPS18A;MRPS7;MRPS14;MRPL23;FASTKD5;GATB;GATC;NDUFA7;MRPS28;MRPL2;PTCD3;TFB2M;MRPL16
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.29835035509401436,-0.7022417480151696,0.8394160583941606,0.9748668085738108,1.0,4/11,21.63%,LMNA;SMAD4;P2RX4;MLIP
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.29016468170761994,-0.7020817425379384,0.8443223443223443,0.9745625793882202,1.0,6/12,33.55%,YTHDC1;SMCHD1;HNRNPU;PCGF3;CDYL;BRCA1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.18756325161911858,-0.7017309434551164,0.9801192842942346,0.974457007762956,1.0,33/84,34.19%,ANAPC5;ANAPC7;ANAPC4;ANAPC16;PSMF1;CUL3;RB1;PSMB2;CDC26;CDC27;UBE2E1;UBE2S;CDK2;ANAPC11;PSMC1;ECRG4;PSMB6;PSMA3;PSMA4;CDC16;ANAPC1;PSME1;PSMD13;FZR1;PSMB10;PSMA5;PSMB9;UBA52;MAD2L1;PSME4;BUB1B;PSMB8;PSMD10
prerank,protein prenylation (GO:0018342),-0.3088003989829579,-0.7016320481944414,0.833941605839416,0.9741023054836934,1.0,5/10,28.41%,RABGGTB;CHM;CHML;FNTA;RCE1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.2914497142710876,0.7014914097782321,0.8336886993603412,0.9977673880641543,1.0,1/11,6.50%,PRKCQ
prerank,UV-damage excision repair (GO:0070914),-0.2917774457293606,-0.7007493472673268,0.8431734317343174,0.9744996486939029,1.0,2/12,8.91%,INO80;DDB2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2764474562152925,-0.7002761524143062,0.8697318007662835,0.9744900201577172,1.0,9/15,40.13%,YTHDF3;PTPN2;USP18;CACTIN;MUL1;SAMHD1;TTLL12;NLRC5;YTHDF2
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.27812835950149256,-0.6999931357743542,0.8696461824953445,0.9743212237434139,1.0,3/14,10.03%,IRS1;PPARGC1A;PTPN2
prerank,T cell homeostasis (GO:0043029),0.30361635815116367,0.6998490940175592,0.8385650224215246,0.9986200417435582,1.0,2/10,18.22%,AKT1;NCKAP1L
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2532328161368849,0.6996255932422168,0.8586723768736617,0.9980578149891676,1.0,4/21,14.55%,YWHAB;PPP1R16B;PPP1R11;MFHAS1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.23650806635097588,0.6994381849852943,0.9032258064516129,0.9974430806693221,1.0,4/26,8.42%,SIRT1;NME5;AKT1;HSPB1
prerank,serine family amino acid catabolic process (GO:0009071),-0.30373376087548776,-0.6989508222704736,0.8584392014519057,0.9748699157032914,1.0,7/10,47.83%,AMT;CBS;SHMT2;DLD;GLDC;SHMT1;DAO
prerank,serine family amino acid metabolic process (GO:0009069),0.27440173809384816,0.6987272195577126,0.8723849372384938,0.9973669908318799,1.0,5/16,21.18%,SEPHS2;MTHFD1;SRR;SEPSECS;THNSL2
prerank,embryonic heart tube development (GO:0035050),-0.27793521764039186,-0.6983494886728824,0.8738898756660746,0.9750060454528385,1.0,5/14,19.53%,HES1;ACVR1;CITED2;TBX2;MEGF8
prerank,regulation of G0 to G1 transition (GO:0070316),-0.22005585278301518,-0.6983428419901102,0.9239543726235742,0.9745646673883371,1.0,8/38,16.89%,RBBP8;CBX5;TFDP2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1
prerank,lipid oxidation (GO:0034440),-0.2907367428962292,-0.6976365479077881,0.8638941398865785,0.9747903557140074,1.0,3/12,27.15%,PPARGC1A;ACOX1;ALOX12
prerank,regulation of cellular protein catabolic process (GO:1903362),0.26004125722545257,0.6975331398565027,0.8879837067209776,0.9977431368632443,1.0,1/18,0.29%,NELL1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.29155673980176633,0.6973453351196736,0.8565310492505354,0.9971417069608377,1.0,2/11,12.48%,CAMK4;ITGAM
prerank,regulation of viral genome replication (GO:0045069),0.20020401775445112,0.6971198783927729,0.9701195219123506,0.9965821911235301,1.0,11/56,18.08%,PROX1;ISG15;TRIM6;IFITM3;PABPC1;SLPI;HACD3;RSAD2;TNIP1;PPIA;ADAR
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.29191003585684283,0.697077798727365,0.8531468531468531,0.9950828277555425,1.0,5/11,19.06%,CCT2;DKC1;CCT4;TCP1;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),0.29191003585684283,0.697077798727365,0.8531468531468531,0.9950828277555425,1.0,5/11,19.06%,CCT2;DKC1;CCT4;TCP1;MEPCE
prerank,protein deneddylation (GO:0000338),-0.30330024094401026,-0.6970749962774193,0.8563218390804598,0.9748652112662913,1.0,5/10,31.23%,COPS2;COPS8;TOR1A;GPS1;COPS5
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2685416524356635,-0.6968885310223062,0.9023941068139963,0.9745930622304172,1.0,9/15,33.41%,ANAPC7;TPR;CDC27;NEK6;CDC16;ANAPC1;CENPE;RIOK2;TACC3
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.3070174160960085,-0.6966637304521495,0.8481781376518218,0.9743413363419826,1.0,5/10,38.74%,WNK1;WNT5A;ADAM10;CCR2;ADAM17
prerank,canonical glycolysis (GO:0061621),-0.2448990661980273,-0.6966202518253347,0.8972332015810277,0.9734893907291692,1.0,11/24,32.20%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.2448990661980273,-0.6966202518253347,0.8972332015810277,0.9734893907291692,1.0,11/24,32.20%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.192548502183954,0.696064319869348,0.9783037475345168,0.9952817003125289,1.0,7/73,8.73%,KITLG;PSMA1;TAL1;LMO2;PSMD12;PSMA6;PSMB3
prerank,negative regulation of leukocyte activation (GO:0002695),0.2715506181121307,0.6956752781003014,0.88,0.9948625511587154,1.0,2/15,9.10%,LRFN5;CD300LF
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.2391998942344727,-0.6936744622703622,0.8906560636182903,0.9757170787897621,1.0,5/24,21.01%,PLA2G4A;PNPLA8;SLC27A1;LPCAT1;CDS2
prerank,DNA biosynthetic process (GO:0071897),0.2655255489448847,0.693647570700742,0.8938428874734607,0.9960045092196816,1.0,7/16,25.04%,SIRT1;POLD1;POLD3;PPIA;CDKN2D;RFC3;TYMS
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.3078424445429142,-0.6932670140236773,0.8673076923076923,0.9756307518930214,1.0,3/10,13.96%,OS9;ERLEC1;UBAC2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.23710984769343307,0.6931034884334011,0.8964757709251101,0.995749837808006,1.0,4/25,13.23%,PDE4B;SPTBN1;PDE4D;RPS3
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.2408980559330099,0.692914113885615,0.9103869653767821,0.9951463498494112,1.0,2/23,9.41%,MBOAT1;PLA2G12A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2646633218710601,-0.6928097582053011,0.8790170132325141,0.9756375283339125,1.0,9/17,44.99%,IK;RB1;BOD1;KNL1;TTK;SPDL1;CENPA;CDK1;MTBP
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.2966702637307207,-0.6925880231294029,0.8586762075134168,0.9753958025754536,1.0,5/11,28.72%,EGLN3;P4HA2;P4HB;P4HA1;EGLN2
prerank,membrane lipid catabolic process (GO:0046466),-0.3050750630423241,-0.6919400434021862,0.8637236084452975,0.9755276865844202,1.0,4/10,21.82%,CYP1B1;PDXDC1;NAGA;SMPD2
prerank,phagosome acidification (GO:0090383),-0.23634605893742805,-0.6919136288567709,0.9035433070866141,0.9751026096039166,1.0,3/26,7.13%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,cellular response to tumor necrosis factor (GO:0071356),0.16741377310761726,0.6918162400589076,0.9960707269155207,0.99535960576293,1.0,23/175,14.26%,ST18;TMSB4X;SIRT1;PSMA1;TRAF1;TNFRSF9;TNFSF13B;AKT1;PSMD12;PSMA6;PSMB3;CCL2;ARHGEF2;DAB2IP;TNFRSF12A;TNFRSF21;TNFRSF25;ACTN4;CD40;RPS3;NFKBIA;CIB1;PSME3
prerank,determination of heart left/right asymmetry (GO:0061371),0.2082054965094659,0.6917257978748838,0.952286282306163,0.9946802012917895,1.0,7/42,13.72%,AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,regulation of neutrophil migration (GO:1902622),0.29583357306590646,0.6902338802756465,0.8404040404040404,0.9952631355054427,1.0,3/10,20.38%,JAM3;NCKAP1L;RAC1
prerank,genitalia development (GO:0048806),-0.29288731796665185,-0.6902254617357714,0.8620689655172413,0.9761608851258913,1.0,4/12,19.26%,PKD1;CHD7;WNT5A;PTPN11
prerank,phagosome maturation (GO:0090382),0.2221942642840352,0.6897468823253047,0.9203354297693921,0.9949269197853915,1.0,15/35,24.48%,ATP6V1F;ATP6V1A;CORO1A;ATP6V1C1;ATP6V0B;RAB31;ATP6V0A1;ATP6V0E2;ATP6V1D;RAB32;RAB14;ATP6V0C;ATP6V1G1;ATP6V1E1;MREG
prerank,response to hydrogen peroxide (GO:0042542),-0.20690737394391553,-0.6884124085462816,0.9555984555984556,0.9773017825618487,1.0,17/45,30.48%,ABL1;ANXA1;MAP3K5;IMPACT;CYP1B1;PRKCD;ADAM9;APTX;GLRX2;PARK7;FXN;MAPK7;SIRPA;PLEKHA1;TNFAIP3;NFE2L2;PPIF
prerank,defense response to symbiont (GO:0140546),-0.18067653189731211,-0.6881225070661916,0.9958932238193019,0.9771059634026652,1.0,27/92,30.86%,FLNA;MOV10;PLSCR1;BCL2;IFIT2;SETD2;MAVS;TRIM5;IRF1;EIF2AK2;STAT1;MAP3K14;OAS2;SHFL;MLKL;IFI27;IFIT3;BNIP3;IRF2;NCBP3;ABCC9;PDE12;CGAS;ZMYND11;SAMHD1;TLR3;IFIH1
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.26919004534122826,-0.6878898692099592,0.8803921568627451,0.9768615180651009,1.0,9/16,39.81%,NUPR1;VCP;PDE12;MLXIPL;PPIF;COX7A2L;ATP7A;SHMT2;UQCC2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2574702477255433,-0.6874971136013973,0.8944444444444445,0.9767625574952177,1.0,4/18,14.98%,VPS4B;RAD51B;RAB11A;CDC25B
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.26761119531558886,0.6873914958710564,0.875,0.9962439005865846,1.0,1/15,1.66%,HUS1B
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.19103477276681533,0.6873798535287075,0.9776286353467561,0.9954908102815413,1.0,12/72,15.38%,DNASE1;MEI4;RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;DDX1;RFC4;POLD3
prerank,positive regulation of stem cell proliferation (GO:2000648),0.25763802578221695,0.687361868009346,0.8956521739130435,0.9947437150549767,1.0,3/17,15.42%,HMGA2;THPO;PDCD2
prerank,cGMP metabolic process (GO:0046068),0.2820433527132131,0.6872034581694071,0.8590308370044053,0.9941192988369623,1.0,1/12,3.36%,PDE2A
prerank,regulation of inclusion body assembly (GO:0090083),0.28804241293680355,0.6864986858829105,0.8471615720524017,0.9940263157725305,1.0,3/11,16.45%,SACS;DNAJA4;DNAJB2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.24715894901947089,0.6850957949913264,0.8984881209503239,0.9944695842458895,1.0,5/19,15.38%,AMPD1;HPRT1;GMPR2;POLD1;POLD3
prerank,cilium-dependent cell motility (GO:0060285),-0.23696945141298975,-0.6831319630549766,0.9296296296296296,0.9800573822061168,1.0,7/22,28.28%,CFAP44;CCDC39;EFHC1;DNAH8;GAS8;RSPH9;DNAH2
prerank,negative regulation of phosphatase activity (GO:0010923),0.23523629287913955,0.6819611275353181,0.893970893970894,0.9963310560222145,1.0,4/25,11.18%,SEMA4D;ZCCHC9;TGFB2;PPP1R11
prerank,lymphocyte proliferation (GO:0046651),-0.2385295997611001,-0.6818607792426624,0.933206106870229,0.9806410138612223,1.0,6/22,25.82%,BCL2;ELF4;MEF2C;CTPS1;MSN;LMBR1L
prerank,steroid catabolic process (GO:0006706),-0.290993009484972,-0.6817023878659437,0.8754716981132076,0.9803255813431493,1.0,2/10,20.22%,HSD17B11;SPP1
prerank,regulation of lipid kinase activity (GO:0043550),-0.29401676782524205,-0.6816097797461346,0.8766859344894027,0.9799639057611278,1.0,4/11,21.16%,WDR91;RB1;PIK3R1;WDR81
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.25418437881373507,0.6810765212781249,0.894,0.9963113453566208,1.0,2/17,11.12%,PLA2G12A;CRLS1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.22318262180192888,0.6810561714692414,0.934640522875817,0.9955706575166983,1.0,9/30,18.37%,PREPL;ANK3;GOLGA7;SPTBN1;MACF1;RAB31;BBS1;BLZF1;OPTN
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.29728472696462865,-0.6800800224851232,0.8523725834797891,0.980804203548776,1.0,1/10,2.74%,DICER1
prerank,coenzyme A metabolic process (GO:0015936),0.27319125260638183,0.6795011066289355,0.8936651583710408,0.9961101067971115,1.0,6/14,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.28870794626641044,0.6792413911734289,0.8494623655913979,0.9955637587599465,1.0,2/10,11.52%,ING4;HIPK2
prerank,negative regulation of hormone secretion (GO:0046888),-0.29444915167705343,-0.6789248927222353,0.8727272727272727,0.9813269773608954,1.0,1/10,8.60%,GJA1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.27067908127988055,0.6785380785559036,0.8660907127429806,0.9953968534126066,1.0,5/13,18.04%,NOS3;GAD1;GLS2;GLS;DDAH1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.2990718307125658,-0.677218264088074,0.9032258064516129,0.982256126213049,1.0,5/10,32.92%,CD9;PRKCD;ALOX12;RDX;ADAMTS18
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2972342818846797,-0.6771304412553381,0.8783542039355993,0.9818780296212065,1.0,1/10,0.81%,STIM1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.22684217567869863,-0.6747614078552727,0.9328214971209213,0.9832724871883362,1.0,4/26,9.27%,CYB5B;ASAH2;ACER3;CYP1B1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.25273902434030693,0.6745407954662391,0.9056603773584906,0.9979018842695322,1.0,1/18,0.74%,ACTB
prerank,regulation of establishment of planar polarity (GO:0090175),-0.17898871624794965,-0.6740788640818424,0.989451476793249,0.9833734112781355,1.0,27/88,29.12%,SMURF2;FZD2;VANGL1;CDC42;DACT1;RHOA;ROR2;PSMF1;FZD7;PSMB2;DAAM1;SMURF1;WNT5A;FZD1;SPEF1;PSMC1;DVL3;PSMB6;PSMA3;AP2A1;PSMA4;DVL2;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,AMP metabolic process (GO:0046033),0.275518087833732,0.6739754014053665,0.9012875536480687,0.9975858419415282,1.0,1/13,2.25%,AMPD1
prerank,nuclear body organization (GO:0030575),0.2788217679417029,0.6738884729846405,0.8821218074656189,0.9969087201150547,1.0,2/12,11.52%,ETS1;HIPK2
prerank,nitric oxide metabolic process (GO:0046209),0.26288688609897165,0.67311312472849,0.8966244725738397,0.9967514863369439,1.0,3/14,15.09%,NOS3;AKT1;GCH1
prerank,mismatch repair (GO:0006298),-0.22496039051214456,-0.6729389103951178,0.9221238938053097,0.98384637910227,1.0,8/27,23.40%,ABL1;MLH1;SETD2;MCM9;MSH3;MSH6;PCNA;ERCC1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.21678871608374128,-0.6726470303486982,0.9537223340040242,0.9836315892166336,1.0,6/33,10.43%,ABL1;ANXA1;MAP3K5;IMPACT;CYP1B1;PRKCD
prerank,regulation of cholesterol storage (GO:0010885),-0.25847687776082184,-0.6726168675846842,0.881578947368421,0.9832149290792378,1.0,6/15,31.68%,ABCA1;NR1H3;PPARA;LPL;EHD1;MSR1
prerank,cellular response to lectin (GO:1990858),-0.172879426742588,-0.6720397420573504,0.9957983193277311,0.982774119718681,1.0,25/104,29.12%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;FBXW11;TRAF6;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.172879426742588,-0.6720397420573504,0.9957983193277311,0.982774119718681,1.0,25/104,29.12%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;FBXW11;TRAF6;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,positive regulation of transmembrane transport (GO:0034764),-0.2738089144310455,-0.6718692721605055,0.895910780669145,0.9824649565575329,1.0,2/13,7.41%,ACSL1;BRAF
prerank,negative regulation of T cell activation (GO:0050868),-0.21516083859929616,-0.6716327240730985,0.9368836291913215,0.9822050182229156,1.0,6/35,22.93%,PAG1;RIPOR2;PTPN22;SDC4;DLG5;CD80
prerank,nerve growth factor signaling pathway (GO:0038180),0.2940171855919946,0.6714975904281988,0.885593220338983,0.99722311745508,1.0,1/10,2.80%,MAGI2
prerank,actin nucleation (GO:0045010),-0.2469736721718655,-0.6712089504422455,0.9132841328413284,0.9820926231699182,1.0,9/21,37.64%,IQGAP2;ARPC2;WHAMM;LMOD1;ACTR2;ARPC5;JMY;ARPC3;ARPC4
prerank,negative regulation of immune response (GO:0050777),-0.16360265352634024,-0.6704668446504444,0.998046875,0.982215702306122,1.0,16/154,11.19%,COL3A1;ADCY9;ADCY5;IRAK3;TRAFD1;RC3H1;ADCY1;LYN;MAPKBP1;RAMP1;ADCY6;PCBP2;PLCG1;FER;ENPP3;YES1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.23946754634070938,-0.670291466885489,0.9319852941176471,0.9819084223769701,1.0,4/22,12.34%,PHF8;EIF2AK3;MTOR;WDR43
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.17181527511705275,-0.6697698242038718,0.9937369519832986,0.9818875852650051,1.0,25/105,29.12%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;FBXW11;TRAF6;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2195452769064932,-0.6695205446037991,0.9421487603305785,0.9816118557669306,1.0,6/29,14.71%,DDX6;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9
prerank,detection of visible light (GO:0009584),-0.2570365890785966,-0.6693455742869259,0.8841121495327103,0.981306335292355,1.0,1/16,5.81%,ABCA4
prerank,melanosome localization (GO:0032400),-0.23720189213253906,-0.6690214278880271,0.9361702127659575,0.9811115411697344,1.0,6/21,28.24%,SHROOM2;RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,oligodendrocyte differentiation (GO:0048709),0.2400389474612535,0.6685807250443658,0.9184549356223176,0.9987947925147338,1.0,5/19,16.78%,NSUN5;EIF2B3;TPPP;PTPRZ1;HES5
prerank,nitric oxide biosynthetic process (GO:0006809),0.2673510490642496,0.6682628652734903,0.9002123142250531,0.998246134145227,1.0,3/13,15.09%,NOS3;AKT1;GCH1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.2930922306409181,-0.6680053413247782,0.8828828828828829,0.9813981883917606,1.0,3/10,15.34%,CCT6A;CCT8;CCT5
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.23565899876880975,-0.667591457496163,0.9168207024029574,0.9812726321286985,1.0,3/22,10.31%,RNF115;VPS4B;VPS37C
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.21481122940712724,-0.667472060481097,0.9309701492537313,0.9809190871331286,1.0,10/32,28.16%,TNKS2;CCT6A;CCT8;CCT5;MAP2K7;ATR;FBXO4;NEK7;CCT3;PARN
prerank,alcohol catabolic process (GO:0046164),-0.2942148898358266,-0.6671062281194621,0.886654478976234,0.980751042025925,1.0,2/10,14.09%,CYP27A1;APOE
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.284585478997342,-0.6667606878767309,0.8890977443609023,0.98056067907026,1.0,6/11,50.75%,AGTR1;ABCG1;LIPC;PLA2G5;PLA2G7;PLA2G3
prerank,neuron projection organization (GO:0106027),-0.2621960280076886,-0.6665729357867525,0.9014336917562724,0.9802651453134756,1.0,3/15,12.16%,GSK3B;ABCD2;ARF1
prerank,steroid metabolic process (GO:0008202),-0.18202798595772443,-0.6657537216860495,0.9881188118811881,0.9804183130312955,1.0,15/72,24.71%,CYP7B1;CYP26B1;CYP27A1;CYP1B1;SULT1A1;PIAS4;CUBN;CYP51A1;AMACR;DHRS11;FDX1;FDFT1;ARV1;CYP2R1;GBA2
prerank,pancreas development (GO:0031016),0.2702211808205258,0.6650308229344203,0.8682505399568035,0.9998427323058015,1.0,2/12,10.18%,PROX1;FOXF1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.1815477476934732,-0.6649343274104922,0.9898373983739838,0.9805969874216286,1.0,23/72,29.21%,DICER1;BTRC;TRAF2;PSMF1;CARD14;COPS8;PSMB2;MAP3K14;FBXW11;TRAF6;IRAK1;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;NFKB2;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;BIRC3
prerank,tRNA wobble uridine modification (GO:0002098),-0.2603118786893643,-0.6642439836598607,0.88996138996139,0.9807034103261288,1.0,7/14,35.21%,TRMT9B;DPH3;GTPBP3;MTO1;TRMU;ALKBH8;MOCS3
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.2576727184154124,0.663883785473118,0.8837719298245614,0.9999083026142458,1.0,4/14,21.73%,BCL10;RPS3;RAB29;CARD11
prerank,spindle assembly checkpoint signaling (GO:0071173),0.23724482970597965,0.6627451420878938,0.9270833333333334,0.998470877587051,1.0,6/20,18.52%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.23724482970597965,0.6627451420878938,0.9270833333333334,0.998470877587051,1.0,6/20,18.52%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.23724482970597965,0.6627451420878938,0.9270833333333334,0.998470877587051,1.0,6/20,18.52%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.2907993131816389,-0.6622501506732322,0.8856624319419237,0.9817080746772279,1.0,3/10,21.34%,THBS1;INPP5K;AKT2
prerank,positive regulation of myelination (GO:0031643),0.27616001746923646,0.6619819754263389,0.8689655172413793,0.9982468837420736,1.0,2/11,9.18%,TENM4;TPPP
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.2819253695089381,0.6605523155564037,0.8760504201680672,0.9984929884830419,1.0,2/11,13.04%,BIN1;STK39
prerank,positive regulation of T cell migration (GO:2000406),0.2392738949173695,0.6589742455311843,0.9171597633136095,0.9989134138583853,1.0,4/20,17.21%,CXCL12;AIF1;STK39;DOCK8
prerank,calcium import into the mitochondrion (GO:0036444),-0.29080760825267266,-0.6588726034806808,0.8876611418047882,0.9836295149323522,1.0,2/10,14.65%,MCU;MICU1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.28218952950946896,-0.6585660239359302,0.8745387453874539,0.9834037962098694,1.0,3/11,14.17%,LDLR;NR1H3;SLC27A1
prerank,rRNA methylation (GO:0031167),-0.23361772203868797,-0.6584378336111386,0.9428571428571428,0.9830556767436884,1.0,5/22,16.54%,ZCCHC4;NSUN3;DIMT1;METTL15;BUD23
prerank,cellular response to interleukin-1 (GO:0071347),0.16184281067131104,0.6584324348787594,0.996219281663516,0.9985328450891328,1.0,30/143,20.51%,ST18;TOLLIP;PSMA1;RPS6KA5;PLCB1;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;CCL2;DAB2IP;NOD1;CD40;NFKBIA;TAB2;PSME3;PELI1;PSMC3;PSMA2;IL1RAP;CCL25;MAPK3;PSMB7;NOD2;CD47;HYAL2;CCL13;CCL19
prerank,protein localization to condensed chromosome (GO:1903083),-0.2707344426974614,-0.6579252724469131,0.8948339483394834,0.9829348484129665,1.0,1/12,5.15%,IK
prerank,regulation of superoxide anion generation (GO:0032928),-0.26772360227278164,-0.6578660407247267,0.8968105065666041,0.9825350568830508,1.0,3/14,24.64%,PRKCD;AATF;SYK
prerank,response to interferon-gamma (GO:0034341),-0.18316513571234747,-0.6566584376541775,0.994,0.9829192280084821,1.0,13/67,19.08%,SYNCRIP;SP100;NUB1;CXCL16;GBP3;STAT1;DAPK1;GBP7;GBP2;TLR4;SHFL;WNT5A;GBP6
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.20496363400827397,0.6561833913221731,0.9664570230607966,0.9993886800242497,1.0,8/37,18.57%,DNASE1;ENTPD3;SND1;RNASEH2A;DFFB;RNASE3;PNPT1;ENTPD1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.1893688935043841,0.6558408649583646,0.9747081712062257,0.9988684135565283,1.0,12/53,21.87%,PSMA1;PSMD12;PSMA6;PSMB3;PSME3;PSMC3;PSMA2;PSMB7;ODC1;OAZ1;AZIN1;PSMD7
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.2517836906974494,0.6552972008547974,0.9071274298056156,0.998499398312722,1.0,2/15,10.32%,PPARG;MID1IP1
prerank,N-terminal protein amino acid modification (GO:0031365),0.26105186334156844,0.6546329695427346,0.9035087719298246,0.9981942760319953,1.0,1/14,3.27%,METAP2
prerank,inner mitochondrial membrane organization (GO:0007007),0.19632643000989158,0.6542120005260014,0.9658848614072495,0.9977257607776393,1.0,13/47,19.38%,ATP5F1D;TIMM22;ATP5F1B;ATP5ME;NDUFA13;GHITM;ATP5MF;DMAC2L;UQCC3;TOMM70;CHCHD6;ATP5MG;TIMM10B
prerank,vitamin transport (GO:0051180),0.2104133936466041,0.6540482028274133,0.9527720739219713,0.9970965837452551,1.0,3/29,7.80%,ABCG2;SLC52A2;SLC52A3
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.23997803665182932,0.6539244513806853,0.9375,0.996432319355676,1.0,3/18,12.21%,DNAAF2;SPEF2;AQP4
prerank,intracellular pH reduction (GO:0051452),-0.21049981022042852,-0.6538710919683481,0.9382239382239382,0.9843507670638009,1.0,11/33,29.79%,ATP6V1B2;ATP6V0D1;ATP6V0A4;TCIRG1;ATP6V1G2;GPR89B;GPR89A;DMXL1;RAB7A;RAB39A;ATP6V0D2
prerank,polyamine metabolic process (GO:0006595),0.26398485044006376,0.6528663103875578,0.9040178571428571,0.996411765107199,1.0,5/13,21.31%,SMS;SMOX;SAT2;ODC1;HDAC6
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.18612554333001602,-0.65077449407449,0.9831578947368421,0.985944843142854,1.0,23/61,34.19%,PRKAG2;PANK2;PSMF1;SIRT5;PSMB2;FGFR4;PSMC1;PSMB6;PSMA3;PSMA4;PPARA;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;NR1H4;CAV1;PSME4;PDK4;NQO1;PSMB8;PSMD10
prerank,protein targeting to membrane (GO:0006612),0.1794955321009831,0.6506171358367612,0.9915966386554622,0.9971077872203228,1.0,18/83,19.70%,GDAP1;AQP11;ARL6IP1;ZDHHC22;SGTB;GOLGA7;ZDHHC15;TAOK2;SRPRA;ZDHHC4;ZDHHC14;VPS37A;RTP4;ARL6;PEX3;SGTA;ZDHHC24;VPS37D
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.2286290721459373,0.6503954182198163,0.9259259259259259,0.9965068791163803,1.0,6/21,18.52%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.26029263030968075,-0.6486646962874897,0.914179104477612,0.9868639240275076,1.0,6/14,30.77%,FOXO3;EARS2;FASTKD1;MRPL12;POLRMT;TWNK
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.17689597683078015,0.6480493202870347,0.9959758551307847,0.996542278080335,1.0,12/78,16.04%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNLL2;DYNC1LI2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.17689597683078015,0.6480493202870347,0.9959758551307847,0.996542278080335,1.0,12/78,16.04%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNLL2;DYNC1LI2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.21774068324055929,-0.6470531940143475,0.9514563106796117,0.9874033033460153,1.0,14/27,36.57%,DDX5;PLA2R1;KMT5A;SPRED2;ATR;SNAI1;TWIST1;KDM1A;DYRK1A;HIC1;PSMD10;CD44;MSX1;SPRED1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2685499058380415,0.6468158138519805,0.9047619047619048,0.9965675819341379,1.0,12/12,73.17%,RMDN1;MAD1L1;MIS12;CHAMP1;CDT1;CENPC;KIF2C;NUF2;NDC80;SEH1L;CENPE;BOD1
prerank,protein homotetramerization (GO:0051289),0.19335935181615593,0.6449746128255324,0.9838383838383838,0.996995911210768,1.0,8/49,15.56%,HCN1;RYR3;TRPM2;HPRT1;AQP4;GOLGA2;B2M;GLS
prerank,positive regulation of cellular respiration (GO:1901857),-0.28021358470402113,-0.644523534297395,0.9087591240875912,0.9885933974458662,1.0,3/11,18.94%,NUPR1;VCP;PARK7
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.25547930065640007,-0.644091918259391,0.9129593810444874,0.9884328378163003,1.0,7/14,31.26%,PPP2CB;DUSP1;NCK1;PPP2CA;PPP2R2C;PPP1R15B;PPP2R2A
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.26419906490898937,-0.6438264143573499,0.9207547169811321,0.9881662848408035,1.0,1/12,2.20%,B3GALT1
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.2336174895922164,-0.6436564824557253,0.927063339731286,0.987828889430604,1.0,3/19,17.56%,MTHFR;MTHFD2L;ALDH1L1
prerank,regulation of cell aging (GO:0090342),-0.2778644556303976,-0.6436213402515979,0.9177570093457944,0.9874106721465353,1.0,6/11,27.16%,LMNA;NEK4;NEK6;NUAK1;RSL1D1;VASH1
prerank,cellular response to gamma radiation (GO:0071480),-0.24433587931033343,-0.6426507323633226,0.9317269076305221,0.9875911670936991,1.0,7/17,25.24%,YAP1;WRN;MAP3K20;XRCC6;ATR;HSF1;KDM1A
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.21519344387237652,-0.6426185948553295,0.959409594095941,0.9867354078806949,1.0,16/29,40.11%,HJURP;CENPP;NASP;ITGB3BP;CENPT;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,CENP-A containing chromatin organization (GO:0061641),-0.21519344387237652,-0.6426185948553295,0.959409594095941,0.9867354078806949,1.0,16/29,40.11%,HJURP;CENPP;NASP;ITGB3BP;CENPT;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,sphingoid metabolic process (GO:0046519),-0.2616326526763422,-0.6423392844530047,0.9202898550724637,0.9864719066282897,1.0,2/12,6.66%,PLPP3;ASAH2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.21203490161437513,0.6415586716661903,0.951063829787234,0.9983935235963799,1.0,6/29,15.73%,ELOVL7;TECR;SCD;HACD1;PPT1;ACSL3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.26556596793851345,0.641519674902598,0.8879310344827587,0.9976723089510777,1.0,5/12,20.61%,HSPA5;SGTB;SEC61G;SGTA;SEC61A2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.258086030905802,0.6413562682837087,0.9089026915113871,0.9970295497449481,1.0,1/12,6.50%,PRKCQ
prerank,ether lipid biosynthetic process (GO:0008611),-0.27535518691315114,-0.640253465192999,0.9163424124513618,0.9872291435351651,1.0,6/10,32.57%,GNPAT;PLA2G4A;PEX7;CHPT1;PLA2G4C;PEDS1
prerank,positive regulation of exocytosis (GO:0045921),-0.20364328128371548,-0.6402080062879241,0.9607843137254902,0.9868223527622546,1.0,11/35,25.62%,STXBP5;VPS4B;RAB2B;SDC4;SYTL4;SNF8;RAB3D;RAB9A;RAB7A;SDC1;RAB5A
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.25053186439603975,-0.6394669950403055,0.9263351749539595,0.9868176310995806,1.0,5/15,26.17%,NFKB1;AGTR1;IL18;MAPK9;LPL
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.19297306476430431,0.6390958412751196,0.9810526315789474,0.9976513407107999,1.0,5/48,8.56%,PPARG;GAS6;ISG15;SLIT3;GPS2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.2183505623643734,-0.6390332272370789,0.9430255402750491,0.9866338099945404,1.0,7/26,20.91%,UBE2N;ALPK1;IRAK2;TRAF6;IRAK1;MAP2K6;AAMP
prerank,centromere complex assembly (GO:0034508),-0.20387787590351983,-0.6383369773211178,0.978021978021978,0.9866149174823197,1.0,19/36,40.11%,HJURP;CENPP;NASP;ITGB3BP;CENPT;POGZ;MIS18BP1;KNL1;CENPE;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPF;CENPA;CENPQ
prerank,postreplication repair (GO:0006301),0.19098303262030067,0.6373534067538427,0.9751131221719457,0.9979777648078483,1.0,12/45,19.15%,ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2;POLI
prerank,positive regulation of mRNA processing (GO:0050685),-0.22752471871599594,-0.6371215802813346,0.9404332129963899,0.9868979783816557,1.0,9/21,32.44%,DHX36;DAZAP1;CDC73;NUP98;NCBP2;SNW1;THRAP3;SF3B4;RBMX
prerank,chromatin disassembly (GO:0031498),0.24588986322428302,0.63687340803554,0.9314775160599572,0.9967721712916728,1.0,3/14,14.93%,SMARCB1;SET;SMARCD1
prerank,nucleosome disassembly (GO:0006337),0.24588986322428302,0.63687340803554,0.9314775160599572,0.9967721712916728,1.0,3/14,14.93%,SMARCB1;SET;SMARCD1
prerank,positive regulation of phagocytosis (GO:0050766),-0.19330530379173472,-0.6361328830452749,0.9864864864864865,0.9870457159942272,1.0,4/47,7.33%,APPL2;CAMK1D;IL15RA;MERTK
prerank,mitochondrial fusion (GO:0008053),0.2346100086828285,0.6353382781491111,0.9364035087719298,0.9968929255941421,1.0,4/18,15.78%,GDAP1;MIEF1;USP30;MFN1
prerank,positive regulation of leukocyte migration (GO:0002687),-0.2152863956505643,-0.6349058713779591,0.9484732824427481,0.9872903633966472,1.0,4/27,17.48%,PTN;IL6R;VEGFA;MIA3
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.25020789551669315,-0.6335020904627793,0.9200779727095516,0.9876117598890168,1.0,3/14,12.44%,PKD1;PKD2;SUFU
prerank,leukotriene biosynthetic process (GO:0019370),0.24369623522626294,0.6331103802474065,0.9313304721030042,0.9974255562893638,1.0,4/14,19.26%,GGT7;GGT1;LTA4H;MGST3
prerank,regulation of aerobic respiration (GO:1903715),0.248649838328099,0.633064599682141,0.9294871794871795,0.9967151499383564,1.0,1/15,3.24%,COX7A1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2056922831315503,0.6326387051827495,0.9670781893004116,0.9962126810751002,1.0,5/29,17.41%,LPCAT2;TMEM86B;PLA2G12A;DBI;PLA2G4E
prerank,positive regulation of viral genome replication (GO:0045070),-0.21118922313154218,-0.6326188852775083,0.9573643410852714,0.9876688813418609,1.0,10/29,33.13%,LARP1;DDX3X;PPIH;TOP2B;PPID;PPARA;PDE12;ADARB1;NR5A2;DDB1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.18413441294630123,-0.6322160073691449,0.9880952380952381,0.9874520708919747,1.0,18/54,29.21%,CFLAR;TAX1BP1;PRKN;UBE2K;HIPK1;PTPN2;TRAF2;CCDC3;CARD16;SHARPIN;SPHK1;SYK;CLIP3;SPPL2A;TRADD;TNFAIP3;NLRP2B;BIRC3
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.1696801461314547,0.6309532830769359,0.9915611814345991,0.9963888155841036,1.0,11/82,12.45%,PRKAR2B;KCNH5;PPP2R1A;DYNLL1;CCP110;HAUS2;TUBB4A;YWHAG;CEP43;TUBA4A;DCTN1
prerank,DNA replication initiation (GO:0006270),-0.19655740955378403,-0.630789885413864,0.9780876494023905,0.9877850787152024,1.0,20/37,39.60%,MCM6;PRIM2;CDK2;POLE4;POLA2;DBF4;POLE2;ORC1;MCM4;CDC34;RPA2;CDC45;POLA1;POLE;MCM2;MCM7;PRIM1;POLE3;MCM5;MCM10
prerank,establishment of spindle localization (GO:0051293),-0.25163694413239146,-0.6307175249370289,0.9288389513108615,0.9873873853001364,1.0,3/14,16.14%,MAP4;ZBED3;DYNC1H1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.24719368229457625,-0.6303863997924352,0.9354207436399217,0.9871262763080382,1.0,8/14,49.49%,WNK1;WNT5A;ADAM10;CCR2;ADAM17;CCL5;CCL4;CCL7
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.2527010630775318,-0.6297231944002711,0.9236641221374046,0.986999467929136,1.0,1/13,2.20%,B3GALT1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.17313658206447066,0.6295719044208649,0.9920159680638723,0.9964174630312346,1.0,7/66,13.89%,CD33;GIT1;HSPB1;F2R;P2RX7;CPTP;CD36
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.22590003207193346,0.6277708272543226,0.9567099567099567,0.9966449406834458,1.0,3/20,11.23%,IPO5;MEN1;APC
prerank,organophosphate biosynthetic process (GO:0090407),0.19852644661880156,0.627633517464905,0.9671457905544147,0.9959871134261905,1.0,13/37,22.40%,MBOAT1;GPAM;FADS1;GK;PIP5K1A;IPMK;TKT;IP6K1;PCYT2;PPIP5K1;IPPK;GPHN;PNPO
prerank,protein import into peroxisome matrix (GO:0016558),-0.26150076204649464,-0.6254319765624404,0.9387755102040817,0.9888130425100511,1.0,8/12,44.81%,PEX6;PEX7;PEX26;PEX10;PEX16;PEX12;PEX1;PEX14
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.1724894302467153,-0.6250696486214097,0.9979550102249489,0.9885847444719617,1.0,24/65,34.19%,FBXL7;FHL1;USP47;PSMF1;NABP2;PSMB2;CUL1;PSMC1;CDK5RAP3;PSMB6;PSMA3;PSMA4;AVEN;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;RBX1;PINX1;ZFYVE19;PSME4;PSMB8;PSMD10
prerank,regulation of protein metabolic process (GO:0051246),-0.1905806611557426,-0.6247487054086289,0.9821428571428571,0.98833721995539,1.0,11/44,23.47%,ROCK2;LDLR;SPOPL;APOE;CENATAC;TRAF3;ABCA7;SNF8;WFS1;PARL;MAPK7
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.21653693979770727,-0.6243375351844833,0.9569471624266145,0.9881030344175991,1.0,11/25,32.20%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.17012226152218995,0.624325504750761,0.998,0.9970210862361117,1.0,12/79,16.04%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNLL2;DYNC1LI2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.25757289956163454,-0.6242805598959715,0.9390962671905697,0.9876954095632328,1.0,2/13,8.13%,CYFIP2;ASPH
prerank,icosanoid biosynthetic process (GO:0046456),0.2599460707277496,0.6238753734847592,0.9209401709401709,0.9964979792886965,1.0,3/10,19.26%,FADS1;LTA4H;MGST3
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.26083428382837914,-0.6229019184973655,0.9194991055456172,0.9879803221481814,1.0,9/12,51.67%,NEK6;PRKCA;LPIN1;PLK1;CDK1;VRK1;NEK9;CCNB1;PRKCB
prerank,endosome organization (GO:0007032),-0.19291688168176266,-0.6228903435752985,0.9872958257713249,0.9875516197284073,1.0,11/41,25.64%,EEA1;RAB22A;SNX10;USP50;TMCC1;PLEKHF1;ALS2;PI4K2B;WASHC4;ARFGEF2;PHETA1
prerank,vasoconstriction (GO:0042310),0.26618138175826866,0.6228624577605355,0.9118942731277533,0.9962632165525698,1.0,3/11,17.97%,SLC8A1;EDN1;EDNRB
prerank,negative regulation of centrosome duplication (GO:0010826),-0.26403472267567396,-0.6220725650622303,0.9398058252427185,0.987528281927623,1.0,1/11,2.52%,KAT2B
prerank,mRNA methylation (GO:0080009),-0.23980132673467597,-0.6185433816045346,0.9356617647058824,0.9888691684215756,1.0,5/15,30.77%,WTAP;NSUN2;ZC3H13;TRMT61B;TRMT10C
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.20739198340713322,0.6150721766464621,0.9679358717434869,0.9994360443163667,1.0,11/28,24.18%,RPS27A;UBC;UBB;NOD1;TAB2;OTULIN;NOD2;CASP8;ITCH;UBE2V1;CYLD
prerank,cellular response to estrogen stimulus (GO:0071391),-0.2466980637136224,-0.6148198112606601,0.9427480916030534,0.9901806104886386,1.0,2/14,7.97%,BCAS3;AR
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.22153034703732144,-0.6148039090413976,0.9680451127819549,0.989753264633374,1.0,3/18,21.30%,ABL1;PRKDC;XRCC6
prerank,ncRNA catabolic process (GO:0034661),0.2004723188337757,0.6135738554038049,0.9609544468546638,0.9993980483312945,1.0,2/28,4.72%,EXOSC5;LIN28B
prerank,DNA strand elongation (GO:0022616),0.22625374659331604,0.6132792033039344,0.9383983572895277,0.9987873769890143,1.0,4/18,15.38%,GINS2;MCM3;RFC4;POLD3
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.26347468436036164,-0.6126014602964045,0.9321100917431193,0.9903236496788996,1.0,1/10,2.99%,PRKN
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.2539265397912127,0.6124804776072436,0.9023354564755839,0.9984151958396452,1.0,2/11,11.52%,ING4;HIPK2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.21835979166519964,-0.6113143463831674,0.9524680073126143,0.9904920486195581,1.0,4/21,14.98%,VPS4B;RAD51B;RAB11A;CDC25B
prerank,double-strand break repair via break-induced replication (GO:0000727),0.25345656119289744,0.6112553072481816,0.9288702928870293,0.9982382339314534,1.0,2/12,11.96%,GINS2;MCM3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.24690305923266892,0.6107732079794492,0.9336188436830836,0.997737694883568,1.0,1/12,3.76%,PPARG
prerank,positive regulation of cilium assembly (GO:0045724),0.22645153446934685,0.6100792291973305,0.9621052631578947,0.9973301792207713,1.0,6/18,20.37%,CCP110;HAP1;CCDC88A;ENTR1;FUZ;CROCC
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.19897888561325366,-0.6099546792477173,0.9675572519083969,0.9906587322903813,1.0,14/31,42.81%,RC3H1;LYN;SDC4;DLG5;CD300A;CD80;SOX11;CEBPB;FCGR2B;CD274;LST1;CD86;LILRB1;IL4I1
prerank,negative regulation of receptor binding (GO:1900121),-0.2619451445417149,-0.6064991536002652,0.9332129963898917,0.9917424458132258,1.0,3/10,30.08%,ATP2A2;ATP2A3;PTPRF
prerank,positive regulation of immune response (GO:0050778),-0.16909178745222073,-0.6064921967008571,0.9940711462450593,0.9913106530443,1.0,9/64,20.00%,IL6ST;PLSCR1;DHX9;STX4;RIOK3;EIF2AK4;CYBA;IFI35;KARS1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.19263096151741363,0.6042928274978323,0.9761431411530815,0.9991130203746696,1.0,8/31,23.25%,SRD5A2;SCP2;GCH1;NOXRED1;LIAS;SRD5A1;GPHN;LSS
prerank,I-kappaB phosphorylation (GO:0007252),0.26301905016668536,0.6022788955599356,0.927437641723356,0.9992591930208284,1.0,2/10,9.89%,TLR2;DAB2IP
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.21030897220783035,0.6022050741789312,0.982532751091703,0.9985607993518842,1.0,1/23,1.05%,DNASE1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.22141180323116574,0.601348257421982,0.9580712788259959,0.9981486951142715,1.0,4/18,15.73%,ELOVL7;TECR;HACD1;ACSL3
prerank,regulation of catabolic process (GO:0009894),-0.22431068056431758,-0.5990682012227363,0.9634369287020109,0.9940761061518659,1.0,4/18,20.14%,ITGB1;FAP;CENATAC;SNF8
prerank,ncRNA export from nucleus (GO:0097064),-0.18867101774072803,-0.5983886237207793,0.9813084112149533,0.9939185658793381,1.0,16/36,37.29%,RANBP2;NUP42;PHAX;NUP214;TPR;NUP98;NUP43;NUP160;NCBP2;NUP93;RAN;NUP133;SEC13;NUP88;NPM1;SEH1L
prerank,regulation of interleukin-10 production (GO:0032653),-0.18098053607739645,-0.5966476229798494,0.9900990099009901,0.9941386540194188,1.0,6/44,17.43%,PIBF1;HMGB1;STAT3;TRIB2;PRKCZ;TLR4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.23310340461029336,-0.5956152534017478,0.9521988527724665,0.9940953599267988,1.0,8/14,41.88%,ECE1;AGTR1;EDN3;ACE2;CORIN;ENPEP;ACE;RASL10B
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.2603810952715416,-0.5953179275998872,0.935969868173258,0.9937832986045884,1.0,2/10,15.32%,ACTN2;CARMIL1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.21837663154138348,-0.5952647567074404,0.9712643678160919,0.9933746574224473,1.0,3/18,14.09%,NCSTN;ADAM19;APOE
prerank,regulation of ERAD pathway (GO:1904292),-0.25356351262983645,-0.5951440151242314,0.947565543071161,0.9929949998124787,1.0,6/11,31.31%,RNFT1;TMEM259;USP13;BAG6;USP19;HERPUD1
prerank,protein deacylation (GO:0035601),0.20800800754130247,0.5946992026446529,0.9790356394129979,1.0,1.0,9/23,22.16%,SIRT1;LYPLA1;SIN3A;PPT1;HDAC7;ABHD17C;NOTUM;HDAC6;SIRT7
prerank,lymphocyte chemotaxis (GO:0048247),-0.18879382658885352,-0.5942623565491076,0.98828125,0.9929117003870921,1.0,3/34,10.08%,CYP7B1;CXCL16;SLC12A2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.24550150549267352,-0.5940284850488191,0.946983546617916,0.9925653380027496,1.0,3/12,17.46%,BTRC;CDC14B;UBE2S
prerank,tRNA metabolic process (GO:0006399),-0.22222601294683886,-0.5910037629529447,0.9564393939393939,0.9933108663964629,1.0,1/17,1.83%,FARS2
prerank,cellular response to ionizing radiation (GO:0071479),0.17745722426175436,0.5907755054892594,0.9920948616600791,1.0,1.0,10/47,16.89%,TMEM109;SIRT1;EEF1D;NET1;HRAS;KDM4D;ATM;CDKN1A;XRCC5;MDM2
prerank,dendritic cell chemotaxis (GO:0002407),-0.23575294079085357,-0.5896832359144399,0.9469548133595285,0.9933652262616318,1.0,7/14,38.77%,HMGB1;TRPM4;GPR183;CCR5;CCR2;CXCR4;PIK3CG
prerank,amino sugar metabolic process (GO:0006040),0.25364597043425774,0.5872111245385867,0.9577167019027484,1.0,1.0,1/10,5.63%,CSGALNACT1
prerank,sphingoid biosynthetic process (GO:0046520),-0.25112657528166704,-0.5868536783958163,0.947565543071161,0.9935319459302845,1.0,5/11,30.40%,ASAH2;ACER3;SPHK1;SPHK2;ASAH1
prerank,sphingosine biosynthetic process (GO:0046512),-0.25112657528166704,-0.5868536783958163,0.947565543071161,0.9935319459302845,1.0,5/11,30.40%,ASAH2;ACER3;SPHK1;SPHK2;ASAH1
prerank,purine ribonucleotide transport (GO:0015868),-0.22468170325892273,-0.5852218014825823,0.9544626593806922,0.9937028908136808,1.0,7/16,34.59%,LRRC8D;ABCC5;SLC25A17;SLC25A24;SLC35B2;SLC17A9;SLC19A1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2503138337936228,0.5846272372035148,0.9492600422832981,1.0,1.0,10/10,74.98%,ATP5F1D;ATP5MG;ATP5MC3;ATP5PD;ATP5PO;VPS9D1;ATP5F1C;ATP5F1A;ATP5MC2;ATP5MC1
prerank,RNA catabolic process (GO:0006401),-0.1765761157818475,-0.5834397503712759,0.996031746031746,0.9938747242662569,1.0,15/46,34.07%,DIS3L2;HNRNPD;XRN2;ERN1;MTREX;CNOT10;SIDT2;PABPC4;LSM6;ZFP36L2;SUPV3L1;NUDT16;NUDT16L1;HSPA1A;RNASEH2C
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.23189987545440516,-0.5834198862252197,0.9504761904761905,0.9934481197840106,1.0,6/14,37.94%,NUDT5;ENTPD6;NUDT1;NUDT16;NUDT18;ADPRM
prerank,determination of left/right symmetry (GO:0007368),-0.18292654617396026,-0.5819180634539775,0.9844961240310077,0.9935027963875673,1.0,7/36,20.94%,SMO;PKD2;CCDC39;CITED2;MEGF8;GALNT11;ZIC3
prerank,pseudouridine synthesis (GO:0001522),-0.23307802705667507,-0.5808513499563157,0.9543795620437956,0.993421192281734,1.0,7/13,41.11%,PUS10;PUS3;GAR1;PUS1;PUS7L;PUSL1;RPUSD2
prerank,regulation of sensory perception of pain (GO:0051930),-0.2497690259883377,-0.5799211613509225,0.9516728624535316,0.9932961662362997,1.0,4/11,21.85%,CCN3;MGLL;ZFHX2;TMEM100
prerank,aromatic amino acid family metabolic process (GO:0009072),0.24860281025513653,0.5796490605177824,0.9536290322580645,1.0,1.0,3/10,22.88%,ASRGL1;KYAT1;KYNU
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.19174470022055978,0.5794422546603083,0.9891067538126361,1.0,1.0,3/31,7.25%,CHCHD4;TIMM21;DNAJC15
prerank,ribosomal subunit export from nucleus (GO:0000054),0.23322242450875763,0.5761700622450299,0.9529652351738241,1.0,1.0,13/13,76.70%,RPS15;NMD3;EIF6;NOP9;LSG1;LTV1;ABCE1;NPM1;NUP88;RAN;RRS1;XPO1;SDAD1
prerank,regulation of vacuole organization (GO:0044088),-0.21210028872515552,-0.5755893399603899,0.9772296015180265,0.9942912205977934,1.0,8/20,32.00%,ANXA2;IFT88;MTMR3;NPRL3;RAB5A;ENO3;ENO1;NPRL2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.15918333712808344,-0.5755248196290336,0.9980988593155894,0.9938819154532013,1.0,20/72,28.75%,MDM4;EP300;NBN;TFDP2;SP100;CNOT8;CASP2;CNOT2;CNOT1;CNOT10;PML;PCNA;TFAP4;CNOT4;PAXIP1;TNKS1BP1;CRADD;PCBP4;ATRX;E2F1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.21774220237042446,-0.5752513594013932,0.9732824427480916,0.9935438078789476,1.0,8/17,46.56%,PLA2G4A;MBOAT7;PLA2G4C;LCLAT1;PLAAT3;PLA2G4F;PLA2G5;PLBD1
prerank,cilium movement (GO:0003341),-0.17284050049541216,-0.573337118387483,0.9942307692307693,0.9937352722679013,1.0,31/47,48.31%,ODAD1;CFAP251;CCDC39;SPEF1;DNAAF5;DNAH11;GAS8;RSPH9;CFAP61;DNAI4;DNHD1;CFAP70;CABYR;CFAP53;ROPN1L;ODAD2;ADCY10;CFAP54;SPAG17;ODAD3;SPA17;ODAD4;TEKT2;DNAH17;CFAP206;CCDC40;DNAAF4;CCDC63;TTC29;CFAP91;TEKT5
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.22055187241094315,0.5706294054881923,0.9414225941422594,1.0,1.0,2/15,12.04%,TGFB2;SMAD7
prerank,histone H2A acetylation (GO:0043968),0.2186007227373578,0.5699693371283173,0.964509394572025,1.0,1.0,2/16,6.80%,RUVBL1;YEATS4
prerank,pigment granule transport (GO:0051904),-0.20802051333614502,-0.5698695440378393,0.9733333333333334,0.9938847952445956,1.0,5/18,28.24%,RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,melanosome transport (GO:0032402),-0.20802051333614502,-0.5698695440378393,0.9733333333333334,0.9938847952445956,1.0,5/18,28.24%,RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.2359010243235892,-0.5684127701550049,0.9628865979381444,0.9938828035719104,1.0,1/12,3.12%,LRRK2
prerank,phasic smooth muscle contraction (GO:0014821),0.24974893296510153,0.567431202781025,0.9631236442516269,1.0,1.0,10/10,75.04%,EDN1;EDNRB;PTGER3;EDN2;DRD2;HTR1D;TIFAB;HTR2B;GDNF;EDN3
prerank,cellular response to superoxide (GO:0071451),-0.24763157949793568,-0.567050728748378,0.9738805970149254,0.9938503708784245,1.0,6/10,33.56%,SOD3;SOD2;PRDX2;CCS;MT3;ATP7A
prerank,negative regulation of potassium ion transport (GO:0043267),0.2326993859520935,0.566671106093458,0.960167714884696,1.0,1.0,2/13,13.04%,BIN1;STK39
prerank,nuclear envelope organization (GO:0006998),-0.20675597452067307,-0.565570739409682,0.9808795411089866,0.9938525218689502,1.0,6/20,26.40%,DMPK;EMD;TOR1A;NEMP1;SUN2;NUP93
prerank,regulation of cellular respiration (GO:0043457),-0.21732438186188752,-0.5649730176991162,0.9691119691119691,0.9935932960802243,1.0,10/17,44.42%,CBFA2T3;NOP53;VCP;NOA1;IDE;PRDM16;SHMT2;TRAP1;IFNLR1;NOS2
prerank,diol biosynthetic process (GO:0034312),-0.21746443507261143,-0.5612349441850771,0.9624765478424016,0.9941969225395751,1.0,2/15,8.43%,ASAH2;ACER3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.23431009362270935,0.5576597954759243,0.9408033826638478,1.0,1.0,3/11,14.31%,CALM1;CALM2;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.23431009362270935,0.5576597954759243,0.9408033826638478,1.0,1.0,3/11,14.31%,CALM1;CALM2;CALM3
prerank,adenine nucleotide transport (GO:0051503),-0.21031668223446429,-0.5574749658763948,0.9723756906077348,0.9947768483757118,1.0,7/17,34.59%,LRRC8D;ABCC5;SLC25A17;SLC25A24;SLC35B2;SLC17A9;SLC19A1
prerank,determination of bilateral symmetry (GO:0009855),0.19283906450079183,0.5571342291519547,0.9825708061002179,1.0,1.0,7/24,23.19%,NOTCH1;FOXJ1;DLL1;ARL6;DNAH5;NPHP3;TBX1
prerank,chromatin remodeling at centromere (GO:0031055),-0.18413813968864684,-0.556112493956193,0.9907578558225508,0.9947106333548142,1.0,16/31,40.11%,HJURP;CENPP;NASP;ITGB3BP;CENPT;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.18696149677675583,0.5556915360345961,0.9916492693110647,1.0,1.0,11/28,25.74%,GABARAP;DAB2IP;DELE1;TNFRSF1A;SORT1;DDX47;CASP8;TNFRSF10B;BAX;CASP8AP2;BID
prerank,meiosis I (GO:0007127),0.19609021243301594,0.5549947193984494,0.9778270509977827,1.0,1.0,22/23,69.13%,ZCWPW1;ING2;FOXJ3;PTTG1;FOXJ2;BTBD18;MEIOC;MEI1;DNMT3L;CCNA1;MEIKIN;MOV10L1;BRDT;SLC25A31;MEIOB;DDX4;TDRD9;SGO1;SYCP3;ZSCAN21;HSF2BP;BCL2L11
prerank,positive regulation of type 2 immune response (GO:0002830),-0.22055310935268468,-0.5540973725953585,0.9668615984405458,0.9947870313483108,1.0,7/14,45.33%,PRKCZ;IL18;CD81;DENND1B;CD86;RARA;NLRP3
prerank,lipoprotein catabolic process (GO:0042159),-0.24171888671467592,-0.5525495579593732,0.9634369287020109,0.9947368161047432,1.0,4/11,24.56%,ABHD17B;APOE;ABHD10;LYPLA2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.2238881260263085,-0.551717932022061,0.9620493358633776,0.9945143878709546,1.0,1/13,6.09%,ADGRV1
prerank,glycine metabolic process (GO:0006544),0.22994350282485862,0.5516126996548185,0.9638297872340426,1.0,1.0,12/12,77.02%,RIDA;GCSH;SDSL;SDS;BAAT;GLYAT;SHMT1;GLDC;DLD;GCAT;SHMT2;AMT
prerank,negative regulation of chemokine production (GO:0032682),-0.22209036358296969,-0.5504512341013793,0.9785575048732943,0.9944201315489262,1.0,4/14,28.27%,APOD;C1QTNF3;SIRPA;MUL1
prerank,protein localization to vacuole (GO:0072665),0.22619122355452315,0.5503768999419456,0.9661016949152542,1.0,1.0,13/13,77.40%,GLMP;RTN4;LMBRD1;SH3BP4;MFSD1;SH3GLB1;ATP13A2;RNF128;LAMTOR5;LAMTOR4;CD81;KPTN;SZT2
prerank,extracellular transport (GO:0006858),-0.228069850661655,-0.5483148760465314,0.9641509433962264,0.9945181007348446,1.0,1/12,3.63%,WWP2
prerank,negative regulation of cyclase activity (GO:0031280),-0.21843846381207666,-0.5481530569635474,0.9580952380952381,0.9941260746991329,1.0,1/14,6.09%,ADGRV1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.18357227128472975,0.5477594760673945,0.9901768172888016,1.0,1.0,10/31,22.02%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;PPP1R13B;BBC3;CASP8;YWHAQ;PPP3CC
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.1688434614963684,0.5449465543874485,0.9934640522875817,1.0,1.0,9/38,20.15%,IPO4;RUVBL1;H3-3A;HIRA;CENPL;SMARCA5;RBBP4;ASF1A;CENPO
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.21591062741250683,-0.5426286772484892,0.9757009345794393,0.994969415419641,1.0,2/14,10.37%,ENPP1;ENPP3
prerank,sympathetic nervous system development (GO:0048485),-0.20953670295836818,-0.5426027715378445,0.9830508474576272,0.9945487995124723,1.0,5/15,35.32%,NRP1;SOX11;NRP2;GDNF;SEMA3F
prerank,macrophage migration (GO:1905517),0.2175101641665001,0.541775632376856,0.9759036144578314,1.0,1.0,3/13,18.29%,CCL2;EDNRB;CKLF
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.20040488993627836,-0.5400578255483856,0.979047619047619,0.9946516734161204,1.0,4/19,19.89%,CYBA;ACOX1;PARK7;PRDX2
prerank,mRNA modification (GO:0016556),-0.19370735031073338,-0.5383929551853692,0.9980952380952381,0.994587847629052,1.0,11/22,43.89%,WTAP;NSUN2;PUS3;ZC3H13;TRMT61B;TRMT10C;PUS1;CBLL1;RPUSD2;TRMT61A;VIRMA
prerank,eye photoreceptor cell development (GO:0042462),0.20219731375163796,0.5350068461053719,0.98559670781893,1.0,1.0,2/15,13.34%,THY1;RORB
prerank,nuclear membrane disassembly (GO:0051081),-0.21525720571365675,-0.5342129134611648,0.9886363636363636,0.9950252327119369,1.0,3/14,22.04%,AKAP8L;NEK6;PRKCA
prerank,snRNA metabolic process (GO:0016073),-0.20127210220152048,-0.5280462647079202,0.9865125240847784,0.995746005784691,1.0,3/17,18.54%,INTS4;MTREX;INTS6
prerank,chromatin assembly (GO:0031497),0.16525623020904914,0.5278744135116272,0.9978768577494692,1.0,1.0,9/38,21.35%,SIRT1;HMGA2;H3-3A;NAA60;SMARCA5;RBBP4;CTCF;ASF1A;NOC2L
prerank,outer dynein arm assembly (GO:0036158),-0.21069879756393645,-0.5223498233407775,0.9907235621521335,0.9963693936766956,1.0,10/14,47.12%,DNAL1;ODAD1;DNAH8;DNAAF5;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63
prerank,regulation of integrin activation (GO:0033623),-0.20474592710007,-0.5186902540650037,0.9785992217898832,0.9965664541232129,1.0,4/15,27.71%,RAP1B;FARP2;FBLIM1;FERMT2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.15638391246557928,-0.5181632765580692,0.99812382739212,0.9962257066528112,1.0,15/45,37.53%,STAT3;GSDMD;USP50;TLR4;WNT5A;TMEM106A;LPL;APP;EGR1;PYCARD;MYD88;RIPK2;CASP1;FZD5;AGER
prerank,receptor recycling (GO:0001881),-0.23242115834754268,-0.5159495691104243,0.9830188679245283,0.9961409166815479,1.0,3/10,25.64%,EHD3;ARFGEF2;PHETA1
prerank,positive regulation of bone resorption (GO:0045780),-0.21638194887885706,-0.5145828544887839,0.9849624060150376,0.9959227994558185,1.0,3/11,24.64%,SPP1;PRKCA;SYK
prerank,inositol phosphate biosynthetic process (GO:0032958),0.21188780684970365,0.5091377428034704,0.9864559819413092,1.0,1.0,4/11,19.57%,IPMK;IP6K1;PPIP5K1;IPPK
prerank,L-serine metabolic process (GO:0006563),0.21228035002228318,0.5068939905638075,0.9828693790149893,1.0,1.0,3/10,20.31%,PHGDH;SERINC3;SRR
prerank,dendritic cell migration (GO:0036336),-0.1926396452594914,-0.5061565289797684,0.9824902723735408,0.9967348273439309,1.0,2/16,12.95%,HMGB1;TRPM4
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.16802003378480135,0.5042271128369645,0.9902152641878669,1.0,1.0,3/29,14.94%,MEI4;ZCWPW1;SYCP2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.19458977200084732,0.503363410180637,0.9866071428571429,1.0,1.0,5/16,21.57%,CELF4;CIRBP;PRDX6;RBMXL1;RBM3
prerank,tRNA transport (GO:0051031),-0.15709256946576244,-0.5010671705189708,1.0,0.9969701202198841,1.0,5/35,13.28%,RANBP2;NUP42;NUP214;TPR;YBX1
prerank,negative regulation of lyase activity (GO:0051350),-0.19316085413510736,-0.5005930976302779,0.9811676082862524,0.9966181890754867,1.0,1/16,6.09%,ADGRV1
prerank,protein neddylation (GO:0045116),-0.20297439315180105,-0.4976257881436575,0.9848197343453511,0.9965844361566825,1.0,5/13,33.49%,DCUN1D3;NAE1;DCUN1D5;RBX1;DCUN1D4
prerank,toxin transport (GO:1901998),-0.2125708643337118,-0.4962457679198074,0.9798792756539235,0.9963176341312215,1.0,4/10,32.86%,ANTXR2;ANTXR1;SLC22A2;ADAM10
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.2124498178432824,0.4950276896479359,0.979296066252588,1.0,1.0,2/10,13.89%,AKT1;CD36
prerank,tRNA export from nucleus (GO:0006409),0.1598726834673119,0.4916261296208846,0.9977777777777778,1.0,1.0,9/32,22.06%,NUP210;NOL6;NUP62;NUP205;NUP54;NUP85;XPOT;RAE1;NUP107
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.1598726834673119,0.4916261296208846,0.9977777777777778,1.0,1.0,9/32,22.06%,NUP210;NOL6;NUP62;NUP205;NUP54;NUP85;XPOT;RAE1;NUP107
prerank,cellular response to radiation (GO:0071478),0.1506784203444107,0.4895431736219652,1.0,1.0,1.0,5/40,14.52%,SIRT1;EEF1D;NET1;KDM4D;CDKN1A
prerank,negative regulation of cell division (GO:0051782),0.20809297136810845,0.4887229446029722,0.9897750511247444,1.0,1.0,5/11,25.92%,E2F7;ORC6;VPS4A;SUSD2;CHMP4C
prerank,pinocytosis (GO:0006907),-0.215967410362492,-0.4885496394830055,0.9726027397260274,0.9967683480166637,1.0,8/10,47.50%,CARMIL1;PYCARD;RAB34;MAPKAPK3;DOCK2;AHSG;SNX33;SNX5
prerank,negative regulation of bone remodeling (GO:0046851),0.20639364409520516,0.4868835971260006,0.9765957446808511,1.0,1.0,2/11,11.50%,UBASH3B;P2RX7
prerank,regulation of B cell activation (GO:0050864),0.16563972999824655,0.4859029322103648,0.9920634920634921,1.0,1.0,24/25,71.71%,FOXJ1;SH3KBP1;NOD2;ZFP36L1;LAPTM5;AHR;SAMSN1;TLR9;IGLL1;TNFSF4;MZB1;IL10;CD19;SLAMF8;IL6;CD22;IL4;THEMIS2;IKZF3;IL4I1;BANK1;FCGR2B;ZFP36L2;TNFAIP3
prerank,heterocycle biosynthetic process (GO:0018130),-0.19300396148557827,-0.4830313413652636,0.994413407821229,0.9969134372592837,1.0,8/14,43.92%,MOCS1;NFS1;PYCR2;MOCS3;PYCR3;MOCS2;PYCR1;ALOX5
prerank,inner dynein arm assembly (GO:0036159),0.20737300397802527,0.48195334029593023,0.9873949579831933,1.0,1.0,1/10,8.92%,CFAP100
prerank,snRNA processing (GO:0016180),0.18472202456074377,0.4802430824560791,0.9957716701902748,1.0,1.0,5/16,20.60%,INTS2;INTS11;INTS10;TOE1;INTS5
prerank,negative regulation of interleukin-10 production (GO:0032693),0.18258129084060637,0.4761017186633339,0.9891540130151844,1.0,1.0,2/16,13.72%,TNFRSF21;DLL1
prerank,ncRNA 3'-end processing (GO:0043628),0.18539678553490693,0.4732661408417304,0.9934924078091106,0.9998881059282732,1.0,14/14,81.48%,INTS2;ERI1;TOE1;INTS5;INTS8;INTS12;PTCD1;SSB;INTS6L;INTS7;ELAC2;TRNT1;INTS14;INTS6
prerank,negative regulation of T cell proliferation (GO:0042130),-0.15517928379051651,-0.4676514341888628,0.9961832061068703,0.9978942681946359,1.0,5/28,22.93%,RC3H1;SDC4;SCRIB;DLG5;CD80
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.1835760924158713,0.46660657697333274,0.9936974789915967,0.999768870268547,1.0,14/14,81.66%,ATP6AP1;POU4F2;IFNG;TYROBP;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;CSF1;TRAF6
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.18890630794999885,-0.45523428865021764,0.9906890130353817,0.9983651151346984,1.0,2/13,24.64%,PRKCD;SYK
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.18056793632528334,-0.4510132256224504,0.9961089494163424,0.9982116134744832,1.0,7/14,38.74%,NCSTN;ADAM19;ABCA7;DYRK1A;ADAM10;ABCG1;ADAM17
prerank,leukotriene metabolic process (GO:0006691),0.1612184497984287,0.45079574887909435,0.9957081545064378,1.0,1.0,4/19,19.26%,GGT1;MAPKAPK2;LTA4H;MGST3
prerank,nuclear pore organization (GO:0006999),0.17773866821547799,0.4483240097569534,0.9955849889624724,0.9996202598755791,1.0,3/14,15.35%,NUP205;RTN4;NUP54
prerank,male meiosis I (GO:0007141),0.1694085143790029,0.4400266761762193,0.9978308026030369,0.9993842707790427,1.0,16/16,83.08%,ING2;FOXJ3;FOXJ2;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;BRDT;SLC25A31;DDX4;TDRD9;SYCP3;ZSCAN21;HSF2BP;MYBL1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.15320854249368074,0.4389244888700947,0.9956427015250545,0.9987426241041033,1.0,7/23,23.69%,TIMM22;NDUFA13;HSP90AA1;TOMM70;TIMM10B;BAX;ROMO1
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.15055340995646588,-0.42168141268792136,0.9980582524271845,0.9991809689614477,1.0,3/22,16.04%,RUNX1;IRF1;DUSP10
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.1577967197955018,0.4214911304875867,1.0,0.9987695119844405,1.0,1/16,6.66%,HFM1
prerank,nuclear pore complex assembly (GO:0051292),-0.1832467237065611,-0.4176713856881482,0.9964028776978417,0.9988731764119618,1.0,4/10,34.39%,TPR;NUP98;NUP93;AHCTF1
